PREDICATE,SUBJECT_NAME,OBJECT_NAME,Factuality_Score,Cancer_Type,Category,text
AFFECTS,Estrogens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Estrogens Malignant neoplasm of breast
PREDISPOSES,FGFR2 gene|FGFR2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FGFR2 gene|FGFR2 Malignant neoplasm of breast
CAUSES,BRCA1 gene|BRCA1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BRCA1 gene|BRCA1 Malignant neoplasm of breast
PREDISPOSES,Hormones,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Hormones Malignant neoplasm of breast
AFFECTS,Mutation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Mutation Malignant neoplasm of breast
AFFECTS,MicroRNAs,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",MicroRNAs Malignant neoplasm of breast
PREDISPOSES,"oxoguanine glycosylase 1, human",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","oxoguanine glycosylase 1, human Malignant neoplasm of breast"
CAUSES,Malignant Neoplasms,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Malignant Neoplasms Malignant neoplasm of breast
AFFECTS,Topoisomerase,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Enzyme,Topoisomerase Breast Carcinoma
PREDISPOSES,Cadmium,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Inorganic Chemical,Cadmium Malignant neoplasm of breast
DISRUPTS,Medroxyprogesterone 17-Acetate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Medroxyprogesterone 17-Acetate Malignant neoplasm of breast
PREDISPOSES,C-reactive protein level,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",C-reactive protein level Malignant neoplasm of breast
AFFECTS,Cell Proliferation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Cell Proliferation Malignant neoplasm of breast
AFFECTS,Carcinoma of the Large Intestine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Carcinoma of the Large Intestine Malignant neoplasm of breast
AFFECTS,Phytoestrogens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Phytoestrogens Malignant neoplasm of breast
AUGMENTS,Estrogens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Estrogens Malignant neoplasm of breast
PREDISPOSES,Single Nucleotide Polymorphism,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Single Nucleotide Polymorphism Malignant neoplasm of breast
AUGMENTS,CD44 gene|CD44,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CD44 gene|CD44 Malignant neoplasm of breast
AFFECTS,Cell Cycle Progression,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Cell Cycle Progression Malignant neoplasm of breast
CAUSES,Hormones,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Hormones Malignant neoplasm of breast
AFFECTS,Vitamin D,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Vitamin D Malignant neoplasm of breast
PREDISPOSES,Estrogen Receptor Status,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptor Status Malignant neoplasm of breast
AFFECTS,Carcinogens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hazardous or Poisonous Substance,Carcinogens Malignant neoplasm of breast
PREDISPOSES,Hormone replacement therapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Hormone replacement therapy Malignant neoplasm of breast
CAUSES,Insulin-Like-Growth Factor I Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Insulin-Like-Growth Factor I Receptor Malignant neoplasm of breast
PREDISPOSES,Metabolic Diseases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Metabolic Diseases Malignant neoplasm of breast
CAUSES,"DNA, Mitochondrial",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","DNA, Mitochondrial Malignant neoplasm of breast"
AUGMENTS,MST1R gene|MST1R,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MST1R gene|MST1R Malignant neoplasm of breast
AFFECTS,Lactation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Lactation Malignant neoplasm of breast
PREDISPOSES,Estrogen Receptors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptors Malignant neoplasm of breast
CAUSES,Human Papillomavirus,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Virus,Human Papillomavirus Malignant neoplasm of breast
CAUSES,BCL9 gene|BCL9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BCL9 gene|BCL9 Malignant neoplasm of breast
CAUSES,Genes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Genes Malignant neoplasm of breast
PREDISPOSES,CHEK2 gene|CHEK2,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Gene or Genome,CHEK2 gene|CHEK2 Carcinoma of Male Breast
PREDISPOSES,Estrogens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Estrogens Malignant neoplasm of breast
AFFECTS,Monocyte Chemoattractant Protein-1|CCL2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Monocyte Chemoattractant Protein-1|CCL2 Malignant neoplasm of breast
PREDISPOSES,Complication,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Complication Malignant neoplasm of breast
PREDISPOSES,PTGS2 gene|PTGS2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PTGS2 gene|PTGS2 Malignant neoplasm of breast
AFFECTS,GLTSCR2 gene|NOP53,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Gene or Genome,"GLTSCR2 gene|NOP53 Carcinoma, Ductal, Breast"
PREDISPOSES,RNA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",RNA Malignant neoplasm of breast
AFFECTS,"Polymorphism, Genetic",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,"Polymorphism, Genetic Malignant neoplasm of breast"
AFFECTS,Malignant Neoplasms,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Malignant Neoplasms Malignant neoplasm of breast
CAUSES,Estrogens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Estrogens Malignant neoplasm of breast
CAUSES,ERBB2 gene|ERBB2,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Gene or Genome,ERBB2 gene|ERBB2 Breast cancer invasive NOS
CAUSES,TP53 gene|TP53,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TP53 gene|TP53 Malignant neoplasm of breast
AFFECTS,Endocrine therapy,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Hormone,Endocrine therapy Noninfiltrating Intraductal Carcinoma
PREDISPOSES,BRCA2 gene|BRCA2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BRCA2 gene|BRCA2 Malignant neoplasm of breast
AFFECTS,Base Excision Repair,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Base Excision Repair Malignant neoplasm of breast
CAUSES,Tumor Suppressor Genes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Tumor Suppressor Genes Malignant neoplasm of breast
AFFECTS,Angiogenesis Inhibitors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Angiogenesis Inhibitors Malignant neoplasm of breast
AFFECTS,ABCB1 gene|ABCB1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ABCB1 gene|ABCB1 Malignant neoplasm of breast
PREDISPOSES,Antisense RNA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Antisense RNA Malignant neoplasm of breast
AFFECTS,Progesterone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Progesterone Malignant neoplasm of breast
PREDISPOSES,Total cholesterol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Lipid,Total cholesterol Malignant neoplasm of breast
AFFECTS,CHEK2 gene|CHEK2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CHEK2 gene|CHEK2 Malignant neoplasm of breast
CAUSES,Estrogen Receptor alpha,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptor alpha Malignant neoplasm of breast
PREDISPOSES,Lesion,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Lesion Malignant neoplasm of breast
AFFECTS,Genes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Genes Malignant neoplasm of breast
DISRUPTS,Single Nucleotide Polymorphism,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Single Nucleotide Polymorphism Malignant neoplasm of breast
AUGMENTS,DNM1 gene|DNM1,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Gene or Genome,DNM1 gene|DNM1 Breast cancer invasive NOS
PREDISPOSES,BRCA1 gene|BRCA1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BRCA1 gene|BRCA1 Malignant neoplasm of breast
AFFECTS,Enzymes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Enzyme,Enzymes Malignant neoplasm of breast
PREDISPOSES,Vitamin D,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Vitamin D Malignant neoplasm of breast
CAUSES,ERBB2 gene|ERBB2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ERBB2 gene|ERBB2 Malignant neoplasm of breast
CAUSES,BRCA2 gene|BRCA2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BRCA2 gene|BRCA2 Malignant neoplasm of breast
AFFECTS,educational intervention,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",educational intervention Malignant neoplasm of breast
PREDISPOSES,Amino Acyl-tRNA Synthetases|TRNA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Amino Acyl-tRNA Synthetases|TRNA Malignant neoplasm of breast
PREDISPOSES,PGR gene|PGR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PGR gene|PGR Malignant neoplasm of breast
AFFECTS,TRANSCRIPTION FACTOR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",TRANSCRIPTION FACTOR Malignant neoplasm of breast
PREDISPOSES,Methionine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Methionine Malignant neoplasm of breast
AFFECTS,TLR3 gene|TLR3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TLR3 gene|TLR3 Malignant neoplasm of breast
PREDISPOSES,Vascular Endothelial Growth Factor Receptor-1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Vascular Endothelial Growth Factor Receptor-1 Malignant neoplasm of breast
AFFECTS,Tamoxifen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,Tamoxifen Malignant neoplasm of breast
AFFECTS,Thromboembolic event,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Phenomenon or Process,Thromboembolic event Malignant neoplasm of breast
AFFECTS,CXCR4 gene|CXCR4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CXCR4 gene|CXCR4 Malignant neoplasm of breast
DISRUPTS,"Alpha-MMC protein, Momordica charantia",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","Alpha-MMC protein, Momordica charantia Malignant neoplasm of breast"
CAUSES,Ovarian Serous Adenocarcinoma,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Ovarian Serous Adenocarcinoma Breast Carcinoma
CAUSES,EGFR gene|EGFR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,EGFR gene|EGFR Malignant neoplasm of breast
AUGMENTS,Aryl Hydrocarbon Receptor|AHR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Aryl Hydrocarbon Receptor|AHR Malignant neoplasm of breast
CAUSES,HRH4 gene|HRH4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HRH4 gene|HRH4 Malignant neoplasm of breast
PREDISPOSES,Medroxyprogesterone 17-Acetate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Medroxyprogesterone 17-Acetate Malignant neoplasm of breast
PREDISPOSES,Carrier of disorder,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Carrier of disorder Malignant neoplasm of breast
PREDISPOSES,"Fatty Acids, Omega-6",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,"Fatty Acids, Omega-6 Malignant neoplasm of breast"
AFFECTS,"Estrogens, Synthetic",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,"Estrogens, Synthetic Malignant neoplasm of breast"
PREDISPOSES,CDKN1A gene|CDKN1A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CDKN1A gene|CDKN1A Malignant neoplasm of breast
AFFECTS,Drug resistance,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,Drug resistance Malignant neoplasm of breast
PREDISPOSES,Alcohol consumption,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Alcohol consumption Malignant neoplasm of breast
AFFECTS,Endocrine therapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Endocrine therapy Malignant neoplasm of breast
AFFECTS,Proto-Oncogenes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Proto-Oncogenes Malignant neoplasm of breast
AFFECTS,Disease,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Disease Malignant neoplasm of breast
AFFECTS,Gene Expression,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Gene Expression Malignant neoplasm of breast
CAUSES,FGF10 gene|FGF10,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FGF10 gene|FGF10 Malignant neoplasm of breast
AFFECTS,Genes,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,Genes Breast cancer metastatic
AFFECTS,Protein Expression,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Protein Expression Malignant neoplasm of breast
AFFECTS,Polyunsaturated Fatty Acids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Polyunsaturated Fatty Acids Malignant neoplasm of breast
PREDISPOSES,Cytokine Gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Cytokine Gene Malignant neoplasm of breast
AUGMENTS,PRKACA gene|PRKACA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PRKACA gene|PRKACA Malignant neoplasm of breast
AUGMENTS,Proto-Oncogenes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Proto-Oncogenes Malignant neoplasm of breast
PREDISPOSES,Genes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Genes Malignant neoplasm of breast
AFFECTS,"Drugs, Investigational",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,"Drugs, Investigational Malignant neoplasm of breast"
CAUSES,Neoplasm Metastasis,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Neoplasm Metastasis Breast Carcinoma
PREDISPOSES,TERT gene|TERT,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TERT gene|TERT Malignant neoplasm of breast
AFFECTS,EGFR gene|EGFR,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,EGFR gene|EGFR Breast cancer metastatic
AFFECTS,Solvents,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Chemical,Solvents Breast cancer invasive NOS
PREDISPOSES,CHEK2 gene|CHEK2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CHEK2 gene|CHEK2 Malignant neoplasm of breast
AFFECTS,ITK gene|ITK,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,ITK gene|ITK Breast cancer metastatic
AFFECTS,Insulin-Like Growth Factor I,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Insulin-Like Growth Factor I Malignant neoplasm of breast
PREDISPOSES,protein tyrosine phosphatase 1B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",protein tyrosine phosphatase 1B Malignant neoplasm of breast
PREDISPOSES,Estrogen Receptor alpha,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptor alpha Malignant neoplasm of breast
AFFECTS,CLOCK gene|CLOCK,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CLOCK gene|CLOCK Malignant neoplasm of breast
CAUSES,Insulin-Like Growth Factor Binding Protein 3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Insulin-Like Growth Factor Binding Protein 3 Malignant neoplasm of breast
PREDISPOSES,CA-15-3 Antigen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Immunologic Factor,CA-15-3 Antigen Malignant neoplasm of breast
AFFECTS,Estrogen Receptors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptors Malignant neoplasm of breast
DISRUPTS,MicroRNAs,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",MicroRNAs Breast cancer metastatic
AFFECTS,Methylation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Methylation Malignant neoplasm of breast
PREDISPOSES,MicroRNAs,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",MicroRNAs Malignant neoplasm of breast
PREDISPOSES,ERBB2 gene|ERBB2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ERBB2 gene|ERBB2 Malignant neoplasm of breast
AFFECTS,ATM Gene Mutation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ATM Gene Mutation Malignant neoplasm of breast
PREDISPOSES,inner centromere protein|INCENP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",inner centromere protein|INCENP Malignant neoplasm of breast
DISRUPTS,MIRN132 gene|MIR132,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,MIRN132 gene|MIR132 Noninfiltrating Intraductal Carcinoma
AFFECTS,Tumorigenesis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Tumorigenesis Malignant neoplasm of breast
PREDISPOSES,CCNB1 gene|CCNB1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CCNB1 gene|CCNB1 Malignant neoplasm of breast
AFFECTS,Germ-Line Mutation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Germ-Line Mutation Malignant neoplasm of breast
PREDISPOSES,Adverse reactions,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Adverse reactions Malignant neoplasm of breast
PREDISPOSES,Epidermal Growth Factor Receptor|EGFR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Epidermal Growth Factor Receptor|EGFR Malignant neoplasm of breast
PREDISPOSES,Sex Hormone-Binding Globulin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Sex Hormone-Binding Globulin Malignant neoplasm of breast
PREDISPOSES,Testosterone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Testosterone Malignant neoplasm of breast
AUGMENTS,c-myc Genes|MYC,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,c-myc Genes|MYC Malignant neoplasm of breast
PREDISPOSES,BARD1 gene|BARD1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BARD1 gene|BARD1 Malignant neoplasm of breast
AFFECTS,ERBB3 gene|ERBB3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ERBB3 gene|ERBB3 Malignant neoplasm of breast
AFFECTS,Somatic mutation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Somatic mutation Malignant neoplasm of breast
AFFECTS,Pharmaceutical Preparations,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,Pharmaceutical Preparations Malignant neoplasm of breast
PREDISPOSES,Klinefelter's Syndrome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Klinefelter's Syndrome Malignant neoplasm of breast
AFFECTS,"Translation, Genetic",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,"Translation, Genetic Malignant neoplasm of breast"
AUGMENTS,Estrogens,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Hormone,Estrogens Breast Carcinoma
PREDISPOSES,Insulin-Like Growth Factor Binding Protein 3,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Insulin-Like Growth Factor Binding Protein 3 Noninfiltrating Intraductal Carcinoma
PREDISPOSES,Cholesterol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Lipid,Cholesterol Malignant neoplasm of breast
AFFECTS,Cessation of life,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Cessation of life Malignant neoplasm of breast
AFFECTS,TP53 gene|TP53,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TP53 gene|TP53 Malignant neoplasm of breast
PREDISPOSES,BRCA2 gene|BRCA2,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,Gene or Genome,BRCA2 gene|BRCA2 Familial cancer of breast
AFFECTS,protein kinase C eta,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",protein kinase C eta Malignant neoplasm of breast
AFFECTS,Steroid hormone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Steroid hormone Malignant neoplasm of breast
AFFECTS,anastrozole,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Pharmacologic Substance,anastrozole Breast cancer metastatic
AFFECTS,Dietary Modification,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Dietary Modification Malignant neoplasm of breast
PREDISPOSES,Prostate-Specific Antigen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Immunologic Factor,Prostate-Specific Antigen Malignant neoplasm of breast
CAUSES,Tumor Angiogenesis,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,Tumor Angiogenesis Breast Carcinoma
AFFECTS,Malignant Neoplasms,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Neoplastic Process,"Malignant Neoplasms Carcinoma, Ductal, Breast"
AFFECTS,Cyclooxygenase 2 Inhibitors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Cyclooxygenase 2 Inhibitors Malignant neoplasm of breast
AUGMENTS,Progesterone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Progesterone Malignant neoplasm of breast
PREDISPOSES,Tumor Markers,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Tumor Markers Malignant neoplasm of breast
AFFECTS,Estrogen Antagonists,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Estrogen Antagonists Malignant neoplasm of breast
CAUSES,Chemicals,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Chemicals Malignant neoplasm of breast
AFFECTS,Matrix Metalloproteinases,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Matrix Metalloproteinases Breast Carcinoma
CAUSES,"Herpesvirus 4, Human",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Virus,"Herpesvirus 4, Human Malignant neoplasm of breast"
AFFECTS,Gene-Environment Interaction,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Gene-Environment Interaction Malignant neoplasm of breast
DISRUPTS,Vitamin D,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Vitamin D Malignant neoplasm of breast
AFFECTS,Aromatase Inhibitors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Aromatase Inhibitors Malignant neoplasm of breast
CAUSES,DNA Adducts,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",DNA Adducts Malignant neoplasm of breast
AFFECTS,BRCA1 gene|BRCA1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BRCA1 gene|BRCA1 Malignant neoplasm of breast
AFFECTS,Axillary Lymph Node Dissection,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Axillary Lymph Node Dissection Malignant neoplasm of breast
AFFECTS,BRCA1 Mutation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BRCA1 Mutation Malignant neoplasm of breast
CAUSES,"Mammary Tumor Virus, Mouse",Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,"Mammary Tumor Virus, Mouse Breast Carcinoma"
AFFECTS,BRCA1 gene|BRCA1,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Gene or Genome,BRCA1 gene|BRCA1 Sporadic Breast Carcinoma
CAUSES,Cytomegalovirus,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Virus,Cytomegalovirus Malignant neoplasm of breast
AFFECTS,Linoleic Acid,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Chemical,Linoleic Acid Breast cancer metastatic
CAUSES,DNA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",DNA Malignant neoplasm of breast
AFFECTS,Fibroblast Growth Factor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Fibroblast Growth Factor Malignant neoplasm of breast
PREDISPOSES,Breast Diseases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Breast Diseases Malignant neoplasm of breast
PREDISPOSES,Vitamin A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Vitamin A Malignant neoplasm of breast
PREDISPOSES,"Carcinogens, Environmental",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hazardous or Poisonous Substance,"Carcinogens, Environmental Malignant neoplasm of breast"
PREDISPOSES,Tamoxifen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,Tamoxifen Malignant neoplasm of breast
AFFECTS,Deficiency of testosterone biosynthesis,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Hormone,Deficiency of testosterone biosynthesis Carcinoma of Male Breast
CAUSES,SV40 T Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",SV40 T Proteins Malignant neoplasm of breast
PREDISPOSES,Food,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Food Malignant neoplasm of breast
CAUSES,Carcinogens,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Hazardous or Poisonous Substance,Carcinogens Breast Carcinoma
AFFECTS,Estrogen excess,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Hormone,Estrogen excess Carcinoma of Male Breast
AUGMENTS,Aromatase Inhibitors,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Hormone,Aromatase Inhibitors Breast cancer metastatic
CAUSES,"Polycyclic Hydrocarbons, Aromatic",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Polycyclic Hydrocarbons, Aromatic Malignant neoplasm of breast"
AFFECTS,Medroxyprogesterone 17-Acetate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Medroxyprogesterone 17-Acetate Malignant neoplasm of breast
PREDISPOSES,Vitamin C intake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Vitamin C intake Malignant neoplasm of breast
PREDISPOSES,Proto-Oncogenes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Proto-Oncogenes Malignant neoplasm of breast
PREDISPOSES,TFF1 gene|TFF1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TFF1 gene|TFF1 Malignant neoplasm of breast
AFFECTS,Radiation therapy,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Radiation therapy Breast Carcinoma
AFFECTS,Breast cancer recurrent,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Breast cancer recurrent Malignant neoplasm of breast
CAUSES,Serum,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Body Substance,Serum Malignant neoplasm of breast
CAUSES,v-Ha-ras Oncogenes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,v-Ha-ras Oncogenes Malignant neoplasm of breast
CAUSES,"Genes, Dominant",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,"Genes, Dominant Malignant neoplasm of breast"
AFFECTS,Growth Factor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Growth Factor Malignant neoplasm of breast
PREDISPOSES,Nuclear Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Nuclear Proteins Malignant neoplasm of breast
PREDISPOSES,Breast Fibrocystic Disease,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Breast Fibrocystic Disease Malignant neoplasm of breast
PREDISPOSES,Disease,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Disease Malignant neoplasm of breast
DISRUPTS,ras Oncogene,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,ras Oncogene Breast Carcinoma
DISRUPTS,Estrogen Antagonists,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Estrogen Antagonists Malignant neoplasm of breast
PREDISPOSES,Egg Food Product,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Egg Food Product Malignant neoplasm of breast
AFFECTS,Agent,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical Viewed Functionally,Agent Malignant neoplasm of breast
CAUSES,Genes,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,Gene or Genome,Genes Familial cancer of breast
CAUSES,c-myc Genes|MYC,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,c-myc Genes|MYC Malignant neoplasm of breast
PREDISPOSES,Cancer-Predisposing Gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Cancer-Predisposing Gene Malignant neoplasm of breast
CAUSES,Thyroid Hormones,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Thyroid Hormones Malignant neoplasm of breast
AFFECTS,Fusion procedure,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",Fusion procedure Noninfiltrating Intraductal Carcinoma
AUGMENTS,Genes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Genes Malignant neoplasm of breast
AFFECTS,Hormone replacement therapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Hormone replacement therapy Malignant neoplasm of breast
AFFECTS,Cytotoxic Chemotherapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hazardous or Poisonous Substance,Cytotoxic Chemotherapy Malignant neoplasm of breast
AFFECTS,Gene Amplification,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Gene Amplification Malignant neoplasm of breast
AFFECTS,Radiation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Radiation Malignant neoplasm of breast
PREDISPOSES,Breast Diseases,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Disease or Syndrome,Breast Diseases Breast cancer invasive NOS
AUGMENTS,Gonadotropin-Releasing Hormone Analog,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Hormone,Gonadotropin-Releasing Hormone Analog Breast Carcinoma
CAUSES,"Genes, Suppressor",Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,"Genes, Suppressor Breast Carcinoma"
CAUSES,Fatty Acids,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Chemical,Fatty Acids Breast Carcinoma
AFFECTS,Cholera Toxin,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Chemical,Cholera Toxin Breast Carcinoma
CAUSES,Propionate,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Propionate Breast Carcinoma
CAUSES,Contraceptive Agents,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical Viewed Functionally,Contraceptive Agents Malignant neoplasm of breast
AFFECTS,alpha-latrotoxin receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,alpha-latrotoxin receptor Malignant neoplasm of breast
COMPLICATES,Acute leukemia,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Acute leukemia Breast cancer metastatic
AFFECTS,leukemia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,leukemia Malignant neoplasm of breast
CAUSES,DNA,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",DNA Breast Carcinoma
PREDISPOSES,Transforming Growth Factor beta,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Biologically Active Substance,Transforming Growth Factor beta Breast cancer metastatic
AFFECTS,"Receptors, Progesterone",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,"Receptors, Progesterone Malignant neoplasm of breast"
DISRUPTS,soy protein isolate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",soy protein isolate Malignant neoplasm of breast
AFFECTS,Peptide Nucleic Acids,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,Peptide Nucleic Acids Breast Carcinoma
CAUSES,BRCA1 gene|BRCA1,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Gene or Genome,BRCA1 gene|BRCA1 Carcinoma of Male Breast
AFFECTS,Combination Chemotherapy,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Combination Chemotherapy Breast Carcinoma
AFFECTS,Digitoxin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Digitoxin Malignant neoplasm of breast
DISRUPTS,Tamoxifen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,Tamoxifen Malignant neoplasm of breast
AFFECTS,Infection,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Infection Malignant neoplasm of breast
AFFECTS,"TGFB1 protein, human|TGFB1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","TGFB1 protein, human|TGFB1 Malignant neoplasm of breast"
PREDISPOSES,Cancer-Predisposing Gene,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,Gene or Genome,Cancer-Predisposing Gene Familial cancer of breast
AUGMENTS,Selective Estrogen Receptor Modulators,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Selective Estrogen Receptor Modulators Malignant neoplasm of breast
AFFECTS,Cell Communication,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Cell Communication Malignant neoplasm of breast
CAUSES,Familial cancer of breast,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Neoplastic Process,Familial cancer of breast Sporadic Breast Carcinoma
PREDISPOSES,C-Peptide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",C-Peptide Malignant neoplasm of breast
AFFECTS,Breast Carcinoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Breast Carcinoma Malignant neoplasm of breast
PREDISPOSES,Tamoxifen,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,Pharmacologic Substance,Tamoxifen Contralateral breast cancer
AFFECTS,Retinoblastoma Genes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Retinoblastoma Genes Malignant neoplasm of breast
CAUSES,Lymphocyte Specific Protein Tyrosine Kinase p56(lck)|LCK,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Lymphocyte Specific Protein Tyrosine Kinase p56(lck)|LCK Malignant neoplasm of breast
AFFECTS,CYP17A1 gene|CYP17A1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CYP17A1 gene|CYP17A1 Malignant neoplasm of breast
CAUSES,Viral Oncogene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Viral Oncogene Malignant neoplasm of breast
AFFECTS,Lymphocyte Specific Protein Tyrosine Kinase p56(lck)|LCK,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Lymphocyte Specific Protein Tyrosine Kinase p56(lck)|LCK Malignant neoplasm of breast
CAUSES,Hereditary Malignant Neoplasm,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Hereditary Malignant Neoplasm Malignant neoplasm of breast
CAUSES,Testosterone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Testosterone Malignant neoplasm of breast
CAUSES,Carcinogens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hazardous or Poisonous Substance,Carcinogens Malignant neoplasm of breast
DISRUPTS,vitamin analog,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Food,vitamin analog Breast Carcinoma
DISRUPTS,Tumor Suppressor Genes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Tumor Suppressor Genes Malignant neoplasm of breast
PREDISPOSES,Hereditary Diseases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Hereditary Diseases Malignant neoplasm of breast
AFFECTS,Prostaglandins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Eicosanoid,Prostaglandins Malignant neoplasm of breast
PREDISPOSES,stearic acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,stearic acid Malignant neoplasm of breast
AFFECTS,steroid hormone receptor,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Hormone,steroid hormone receptor Sporadic Breast Carcinoma
AUGMENTS,CUL4A gene|CUL4A,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,CUL4A gene|CUL4A Breast Carcinoma
AFFECTS,Mutation,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Mutation Sporadic Breast Carcinoma
CAUSES,Estrogen Receptors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptors Malignant neoplasm of breast
CAUSES,Agent,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical Viewed Functionally,Agent Malignant neoplasm of breast
PREDISPOSES,NCOA3 gene|NCOA3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NCOA3 gene|NCOA3 Malignant neoplasm of breast
AFFECTS,MYC gene|MYC,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MYC gene|MYC Malignant neoplasm of breast
AFFECTS,Ovarian Carcinoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Ovarian Carcinoma Malignant neoplasm of breast
AFFECTS,ATM gene|ATM,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ATM gene|ATM Malignant neoplasm of breast
DISRUPTS,Antigens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Immunologic Factor,Antigens Malignant neoplasm of breast
PREDISPOSES,"TACSTD1 protein, human|EPCAM",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","TACSTD1 protein, human|EPCAM Malignant neoplasm of breast"
PREDISPOSES,"Hydrocarbons, Chlorinated",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Hydrocarbons, Chlorinated Malignant neoplasm of breast"
CAUSES,"Mammary Tumor Virus, Mouse",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,"Mammary Tumor Virus, Mouse Malignant neoplasm of breast"
AFFECTS,Signal Transduction Pathways,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Signal Transduction Pathways Malignant neoplasm of breast
PREDISPOSES,AFP gene|AFP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,AFP gene|AFP Malignant neoplasm of breast
CAUSES,Growth Factor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Growth Factor Malignant neoplasm of breast
AFFECTS,FHIT gene|FHIT,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FHIT gene|FHIT Malignant neoplasm of breast
PREDISPOSES,Merozoite Surface Protein 1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Merozoite Surface Protein 1 Malignant neoplasm of breast
PREDISPOSES,Micronutrients,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Micronutrients Malignant neoplasm of breast
PREDISPOSES,Hexachlorobenzene,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,Hazardous or Poisonous Substance,Hexachlorobenzene Female Breast Carcinoma
CAUSES,Growth Factor,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Biologically Active Substance,Growth Factor Breast Carcinoma
PREDISPOSES,17-Ketosteroids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Steroid,17-Ketosteroids Malignant neoplasm of breast
AUGMENTS,"PTPN6 protein, human|PTPN6",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","PTPN6 protein, human|PTPN6 Malignant neoplasm of breast"
PREDISPOSES,Epidermal Growth Factor|EGF,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Epidermal Growth Factor|EGF Malignant neoplasm of breast
PREDISPOSES,GSTT1 gene|GSTT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GSTT1 gene|GSTT1 Malignant neoplasm of breast
PREDISPOSES,impression,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",impression Malignant neoplasm of breast
CAUSES,Transforming Growth Factor beta,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Transforming Growth Factor beta Malignant neoplasm of breast
CAUSES,hydroxytamoxifen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,hydroxytamoxifen Malignant neoplasm of breast
PREDISPOSES,Estrogens,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Hormone,Estrogens Carcinoma of Male Breast
AFFECTS,"Fatty Acids, Essential",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,"Fatty Acids, Essential Malignant neoplasm of breast"
DISRUPTS,Somatotropin-Releasing Hormone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Somatotropin-Releasing Hormone Malignant neoplasm of breast
CAUSES,Oncogenes,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,Oncogenes Breast Carcinoma
PREDISPOSES,Oestrogen deficiency,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Oestrogen deficiency Malignant neoplasm of breast
PREDISPOSES,leukemia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,leukemia Malignant neoplasm of breast
DISRUPTS,Butyric Acid,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Chemical,Butyric Acid Breast Carcinoma
AUGMENTS,Retinoblastoma Genes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Retinoblastoma Genes Malignant neoplasm of breast
AFFECTS,Epidermal Growth Factor Receptor|EGFR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Epidermal Growth Factor Receptor|EGFR Malignant neoplasm of breast
CAUSES,Apoptosis Inhibiting Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Apoptosis Inhibiting Proteins Malignant neoplasm of breast
PREDISPOSES,Li-Fraumeni Syndrome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Li-Fraumeni Syndrome Malignant neoplasm of breast
DISRUPTS,Phytic Acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Phytic Acid Malignant neoplasm of breast
AFFECTS,Aryl Hydrocarbon Receptor|AHR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Aryl Hydrocarbon Receptor|AHR Malignant neoplasm of breast
DISRUPTS,anastrozole,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,Pharmacologic Substance,anastrozole Contralateral breast cancer
PREDISPOSES,DNA Sequence,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Nucleotide Sequence,DNA Sequence Sporadic Breast Carcinoma
PREDISPOSES,Conjugated Equine Estrogens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Conjugated Equine Estrogens Malignant neoplasm of breast
AUGMENTS,Hormones,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Hormones Malignant neoplasm of breast
CAUSES,EGFR gene|EGFR,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Gene or Genome,EGFR gene|EGFR Sporadic Breast Carcinoma
AFFECTS,Protein Kinase C,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Protein Kinase C Malignant neoplasm of breast
PREDISPOSES,Nutrients,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Nutrients Malignant neoplasm of breast
AFFECTS,Receptor Protein-Tyrosine Kinases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Receptor Protein-Tyrosine Kinases Malignant neoplasm of breast
AUGMENTS,Tamoxifen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,Tamoxifen Malignant neoplasm of breast
PREDISPOSES,Glucose,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Carbohydrate,Glucose Malignant neoplasm of breast
DISRUPTS,Vitamins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Vitamins Malignant neoplasm of breast
AFFECTS,Epithelial Cell Proliferation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Epithelial Cell Proliferation Malignant neoplasm of breast
CAUSES,Transgenes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Transgenes Malignant neoplasm of breast
AUGMENTS,PGR gene|PGR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PGR gene|PGR Malignant neoplasm of breast
PREDISPOSES,GSTM1 gene|GSTM1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GSTM1 gene|GSTM1 Malignant neoplasm of breast
DISRUPTS,Vitamin A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Vitamin A Malignant neoplasm of breast
PREDISPOSES,Insulin-Like Growth Factor I,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Insulin-Like Growth Factor I Malignant neoplasm of breast
PREDISPOSES,TP53 gene|TP53,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TP53 gene|TP53 Malignant neoplasm of breast
DISRUPTS,Phytoestrogens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Phytoestrogens Malignant neoplasm of breast
CAUSES,Tamoxifen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,Tamoxifen Malignant neoplasm of breast
PREDISPOSES,TSG101 gene|TSG101,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,Gene or Genome,TSG101 gene|TSG101 Familial cancer of breast
PREDISPOSES,Aromatase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Enzyme,Aromatase Malignant neoplasm of breast
AFFECTS,trastuzumab,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,trastuzumab Malignant neoplasm of breast
AFFECTS,Nutrients,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Nutrients Malignant neoplasm of breast
CAUSES,Primary carcinoma of the liver cells,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Primary carcinoma of the liver cells Breast Carcinoma
DISRUPTS,Cellular Retinol Binding Protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Cellular Retinol Binding Protein Malignant neoplasm of breast
AFFECTS,Down-Regulation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Down-Regulation Malignant neoplasm of breast
CAUSES,Oncogenes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Oncogenes Malignant neoplasm of breast
PREDISPOSES,Body Fat Distribution,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Body Fat Distribution Malignant neoplasm of breast
AUGMENTS,CYP19A1 gene|CYP19A1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CYP19A1 gene|CYP19A1 Malignant neoplasm of breast
PREDISPOSES,Thyroid Diseases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Thyroid Diseases Malignant neoplasm of breast
PREDISPOSES,Spontaneous abortion,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Spontaneous abortion Malignant neoplasm of breast
AFFECTS,"Mutation, Missense",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Mutation, Missense Malignant neoplasm of breast"
AFFECTS,"Abortion, Induced",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Abortion, Induced Malignant neoplasm of breast"
AFFECTS,Epidermal Growth Factor|EGF,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Epidermal Growth Factor|EGF Malignant neoplasm of breast
PREDISPOSES,Oestrogen increased,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Oestrogen increased Malignant neoplasm of breast
AFFECTS,cyclooxygenase 2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",cyclooxygenase 2 Malignant neoplasm of breast
AFFECTS,NCOA3 gene|NCOA3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NCOA3 gene|NCOA3 Malignant neoplasm of breast
DISRUPTS,"Fatty Acids, Omega-3",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,"Fatty Acids, Omega-3 Malignant neoplasm of breast"
PREDISPOSES,Adhesions,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Adhesions Malignant neoplasm of breast
PREDISPOSES,Unspecified Abortion,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Unspecified Abortion Malignant neoplasm of breast
AFFECTS,DNA Damage,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",DNA Damage Malignant neoplasm of breast
PREDISPOSES,Tumor Promoters,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Tumor Promoters Malignant neoplasm of breast
AFFECTS,Noninfiltrating Intraductal Carcinoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Noninfiltrating Intraductal Carcinoma Malignant neoplasm of breast
DISRUPTS,Docosahexaenoic Acids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Docosahexaenoic Acids Malignant neoplasm of breast
CAUSES,Enzymes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Enzyme,Enzymes Malignant neoplasm of breast
PREDISPOSES,cyclooxygenase 2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",cyclooxygenase 2 Malignant neoplasm of breast
AFFECTS,protein kinase inhibitor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",protein kinase inhibitor Malignant neoplasm of breast
AUGMENTS,Nuclear Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Nuclear Proteins Malignant neoplasm of breast
PREDISPOSES,Breast Microcalcification,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Breast Microcalcification Malignant neoplasm of breast
AFFECTS,Progestogen hormone therapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Progestogen hormone therapy Malignant neoplasm of breast
AUGMENTS,Epidermal growth factor receptor inhibitor,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Biologically Active Substance,Epidermal growth factor receptor inhibitor Noninfiltrating Intraductal Carcinoma
AFFECTS,"Oligonucleotides, Antisense",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","Oligonucleotides, Antisense Malignant neoplasm of breast"
AFFECTS,Infiltrating duct carcinoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Infiltrating duct carcinoma Malignant neoplasm of breast
AFFECTS,"Mutation, Nonsense",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Mutation, Nonsense Malignant neoplasm of breast"
PREDISPOSES,"Metals, Heavy",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Metals, Heavy Malignant neoplasm of breast"
CAUSES,Single Nucleotide Polymorphism,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Single Nucleotide Polymorphism Malignant neoplasm of breast
AFFECTS,Insulin-Like Growth Factor II,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Insulin-Like Growth Factor II Malignant neoplasm of breast
AUGMENTS,MCM2 gene|MCM2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MCM2 gene|MCM2 Malignant neoplasm of breast
PREDISPOSES,ESTROGEN USE,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Hormone,ESTROGEN USE Breast cancer invasive NOS
PREDISPOSES,Vitamin D3 Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Vitamin D3 Receptor Malignant neoplasm of breast
AFFECTS,genotoxicity,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hazardous or Poisonous Substance,genotoxicity Malignant neoplasm of breast
CAUSES,TRANSCRIPTION FACTOR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",TRANSCRIPTION FACTOR Malignant neoplasm of breast
PREDISPOSES,DDT (Insecticide),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Invertebrate,DDT (Insecticide) Malignant neoplasm of breast
AFFECTS,STK6 gene|AURKA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,STK6 gene|AURKA Malignant neoplasm of breast
DISRUPTS,Vitamin E,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Food,Vitamin E Breast cancer metastatic
PREDISPOSES,Soy Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Soy Proteins Malignant neoplasm of breast
AFFECTS,Transcriptional Activation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Transcriptional Activation Malignant neoplasm of breast
PREDISPOSES,Thromboembolic event,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Phenomenon or Process,Thromboembolic event Malignant neoplasm of breast
AUGMENTS,Testosterone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Testosterone Malignant neoplasm of breast
PREDISPOSES,Encounter due to Screening for malignant neoplasm of breast,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Encounter due to Screening for malignant neoplasm of breast Malignant neoplasm of breast
AFFECTS,LAG3 gene|LAG3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LAG3 gene|LAG3 Malignant neoplasm of breast
AFFECTS,Estrogenic,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Estrogenic Malignant neoplasm of breast
AFFECTS,Signal Transduction,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Signal Transduction Malignant neoplasm of breast
AUGMENTS,Estrogen Receptors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptors Malignant neoplasm of breast
CAUSES,cyclooxygenase 2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",cyclooxygenase 2 Malignant neoplasm of breast
AUGMENTS,Pharmaceutical Preparations,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,Pharmaceutical Preparations Malignant neoplasm of breast
PREDISPOSES,Lipoproteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Lipoproteins Malignant neoplasm of breast
DISRUPTS,Transforming Growth Factor beta|TGFB1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Transforming Growth Factor beta|TGFB1 Malignant neoplasm of breast
PREDISPOSES,"Polycyclic Hydrocarbons, Aromatic",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Polycyclic Hydrocarbons, Aromatic Malignant neoplasm of breast"
AFFECTS,CA9 gene|CA9,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Gene or Genome,CA9 gene|CA9 Breast cancer invasive NOS
DISRUPTS,Estrogen Receptor alpha,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptor alpha Malignant neoplasm of breast
AFFECTS,Cytotoxin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Cytotoxin Malignant neoplasm of breast
PREDISPOSES,Dietary Carbohydrates,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Carbohydrate,Dietary Carbohydrates Malignant neoplasm of breast
AUGMENTS,"VEGF protein, human|VEGFA",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","VEGF protein, human|VEGFA Malignant neoplasm of breast"
AFFECTS,Estrogen Receptor alpha|EREG|ESR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptor alpha|EREG|ESR1 Malignant neoplasm of breast
AFFECTS,CXCR4 gene|CXCR4,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,CXCR4 gene|CXCR4 Breast cancer metastatic
PREDISPOSES,Encounter due to genetic counseling,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Encounter due to genetic counseling Malignant neoplasm of breast
CAUSES,Estrogens,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Hormone,Estrogens Breast Carcinoma
AFFECTS,PGR gene|PGR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PGR gene|PGR Malignant neoplasm of breast
PREDISPOSES,"Progestational Hormones, Synthetic",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,"Progestational Hormones, Synthetic Malignant neoplasm of breast"
AUGMENTS,Focal Adhesion Protein-Tyrosine Kinases,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Focal Adhesion Protein-Tyrosine Kinases Noninfiltrating Intraductal Carcinoma
PREDISPOSES,Estrogenic,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Estrogenic Malignant neoplasm of breast
PREDISPOSES,Phytoestrogens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Phytoestrogens Malignant neoplasm of breast
AFFECTS,Metabolic Diseases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Metabolic Diseases Malignant neoplasm of breast
PREDISPOSES,Contraceptive Agents,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical Viewed Functionally,Contraceptive Agents Malignant neoplasm of breast
CAUSES,"Hydrocarbons, Chlorinated",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Hydrocarbons, Chlorinated Malignant neoplasm of breast"
AUGMENTS,SULT gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SULT gene Malignant neoplasm of breast
AUGMENTS,ERBB2 gene|ERBB2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ERBB2 gene|ERBB2 Malignant neoplasm of breast
DISRUPTS,PTGS2 gene|PTGS2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,PTGS2 gene|PTGS2 Breast cancer metastatic
DISRUPTS,Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Proteins Malignant neoplasm of breast
CAUSES,Human papillomavirus 16,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Virus,Human papillomavirus 16 Breast Carcinoma
PREDISPOSES,MET gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MET gene Malignant neoplasm of breast
PREDISPOSES,Cholesterol levels raised,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Lipid,Cholesterol levels raised Malignant neoplasm of breast
AUGMENTS,CHEK2 gene|CHEK2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CHEK2 gene|CHEK2 Malignant neoplasm of breast
CAUSES,Female Breast Carcinoma,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Neoplastic Process,Female Breast Carcinoma Carcinoma of Male Breast
AFFECTS,Dietary restriction NOS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Dietary restriction NOS Malignant neoplasm of breast
CAUSES,Polycyclic Hydrocarbons,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Polycyclic Hydrocarbons Breast Carcinoma
CAUSES,Li-Fraumeni Syndrome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Li-Fraumeni Syndrome Malignant neoplasm of breast
AFFECTS,Estrogen receptor positive tumor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen receptor positive tumor Malignant neoplasm of breast
CAUSES,migration stimulating factor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",migration stimulating factor Malignant neoplasm of breast
CAUSES,Chemicals,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Chemical,Chemicals Breast Carcinoma
AFFECTS,Selective Estrogen Receptor Modulators,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Selective Estrogen Receptor Modulators Malignant neoplasm of breast
PREDISPOSES,ERCC2 gene|ERCC2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ERCC2 gene|ERCC2 Malignant neoplasm of breast
AFFECTS,Monoclonal Antibody Therapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Indicator, Reagent, or Diagnostic Aid",Monoclonal Antibody Therapy Malignant neoplasm of breast
CAUSES,Arachidonic Acid,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Chemical,Arachidonic Acid Breast Carcinoma
AFFECTS,"Polycyclic Hydrocarbons, Aromatic",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Polycyclic Hydrocarbons, Aromatic Malignant neoplasm of breast"
AUGMENTS,Medroxyprogesterone 17-Acetate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Medroxyprogesterone 17-Acetate Malignant neoplasm of breast
AFFECTS,apolipoprotein D|APOD,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",apolipoprotein D|APOD Malignant neoplasm of breast
PREDISPOSES,"progesterone, micronized",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,"progesterone, micronized Malignant neoplasm of breast"
AFFECTS,rho GTP-Binding Proteins,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Amino Acid, Peptide, or Protein",rho GTP-Binding Proteins Breast cancer invasive NOS
CAUSES,NCOA3 gene|NCOA3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NCOA3 gene|NCOA3 Malignant neoplasm of breast
PREDISPOSES,RETN gene|RETN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RETN gene|RETN Malignant neoplasm of breast
AFFECTS,Soy Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Soy Proteins Malignant neoplasm of breast
PREDISPOSES,Cancer Promoting Genes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Cancer Promoting Genes Malignant neoplasm of breast
CAUSES,HIC1 gene|HIC1,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Gene or Genome,"HIC1 gene|HIC1 Carcinoma, Ductal, Breast"
AFFECTS,cytokine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,cytokine Malignant neoplasm of breast
AFFECTS,Oestrogen therapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Oestrogen therapy Malignant neoplasm of breast
AFFECTS,Receptor Gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Receptor Gene Malignant neoplasm of breast
AUGMENTS,Fusion Protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Fusion Protein Malignant neoplasm of breast
PREDISPOSES,Molecular Fingerprint of Tumor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Molecular Fingerprint of Tumor Malignant neoplasm of breast
PREDISPOSES,Impaired cognition,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Impaired cognition Malignant neoplasm of breast
AFFECTS,Disease,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Disease or Syndrome,Disease Breast cancer metastatic
PREDISPOSES,ATM gene|ATM,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ATM gene|ATM Malignant neoplasm of breast
AFFECTS,Transcription Repressor/Corepressor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Transcription Repressor/Corepressor Malignant neoplasm of breast
PREDISPOSES,Nicotinamide adenine dinucleotide (NAD),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Nicotinamide adenine dinucleotide (NAD) Malignant neoplasm of breast
AFFECTS,ETS1 gene|ETS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ETS1 gene|ETS1 Malignant neoplasm of breast
PREDISPOSES,S-Phase Fraction,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",S-Phase Fraction Malignant neoplasm of breast
DISRUPTS,HSF1 gene|HSF1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HSF1 gene|HSF1 Malignant neoplasm of breast
AUGMENTS,DNA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",DNA Malignant neoplasm of breast
PREDISPOSES,"TNF protein, human|TNF",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","TNF protein, human|TNF Malignant neoplasm of breast"
AFFECTS,Acids,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Chemical,Acids Breast Carcinoma
AFFECTS,WISP3 gene|WISP3,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Gene or Genome,WISP3 gene|WISP3 Inflammatory Breast Carcinoma
AUGMENTS,Estrogen Receptor alpha,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptor alpha Malignant neoplasm of breast
AFFECTS,Estrogen Receptor alpha,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptor alpha Malignant neoplasm of breast
CAUSES,Neoplasm Metastasis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Neoplasm Metastasis Malignant neoplasm of breast
AUGMENTS,Steroids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Steroid,Steroids Malignant neoplasm of breast
PREDISPOSES,LAMR1 gene|RPSA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LAMR1 gene|RPSA Malignant neoplasm of breast
AFFECTS,osteosarcoma,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Neoplastic Process,osteosarcoma Breast cancer metastatic
PREDISPOSES,TWIST1 gene|TWIST1,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Gene or Genome,TWIST1 gene|TWIST1 Breast cancer recurrent
AFFECTS,"RNA, Untranslated",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","RNA, Untranslated Malignant neoplasm of breast"
AFFECTS,"RBL2 protein, human|RBL2",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","RBL2 protein, human|RBL2 Malignant neoplasm of breast"
CAUSES,Oncogene ErbB2|ERBB2|NEU1|NEURL1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Oncogene ErbB2|ERBB2|NEU1|NEURL1 Malignant neoplasm of breast
AUGMENTS,SHFM1 gene|SEM1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SHFM1 gene|SEM1 Malignant neoplasm of breast
PREDISPOSES,participation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",participation Malignant neoplasm of breast
AFFECTS,DNA Repair Gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,DNA Repair Gene Malignant neoplasm of breast
PREDISPOSES,Processed meat intake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Phenomenon or Process,Processed meat intake Malignant neoplasm of breast
AUGMENTS,"Receptors, Progesterone",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,"Receptors, Progesterone Malignant neoplasm of breast"
DISRUPTS,MicroRNAs,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",MicroRNAs Malignant neoplasm of breast
AFFECTS,stress-activated protein kinase 1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",stress-activated protein kinase 1 Malignant neoplasm of breast
PREDISPOSES,MTHFR gene|MTHFR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MTHFR gene|MTHFR Malignant neoplasm of breast
PREDISPOSES,Pharmaceutical Preparations,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,Pharmaceutical Preparations Malignant neoplasm of breast
PREDISPOSES,Cardiovascular Diseases,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Disease or Syndrome,Cardiovascular Diseases Breast cancer recurrent
DISRUPTS,Phytochemical,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Phytochemical Malignant neoplasm of breast
CAUSES,trastuzumab,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,trastuzumab Malignant neoplasm of breast
AUGMENTS,Aromatase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Enzyme,Aromatase Malignant neoplasm of breast
PREDISPOSES,Angiogenesis Inhibitors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Angiogenesis Inhibitors Malignant neoplasm of breast
CAUSES,Phosphoglycerate dehydrogenase|PHGDH,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Phosphoglycerate dehydrogenase|PHGDH Malignant neoplasm of breast
AFFECTS,Tumor Suppressor Genes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Tumor Suppressor Genes Malignant neoplasm of breast
PREDISPOSES,Topoisomerase Inhibitors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Enzyme,Topoisomerase Inhibitors Malignant neoplasm of breast
AFFECTS,Neoplasm progression,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Neoplasm progression Malignant neoplasm of breast
AFFECTS,Contraceptive Agents,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical Viewed Functionally,Contraceptive Agents Malignant neoplasm of breast
CAUSES,Virus,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Virus,Virus Malignant neoplasm of breast
CAUSES,Epidermal Growth Factor|EGF,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Epidermal Growth Factor|EGF Malignant neoplasm of breast
AFFECTS,Point Mutation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Point Mutation Malignant neoplasm of breast
PREDISPOSES,Lesion,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Element, Ion, or Isotope",Lesion Breast cancer invasive NOS
AFFECTS,MicroRNAs,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",MicroRNAs Sporadic Breast Carcinoma
AFFECTS,Vitamins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Vitamins Malignant neoplasm of breast
AFFECTS,Carcinogenesis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hazardous or Poisonous Substance,Carcinogenesis Malignant neoplasm of breast
AFFECTS,Pathogenesis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Pathogenesis Malignant neoplasm of breast
AFFECTS,Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Proteins Malignant neoplasm of breast
AFFECTS,Angiogenesis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Angiogenesis Malignant neoplasm of breast
PREDISPOSES,Vitamin D intake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Vitamin D intake Malignant neoplasm of breast
AUGMENTS,TRANSCRIPTION FACTOR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",TRANSCRIPTION FACTOR Malignant neoplasm of breast
AFFECTS,AXL gene|AXL,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,AXL gene|AXL Breast cancer metastatic
AFFECTS,JTB gene|JTB,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,JTB gene|JTB Malignant neoplasm of breast
PREDISPOSES,Vitamin intake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Vitamin intake Malignant neoplasm of breast
PREDISPOSES,toxicant,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hazardous or Poisonous Substance,toxicant Malignant neoplasm of breast
PREDISPOSES,Soy Foods,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Soy Foods Malignant neoplasm of breast
AFFECTS,HIF1A gene|HIF1A,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Gene or Genome,"HIF1A gene|HIF1A Carcinoma, Ductal, Breast"
PREDISPOSES,Metabolic syndrome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Metabolic syndrome Malignant neoplasm of breast
AFFECTS,BRCA2 gene|BRCA2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BRCA2 gene|BRCA2 Malignant neoplasm of breast
AUGMENTS,Proto-Oncogene Proteins c-akt|AKT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Proto-Oncogene Proteins c-akt|AKT1 Malignant neoplasm of breast
AFFECTS,"Transcription, Genetic",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,"Transcription, Genetic Malignant neoplasm of breast"
PREDISPOSES,Visual Accommodation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Visual Accommodation Malignant neoplasm of breast
AFFECTS,cancer prevention,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,cancer prevention Malignant neoplasm of breast
PREDISPOSES,Hormone Receptor,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,Hormone,Hormone Receptor Contralateral breast cancer
CAUSES,Placental Hormones,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Placental Hormones Malignant neoplasm of breast
AFFECTS,ERBB2 gene|ERBB2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ERBB2 gene|ERBB2 Malignant neoplasm of breast
AFFECTS,congener,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,congener Malignant neoplasm of breast
AFFECTS,Xanthine Dehydrogenase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Xanthine Dehydrogenase Malignant neoplasm of breast
PREDISPOSES,progesterone analog,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,progesterone analog Malignant neoplasm of breast
AUGMENTS,Single Nucleotide Polymorphism,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Single Nucleotide Polymorphism Malignant neoplasm of breast
AFFECTS,Epidermal Growth Factor Receptor|EREG|ESR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Epidermal Growth Factor Receptor|EREG|ESR1 Malignant neoplasm of breast
PREDISPOSES,CASP8 gene|CASP8,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CASP8 gene|CASP8 Malignant neoplasm of breast
PREDISPOSES,Estrogen Receptor beta,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptor beta Malignant neoplasm of breast
PREDISPOSES,Glutathione S-Transferase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Glutathione S-Transferase Malignant neoplasm of breast
DISRUPTS,BHMT gene|BHMT,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BHMT gene|BHMT Malignant neoplasm of breast
PREDISPOSES,CXCL12 gene|CXCL12,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CXCL12 gene|CXCL12 Malignant neoplasm of breast
AFFECTS,Phytochemical,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Phytochemical Malignant neoplasm of breast
PREDISPOSES,DNA Adducts,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",DNA Adducts Malignant neoplasm of breast
CAUSES,PTEN gene|PTEN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PTEN gene|PTEN Malignant neoplasm of breast
AUGMENTS,Candidate Disease Gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Candidate Disease Gene Malignant neoplasm of breast
PREDISPOSES,ESTROGEN USE,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,ESTROGEN USE Malignant neoplasm of breast
AFFECTS,Mutation,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,"Element, Ion, or Isotope",Mutation Familial cancer of breast
AFFECTS,Cyclooxygenase 2 Inhibitors,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Cyclooxygenase 2 Inhibitors Breast Carcinoma
AFFECTS,Tumorigenicity,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Tumorigenicity Malignant neoplasm of breast
AFFECTS,Small Nucleolar RNA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Small Nucleolar RNA Malignant neoplasm of breast
AFFECTS,Protein p53|TP53,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Protein p53|TP53 Malignant neoplasm of breast
PREDISPOSES,DNA Repair Gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,DNA Repair Gene Malignant neoplasm of breast
AUGMENTS,Matrix Metalloproteinases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Matrix Metalloproteinases Malignant neoplasm of breast
AFFECTS,gene polymorphism,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,gene polymorphism Malignant neoplasm of breast
CAUSES,MicroRNAs,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",MicroRNAs Malignant neoplasm of breast
CAUSES,TP53 gene|TP53,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Gene or Genome,"TP53 gene|TP53 Carcinoma, Ductal, Breast"
PREDISPOSES,Hypertensive disease,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Hypertensive disease Malignant neoplasm of breast
AFFECTS,Malignant Bone Neoplasm,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Malignant Bone Neoplasm Breast cancer metastatic
CAUSES,Endocrine Disruptors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Endocrine Disruptors Malignant neoplasm of breast
PREDISPOSES,Cardiovascular Diseases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Cardiovascular Diseases Malignant neoplasm of breast
DISRUPTS,MIRN34A gene|MIR34A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIRN34A gene|MIR34A Malignant neoplasm of breast
AFFECTS,systemic administration,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",systemic administration Malignant neoplasm of breast
PREDISPOSES,progesterone receptor positive,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,progesterone receptor positive Malignant neoplasm of breast
PREDISPOSES,Alcohol consumption,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,"Element, Ion, or Isotope",Alcohol consumption Contralateral breast cancer
AUGMENTS,Cholesterol,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Lipid,Cholesterol Breast cancer metastatic
AFFECTS,Epidermal growth factor receptor inhibitor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Epidermal growth factor receptor inhibitor Malignant neoplasm of breast
AFFECTS,Vitamin D3 Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Vitamin D3 Receptor Malignant neoplasm of breast
AFFECTS,Receptor Activation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Receptor Activation Malignant neoplasm of breast
DISRUPTS,Epidermal growth factor receptor inhibitor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Epidermal growth factor receptor inhibitor Malignant neoplasm of breast
AFFECTS,Secondary malignant neoplasm of lymph node,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Secondary malignant neoplasm of lymph node Malignant neoplasm of breast
PREDISPOSES,F3 gene|F3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,F3 gene|F3 Malignant neoplasm of breast
AUGMENTS,RSU1 gene|RSU1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RSU1 gene|RSU1 Malignant neoplasm of breast
CAUSES,3' Untranslated Regions,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",3' Untranslated Regions Malignant neoplasm of breast
AFFECTS,Induction,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Induction Malignant neoplasm of breast
AFFECTS,Paget's Disease,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Paget's Disease Malignant neoplasm of breast
AFFECTS,curdione,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",curdione Malignant neoplasm of breast
PREDISPOSES,GATA3 gene|GATA3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GATA3 gene|GATA3 Malignant neoplasm of breast
DISRUPTS,Response Elements,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Response Elements Malignant neoplasm of breast
DISRUPTS,LOH11CR2A gene|VWA5A,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,LOH11CR2A gene|VWA5A Breast cancer metastatic
PREDISPOSES,Tumor Suppressor Genes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Tumor Suppressor Genes Malignant neoplasm of breast
AFFECTS,Prevention,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Prevention Malignant neoplasm of breast
AFFECTS,PTPN12 gene|PTPN12,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PTPN12 gene|PTPN12 Malignant neoplasm of breast
CAUSES,Extracellular Protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Extracellular Protein Malignant neoplasm of breast
AFFECTS,Functional RNA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Functional RNA Malignant neoplasm of breast
AFFECTS,Estrogen Receptor beta|ESR2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptor beta|ESR2 Malignant neoplasm of breast
PREDISPOSES,FOXC1 gene|FOXC1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FOXC1 gene|FOXC1 Malignant neoplasm of breast
AFFECTS,Infiltration,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Infiltration Breast cancer metastatic
CAUSES,Therapeutic agent (substance),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical Viewed Functionally,Therapeutic agent (substance) Malignant neoplasm of breast
AFFECTS,DNA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",DNA Malignant neoplasm of breast
CAUSES,Neoplasm Metastasis,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Neoplasm Metastasis Breast cancer metastatic
PREDISPOSES,DNA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",DNA Malignant neoplasm of breast
PREDISPOSES,Hyperandrogenemia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Hyperandrogenemia Malignant neoplasm of breast
DISRUPTS,RAB8A gene|RAB8A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RAB8A gene|RAB8A Malignant neoplasm of breast
AUGMENTS,ZYX gene|ZYX,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ZYX gene|ZYX Malignant neoplasm of breast
PREDISPOSES,NCOR2 gene|NCOR2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NCOR2 gene|NCOR2 Malignant neoplasm of breast
AFFECTS,Ethacrynic Acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Ethacrynic Acid Malignant neoplasm of breast
AFFECTS,Exertion,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Exertion Malignant neoplasm of breast
PREDISPOSES,"MAPK14 protein, human|MAPK14",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","MAPK14 protein, human|MAPK14 Malignant neoplasm of breast"
DISRUPTS,Functional RNA,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Functional RNA Breast Carcinoma
PREDISPOSES,Disease,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Disease or Syndrome,Disease Breast Carcinoma
DISRUPTS,Fibroblast Growth Factor Receptors,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Biologically Active Substance,Fibroblast Growth Factor Receptors Breast cancer metastatic
PREDISPOSES,Dehydration,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Dehydration Malignant neoplasm of breast
PREDISPOSES,Steroids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Steroid,Steroids Malignant neoplasm of breast
CAUSES,Progesterone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Progesterone Malignant neoplasm of breast
PREDISPOSES,Tumor Cell Invasion,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,Tumor Cell Invasion Breast cancer invasive NOS
PREDISPOSES,Transforming Growth Factor beta Receptors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Transforming Growth Factor beta Receptors Malignant neoplasm of breast
AFFECTS,Forkhead Transcription Factors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Forkhead Transcription Factors Malignant neoplasm of breast
AFFECTS,zoledronic acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,zoledronic acid Malignant neoplasm of breast
AUGMENTS,"Ribosomal Protein S6 Kinases, 70-kDa|RPS6KB1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","Ribosomal Protein S6 Kinases, 70-kDa|RPS6KB1 Malignant neoplasm of breast"
CAUSES,Metalloproteases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Metalloproteases Malignant neoplasm of breast
AFFECTS,"Receptors, Progesterone|PGR",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,"Receptors, Progesterone|PGR Malignant neoplasm of breast"
PREDISPOSES,vasodilator-stimulated phosphoprotein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",vasodilator-stimulated phosphoprotein Malignant neoplasm of breast
PREDISPOSES,anastrozole,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Pharmacologic Substance,anastrozole Breast cancer invasive NOS
AFFECTS,Transforming Growth Factor beta|TGFB1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Transforming Growth Factor beta|TGFB1 Malignant neoplasm of breast
PREDISPOSES,Neoantigen,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Immunologic Factor,Neoantigen Inflammatory Breast Carcinoma
PREDISPOSES,TNFRSF6B gene|TNFRSF6B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TNFRSF6B gene|TNFRSF6B Malignant neoplasm of breast
PREDISPOSES,XRCC3 gene|XRCC3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,XRCC3 gene|XRCC3 Malignant neoplasm of breast
AFFECTS,prevention through information dissemination,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",prevention through information dissemination Malignant neoplasm of breast
AFFECTS,Metaplastic Breast Carcinoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Metaplastic Breast Carcinoma Malignant neoplasm of breast
AFFECTS,Cytotoxic Chemotherapy,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Hazardous or Poisonous Substance,Cytotoxic Chemotherapy Breast cancer metastatic
PREDISPOSES,"Fatty Acids, Omega-3",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,"Fatty Acids, Omega-3 Malignant neoplasm of breast"
PREDISPOSES,CA-15-3 Antigen,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Immunologic Factor,CA-15-3 Antigen Breast cancer recurrent
AFFECTS,tumor growth,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,tumor growth Malignant neoplasm of breast
AFFECTS,Genes,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,Genes Noninfiltrating Intraductal Carcinoma
PREDISPOSES,Aromatase Inhibitors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Aromatase Inhibitors Malignant neoplasm of breast
AFFECTS,Transforming Growth Factor beta,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Biologically Active Substance,Transforming Growth Factor beta Breast cancer metastatic
AFFECTS,Signal Transduction Pathways,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Element, Ion, or Isotope",Signal Transduction Pathways Breast cancer invasive NOS
AFFECTS,RUNX1 gene|RUNX1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RUNX1 gene|RUNX1 Malignant neoplasm of breast
DISRUPTS,hepatocellular carcinoma protein 1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",hepatocellular carcinoma protein 1 Breast cancer metastatic
AFFECTS,"RNA, Messenger",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","RNA, Messenger Malignant neoplasm of breast"
PREDISPOSES,Regulatory Element,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Regulatory Element Malignant neoplasm of breast
AFFECTS,MIR gene|MLXIP|MYLIP|MARCH8,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIR gene|MLXIP|MYLIP|MARCH8 Malignant neoplasm of breast
PREDISPOSES,Cytotoxic T-Lymphocyte-Associated Protein 4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hazardous or Poisonous Substance,Cytotoxic T-Lymphocyte-Associated Protein 4 Malignant neoplasm of breast
AFFECTS,Malignant neoplasm of breast,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Neoplastic Process,Malignant neoplasm of breast Noninfiltrating Intraductal Carcinoma
AFFECTS,OBSCN gene|OBSCN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,OBSCN gene|OBSCN Malignant neoplasm of breast
DISRUPTS,STAT5A gene|STAT5A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,STAT5A gene|STAT5A Malignant neoplasm of breast
AFFECTS,Secondary malignant neoplasm of bone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Secondary malignant neoplasm of bone Malignant neoplasm of breast
PREDISPOSES,AKT2 gene|AKT2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,AKT2 gene|AKT2 Malignant neoplasm of breast
AFFECTS,GPR1 gene|GPR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GPR1 gene|GPR1 Malignant neoplasm of breast
PREDISPOSES,DNAJB4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",DNAJB4 Malignant neoplasm of breast
PREDISPOSES,PLAUR gene|PLAUR,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Gene or Genome,PLAUR gene|PLAUR Breast cancer recurrent
PREDISPOSES,SHH gene|SHH,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SHH gene|SHH Malignant neoplasm of breast
PREDISPOSES,trastuzumab,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,trastuzumab Malignant neoplasm of breast
PREDISPOSES,Phosphoproteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Phosphoproteins Malignant neoplasm of breast
PREDISPOSES,MicroRNAs,"cellular diagnosis, breast cancer",0.0,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","MicroRNAs cellular diagnosis, breast cancer"
COMPLICATES,"Lung Diseases, Interstitial",Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Disease or Syndrome,"Lung Diseases, Interstitial Breast cancer recurrent"
CAUSES,BRCA2 gene|BRCA2,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,Gene or Genome,BRCA2 gene|BRCA2 Familial cancer of breast
AFFECTS,depolarization,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",depolarization Malignant neoplasm of breast
AUGMENTS,MERTK gene|MERTK,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MERTK gene|MERTK Malignant neoplasm of breast
PREDISPOSES,Vitamin B 12,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Vitamin B 12 Malignant neoplasm of breast
DISRUPTS,Peptides,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Peptides Malignant neoplasm of breast
DISRUPTS,Cyclic AMP-Responsive DNA-Binding Protein,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Cyclic AMP-Responsive DNA-Binding Protein Breast cancer metastatic
AFFECTS,Variation (Genetics),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Variation (Genetics) Malignant neoplasm of breast
AFFECTS,"Genes, X-Linked",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,"Genes, X-Linked Malignant neoplasm of breast"
DISRUPTS,"PDGFA protein, human|PDGFA",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","PDGFA protein, human|PDGFA Malignant neoplasm of breast"
AFFECTS,"Biological function, NOS",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Biological function, NOS Malignant neoplasm of breast"
PREDISPOSES,CYP3A4 gene|CYP3A4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CYP3A4 gene|CYP3A4 Malignant neoplasm of breast
DISRUPTS,CXCL13 gene|CXCL13,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CXCL13 gene|CXCL13 Malignant neoplasm of breast
AFFECTS,"Carcinoma, Non-Small-Cell Lung",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,"Carcinoma, Non-Small-Cell Lung Malignant neoplasm of breast"
AFFECTS,Small cell carcinoma of lung,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Small cell carcinoma of lung Malignant neoplasm of breast
AUGMENTS,PTHLH gene|PTHLH,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PTHLH gene|PTHLH Malignant neoplasm of breast
PREDISPOSES,BRCA1 gene|BRCA1,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,Gene or Genome,BRCA1 gene|BRCA1 Familial cancer of breast
AFFECTS,Topoisomerase Inhibitors,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Enzyme,Topoisomerase Inhibitors Breast Carcinoma
AFFECTS,ERBB2 gene|ERBB2,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Gene or Genome,ERBB2 gene|ERBB2 Breast cancer invasive NOS
AFFECTS,Radionuclide Imaging,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Radionuclide Imaging Malignant neoplasm of breast
AFFECTS,cyclooxygenase 2,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",cyclooxygenase 2 Noninfiltrating Intraductal Carcinoma
AFFECTS,DNAJC2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",DNAJC2 Malignant neoplasm of breast
AFFECTS,CDKN1A gene|CDKN1A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CDKN1A gene|CDKN1A Malignant neoplasm of breast
PREDISPOSES,TYMS gene|TYMS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TYMS gene|TYMS Malignant neoplasm of breast
DISRUPTS,"sal protein, Drosophila",Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Amino Acid, Peptide, or Protein","sal protein, Drosophila Breast cancer invasive NOS"
PREDISPOSES,Gonadal Steroid Hormones,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Gonadal Steroid Hormones Malignant neoplasm of breast
PREDISPOSES,Endocrine substance,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Endocrine substance Malignant neoplasm of breast
PREDISPOSES,EGFL6 gene|EGFL6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,EGFL6 gene|EGFL6 Malignant neoplasm of breast
AFFECTS,Focal Adhesion Protein-Tyrosine Kinases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Focal Adhesion Protein-Tyrosine Kinases Malignant neoplasm of breast
PREDISPOSES,MULTISECTION:FINDING:POINT IN TIME:BREAST:NARRATIVE:MRI,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",MULTISECTION:FINDING:POINT IN TIME:BREAST:NARRATIVE:MRI Malignant neoplasm of breast
AFFECTS,NOTCH1 gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NOTCH1 gene Malignant neoplasm of breast
AFFECTS,blood lipid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Lipid,blood lipid Malignant neoplasm of breast
PREDISPOSES,ESR2 gene|ESR2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ESR2 gene|ESR2 Malignant neoplasm of breast
PREDISPOSES,Inflammation Mediators,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Inflammation Mediators Malignant neoplasm of breast
AFFECTS,"UBD protein, human|UBD",Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein","UBD protein, human|UBD Breast cancer metastatic"
AFFECTS,Mammary Tumorigenesis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Mammary Tumorigenesis Malignant neoplasm of breast
PREDISPOSES,DNA Modification Methylases|DNMT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",DNA Modification Methylases|DNMT1 Malignant neoplasm of breast
AFFECTS,"FRAP1 protein, human|MTOR",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","FRAP1 protein, human|MTOR Malignant neoplasm of breast"
PREDISPOSES,"VEGF protein, human|VEGFA",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","VEGF protein, human|VEGFA Malignant neoplasm of breast"
PREDISPOSES,Estrogenic effect,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Estrogenic effect Malignant neoplasm of breast
PREDISPOSES,Membrane Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Membrane Proteins Malignant neoplasm of breast
AFFECTS,cell invasion,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",cell invasion Malignant neoplasm of breast
CAUSES,lysophosphatidic acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,lysophosphatidic acid Malignant neoplasm of breast
AUGMENTS,MMP9 gene|MMP9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MMP9 gene|MMP9 Malignant neoplasm of breast
PREDISPOSES,Postmenopausal syndrome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Postmenopausal syndrome Malignant neoplasm of breast
AFFECTS,Succinate Dehydrogenase|SARDH|SDHB|SDS,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Succinate Dehydrogenase|SARDH|SDHB|SDS Sporadic Breast Carcinoma
AFFECTS,Estrogen hormone therapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Estrogen hormone therapy Malignant neoplasm of breast
PREDISPOSES,"Pleural Effusion, Malignant",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,"Pleural Effusion, Malignant Malignant neoplasm of breast"
AUGMENTS,SULF2 gene|SULF2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SULF2 gene|SULF2 Malignant neoplasm of breast
AFFECTS,BAX gene|BAX,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BAX gene|BAX Malignant neoplasm of breast
AFFECTS,Hormone replacement therapy,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Hormone,Hormone replacement therapy Breast Carcinoma
AFFECTS,Uterine Cancer,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Uterine Cancer Malignant neoplasm of breast
AFFECTS,"VEGF protein, human|VEGFA",Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein","VEGF protein, human|VEGFA Breast Carcinoma"
AFFECTS,Lactation,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Lactation Breast Carcinoma
AFFECTS,genetic aspects,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,genetic aspects Malignant neoplasm of breast
CAUSES,Sulfuric Acid Esters,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Sulfuric Acid Esters Malignant neoplasm of breast
PREDISPOSES,CDKN2A gene|CDKN2A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CDKN2A gene|CDKN2A Malignant neoplasm of breast
CAUSES,Steroid hormone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Steroid hormone Malignant neoplasm of breast
AFFECTS,Reexcision,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",Reexcision Noninfiltrating Intraductal Carcinoma
AUGMENTS,GSTT1 gene|GSTT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GSTT1 gene|GSTT1 Malignant neoplasm of breast
PREDISPOSES,"Anti-Inflammatory Agents, Non-Steroidal",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical Viewed Functionally,"Anti-Inflammatory Agents, Non-Steroidal Malignant neoplasm of breast"
PREDISPOSES,GSTP1 gene|GSTP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GSTP1 gene|GSTP1 Malignant neoplasm of breast
AFFECTS,"TACSTD2 protein, human|TACSTD2",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","TACSTD2 protein, human|TACSTD2 Malignant neoplasm of breast"
CAUSES,VEGF gene|VEGFA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,VEGF gene|VEGFA Malignant neoplasm of breast
PREDISPOSES,Progesterone Receptor Status,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Progesterone Receptor Status Malignant neoplasm of breast
AFFECTS,Proto-Oncogene Proteins c-akt|AKT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Proto-Oncogene Proteins c-akt|AKT1 Malignant neoplasm of breast
PREDISPOSES,Progesterone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Progesterone Malignant neoplasm of breast
AFFECTS,Malignant neoplasm of breast,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,Malignant neoplasm of breast Breast cancer invasive NOS
AFFECTS,Up-Regulation (Physiology),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Up-Regulation (Physiology) Malignant neoplasm of breast
PREDISPOSES,ERCC5 gene|ERCC5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ERCC5 gene|ERCC5 Malignant neoplasm of breast
AFFECTS,Secondary malignant neoplasm of liver,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Secondary malignant neoplasm of liver Malignant neoplasm of breast
AFFECTS,RHOA gene|RHOA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RHOA gene|RHOA Malignant neoplasm of breast
PREDISPOSES,LGMN gene|LGMN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LGMN gene|LGMN Malignant neoplasm of breast
PREDISPOSES,Antihypertensive Agents,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical Viewed Functionally,Antihypertensive Agents Malignant neoplasm of breast
AFFECTS,Gonadal Steroid Hormones,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Gonadal Steroid Hormones Malignant neoplasm of breast
PREDISPOSES,"Antigens, CD5",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Immunologic Factor,"Antigens, CD5 Malignant neoplasm of breast"
AFFECTS,MicroRNAs,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",MicroRNAs Carcinoma of Male Breast
AUGMENTS,MicroRNAs,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",MicroRNAs Malignant neoplasm of breast
AUGMENTS,Tumor Antigens,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Neoplastic Process,Tumor Antigens Noninfiltrating Intraductal Carcinoma
PREDISPOSES,Recreation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Recreation Malignant neoplasm of breast
AFFECTS,Tumor Angiogenesis,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Gene or Genome,Tumor Angiogenesis Breast cancer invasive NOS
AFFECTS,Angiotensin-Converting Enzyme Inhibitors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Enzyme,Angiotensin-Converting Enzyme Inhibitors Malignant neoplasm of breast
AFFECTS,"VEGF protein, human|VEGFA",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","VEGF protein, human|VEGFA Malignant neoplasm of breast"
AFFECTS,Ablation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Ablation Malignant neoplasm of breast
AFFECTS,Detection,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Detection Malignant neoplasm of breast
AUGMENTS,Aromatase Inhibitors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Aromatase Inhibitors Malignant neoplasm of breast
AUGMENTS,BRCA2 gene|BRCA2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BRCA2 gene|BRCA2 Malignant neoplasm of breast
PREDISPOSES,Breast Diseases,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Disease or Syndrome,Breast Diseases Breast Carcinoma
PREDISPOSES,Angiotensin-Converting Enzyme Inhibitors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Enzyme,Angiotensin-Converting Enzyme Inhibitors Malignant neoplasm of breast
CAUSES,Estrogen Antagonists,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Hormone,Estrogen Antagonists Breast Carcinoma
PREDISPOSES,IGFBP3 gene|IGFBP3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IGFBP3 gene|IGFBP3 Malignant neoplasm of breast
AUGMENTS,RHOC gene|RHOC,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RHOC gene|RHOC Malignant neoplasm of breast
PREDISPOSES,Promoter Regions (Genetics),Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,Promoter Regions (Genetics) Breast Carcinoma
PREDISPOSES,Disease,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Disease or Syndrome,Disease Breast cancer invasive NOS
PREDISPOSES,Malignant Neoplasms,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Malignant Neoplasms Malignant neoplasm of breast
PREDISPOSES,Cyclooxygenase 2 Inhibitors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Cyclooxygenase 2 Inhibitors Malignant neoplasm of breast
PREDISPOSES,Antidepressive Agents,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical Viewed Functionally,Antidepressive Agents Malignant neoplasm of breast
CAUSES,mammary tumor virus,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,mammary tumor virus Malignant neoplasm of breast
PREDISPOSES,"KLK15 protein, human|KLK15",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","KLK15 protein, human|KLK15 Malignant neoplasm of breast"
PREDISPOSES,IL6 gene|IL6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IL6 gene|IL6 Malignant neoplasm of breast
AFFECTS,Positron-Emission Tomography,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Positron-Emission Tomography Malignant neoplasm of breast
AUGMENTS,Insulin-Like Growth Factor I,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Insulin-Like Growth Factor I Malignant neoplasm of breast
PREDISPOSES,PRLR gene|PRLR|PTP4A3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PRLR gene|PRLR|PTP4A3 Malignant neoplasm of breast
PREDISPOSES,LOC118430 gene,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,LOC118430 gene Breast cancer metastatic
CAUSES,Endometrial Carcinoma,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Endometrial Carcinoma Breast Carcinoma
AFFECTS,Exploration procedure,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Exploration procedure Malignant neoplasm of breast
PREDISPOSES,SHC1 gene|SHC1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SHC1 gene|SHC1 Malignant neoplasm of breast
PREDISPOSES,Hormone Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Hormone Receptor Malignant neoplasm of breast
PREDISPOSES,ELF3 gene|ELF3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ELF3 gene|ELF3 Malignant neoplasm of breast
PREDISPOSES,"Fatty Acids, Saturated",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,"Fatty Acids, Saturated Malignant neoplasm of breast"
AUGMENTS,Antidepressive Agents,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical Viewed Functionally,Antidepressive Agents Malignant neoplasm of breast
AFFECTS,BMP7 gene|BMP7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BMP7 gene|BMP7 Malignant neoplasm of breast
AFFECTS,Complication,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Complication Malignant neoplasm of breast
AFFECTS,Low Dose Radiation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Low Dose Radiation Malignant neoplasm of breast
PREDISPOSES,HPR gene|HPR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HPR gene|HPR Malignant neoplasm of breast
AFFECTS,soy protein isolate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",soy protein isolate Malignant neoplasm of breast
AFFECTS,Endocrine Disruptors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Endocrine Disruptors Malignant neoplasm of breast
PREDISPOSES,soy protein isolate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",soy protein isolate Malignant neoplasm of breast
AFFECTS,Folic Acid Deficiency,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Folic Acid Deficiency Malignant neoplasm of breast
PREDISPOSES,"NUP214 protein, human|NUP214",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","NUP214 protein, human|NUP214 Malignant neoplasm of breast"
PREDISPOSES,CCNE1 gene|CCNE1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CCNE1 gene|CCNE1 Malignant neoplasm of breast
AFFECTS,Genes,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,Gene or Genome,Genes Familial cancer of breast
PREDISPOSES,retinoic acid receptor beta 2,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Chemical,"retinoic acid receptor beta 2 Carcinoma, Ductal, Breast"
PREDISPOSES,CLOCK gene|CLOCK,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CLOCK gene|CLOCK Malignant neoplasm of breast
AUGMENTS,Proto-Oncogene Proteins c-akt|AKT1,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,Proto-Oncogene Proteins c-akt|AKT1 Noninfiltrating Intraductal Carcinoma
AFFECTS,pulmonary complications,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",pulmonary complications Malignant neoplasm of breast
AFFECTS,mRNA Expression,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",mRNA Expression Malignant neoplasm of breast
DISRUPTS,Gonadal Steroid Hormones,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Gonadal Steroid Hormones Malignant neoplasm of breast
PREDISPOSES,RHOA gene|RHOA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RHOA gene|RHOA Malignant neoplasm of breast
AFFECTS,Fine needle aspiration biopsy,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Fine needle aspiration biopsy Breast Carcinoma
AFFECTS,Oncogene ErbB2|ERBB2|NEU1|NEURL1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Oncogene ErbB2|ERBB2|NEU1|NEURL1 Malignant neoplasm of breast
PREDISPOSES,Low glycemic index food,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Low glycemic index food Malignant neoplasm of breast
PREDISPOSES,Encounter due to In vitro fertilization,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Encounter due to In vitro fertilization Malignant neoplasm of breast
AFFECTS,ovarian cancer prevention,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ovarian cancer prevention Malignant neoplasm of breast
AFFECTS,Endocrine therapy,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Hormone,Endocrine therapy Breast cancer invasive NOS
AFFECTS,Transforming Growth Factor beta,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Transforming Growth Factor beta Malignant neoplasm of breast
CAUSES,Insulin-Like Growth Factor I,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Insulin-Like Growth Factor I Malignant neoplasm of breast
CAUSES,HGS gene|HGS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HGS gene|HGS Malignant neoplasm of breast
PREDISPOSES,hypercholesterolemia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Lipid,hypercholesterolemia Malignant neoplasm of breast
PREDISPOSES,Gross' disease,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Gross' disease Malignant neoplasm of breast
PREDISPOSES,Mucin 1 protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Mucin 1 protein Malignant neoplasm of breast
AFFECTS,Metastatic malignant neoplasm to brain,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Metastatic malignant neoplasm to brain Malignant neoplasm of breast
AFFECTS,Ductal Carcinoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Ductal Carcinoma Malignant neoplasm of breast
PREDISPOSES,abnormal glucose tolerance test,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Carbohydrate,abnormal glucose tolerance test Malignant neoplasm of breast
PREDISPOSES,Functional RNA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Functional RNA Malignant neoplasm of breast
AUGMENTS,Cadmium,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Inorganic Chemical,Cadmium Malignant neoplasm of breast
PREDISPOSES,PPARG gene|PPARG,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PPARG gene|PPARG Malignant neoplasm of breast
PREDISPOSES,LOX gene|LOX,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LOX gene|LOX Malignant neoplasm of breast
AFFECTS,Human papilloma virus infection,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Human papilloma virus infection Malignant neoplasm of breast
AFFECTS,3' Untranslated Regions,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",3' Untranslated Regions Malignant neoplasm of breast
DISRUPTS,Cyclooxygenase Inhibitors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Cyclooxygenase Inhibitors Malignant neoplasm of breast
AFFECTS,Antigens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Immunologic Factor,Antigens Malignant neoplasm of breast
PREDISPOSES,C-reactive protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",C-reactive protein Malignant neoplasm of breast
PREDISPOSES,TNF gene|TNF,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TNF gene|TNF Malignant neoplasm of breast
PREDISPOSES,Carcinoembryonic Antigen|CEACAM5|CEACAM3|PSG2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Immunologic Factor,Carcinoembryonic Antigen|CEACAM5|CEACAM3|PSG2 Malignant neoplasm of breast
AFFECTS,BRCA2 Mutation,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Gene or Genome,BRCA2 Mutation Sporadic Breast Carcinoma
PREDISPOSES,STN gene|EEF1A2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,STN gene|EEF1A2 Malignant neoplasm of breast
AFFECTS,Depressive disorder,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Depressive disorder Malignant neoplasm of breast
PREDISPOSES,Ascorbic Acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Ascorbic Acid Malignant neoplasm of breast
PREDISPOSES,Estrogen Receptors,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptors Breast Carcinoma
PREDISPOSES,Thyroid dysfunction,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Thyroid dysfunction Malignant neoplasm of breast
CAUSES,NMU gene|NMU,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NMU gene|NMU Malignant neoplasm of breast
AFFECTS,Motion,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Motion Malignant neoplasm of breast
PREDISPOSES,PTGS2 gene|PTGS2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,PTGS2 gene|PTGS2 Breast cancer metastatic
AFFECTS,breast cancer diagnosis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,breast cancer diagnosis Malignant neoplasm of breast
AFFECTS,"RNA, circular",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","RNA, circular Malignant neoplasm of breast"
AFFECTS,ELK3 gene|ELK3|KCNH8,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ELK3 gene|ELK3|KCNH8 Malignant neoplasm of breast
DISRUPTS,Metastasis Suppressor Genes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Metastasis Suppressor Genes Malignant neoplasm of breast
AUGMENTS,Estrogen Receptor alpha|EREG|ESR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptor alpha|EREG|ESR1 Malignant neoplasm of breast
AFFECTS,Oral contraception,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Oral contraception Malignant neoplasm of breast
AFFECTS,Reduction mammaplasty,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,"Element, Ion, or Isotope",Reduction mammaplasty Contralateral breast cancer
AFFECTS,Excision,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",Excision Noninfiltrating Intraductal Carcinoma
DISRUPTS,ELK3 gene|ELK3|KCNH8,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ELK3 gene|ELK3|KCNH8 Malignant neoplasm of breast
DISRUPTS,Transforming Growth Factor beta,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Transforming Growth Factor beta Malignant neoplasm of breast
AFFECTS,CCND1 gene|CCND1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CCND1 gene|CCND1 Malignant neoplasm of breast
PREDISPOSES,Zn-alpha-2-glycoprotein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Zn-alpha-2-glycoprotein Malignant neoplasm of breast
AFFECTS,Nuclear Hormone Receptors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Nuclear Hormone Receptors Malignant neoplasm of breast
PREDISPOSES,Inflammation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Inflammation Malignant neoplasm of breast
AFFECTS,KISS1 gene|KISS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,KISS1 gene|KISS1 Malignant neoplasm of breast
PREDISPOSES,Protein Subunits,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Protein Subunits Malignant neoplasm of breast
CAUSES,BRCA1 gene|BRCA1,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Gene or Genome,BRCA1 gene|BRCA1 Sporadic Breast Carcinoma
AFFECTS,zoledronic acid,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Chemical,zoledronic acid Breast cancer invasive NOS
PREDISPOSES,Estrogen Receptor 1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptor 1 Malignant neoplasm of breast
AFFECTS,"Tomography, Emission-Computed",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Tomography, Emission-Computed Malignant neoplasm of breast"
PREDISPOSES,"Metals, Heavy",Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Element, Ion, or Isotope","Metals, Heavy Breast cancer invasive NOS"
PREDISPOSES,Migraine Disorders,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Disease or Syndrome,Migraine Disorders Breast cancer invasive NOS
AFFECTS,PRLR gene|PRLR|PTP4A3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PRLR gene|PRLR|PTP4A3 Malignant neoplasm of breast
PREDISPOSES,HIF1A gene|HIF1A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HIF1A gene|HIF1A Malignant neoplasm of breast
PREDISPOSES,Dioxygenases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Dioxygenases Malignant neoplasm of breast
AFFECTS,cyclooxygenase 2,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,"Element, Ion, or Isotope","cyclooxygenase 2 Carcinoma, Ductal, Breast"
DISRUPTS,Cyclooxygenase 2 Inhibitors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Cyclooxygenase 2 Inhibitors Malignant neoplasm of breast
PREDISPOSES,"Antidepressive Agents, Tricyclic",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical Viewed Functionally,"Antidepressive Agents, Tricyclic Malignant neoplasm of breast"
PREDISPOSES,Oncogene Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Oncogene Proteins Malignant neoplasm of breast
PREDISPOSES,anastrozole,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,anastrozole Malignant neoplasm of breast
PREDISPOSES,Vitamins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Vitamins Malignant neoplasm of breast
PREDISPOSES,mullerian-inhibiting hormone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,mullerian-inhibiting hormone Malignant neoplasm of breast
AUGMENTS,XRCC1 gene|XRCC1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,XRCC1 gene|XRCC1 Malignant neoplasm of breast
AFFECTS,Dissection,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Dissection Malignant neoplasm of breast
PREDISPOSES,XRCC2 gene|XRCC2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,XRCC2 gene|XRCC2 Malignant neoplasm of breast
AFFECTS,Estrogens,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Hormone,Estrogens Noninfiltrating Intraductal Carcinoma
DISRUPTS,DNA Repair Gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,DNA Repair Gene Malignant neoplasm of breast
PREDISPOSES,Non-Invasive Lesion,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",Non-Invasive Lesion Noninfiltrating Intraductal Carcinoma
DISRUPTS,trastuzumab,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,trastuzumab Malignant neoplasm of breast
AFFECTS,Hormone Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Hormone Receptor Malignant neoplasm of breast
PREDISPOSES,Blood hormone levels,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Blood hormone levels Malignant neoplasm of breast
PREDISPOSES,Chemopreventive Agent,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical Viewed Functionally,Chemopreventive Agent Malignant neoplasm of breast
CAUSES,Malignant Neoplasms,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Malignant Neoplasms Breast Carcinoma
AFFECTS,Progesterone,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Hormone,Progesterone Breast cancer metastatic
PREDISPOSES,Lesion,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Lesion Breast Carcinoma
AFFECTS,"Polymorphism, Genetic",Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,"Polymorphism, Genetic Breast Carcinoma"
PREDISPOSES,GH1 gene|GH1,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,GH1 gene|GH1 Breast Carcinoma
CAUSES,Glucose,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Carbohydrate,Glucose Malignant neoplasm of breast
AFFECTS,Untranslated Regions,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Untranslated Regions Malignant neoplasm of breast
AFFECTS,Virus Diseases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Virus,Virus Diseases Malignant neoplasm of breast
AFFECTS,Epidermal Growth Factor Receptor|EGFR,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Biologically Active Substance,Epidermal Growth Factor Receptor|EGFR Breast cancer metastatic
PREDISPOSES,Angiogenesis Factor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Angiogenesis Factor Malignant neoplasm of breast
PREDISPOSES,Genes,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,Genes Breast Carcinoma
AFFECTS,25-hydroxyvitamin D,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,25-hydroxyvitamin D Malignant neoplasm of breast
DISRUPTS,Genes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Genes Malignant neoplasm of breast
AFFECTS,DNA topoisomerase II alpha|TOP2A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",DNA topoisomerase II alpha|TOP2A Malignant neoplasm of breast
DISRUPTS,MIRN150 gene|MIR150,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,MIRN150 gene|MIR150 Breast cancer metastatic
AFFECTS,Secondary malignant neoplasm of lung,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Secondary malignant neoplasm of lung Malignant neoplasm of breast
PREDISPOSES,Medroxyprogesterone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Medroxyprogesterone Malignant neoplasm of breast
AFFECTS,Invasive Carcinoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Invasive Carcinoma Malignant neoplasm of breast
PREDISPOSES,CYP2D6 gene|CYP2D6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CYP2D6 gene|CYP2D6 Malignant neoplasm of breast
CAUSES,Hormone Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Hormone Receptor Malignant neoplasm of breast
PREDISPOSES,Lipids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Lipid,Lipids Malignant neoplasm of breast
AFFECTS,Serotonin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neuroreactive Substance or Biogenic Amine,Serotonin Malignant neoplasm of breast
PREDISPOSES,SMAD3 gene|SMAD3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SMAD3 gene|SMAD3 Malignant neoplasm of breast
PREDISPOSES,IRF4 gene|IRF4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IRF4 gene|IRF4 Malignant neoplasm of breast
AFFECTS,Radiation therapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Radiation therapy Malignant neoplasm of breast
PREDISPOSES,Composition,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Composition Malignant neoplasm of breast
PREDISPOSES,CYP2D6 gene|CYP2D6,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Gene or Genome,CYP2D6 gene|CYP2D6 Breast cancer recurrent
PREDISPOSES,CXCR4 gene|CXCR4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CXCR4 gene|CXCR4 Malignant neoplasm of breast
AFFECTS,DNA Repair,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",DNA Repair Inflammatory Breast Carcinoma
PREDISPOSES,Proto-Oncogene Proteins c-akt|AKT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Proto-Oncogene Proteins c-akt|AKT1 Malignant neoplasm of breast
AFFECTS,Diagnostic radiologic examination,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",Diagnostic radiologic examination Noninfiltrating Intraductal Carcinoma
AUGMENTS,Environmental Estrogen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Environmental Estrogen Malignant neoplasm of breast
AFFECTS,collapsin response mediator protein-2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",collapsin response mediator protein-2 Malignant neoplasm of breast
PREDISPOSES,Vitamin D Deficiency,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Vitamin D Deficiency Malignant neoplasm of breast
PREDISPOSES,GSTT1 gene|GSTT1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,GSTT1 gene|GSTT1 Breast cancer metastatic
PREDISPOSES,Vitamin A intake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Vitamin A intake Malignant neoplasm of breast
PREDISPOSES,Genome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Genome Malignant neoplasm of breast
CAUSES,endogenous steroids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Steroid,endogenous steroids Malignant neoplasm of breast
DISRUPTS,Hetastarch,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Carbohydrate,Hetastarch Malignant neoplasm of breast
PREDISPOSES,Polyunsaturated Fatty Acids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Polyunsaturated Fatty Acids Malignant neoplasm of breast
PREDISPOSES,Carcinogens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hazardous or Poisonous Substance,Carcinogens Malignant neoplasm of breast
PREDISPOSES,DNA,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",DNA Breast cancer metastatic
CAUSES,Noninfiltrating Intraductal Carcinoma,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Neoplastic Process,"Noninfiltrating Intraductal Carcinoma Carcinoma, Ductal, Breast"
PREDISPOSES,XRCC3 gene|XRCC3,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,XRCC3 gene|XRCC3 Breast cancer metastatic
PREDISPOSES,G-T mismatch-binding protein|MSH6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",G-T mismatch-binding protein|MSH6 Malignant neoplasm of breast
AFFECTS,CCL1 gene|CCL1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CCL1 gene|CCL1 Malignant neoplasm of breast
PREDISPOSES,STAT3 gene|STAT3,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,STAT3 gene|STAT3 Breast cancer metastatic
PREDISPOSES,retinoic acid receptor beta 2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,retinoic acid receptor beta 2 Malignant neoplasm of breast
PREDISPOSES,ID2 gene|ID2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ID2 gene|ID2 Malignant neoplasm of breast
CAUSES,Functional RNA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Functional RNA Malignant neoplasm of breast
AFFECTS,Genetic Markers,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Genetic Markers Malignant neoplasm of breast
PREDISPOSES,Chronic inflammatory disorder,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Chronic inflammatory disorder Malignant neoplasm of breast
AFFECTS,PIK3CA gene|PIK3CA,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,PIK3CA gene|PIK3CA Breast cancer metastatic
PREDISPOSES,Trans Fatty Acids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Trans Fatty Acids Malignant neoplasm of breast
DISRUPTS,Protein phosphatase,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Protein phosphatase Breast cancer metastatic
AUGMENTS,K-ras Oncogene|KRAS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,K-ras Oncogene|KRAS Malignant neoplasm of breast
PREDISPOSES,DNA Sequence,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Nucleotide Sequence,DNA Sequence Malignant neoplasm of breast
AFFECTS,GTP-Binding Protein alpha Subunits,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",GTP-Binding Protein alpha Subunits Malignant neoplasm of breast
DISRUPTS,HOXC6 gene|HOXC6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HOXC6 gene|HOXC6 Malignant neoplasm of breast
AFFECTS,Peptide Nucleic Acids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Peptide Nucleic Acids Malignant neoplasm of breast
PREDISPOSES,Disease,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Disease or Syndrome,Disease Noninfiltrating Intraductal Carcinoma
DISRUPTS,anastrozole,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,anastrozole Malignant neoplasm of breast
DISRUPTS,Growth Hormone Receptor|GHR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Growth Hormone Receptor|GHR Malignant neoplasm of breast
AUGMENTS,Proto-Oncogene Proteins c-myc|MYC,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Proto-Oncogene Proteins c-myc|MYC Malignant neoplasm of breast
PREDISPOSES,Small Inducible Cytokine A18|CCL18,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Biologically Active Substance,Small Inducible Cytokine A18|CCL18 Breast cancer invasive NOS
AFFECTS,BRCA2 Mutation,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,BRCA2 Mutation Breast cancer metastatic
AFFECTS,Serum Proteins,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,"Amino Acid, Peptide, or Protein",Serum Proteins Carcinoma of Male Breast
CAUSES,STAR gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,STAR gene Malignant neoplasm of breast
AFFECTS,"Genes, ras",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,"Genes, ras Malignant neoplasm of breast"
CAUSES,MAFG gene|MAFG,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,MAFG gene|MAFG Breast Carcinoma
AFFECTS,TWIST1 gene|TWIST1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TWIST1 gene|TWIST1 Malignant neoplasm of breast
AFFECTS,Self-Examination,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Self-Examination Malignant neoplasm of breast
PREDISPOSES,PARVA gene|PARVA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PARVA gene|PARVA Malignant neoplasm of breast
DISRUPTS,CBFB gene|CBFB|NFYA|NFYB,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CBFB gene|CBFB|NFYA|NFYB Malignant neoplasm of breast
AFFECTS,Arachidonic Acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Arachidonic Acid Malignant neoplasm of breast
AFFECTS,Plant Preparations,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Plant Preparations Malignant neoplasm of breast
AFFECTS,leukemia,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Neoplastic Process,leukemia Inflammatory Breast Carcinoma
PREDISPOSES,Gastric Inhibitory Polypeptide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Gastric Inhibitory Polypeptide Malignant neoplasm of breast
AFFECTS,Tic disorder,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Tic disorder Malignant neoplasm of breast
AFFECTS,"RNA, Untranslated",Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","RNA, Untranslated Breast cancer invasive NOS"
PREDISPOSES,Disease susceptibility,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Disease susceptibility Malignant neoplasm of breast
CAUSES,"CHEK2 protein, human|CHEK2",Familial cancer of breast,0.0039960039960039,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CHEK2 protein, human|CHEK2 Familial cancer of breast"
AFFECTS,DNA Repair,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",DNA Repair Malignant neoplasm of breast
PREDISPOSES,Epstein-Barr Virus Infections,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Epstein-Barr Virus Infections Breast Carcinoma
PREDISPOSES,Tumor Cell Invasion,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Tumor Cell Invasion Breast cancer metastatic
CAUSES,Malignant neoplasm of lung,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Malignant neoplasm of lung Malignant neoplasm of breast
AUGMENTS,Anthracycline Antibiotics,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Antibiotic,Anthracycline Antibiotics Malignant neoplasm of breast
AUGMENTS,trastuzumab,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,trastuzumab Malignant neoplasm of breast
PREDISPOSES,Aromatase|CYP19A1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Enzyme,Aromatase|CYP19A1 Malignant neoplasm of breast
CAUSES,"Receptors, Steroid",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Steroid,"Receptors, Steroid Malignant neoplasm of breast"
PREDISPOSES,Insulin-Like Growth Factor II,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Insulin-Like Growth Factor II Malignant neoplasm of breast
PREDISPOSES,Medication use,Carcinoma in situ of breast,0.0019980019980019,Female Breast Cancer,Pharmacologic Substance,Medication use Carcinoma in situ of breast
AFFECTS,Vascular Endothelial Growth Factor Receptor-2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Vascular Endothelial Growth Factor Receptor-2 Malignant neoplasm of breast
CAUSES,Gonadal Steroid Hormones,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Gonadal Steroid Hormones Malignant neoplasm of breast
PREDISPOSES,MIRN34A gene|MIR34A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIRN34A gene|MIR34A Malignant neoplasm of breast
DISRUPTS,Ascorbic Acid,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Chemical,Ascorbic Acid Breast cancer metastatic
DISRUPTS,activated RNA polymerase II transcription cofactor 4|IFRD1|KRT6B|SUB1|PCSK4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",activated RNA polymerase II transcription cofactor 4|IFRD1|KRT6B|SUB1|PCSK4 Malignant neoplasm of breast
AFFECTS,Methyl-CpG-Binding Protein 2|MECP2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Methyl-CpG-Binding Protein 2|MECP2 Malignant neoplasm of breast
PREDISPOSES,Syndrome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Syndrome Malignant neoplasm of breast
AUGMENTS,RHOA gene|RHOA,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,RHOA gene|RHOA Breast cancer metastatic
AFFECTS,Functional assessment,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Functional assessment Malignant neoplasm of breast
DISRUPTS,MIR99A gene|MIR99A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIR99A gene|MIR99A Malignant neoplasm of breast
PREDISPOSES,27-hydroxycholesterol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Lipid,27-hydroxycholesterol Malignant neoplasm of breast
AFFECTS,CELF6 gene|CELF6,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,CELF6 gene|CELF6 Triple Negative Breast Neoplasms
AFFECTS,Menstruation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Menstruation Malignant neoplasm of breast
DISRUPTS,Mitogen-Activated Protein Kinase 3|MAPK3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Mitogen-Activated Protein Kinase 3|MAPK3 Malignant neoplasm of breast
AUGMENTS,DNMT3B gene|DNMT3B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,DNMT3B gene|DNMT3B Malignant neoplasm of breast
PREDISPOSES,MicroRNAs,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",MicroRNAs Breast Carcinoma
AFFECTS,RNA metabolic process,Carcinoma breast stage IV,0.0,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",RNA metabolic process Carcinoma breast stage IV
PREDISPOSES,Vascular Endothelial Growth Factors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Vascular Endothelial Growth Factors Malignant neoplasm of breast
PREDISPOSES,Bilateral Disease,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Bilateral Disease Malignant neoplasm of breast
PREDISPOSES,Paralogous Gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Paralogous Gene Malignant neoplasm of breast
AUGMENTS,PAK6 gene|PAK6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PAK6 gene|PAK6 Malignant neoplasm of breast
AUGMENTS,LINC00173 gene|LINC00173,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,LINC00173 gene|LINC00173 Triple Negative Breast Neoplasms
AFFECTS,Angiogenic Process,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Phenomenon or Process,Angiogenic Process Triple Negative Breast Neoplasms
AFFECTS,Positron Emission Tomography and Magnetic Resonance Imaging,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",Positron Emission Tomography and Magnetic Resonance Imaging HER2-positive carcinoma of breast
PREDISPOSES,Hypertriglyceridemic Waist,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Lipid,Hypertriglyceridemic Waist Malignant neoplasm of breast
PREDISPOSES,PDZRN4 gene|PDZRN4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PDZRN4 gene|PDZRN4 Malignant neoplasm of breast
CAUSES,BRD7 gene|BRD7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BRD7 gene|BRD7 Malignant neoplasm of breast
AFFECTS,KDM1A gene|KDM1A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,KDM1A gene|KDM1A Malignant neoplasm of breast
PREDISPOSES,MIR451A gene|MIR451A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIR451A gene|MIR451A Malignant neoplasm of breast
PREDISPOSES,Genes,Hereditary Breast and Ovarian Cancer Syndrome,0.0,Female Breast Cancer,Gene or Genome,Genes Hereditary Breast and Ovarian Cancer Syndrome
DISRUPTS,LINC00993 gene|LINC00993,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,LINC00993 gene|LINC00993 Triple Negative Breast Neoplasms
CAUSES,JAG1 gene|JAG1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,JAG1 gene|JAG1 Triple Negative Breast Neoplasms
CAUSES,"Leukemia Virus, Bovine",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,"Leukemia Virus, Bovine Malignant neoplasm of breast"
AFFECTS,Long Intergenic Non-Protein Coding RNA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Long Intergenic Non-Protein Coding RNA Malignant neoplasm of breast
PREDISPOSES,tamoxifen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,tamoxifen Malignant neoplasm of breast
PREDISPOSES,TP53 gene|TP53,contralateral breast cancer,0.0029970029970029,Female Breast Cancer,Gene or Genome,TP53 gene|TP53 contralateral breast cancer
AFFECTS,SFRP2 gene|SFRP2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SFRP2 gene|SFRP2 Malignant neoplasm of breast
AFFECTS,tamoxifen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,tamoxifen Malignant neoplasm of breast
AFFECTS,FNDC5 gene|FNDC5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FNDC5 gene|FNDC5 Malignant neoplasm of breast
CAUSES,CNN1 gene|CNN1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CNN1 gene|CNN1 Malignant neoplasm of breast
AUGMENTS,FOXK1 gene|FOXK1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FOXK1 gene|FOXK1 Malignant neoplasm of breast
AFFECTS,Variation (Genetics),Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Gene or Genome,Variation (Genetics) Invasive carcinoma of breast
PREDISPOSES,RNA Sequence,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Nucleotide Sequence,RNA Sequence Malignant neoplasm of breast
PREDISPOSES,"ITK protein, human|ITK",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","ITK protein, human|ITK Malignant neoplasm of breast"
DISRUPTS,Proteins,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Proteins Breast Carcinoma
AFFECTS,GSTM1 gene|GSTM1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GSTM1 gene|GSTM1 Malignant neoplasm of breast
PREDISPOSES,Tumor size,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Tumor size Malignant neoplasm of breast
PREDISPOSES,DNA Motifs,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",DNA Motifs Malignant neoplasm of breast
AFFECTS,"Mirn124a microRNA, human",Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","Mirn124a microRNA, human Breast Carcinoma"
CAUSES,SDHC gene|SDHC,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,SDHC gene|SDHC Noninfiltrating Intraductal Carcinoma
CAUSES,Gene Mutant,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,Gene Mutant Noninfiltrating Intraductal Carcinoma
AFFECTS,TFCP2 gene|TFCP2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TFCP2 gene|TFCP2 Malignant neoplasm of breast
CAUSES,RWDD4 gene|RWDD4,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,RWDD4 gene|RWDD4 Noninfiltrating Intraductal Carcinoma
AFFECTS,Hormone Receptor,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Hormone,Hormone Receptor Triple Negative Breast Neoplasms
PREDISPOSES,Tumor Escape,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Tumor Escape Malignant neoplasm of breast
PREDISPOSES,SOX10 gene|SOX10,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,SOX10 gene|SOX10 Triple Negative Breast Neoplasms
AUGMENTS,"MET protein, human",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein","MET protein, human Triple Negative Breast Neoplasms"
AUGMENTS,Long Intergenic Non-Protein Coding RNA,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Long Intergenic Non-Protein Coding RNA Triple Negative Breast Neoplasms
PREDISPOSES,CDYL2 gene|CDYL2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CDYL2 gene|CDYL2 Malignant neoplasm of breast
PREDISPOSES,Matrix Metalloproteinase 3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Matrix Metalloproteinase 3 Malignant neoplasm of breast
PREDISPOSES,CBLB gene|CBLB|MMAB,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CBLB gene|CBLB|MMAB Malignant neoplasm of breast
DISRUPTS,NES gene|NES,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NES gene|NES Malignant neoplasm of breast
PREDISPOSES,ribonucleotide reductase M2|RRM2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",ribonucleotide reductase M2|RRM2 Malignant neoplasm of breast
PREDISPOSES,TRDMT1 gene|TRDMT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TRDMT1 gene|TRDMT1 Malignant neoplasm of breast
CAUSES,tamoxifen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,tamoxifen Malignant neoplasm of breast
DISRUPTS,brown adipose tissue uncoupling protein,Basal-Like Breast Carcinoma,0.0039960039960039,Female Breast Cancer,"Amino Acid, Peptide, or Protein",brown adipose tissue uncoupling protein Basal-Like Breast Carcinoma
PREDISPOSES,Tumor Suppressor Genes,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,Tumor Suppressor Genes Triple Negative Breast Neoplasms
AUGMENTS,"TGFB1 protein, human|TGFB1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","TGFB1 protein, human|TGFB1 Malignant neoplasm of breast"
CAUSES,Aromatase Inhibitors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Aromatase Inhibitors Malignant neoplasm of breast
AFFECTS,TMPO-AS1 gene|TMPO-AS1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,TMPO-AS1 gene|TMPO-AS1 Triple Negative Breast Neoplasms
AFFECTS,Epidermal Growth Factor Receptor,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Biologically Active Substance,Epidermal Growth Factor Receptor Triple Negative Breast Neoplasms
PREDISPOSES,Prune Belly Syndrome,contralateral breast cancer,0.0029970029970029,Female Breast Cancer,Disease or Syndrome,Prune Belly Syndrome contralateral breast cancer
PREDISPOSES,Human Class I Antigens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Immunologic Factor,Human Class I Antigens Malignant neoplasm of breast
PREDISPOSES,NUDT21 gene|NUDT21,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NUDT21 gene|NUDT21 Malignant neoplasm of breast
PREDISPOSES,NEK10 gene|NEK10,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NEK10 gene|NEK10 Malignant neoplasm of breast
CAUSES,GPER1 gene|GPER1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GPER1 gene|GPER1 Malignant neoplasm of breast
AFFECTS,letrozole,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Pharmacologic Substance,letrozole HER2-positive carcinoma of breast
PREDISPOSES,CCL8 gene|CCL8,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CCL8 gene|CCL8 Malignant neoplasm of breast
AFFECTS,polygene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,polygene Malignant neoplasm of breast
PREDISPOSES,Carbohydrate intake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Carbohydrate,Carbohydrate intake Malignant neoplasm of breast
AFFECTS,Neoplastic Cell Transformation,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Neoplastic Process,Neoplastic Cell Transformation Triple Negative Breast Neoplasms
PREDISPOSES,MCM3AP-AS1 gene|MCM3AP-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MCM3AP-AS1 gene|MCM3AP-AS1 Malignant neoplasm of breast
AFFECTS,ELAVL2 gene|ELAVL2,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Gene or Genome,ELAVL2 gene|ELAVL2 Inflammatory Breast Carcinoma
PREDISPOSES,Genes,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,Genes Triple Negative Breast Neoplasms
AUGMENTS,RNA Sequence,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Nucleotide Sequence,RNA Sequence Malignant neoplasm of breast
CAUSES,"CD69 protein, human|CD69",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CD69 protein, human|CD69 Malignant neoplasm of breast"
PREDISPOSES,DAPK1 gene|DAPK1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,DAPK1 gene|DAPK1 Malignant neoplasm of breast
AUGMENTS,FGFBP1 gene|FGFBP1,estrogen receptor-negative breast cancer,0.0,Female Breast Cancer,Gene or Genome,FGFBP1 gene|FGFBP1 estrogen receptor-negative breast cancer
AFFECTS,ZEB1 gene|ZEB1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,ZEB1 gene|ZEB1 Triple Negative Breast Neoplasms
DISRUPTS,Proto-Oncogene Proteins c-akt|AKT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Proto-Oncogene Proteins c-akt|AKT1 Malignant neoplasm of breast
PREDISPOSES,RIOK1 gene|RIOK1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RIOK1 gene|RIOK1 Malignant neoplasm of breast
PREDISPOSES,IMPACT gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IMPACT gene Malignant neoplasm of breast
PREDISPOSES,Disease,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Disease or Syndrome,Disease Triple Negative Breast Neoplasms
PREDISPOSES,"CD69 protein, human|CD69",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CD69 protein, human|CD69 Malignant neoplasm of breast"
AFFECTS,Metastatic malignant neoplasm to brain,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Neoplastic Process,Metastatic malignant neoplasm to brain Triple Negative Breast Neoplasms
PREDISPOSES,"RNA, Messenger",Recurrent Breast Carcinoma,0.0009990009990009,Recurrent Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","RNA, Messenger Recurrent Breast Carcinoma"
PREDISPOSES,BCL11A gene|BCL11A,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,BCL11A gene|BCL11A Triple Negative Breast Neoplasms
PREDISPOSES,estrogens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,estrogens Malignant neoplasm of breast
DISRUPTS,ERR1 protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",ERR1 protein Malignant neoplasm of breast
PREDISPOSES,LIMK2 gene|LIMK2,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,LIMK2 gene|LIMK2 Triple Negative Breast Neoplasms
PREDISPOSES,MLF2 gene|MLF2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MLF2 gene|MLF2 Malignant neoplasm of breast
AUGMENTS,MALAT1 gene|MALAT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MALAT1 gene|MALAT1 Malignant neoplasm of breast
PREDISPOSES,Tumor size,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Neoplastic Process,Tumor size estrogen receptor-positive breast cancer
PREDISPOSES,AMH gene|AMH,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,AMH gene|AMH Malignant neoplasm of breast
AUGMENTS,ELAVL2 gene|ELAVL2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ELAVL2 gene|ELAVL2 Malignant neoplasm of breast
PREDISPOSES,CKLF gene|CKLF,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CKLF gene|CKLF Malignant neoplasm of breast
AFFECTS,PRKN gene|PRKN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PRKN gene|PRKN Malignant neoplasm of breast
DISRUPTS,Epidermal Growth Factor Receptor,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Biologically Active Substance,Epidermal Growth Factor Receptor Triple Negative Breast Neoplasms
PREDISPOSES,"Anti-Mullerian Hormone Receptor Type II, Human|AMHR2",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,"Anti-Mullerian Hormone Receptor Type II, Human|AMHR2 Malignant neoplasm of breast"
AFFECTS,Genetic Polymorphism,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Genetic Polymorphism Malignant neoplasm of breast
PREDISPOSES,SNAI1 gene|SNAI1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SNAI1 gene|SNAI1 Malignant neoplasm of breast
AFFECTS,ADIPOR1 gene|ADIPOR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ADIPOR1 gene|ADIPOR1 Malignant neoplasm of breast
DISRUPTS,Fibroblast Growth Factor Receptors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Fibroblast Growth Factor Receptors Malignant neoplasm of breast
PREDISPOSES,"Protein, Organized by Structure",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","Protein, Organized by Structure Malignant neoplasm of breast"
AFFECTS,Angiogenic Process,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Phenomenon or Process,Angiogenic Process Malignant neoplasm of breast
AUGMENTS,tamoxifen,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Pharmacologic Substance,tamoxifen estrogen receptor-positive breast cancer
PREDISPOSES,HER-2 protein|ERBB2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",HER-2 protein|ERBB2 Malignant neoplasm of breast
AFFECTS,Hormone Therapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Hormone Therapy Malignant neoplasm of breast
AFFECTS,dna genetics,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,dna genetics Malignant neoplasm of breast
AUGMENTS,"DNM1L protein, human|DNM1L",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","DNM1L protein, human|DNM1L Malignant neoplasm of breast"
CAUSES,GSTP1P1 gene|GSTP1P1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GSTP1P1 gene|GSTP1P1 Malignant neoplasm of breast
PREDISPOSES,FANCM gene|FANCM,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FANCM gene|FANCM Malignant neoplasm of breast
CAUSES,SNAI2 gene|SNAI2,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Gene or Genome,SNAI2 gene|SNAI2 HER2-positive carcinoma of breast
AFFECTS,Sodium-Glucose Transporter 2 Inhibitors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Carbohydrate,Sodium-Glucose Transporter 2 Inhibitors Malignant neoplasm of breast
AUGMENTS,ZFPM2-AS1 gene|ZFPM2-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ZFPM2-AS1 gene|ZFPM2-AS1 Malignant neoplasm of breast
PREDISPOSES,BBOX1 gene|BBOX1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,BBOX1 gene|BBOX1 Triple Negative Breast Neoplasms
AFFECTS,Conventional Treatment,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Conventional Treatment Triple Negative Breast Neoplasms
CAUSES,Injection,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Injection Malignant neoplasm of breast
PREDISPOSES,TP53 gene|TP53,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,TP53 gene|TP53 Triple Negative Breast Neoplasms
DISRUPTS,SERPINE1 gene|SERPINE1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,SERPINE1 gene|SERPINE1 Triple Negative Breast Neoplasms
AUGMENTS,RASAL2 gene|RASAL2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RASAL2 gene|RASAL2 Malignant neoplasm of breast
AFFECTS,LINC00922 gene|LINC00922,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LINC00922 gene|LINC00922 Malignant neoplasm of breast
PREDISPOSES,Processed meat,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Phenomenon or Process,Processed meat Malignant neoplasm of breast
AFFECTS,estrogens,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Hormone,estrogens Triple Negative Breast Neoplasms
PREDISPOSES,HMGB1 gene|HMGB1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HMGB1 gene|HMGB1 Malignant neoplasm of breast
AUGMENTS,"PDIA3 protein, human|PDIA3",Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Amino Acid, Peptide, or Protein","PDIA3 protein, human|PDIA3 Invasive carcinoma of breast"
DISRUPTS,MIR30E gene|MIR30E,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIR30E gene|MIR30E Malignant neoplasm of breast
AUGMENTS,HOTAIR gene|HOTAIR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HOTAIR gene|HOTAIR Malignant neoplasm of breast
AFFECTS,Estrogen Receptor beta,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptor beta Triple Negative Breast Neoplasms
DISRUPTS,MTOR gene|MTOR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MTOR gene|MTOR Malignant neoplasm of breast
PREDISPOSES,American College of Cardiology/American Heart Association Lesion Complexity Score C,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",American College of Cardiology/American Heart Association Lesion Complexity Score C Invasive carcinoma of breast
AFFECTS,estrogens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,estrogens Malignant neoplasm of breast
AUGMENTS,RSPO3 Gene|RSPO3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RSPO3 Gene|RSPO3 Malignant neoplasm of breast
PREDISPOSES,CYP1A1 gene|CYP1A1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CYP1A1 gene|CYP1A1 Malignant neoplasm of breast
AUGMENTS,A2M-AS1 gene|A2M-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,A2M-AS1 gene|A2M-AS1 Malignant neoplasm of breast
AUGMENTS,SALL4 gene|SALL4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SALL4 gene|SALL4 Malignant neoplasm of breast
AFFECTS,KCNQ1OT1 gene|KCNQ1OT1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,KCNQ1OT1 gene|KCNQ1OT1 Triple Negative Breast Neoplasms
DISRUPTS,METTL14 gene|METTL14,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,METTL14 gene|METTL14 Malignant neoplasm of breast
AFFECTS,Malignant neoplasm of breast,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Neoplastic Process,Malignant neoplasm of breast estrogen receptor-positive breast cancer
AFFECTS,TUG1 gene|TUG1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TUG1 gene|TUG1 Malignant neoplasm of breast
AFFECTS,Alternative Splicing,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Alternative Splicing Triple Negative Breast Neoplasms
PREDISPOSES,PCAT7 gene|PCAT7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PCAT7 gene|PCAT7 Malignant neoplasm of breast
AFFECTS,LINC01271 gene|LINC01271,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LINC01271 gene|LINC01271 Malignant neoplasm of breast
PREDISPOSES,Epidermal Growth Factor Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Epidermal Growth Factor Receptor Malignant neoplasm of breast
CAUSES,"RNA, Untranslated",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","RNA, Untranslated Triple Negative Breast Neoplasms"
AFFECTS,PTEN gene|PTEN,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,PTEN gene|PTEN Triple Negative Breast Neoplasms
PREDISPOSES,UBE3C gene|UBE3C,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,UBE3C gene|UBE3C Malignant neoplasm of breast
PREDISPOSES,"IL2RB protein, human|IL2RB",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","IL2RB protein, human|IL2RB Malignant neoplasm of breast"
AUGMENTS,ZNF670-ZNF695 gene|ZNF670-ZNF695,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ZNF670-ZNF695 gene|ZNF670-ZNF695 Malignant neoplasm of breast
AUGMENTS,ATM gene|ATM,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ATM gene|ATM Malignant neoplasm of breast
AUGMENTS,estrogens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,estrogens Malignant neoplasm of breast
AUGMENTS,OXER1 gene|OXER1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,OXER1 gene|OXER1 Malignant neoplasm of breast
PREDISPOSES,FBXO22 gene|FBXO22,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FBXO22 gene|FBXO22 Malignant neoplasm of breast
CAUSES,mullerian-inhibiting hormone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,mullerian-inhibiting hormone Malignant neoplasm of breast
AUGMENTS,TINCR gene|TINCR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TINCR gene|TINCR Malignant neoplasm of breast
PREDISPOSES,LINC00665 gene|LINC00665,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LINC00665 gene|LINC00665 Malignant neoplasm of breast
CAUSES,Long Intergenic Non-Protein Coding RNA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Long Intergenic Non-Protein Coding RNA Malignant neoplasm of breast
AFFECTS,Tumor Promotion,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Tumor Promotion Malignant neoplasm of breast
PREDISPOSES,UCHL1 gene|UCHL1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,UCHL1 gene|UCHL1 Malignant neoplasm of breast
PREDISPOSES,CHEK2 gene|CHEK2,Hereditary Breast and Ovarian Cancer Syndrome,0.0,Female Breast Cancer,Gene or Genome,CHEK2 gene|CHEK2 Hereditary Breast and Ovarian Cancer Syndrome
PREDISPOSES,AGAP2-AS1 gene|AGAP2-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,AGAP2-AS1 gene|AGAP2-AS1 Malignant neoplasm of breast
AFFECTS,Psychosocial Intervention,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Psychosocial Intervention Malignant neoplasm of breast
PREDISPOSES,SDHC gene|SDHC,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SDHC gene|SDHC Malignant neoplasm of breast
PREDISPOSES,MBD2 gene|MBD2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MBD2 gene|MBD2 Malignant neoplasm of breast
AUGMENTS,LINC01271 gene|LINC01271,malignant neoplasm of breast staging,0.0,Female Breast Cancer,Gene or Genome,LINC01271 gene|LINC01271 malignant neoplasm of breast staging
DISRUPTS,tamoxifen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,tamoxifen Malignant neoplasm of breast
CAUSES,Nutrients,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Nutrients Malignant neoplasm of breast
DISRUPTS,TP53 gene|TP53,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TP53 gene|TP53 Malignant neoplasm of breast
AFFECTS,"RNA, Circular",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","RNA, Circular Malignant neoplasm of breast"
PREDISPOSES,Metric (substance),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Substance,Metric (substance) Malignant neoplasm of breast
AUGMENTS,FZD2 gene|FZD2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FZD2 gene|FZD2 Malignant neoplasm of breast
DISRUPTS,gambogic acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,gambogic acid Malignant neoplasm of breast
AFFECTS,Malignant neoplasm of breast,"Breast Cancer, Familial",0.0,Female Breast Cancer,Neoplastic Process,"Malignant neoplasm of breast Breast Cancer, Familial"
PREDISPOSES,CPT1A gene|CPT1A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CPT1A gene|CPT1A Malignant neoplasm of breast
AUGMENTS,calmodulin-dependent protein kinase III,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",calmodulin-dependent protein kinase III Malignant neoplasm of breast
AUGMENTS,SENP3 gene|SENP3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SENP3 gene|SENP3 Malignant neoplasm of breast
PREDISPOSES,elaidic acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,elaidic acid Malignant neoplasm of breast
AFFECTS,"CD69 protein, human|CD69",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CD69 protein, human|CD69 Malignant neoplasm of breast"
PREDISPOSES,"CDKN1A protein, human|CDKN1A",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CDKN1A protein, human|CDKN1A Malignant neoplasm of breast"
PREDISPOSES,ATM gene|ATM,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,ATM gene|ATM Breast Carcinoma
AFFECTS,Heterogeneous-Nuclear Ribonucleoprotein K,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Heterogeneous-Nuclear Ribonucleoprotein K Malignant neoplasm of breast
PREDISPOSES,O(6)-Methylguanine-DNA Methyltransferase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",O(6)-Methylguanine-DNA Methyltransferase Malignant neoplasm of breast
PREDISPOSES,CYTOR gene|CYTOR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CYTOR gene|CYTOR Malignant neoplasm of breast
AFFECTS,Tumor Microenvironment,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Tumor Microenvironment Malignant neoplasm of breast
PREDISPOSES,LRRC3B gene|LRRC3B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LRRC3B gene|LRRC3B Malignant neoplasm of breast
AFFECTS,Fatty Acids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Fatty Acids Malignant neoplasm of breast
PREDISPOSES,recreational activity,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",recreational activity Malignant neoplasm of breast
PREDISPOSES,Systemic Inflammatory Response Syndrome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Systemic Inflammatory Response Syndrome Malignant neoplasm of breast
AFFECTS,"PLK1 protein, human|PLK1",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein","PLK1 protein, human|PLK1 Triple Negative Breast Neoplasms"
PREDISPOSES,FBXO32 gene|FBXO32,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FBXO32 gene|FBXO32 Malignant neoplasm of breast
DISRUPTS,ELF5 gene|ELF5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ELF5 gene|ELF5 Malignant neoplasm of breast
PREDISPOSES,CDK15 gene|CDK15,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CDK15 gene|CDK15 Malignant neoplasm of breast
AFFECTS,Transcription Coactivator,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Transcription Coactivator Malignant neoplasm of breast
AUGMENTS,Neoantigen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Immunologic Factor,Neoantigen Malignant neoplasm of breast
AUGMENTS,FADS1 gene|FADS1,Recurrent Breast Carcinoma,0.0009990009990009,Recurrent Breast Cancer,Gene or Genome,FADS1 gene|FADS1 Recurrent Breast Carcinoma
DISRUPTS,hyaluronic acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,hyaluronic acid Malignant neoplasm of breast
PREDISPOSES,Fetal valproate syndrome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Fetal valproate syndrome Malignant neoplasm of breast
AFFECTS,DPP6 gene|DPP6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,DPP6 gene|DPP6 Malignant neoplasm of breast
PREDISPOSES,TWIST1 gene|TWIST1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TWIST1 gene|TWIST1 Malignant neoplasm of breast
AFFECTS,Intronic Mutation,"Breast Cancer, Familial",0.0,Female Breast Cancer,"Element, Ion, or Isotope","Intronic Mutation Breast Cancer, Familial"
PREDISPOSES,PADI1 gene|PADI1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PADI1 gene|PADI1 Malignant neoplasm of breast
DISRUPTS,MIR599 gene|MIR599,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIR599 gene|MIR599 Malignant neoplasm of breast
AFFECTS,FANCA gene|FANCA,"Breast Cancer, Familial",0.0,Female Breast Cancer,Gene or Genome,"FANCA gene|FANCA Breast Cancer, Familial"
DISRUPTS,MIR638 gene|MIR638,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIR638 gene|MIR638 Malignant neoplasm of breast
PREDISPOSES,Carcinoembryonic Antigen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Immunologic Factor,Carcinoembryonic Antigen Malignant neoplasm of breast
DISRUPTS,vitamin A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,vitamin A Malignant neoplasm of breast
DISRUPTS,ARHGAP1 gene|ARHGAP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ARHGAP1 gene|ARHGAP1 Malignant neoplasm of breast
PREDISPOSES,WNT9B gene|WNT9B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,WNT9B gene|WNT9B Malignant neoplasm of breast
PREDISPOSES,VGLL1 gene|VGLL1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,VGLL1 gene|VGLL1 Malignant neoplasm of breast
PREDISPOSES,Collagen Gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Collagen Gene Malignant neoplasm of breast
PREDISPOSES,MIR21 gene|MIR21,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIR21 gene|MIR21 Malignant neoplasm of breast
AFFECTS,HAGLR gene|HAGLR,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,HAGLR gene|HAGLR Triple Negative Breast Neoplasms
AFFECTS,cytotoxicity,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Hazardous or Poisonous Substance,cytotoxicity Triple Negative Breast Neoplasms
PREDISPOSES,KIF23 gene|KIF23,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,KIF23 gene|KIF23 Triple Negative Breast Neoplasms
PREDISPOSES,Consideration,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Consideration Malignant neoplasm of breast
AFFECTS,"herstatin protein, human",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein","herstatin protein, human Triple Negative Breast Neoplasms"
DISRUPTS,CDKN2B-AS1 gene|CDKN2B-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CDKN2B-AS1 gene|CDKN2B-AS1 Malignant neoplasm of breast
PREDISPOSES,medication risk,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,medication risk Malignant neoplasm of breast
AUGMENTS,VCAN-AS1 gene|VCAN-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,VCAN-AS1 gene|VCAN-AS1 Malignant neoplasm of breast
AFFECTS,"EZH2 protein, human|EZH2",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","EZH2 protein, human|EZH2 Malignant neoplasm of breast"
AFFECTS,LINC01094 gene|LINC01094,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LINC01094 gene|LINC01094 Malignant neoplasm of breast
AFFECTS,epithelial to mesenchymal transition,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",epithelial to mesenchymal transition Malignant neoplasm of breast
PREDISPOSES,IL27 gene|MYDGF|IL27,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IL27 gene|MYDGF|IL27 Malignant neoplasm of breast
CAUSES,"Metals, Heavy",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Metals, Heavy Malignant neoplasm of breast"
DISRUPTS,GLUT-1 protein,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,"Amino Acid, Peptide, or Protein",GLUT-1 protein Secondary malignant neoplasm of breast
PREDISPOSES,LINC01315 gene|LINC01315,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LINC01315 gene|LINC01315 Malignant neoplasm of breast
AFFECTS,Adhesions,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Adhesions Malignant neoplasm of breast
AFFECTS,"Drug Resistance, Neoplasm",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Pharmacologic Substance,"Drug Resistance, Neoplasm Triple Negative Breast Neoplasms"
AFFECTS,NEIL2 gene|NEIL2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NEIL2 gene|NEIL2 Malignant neoplasm of breast
DISRUPTS,ursolic acid,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Chemical,ursolic acid Breast cancer metastatic
AFFECTS,bone morphogenetic protein 4|BMP4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,bone morphogenetic protein 4|BMP4 Malignant neoplasm of breast
COMPLICATES,LINC00922 gene|LINC00922,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LINC00922 gene|LINC00922 Malignant neoplasm of breast
AFFECTS,Inflammation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Inflammation Malignant neoplasm of breast
PREDISPOSES,cytokine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,cytokine Malignant neoplasm of breast
AFFECTS,Carbohydrates,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Carbohydrate,Carbohydrates Malignant neoplasm of breast
DISRUPTS,Vascular Endothelial Growth Factor A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Vascular Endothelial Growth Factor A Malignant neoplasm of breast
AUGMENTS,HOXC10 gene|HOXC10,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HOXC10 gene|HOXC10 Malignant neoplasm of breast
AUGMENTS,New medications,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,New medications Malignant neoplasm of breast
AFFECTS,Tumor Progression,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Tumor Progression Malignant neoplasm of breast
PREDISPOSES,American College of Cardiology/American Heart Association Lesion Complexity Score C,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",American College of Cardiology/American Heart Association Lesion Complexity Score C Malignant neoplasm of breast
AUGMENTS,"EIF4EL3 protein, human|EIF4E2",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein","EIF4EL3 protein, human|EIF4E2 Triple Negative Breast Neoplasms"
AUGMENTS,"herstatin protein, human",HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Amino Acid, Peptide, or Protein","herstatin protein, human HER2-positive carcinoma of breast"
DISRUPTS,"RNA, Small Interfering",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","RNA, Small Interfering Triple Negative Breast Neoplasms"
AUGMENTS,Mucin-1 Antigen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Immunologic Factor,Mucin-1 Antigen Malignant neoplasm of breast
AFFECTS,MICAL2 gene|MICAL2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MICAL2 gene|MICAL2 Malignant neoplasm of breast
AFFECTS,"CD69 protein, human|CD69",malignant neoplasm of breast staging,0.0,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CD69 protein, human|CD69 malignant neoplasm of breast staging"
CAUSES,HSPA9 gene|HSPA9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HSPA9 gene|HSPA9 Malignant neoplasm of breast
AUGMENTS,RBM38 gene|RBM38,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RBM38 gene|RBM38 Malignant neoplasm of breast
PREDISPOSES,"herstatin protein, human",HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Amino Acid, Peptide, or Protein","herstatin protein, human HER2-positive carcinoma of breast"
PREDISPOSES,Lactation established in non-human animal,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Lactation established in non-human animal Malignant neoplasm of breast
PREDISPOSES,CDC20 gene|CDC20,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CDC20 gene|CDC20 Malignant neoplasm of breast
PREDISPOSES,Prieto X-linked mental retardation syndrome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Prieto X-linked mental retardation syndrome Malignant neoplasm of breast
PREDISPOSES,NFIL3 gene|NFIL3,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,NFIL3 gene|NFIL3 Triple Negative Breast Neoplasms
DISRUPTS,KRT19P3 gene|KRT19P3,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,KRT19P3 gene|KRT19P3 Breast Carcinoma
AUGMENTS,PTEN gene|PTEN,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Gene or Genome,PTEN gene|PTEN Ductal Breast Carcinoma
DISRUPTS,"LATS1 protein, human|LATS1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","LATS1 protein, human|LATS1 Malignant neoplasm of breast"
AUGMENTS,"Genes, cdc",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,"Genes, cdc Malignant neoplasm of breast"
PREDISPOSES,omega-3 fatty acids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,omega-3 fatty acids Malignant neoplasm of breast
AFFECTS,ADRB2 gene|ADRB2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ADRB2 gene|ADRB2 Malignant neoplasm of breast
PREDISPOSES,"EZH2 protein, human|EZH2",Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,"Amino Acid, Peptide, or Protein","EZH2 protein, human|EZH2 Secondary malignant neoplasm of breast"
AFFECTS,Antibody Therapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Indicator, Reagent, or Diagnostic Aid",Antibody Therapy Malignant neoplasm of breast
PREDISPOSES,hydrogen peroxide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",hydrogen peroxide Malignant neoplasm of breast
AFFECTS,Chemicals,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Chemicals Malignant neoplasm of breast
AUGMENTS,SRP9 gene|SRP9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SRP9 gene|SRP9 Malignant neoplasm of breast
DISRUPTS,HTR1A gene|HTR1A,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,HTR1A gene|HTR1A Triple Negative Breast Neoplasms
AUGMENTS,LINC00466 gene|LINC00466,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,LINC00466 gene|LINC00466 Triple Negative Breast Neoplasms
PREDISPOSES,OPRM1 gene|OPRM1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,OPRM1 gene|OPRM1 Malignant neoplasm of breast
PREDISPOSES,KLK3 gene|KLK3,"Breast Cancer, Familial",0.0,Female Breast Cancer,Gene or Genome,"KLK3 gene|KLK3 Breast Cancer, Familial"
AUGMENTS,DDT (Insecticide),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Invertebrate,DDT (Insecticide) Malignant neoplasm of breast
AFFECTS,ARHGAP17 gene|ARHGAP17,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ARHGAP17 gene|ARHGAP17 Malignant neoplasm of breast
AFFECTS,Duration,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Duration Malignant neoplasm of breast
CAUSES,NEAT1 gene|NEAT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NEAT1 gene|NEAT1 Malignant neoplasm of breast
CAUSES,Nutrients,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Food,Nutrients Triple Negative Breast Neoplasms
PREDISPOSES,Migraine Disorders,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Migraine Disorders Malignant neoplasm of breast
AFFECTS,NEDD4L gene|NEDD4L,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NEDD4L gene|NEDD4L Malignant neoplasm of breast
PREDISPOSES,MIR210HG gene|MIR210HG,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIR210HG gene|MIR210HG Malignant neoplasm of breast
PREDISPOSES,CD31 Antigens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Immunologic Factor,CD31 Antigens Malignant neoplasm of breast
AFFECTS,mRNA Expression,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",mRNA Expression Triple Negative Breast Neoplasms
AFFECTS,G-Protein-Coupled Receptors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",G-Protein-Coupled Receptors Malignant neoplasm of breast
AUGMENTS,TRIP13 gene|TRIP13,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TRIP13 gene|TRIP13 Malignant neoplasm of breast
AFFECTS,RAB8A gene|RAB8A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RAB8A gene|RAB8A Malignant neoplasm of breast
PREDISPOSES,PSAT1 gene|PSAT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PSAT1 gene|PSAT1 Malignant neoplasm of breast
AFFECTS,CCR2 gene|CCR2,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,CCR2 gene|CCR2 Noninfiltrating Intraductal Carcinoma
PREDISPOSES,RAB8A gene|RAB8A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RAB8A gene|RAB8A Malignant neoplasm of breast
AFFECTS,Epithelial ovarian cancer,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Epithelial ovarian cancer Malignant neoplasm of breast
AUGMENTS,SREBF1 gene|SREBF1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SREBF1 gene|SREBF1 Malignant neoplasm of breast
PREDISPOSES,NCAPD2 gene|NCAPD2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NCAPD2 gene|NCAPD2 Malignant neoplasm of breast
AFFECTS,Manipulation procedure,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Manipulation procedure Malignant neoplasm of breast
PREDISPOSES,"CD274 protein, human|CD274",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CD274 protein, human|CD274 Malignant neoplasm of breast"
AUGMENTS,GTSE1 gene|GTSE1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GTSE1 gene|GTSE1 Malignant neoplasm of breast
PREDISPOSES,"Human B-Lymphocyte Antigen CD20, human|MS4A1|KRT20",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Immunologic Factor,"Human B-Lymphocyte Antigen CD20, human|MS4A1|KRT20 Malignant neoplasm of breast"
PREDISPOSES,Growth Factor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Growth Factor Malignant neoplasm of breast
PREDISPOSES,Physical function,Locally advanced breast cancer,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Physical function Locally advanced breast cancer
AFFECTS,Breast Self-Examination,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Breast Self-Examination Malignant neoplasm of breast
AFFECTS,LINC01287 gene|LINC01287,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LINC01287 gene|LINC01287 Malignant neoplasm of breast
AUGMENTS,ATAD2B gene|ATAD2B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ATAD2B gene|ATAD2B Malignant neoplasm of breast
PREDISPOSES,FOXD3-AS1 gene|FOXD3-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FOXD3-AS1 gene|FOXD3-AS1 Malignant neoplasm of breast
PREDISPOSES,Triglycerides,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Lipid,Triglycerides Malignant neoplasm of breast
AFFECTS,DDX21 gene|DDX21,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,DDX21 gene|DDX21 Triple Negative Breast Neoplasms
AFFECTS,"protein TDP-43, human",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein","protein TDP-43, human Triple Negative Breast Neoplasms"
DISRUPTS,folic acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,folic acid Malignant neoplasm of breast
PREDISPOSES,benzene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hazardous or Poisonous Substance,benzene Malignant neoplasm of breast
AFFECTS,Hydrogen Sulfide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Hydrogen Sulfide Malignant neoplasm of breast
AFFECTS,Vascular Endothelial Growth Factor A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Vascular Endothelial Growth Factor A Malignant neoplasm of breast
AFFECTS,2-mercaptoethanesulfonic acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,2-mercaptoethanesulfonic acid Malignant neoplasm of breast
PREDISPOSES,PSME2 gene|PSME2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PSME2 gene|PSME2 Malignant neoplasm of breast
AUGMENTS,Carcinogens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hazardous or Poisonous Substance,Carcinogens Malignant neoplasm of breast
DISRUPTS,ZNHIT1 gene|ZNHIT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ZNHIT1 gene|ZNHIT1 Malignant neoplasm of breast
DISRUPTS,GUSBP11 gene|GUSBP11,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,GUSBP11 gene|GUSBP11 Triple Negative Breast Neoplasms
AFFECTS,CUEDC2 gene|CUEDC2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CUEDC2 gene|CUEDC2 Malignant neoplasm of breast
DISRUPTS,RNA Recognition Motif,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",RNA Recognition Motif Malignant neoplasm of breast
AUGMENTS,TP53,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,TP53 Triple Negative Breast Neoplasms
PREDISPOSES,Florid red complexion (finding),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Florid red complexion (finding) Malignant neoplasm of breast
DISRUPTS,Orthologous Gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Orthologous Gene Malignant neoplasm of breast
AFFECTS,GTF2H1 gene|GTF2H1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GTF2H1 gene|GTF2H1 Malignant neoplasm of breast
PREDISPOSES,PON1 gene|PON1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PON1 gene|PON1 Malignant neoplasm of breast
PREDISPOSES,"Eosinum, eosin, Homeopathic preparation",malignant neoplasm of breast staging,0.0,Female Breast Cancer,"Element, Ion, or Isotope","Eosinum, eosin, Homeopathic preparation malignant neoplasm of breast staging"
PREDISPOSES,Androgen Binding Protein|SHBG|CCHCR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Androgen Binding Protein|SHBG|CCHCR1 Malignant neoplasm of breast
PREDISPOSES,"CD274 protein, human|CD274",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CD274 protein, human|CD274 Triple Negative Breast Neoplasms"
CAUSES,Peptides,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Peptides Triple Negative Breast Neoplasms
AFFECTS,Lymphatic Metastasis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Lymphatic Metastasis Malignant neoplasm of breast
AUGMENTS,LINC00520 gene|LINC00520,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LINC00520 gene|LINC00520 Malignant neoplasm of breast
CAUSES,"RNA, Untranslated",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","RNA, Untranslated Malignant neoplasm of breast"
AFFECTS,High grade serous carcinoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,High grade serous carcinoma Malignant neoplasm of breast
AFFECTS,PIK3CA Gene Mutation,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Gene or Genome,PIK3CA Gene Mutation HER2-positive carcinoma of breast
PREDISPOSES,TRANSCRIPTION FACTOR,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,"Element, Ion, or Isotope",TRANSCRIPTION FACTOR Secondary malignant neoplasm of breast
PREDISPOSES,Rich food,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Rich food Malignant neoplasm of breast
AFFECTS,"RNA, Long Untranslated",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","RNA, Long Untranslated Triple Negative Breast Neoplasms"
CAUSES,Colorectal Carcinoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Colorectal Carcinoma Malignant neoplasm of breast
AFFECTS,Antibody-Drug Conjugates,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Pharmacologic Substance,Antibody-Drug Conjugates HER2-positive carcinoma of breast
AFFECTS,Carcinogens,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Hazardous or Poisonous Substance,Carcinogens Triple Negative Breast Neoplasms
AUGMENTS,BVES gene|BVES,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BVES gene|BVES Malignant neoplasm of breast
AFFECTS,cardiac event,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Phenomenon or Process,cardiac event Malignant neoplasm of breast
PREDISPOSES,SLC1A5 gene|SLC1A5,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,SLC1A5 gene|SLC1A5 Breast Carcinoma
CAUSES,Pharmaceutical Preparations,Carcinoma breast stage IV,0.0,Female Breast Cancer,Pharmacologic Substance,Pharmaceutical Preparations Carcinoma breast stage IV
PREDISPOSES,BRCA2 gene|BRCA2,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Gene or Genome,BRCA2 gene|BRCA2 estrogen receptor-positive breast cancer
PREDISPOSES,SPATA25 gene|SPATA25,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SPATA25 gene|SPATA25 Malignant neoplasm of breast
AFFECTS,Metric (substance),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Substance,Metric (substance) Malignant neoplasm of breast
AUGMENTS,Intercellular adhesion molecule 1|ICAM1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Intercellular adhesion molecule 1|ICAM1 Triple Negative Breast Neoplasms
PREDISPOSES,IGHG1 gene|IGHG1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IGHG1 gene|IGHG1 Malignant neoplasm of breast
PREDISPOSES,GAS5 gene|GAS5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GAS5 gene|GAS5 Malignant neoplasm of breast
PREDISPOSES,DDX11-AS1 gene|DDX11-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,DDX11-AS1 gene|DDX11-AS1 Malignant neoplasm of breast
PREDISPOSES,FTO gene|FTO,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FTO gene|FTO Malignant neoplasm of breast
CAUSES,High Density Lipoprotein Cholesterol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",High Density Lipoprotein Cholesterol Malignant neoplasm of breast
CAUSES,"Receptors, Progesterone",Advanced breast cancer diagnosis,0.0,Female Breast Cancer,Hormone,"Receptors, Progesterone Advanced breast cancer diagnosis"
DISRUPTS,"RAF Proto-Oncogene Serine/Threonine-Protein Kinase, human|RAF1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,"RAF Proto-Oncogene Serine/Threonine-Protein Kinase, human|RAF1 Malignant neoplasm of breast"
PREDISPOSES,Provisional,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Provisional Malignant neoplasm of breast
AUGMENTS,"CD69 protein, human|CD69",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CD69 protein, human|CD69 Malignant neoplasm of breast"
CAUSES,Polyunsaturated Fatty Acids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Polyunsaturated Fatty Acids Malignant neoplasm of breast
AFFECTS,Transection (procedure),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Transection (procedure) Malignant neoplasm of breast
PREDISPOSES,"Drugs, Non-Prescription",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,"Drugs, Non-Prescription Malignant neoplasm of breast"
DISRUPTS,SMURF1 gene|SMURF1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SMURF1 gene|SMURF1 Malignant neoplasm of breast
PREDISPOSES,insulin-like growth factor 2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,insulin-like growth factor 2 Malignant neoplasm of breast
PREDISPOSES,Microcalcification,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Microcalcification Malignant neoplasm of breast
PREDISPOSES,methionine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",methionine Malignant neoplasm of breast
DISRUPTS,GNAO1 gene|GNAO1,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,GNAO1 gene|GNAO1 Secondary malignant neoplasm of breast
PREDISPOSES,CCND1 gene|CCND1,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,CCND1 gene|CCND1 Breast Carcinoma
DISRUPTS,FOXO1 gene|FOXO1,Basal-Like Breast Carcinoma,0.0039960039960039,Female Breast Cancer,Gene or Genome,FOXO1 gene|FOXO1 Basal-Like Breast Carcinoma
AFFECTS,CCN1 gene|CCNA2|CYR61|PPP3CA,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,CCN1 gene|CCNA2|CYR61|PPP3CA Breast Carcinoma
PREDISPOSES,Transcription Factor AP-2 Beta,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Transcription Factor AP-2 Beta Malignant neoplasm of breast
PREDISPOSES,SIRT1 gene|SIRT1,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,SIRT1 gene|SIRT1 Secondary malignant neoplasm of breast
CAUSES,DANCR gene|DANCR,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,DANCR gene|DANCR Triple Negative Breast Neoplasms
AUGMENTS,Tumor Suppressor Genes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Tumor Suppressor Genes Malignant neoplasm of breast
AFFECTS,malignant disease,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Neoplastic Process,malignant disease Invasive carcinoma of breast
CAUSES,IGF2BP1 gene|IGF2BP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IGF2BP1 gene|IGF2BP1 Malignant neoplasm of breast
DISRUPTS,Pharmaceutical Preparations,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,Pharmaceutical Preparations Malignant neoplasm of breast
AFFECTS,"High Mobility Group Protein HMG-I, Human|HMGA1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","High Mobility Group Protein HMG-I, Human|HMGA1 Malignant neoplasm of breast"
AUGMENTS,AKTIP gene|AKTIP,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Gene or Genome,AKTIP gene|AKTIP estrogen receptor-positive breast cancer
AFFECTS,Drug resistance,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Pharmacologic Substance,Drug resistance Triple Negative Breast Neoplasms
PREDISPOSES,HULC gene|HULC,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HULC gene|HULC Malignant neoplasm of breast
CAUSES,Fatty Acids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Fatty Acids Malignant neoplasm of breast
PREDISPOSES,USP13 gene|USP13,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,USP13 gene|USP13 Secondary malignant neoplasm of breast
DISRUPTS,NLRP3 gene|NLRP3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NLRP3 gene|NLRP3 Malignant neoplasm of breast
DISRUPTS,PHB2 gene|PHB2,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,PHB2 gene|PHB2 Secondary malignant neoplasm of breast
PREDISPOSES,VDR gene|VDR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,VDR gene|VDR Malignant neoplasm of breast
CAUSES,Amino Sugars,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Carbohydrate,Amino Sugars Malignant neoplasm of breast
PREDISPOSES,Meal (occasion for eating),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Meal (occasion for eating) Malignant neoplasm of breast
PREDISPOSES,TTC17 gene|TTC17,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,TTC17 gene|TTC17 Secondary malignant neoplasm of breast
CAUSES,BRCA2 gene|BRCA2,"Breast Cancer, Familial",0.0,Female Breast Cancer,Gene or Genome,"BRCA2 gene|BRCA2 Breast Cancer, Familial"
PREDISPOSES,Atrial Fibrillation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Atrial Fibrillation Malignant neoplasm of breast
CAUSES,Exogenous hormones,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Exogenous hormones Malignant neoplasm of breast
CAUSES,Amino Acids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Amino Acids Malignant neoplasm of breast
AUGMENTS,PKMYT1 gene|PKMYT1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,PKMYT1 gene|PKMYT1 Triple Negative Breast Neoplasms
PREDISPOSES,Specific antibody,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Indicator, Reagent, or Diagnostic Aid",Specific antibody Malignant neoplasm of breast
PREDISPOSES,"DICER1 protein, human|DICER1",Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,"Amino Acid, Peptide, or Protein","DICER1 protein, human|DICER1 Secondary malignant neoplasm of breast"
PREDISPOSES,NUMB gene|NUMB,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NUMB gene|NUMB Malignant neoplasm of breast
AFFECTS,Tumor Microenvironment,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Neoplastic Process,Tumor Microenvironment estrogen receptor-positive breast cancer
PREDISPOSES,Sleep duration:Time:Pt:^Patient:Qn,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Sleep duration:Time:Pt:^Patient:Qn Malignant neoplasm of breast
PREDISPOSES,ursolic acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,ursolic acid Malignant neoplasm of breast
PREDISPOSES,Hydroxy Acids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Hydroxy Acids Malignant neoplasm of breast
AFFECTS,"SDHD protein, human|SDHD",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","SDHD protein, human|SDHD Malignant neoplasm of breast"
AFFECTS,cholesterol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Lipid,cholesterol Malignant neoplasm of breast
AFFECTS,"CTSH protein, human|CTSH",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CTSH protein, human|CTSH Malignant neoplasm of breast"
AUGMENTS,Immune Checkpoint Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Immune Checkpoint Proteins Malignant neoplasm of breast
AUGMENTS,CDK1 gene|CDK1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,CDK1 gene|CDK1 Triple Negative Breast Neoplasms
AFFECTS,SNRPC gene|SNRPC,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,SNRPC gene|SNRPC Triple Negative Breast Neoplasms
PREDISPOSES,Epithelial proliferation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Epithelial proliferation Malignant neoplasm of breast
PREDISPOSES,COPS6 gene|COPS6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,COPS6 gene|COPS6 Malignant neoplasm of breast
AUGMENTS,KIF2C gene|KIF2C,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,KIF2C gene|KIF2C Triple Negative Breast Neoplasms
AFFECTS,MIR326 gene|MIR326,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIR326 gene|MIR326 Malignant neoplasm of breast
AFFECTS,"HMGA2 protein, human|HMGA2",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein","HMGA2 protein, human|HMGA2 Triple Negative Breast Neoplasms"
AUGMENTS,RNA-Binding Protein Musashi Homolog 1,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,"Amino Acid, Peptide, or Protein",RNA-Binding Protein Musashi Homolog 1 Inflammatory Breast Carcinoma
AFFECTS,Non-Small Cell Lung Carcinoma,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Neoplastic Process,Non-Small Cell Lung Carcinoma HER2-positive carcinoma of breast
PREDISPOSES,IPO7 gene|IPO7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IPO7 gene|IPO7 Malignant neoplasm of breast
AUGMENTS,"TNF protein, human|TNF",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein","TNF protein, human|TNF Triple Negative Breast Neoplasms"
AUGMENTS,RNA-Binding Protein Musashi Homolog 2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",RNA-Binding Protein Musashi Homolog 2 Malignant neoplasm of breast
DISRUPTS,Peptides,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Peptides Triple Negative Breast Neoplasms
AUGMENTS,PPP1R14B-AS1 gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PPP1R14B-AS1 gene Malignant neoplasm of breast
AUGMENTS,RNA-Binding Protein Musashi Homolog 1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",RNA-Binding Protein Musashi Homolog 1 Malignant neoplasm of breast
AFFECTS,FOXP3 gene|FOXP3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FOXP3 gene|FOXP3 Malignant neoplasm of breast
CAUSES,GATA3 gene|GATA3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GATA3 gene|GATA3 Malignant neoplasm of breast
CAUSES,palbociclib,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,palbociclib Malignant neoplasm of breast
AFFECTS,BRCA2 Gene Mutation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BRCA2 Gene Mutation Malignant neoplasm of breast
AFFECTS,Malignant Neoplasms,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Neoplastic Process,Malignant Neoplasms Triple Negative Breast Neoplasms
PREDISPOSES,HIPK3 gene|HIPK3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HIPK3 gene|HIPK3 Malignant neoplasm of breast
PREDISPOSES,pre-miRNA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",pre-miRNA Malignant neoplasm of breast
PREDISPOSES,YOD1 gene|YOD1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,YOD1 gene|YOD1 Triple Negative Breast Neoplasms
AFFECTS,SMYD2 gene|SMYD2,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,SMYD2 gene|SMYD2 Secondary malignant neoplasm of breast
CAUSES,TUSC2 gene|TUSC2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TUSC2 gene|TUSC2 Malignant neoplasm of breast
PREDISPOSES,GPX4 gene|GPX4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GPX4 gene|GPX4 Malignant neoplasm of breast
CAUSES,Circulating Tumor DNA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Circulating Tumor DNA Malignant neoplasm of breast
PREDISPOSES,AURKA gene|AURKA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,AURKA gene|AURKA Malignant neoplasm of breast
AUGMENTS,"CREB1 protein, human|CREB1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CREB1 protein, human|CREB1 Malignant neoplasm of breast"
AFFECTS,Cervical Cancer Screening,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Cervical Cancer Screening Malignant neoplasm of breast
AFFECTS,ascorbic acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,ascorbic acid Malignant neoplasm of breast
AFFECTS,TMED2 gene|TMED2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TMED2 gene|TMED2 Malignant neoplasm of breast
AFFECTS,HASPIN gene|HASPIN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HASPIN gene|HASPIN Malignant neoplasm of breast
AUGMENTS,SNHG14 gene|SNHG14,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SNHG14 gene|SNHG14 Malignant neoplasm of breast
PREDISPOSES,Lymphatic Invasion,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",Lymphatic Invasion Invasive carcinoma of breast
AFFECTS,Allele-Specific Oligonucleotide,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Allele-Specific Oligonucleotide Triple Negative Breast Neoplasms
AUGMENTS,NR1D1 gene|NR1D1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NR1D1 gene|NR1D1 Malignant neoplasm of breast
AFFECTS,estrogens,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Hormone,estrogens estrogen receptor-positive breast cancer
AFFECTS,Oncogenes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Oncogenes Malignant neoplasm of breast
PREDISPOSES,FOXO3 gene|FOXO3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FOXO3 gene|FOXO3 Malignant neoplasm of breast
PREDISPOSES,NEK2 gene|NEK2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NEK2 gene|NEK2 Malignant neoplasm of breast
PREDISPOSES,Pharmacologic Substance,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,Pharmacologic Substance Malignant neoplasm of breast
AFFECTS,PAXX gene|PAXX,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,PAXX gene|PAXX Triple Negative Breast Neoplasms
PREDISPOSES,TP53,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TP53 Malignant neoplasm of breast
AFFECTS,Colorectal Carcinoma,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Colorectal Carcinoma Breast Carcinoma
AUGMENTS,PIN1 gene|PIN1,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,PIN1 gene|PIN1 Noninfiltrating Intraductal Carcinoma
CAUSES,Trace Elements,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Trace Elements Malignant neoplasm of breast
DISRUPTS,FMO4 gene|FMO4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FMO4 gene|FMO4 Malignant neoplasm of breast
AFFECTS,Fibroblast Growth Factor Receptors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Fibroblast Growth Factor Receptors Malignant neoplasm of breast
PREDISPOSES,"POSTN protein, human|POSTN",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein","POSTN protein, human|POSTN Triple Negative Breast Neoplasms"
CAUSES,TWIST1 gene|TWIST1,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,TWIST1 gene|TWIST1 Secondary malignant neoplasm of breast
AFFECTS,Homologous Recombination Repair Gene,Carcinoma breast stage IV,0.0,Female Breast Cancer,Gene or Genome,Homologous Recombination Repair Gene Carcinoma breast stage IV
DISRUPTS,YBX1 gene|YBX1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,YBX1 gene|YBX1 Triple Negative Breast Neoplasms
PREDISPOSES,Plasma Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Plasma Proteins Malignant neoplasm of breast
AFFECTS,FBXO3 gene|FBXO3,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,FBXO3 gene|FBXO3 Secondary malignant neoplasm of breast
AFFECTS,Precision Medicine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Precision Medicine Malignant neoplasm of breast
PREDISPOSES,American College of Cardiology/American Heart Association Lesion Complexity Score A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",American College of Cardiology/American Heart Association Lesion Complexity Score A Malignant neoplasm of breast
PREDISPOSES,MTDH gene|MTDH,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,MTDH gene|MTDH Secondary malignant neoplasm of breast
DISRUPTS,c-src Genes|SRC,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,c-src Genes|SRC Secondary malignant neoplasm of breast
AFFECTS,Psychotic Disorders,Carcinoma breast stage IV,0.0,Female Breast Cancer,Disease or Syndrome,Psychotic Disorders Carcinoma breast stage IV
AUGMENTS,Ubiquitin-Conjugating Enzymes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Enzyme,Ubiquitin-Conjugating Enzymes Malignant neoplasm of breast
AFFECTS,TIPARP gene|TIPARP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TIPARP gene|TIPARP Malignant neoplasm of breast
AFFECTS,RAD51 gene|RAD51,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RAD51 gene|RAD51 Malignant neoplasm of breast
AFFECTS,Duration,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",Duration Noninfiltrating Intraductal Carcinoma
AUGMENTS,GALNT7 gene|GALNT7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GALNT7 gene|GALNT7 Malignant neoplasm of breast
AFFECTS,MELK gene|MELK,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MELK gene|MELK Malignant neoplasm of breast
PREDISPOSES,Leukotriene B4 Receptors,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Eicosanoid,Leukotriene B4 Receptors Triple Negative Breast Neoplasms
AFFECTS,GRB2 gene|GRB2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GRB2 gene|GRB2 Malignant neoplasm of breast
DISRUPTS,LIAS gene|LIAS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LIAS gene|LIAS Malignant neoplasm of breast
PREDISPOSES,HER2/Neu Positive,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,"Amino Acid, Peptide, or Protein",HER2/Neu Positive Secondary malignant neoplasm of breast
AUGMENTS,SNORD16 gene|SNORD16,Early-Stage Breast Carcinoma,0.0,Female Breast Cancer,Gene or Genome,SNORD16 gene|SNORD16 Early-Stage Breast Carcinoma
AFFECTS,FBXO8 gene|FBXO8,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,FBXO8 gene|FBXO8 Secondary malignant neoplasm of breast
PREDISPOSES,Fertility Agents,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical Viewed Functionally,Fertility Agents Malignant neoplasm of breast
AFFECTS,Receptor Protein-Tyrosine Kinases,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Receptor Protein-Tyrosine Kinases Triple Negative Breast Neoplasms
CAUSES,cadmium chloride,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Inorganic Chemical,cadmium chloride Malignant neoplasm of breast
CAUSES,Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Proteins Malignant neoplasm of breast
AFFECTS,ECM1 gene|ECM1,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,ECM1 gene|ECM1 Secondary malignant neoplasm of breast
PREDISPOSES,SNHG1 gene|SNHG1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SNHG1 gene|SNHG1 Malignant neoplasm of breast
AFFECTS,"ORF74 protein, Human herpesvirus 8",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein","ORF74 protein, Human herpesvirus 8 Triple Negative Breast Neoplasms"
CAUSES,DNA Modification Methylases|DNMT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",DNA Modification Methylases|DNMT1 Malignant neoplasm of breast
AUGMENTS,SNORD49B gene|SNORD49B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SNORD49B gene|SNORD49B Malignant neoplasm of breast
AFFECTS,YAP1 gene|YAP1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,YAP1 gene|YAP1 Triple Negative Breast Neoplasms
PREDISPOSES,"herstatin protein, human",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","herstatin protein, human Malignant neoplasm of breast"
PREDISPOSES,HOTAIR gene|HOTAIR,malignant neoplasm of breast staging,0.0,Female Breast Cancer,Gene or Genome,HOTAIR gene|HOTAIR malignant neoplasm of breast staging
AUGMENTS,Reactive Oxygen Species,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Reactive Oxygen Species Malignant neoplasm of breast
CAUSES,"ATP8A2 protein, human|ATP8A2",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","ATP8A2 protein, human|ATP8A2 Malignant neoplasm of breast"
AFFECTS,Alzheimer's Disease,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Alzheimer's Disease Malignant neoplasm of breast
PREDISPOSES,Pathogenic Variant,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Virus,Pathogenic Variant Malignant neoplasm of breast
PREDISPOSES,Alzheimer's Disease,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Disease or Syndrome,Alzheimer's Disease estrogen receptor-positive breast cancer
AFFECTS,UGT2B7 gene|UGT2B7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,UGT2B7 gene|UGT2B7 Malignant neoplasm of breast
PREDISPOSES,HIF1A gene|HIF1A,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,HIF1A gene|HIF1A Triple Negative Breast Neoplasms
PREDISPOSES,O(6)-Methylguanine-DNA Methyltransferase|MGMT,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",O(6)-Methylguanine-DNA Methyltransferase|MGMT Triple Negative Breast Neoplasms
AFFECTS,Biological Processes,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Phenomenon or Process,Biological Processes Triple Negative Breast Neoplasms
PREDISPOSES,GCKR gene|GCKR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GCKR gene|GCKR Malignant neoplasm of breast
PREDISPOSES,PDP1 gene|PDP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PDP1 gene|PDP1 Malignant neoplasm of breast
AFFECTS,Gene Family,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Gene Family Malignant neoplasm of breast
CAUSES,FSCN1 gene|FSCN1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FSCN1 gene|FSCN1 Malignant neoplasm of breast
AFFECTS,Malignant Neoplasms,Hereditary Breast and Ovarian Cancer Syndrome,0.0,Female Breast Cancer,Neoplastic Process,Malignant Neoplasms Hereditary Breast and Ovarian Cancer Syndrome
AFFECTS,"CDK7 protein, human|CDK7",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CDK7 protein, human|CDK7 Malignant neoplasm of breast"
PREDISPOSES,NODAL gene,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,NODAL gene Noninfiltrating Intraductal Carcinoma
AUGMENTS,"Carcinoembryonic Antigen-Related Cell Adhesion Molecule 6, human|CEACAM6",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Carcinoembryonic Antigen-Related Cell Adhesion Molecule 6, human|CEACAM6 Malignant neoplasm of breast"
AFFECTS,Uridine Diphosphate Glucose Dehydrogenase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Uridine Diphosphate Glucose Dehydrogenase Malignant neoplasm of breast
DISRUPTS,Oligoribonucleotides,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Oligoribonucleotides Malignant neoplasm of breast
PREDISPOSES,TCF7L2 gene|TCF7L2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TCF7L2 gene|TCF7L2 Malignant neoplasm of breast
PREDISPOSES,NCOA1 gene|NCOA1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,NCOA1 gene|NCOA1 Breast cancer metastatic
AFFECTS,CYP19A1 gene|CYP19A1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CYP19A1 gene|CYP19A1 Malignant neoplasm of breast
PREDISPOSES,MLH1 gene|MLH1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MLH1 gene|MLH1 Malignant neoplasm of breast
PREDISPOSES,"GMNN protein, human|GMNN",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","GMNN protein, human|GMNN Malignant neoplasm of breast"
AUGMENTS,Fatty Acids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Fatty Acids Malignant neoplasm of breast
AFFECTS,Aromatase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Enzyme,Aromatase Malignant neoplasm of breast
AFFECTS,Carcinogens,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Hazardous or Poisonous Substance,Carcinogens Breast Carcinoma
PREDISPOSES,LSP1 gene|LSP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LSP1 gene|LSP1 Malignant neoplasm of breast
AFFECTS,TNFSF6 gene|FASLG,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TNFSF6 gene|FASLG Malignant neoplasm of breast
AFFECTS,Prevention,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,"Element, Ion, or Isotope",Prevention Familial cancer of breast
AFFECTS,Methionine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Methionine Malignant neoplasm of breast
DISRUPTS,NME1 gene|NME1,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Gene or Genome,NME1 gene|NME1 Breast cancer invasive NOS
AUGMENTS,Amyloid beta-Protein Precursor,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Amyloid beta-Protein Precursor Breast Carcinoma
DISRUPTS,Compound V,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Compound V Malignant neoplasm of breast
AFFECTS,Pharmaceutical Preparations,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Pharmacologic Substance,Pharmaceutical Preparations Breast Carcinoma
DISRUPTS,"VEGF protein, human|VEGFA",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","VEGF protein, human|VEGFA Malignant neoplasm of breast"
AFFECTS,Bacterial Endocarditis,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Bacterium,Bacterial Endocarditis Breast cancer metastatic
AUGMENTS,activating transcription factor 3|ATF3,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",activating transcription factor 3|ATF3 Breast cancer metastatic
AFFECTS,Immune Cell Activation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Immune Cell Activation Malignant neoplasm of breast
PREDISPOSES,CD47 gene|CD47,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CD47 gene|CD47 Malignant neoplasm of breast
AFFECTS,Estrogen Receptors,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptors Breast cancer metastatic
CAUSES,bone morphogenetic protein 6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,bone morphogenetic protein 6 Malignant neoplasm of breast
PREDISPOSES,AR gene|AR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,AR gene|AR Malignant neoplasm of breast
PREDISPOSES,NTRK2 gene|NTRK2,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Gene or Genome,NTRK2 gene|NTRK2 Breast cancer recurrent
PREDISPOSES,IGKC gene|IGKC,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IGKC gene|IGKC Malignant neoplasm of breast
AFFECTS,Cadmium,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Inorganic Chemical,Cadmium Malignant neoplasm of breast
PREDISPOSES,Vitamin B6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Vitamin B6 Malignant neoplasm of breast
PREDISPOSES,Estrogen Receptor beta|EREG|ESR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptor beta|EREG|ESR1 Malignant neoplasm of breast
PREDISPOSES,Encounter due to genetic counseling,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,Gene or Genome,Encounter due to genetic counseling Familial cancer of breast
CAUSES,BMP2 gene|BMP2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BMP2 gene|BMP2 Malignant neoplasm of breast
AFFECTS,"TNF protein, human|TNF",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","TNF protein, human|TNF Malignant neoplasm of breast"
PREDISPOSES,Estrogen receptor positive,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen receptor positive Malignant neoplasm of breast
PREDISPOSES,High Density Lipoprotein Cholesterol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",High Density Lipoprotein Cholesterol Malignant neoplasm of breast
AFFECTS,mullerian-inhibiting hormone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,mullerian-inhibiting hormone Malignant neoplasm of breast
AFFECTS,Antineoplastic Agents,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Antineoplastic Agents Malignant neoplasm of breast
PREDISPOSES,MYC gene|MYC,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MYC gene|MYC Malignant neoplasm of breast
PREDISPOSES,"Genes, cdc",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,"Genes, cdc Malignant neoplasm of breast"
PREDISPOSES,"DNA, Mitochondrial",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","DNA, Mitochondrial Malignant neoplasm of breast"
PREDISPOSES,BIRC4 gene|XIAP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BIRC4 gene|XIAP Malignant neoplasm of breast
AUGMENTS,Contraceptive Agents,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical Viewed Functionally,Contraceptive Agents Malignant neoplasm of breast
AUGMENTS,MC4R gene|MC4R,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MC4R gene|MC4R Malignant neoplasm of breast
PREDISPOSES,Syndrome,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,Disease or Syndrome,Syndrome Contralateral breast cancer
DISRUPTS,RNA-Binding Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",RNA-Binding Proteins Malignant neoplasm of breast
PREDISPOSES,FOXM1 gene|FOXM1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,FOXM1 gene|FOXM1 Breast cancer metastatic
AFFECTS,PAWR gene|PAWR,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Gene or Genome,PAWR gene|PAWR Breast cancer recurrent
PREDISPOSES,Mullerian-inhibiting substance receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Substance,Mullerian-inhibiting substance receptor Malignant neoplasm of breast
PREDISPOSES,Estrogen Receptor alpha|EREG|ESR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptor alpha|EREG|ESR1 Malignant neoplasm of breast
AUGMENTS,Hormone Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Hormone Receptor Malignant neoplasm of breast
AUGMENTS,MIRN21 gene|MIR21,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIRN21 gene|MIR21 Malignant neoplasm of breast
AFFECTS,ERBB2IP gene|ERBIN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ERBB2IP gene|ERBIN Malignant neoplasm of breast
DISRUPTS,RARRES3 gene|RARRES3,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,RARRES3 gene|RARRES3 Breast cancer metastatic
AFFECTS,Adenocarcinoma of large intestine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Adenocarcinoma of large intestine Malignant neoplasm of breast
PREDISPOSES,"RNA, Messenger",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","RNA, Messenger Malignant neoplasm of breast"
CAUSES,EPSTI1 gene|EPSTI1,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Gene or Genome,EPSTI1 gene|EPSTI1 Breast cancer invasive NOS
AFFECTS,Prodrugs,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,Prodrugs Malignant neoplasm of breast
AFFECTS,NRIP1 gene|NRIP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NRIP1 gene|NRIP1 Malignant neoplasm of breast
AFFECTS,platelet-derived growth factor C,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,platelet-derived growth factor C Malignant neoplasm of breast
AFFECTS,"TIMP1 protein, human|TIMP1",Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein","TIMP1 protein, human|TIMP1 Breast cancer metastatic"
PREDISPOSES,Encounter due to genetic counseling,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,Gene or Genome,Encounter due to genetic counseling Contralateral breast cancer
AFFECTS,APC gene|APC,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,APC gene|APC Malignant neoplasm of breast
PREDISPOSES,Genes,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Gene or Genome,Genes Breast cancer recurrent
DISRUPTS,cyclooxygenase 2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",cyclooxygenase 2 Malignant neoplasm of breast
AFFECTS,Breast cancer invasive NOS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Breast cancer invasive NOS Malignant neoplasm of breast
PREDISPOSES,TLR4 gene|TLR4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TLR4 gene|TLR4 Malignant neoplasm of breast
AFFECTS,Sialoproteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Sialoproteins Malignant neoplasm of breast
DISRUPTS,Trace Elements,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Trace Elements Malignant neoplasm of breast
AUGMENTS,PIK3CA gene|PIK3CA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PIK3CA gene|PIK3CA Malignant neoplasm of breast
PREDISPOSES,CHEK1 gene|CHEK1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CHEK1 gene|CHEK1 Malignant neoplasm of breast
PREDISPOSES,Organic Chemicals,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Organic Chemicals Malignant neoplasm of breast
PREDISPOSES,XRCC4 gene|XRCC4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,XRCC4 gene|XRCC4 Malignant neoplasm of breast
AFFECTS,CDH1 gene|CDH1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CDH1 gene|CDH1 Malignant neoplasm of breast
AFFECTS,"HGF protein, human|HGF",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","HGF protein, human|HGF Malignant neoplasm of breast"
PREDISPOSES,STAT5B gene|STAT5B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,STAT5B gene|STAT5B Malignant neoplasm of breast
AFFECTS,transcription cofactor activity,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",transcription cofactor activity Malignant neoplasm of breast
AFFECTS,Wiskott-Aldrich Syndrome Protein,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Wiskott-Aldrich Syndrome Protein Breast cancer metastatic
PREDISPOSES,Proto-Oncogene Proteins c-sis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Proto-Oncogene Proteins c-sis Malignant neoplasm of breast
PREDISPOSES,CA-125 Antigen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Immunologic Factor,CA-125 Antigen Malignant neoplasm of breast
AFFECTS,Epigenetic Process,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Epigenetic Process Malignant neoplasm of breast
AUGMENTS,Glutamic Acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Glutamic Acid Malignant neoplasm of breast
CAUSES,"Receptors, Tumor Necrosis Factor, Type II",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,"Receptors, Tumor Necrosis Factor, Type II Malignant neoplasm of breast"
PREDISPOSES,Atrial Fibrillation,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Element, Ion, or Isotope",Atrial Fibrillation Breast cancer invasive NOS
AFFECTS,Cancer of Rectum,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Cancer of Rectum Malignant neoplasm of breast
CAUSES,TNFSF10 gene|TNFSF10,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TNFSF10 gene|TNFSF10 Malignant neoplasm of breast
PREDISPOSES,Epstein-Barr virus antibody,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Indicator, Reagent, or Diagnostic Aid",Epstein-Barr virus antibody Malignant neoplasm of breast
AFFECTS,TSG101 gene|TSG101,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Gene or Genome,TSG101 gene|TSG101 Breast cancer invasive NOS
AFFECTS,Castration,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Castration Malignant neoplasm of breast
PREDISPOSES,MIRN17 gene|MIR17,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIRN17 gene|MIR17 Malignant neoplasm of breast
AFFECTS,"SHC1 protein, human|SHC1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","SHC1 protein, human|SHC1 Malignant neoplasm of breast"
PREDISPOSES,In complete remission,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",In complete remission Malignant neoplasm of breast
AFFECTS,Reproduction,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Reproduction Malignant neoplasm of breast
AFFECTS,Up-Regulation (Physiology),Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Up-Regulation (Physiology) Breast cancer metastatic
AFFECTS,Chronic inflammation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Chronic inflammation Malignant neoplasm of breast
AUGMENTS,SRC gene|SRC,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SRC gene|SRC Malignant neoplasm of breast
PREDISPOSES,OLFM4 gene|OLFM4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,OLFM4 gene|OLFM4 Malignant neoplasm of breast
CAUSES,Virus,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,Virus,Virus Female Breast Carcinoma
AFFECTS,BRCA2 gene|BRCA2,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,Gene or Genome,BRCA2 gene|BRCA2 Familial cancer of breast
PREDISPOSES,Exogenous hormones,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Exogenous hormones Malignant neoplasm of breast
PREDISPOSES,calcification,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",calcification Malignant neoplasm of breast
DISRUPTS,"RARB protein, human|RARB",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","RARB protein, human|RARB Malignant neoplasm of breast"
AUGMENTS,LEPR gene|LEPR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LEPR gene|LEPR Malignant neoplasm of breast
AFFECTS,Exogenous hormones,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Exogenous hormones Malignant neoplasm of breast
AFFECTS,Estrogens,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Hormone,Estrogens Breast cancer metastatic
DISRUPTS,"CST6 protein, human|CST6",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CST6 protein, human|CST6 Malignant neoplasm of breast"
PREDISPOSES,"Fatty Acids, Essential",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,"Fatty Acids, Essential Malignant neoplasm of breast"
AUGMENTS,Vitamin D3 Receptor|VDR,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Food,Vitamin D3 Receptor|VDR Breast Carcinoma
PREDISPOSES,pyrrolidino-4-iodotamoxifen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,pyrrolidino-4-iodotamoxifen Malignant neoplasm of breast
AFFECTS,Transcriptional Activation,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Transcriptional Activation Breast cancer metastatic
AFFECTS,Infusion procedures,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Infusion procedures Breast cancer metastatic
DISRUPTS,Proto-Oncogene Proteins c-akt|AKT1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,Proto-Oncogene Proteins c-akt|AKT1 Breast cancer metastatic
AFFECTS,Progesterone,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Hormone,Progesterone Breast Carcinoma
PREDISPOSES,Fibroblast Growth Factor 2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Fibroblast Growth Factor 2 Malignant neoplasm of breast
PREDISPOSES,Candidate Disease Gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Candidate Disease Gene Malignant neoplasm of breast
AFFECTS,Immunotherapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Immunologic Factor,Immunotherapy Malignant neoplasm of breast
AFFECTS,Involution,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Involution Malignant neoplasm of breast
AUGMENTS,Enzymes,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Enzyme,Enzymes Breast Carcinoma
CAUSES,neu Differentiation Factor,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",neu Differentiation Factor Breast Carcinoma
CAUSES,parathyroid hormone-related protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",parathyroid hormone-related protein Malignant neoplasm of breast
CAUSES,Proto-Oncogenes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Proto-Oncogenes Malignant neoplasm of breast
AUGMENTS,"Oncogene, HST|FGF4|HSF1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,"Oncogene, HST|FGF4|HSF1 Malignant neoplasm of breast"
AFFECTS,Estrogen Replacement Therapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Estrogen Replacement Therapy Malignant neoplasm of breast
AFFECTS,Cytotoxic agent,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hazardous or Poisonous Substance,Cytotoxic agent Malignant neoplasm of breast
AFFECTS,3-hydroxytamoxifen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,3-hydroxytamoxifen Malignant neoplasm of breast
AFFECTS,Termination of pregnancy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Termination of pregnancy Malignant neoplasm of breast
CAUSES,Secondary malignant neoplasm of bone,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Secondary malignant neoplasm of bone Breast Carcinoma
AUGMENTS,Growth Factor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Growth Factor Malignant neoplasm of breast
CAUSES,Breast Carcinoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Breast Carcinoma Malignant neoplasm of breast
PREDISPOSES,EGF gene|EGF,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,EGF gene|EGF Malignant neoplasm of breast
AFFECTS,Hormones,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Hormones Malignant neoplasm of breast
AFFECTS,Breast Diseases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Breast Diseases Malignant neoplasm of breast
AFFECTS,Induction,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Induction Breast Carcinoma
CAUSES,Malignant transformation,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Malignant transformation Breast Carcinoma
PREDISPOSES,Thyroid Hormones,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Thyroid Hormones Malignant neoplasm of breast
PREDISPOSES,Tissue Polypeptide Antigen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Tissue Polypeptide Antigen Malignant neoplasm of breast
CAUSES,Glycoproteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Glycoproteins Malignant neoplasm of breast
CAUSES,Malignant neoplasm of stomach,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Malignant neoplasm of stomach Malignant neoplasm of breast
AFFECTS,Medroxyprogesterone 17-Acetate,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Hormone,Medroxyprogesterone 17-Acetate Breast Carcinoma
CAUSES,v-H-ras Oncogenes,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,v-H-ras Oncogenes Breast Carcinoma
AFFECTS,Hair Dyes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Indicator, Reagent, or Diagnostic Aid",Hair Dyes Malignant neoplasm of breast
AFFECTS,Estrogen Antagonists,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Hormone,Estrogen Antagonists Breast Carcinoma
PREDISPOSES,Cystic Lesion,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Cystic Lesion Malignant neoplasm of breast
AFFECTS,Contraction,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Contraction Malignant neoplasm of breast
AUGMENTS,Prostaglandins,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Eicosanoid,Prostaglandins Breast Carcinoma
PREDISPOSES,"Hamartoma Syndrome, Multiple",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,"Hamartoma Syndrome, Multiple Malignant neoplasm of breast"
DISRUPTS,PGR gene|PGR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PGR gene|PGR Malignant neoplasm of breast
AFFECTS,Tumor Antigens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Tumor Antigens Malignant neoplasm of breast
AFFECTS,Estrogenic,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Hormone,Estrogenic Breast Carcinoma
AUGMENTS,TP53 gene|TP53,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,TP53 gene|TP53 Breast Carcinoma
PREDISPOSES,Carrier of disorder,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,Disease or Syndrome,Carrier of disorder Female Breast Carcinoma
PREDISPOSES,E2F1 gene|E2F1|UBE2L3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,E2F1 gene|E2F1|UBE2L3 Malignant neoplasm of breast
DISRUPTS,Human Chorionic Gonadotropin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Human Chorionic Gonadotropin Malignant neoplasm of breast
DISRUPTS,Complex carbohydrate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Carbohydrate,Complex carbohydrate Malignant neoplasm of breast
DISRUPTS,SERPINB2 gene|SERPINB2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SERPINB2 gene|SERPINB2 Malignant neoplasm of breast
AUGMENTS,PTK2B gene|PTK2B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PTK2B gene|PTK2B Malignant neoplasm of breast
AUGMENTS,Focal Adhesion Protein-Tyrosine Kinases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Focal Adhesion Protein-Tyrosine Kinases Malignant neoplasm of breast
AFFECTS,retinoic acid receptor alpha,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,retinoic acid receptor alpha Malignant neoplasm of breast
AUGMENTS,Cyclic AMP Receptor Protein,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Cyclic AMP Receptor Protein Breast Carcinoma
PREDISPOSES,Maternal history,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Maternal history Malignant neoplasm of breast
CAUSES,Insulin-Like Growth-Factor-Binding Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Insulin-Like Growth-Factor-Binding Proteins Malignant neoplasm of breast
PREDISPOSES,Enzymes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Enzyme,Enzymes Malignant neoplasm of breast
CAUSES,"Herpesvirus 4, Human",Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Virus,"Herpesvirus 4, Human Breast Carcinoma"
AUGMENTS,DNA,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",DNA Breast Carcinoma
PREDISPOSES,Lhermitte-Duclos disease,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Disease or Syndrome,Lhermitte-Duclos disease Breast Carcinoma
PREDISPOSES,BRCA2 gene|BRCA2,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Gene or Genome,BRCA2 gene|BRCA2 Carcinoma of Male Breast
AFFECTS,"Hydrocarbons, Chlorinated",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Hydrocarbons, Chlorinated Malignant neoplasm of breast"
CAUSES,CDKN2A gene|CDKN2A,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Gene or Genome,CDKN2A gene|CDKN2A Sporadic Breast Carcinoma
PREDISPOSES,Overnutrition,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Overnutrition Malignant neoplasm of breast
AFFECTS,Transcription Factor AP-2 Alpha|FABP4|GTF3A|TFAP2A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Transcription Factor AP-2 Alpha|FABP4|GTF3A|TFAP2A Malignant neoplasm of breast
AUGMENTS,SPO11 gene|SPO11,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SPO11 gene|SPO11 Malignant neoplasm of breast
PREDISPOSES,Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Proteins Malignant neoplasm of breast
AFFECTS,Gene Expression,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,Gene Expression Breast Carcinoma
AFFECTS,Gene Amplification,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,Gene Amplification Noninfiltrating Intraductal Carcinoma
CAUSES,ras Oncogene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ras Oncogene Malignant neoplasm of breast
AFFECTS,Invasive Carcinoma,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Neoplastic Process,Invasive Carcinoma Noninfiltrating Intraductal Carcinoma
AFFECTS,CHGA gene|CHGA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CHGA gene|CHGA Malignant neoplasm of breast
AFFECTS,MDM2 gene|MDM2,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Gene or Genome,MDM2 gene|MDM2 Breast cancer invasive NOS
AFFECTS,Vascular Endothelial Growth Factor Receptor-1|VEGFA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Vascular Endothelial Growth Factor Receptor-1|VEGFA Malignant neoplasm of breast
CAUSES,NMU gene|NMU,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,NMU gene|NMU Breast Carcinoma
AFFECTS,ovarian function,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",ovarian function Malignant neoplasm of breast
AFFECTS,Estrogens,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Hormone,Estrogens Breast Carcinoma
CAUSES,Gross' disease,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Gross' disease Malignant neoplasm of breast
CAUSES,"Polycyclic Hydrocarbons, Aromatic",Sporadic Breast Carcinoma,0.0,Female Breast Cancer,"Element, Ion, or Isotope","Polycyclic Hydrocarbons, Aromatic Sporadic Breast Carcinoma"
PREDISPOSES,Vitamin E,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Vitamin E Malignant neoplasm of breast
AFFECTS,glutathione S-transferase M1|CHRM1|MRLN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",glutathione S-transferase M1|CHRM1|MRLN Malignant neoplasm of breast
AFFECTS,Radiation therapy,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Element, Ion, or Isotope",Radiation therapy Breast cancer invasive NOS
AUGMENTS,bone sialoprotein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",bone sialoprotein Malignant neoplasm of breast
AFFECTS,"TRIM25 protein, human|TRIM25",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","TRIM25 protein, human|TRIM25 Malignant neoplasm of breast"
PREDISPOSES,Adrenal carcinoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Adrenal carcinoma Malignant neoplasm of breast
PREDISPOSES,Opioid Peptide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Opioid Peptide Malignant neoplasm of breast
DISRUPTS,BRCA1 Protein|BRCA1,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Gene or Genome,BRCA1 Protein|BRCA1 Sporadic Breast Carcinoma
AFFECTS,Malignant neoplasm of breast,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Malignant neoplasm of breast Breast cancer metastatic
CAUSES,Chemopreventive Agent,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical Viewed Functionally,Chemopreventive Agent Malignant neoplasm of breast
PREDISPOSES,Epoxy Compounds,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Epoxy Compounds Malignant neoplasm of breast
AUGMENTS,ERBB2 gene|ERBB2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,ERBB2 gene|ERBB2 Breast cancer metastatic
PREDISPOSES,Repressor Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Repressor Proteins Malignant neoplasm of breast
AFFECTS,Radioimmunotherapy,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Immunologic Factor,Radioimmunotherapy Breast cancer metastatic
PREDISPOSES,TIE gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TIE gene Malignant neoplasm of breast
AFFECTS,Thyroid Hormone Receptor Gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Thyroid Hormone Receptor Gene Malignant neoplasm of breast
AFFECTS,HDAC1 gene|HDAC1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HDAC1 gene|HDAC1 Malignant neoplasm of breast
DISRUPTS,ATM gene|ATM,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ATM gene|ATM Malignant neoplasm of breast
AFFECTS,XRCC2 gene|XRCC2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,XRCC2 gene|XRCC2 Malignant neoplasm of breast
CAUSES,EGFR gene|EGFR,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,EGFR gene|EGFR Breast Carcinoma
CAUSES,Substance,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Substance,Substance Malignant neoplasm of breast
AFFECTS,Sporadic Breast Carcinoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Sporadic Breast Carcinoma Malignant neoplasm of breast
PREDISPOSES,Oleic Acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Oleic Acid Malignant neoplasm of breast
PREDISPOSES,GTPase-Activating Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",GTPase-Activating Proteins Malignant neoplasm of breast
CAUSES,CHEK2 gene|CHEK2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CHEK2 gene|CHEK2 Malignant neoplasm of breast
PREDISPOSES,Insulin-Like Growth-Factor-Binding Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Insulin-Like Growth-Factor-Binding Proteins Malignant neoplasm of breast
PREDISPOSES,"Estrogens, Synthetic",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,"Estrogens, Synthetic Malignant neoplasm of breast"
AFFECTS,TP53 gene|TP53,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Gene or Genome,TP53 gene|TP53 Breast cancer recurrent
AUGMENTS,"Hydrocarbons, Chlorinated",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Hydrocarbons, Chlorinated Malignant neoplasm of breast"
AUGMENTS,parathyroid hormone-related protein,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",parathyroid hormone-related protein Breast cancer metastatic
AFFECTS,Fatty food,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Fatty food Malignant neoplasm of breast
CAUSES,CHEK2 gene|CHEK2,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Gene or Genome,CHEK2 gene|CHEK2 Carcinoma of Male Breast
CAUSES,Carcinoma of Male Breast,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Carcinoma of Male Breast Malignant neoplasm of breast
DISRUPTS,"SKIL protein, human|SKIL",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","SKIL protein, human|SKIL Malignant neoplasm of breast"
DISRUPTS,"retinoic acid binding protein II, cellular",Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein","retinoic acid binding protein II, cellular Breast Carcinoma"
AFFECTS,"Carcinoma, Lobular","Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Neoplastic Process,"Carcinoma, Lobular Carcinoma, Ductal, Breast"
CAUSES,Medroxyprogesterone 17-Acetate,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Hormone,Medroxyprogesterone 17-Acetate Breast Carcinoma
AFFECTS,BRCA1 Mutation,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,Gene or Genome,BRCA1 Mutation Familial cancer of breast
PREDISPOSES,BIRC5 gene|BIRC5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BIRC5 gene|BIRC5 Malignant neoplasm of breast
AUGMENTS,Epidermal Growth Factor Receptor|EGFR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Epidermal Growth Factor Receptor|EGFR Malignant neoplasm of breast
CAUSES,Mammary Tumorigenesis,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Gene or Genome,Mammary Tumorigenesis Sporadic Breast Carcinoma
AFFECTS,Hepatocyte Growth Factor|HGF,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Hepatocyte Growth Factor|HGF Malignant neoplasm of breast
AUGMENTS,"JARID1B protein, human|KDM5B",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","JARID1B protein, human|KDM5B Malignant neoplasm of breast"
PREDISPOSES,pregnancy hormones,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,pregnancy hormones Malignant neoplasm of breast
PREDISPOSES,Recreation,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Element, Ion, or Isotope",Recreation Breast cancer invasive NOS
AFFECTS,peptide I,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",peptide I Malignant neoplasm of breast
PREDISPOSES,Carbohydrates,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Carbohydrate,Carbohydrates Malignant neoplasm of breast
AFFECTS,Malignant neoplasm of prostate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Malignant neoplasm of prostate Malignant neoplasm of breast
CAUSES,Hexachlorobenzene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hazardous or Poisonous Substance,Hexachlorobenzene Malignant neoplasm of breast
PREDISPOSES,HFE gene|HFE,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Gene or Genome,HFE gene|HFE Carcinoma of Male Breast
PREDISPOSES,Single-Stranded Conformational Polymorphism,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Single-Stranded Conformational Polymorphism Malignant neoplasm of breast
AFFECTS,Emotional support,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Emotional support Malignant neoplasm of breast
AUGMENTS,Conjugated Equine Estrogens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Conjugated Equine Estrogens Malignant neoplasm of breast
DISRUPTS,beta-ionone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",beta-ionone Malignant neoplasm of breast
DISRUPTS,Tumor Protein p53 Binding Protein 2,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Tumor Protein p53 Binding Protein 2 Breast cancer invasive NOS
AUGMENTS,Oncogenes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Oncogenes Malignant neoplasm of breast
PREDISPOSES,Endocrine Disruptors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Endocrine Disruptors Malignant neoplasm of breast
AUGMENTS,Estrogenic,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,Hormone,Estrogenic Female Breast Carcinoma
AFFECTS,"Carcinogens, Environmental",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hazardous or Poisonous Substance,"Carcinogens, Environmental Malignant neoplasm of breast"
PREDISPOSES,Convenience food,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Food,Convenience food Breast cancer invasive NOS
PREDISPOSES,Estrogen Receptor beta|ESR2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptor beta|ESR2 Malignant neoplasm of breast
PREDISPOSES,Estrogens,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Hormone,Estrogens Breast cancer invasive NOS
PREDISPOSES,CYP1A2 gene|CYP1A2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CYP1A2 gene|CYP1A2 Malignant neoplasm of breast
PREDISPOSES,Transcription Initiation Site,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Transcription Initiation Site Malignant neoplasm of breast
AFFECTS,Aggressive cancer,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Aggressive cancer Malignant neoplasm of breast
AFFECTS,connective tissue growth factor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,connective tissue growth factor Malignant neoplasm of breast
AUGMENTS,Dopamine Antagonists,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neuroreactive Substance or Biogenic Amine,Dopamine Antagonists Malignant neoplasm of breast
DISRUPTS,Cyclic Peptides,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Cyclic Peptides Malignant neoplasm of breast
AFFECTS,Antibiotics,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Antibiotic,Antibiotics Malignant neoplasm of breast
AFFECTS,EGFR gene|EGFR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,EGFR gene|EGFR Malignant neoplasm of breast
AFFECTS,HSP90 Heat-Shock Proteins|HSP90AA1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",HSP90 Heat-Shock Proteins|HSP90AA1 Malignant neoplasm of breast
AFFECTS,Malignant neoplasm of breast,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,Neoplastic Process,Malignant neoplasm of breast Female Breast Carcinoma
AUGMENTS,Trans Fatty Acids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Trans Fatty Acids Malignant neoplasm of breast
PREDISPOSES,"Diabetes, Gestational",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Diabetes, Gestational Malignant neoplasm of breast"
CAUSES,intestinal bacteria,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Bacterium,intestinal bacteria Breast Carcinoma
AFFECTS,Neoplasm Metastasis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Neoplasm Metastasis Malignant neoplasm of breast
AFFECTS,Tumor Suppressor Genes,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Gene or Genome,Tumor Suppressor Genes Sporadic Breast Carcinoma
AUGMENTS,IRS1 gene|IRS1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,IRS1 gene|IRS1 Breast cancer metastatic
DISRUPTS,Hormones,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Hormones Malignant neoplasm of breast
PREDISPOSES,Carbon,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Carbon Malignant neoplasm of breast
AUGMENTS,PTH gene|PTH,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PTH gene|PTH Malignant neoplasm of breast
PREDISPOSES,IGF1 gene|IGF1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IGF1 gene|IGF1 Malignant neoplasm of breast
PREDISPOSES,Insulin-Like Growth Factor Binding Protein 3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Insulin-Like Growth Factor Binding Protein 3 Malignant neoplasm of breast
CAUSES,Antibiotics,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Antibiotic,Antibiotics Malignant neoplasm of breast
DISRUPTS,"Estrogens, Catechol",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,"Estrogens, Catechol Malignant neoplasm of breast"
AFFECTS,Anti-Inflammatory Agents,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical Viewed Functionally,Anti-Inflammatory Agents Malignant neoplasm of breast
AFFECTS,Platelet-Derived Growth Factor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Platelet-Derived Growth Factor Malignant neoplasm of breast
AUGMENTS,Endocrine Disruptors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Endocrine Disruptors Malignant neoplasm of breast
PREDISPOSES,CD44 gene|CD44,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CD44 gene|CD44 Malignant neoplasm of breast
AFFECTS,Matrix Metalloproteinases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Matrix Metalloproteinases Malignant neoplasm of breast
PREDISPOSES,Vitamin B Complex,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Vitamin B Complex Malignant neoplasm of breast
AFFECTS,Mutation,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Element, Ion, or Isotope",Mutation Breast cancer invasive NOS
DISRUPTS,BRMS1 gene|BRMS1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,BRMS1 gene|BRMS1 Breast cancer metastatic
DISRUPTS,phospholipid-hydroperoxide glutathione peroxidase,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,"Element, Ion, or Isotope","phospholipid-hydroperoxide glutathione peroxidase Carcinoma, Ductal, Breast"
DISRUPTS,alpha-Fetoproteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",alpha-Fetoproteins Malignant neoplasm of breast
AFFECTS,TP53 gene|TP53,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Gene or Genome,TP53 gene|TP53 Breast cancer invasive NOS
PREDISPOSES,TP53 gene|TP53,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,Gene or Genome,TP53 gene|TP53 Familial cancer of breast
AUGMENTS,Metalloproteases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Metalloproteases Malignant neoplasm of breast
PREDISPOSES,Coronary heart disease,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Coronary heart disease Malignant neoplasm of breast
PREDISPOSES,Serotonin Uptake Inhibitors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neuroreactive Substance or Biogenic Amine,Serotonin Uptake Inhibitors Malignant neoplasm of breast
PREDISPOSES,XRCC1 gene|XRCC1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,XRCC1 gene|XRCC1 Malignant neoplasm of breast
PREDISPOSES,Serine Protease,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Enzyme,Serine Protease Malignant neoplasm of breast
PREDISPOSES,CHEK2 gene|CHEK2,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,Gene or Genome,CHEK2 gene|CHEK2 Contralateral breast cancer
PREDISPOSES,BRCA1 Protein|BRCA1,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,Gene or Genome,BRCA1 Protein|BRCA1 Familial cancer of breast
DISRUPTS,EGFR gene|EGFR,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,EGFR gene|EGFR Breast Carcinoma
AFFECTS,Anthracycline Antibiotics,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Antibiotic,Anthracycline Antibiotics Malignant neoplasm of breast
AFFECTS,CCNA2 gene|CCNA2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CCNA2 gene|CCNA2 Malignant neoplasm of breast
PREDISPOSES,"Anti-Inflammatory Agents, Non-Steroidal",Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Chemical Viewed Functionally,"Anti-Inflammatory Agents, Non-Steroidal Breast cancer invasive NOS"
AFFECTS,Estrogen Receptor beta|EREG|ESR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptor beta|EREG|ESR1 Malignant neoplasm of breast
PREDISPOSES,Tumor Cell Invasion,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Tumor Cell Invasion Malignant neoplasm of breast
PREDISPOSES,NES gene|NES,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NES gene|NES Malignant neoplasm of breast
AUGMENTS,TRANSCRIPTION FACTOR,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",TRANSCRIPTION FACTOR Breast Carcinoma
PREDISPOSES,NPY1R gene|NPY1R,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,NPY1R gene|NPY1R Breast cancer metastatic
AFFECTS,High Density Lipoprotein Cholesterol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",High Density Lipoprotein Cholesterol Malignant neoplasm of breast
PREDISPOSES,HGS gene|HGS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HGS gene|HGS Malignant neoplasm of breast
AUGMENTS,Ascorbic Acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Ascorbic Acid Malignant neoplasm of breast
PREDISPOSES,Actin bundling protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Actin bundling protein Malignant neoplasm of breast
AFFECTS,Hypermethylation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Hypermethylation Malignant neoplasm of breast
DISRUPTS,Oligonucleotides,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Oligonucleotides Breast cancer metastatic
AFFECTS,Metabolic syndrome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Metabolic syndrome Malignant neoplasm of breast
AFFECTS,PGR gene|PGR,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Gene or Genome,PGR gene|PGR Breast cancer invasive NOS
AFFECTS,Malignant Neoplasms,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Malignant Neoplasms Breast cancer metastatic
AUGMENTS,"EPIDERMAL GROWTH FACTOR, HUMAN",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,"EPIDERMAL GROWTH FACTOR, HUMAN Malignant neoplasm of breast"
AFFECTS,steroid hormone receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,steroid hormone receptor Malignant neoplasm of breast
PREDISPOSES,ANXA1 gene|ANXA1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ANXA1 gene|ANXA1 Malignant neoplasm of breast
PREDISPOSES,NF1 gene|NF1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NF1 gene|NF1 Malignant neoplasm of breast
DISRUPTS,ERBB2 gene|ERBB2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ERBB2 gene|ERBB2 Malignant neoplasm of breast
AUGMENTS,Organic Anion Transport Polypeptides,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Organic Anion Transport Polypeptides Malignant neoplasm of breast
AUGMENTS,Nucleotides,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Nucleotides Malignant neoplasm of breast
CAUSES,Polyomavirus Middle T Antigens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Virus,Polyomavirus Middle T Antigens Malignant neoplasm of breast
PREDISPOSES,CENPH gene|CENPH,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CENPH gene|CENPH Malignant neoplasm of breast
PREDISPOSES,"Carcinogens, Environmental",Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Hazardous or Poisonous Substance,"Carcinogens, Environmental Sporadic Breast Carcinoma"
AUGMENTS,Mitogen-Activated Protein Kinases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Mitogen-Activated Protein Kinases Malignant neoplasm of breast
PREDISPOSES,"Estrogens, Catechol",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,"Estrogens, Catechol Malignant neoplasm of breast"
AFFECTS,Cancer Treatment,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Cancer Treatment Malignant neoplasm of breast
PREDISPOSES,CLDN2 gene|CLDN2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,CLDN2 gene|CLDN2 Breast cancer metastatic
AFFECTS,Estrogen Antagonists,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Hormone,Estrogen Antagonists Breast cancer invasive NOS
DISRUPTS,BRCA1 gene|BRCA1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BRCA1 gene|BRCA1 Malignant neoplasm of breast
PREDISPOSES,Enzyme variant,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Enzyme,Enzyme variant Malignant neoplasm of breast
AUGMENTS,Vascular Endothelial Growth Factor C|VEGFA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Vascular Endothelial Growth Factor C|VEGFA Malignant neoplasm of breast
PREDISPOSES,"TGFB1 protein, human|TGFB1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","TGFB1 protein, human|TGFB1 Malignant neoplasm of breast"
AFFECTS,MicroRNAs,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",MicroRNAs Breast cancer metastatic
PREDISPOSES,LEPR gene|LEPR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LEPR gene|LEPR Malignant neoplasm of breast
AUGMENTS,Mutagens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hazardous or Poisonous Substance,Mutagens Malignant neoplasm of breast
PREDISPOSES,ESR1 gene|ESR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ESR1 gene|ESR1 Malignant neoplasm of breast
AFFECTS,Migraine Disorders,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Migraine Disorders Malignant neoplasm of breast
AFFECTS,Mastication,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Mastication Malignant neoplasm of breast
CAUSES,Carcinogenesis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hazardous or Poisonous Substance,Carcinogenesis Malignant neoplasm of breast
AFFECTS,Angiogenesis,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,Angiogenesis Noninfiltrating Intraductal Carcinoma
PREDISPOSES,Increased estrogen level,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Increased estrogen level Malignant neoplasm of breast
AFFECTS,Oxidation-Reduction,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Oxidation-Reduction Malignant neoplasm of breast
PREDISPOSES,MicroRNAs,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",MicroRNAs Breast cancer recurrent
AFFECTS,CD44 gene|CD44,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Gene or Genome,"CD44 gene|CD44 Carcinoma, Ductal, Breast"
PREDISPOSES,Elevated insulin-like growth factor I,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Elevated insulin-like growth factor I Malignant neoplasm of breast
AFFECTS,High Mobility Group Proteins,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",High Mobility Group Proteins Breast cancer metastatic
AFFECTS,Hydroxide Ion,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Hydroxide Ion Malignant neoplasm of breast
PREDISPOSES,Angiotensin-Converting Enzyme Inhibitors,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Enzyme,Angiotensin-Converting Enzyme Inhibitors Breast cancer recurrent
PREDISPOSES,RAD51C gene|RAD51C,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RAD51C gene|RAD51C Malignant neoplasm of breast
AUGMENTS,TOPBP1 Gene|TOPBP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TOPBP1 Gene|TOPBP1 Malignant neoplasm of breast
PREDISPOSES,Proteins,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Proteins Inflammatory Breast Carcinoma
AFFECTS,epithelial to mesenchymal transition,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",epithelial to mesenchymal transition Breast cancer metastatic
DISRUPTS,Phosphatidylethanolamine Binding Protein,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Phosphatidylethanolamine Binding Protein Breast cancer metastatic
PREDISPOSES,PTPN11 gene|PTPN11,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PTPN11 gene|PTPN11 Malignant neoplasm of breast
AFFECTS,Disease,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Disease or Syndrome,Disease Breast Carcinoma
AUGMENTS,soy protein isolate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",soy protein isolate Malignant neoplasm of breast
AFFECTS,Estrogen Receptor beta,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptor beta Malignant neoplasm of breast
PREDISPOSES,Tamoxifen,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Pharmacologic Substance,Tamoxifen Breast cancer recurrent
AFFECTS,Sirolimus (substance),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Substance,Sirolimus (substance) Malignant neoplasm of breast
PREDISPOSES,MicroRNAs,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",MicroRNAs Inflammatory Breast Carcinoma
CAUSES,Malignant neoplasm of cervix uteri,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Malignant neoplasm of cervix uteri Malignant neoplasm of breast
CAUSES,"TNF protein, human|TNF",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","TNF protein, human|TNF Malignant neoplasm of breast"
AFFECTS,Mutation,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Mutation Breast cancer metastatic
DISRUPTS,Integral Membrane Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Integral Membrane Proteins Malignant neoplasm of breast
AFFECTS,Lead compound,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Lead compound Malignant neoplasm of breast
PREDISPOSES,STAT3 gene|STAT3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,STAT3 gene|STAT3 Malignant neoplasm of breast
AFFECTS,Transfer RNA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Transfer RNA Malignant neoplasm of breast
AUGMENTS,PROTEIN KINASE,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",PROTEIN KINASE Malignant neoplasm of breast
PREDISPOSES,Choline dehydrogenase|CHDH,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Choline dehydrogenase|CHDH Malignant neoplasm of breast
PREDISPOSES,N-ras Genes|NRAS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,N-ras Genes|NRAS Malignant neoplasm of breast
AFFECTS,Extravasation,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Extravasation Breast cancer metastatic
PREDISPOSES,ABCG2 gene|ABCG2,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,ABCG2 gene|ABCG2 Breast Carcinoma
AFFECTS,PTEN gene|PTEN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PTEN gene|PTEN Malignant neoplasm of breast
AFFECTS,"Tumor Necrosis Factor Receptor Superfamily, Member 10B",Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Neoplastic Process,"Tumor Necrosis Factor Receptor Superfamily, Member 10B Breast cancer metastatic"
CAUSES,Noninfiltrating Intraductal Carcinoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Noninfiltrating Intraductal Carcinoma Malignant neoplasm of breast
PREDISPOSES,Vascular Cell Adhesion Molecule-1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Vascular Cell Adhesion Molecule-1 Breast cancer metastatic
CAUSES,BRCA1 gene|BRCA1,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,Gene or Genome,BRCA1 gene|BRCA1 Familial cancer of breast
PREDISPOSES,Environmental Estrogen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Environmental Estrogen Malignant neoplasm of breast
AUGMENTS,Processed meat,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Phenomenon or Process,Processed meat Malignant neoplasm of breast
AFFECTS,G-Protein-Coupled Receptors,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",G-Protein-Coupled Receptors Breast cancer metastatic
PREDISPOSES,RECQL gene|RECQL,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RECQL gene|RECQL Malignant neoplasm of breast
AFFECTS,Trans-Activation (Genetics),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Trans-Activation (Genetics) Malignant neoplasm of breast
PREDISPOSES,Disease,Carcinoma in situ of breast,0.0019980019980019,Female Breast Cancer,Disease or Syndrome,Disease Carcinoma in situ of breast
DISRUPTS,"DICER1 protein, human|DICER1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","DICER1 protein, human|DICER1 Malignant neoplasm of breast"
AFFECTS,Ovarian ablation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Ovarian ablation Malignant neoplasm of breast
CAUSES,Secondary malignant neoplasm of lymph node,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Secondary malignant neoplasm of lymph node Malignant neoplasm of breast
AFFECTS,Extracellular Matrix Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Extracellular Matrix Proteins Malignant neoplasm of breast
PREDISPOSES,Dietary cholesterol intake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Lipid,Dietary cholesterol intake Malignant neoplasm of breast
AUGMENTS,TAF7L gene|TAF7L,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TAF7L gene|TAF7L Malignant neoplasm of breast
PREDISPOSES,IL8RB gene|CXCR2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,IL8RB gene|CXCR2 Breast cancer metastatic
PREDISPOSES,Maternal history,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Maternal history Contralateral breast cancer
AFFECTS,Solid tumor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Solid tumor Malignant neoplasm of breast
DISRUPTS,Matrix Metalloproteinase Inhibitor,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Matrix Metalloproteinase Inhibitor Breast cancer metastatic
PREDISPOSES,STXBP4 gene|STXBP4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,STXBP4 gene|STXBP4 Malignant neoplasm of breast
PREDISPOSES,Extracellular Matrix Proteins,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Extracellular Matrix Proteins Breast Carcinoma
AFFECTS,EGF gene|EGF,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,EGF gene|EGF Malignant neoplasm of breast
AFFECTS,PRDM1 gene|PRDM1,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Gene or Genome,PRDM1 gene|PRDM1 Breast cancer invasive NOS
AFFECTS,XRCC1 gene|XRCC1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,XRCC1 gene|XRCC1 Malignant neoplasm of breast
AFFECTS,Epigenetic Process,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,Epigenetic Process Breast cancer metastatic
AFFECTS,RNA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",RNA Malignant neoplasm of breast
AFFECTS,MicroRNAs,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",MicroRNAs Breast Carcinoma
AFFECTS,recombinational repair,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,"Element, Ion, or Isotope",recombinational repair Sporadic Breast Carcinoma
CAUSES,BMP4 gene|BMP4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BMP4 gene|BMP4 Malignant neoplasm of breast
AFFECTS,MAS1 gene|MAS1,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Gene or Genome,"MAS1 gene|MAS1 Carcinoma, Ductal, Breast"
PREDISPOSES,Housekeeping Gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Housekeeping Gene Malignant neoplasm of breast
CAUSES,"Genes, Developmental",Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,"Genes, Developmental Breast Carcinoma"
DISRUPTS,Epidermal Growth Factor Receptor|EGFR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Epidermal Growth Factor Receptor|EGFR Malignant neoplasm of breast
AFFECTS,Genes,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Gene or Genome,Genes Breast cancer recurrent
PREDISPOSES,WNT10B gene|WNT10B,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,WNT10B gene|WNT10B Breast cancer metastatic
AFFECTS,Cholesterol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Lipid,Cholesterol Malignant neoplasm of breast
DISRUPTS,MIRN200A gene|MIR200A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIRN200A gene|MIR200A Malignant neoplasm of breast
PREDISPOSES,PVT1 gene|PVT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PVT1 gene|PVT1 Malignant neoplasm of breast
AUGMENTS,BRF1 gene|ZFP36L1|BRF1|MST1L,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BRF1 gene|ZFP36L1|BRF1|MST1L Malignant neoplasm of breast
AUGMENTS,RECQL4 gene|RECQL4,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Gene or Genome,RECQL4 gene|RECQL4 Sporadic Breast Carcinoma
PREDISPOSES,"EPIDERMAL GROWTH FACTOR, HUMAN|EREG|ESR1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,"EPIDERMAL GROWTH FACTOR, HUMAN|EREG|ESR1 Malignant neoplasm of breast"
AFFECTS,Malignant neoplasm of stomach,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Malignant neoplasm of stomach Malignant neoplasm of breast
AUGMENTS,Sirolimus (substance),Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Substance,Sirolimus (substance) Breast cancer invasive NOS
PREDISPOSES,Fibroblast Growth Factor Receptor 2|FGFR2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Fibroblast Growth Factor Receptor 2|FGFR2 Malignant neoplasm of breast
AUGMENTS,Vascular Endothelial Growth Factor C,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Vascular Endothelial Growth Factor C Malignant neoplasm of breast
AFFECTS,FGFR1 gene|FGFR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FGFR1 gene|FGFR1 Malignant neoplasm of breast
AFFECTS,CDK6-associated protein p18,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",CDK6-associated protein p18 Malignant neoplasm of breast
AUGMENTS,Metastasis Suppressor Genes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Metastasis Suppressor Genes Malignant neoplasm of breast
AUGMENTS,SKP2 gene|SKP2,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,SKP2 gene|SKP2 Noninfiltrating Intraductal Carcinoma
CAUSES,Reactive Oxygen Species,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Reactive Oxygen Species Malignant neoplasm of breast
AFFECTS,chrysophanic acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,chrysophanic acid Malignant neoplasm of breast
PREDISPOSES,SRD5A2 gene|SRD5A2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SRD5A2 gene|SRD5A2 Malignant neoplasm of breast
PREDISPOSES,proto-oncogene protein Spi-1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,proto-oncogene protein Spi-1 Malignant neoplasm of breast
PREDISPOSES,Cardiovascular event,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Phenomenon or Process,Cardiovascular event Malignant neoplasm of breast
AFFECTS,EZH2 gene|EZH2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,EZH2 gene|EZH2 Malignant neoplasm of breast
AFFECTS,Tumor Suppressor Genes,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Gene or Genome,Tumor Suppressor Genes Breast cancer invasive NOS
DISRUPTS,LATS1 gene|LATS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LATS1 gene|LATS1 Malignant neoplasm of breast
AFFECTS,"RNA, Small Interfering",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","RNA, Small Interfering Malignant neoplasm of breast"
PREDISPOSES,PIK3CA gene|PIK3CA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PIK3CA gene|PIK3CA Malignant neoplasm of breast
CAUSES,CD8B1 gene|CD8B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CD8B1 gene|CD8B Malignant neoplasm of breast
AUGMENTS,endogenous steroids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Steroid,endogenous steroids Malignant neoplasm of breast
PREDISPOSES,POMC gene|POMC,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,POMC gene|POMC Malignant neoplasm of breast
AFFECTS,Therapeutic agent (substance),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical Viewed Functionally,Therapeutic agent (substance) Malignant neoplasm of breast
PREDISPOSES,genetic locus,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,genetic locus Malignant neoplasm of breast
CAUSES,PMS2 gene|PMS2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PMS2 gene|PMS2 Malignant neoplasm of breast
PREDISPOSES,TSLP gene|TSLP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TSLP gene|TSLP Malignant neoplasm of breast
PREDISPOSES,TP53BP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TP53BP1 Malignant neoplasm of breast
DISRUPTS,ITGB2 gene|ITGB2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ITGB2 gene|ITGB2 Malignant neoplasm of breast
CAUSES,Tumorigenesis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Tumorigenesis Malignant neoplasm of breast
AFFECTS,Extracellular Matrix Proteins,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,"Amino Acid, Peptide, or Protein","Extracellular Matrix Proteins Carcinoma, Ductal, Breast"
AFFECTS,MFN2 gene|MFN2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MFN2 gene|MFN2 Malignant neoplasm of breast
DISRUPTS,Insulin-Like Growth Factor I,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Insulin-Like Growth Factor I Malignant neoplasm of breast
PREDISPOSES,brca gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,brca gene Malignant neoplasm of breast
AFFECTS,REST gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,REST gene Malignant neoplasm of breast
PREDISPOSES,Insulin-Like Growth-Factor Binding Protein 1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Insulin-Like Growth-Factor Binding Protein 1 Malignant neoplasm of breast
AFFECTS,E2F1 gene|E2F1|UBE2L3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,E2F1 gene|E2F1|UBE2L3 Malignant neoplasm of breast
PREDISPOSES,CYP17A1 gene|CYP17A1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CYP17A1 gene|CYP17A1 Malignant neoplasm of breast
AUGMENTS,Membrane Transport Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Membrane Transport Proteins Malignant neoplasm of breast
PREDISPOSES,"PER2 protein, mammalian",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","PER2 protein, mammalian Malignant neoplasm of breast"
CAUSES,cytokine,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Biologically Active Substance,cytokine Breast cancer metastatic
CAUSES,Eicosanoids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Eicosanoid,Eicosanoids Malignant neoplasm of breast
AFFECTS,Vision,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Vision Malignant neoplasm of breast
AUGMENTS,TP53 gene|TP53,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TP53 gene|TP53 Malignant neoplasm of breast
PREDISPOSES,Insulin-Like Growth Factor II|CD74|GCNT2|TCN2|VIPR1|TAF8,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Insulin-Like Growth Factor II|CD74|GCNT2|TCN2|VIPR1|TAF8 Malignant neoplasm of breast
PREDISPOSES,FAS gene|FAS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FAS gene|FAS Malignant neoplasm of breast
PREDISPOSES,Mutagens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hazardous or Poisonous Substance,Mutagens Malignant neoplasm of breast
AFFECTS,NAT2 gene|NAT2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NAT2 gene|NAT2 Malignant neoplasm of breast
PREDISPOSES,Nuclear Factor 45 Protein|ILF2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Nuclear Factor 45 Protein|ILF2 Malignant neoplasm of breast
AFFECTS,"DNA, Mitochondrial",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","DNA, Mitochondrial Malignant neoplasm of breast"
AFFECTS,antibody conjugate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Indicator, Reagent, or Diagnostic Aid",antibody conjugate Malignant neoplasm of breast
PREDISPOSES,Sterol Regulatory Element Binding Protein 1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Sterol Regulatory Element Binding Protein 1 Malignant neoplasm of breast
AFFECTS,MYC gene|MYC,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Gene or Genome,MYC gene|MYC Sporadic Breast Carcinoma
PREDISPOSES,UGT1A1 gene|UGT1A1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,UGT1A1 gene|UGT1A1 Malignant neoplasm of breast
AUGMENTS,ERBB2 gene|ERBB2,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Gene or Genome,ERBB2 gene|ERBB2 Breast cancer invasive NOS
AFFECTS,Signal Transduction,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Signal Transduction Breast cancer metastatic
AUGMENTS,Epidermal Growth Factor|EGF,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Epidermal Growth Factor|EGF Malignant neoplasm of breast
CAUSES,Estrogenic,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Estrogenic Malignant neoplasm of breast
PREDISPOSES,Functional disorder,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Functional disorder Malignant neoplasm of breast
PREDISPOSES,Intellectual functioning disability,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Intellectual functioning disability Malignant neoplasm of breast
AUGMENTS,Epidermal Growth Factor Receptor|EREG|ESR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Epidermal Growth Factor Receptor|EREG|ESR1 Malignant neoplasm of breast
PREDISPOSES,Transfer RNA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Transfer RNA Malignant neoplasm of breast
AFFECTS,gene therapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,gene therapy Malignant neoplasm of breast
AUGMENTS,lysophosphatidic acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,lysophosphatidic acid Malignant neoplasm of breast
DISRUPTS,THBS1 gene|THBS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,THBS1 gene|THBS1 Malignant neoplasm of breast
CAUSES,Deoxycholic Acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Deoxycholic Acid Malignant neoplasm of breast
DISRUPTS,Epidermal Growth Factor Receptor|EGFR,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Biologically Active Substance,Epidermal Growth Factor Receptor|EGFR Noninfiltrating Intraductal Carcinoma
CAUSES,cytokine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,cytokine Malignant neoplasm of breast
AFFECTS,Malignant neoplasm of endometrium,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Malignant neoplasm of endometrium Malignant neoplasm of breast
AFFECTS,dietary intervention,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",dietary intervention Malignant neoplasm of breast
CAUSES,Neoplastic Processes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Neoplastic Processes Malignant neoplasm of breast
AFFECTS,Fibroblast Growth Factor Receptor 2|FGF7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Fibroblast Growth Factor Receptor 2|FGF7 Malignant neoplasm of breast
DISRUPTS,"RNA, Messenger",Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","RNA, Messenger Breast cancer metastatic"
AFFECTS,"DNA, Complementary",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","DNA, Complementary Malignant neoplasm of breast"
AUGMENTS,Antipsychotic Agents,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical Viewed Functionally,Antipsychotic Agents Malignant neoplasm of breast
CAUSES,Hormones,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Hormone,Hormones Breast Carcinoma
AFFECTS,ESR1 gene|ESR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ESR1 gene|ESR1 Malignant neoplasm of breast
AUGMENTS,CXCL1 gene|CXCL1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,CXCL1 gene|CXCL1 Breast cancer metastatic
CAUSES,Malignant neoplasm of breast,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,Neoplastic Process,Malignant neoplasm of breast Female Breast Carcinoma
AUGMENTS,GSTM1 gene|GSTM1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GSTM1 gene|GSTM1 Malignant neoplasm of breast
AFFECTS,Disease Progression,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Disease Progression Malignant neoplasm of breast
AFFECTS,Radiation therapy,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,"Element, Ion, or Isotope",Radiation therapy Contralateral breast cancer
PREDISPOSES,EGR1 gene|EGR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,EGR1 gene|EGR1 Malignant neoplasm of breast
PREDISPOSES,Estrogen Receptors,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptors Noninfiltrating Intraductal Carcinoma
AFFECTS,Malignant Neoplasms,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,Neoplastic Process,Malignant Neoplasms Familial cancer of breast
AFFECTS,Immune response,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Immunologic Factor,Immune response Malignant neoplasm of breast
PREDISPOSES,BRCA1 gene|BRCA1,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,BRCA1 gene|BRCA1 Breast Carcinoma
CAUSES,Ovarian Carcinoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Ovarian Carcinoma Malignant neoplasm of breast
AFFECTS,Proto-Oncogene Protein pp60 (c-src)|SRC,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Proto-Oncogene Protein pp60 (c-src)|SRC Malignant neoplasm of breast
PREDISPOSES,Receptor Gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Receptor Gene Malignant neoplasm of breast
AUGMENTS,HMGB1 gene|HMGB1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HMGB1 gene|HMGB1 Malignant neoplasm of breast
AUGMENTS,Growth Factor,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Biologically Active Substance,Growth Factor Breast Carcinoma
AFFECTS,DNA Methylation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",DNA Methylation Malignant neoplasm of breast
PREDISPOSES,ZNF217 gene|ZNF217,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ZNF217 gene|ZNF217 Malignant neoplasm of breast
PREDISPOSES,IRS1 gene|IRS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IRS1 gene|IRS1 Malignant neoplasm of breast
PREDISPOSES,Organic solvent product,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Chemical,Organic solvent product Carcinoma of Male Breast
AFFECTS,Inflammation Process,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Inflammation Process Malignant neoplasm of breast
AFFECTS,Injection procedure,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Injection procedure Malignant neoplasm of breast
PREDISPOSES,JNK Mitogen-Activated Protein Kinases|JUN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",JNK Mitogen-Activated Protein Kinases|JUN Malignant neoplasm of breast
PREDISPOSES,BRCA1 gene|BRCA1,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,Gene or Genome,BRCA1 gene|BRCA1 Contralateral breast cancer
CAUSES,Heme Oxygenase-1,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Heme Oxygenase-1 Breast Carcinoma
PREDISPOSES,participation,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Element, Ion, or Isotope",participation Breast cancer invasive NOS
PREDISPOSES,FLOT2 gene|FLOT2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FLOT2 gene|FLOT2 Malignant neoplasm of breast
PREDISPOSES,Chronic lymphocytic inflammation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Chronic lymphocytic inflammation Malignant neoplasm of breast
PREDISPOSES,Organic Food,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Organic Food Malignant neoplasm of breast
AFFECTS,"APEX1 protein, human|APEX1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","APEX1 protein, human|APEX1 Malignant neoplasm of breast"
PREDISPOSES,RRM2 gene|RRM2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RRM2 gene|RRM2 Malignant neoplasm of breast
AUGMENTS,ERBB2 gene|ERBB2,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,ERBB2 gene|ERBB2 Noninfiltrating Intraductal Carcinoma
CAUSES,Hair Dyes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Indicator, Reagent, or Diagnostic Aid",Hair Dyes Malignant neoplasm of breast
PREDISPOSES,Renin-angiotensin system inhibition,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Element, Ion, or Isotope",Renin-angiotensin system inhibition Breast cancer recurrent
PREDISPOSES,MAP Kinase Gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MAP Kinase Gene Malignant neoplasm of breast
PREDISPOSES,Autoantibody NOS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Indicator, Reagent, or Diagnostic Aid",Autoantibody NOS Malignant neoplasm of breast
PREDISPOSES,Decalcification,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Decalcification Malignant neoplasm of breast
PREDISPOSES,Sulfonylurea Compounds,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Chemical,Sulfonylurea Compounds Breast cancer invasive NOS
DISRUPTS,Protein-Serine-Threonine Kinases,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,"Amino Acid, Peptide, or Protein","Protein-Serine-Threonine Kinases Carcinoma, Ductal, Breast"
PREDISPOSES,Vitamin D-Binding Protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Vitamin D-Binding Protein Malignant neoplasm of breast
AFFECTS,ursolic acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,ursolic acid Malignant neoplasm of breast
DISRUPTS,CHEK2 gene|CHEK2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CHEK2 gene|CHEK2 Malignant neoplasm of breast
CAUSES,TRAN gene|TRA-TGC7-1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TRAN gene|TRA-TGC7-1 Malignant neoplasm of breast
PREDISPOSES,Estrogens,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Hormone,Estrogens Breast cancer metastatic
PREDISPOSES,receptor for advanced glycation endproducts,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",receptor for advanced glycation endproducts Malignant neoplasm of breast
AFFECTS,AKT1 gene|AKT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,AKT1 gene|AKT1 Malignant neoplasm of breast
PREDISPOSES,apolipoprotein D|APOD,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Amino Acid, Peptide, or Protein",apolipoprotein D|APOD Breast cancer recurrent
PREDISPOSES,Inflammation,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Element, Ion, or Isotope",Inflammation Breast cancer recurrent
PREDISPOSES,Radiation-Induced Change,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Radiation-Induced Change Malignant neoplasm of breast
AFFECTS,Self-Examination,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Self-Examination Breast Carcinoma
PREDISPOSES,BRCA1 gene|BRCA1,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,Gene or Genome,BRCA1 gene|BRCA1 Female Breast Carcinoma
AFFECTS,CLCN3 gene|CLCN3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CLCN3 gene|CLCN3 Malignant neoplasm of breast
AFFECTS,ethylmalonic acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,ethylmalonic acid Malignant neoplasm of breast
DISRUPTS,HTATIP gene|KAT5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HTATIP gene|KAT5 Malignant neoplasm of breast
PREDISPOSES,Genes,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,Gene or Genome,Genes Female Breast Carcinoma
AFFECTS,Angiotensin-Converting Enzyme Inhibitors,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Enzyme,Angiotensin-Converting Enzyme Inhibitors Breast cancer recurrent
PREDISPOSES,Untranslated Regions,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Element, Ion, or Isotope",Untranslated Regions Breast cancer recurrent
PREDISPOSES,MGMT gene|MGMT,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MGMT gene|MGMT Malignant neoplasm of breast
AFFECTS,Serine Protease,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Enzyme,Serine Protease Breast cancer metastatic
AFFECTS,Emergency contraception,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Emergency contraception Malignant neoplasm of breast
CAUSES,Carbon ion,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Carbon ion Breast Carcinoma
CAUSES,"EPIDERMAL GROWTH FACTOR, HUMAN|EREG|ESR1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,"EPIDERMAL GROWTH FACTOR, HUMAN|EREG|ESR1 Malignant neoplasm of breast"
PREDISPOSES,Chemical Exposure,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Chemical Exposure Malignant neoplasm of breast
PREDISPOSES,vitamin supplement,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,vitamin supplement Malignant neoplasm of breast
PREDISPOSES,coenzyme Q10,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Enzyme,coenzyme Q10 Malignant neoplasm of breast
AFFECTS,MicroRNAs,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",MicroRNAs Breast cancer invasive NOS
AUGMENTS,Genes,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,Genes Noninfiltrating Intraductal Carcinoma
PREDISPOSES,PGR gene|PGR,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,PGR gene|PGR Breast cancer metastatic
PREDISPOSES,CCDC6 gene|CCDC6,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Gene or Genome,CCDC6 gene|CCDC6 Sporadic Breast Carcinoma
CAUSES,BRCA2 gene|BRCA2,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Gene or Genome,BRCA2 gene|BRCA2 Sporadic Breast Carcinoma
PREDISPOSES,Personal Satisfaction,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Personal Satisfaction Malignant neoplasm of breast
CAUSES,Oligonucleotide Arrays,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Oligonucleotide Arrays Malignant neoplasm of breast
AFFECTS,Ions,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Ions Malignant neoplasm of breast
PREDISPOSES,BLM gene|BLM,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BLM gene|BLM Malignant neoplasm of breast
DISRUPTS,Tamoxifen,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Pharmacologic Substance,Tamoxifen Breast cancer invasive NOS
PREDISPOSES,DMBT1 gene|DMBT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,DMBT1 gene|DMBT1 Malignant neoplasm of breast
AFFECTS,Positron-Emission Tomography,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Element, Ion, or Isotope",Positron-Emission Tomography Breast cancer recurrent
AFFECTS,Noninfiltrating Intraductal Carcinoma,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,Noninfiltrating Intraductal Carcinoma Breast cancer invasive NOS
PREDISPOSES,Human Chorionic Gonadotropin|CGA|HTC2|CGB5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Human Chorionic Gonadotropin|CGA|HTC2|CGB5 Malignant neoplasm of breast
CAUSES,Steroidal Aromatase Inhibitor,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Steroid,Steroidal Aromatase Inhibitor Breast cancer metastatic
PREDISPOSES,perfluorooctanoic acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,perfluorooctanoic acid Malignant neoplasm of breast
AFFECTS,"prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase), human",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase), human Malignant neoplasm of breast"
AFFECTS,letrozole,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Pharmacologic Substance,letrozole Breast cancer metastatic
AUGMENTS,MATP gene|SLC45A2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MATP gene|SLC45A2 Malignant neoplasm of breast
AUGMENTS,BRCA1 gene|BRCA1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,BRCA1 gene|BRCA1 Breast cancer metastatic
PREDISPOSES,CYP19A1 gene|CYP19A1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CYP19A1 gene|CYP19A1 Malignant neoplasm of breast
CAUSES,Dietary Carbohydrates,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Carbohydrate,Dietary Carbohydrates Malignant neoplasm of breast
CAUSES,NBS1 gene|NBN|NLRP2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NBS1 gene|NBN|NLRP2 Malignant neoplasm of breast
PREDISPOSES,[V]Follow-up examination,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",[V]Follow-up examination Malignant neoplasm of breast
DISRUPTS,Long chain fatty acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Long chain fatty acid Malignant neoplasm of breast
PREDISPOSES,XRCC5 gene|XRCC5,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Gene or Genome,XRCC5 gene|XRCC5 Breast cancer recurrent
DISRUPTS,Epidermal Growth Factor Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Epidermal Growth Factor Receptor Malignant neoplasm of breast
CAUSES,Triglycerides,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Lipid,Triglycerides Malignant neoplasm of breast
AFFECTS,Membrane Glycoproteins,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Membrane Glycoproteins Breast cancer metastatic
PREDISPOSES,Breast composition,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Breast composition Malignant neoplasm of breast
AUGMENTS,LHX1 gene|LHX1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LHX1 gene|LHX1 Malignant neoplasm of breast
PREDISPOSES,Infection,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Infection Malignant neoplasm of breast
PREDISPOSES,PGRMC1 gene|PGRMC1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PGRMC1 gene|PGRMC1 Malignant neoplasm of breast
PREDISPOSES,NAT2 gene|NAT2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NAT2 gene|NAT2 Malignant neoplasm of breast
AFFECTS,Behcet Syndrome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Behcet Syndrome Malignant neoplasm of breast
PREDISPOSES,Carrier of disorder,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,Disease or Syndrome,Carrier of disorder Contralateral breast cancer
AUGMENTS,"Polycyclic Hydrocarbons, Aromatic",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Polycyclic Hydrocarbons, Aromatic Malignant neoplasm of breast"
AFFECTS,Egg Food Product,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Egg Food Product Malignant neoplasm of breast
AFFECTS,Glutamate Dehydrogenase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Glutamate Dehydrogenase Malignant neoplasm of breast
AFFECTS,Anovulation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Anovulation Malignant neoplasm of breast
PREDISPOSES,Ovarian Diseases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Ovarian Diseases Malignant neoplasm of breast
AFFECTS,Invasive Malignant Neoplasm,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Neoplastic Process,Invasive Malignant Neoplasm Noninfiltrating Intraductal Carcinoma
PREDISPOSES,Free testosterone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Free testosterone Malignant neoplasm of breast
AFFECTS,Breast cancer invasive NOS,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Neoplastic Process,Breast cancer invasive NOS Noninfiltrating Intraductal Carcinoma
CAUSES,MME gene|MME,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MME gene|MME Malignant neoplasm of breast
PREDISPOSES,MicroRNAs,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",MicroRNAs Breast cancer metastatic
AFFECTS,Gene Mutation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Gene Mutation Malignant neoplasm of breast
AFFECTS,Excision,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Excision Malignant neoplasm of breast
AFFECTS,Endocrine therapy,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Hormone,Endocrine therapy Breast cancer recurrent
AFFECTS,Protein Overexpression,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Protein Overexpression Malignant neoplasm of breast
PREDISPOSES,Estrogen receptor negative,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen receptor negative Inflammatory Breast Carcinoma
AFFECTS,BRCA2 Mutation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BRCA2 Mutation Malignant neoplasm of breast
PREDISPOSES,Gall Bladder Diseases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Gall Bladder Diseases Malignant neoplasm of breast
PREDISPOSES,STAT5A gene|STAT5A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,STAT5A gene|STAT5A Malignant neoplasm of breast
PREDISPOSES,PTEN gene|PTEN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PTEN gene|PTEN Malignant neoplasm of breast
AFFECTS,Ionizing radiation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Ionizing radiation Malignant neoplasm of breast
PREDISPOSES,Insulin-Like Growth Factor I|INS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Insulin-Like Growth Factor I|INS Malignant neoplasm of breast
DISRUPTS,Polyunsaturated Fatty Acids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Polyunsaturated Fatty Acids Malignant neoplasm of breast
CAUSES,Carcinoma,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Carcinoma Breast Carcinoma
AFFECTS,Testosterone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Testosterone Malignant neoplasm of breast
PREDISPOSES,MSH6 gene|MSH6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MSH6 gene|MSH6 Malignant neoplasm of breast
AFFECTS,Suspensions,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Suspensions Malignant neoplasm of breast
PREDISPOSES,Maternal Mortality,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Maternal Mortality Malignant neoplasm of breast
PREDISPOSES,Reaction emotional,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Reaction emotional Malignant neoplasm of breast
PREDISPOSES,Sulfonylurea Compounds,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Sulfonylurea Compounds Malignant neoplasm of breast
AFFECTS,Undifferentiated carcinoma of ovary,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Undifferentiated carcinoma of ovary Malignant neoplasm of breast
PREDISPOSES,glutathione S-transferase M1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",glutathione S-transferase M1 Malignant neoplasm of breast
PREDISPOSES,brca gene,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Gene or Genome,brca gene Sporadic Breast Carcinoma
AFFECTS,FOXM1 gene|FOXM1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FOXM1 gene|FOXM1 Malignant neoplasm of breast
AFFECTS,cytotoxicity,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Hazardous or Poisonous Substance,cytotoxicity Breast Carcinoma
PREDISPOSES,Tamoxifen,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Pharmacologic Substance,Tamoxifen Breast cancer invasive NOS
PREDISPOSES,Carcinoembryonic Antigen|CEACAM5,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Immunologic Factor,Carcinoembryonic Antigen|CEACAM5 Breast cancer metastatic
PREDISPOSES,Amino Acids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Amino Acids Malignant neoplasm of breast
PREDISPOSES,Little's Disease,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Little's Disease Malignant neoplasm of breast
AFFECTS,Physiological Processes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Phenomenon or Process,Physiological Processes Malignant neoplasm of breast
DISRUPTS,RNA Sequence,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Nucleotide Sequence,RNA Sequence Breast cancer metastatic
AUGMENTS,HIF1alpha protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",HIF1alpha protein Malignant neoplasm of breast
AFFECTS,Glucose,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Carbohydrate,Glucose Malignant neoplasm of breast
AUGMENTS,MIRN106A gene|MIR106A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIRN106A gene|MIR106A Malignant neoplasm of breast
CAUSES,CXCR4 gene|CXCR4,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,CXCR4 gene|CXCR4 Breast cancer metastatic
DISRUPTS,Epidermal Growth Factor Receptor|EGFR,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Biologically Active Substance,Epidermal Growth Factor Receptor|EGFR Breast Carcinoma
AFFECTS,CDC2 gene|CDK1|POLD1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CDC2 gene|CDK1|POLD1 Malignant neoplasm of breast
CAUSES,Cancer-Predisposing Gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Cancer-Predisposing Gene Malignant neoplasm of breast
AUGMENTS,Monomeric GTP-Binding Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Monomeric GTP-Binding Proteins Malignant neoplasm of breast
PREDISPOSES,Endocrine System Diseases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Endocrine System Diseases Malignant neoplasm of breast
PREDISPOSES,ataxia telangiectasia mutated protein|ATM,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",ataxia telangiectasia mutated protein|ATM Malignant neoplasm of breast
PREDISPOSES,glutathione S-transferase M1|GSTM1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",glutathione S-transferase M1|GSTM1 Malignant neoplasm of breast
AFFECTS,9-deoxy-delta-9-prostaglandin D2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Eicosanoid,9-deoxy-delta-9-prostaglandin D2 Malignant neoplasm of breast
AUGMENTS,activated RNA polymerase II transcription cofactor 4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",activated RNA polymerase II transcription cofactor 4 Malignant neoplasm of breast
PREDISPOSES,HGS gene|HGS,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Gene or Genome,HGS gene|HGS Breast cancer invasive NOS
CAUSES,Cadmium,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Inorganic Chemical,Cadmium Malignant neoplasm of breast
PREDISPOSES,Formaldehyde,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hazardous or Poisonous Substance,Formaldehyde Malignant neoplasm of breast
PREDISPOSES,Platelet-Derived Growth Factor beta Receptor|PDGFRB,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Platelet-Derived Growth Factor beta Receptor|PDGFRB Malignant neoplasm of breast
PREDISPOSES,Single Nucleotide Polymorphism,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Single Nucleotide Polymorphism Sporadic Breast Carcinoma
AFFECTS,Homologous Gene,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,Homologous Gene Breast cancer metastatic
AFFECTS,SERPINI2 gene|SERPINI2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SERPINI2 gene|SERPINI2 Malignant neoplasm of breast
AFFECTS,centromere protein F,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",centromere protein F Breast cancer metastatic
AFFECTS,Aging-Related Process,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Phenomenon or Process,Aging-Related Process Malignant neoplasm of breast
CAUSES,"PTTG1 protein, human|PTTG1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","PTTG1 protein, human|PTTG1 Malignant neoplasm of breast"
PREDISPOSES,TAGLN2 gene|TAGLN2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,TAGLN2 gene|TAGLN2 Breast cancer metastatic
AFFECTS,Antipsychotic Agents,Carcinoma in situ of breast,0.0019980019980019,Female Breast Cancer,Chemical Viewed Functionally,Antipsychotic Agents Carcinoma in situ of breast
AFFECTS,Antioestrogen therapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Antioestrogen therapy Malignant neoplasm of breast
PREDISPOSES,Mitochondrial Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Mitochondrial Proteins Malignant neoplasm of breast
PREDISPOSES,CHD4 gene|CHD4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CHD4 gene|CHD4 Malignant neoplasm of breast
AFFECTS,gambogic acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,gambogic acid Malignant neoplasm of breast
DISRUPTS,RPS27 gene|RPS27,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RPS27 gene|RPS27 Malignant neoplasm of breast
AFFECTS,BARD1 gene|BARD1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BARD1 gene|BARD1 Malignant neoplasm of breast
PREDISPOSES,food product,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,food product Malignant neoplasm of breast
AFFECTS,Functional RNA,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Functional RNA Breast cancer metastatic
PREDISPOSES,Untranslated Regions,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Untranslated Regions Malignant neoplasm of breast
AFFECTS,LINC-ROR gene|LINC-ROR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LINC-ROR gene|LINC-ROR Malignant neoplasm of breast
PREDISPOSES,TTN-AS1 gene|TTN-AS1,Carcinoma breast stage IV,0.0,Female Breast Cancer,Gene or Genome,TTN-AS1 gene|TTN-AS1 Carcinoma breast stage IV
PREDISPOSES,"MMP14 protein, human|MMP14",Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein","MMP14 protein, human|MMP14 Breast cancer metastatic"
CAUSES,Lipid Peroxides,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Lipid,Lipid Peroxides Malignant neoplasm of breast
AUGMENTS,SOX2 Transcription Factor|SOX2,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",SOX2 Transcription Factor|SOX2 Breast Carcinoma
PREDISPOSES,CYP27A1 gene|CYP27A1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CYP27A1 gene|CYP27A1 Malignant neoplasm of breast
AFFECTS,ENO1 gene|ENO1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ENO1 gene|ENO1 Malignant neoplasm of breast
AFFECTS,BRCA2 Gene Mutation,Carcinoma breast stage IV,0.0,Female Breast Cancer,Gene or Genome,BRCA2 Gene Mutation Carcinoma breast stage IV
PREDISPOSES,Fatty Acids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Fatty Acids Malignant neoplasm of breast
PREDISPOSES,Hormone use,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Hormone use Malignant neoplasm of breast
PREDISPOSES,RESF1 gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RESF1 gene Malignant neoplasm of breast
PREDISPOSES,PPEF1 gene|PPEF1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PPEF1 gene|PPEF1 Malignant neoplasm of breast
DISRUPTS,HDAC5 gene|HDAC5,Malignant neoplasm of female breast,0.0,Female Breast Cancer,Gene or Genome,HDAC5 gene|HDAC5 Malignant neoplasm of female breast
AFFECTS,Colorectal Carcinoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Colorectal Carcinoma Malignant neoplasm of breast
PREDISPOSES,CYP7B1 gene|CYP7B1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CYP7B1 gene|CYP7B1 Malignant neoplasm of breast
AUGMENTS,PAK2 gene|PAK2|PKN2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PAK2 gene|PAK2|PKN2 Malignant neoplasm of breast
AFFECTS,FTSJ3 gene|FTSJ3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FTSJ3 gene|FTSJ3 Malignant neoplasm of breast
PREDISPOSES,"SFRP1 protein, human|SFRP1",Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Amino Acid, Peptide, or Protein","SFRP1 protein, human|SFRP1 Noninfiltrating Intraductal Carcinoma"
AFFECTS,Alternative Splicing,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Alternative Splicing Malignant neoplasm of breast
AFFECTS,"CD69 protein, human|CD69",HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CD69 protein, human|CD69 HER2-positive carcinoma of breast"
PREDISPOSES,GACAT3 gene|GACAT3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GACAT3 gene|GACAT3 Malignant neoplasm of breast
PREDISPOSES,SPRY4-IT1 gene|SPRY4-IT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SPRY4-IT1 gene|SPRY4-IT1 Malignant neoplasm of breast
AFFECTS,KLK12 gene|KLK12,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,KLK12 gene|KLK12 Triple Negative Breast Neoplasms
PREDISPOSES,"GOLPH3 protein, human|GOLPH3",Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Amino Acid, Peptide, or Protein","GOLPH3 protein, human|GOLPH3 Invasive carcinoma of breast"
AUGMENTS,USP43 gene|USP43,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,USP43 gene|USP43 Malignant neoplasm of breast
DISRUPTS,"CEACAM5 protein, human|CEACAM5",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CEACAM5 protein, human|CEACAM5 Malignant neoplasm of breast"
PREDISPOSES,TRIP6 gene|TRIP6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TRIP6 gene|TRIP6 Malignant neoplasm of breast
AFFECTS,Detection,Early-Stage Breast Carcinoma,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Detection Early-Stage Breast Carcinoma
AFFECTS,ERR1 protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",ERR1 protein Malignant neoplasm of breast
AFFECTS,Immune response,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Immunologic Factor,Immune response HER2-positive carcinoma of breast
DISRUPTS,FOXN4 gene|FOXN4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FOXN4 gene|FOXN4 Malignant neoplasm of breast
PREDISPOSES,Soluble fiber (substance),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Substance,Soluble fiber (substance) Malignant neoplasm of breast
PREDISPOSES,High expression,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",High expression Breast Carcinoma
AFFECTS,"CD69 protein, human|CD69",Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CD69 protein, human|CD69 Breast Carcinoma"
PREDISPOSES,MYCN gene|MYCN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MYCN gene|MYCN Malignant neoplasm of breast
AFFECTS,Transforming Growth Factor alpha,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Transforming Growth Factor alpha Malignant neoplasm of breast
AFFECTS,Genome,Carcinoma breast stage IV,0.0,Female Breast Cancer,Gene or Genome,Genome Carcinoma breast stage IV
PREDISPOSES,PTTG1 gene|PTTG1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PTTG1 gene|PTTG1 Malignant neoplasm of breast
AUGMENTS,NEAT1 gene|NEAT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NEAT1 gene|NEAT1 Malignant neoplasm of breast
PREDISPOSES,FOXM1 gene|FOXM1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FOXM1 gene|FOXM1 Malignant neoplasm of breast
PREDISPOSES,Gestational Diabetes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Gestational Diabetes Malignant neoplasm of breast
AFFECTS,CERNA2 gene|CERNA2,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,CERNA2 gene|CERNA2 Triple Negative Breast Neoplasms
DISRUPTS,"TP53BP1 protein, human|TP53BP1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,"TP53BP1 protein, human|TP53BP1 Malignant neoplasm of breast"
AUGMENTS,CBR3-AS1 gene|CBR3-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CBR3-AS1 gene|CBR3-AS1 Malignant neoplasm of breast
PREDISPOSES,ALKBH5 gene|ALKBH5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ALKBH5 gene|ALKBH5 Malignant neoplasm of breast
AFFECTS,Estrogen Receptor alpha,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptor alpha estrogen receptor-positive breast cancer
AFFECTS,IMPACT gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IMPACT gene Malignant neoplasm of breast
PREDISPOSES,ECE1 gene|ECE1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ECE1 gene|ECE1 Malignant neoplasm of breast
AFFECTS,Invasive Carcinoma,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Neoplastic Process,Invasive Carcinoma Triple Negative Breast Neoplasms
CAUSES,XRCC3 gene|XRCC3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,XRCC3 gene|XRCC3 Malignant neoplasm of breast
AFFECTS,Angiogenic Process,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Phenomenon or Process,Angiogenic Process Invasive carcinoma of breast
DISRUPTS,GKLF protein,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein",GKLF protein Triple Negative Breast Neoplasms
AFFECTS,PRR14 gene|PRR14,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PRR14 gene|PRR14 Malignant neoplasm of breast
AFFECTS,GKLF protein,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein",GKLF protein Triple Negative Breast Neoplasms
DISRUPTS,RNA-Binding Protein Musashi Homolog 2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",RNA-Binding Protein Musashi Homolog 2 Malignant neoplasm of breast
AUGMENTS,KIF15 gene|KIF15,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,KIF15 gene|KIF15 Malignant neoplasm of breast
AFFECTS,D Vitamin,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Food,D Vitamin Noninfiltrating Intraductal Carcinoma
PREDISPOSES,LINC00707 gene|LINC00707,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LINC00707 gene|LINC00707 Malignant neoplasm of breast
AFFECTS,COTL1 gene|COTL1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,COTL1 gene|COTL1 Malignant neoplasm of breast
DISRUPTS,GPX3 gene|GPX3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GPX3 gene|GPX3 Malignant neoplasm of breast
PREDISPOSES,"SLC16A3 protein, human|SLC16A3",Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Amino Acid, Peptide, or Protein","SLC16A3 protein, human|SLC16A3 Invasive carcinoma of breast"
CAUSES,NME1 gene|NME1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NME1 gene|NME1 Malignant neoplasm of breast
CAUSES,Metastatic malignant neoplasm to brain,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Metastatic malignant neoplasm to brain Malignant neoplasm of breast
DISRUPTS,Anti-Inflammatory Agents,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical Viewed Functionally,Anti-Inflammatory Agents Malignant neoplasm of breast
CAUSES,Tumor Progression,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Tumor Progression Malignant neoplasm of breast
AFFECTS,TNIP2 gene|TNIP2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TNIP2 gene|TNIP2 Malignant neoplasm of breast
AFFECTS,Alternative Splicing,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Alternative Splicing Breast Carcinoma
PREDISPOSES,XIST gene|XIST,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,XIST gene|XIST Malignant neoplasm of breast
CAUSES,ado-trastuzumab emtansine|DMPK|IGHD1-7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,ado-trastuzumab emtansine|DMPK|IGHD1-7 Malignant neoplasm of breast
PREDISPOSES,Matrix Metalloproteinase 2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Matrix Metalloproteinase 2 Malignant neoplasm of breast
AFFECTS,Fatty-acid synthase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Fatty-acid synthase Malignant neoplasm of breast
PREDISPOSES,Mucin-1 Antigen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Immunologic Factor,Mucin-1 Antigen Malignant neoplasm of breast
PREDISPOSES,OIP5-AS1 gene|OIP5-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,OIP5-AS1 gene|OIP5-AS1 Malignant neoplasm of breast
AFFECTS,Hyperlipidemia,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Lipid,Hyperlipidemia estrogen receptor-positive breast cancer
AFFECTS,Sexual function,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Sexual function Malignant neoplasm of breast
AFFECTS,Diagnostic radiologic examination,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Diagnostic radiologic examination Malignant neoplasm of breast
AFFECTS,CERNA2 gene|CERNA2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CERNA2 gene|CERNA2 Malignant neoplasm of breast
CAUSES,Viral Tumor Antigens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Viral Tumor Antigens Malignant neoplasm of breast
AUGMENTS,"RNA, Circular",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","RNA, Circular Malignant neoplasm of breast"
AFFECTS,Disease Progression,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",Disease Progression Noninfiltrating Intraductal Carcinoma
DISRUPTS,CMTM5 gene|CMTM5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CMTM5 gene|CMTM5 Malignant neoplasm of breast
PREDISPOSES,Serum Proteins,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Serum Proteins HER2-positive carcinoma of breast
PREDISPOSES,MSH2 gene|MSH2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MSH2 gene|MSH2 Malignant neoplasm of breast
PREDISPOSES,PCNAP1 gene|PCNAP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PCNAP1 gene|PCNAP1 Malignant neoplasm of breast
AFFECTS,LINC00346 gene|LINC00346,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LINC00346 gene|LINC00346 Malignant neoplasm of breast
AFFECTS,Signaling Protein,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Signaling Protein HER2-positive carcinoma of breast
CAUSES,YTHDF1 gene|YTHDF1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,YTHDF1 gene|YTHDF1 Malignant neoplasm of breast
PREDISPOSES,ANGPTL4 gene|ANGPTL4,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,ANGPTL4 gene|ANGPTL4 Triple Negative Breast Neoplasms
AFFECTS,Negative Regulation of Apoptosis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Negative Regulation of Apoptosis Malignant neoplasm of breast
PREDISPOSES,Insulin-Like Growth Factor Binding Protein 5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Insulin-Like Growth Factor Binding Protein 5 Malignant neoplasm of breast
PREDISPOSES,cyclooxygenase 2|PTGS2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",cyclooxygenase 2|PTGS2 Malignant neoplasm of breast
PREDISPOSES,RAD21 gene|RAD21,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,RAD21 gene|RAD21 Breast Carcinoma
PREDISPOSES,DYRK2 gene|DYRK2,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,DYRK2 gene|DYRK2 Triple Negative Breast Neoplasms
PREDISPOSES,Interpretation:Impression/interpretation of study:Point in time:^Patient:Nominal,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Interpretation:Impression/interpretation of study:Point in time:^Patient:Nominal Malignant neoplasm of breast
AFFECTS,Water consumption,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Water consumption Malignant neoplasm of breast
CAUSES,estrogens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,estrogens Malignant neoplasm of breast
PREDISPOSES,Product containing glucagon-like peptide 1 receptor agonist (product),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Product containing glucagon-like peptide 1 receptor agonist (product) Malignant neoplasm of breast
DISRUPTS,MIR100HG gene|MIR100HG,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,MIR100HG gene|MIR100HG Triple Negative Breast Neoplasms
PREDISPOSES,Infiltration,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",Infiltration Invasive carcinoma of breast
AUGMENTS,Thyroid Hormones,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Thyroid Hormones Malignant neoplasm of breast
AFFECTS,Acetylserotonin N-Methyltransferase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neuroreactive Substance or Biogenic Amine,Acetylserotonin N-Methyltransferase Malignant neoplasm of breast
AFFECTS,MicroRNAs,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",MicroRNAs Triple Negative Breast Neoplasms
DISRUPTS,MicroRNA 205-5p,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",MicroRNA 205-5p estrogen receptor-positive breast cancer
PREDISPOSES,Acidosis,Carcinoma breast stage IV,0.0,Female Breast Cancer,Chemical,Acidosis Carcinoma breast stage IV
AFFECTS,Intercellular adhesion molecule 1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Intercellular adhesion molecule 1 Malignant neoplasm of breast
AUGMENTS,KIF15 gene|KIF15,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,KIF15 gene|KIF15 Triple Negative Breast Neoplasms
PREDISPOSES,K-ras Oncogene|KRAS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,K-ras Oncogene|KRAS Malignant neoplasm of breast
AFFECTS,Circulating Tumor DNA,Carcinoma breast stage IV,0.0,Female Breast Cancer,Neoplastic Process,Circulating Tumor DNA Carcinoma breast stage IV
DISRUPTS,NRG1 gene|NRG1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NRG1 gene|NRG1 Malignant neoplasm of breast
PREDISPOSES,PPP2R2B gene|PPP2R2B,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,PPP2R2B gene|PPP2R2B Triple Negative Breast Neoplasms
PREDISPOSES,FN1 gene|FN1,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,FN1 gene|FN1 Breast Carcinoma
PREDISPOSES,GPM6B gene|GPM6B,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,GPM6B gene|GPM6B Breast Carcinoma
DISRUPTS,HHEX gene|HHEX,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HHEX gene|HHEX Malignant neoplasm of breast
PREDISPOSES,High expression,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",High expression Malignant neoplasm of breast
AFFECTS,Apoptosis Inducing Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Apoptosis Inducing Proteins Malignant neoplasm of breast
PREDISPOSES,BTF3 gene|BTF3,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,BTF3 gene|BTF3 Triple Negative Breast Neoplasms
AFFECTS,Metastatic malignant neoplasm to brain,Carcinoma breast stage IV,0.0,Female Breast Cancer,Neoplastic Process,Metastatic malignant neoplasm to brain Carcinoma breast stage IV
PREDISPOSES,ST8SIA6-AS1 gene|ST8SIA6-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ST8SIA6-AS1 gene|ST8SIA6-AS1 Malignant neoplasm of breast
AUGMENTS,"ITK protein, human|ITK",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","ITK protein, human|ITK Malignant neoplasm of breast"
PREDISPOSES,A2M-AS1 gene|A2M-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,A2M-AS1 gene|A2M-AS1 Malignant neoplasm of breast
CAUSES,Matrix Metalloproteinases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Matrix Metalloproteinases Malignant neoplasm of breast
AFFECTS,Malignant Neoplasms,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Malignant Neoplasms Breast Carcinoma
PREDISPOSES,MIR22HG gene|MIR22HG,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIR22HG gene|MIR22HG Malignant neoplasm of breast
AFFECTS,CBR3-AS1 gene|CBR3-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CBR3-AS1 gene|CBR3-AS1 Malignant neoplasm of breast
CAUSES,27-hydroxycholesterol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Lipid,27-hydroxycholesterol Malignant neoplasm of breast
AFFECTS,Detection,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Detection Breast Carcinoma
AUGMENTS,DSCAM-AS1 gene|DSCAM-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,DSCAM-AS1 gene|DSCAM-AS1 Malignant neoplasm of breast
PREDISPOSES,PGK1 gene|PGK1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PGK1 gene|PGK1 Malignant neoplasm of breast
CAUSES,Neuropeptides,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Neuropeptides Malignant neoplasm of breast
PREDISPOSES,Tumor size,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Neoplastic Process,Tumor size Triple Negative Breast Neoplasms
DISRUPTS,EZH2 gene|EZH2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,EZH2 gene|EZH2 Malignant neoplasm of breast
PREDISPOSES,"WFDC2 protein, human|WFDC2",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","WFDC2 protein, human|WFDC2 Malignant neoplasm of breast"
AFFECTS,Proliferation (morphologic abnormality),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Proliferation (morphologic abnormality) Malignant neoplasm of breast
PREDISPOSES,testosterone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,testosterone Malignant neoplasm of breast
PREDISPOSES,SMAD2 gene|SMAD2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SMAD2 gene|SMAD2 Malignant neoplasm of breast
AFFECTS,IL6ST gene|IL6ST,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,IL6ST gene|IL6ST Triple Negative Breast Neoplasms
DISRUPTS,TRIM6 gene|TRIM6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TRIM6 gene|TRIM6 Malignant neoplasm of breast
PREDISPOSES,"UBASH3A protein, human|UBASH3A",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","UBASH3A protein, human|UBASH3A Malignant neoplasm of breast"
PREDISPOSES,PALB2 gene|PALB2,Hereditary Breast and Ovarian Cancer Syndrome,0.0,Female Breast Cancer,Gene or Genome,PALB2 gene|PALB2 Hereditary Breast and Ovarian Cancer Syndrome
PREDISPOSES,"CD69 protein, human|CD69",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CD69 protein, human|CD69 Triple Negative Breast Neoplasms"
AUGMENTS,YY1 gene|YY1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,YY1 gene|YY1 Malignant neoplasm of breast
PREDISPOSES,LAGE3 gene|LAGE3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LAGE3 gene|LAGE3 Malignant neoplasm of breast
AUGMENTS,LINC00885 gene|LINC00885,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,LINC00885 gene|LINC00885 Noninfiltrating Intraductal Carcinoma
AFFECTS,Mutation,"Breast Cancer, Familial",0.0,Female Breast Cancer,"Element, Ion, or Isotope","Mutation Breast Cancer, Familial"
PREDISPOSES,ZNF385B gene|ZNF385B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ZNF385B gene|ZNF385B Malignant neoplasm of breast
AUGMENTS,CHFR gene|CHFR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CHFR gene|CHFR Malignant neoplasm of breast
CAUSES,Secondary malignant neoplasm of bone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Secondary malignant neoplasm of bone Malignant neoplasm of breast
AFFECTS,Trans Fatty Acids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Trans Fatty Acids Malignant neoplasm of breast
PREDISPOSES,IL20RA gene|IL20RA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IL20RA gene|IL20RA Malignant neoplasm of breast
PREDISPOSES,Functional Status,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Functional Status Malignant neoplasm of breast
AUGMENTS,AQP5 gene|AQP5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,AQP5 gene|AQP5 Malignant neoplasm of breast
AFFECTS,LINC00511 gene|LINC00511,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LINC00511 gene|LINC00511 Malignant neoplasm of breast
AFFECTS,MDM2 gene|MDM2,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,MDM2 gene|MDM2 Triple Negative Breast Neoplasms
CAUSES,Transforming Growth Factor beta,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Biologically Active Substance,Transforming Growth Factor beta Triple Negative Breast Neoplasms
CAUSES,"FRAP1 protein, human|MTOR",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","FRAP1 protein, human|MTOR Malignant neoplasm of breast"
AFFECTS,OLFML2A gene|OLFML2A,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,OLFML2A gene|OLFML2A Triple Negative Breast Neoplasms
PREDISPOSES,Gene Mutant,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Gene Mutant Malignant neoplasm of breast
PREDISPOSES,Volatile Organic Compounds,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Volatile Organic Compounds Malignant neoplasm of breast
PREDISPOSES,USP6NL gene|USP6NL,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,USP6NL gene|USP6NL Triple Negative Breast Neoplasms
AFFECTS,"Transcription, Genetic",HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Gene or Genome,"Transcription, Genetic HER2-positive carcinoma of breast"
AFFECTS,Tumor Microenvironment,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Neoplastic Process,Tumor Microenvironment Triple Negative Breast Neoplasms
PREDISPOSES,HOXB5 gene|HOXB5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HOXB5 gene|HOXB5 Malignant neoplasm of breast
AFFECTS,Hormone Therapy,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Hormone,Hormone Therapy estrogen receptor-positive breast cancer
DISRUPTS,MTUS1 gene|MTUS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MTUS1 gene|MTUS1 Malignant neoplasm of breast
AFFECTS,SF3B3 gene|SF3B3,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,SF3B3 gene|SF3B3 Breast Carcinoma
AUGMENTS,cytokine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,cytokine Malignant neoplasm of breast
CAUSES,IMPACT gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IMPACT gene Malignant neoplasm of breast
CAUSES,"LCN2 protein, human|LCN2",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","LCN2 protein, human|LCN2 Malignant neoplasm of breast"
AFFECTS,ATP5F1B gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ATP5F1B gene Malignant neoplasm of breast
PREDISPOSES,Breast Cancer Prognostic Factor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Breast Cancer Prognostic Factor Malignant neoplasm of breast
AFFECTS,Estrogen Receptor 1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptor 1 Malignant neoplasm of breast
AFFECTS,Neoantigen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Immunologic Factor,Neoantigen Malignant neoplasm of breast
AFFECTS,Long Intergenic Non-Protein Coding RNA,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Long Intergenic Non-Protein Coding RNA Triple Negative Breast Neoplasms
AFFECTS,Matrix Metalloproteinases,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Matrix Metalloproteinases Triple Negative Breast Neoplasms
PREDISPOSES,Autoimmune Diseases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Autoimmune Diseases Malignant neoplasm of breast
AFFECTS,Radiation,Early-Stage Breast Carcinoma,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Radiation Early-Stage Breast Carcinoma
PREDISPOSES,GA-Binding Protein Transcription Factor|GABPA|NFE2L2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",GA-Binding Protein Transcription Factor|GABPA|NFE2L2 Malignant neoplasm of breast
PREDISPOSES,Candidate Disease Gene,Recurrent Breast Carcinoma,0.0009990009990009,Recurrent Breast Cancer,Gene or Genome,Candidate Disease Gene Recurrent Breast Carcinoma
PREDISPOSES,RAD51 gene|RAD51,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RAD51 gene|RAD51 Malignant neoplasm of breast
AFFECTS,"HIF1A protein, human|HIF1A",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","HIF1A protein, human|HIF1A Malignant neoplasm of breast"
DISRUPTS,high density lipoprotein binding protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",high density lipoprotein binding protein Malignant neoplasm of breast
AUGMENTS,HOXB7 gene|HOXB7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HOXB7 gene|HOXB7 Malignant neoplasm of breast
AFFECTS,Infiltration,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Infiltration Malignant neoplasm of breast
AUGMENTS,PIR gene|PIR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PIR gene|PIR Malignant neoplasm of breast
PREDISPOSES,CDC25C gene|CDC25C,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CDC25C gene|CDC25C Malignant neoplasm of breast
AFFECTS,progesterone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,progesterone Malignant neoplasm of breast
DISRUPTS,CLEC2D gene|CLEC2D,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,CLEC2D gene|CLEC2D Triple Negative Breast Neoplasms
AFFECTS,"MEN1 protein, human|MEN1",estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,"Amino Acid, Peptide, or Protein","MEN1 protein, human|MEN1 estrogen receptor-positive breast cancer"
PREDISPOSES,ACSL4 gene|ACSL4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ACSL4 gene|ACSL4 Malignant neoplasm of breast
AUGMENTS,IDO1 gene|IDO1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,IDO1 gene|IDO1 Triple Negative Breast Neoplasms
AFFECTS,Immune response,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Immunologic Factor,Immune response Triple Negative Breast Neoplasms
AFFECTS,DPP3 gene|DPP3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,DPP3 gene|DPP3 Malignant neoplasm of breast
CAUSES,PQBP1 gene|PQBP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PQBP1 gene|PQBP1 Malignant neoplasm of breast
AFFECTS,Antihypertensive Agents,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemical Viewed Functionally,Antihypertensive Agents HER2-positive carcinoma of breast
PREDISPOSES,Responsive Disease,Locally advanced breast cancer,0.0,Female Breast Cancer,Disease or Syndrome,Responsive Disease Locally advanced breast cancer
PREDISPOSES,CEP295 gene|CEP295,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CEP295 gene|CEP295 Malignant neoplasm of breast
PREDISPOSES,tissue polypeptide specific antigen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",tissue polypeptide specific antigen Malignant neoplasm of breast
AUGMENTS,PBXIP1 gene|PBXIP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PBXIP1 gene|PBXIP1 Malignant neoplasm of breast
PREDISPOSES,Duration,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Duration Malignant neoplasm of breast
PREDISPOSES,Axillary node METASTASIS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Axillary node METASTASIS Malignant neoplasm of breast
PREDISPOSES,MIR655 gene|MIR655,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIR655 gene|MIR655 Malignant neoplasm of breast
CAUSES,Pathogenic Variant,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Virus,Pathogenic Variant Malignant neoplasm of breast
AUGMENTS,"E2F1 protein, human|E2F1|UBE2L3",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein","E2F1 protein, human|E2F1|UBE2L3 Triple Negative Breast Neoplasms"
DISRUPTS,IL27 gene|MYDGF|IL27,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IL27 gene|MYDGF|IL27 Malignant neoplasm of breast
AUGMENTS,Gene Mutant,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Gene Mutant Malignant neoplasm of breast
PREDISPOSES,MARCHF5 gene,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,MARCHF5 gene Breast Carcinoma
AFFECTS,GLI1 gene|GLI1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GLI1 gene|GLI1 Malignant neoplasm of breast
PREDISPOSES,LGALS8-AS1 gene|LGALS8-AS1,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,LGALS8-AS1 gene|LGALS8-AS1 Secondary malignant neoplasm of breast
AFFECTS,Drug resistance,Carcinoma breast stage IV,0.0,Female Breast Cancer,Pharmacologic Substance,Drug resistance Carcinoma breast stage IV
CAUSES,HOXD9 gene|HOXD9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HOXD9 gene|HOXD9 Malignant neoplasm of breast
AFFECTS,Genome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Genome Malignant neoplasm of breast
PREDISPOSES,POTEH-AS1 gene|POTEH-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,POTEH-AS1 gene|POTEH-AS1 Malignant neoplasm of breast
PREDISPOSES,STAT3 gene|STAT3,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,STAT3 gene|STAT3 Secondary malignant neoplasm of breast
AUGMENTS,FAM111B gene|FAM111B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FAM111B gene|FAM111B Malignant neoplasm of breast
PREDISPOSES,Growth Differentiation Factor 15|PAEP,Early-Stage Breast Carcinoma,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Growth Differentiation Factor 15|PAEP Early-Stage Breast Carcinoma
DISRUPTS,AR gene|AR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,AR gene|AR Malignant neoplasm of breast
PREDISPOSES,TSPAN1 gene|TSPAN1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TSPAN1 gene|TSPAN1 Malignant neoplasm of breast
PREDISPOSES,Elevated Expression,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,"Element, Ion, or Isotope",Elevated Expression Inflammatory Breast Carcinoma
PREDISPOSES,KLF5 gene|KLF5,Basal-Like Breast Carcinoma,0.0039960039960039,Female Breast Cancer,Gene or Genome,KLF5 gene|KLF5 Basal-Like Breast Carcinoma
AFFECTS,SETDB1 gene|SETDB1,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,SETDB1 gene|SETDB1 Breast Carcinoma
AFFECTS,"RNA, Circular",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","RNA, Circular Triple Negative Breast Neoplasms"
PREDISPOSES,"TNFSF10 protein, human|TNFSF10",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","TNFSF10 protein, human|TNFSF10 Malignant neoplasm of breast"
DISRUPTS,"WNK1 protein, human|WNK1",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein","WNK1 protein, human|WNK1 Triple Negative Breast Neoplasms"
PREDISPOSES,ENPP1 gene|ENPP1,Recurrent Breast Carcinoma,0.0009990009990009,Recurrent Breast Cancer,Gene or Genome,ENPP1 gene|ENPP1 Recurrent Breast Carcinoma
AFFECTS,METTL14 gene|METTL14,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,METTL14 gene|METTL14 Malignant neoplasm of breast
DISRUPTS,NDUFV1 gene|NDUFV1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NDUFV1 gene|NDUFV1 Malignant neoplasm of breast
PREDISPOSES,NOLC1 gene|NOLC1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NOLC1 gene|NOLC1 Malignant neoplasm of breast
DISRUPTS,ADRB2 gene|ADRB2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ADRB2 gene|ADRB2 Malignant neoplasm of breast
PREDISPOSES,"SEP15 protein, human|SELENOF",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","SEP15 protein, human|SELENOF Malignant neoplasm of breast"
PREDISPOSES,HOXC-AS3 gene|HOXC-AS3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HOXC-AS3 gene|HOXC-AS3 Malignant neoplasm of breast
PREDISPOSES,Mutant Proteins,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Mutant Proteins Triple Negative Breast Neoplasms
PREDISPOSES,Architectural Distortion,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Architectural Distortion Malignant neoplasm of breast
DISRUPTS,EPB41L4A-AS1 gene|EPB41L4A-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,EPB41L4A-AS1 gene|EPB41L4A-AS1 Malignant neoplasm of breast
PREDISPOSES,Consideration,"Breast Cancer, Familial",0.0,Female Breast Cancer,"Element, Ion, or Isotope","Consideration Breast Cancer, Familial"
PREDISPOSES,Circulating Protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Circulating Protein Malignant neoplasm of breast
PREDISPOSES,Elevated Expression,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,"Element, Ion, or Isotope",Elevated Expression Female Breast Carcinoma
CAUSES,KCNQ1OT1 gene|KCNQ1OT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,KCNQ1OT1 gene|KCNQ1OT1 Malignant neoplasm of breast
CAUSES,GA-Binding Protein Transcription Factor|GABPA|NFE2L2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",GA-Binding Protein Transcription Factor|GABPA|NFE2L2 Malignant neoplasm of breast
AFFECTS,Hormone Receptor,Recurrent Breast Carcinoma,0.0009990009990009,Recurrent Breast Cancer,Hormone,Hormone Receptor Recurrent Breast Carcinoma
PREDISPOSES,fusion transcript,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",fusion transcript Malignant neoplasm of breast
PREDISPOSES,YTHDF1 gene|YTHDF1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,YTHDF1 gene|YTHDF1 Malignant neoplasm of breast
CAUSES,Protein Subunits,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Protein Subunits Malignant neoplasm of breast
PREDISPOSES,PPP1R14C gene|PPP1R14C,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,PPP1R14C gene|PPP1R14C Triple Negative Breast Neoplasms
AFFECTS,Ovarian hyperstimulation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Ovarian hyperstimulation Malignant neoplasm of breast
AFFECTS,Breast Cancer Therapeutic Procedure,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Breast Cancer Therapeutic Procedure Malignant neoplasm of breast
PREDISPOSES,NFIB gene|NFIB,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,NFIB gene|NFIB Triple Negative Breast Neoplasms
PREDISPOSES,Pathogenic Variant,"Breast Cancer, Familial",0.0,Female Breast Cancer,Virus,"Pathogenic Variant Breast Cancer, Familial"
AUGMENTS,RAC2 gene|RAC2,estrogen receptor-negative breast cancer,0.0,Female Breast Cancer,Gene or Genome,RAC2 gene|RAC2 estrogen receptor-negative breast cancer
AFFECTS,GSDMB gene|GSDMB,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Gene or Genome,GSDMB gene|GSDMB HER2-positive carcinoma of breast
PREDISPOSES,Hypercholesterolemia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Lipid,Hypercholesterolemia Malignant neoplasm of breast
DISRUPTS,LINC00092 gene|LINC00092,Invasive Ductal Breast Carcinoma,0.0,Female Breast Cancer,Gene or Genome,LINC00092 gene|LINC00092 Invasive Ductal Breast Carcinoma
DISRUPTS,estrogens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,estrogens Malignant neoplasm of breast
AFFECTS,Agent,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Chemical Viewed Functionally,Agent Triple Negative Breast Neoplasms
PREDISPOSES,Organic solvent product,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,Chemical,Organic solvent product Female Breast Carcinoma
AFFECTS,DDX5 gene|DDX5,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,DDX5 gene|DDX5 Triple Negative Breast Neoplasms
DISRUPTS,Pharmacologic Substance,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,Pharmacologic Substance Malignant neoplasm of breast
AUGMENTS,secretory protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",secretory protein Malignant neoplasm of breast
DISRUPTS,MDM2 gene|MDM2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MDM2 gene|MDM2 Malignant neoplasm of breast
PREDISPOSES,Alcohol consumption,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",Alcohol consumption Invasive carcinoma of breast
AUGMENTS,"IL17A protein, human|IL17A",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","IL17A protein, human|IL17A Malignant neoplasm of breast"
AFFECTS,LINC00472 gene|LINC00472,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LINC00472 gene|LINC00472 Malignant neoplasm of breast
AFFECTS,Diffusion Kurtosis Imaging,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Diffusion Kurtosis Imaging Triple Negative Breast Neoplasms
PREDISPOSES,CCNB2 gene|CCNB2,Stage 0 Breast Cancer AJCC v6 and v7,0.0,Female Breast Cancer,Gene or Genome,CCNB2 gene|CCNB2 Stage 0 Breast Cancer AJCC v6 and v7
CAUSES,Adenocarcinoma in Situ,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Adenocarcinoma in Situ Malignant neoplasm of breast
AFFECTS,"Carcinoma, Lobular","Breast Cancer, Familial",0.0,Female Breast Cancer,Neoplastic Process,"Carcinoma, Lobular Breast Cancer, Familial"
AFFECTS,anastrozole,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,anastrozole Malignant neoplasm of breast
PREDISPOSES,"CD69 protein, human|CD69","Breast Cancer, Familial",0.0,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CD69 protein, human|CD69 Breast Cancer, Familial"
AUGMENTS,RBMS1 gene|RBMS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RBMS1 gene|RBMS1 Malignant neoplasm of breast
PREDISPOSES,genetic risk factors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,genetic risk factors Malignant neoplasm of breast
AFFECTS,SNHG3 gene|SNHG3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SNHG3 gene|SNHG3 Malignant neoplasm of breast
AFFECTS,HMGB1 gene|HMGB1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HMGB1 gene|HMGB1 Malignant neoplasm of breast
AFFECTS,Biological Processes,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Phenomenon or Process,Biological Processes Secondary malignant neoplasm of breast
AFFECTS,Gene Silencing,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Gene Silencing Malignant neoplasm of breast
AFFECTS,MEDAG gene|MEDAG,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MEDAG gene|MEDAG Malignant neoplasm of breast
DISRUPTS,GTF2H1 gene|GTF2H1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GTF2H1 gene|GTF2H1 Malignant neoplasm of breast
AFFECTS,PIK3CA gene|PIK3CA,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Gene or Genome,PIK3CA gene|PIK3CA Inflammatory Breast Carcinoma
AFFECTS,FBXW7 gene|FBXW7,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Gene or Genome,FBXW7 gene|FBXW7 Inflammatory Breast Carcinoma
AFFECTS,Mitochondrial mutation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Mitochondrial mutation Malignant neoplasm of breast
PREDISPOSES,GLI4 gene|GLI4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GLI4 gene|GLI4 Malignant neoplasm of breast
PREDISPOSES,Convenience food intake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Convenience food intake Malignant neoplasm of breast
AFFECTS,Cancer Therapeutic Procedure,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Cancer Therapeutic Procedure Breast Carcinoma
PREDISPOSES,PEDS1 gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PEDS1 gene Malignant neoplasm of breast
AFFECTS,PAFAH1B1 gene|PAFAH1B1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PAFAH1B1 gene|PAFAH1B1 Malignant neoplasm of breast
AFFECTS,Proto-Oncogene Protein c-kit,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,Proto-Oncogene Protein c-kit Triple Negative Breast Neoplasms
PREDISPOSES,CCDC102B gene|CCDC102B,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,CCDC102B gene|CCDC102B Secondary malignant neoplasm of breast
PREDISPOSES,RACK1 gene|RACK1,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,RACK1 gene|RACK1 Secondary malignant neoplasm of breast
AFFECTS,Imbrication (procedure),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Imbrication (procedure) Malignant neoplasm of breast
AUGMENTS,"RNA, Untranslated",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","RNA, Untranslated Malignant neoplasm of breast"
PREDISPOSES,Responsive Disease,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Responsive Disease Malignant neoplasm of breast
AUGMENTS,"IL17A protein, human|IL17A",Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,"Amino Acid, Peptide, or Protein","IL17A protein, human|IL17A Inflammatory Breast Carcinoma"
PREDISPOSES,ZNF276 gene|ZNF276,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,ZNF276 gene|ZNF276 Breast Carcinoma
AFFECTS,TIMM8A gene|TIMM8A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TIMM8A gene|TIMM8A Malignant neoplasm of breast
PREDISPOSES,METTL3 gene|METTL3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,METTL3 gene|METTL3 Malignant neoplasm of breast
DISRUPTS,FER1L4 gene|FER1L4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FER1L4 gene|FER1L4 Malignant neoplasm of breast
AFFECTS,Vitamin D Deficiency,Malignant neoplasm of female breast,0.0,Female Breast Cancer,Food,Vitamin D Deficiency Malignant neoplasm of female breast
AUGMENTS,UBE2C gene|UBE2C,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,UBE2C gene|UBE2C Malignant neoplasm of breast
AUGMENTS,FRG1 gene|FRG1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FRG1 gene|FRG1 Malignant neoplasm of breast
AUGMENTS,NF2 gene|NF2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NF2 gene|NF2 Malignant neoplasm of breast
PREDISPOSES,Observation parameter,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Observation parameter Malignant neoplasm of breast
AUGMENTS,"PIK3CB protein, human|PIK3CB",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","PIK3CB protein, human|PIK3CB Malignant neoplasm of breast"
AUGMENTS,METTL14 gene|METTL14,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,METTL14 gene|METTL14 Malignant neoplasm of breast
AUGMENTS,progesterone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,progesterone Malignant neoplasm of breast
AUGMENTS,Selective Estrogen Receptor Down Regulator,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Selective Estrogen Receptor Down Regulator Malignant neoplasm of breast
AFFECTS,Diffusion weighted imaging,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",Diffusion weighted imaging Noninfiltrating Intraductal Carcinoma
AUGMENTS,ARL11 gene|ARL11,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ARL11 gene|ARL11 Malignant neoplasm of breast
COMPLICATES,MIR217 gene|MIR217,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIR217 gene|MIR217 Malignant neoplasm of breast
PREDISPOSES,ERBB2 Overexpression,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",ERBB2 Overexpression Malignant neoplasm of breast
PREDISPOSES,FOXN3 gene|FOXN3,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,FOXN3 gene|FOXN3 Triple Negative Breast Neoplasms
PREDISPOSES,ellagic acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,ellagic acid Malignant neoplasm of breast
CAUSES,"Retinol-Binding Proteins, Cellular",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","Retinol-Binding Proteins, Cellular Malignant neoplasm of breast"
PREDISPOSES,Cancer-Related Death,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Neoplastic Process,Cancer-Related Death Secondary malignant neoplasm of breast
PREDISPOSES,Cell-Free DNA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Cell-Free DNA Malignant neoplasm of breast
PREDISPOSES,Duration,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,"Element, Ion, or Isotope",Duration Female Breast Carcinoma
PREDISPOSES,Matrix Metalloproteinase 9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Matrix Metalloproteinase 9 Malignant neoplasm of breast
DISRUPTS,HDAC7 gene|HDAC7,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,HDAC7 gene|HDAC7 Triple Negative Breast Neoplasms
PREDISPOSES,IGF2BP2 gene|IGF2BP2,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,IGF2BP2 gene|IGF2BP2 Triple Negative Breast Neoplasms
DISRUPTS,BCL2A1 gene|BCL2A1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BCL2A1 gene|BCL2A1 Malignant neoplasm of breast
CAUSES,GNAS gene|GNAS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GNAS gene|GNAS Malignant neoplasm of breast
AUGMENTS,hexanoic acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,hexanoic acid Malignant neoplasm of breast
AFFECTS,Antipsychotic Agents,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical Viewed Functionally,Antipsychotic Agents Malignant neoplasm of breast
PREDISPOSES,RMI2 gene|RMI2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RMI2 gene|RMI2 Malignant neoplasm of breast
PREDISPOSES,SCAMP3 gene|SCAMP3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SCAMP3 gene|SCAMP3 Malignant neoplasm of breast
PREDISPOSES,SPC25 gene|SPC25,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SPC25 gene|SPC25 Malignant neoplasm of breast
DISRUPTS,"RNA, Circular",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","RNA, Circular Malignant neoplasm of breast"
AUGMENTS,KDM4A gene|KDM4A,Carcinoma breast stage IV,0.0,Female Breast Cancer,Gene or Genome,KDM4A gene|KDM4A Carcinoma breast stage IV
AFFECTS,Pharmaceutical Preparations,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Pharmacologic Substance,Pharmaceutical Preparations HER2-positive carcinoma of breast
DISRUPTS,CBX7 gene|CBX7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CBX7 gene|CBX7 Malignant neoplasm of breast
AUGMENTS,PRAF2 gene|PRAF2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PRAF2 gene|PRAF2 Malignant neoplasm of breast
AFFECTS,"WWTR1 protein, human|WWTR1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","WWTR1 protein, human|WWTR1 Malignant neoplasm of breast"
COMPLICATES,Malignant neoplasm of breast,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Neoplastic Process,Malignant neoplasm of breast Secondary malignant neoplasm of breast
PREDISPOSES,Genetic Loci,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Genetic Loci Malignant neoplasm of breast
AFFECTS,Genes,Carcinoma breast stage IV,0.0,Female Breast Cancer,Gene or Genome,Genes Carcinoma breast stage IV
AFFECTS,FKBP12-rapamycin associated protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",FKBP12-rapamycin associated protein Malignant neoplasm of breast
CAUSES,"FABP1 protein, human|FABP1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","FABP1 protein, human|FABP1 Malignant neoplasm of breast"
CAUSES,gamma-aminobutyric acid,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Chemical,gamma-aminobutyric acid Secondary malignant neoplasm of breast
CAUSES,Mouse mammary tumor virus infection,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Mouse mammary tumor virus infection Malignant neoplasm of breast
PREDISPOSES,Estrogen receptor positive,estrogen receptor-negative breast cancer,0.0,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen receptor positive estrogen receptor-negative breast cancer
PREDISPOSES,KAT7 gene|KAT7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,KAT7 gene|KAT7 Malignant neoplasm of breast
AFFECTS,RNF43 gene|RNF43,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,RNF43 gene|RNF43 Triple Negative Breast Neoplasms
AFFECTS,SLC2A1 gene|SLC2A1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SLC2A1 gene|SLC2A1 Malignant neoplasm of breast
AFFECTS,CPVL gene|CPVL,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CPVL gene|CPVL Malignant neoplasm of breast
CAUSES,TMEM105 gene|TMEM105,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,TMEM105 gene|TMEM105 Secondary malignant neoplasm of breast
PREDISPOSES,SIRT7 gene|SIRT7,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,SIRT7 gene|SIRT7 Secondary malignant neoplasm of breast
DISRUPTS,SNRPC gene|SNRPC,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,SNRPC gene|SNRPC Triple Negative Breast Neoplasms
AFFECTS,RHD gene|RHD,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RHD gene|RHD Malignant neoplasm of breast
AUGMENTS,STAT1 gene|STAT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,STAT1 gene|STAT1 Malignant neoplasm of breast
PREDISPOSES,Axillary node METASTASIS,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Axillary node METASTASIS Breast Carcinoma
PREDISPOSES,SNRPC gene|SNRPC,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,SNRPC gene|SNRPC Triple Negative Breast Neoplasms
CAUSES,HHEX gene|HHEX,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HHEX gene|HHEX Malignant neoplasm of breast
AFFECTS,Kanglaite Injection,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Kanglaite Injection Triple Negative Breast Neoplasms
PREDISPOSES,SIRT7 gene|SIRT7,Carcinoma breast stage IV,0.0,Female Breast Cancer,Gene or Genome,SIRT7 gene|SIRT7 Carcinoma breast stage IV
PREDISPOSES,SDC1 gene|SDC1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,SDC1 gene|SDC1 Triple Negative Breast Neoplasms
AFFECTS,"RNA, Long Untranslated",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","RNA, Long Untranslated Malignant neoplasm of breast"
CAUSES,Agent,Carcinoma breast stage IV,0.0,Female Breast Cancer,Chemical Viewed Functionally,Agent Carcinoma breast stage IV
CAUSES,human papillomavirus,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Virus,human papillomavirus Malignant neoplasm of breast
AFFECTS,"Ribonucleoprotein, U1 Small Nuclear",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein","Ribonucleoprotein, U1 Small Nuclear Triple Negative Breast Neoplasms"
AUGMENTS,USP29 gene|USP29,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,USP29 gene|USP29 Triple Negative Breast Neoplasms
AFFECTS,"Galanin peptides, human (123 aa, ~13 kDa)",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","Galanin peptides, human (123 aa, ~13 kDa) Malignant neoplasm of breast"
AUGMENTS,NDC80 gene|NDC80,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NDC80 gene|NDC80 Malignant neoplasm of breast
PREDISPOSES,KLF2 gene|KLF2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,KLF2 gene|KLF2 Malignant neoplasm of breast
AUGMENTS,"PDCD1 protein, human|PDCD1",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein","PDCD1 protein, human|PDCD1 Triple Negative Breast Neoplasms"
AFFECTS,VEGFA gene|VEGFA,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,VEGFA gene|VEGFA Triple Negative Breast Neoplasms
AFFECTS,GAS5 gene|GAS5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GAS5 gene|GAS5 Malignant neoplasm of breast
CAUSES,NUCB2 gene|NUCB2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NUCB2 gene|NUCB2 Malignant neoplasm of breast
CAUSES,Mouse mammary tumor virus,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Mouse mammary tumor virus Malignant neoplasm of breast
AFFECTS,ZEB1 gene|ZEB1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ZEB1 gene|ZEB1 Malignant neoplasm of breast
AUGMENTS,Oligonucleotides,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Oligonucleotides Malignant neoplasm of breast
CAUSES,Betaretrovirus,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Virus,Betaretrovirus Malignant neoplasm of breast
AFFECTS,epithelial to mesenchymal transition,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",epithelial to mesenchymal transition Triple Negative Breast Neoplasms
PREDISPOSES,CDH12 gene|CDH12,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CDH12 gene|CDH12 Malignant neoplasm of breast
CAUSES,Invasive Ductal Breast Carcinoma,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Neoplastic Process,Invasive Ductal Breast Carcinoma Inflammatory Breast Carcinoma
AUGMENTS,RNA-Binding Protein Musashi Homolog 2,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,"Amino Acid, Peptide, or Protein",RNA-Binding Protein Musashi Homolog 2 Inflammatory Breast Carcinoma
PREDISPOSES,ectonucleotide pyrophosphatase phosphodiesterase 1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",ectonucleotide pyrophosphatase phosphodiesterase 1 Malignant neoplasm of breast
PREDISPOSES,NR2F1-AS1 gene|NR2F1-AS1,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,NR2F1-AS1 gene|NR2F1-AS1 Secondary malignant neoplasm of breast
PREDISPOSES,MCM6 gene|MCM6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MCM6 gene|MCM6 Malignant neoplasm of breast
PREDISPOSES,MAP7D3 gene|MAP7D3,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,MAP7D3 gene|MAP7D3 Triple Negative Breast Neoplasms
AUGMENTS,SPDEF gene|SPDEF,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SPDEF gene|SPDEF Malignant neoplasm of breast
AUGMENTS,FAM171A1 gene|FAM171A1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FAM171A1 gene|FAM171A1 Malignant neoplasm of breast
PREDISPOSES,HNRNPA2B1 gene|HNRNPA2B1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HNRNPA2B1 gene|HNRNPA2B1 Malignant neoplasm of breast
PREDISPOSES,EYA4 gene|EYA4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,EYA4 gene|EYA4 Malignant neoplasm of breast
AFFECTS,RHOV gene|RHOV,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,RHOV gene|RHOV Triple Negative Breast Neoplasms
AFFECTS,LINC01140 gene|LINC01140,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LINC01140 gene|LINC01140 Malignant neoplasm of breast
AFFECTS,Tumor Progression,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Neoplastic Process,Tumor Progression Carcinoma of Male Breast
AFFECTS,"TNFSF10 protein, human|TNFSF10",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","TNFSF10 protein, human|TNFSF10 Malignant neoplasm of breast"
AFFECTS,TYMSOS gene|TYMSOS,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,TYMSOS gene|TYMSOS Secondary malignant neoplasm of breast
AFFECTS,Mutation,Basal-Like Breast Carcinoma,0.0039960039960039,Female Breast Cancer,"Element, Ion, or Isotope",Mutation Basal-Like Breast Carcinoma
DISRUPTS,Glycoproteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Glycoproteins Malignant neoplasm of breast
PREDISPOSES,Decreased Expression,Early-Stage Breast Carcinoma,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Decreased Expression Early-Stage Breast Carcinoma
PREDISPOSES,medroxyprogesterone acetate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,medroxyprogesterone acetate Malignant neoplasm of breast
DISRUPTS,SEMA3B-AS1 gene|SEMA3B-AS1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,SEMA3B-AS1 gene|SEMA3B-AS1 Triple Negative Breast Neoplasms
AFFECTS,Anti-HER2 Monoclonal Antibody|ERBB2,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Anti-HER2 Monoclonal Antibody|ERBB2 HER2-positive carcinoma of breast
PREDISPOSES,C-reactive protein,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Amino Acid, Peptide, or Protein",C-reactive protein Noninfiltrating Intraductal Carcinoma
PREDISPOSES,MIR122 gene|MIR122,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIR122 gene|MIR122 Malignant neoplasm of breast
PREDISPOSES,MAF1 gene|MAF1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MAF1 gene|MAF1 Malignant neoplasm of breast
CAUSES,perfluorooctanoic acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,perfluorooctanoic acid Malignant neoplasm of breast
CAUSES,Oncogenes,Carcinoma breast stage IV,0.0,Female Breast Cancer,Gene or Genome,Oncogenes Carcinoma breast stage IV
AUGMENTS,CD82 gene|CD82,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,CD82 gene|CD82 Triple Negative Breast Neoplasms
PREDISPOSES,Matrix Metalloproteinases,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Matrix Metalloproteinases Noninfiltrating Intraductal Carcinoma
AUGMENTS,Carbohydrates,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Carbohydrate,Carbohydrates Malignant neoplasm of breast
PREDISPOSES,MicroRNA Gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MicroRNA Gene Malignant neoplasm of breast
AUGMENTS,PSMD14 gene|PSMD14,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PSMD14 gene|PSMD14 Malignant neoplasm of breast
PREDISPOSES,LINC00702 gene|LINC00702,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LINC00702 gene|LINC00702 Malignant neoplasm of breast
AUGMENTS,Phytochemicals,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Phytochemicals Malignant neoplasm of breast
PREDISPOSES,DNPH1 gene|DNPH1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,DNPH1 gene|DNPH1 Malignant neoplasm of breast
AUGMENTS,IMPA2 gene|IMPA2,Basal-Like Breast Carcinoma,0.0039960039960039,Female Breast Cancer,Gene or Genome,IMPA2 gene|IMPA2 Basal-Like Breast Carcinoma
DISRUPTS,FBXO3 gene|FBXO3,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,FBXO3 gene|FBXO3 Secondary malignant neoplasm of breast
PREDISPOSES,Neuroleptic Malignant Syndrome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Neuroleptic Malignant Syndrome Malignant neoplasm of breast
CAUSES,Proto-Oncogene Proteins c-akt|AKT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Proto-Oncogene Proteins c-akt|AKT1 Malignant neoplasm of breast
PREDISPOSES,Crohn Disease,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Crohn Disease Malignant neoplasm of breast
PREDISPOSES,HMGB3 gene|HMGB3,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Gene or Genome,HMGB3 gene|HMGB3 Invasive carcinoma of breast
AFFECTS,Tumor Markers,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Neoplastic Process,Tumor Markers Triple Negative Breast Neoplasms
PREDISPOSES,"COPEB protein, human|KLF6",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","COPEB protein, human|KLF6 Malignant neoplasm of breast"
AFFECTS,"PIK3CB protein, human|PIK3CB",Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,"Amino Acid, Peptide, or Protein","PIK3CB protein, human|PIK3CB Secondary malignant neoplasm of breast"
AFFECTS,Radiation-Sensitizing Agents,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Radiation-Sensitizing Agents Malignant neoplasm of breast
PREDISPOSES,PALMD gene|PALMD,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PALMD gene|PALMD Malignant neoplasm of breast
DISRUPTS,NOTCH3 gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NOTCH3 gene Malignant neoplasm of breast
PREDISPOSES,WASF3 gene|WASF3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,WASF3 gene|WASF3 Malignant neoplasm of breast
DISRUPTS,MIR203A gene|MIR203A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIR203A gene|MIR203A Malignant neoplasm of breast
CAUSES,Secondary malignant neoplasm of liver,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Neoplastic Process,Secondary malignant neoplasm of liver HER2-positive carcinoma of breast
PREDISPOSES,Macrophage Activation Syndrome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Macrophage Activation Syndrome Malignant neoplasm of breast
AFFECTS,post surgery radiation therapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",post surgery radiation therapy Malignant neoplasm of breast
CAUSES,Pathogenic Variant,Hereditary Breast and Ovarian Cancer Syndrome,0.0,Female Breast Cancer,Virus,Pathogenic Variant Hereditary Breast and Ovarian Cancer Syndrome
CAUSES,Plasma Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Plasma Proteins Malignant neoplasm of breast
AFFECTS,ARHGAP6 gene|ARHGAP6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ARHGAP6 gene|ARHGAP6 Malignant neoplasm of breast
AFFECTS,ELAVL1 gene|ELAVL1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ELAVL1 gene|ELAVL1 Malignant neoplasm of breast
PREDISPOSES,FRY gene|FRY,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FRY gene|FRY Malignant neoplasm of breast
AUGMENTS,IDO1 gene|IDO1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IDO1 gene|IDO1 Malignant neoplasm of breast
AFFECTS,"CLEC11A protein, human|CLEC11A",Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CLEC11A protein, human|CLEC11A Secondary malignant neoplasm of breast"
DISRUPTS,Polynucleotide Adenylyltransferase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Polynucleotide Adenylyltransferase Malignant neoplasm of breast
PREDISPOSES,Breast Fibrocystic Disease,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Disease or Syndrome,Breast Fibrocystic Disease Invasive carcinoma of breast
PREDISPOSES,OGG1 gene|OGG1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,OGG1 gene|OGG1 Malignant neoplasm of breast
DISRUPTS,PDZK1 gene|PDZK1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,PDZK1 gene|PDZK1 Triple Negative Breast Neoplasms
AUGMENTS,MTCH2 gene|MTCH2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MTCH2 gene|MTCH2 Malignant neoplasm of breast
PREDISPOSES,Infiltration,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Infiltration Malignant neoplasm of breast
AUGMENTS,KLRK1 gene|KLRK1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,KLRK1 gene|KLRK1 Malignant neoplasm of breast
PREDISPOSES,LINC01572 gene|LINC01572,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,LINC01572 gene|LINC01572 Triple Negative Breast Neoplasms
DISRUPTS,Dickkopf-Related Protein 1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Dickkopf-Related Protein 1 Malignant neoplasm of breast
DISRUPTS,RAMP2-AS1 gene|RAMP2-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RAMP2-AS1 gene|RAMP2-AS1 Malignant neoplasm of breast
CAUSES,HOTAIR gene|HOTAIR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HOTAIR gene|HOTAIR Malignant neoplasm of breast
CAUSES,BRCA1 gene|BRCA1,"Breast Cancer, Familial",0.0,Female Breast Cancer,Gene or Genome,"BRCA1 gene|BRCA1 Breast Cancer, Familial"
PREDISPOSES,SLCO1B1 gene|SLCO1B1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SLCO1B1 gene|SLCO1B1 Malignant neoplasm of breast
PREDISPOSES,NR2F2 gene|NR2F2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NR2F2 gene|NR2F2 Malignant neoplasm of breast
AFFECTS,"Nanotubes, Carbon",Carcinoma breast stage IV,0.0,Female Breast Cancer,"Element, Ion, or Isotope","Nanotubes, Carbon Carcinoma breast stage IV"
DISRUPTS,AGRN gene|AGRN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,AGRN gene|AGRN Malignant neoplasm of breast
PREDISPOSES,NKAIN1 gene|NKAIN1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NKAIN1 gene|NKAIN1 Malignant neoplasm of breast
AUGMENTS,S14 gene|PSMD8|RPS14|THRSP|LOC107228383,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,S14 gene|PSMD8|RPS14|THRSP|LOC107228383 Malignant neoplasm of breast
CAUSES,TCF7L2 gene|TCF7L2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TCF7L2 gene|TCF7L2 Malignant neoplasm of breast
AFFECTS,Prostaglandins,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Eicosanoid,Prostaglandins Ductal Breast Carcinoma
DISRUPTS,TRANSCRIPTION FACTOR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",TRANSCRIPTION FACTOR Malignant neoplasm of breast
AFFECTS,TAL1 gene|TAL1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,TAL1 gene|TAL1 Breast cancer metastatic
AUGMENTS,Tumor Markers,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Tumor Markers Malignant neoplasm of breast
PREDISPOSES,DNMT3B gene|DNMT3B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,DNMT3B gene|DNMT3B Malignant neoplasm of breast
AFFECTS,RHOC gene|RHOC,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Gene or Genome,RHOC gene|RHOC Inflammatory Breast Carcinoma
PREDISPOSES,Human plasma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Body Substance,Human plasma Malignant neoplasm of breast
AFFECTS,glycosylation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",glycosylation Malignant neoplasm of breast
AFFECTS,Estrogen Antagonists,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Hormone,Estrogen Antagonists Breast cancer recurrent
AFFECTS,Carcinoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Carcinoma Malignant neoplasm of breast
AUGMENTS,Steroid 17-alpha-monooxygenase|CYP17A1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Steroid 17-alpha-monooxygenase|CYP17A1 Malignant neoplasm of breast
PREDISPOSES,EZH2 gene|EZH2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,EZH2 gene|EZH2 Malignant neoplasm of breast
PREDISPOSES,Tumor Necrosis Factor Ligand Superfamily Member 6|FASLG,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Tumor Necrosis Factor Ligand Superfamily Member 6|FASLG Malignant neoplasm of breast
AUGMENTS,TAZ gene|TAZ,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TAZ gene|TAZ Malignant neoplasm of breast
PREDISPOSES,Protein-tyrosine kinase inhibitor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Protein-tyrosine kinase inhibitor Malignant neoplasm of breast
AFFECTS,Benzoic Acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Benzoic Acid Malignant neoplasm of breast
DISRUPTS,"Anti-Inflammatory Agents, Non-Steroidal",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical Viewed Functionally,"Anti-Inflammatory Agents, Non-Steroidal Malignant neoplasm of breast"
DISRUPTS,Estrogen Receptor alpha,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptor alpha Breast cancer metastatic
CAUSES,SMARCA4 gene|SMARCA4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SMARCA4 gene|SMARCA4 Malignant neoplasm of breast
AFFECTS,Radioisotope scan of lymphatic system,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Radioisotope scan of lymphatic system Malignant neoplasm of breast
PREDISPOSES,RHOA gene|RHOA,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,RHOA gene|RHOA Breast cancer metastatic
PREDISPOSES,Folic acid supplementation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Folic acid supplementation Malignant neoplasm of breast
PREDISPOSES,ESTROGEN USE,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Hormone,ESTROGEN USE Noninfiltrating Intraductal Carcinoma
AFFECTS,recombinational repair,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",recombinational repair Malignant neoplasm of breast
CAUSES,APC2 gene|APC2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,APC2 gene|APC2 Malignant neoplasm of breast
AFFECTS,Metaplastic carcinoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Metaplastic carcinoma Malignant neoplasm of breast
AFFECTS,Suicide Gene Therapy,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,Suicide Gene Therapy Breast cancer metastatic
PREDISPOSES,CDX2 gene|CDX2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CDX2 gene|CDX2 Malignant neoplasm of breast
CAUSES,PIK3CA gene|PIK3CA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PIK3CA gene|PIK3CA Malignant neoplasm of breast
PREDISPOSES,DUSP4 gene|DUSP4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,DUSP4 gene|DUSP4 Malignant neoplasm of breast
PREDISPOSES,FLT1 gene|FLT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FLT1 gene|FLT1 Malignant neoplasm of breast
CAUSES,Malignant transformation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Malignant transformation Malignant neoplasm of breast
PREDISPOSES,Nucleic Acids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Nucleic Acids Malignant neoplasm of breast
AFFECTS,Cancer Model,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Cancer Model Malignant neoplasm of breast
AFFECTS,High fiber food,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,High fiber food Malignant neoplasm of breast
AFFECTS,Malignant neoplasm of breast,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Malignant neoplasm of breast Breast Carcinoma
PREDISPOSES,CADMIUM EXPOSURE,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Inorganic Chemical,CADMIUM EXPOSURE Malignant neoplasm of breast
AFFECTS,Glycoproteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Glycoproteins Malignant neoplasm of breast
DISRUPTS,Therapeutic agent (substance),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical Viewed Functionally,Therapeutic agent (substance) Malignant neoplasm of breast
PREDISPOSES,VEGF gene|VEGFA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,VEGF gene|VEGFA Malignant neoplasm of breast
DISRUPTS,"Fatty Acids, Saturated",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,"Fatty Acids, Saturated Malignant neoplasm of breast"
PREDISPOSES,transcription factor PEA3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",transcription factor PEA3 Malignant neoplasm of breast
AFFECTS,TLR4 gene|TLR4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TLR4 gene|TLR4 Malignant neoplasm of breast
AUGMENTS,"Genes, Homeobox",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,"Genes, Homeobox Malignant neoplasm of breast"
AFFECTS,Estrogens,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Hormone,Estrogens Carcinoma of Male Breast
PREDISPOSES,PCAF gene|KAT2B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PCAF gene|KAT2B Malignant neoplasm of breast
AUGMENTS,BIRC5 gene|BIRC5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BIRC5 gene|BIRC5 Malignant neoplasm of breast
AFFECTS,RNASE3L gene|DROSHA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RNASE3L gene|DROSHA Malignant neoplasm of breast
PREDISPOSES,TP53 gene|TP53,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,TP53 gene|TP53 Breast Carcinoma
PREDISPOSES,Estrogen excess,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Hormone,Estrogen excess Carcinoma of Male Breast
AUGMENTS,cyclooxygenase 2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",cyclooxygenase 2 Malignant neoplasm of breast
PREDISPOSES,MULTISECTION:FINDING:POINT IN TIME:BREAST:NARRATIVE:MRI,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,"Element, Ion, or Isotope",MULTISECTION:FINDING:POINT IN TIME:BREAST:NARRATIVE:MRI Inflammatory Breast Carcinoma
PREDISPOSES,"Genes, Homeobox",Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,"Genes, Homeobox Breast Carcinoma"
PREDISPOSES,BIRC7 gene|BIRC7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BIRC7 gene|BIRC7 Malignant neoplasm of breast
PREDISPOSES,ATR gene|ATR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ATR gene|ATR Malignant neoplasm of breast
AUGMENTS,Fatty-acid synthase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Fatty-acid synthase Malignant neoplasm of breast
AFFECTS,TSLP gene|TSLP,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,TSLP gene|TSLP Breast cancer metastatic
DISRUPTS,S100A9 gene|S100A9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,S100A9 gene|S100A9 Malignant neoplasm of breast
AFFECTS,Breast Cancer Treatment,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Breast Cancer Treatment Malignant neoplasm of breast
AFFECTS,Protein-tyrosine kinase inhibitor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Protein-tyrosine kinase inhibitor Malignant neoplasm of breast
AUGMENTS,Gonadal Steroid Hormones,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Gonadal Steroid Hormones Malignant neoplasm of breast
PREDISPOSES,CDKN1B gene|CDKN1B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CDKN1B gene|CDKN1B Malignant neoplasm of breast
AFFECTS,CTNNB1 gene|CTNNB1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CTNNB1 gene|CTNNB1 Malignant neoplasm of breast
PREDISPOSES,EGFR gene|EGFR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,EGFR gene|EGFR Malignant neoplasm of breast
AFFECTS,Signaling Protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Signaling Protein Malignant neoplasm of breast
AFFECTS,Soy Foods,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Soy Foods Malignant neoplasm of breast
AFFECTS,STAT3 gene|STAT3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,STAT3 gene|STAT3 Malignant neoplasm of breast
DISRUPTS,CXCR3 gene|CXCR3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CXCR3 gene|CXCR3 Malignant neoplasm of breast
AFFECTS,PTPN11 gene|PTPN11,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PTPN11 gene|PTPN11 Malignant neoplasm of breast
CAUSES,Malignant neoplasm of endometrium,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Malignant neoplasm of endometrium Malignant neoplasm of breast
PREDISPOSES,Disease Outcome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Disease Outcome Malignant neoplasm of breast
PREDISPOSES,Sulfuric Acid Esters,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Sulfuric Acid Esters Malignant neoplasm of breast
PREDISPOSES,BMPR2 gene|BMPR2,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Gene or Genome,BMPR2 gene|BMPR2 Inflammatory Breast Carcinoma
DISRUPTS,Antineoplastic Agents,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Antineoplastic Agents Malignant neoplasm of breast
PREDISPOSES,Protein-Serine-Threonine Kinases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Protein-Serine-Threonine Kinases Malignant neoplasm of breast
PREDISPOSES,Environmental Effects,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Environmental Effect of Humans,Environmental Effects Malignant neoplasm of breast
AFFECTS,Growth Factor Receptors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Growth Factor Receptors Malignant neoplasm of breast
CAUSES,Insulin-Like Growth Factor Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Insulin-Like Growth Factor Receptor Malignant neoplasm of breast
PREDISPOSES,cDNA Library,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",cDNA Library Malignant neoplasm of breast
COMPLICATES,Toxic effect,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hazardous or Poisonous Substance,Toxic effect Malignant neoplasm of breast
PREDISPOSES,TACSTD2 gene|TACSTD2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TACSTD2 gene|TACSTD2 Malignant neoplasm of breast
PREDISPOSES,Cystic Breast Disease,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Cystic Breast Disease Malignant neoplasm of breast
AFFECTS,BRCA1 gene|BRCA1,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,Gene or Genome,BRCA1 gene|BRCA1 Familial cancer of breast
AFFECTS,LAMR1 gene|RPSA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LAMR1 gene|RPSA Malignant neoplasm of breast
AFFECTS,BCAS1 gene|BCAS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BCAS1 gene|BCAS1 Malignant neoplasm of breast
PREDISPOSES,MDM2 gene|MDM2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MDM2 gene|MDM2 Malignant neoplasm of breast
DISRUPTS,Cysteine Proteinase Inhibitors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Cysteine Proteinase Inhibitors Malignant neoplasm of breast
AUGMENTS,mutant gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,mutant gene Malignant neoplasm of breast
DISRUPTS,Prostaglandin-Endoperoxide Synthase,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Eicosanoid,Prostaglandin-Endoperoxide Synthase Breast cancer metastatic
CAUSES,mammary tumor virus,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,mammary tumor virus Breast Carcinoma
CAUSES,Medroxyprogesterone 17-Acetate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Medroxyprogesterone 17-Acetate Malignant neoplasm of breast
DISRUPTS,Genes,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Gene or Genome,Genes Breast cancer invasive NOS
CAUSES,Medroxyprogesterone,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Hormone,Medroxyprogesterone Ductal Breast Carcinoma
PREDISPOSES,Antigens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Immunologic Factor,Antigens Malignant neoplasm of breast
CAUSES,hybrid gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,hybrid gene Malignant neoplasm of breast
AUGMENTS,CCND1 gene|CCND1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CCND1 gene|CCND1 Malignant neoplasm of breast
PREDISPOSES,SHBG gene|SHBG,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SHBG gene|SHBG Malignant neoplasm of breast
PREDISPOSES,Anovulation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Anovulation Malignant neoplasm of breast
CAUSES,FGF3 gene|FGF3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FGF3 gene|FGF3 Malignant neoplasm of breast
PREDISPOSES,Serum Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Serum Proteins Malignant neoplasm of breast
DISRUPTS,Tamoxifen,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Pharmacologic Substance,Tamoxifen Breast Carcinoma
CAUSES,Female Breast Carcinoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Female Breast Carcinoma Malignant neoplasm of breast
AFFECTS,DNA biosynthesis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",DNA biosynthesis Malignant neoplasm of breast
PREDISPOSES,"TFF1 protein, human|TFF1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","TFF1 protein, human|TFF1 Malignant neoplasm of breast"
PREDISPOSES,"serine repeat antigen, Plasmodium",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Immunologic Factor,"serine repeat antigen, Plasmodium Malignant neoplasm of breast"
AUGMENTS,Estrogenic,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Estrogenic Malignant neoplasm of breast
PREDISPOSES,Pharmaceutical Preparations,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Pharmacologic Substance,Pharmaceutical Preparations Carcinoma of Male Breast
PREDISPOSES,Animal protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Animal protein Malignant neoplasm of breast
AUGMENTS,Proto-Oncogene Proteins p21(ras)|HRAS,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,Proto-Oncogene Proteins p21(ras)|HRAS Breast Carcinoma
DISRUPTS,Estrogen Antagonists,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Hormone,Estrogen Antagonists Breast Carcinoma
CAUSES,FGF3 gene|FGF3,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,FGF3 gene|FGF3 Breast Carcinoma
PREDISPOSES,international differences,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",international differences Malignant neoplasm of breast
CAUSES,"Genes, Suppressor",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,"Genes, Suppressor Malignant neoplasm of breast"
CAUSES,"Hydrocarbons, Aromatic",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Hydrocarbons, Aromatic Malignant neoplasm of breast"
AFFECTS,Tumor Burden,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Tumor Burden Breast cancer metastatic
PREDISPOSES,BCL-2 Protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",BCL-2 Protein Malignant neoplasm of breast
DISRUPTS,IGF2 gene|IGF2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IGF2 gene|IGF2 Malignant neoplasm of breast
CAUSES,Secondary malignant neoplasm of bone,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Secondary malignant neoplasm of bone Breast cancer metastatic
AFFECTS,Pathogenesis,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,Pathogenesis Breast Carcinoma
CAUSES,Advanced cancer,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Advanced cancer Malignant neoplasm of breast
AFFECTS,Ascorbic Acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Ascorbic Acid Malignant neoplasm of breast
CAUSES,"Antigens, Viral",Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Immunologic Factor,"Antigens, Viral Breast Carcinoma"
DISRUPTS,Steroids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Steroid,Steroids Malignant neoplasm of breast
DISRUPTS,AFP gene|AFP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,AFP gene|AFP Malignant neoplasm of breast
PREDISPOSES,Antipsychotic Agents,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical Viewed Functionally,Antipsychotic Agents Malignant neoplasm of breast
PREDISPOSES,HRAS gene|HRAS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HRAS gene|HRAS Malignant neoplasm of breast
AUGMENTS,Antineoplastic Agents,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Antineoplastic Agents Malignant neoplasm of breast
CAUSES,Breast cancer invasive NOS,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Neoplastic Process,Breast cancer invasive NOS Noninfiltrating Intraductal Carcinoma
DISRUPTS,CDKN2A gene|CDKN2A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CDKN2A gene|CDKN2A Malignant neoplasm of breast
AUGMENTS,Proteins,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Proteins Breast cancer metastatic
AFFECTS,Lymph node excision,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Lymph node excision Malignant neoplasm of breast
AFFECTS,"Genes, Regulator",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,"Genes, Regulator Malignant neoplasm of breast"
AFFECTS,Radionuclide Imaging,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Element, Ion, or Isotope",Radionuclide Imaging Breast cancer recurrent
PREDISPOSES,Antibiotics,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Antibiotic,Antibiotics Malignant neoplasm of breast
AFFECTS,alpha-Linolenic Acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,alpha-Linolenic Acid Malignant neoplasm of breast
AFFECTS,MLH1 gene|MLH1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MLH1 gene|MLH1 Malignant neoplasm of breast
PREDISPOSES,ELK3 gene|ELK3|KCNH8,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ELK3 gene|ELK3|KCNH8 Malignant neoplasm of breast
AFFECTS,Transfection,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Transfection Malignant neoplasm of breast
PREDISPOSES,Linoleic Acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Linoleic Acid Malignant neoplasm of breast
AFFECTS,Carcinoma in Situ,Lobular carcinoma in situ of breast,0.0,Female Breast Cancer,Neoplastic Process,Carcinoma in Situ Lobular carcinoma in situ of breast
AFFECTS,"Fatty Acids, Unsaturated",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,"Fatty Acids, Unsaturated Malignant neoplasm of breast"
CAUSES,ETS Variant Gene 6 Protein|ETV6,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,ETS Variant Gene 6 Protein|ETV6 Breast Carcinoma
AUGMENTS,"Genes, Regulator",Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Gene or Genome,"Genes, Regulator Breast cancer invasive NOS"
CAUSES,MYC gene|MYC,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MYC gene|MYC Malignant neoplasm of breast
AFFECTS,HIV Infections,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",HIV Infections Malignant neoplasm of breast
AFFECTS,response to hormone stimulus,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,response to hormone stimulus Malignant neoplasm of breast
AFFECTS,glycosylation,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",glycosylation Breast cancer metastatic
AFFECTS,Cell Communication,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Cell Communication Breast cancer metastatic
PREDISPOSES,Chronic Disease,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Chronic Disease Malignant neoplasm of breast
AFFECTS,Protein Overexpression,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Protein Overexpression Breast Carcinoma
AFFECTS,CDC25A gene|CDC25A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CDC25A gene|CDC25A Malignant neoplasm of breast
AFFECTS,Isotopes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Isotopes Malignant neoplasm of breast
AUGMENTS,Sterol Regulatory Element Binding Protein 1c,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Sterol Regulatory Element Binding Protein 1c Malignant neoplasm of breast
AFFECTS,fluorodeoxyglucose positron emission tomography,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",fluorodeoxyglucose positron emission tomography Malignant neoplasm of breast
AFFECTS,NFKBIA gene|NFKBIA,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Gene or Genome,NFKBIA gene|NFKBIA Sporadic Breast Carcinoma
PREDISPOSES,Fibroblast Growth Factor 1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Fibroblast Growth Factor 1 Malignant neoplasm of breast
CAUSES,ral Guanine Nucleotide Exchange Factor|RALGDS,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",ral Guanine Nucleotide Exchange Factor|RALGDS Breast Carcinoma
AUGMENTS,letrozole,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,letrozole Malignant neoplasm of breast
AUGMENTS,Transcription Coactivator,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Transcription Coactivator Malignant neoplasm of breast
PREDISPOSES,Selective Estrogen Receptor Modulators,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Selective Estrogen Receptor Modulators Malignant neoplasm of breast
DISRUPTS,Serine Protease,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Enzyme,Serine Protease Breast cancer invasive NOS
AFFECTS,BRCA1 gene|BRCA1,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Gene or Genome,BRCA1 gene|BRCA1 Carcinoma of Male Breast
PREDISPOSES,Family history of breast cancer,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Family history of breast cancer Malignant neoplasm of breast
AFFECTS,Amino Acid Substitution,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Amino Acid Substitution Malignant neoplasm of breast
PREDISPOSES,ERCC4 gene|ERCC4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ERCC4 gene|ERCC4 Malignant neoplasm of breast
CAUSES,Steroids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Steroid,Steroids Malignant neoplasm of breast
AFFECTS,Genes,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Gene or Genome,Genes Inflammatory Breast Carcinoma
AUGMENTS,VEGF gene|VEGFA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,VEGF gene|VEGFA Malignant neoplasm of breast
CAUSES,PGR gene|PGR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PGR gene|PGR Malignant neoplasm of breast
AFFECTS,Micronutrients,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Micronutrients Malignant neoplasm of breast
DISRUPTS,Polypeptides,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Polypeptides Breast cancer metastatic
CAUSES,Cancer-Predisposing Gene,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,Gene or Genome,Cancer-Predisposing Gene Familial cancer of breast
DISRUPTS,CD82 gene|CD82,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CD82 gene|CD82 Malignant neoplasm of breast
AFFECTS,Protein Kinase C Inhibitor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Protein Kinase C Inhibitor Malignant neoplasm of breast
PREDISPOSES,NQO1 gene|NQO1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NQO1 gene|NQO1 Malignant neoplasm of breast
CAUSES,Neoplasm Metastasis,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Neoplastic Process,Neoplasm Metastasis Inflammatory Breast Carcinoma
CAUSES,repair enzyme,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Enzyme,repair enzyme Sporadic Breast Carcinoma
AFFECTS,Orthologous Gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Orthologous Gene Malignant neoplasm of breast
AUGMENTS,Estrogen Antagonists,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Estrogen Antagonists Malignant neoplasm of breast
PREDISPOSES,CASP1 gene|CASP1,Lobular carcinoma in situ of breast,0.0,Female Breast Cancer,Gene or Genome,CASP1 gene|CASP1 Lobular carcinoma in situ of breast
PREDISPOSES,TNFRSF1B gene|TNFRSF1B,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,TNFRSF1B gene|TNFRSF1B Noninfiltrating Intraductal Carcinoma
PREDISPOSES,Tamoxifen,Carcinoma in situ of breast,0.0019980019980019,Female Breast Cancer,Pharmacologic Substance,Tamoxifen Carcinoma in situ of breast
AFFECTS,cyclooxygenase 2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",cyclooxygenase 2 Breast cancer metastatic
PREDISPOSES,IL8 gene|CXCL8,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,IL8 gene|CXCL8 Breast Carcinoma
PREDISPOSES,Steroidal Estrogen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Steroidal Estrogen Malignant neoplasm of breast
CAUSES,Fibroblast Growth Factor 7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Fibroblast Growth Factor 7 Malignant neoplasm of breast
AFFECTS,Aromatase Inhibitors,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Hormone,Aromatase Inhibitors Noninfiltrating Intraductal Carcinoma
CAUSES,CAV1 gene|CAV1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CAV1 gene|CAV1 Malignant neoplasm of breast
DISRUPTS,Tamoxifen,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,Pharmacologic Substance,Tamoxifen Contralateral breast cancer
CAUSES,Single Nucleotide Polymorphism,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Single Nucleotide Polymorphism Sporadic Breast Carcinoma
DISRUPTS,CLCA2 gene|CLCA2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CLCA2 gene|CLCA2 Malignant neoplasm of breast
DISRUPTS,Xanthine Dehydrogenase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Xanthine Dehydrogenase Malignant neoplasm of breast
CAUSES,Glutathione S-Transferase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Glutathione S-Transferase Malignant neoplasm of breast
AUGMENTS,HPSE gene|HPSE,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HPSE gene|HPSE Malignant neoplasm of breast
PREDISPOSES,Signaling Protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Signaling Protein Malignant neoplasm of breast
PREDISPOSES,Estrogen Receptors,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptors Breast cancer metastatic
AFFECTS,Retinoblastoma Protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Retinoblastoma Protein Malignant neoplasm of breast
AFFECTS,Adaptor Signaling Protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Adaptor Signaling Protein Malignant neoplasm of breast
PREDISPOSES,Estrogen Receptor alpha|EREG|ESR1,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptor alpha|EREG|ESR1 Breast cancer invasive NOS
AFFECTS,Fertility Agents,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical Viewed Functionally,Fertility Agents Malignant neoplasm of breast
PREDISPOSES,Apolipoprotein E|APOE,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Apolipoprotein E|APOE Malignant neoplasm of breast
AFFECTS,CXCL12 gene|CXCL12,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CXCL12 gene|CXCL12 Malignant neoplasm of breast
CAUSES,PLAT gene|PLAT,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,PLAT gene|PLAT Breast cancer metastatic
AUGMENTS,Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Proteins Malignant neoplasm of breast
PREDISPOSES,CXCR4 gene|CXCR4,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,CXCR4 gene|CXCR4 Breast cancer metastatic
AFFECTS,Vitamin E,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Food,Vitamin E Breast Carcinoma
PREDISPOSES,CXCL12 gene|CXCL12,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,CXCL12 gene|CXCL12 Breast cancer metastatic
AFFECTS,Primary Prevention,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Primary Prevention Malignant neoplasm of breast
PREDISPOSES,SHFM1 gene|SEM1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SHFM1 gene|SEM1 Malignant neoplasm of breast
PREDISPOSES,"PSMD10 protein, human|PSMD10",Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein","PSMD10 protein, human|PSMD10 Breast cancer metastatic"
AFFECTS,"Receptors, Progesterone|PGR",Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Hormone,"Receptors, Progesterone|PGR Breast cancer invasive NOS"
AFFECTS,Gastric Adenocarcinoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Gastric Adenocarcinoma Malignant neoplasm of breast
PREDISPOSES,Clonal Expansion,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Clonal Expansion Malignant neoplasm of breast
PREDISPOSES,ADH1B gene|ADH1B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ADH1B gene|ADH1B Malignant neoplasm of breast
AFFECTS,TNFSF11 gene|TNFSF11,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,TNFSF11 gene|TNFSF11 Breast cancer metastatic
CAUSES,Phytoestrogens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Phytoestrogens Malignant neoplasm of breast
AFFECTS,Transfection,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Transfection Breast Carcinoma
AUGMENTS,K-ras Oncogene|KRAS,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Gene or Genome,K-ras Oncogene|KRAS Ductal Breast Carcinoma
CAUSES,Carcinogenesis,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Hazardous or Poisonous Substance,Carcinogenesis Breast Carcinoma
PREDISPOSES,Transforming Growth Factor beta,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Transforming Growth Factor beta Malignant neoplasm of breast
AFFECTS,gene polymorphism,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Gene or Genome,gene polymorphism Sporadic Breast Carcinoma
AFFECTS,estrogen receptor gamma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",estrogen receptor gamma Malignant neoplasm of breast
PREDISPOSES,Single Nucleotide Polymorphism,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Single Nucleotide Polymorphism Breast cancer invasive NOS
CAUSES,TRANCE protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",TRANCE protein Malignant neoplasm of breast
AFFECTS,KL gene|KL,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,KL gene|KL Malignant neoplasm of breast
CAUSES,Estrogen Receptors|EREG|ESR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptors|EREG|ESR1 Malignant neoplasm of breast
AFFECTS,Agent,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Chemical Viewed Functionally,Agent Breast cancer metastatic
DISRUPTS,"Fatty Acids, Omega-6",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,"Fatty Acids, Omega-6 Malignant neoplasm of breast"
AUGMENTS,SP1 gene|SP1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,SP1 gene|SP1 Breast cancer metastatic
PREDISPOSES,G-Protein-Coupled Receptors,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",G-Protein-Coupled Receptors Breast cancer metastatic
CAUSES,Carbon,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Carbon Malignant neoplasm of breast
AFFECTS,CYP1A1 gene|CYP1A1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CYP1A1 gene|CYP1A1 Malignant neoplasm of breast
AFFECTS,Hypermethylation,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Hypermethylation Sporadic Breast Carcinoma
PREDISPOSES,"TGFB1 protein, human|TGFB1",Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein","TGFB1 protein, human|TGFB1 Breast Carcinoma"
AUGMENTS,IL8 gene|CXCL8,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IL8 gene|CXCL8 Malignant neoplasm of breast
PREDISPOSES,ANP32B gene|ANP32B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ANP32B gene|ANP32B Malignant neoplasm of breast
PREDISPOSES,ERR1 protein|ESRRA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",ERR1 protein|ESRRA Malignant neoplasm of breast
AFFECTS,Bone Morphogenetic Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Bone Morphogenetic Proteins Malignant neoplasm of breast
AFFECTS,"PTH protein, human|PTH",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","PTH protein, human|PTH Malignant neoplasm of breast"
PREDISPOSES,Anabolic steroids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Steroid,Anabolic steroids Malignant neoplasm of breast
CAUSES,NOTCH4 gene,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,NOTCH4 gene Breast Carcinoma
AFFECTS,Growth retardation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Growth retardation Malignant neoplasm of breast
CAUSES,CYP1A1 gene|CYP1A1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CYP1A1 gene|CYP1A1 Malignant neoplasm of breast
AUGMENTS,EGFR gene|EGFR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,EGFR gene|EGFR Malignant neoplasm of breast
AUGMENTS,chromosome decondensation factors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",chromosome decondensation factors Malignant neoplasm of breast
DISRUPTS,MAPK14 gene|MAPK14,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MAPK14 gene|MAPK14 Malignant neoplasm of breast
PREDISPOSES,Protein Isoforms,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Protein Isoforms Malignant neoplasm of breast
AUGMENTS,DNA Adducts,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",DNA Adducts Malignant neoplasm of breast
PREDISPOSES,amsonic acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,amsonic acid Malignant neoplasm of breast
PREDISPOSES,Alcoholic Liver Diseases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Alcoholic Liver Diseases Malignant neoplasm of breast
AUGMENTS,AKT1 gene|AKT1,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Gene or Genome,AKT1 gene|AKT1 Sporadic Breast Carcinoma
AFFECTS,Sex Hormone-Binding Globulin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Sex Hormone-Binding Globulin Malignant neoplasm of breast
AUGMENTS,protein-tyrosine kinase c-src|SRC,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",protein-tyrosine kinase c-src|SRC Malignant neoplasm of breast
PREDISPOSES,vasodilator-stimulated phosphoprotein,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",vasodilator-stimulated phosphoprotein Breast cancer metastatic
PREDISPOSES,Phosphatidylethanolamine Binding Protein,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Phosphatidylethanolamine Binding Protein Breast cancer metastatic
PREDISPOSES,Aromatase Inhibitors,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Hormone,Aromatase Inhibitors Breast cancer recurrent
PREDISPOSES,Pharmaceutical Preparations,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Pharmacologic Substance,Pharmaceutical Preparations Breast cancer recurrent
AUGMENTS,BRCA1 gene|BRCA1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BRCA1 gene|BRCA1 Malignant neoplasm of breast
AUGMENTS,BCL6 gene|BCL6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BCL6 gene|BCL6 Malignant neoplasm of breast
DISRUPTS,"TNF protein, human|TNF",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","TNF protein, human|TNF Malignant neoplasm of breast"
AUGMENTS,MYC gene|MYC,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MYC gene|MYC Malignant neoplasm of breast
DISRUPTS,KLF9 gene|KLF9,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,KLF9 gene|KLF9 Breast cancer metastatic
AFFECTS,Hyperbaric Oxygenation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Hyperbaric Oxygenation Malignant neoplasm of breast
AUGMENTS,USP21 gene|USP21,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,USP21 gene|USP21 Malignant neoplasm of breast
AFFECTS,Hexachlorobenzene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hazardous or Poisonous Substance,Hexachlorobenzene Malignant neoplasm of breast
PREDISPOSES,CRHBP gene|CRHBP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CRHBP gene|CRHBP Malignant neoplasm of breast
CAUSES,"Myeloid Leukemia, Chronic",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,"Myeloid Leukemia, Chronic Malignant neoplasm of breast"
AUGMENTS,Genes,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,Genes Breast Carcinoma
AFFECTS,SMAD3 gene|SMAD3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SMAD3 gene|SMAD3 Malignant neoplasm of breast
PREDISPOSES,"TACSTD2 protein, human|TACSTD2",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","TACSTD2 protein, human|TACSTD2 Malignant neoplasm of breast"
AFFECTS,"20-hydroxy-5,8,11,14-eicosatetraenoic acid",Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Chemical,"20-hydroxy-5,8,11,14-eicosatetraenoic acid Breast cancer metastatic"
AFFECTS,PROTEIN KINASE,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",PROTEIN KINASE Malignant neoplasm of breast
AFFECTS,letrozole,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Pharmacologic Substance,letrozole Inflammatory Breast Carcinoma
AFFECTS,Steroids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Steroid,Steroids Malignant neoplasm of breast
AFFECTS,BRCA1 gene|BRCA1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,BRCA1 gene|BRCA1 Breast cancer metastatic
AFFECTS,Lipogenesis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Lipogenesis Malignant neoplasm of breast
AFFECTS,Malignant meningitis,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Malignant meningitis Breast Carcinoma
AFFECTS,Folic Acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Folic Acid Malignant neoplasm of breast
AFFECTS,Promoter Regions (Genetics),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Promoter Regions (Genetics) Malignant neoplasm of breast
AFFECTS,Acids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Acids Malignant neoplasm of breast
AFFECTS,iron ion homeostasis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",iron ion homeostasis Malignant neoplasm of breast
AFFECTS,Oxygen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Oxygen Malignant neoplasm of breast
DISRUPTS,LRRC3B gene|LRRC3B,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Gene or Genome,LRRC3B gene|LRRC3B Breast cancer recurrent
AFFECTS,MET gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MET gene Malignant neoplasm of breast
PREDISPOSES,protein tyrosine phosphatase 1B,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",protein tyrosine phosphatase 1B Breast cancer metastatic
AFFECTS,Heat Shock Protein 27,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Heat Shock Protein 27 Malignant neoplasm of breast
PREDISPOSES,"prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase), human",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase), human Malignant neoplasm of breast"
AFFECTS,cell invasion,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,"Element, Ion, or Isotope","cell invasion Carcinoma, Ductal, Breast"
PREDISPOSES,Heightened perception,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Heightened perception Malignant neoplasm of breast
CAUSES,Functional RNA,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Functional RNA Breast Carcinoma
AFFECTS,Malignant neoplasm of breast,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Neoplastic Process,Malignant neoplasm of breast Sporadic Breast Carcinoma
AFFECTS,Malignant tumor of colon,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Malignant tumor of colon Malignant neoplasm of breast
CAUSES,PGR gene|PGR,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,PGR gene|PGR Breast Carcinoma
PREDISPOSES,Serotonin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neuroreactive Substance or Biogenic Amine,Serotonin Malignant neoplasm of breast
PREDISPOSES,ANG gene|ANG,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,ANG gene|ANG Breast cancer metastatic
PREDISPOSES,CALCA gene|CALCA,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Gene or Genome,CALCA gene|CALCA Ductal Breast Carcinoma
AFFECTS,Agent,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Chemical Viewed Functionally,Agent Breast Carcinoma
AFFECTS,Dyslipidemias,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Lipid,Dyslipidemias Malignant neoplasm of breast
AFFECTS,Neoplasm Metastasis,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,Neoplasm Metastasis Breast cancer invasive NOS
AFFECTS,OGG1 gene|OGG1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,OGG1 gene|OGG1 Malignant neoplasm of breast
AFFECTS,Endocrine therapy,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Hormone,Endocrine therapy Breast cancer metastatic
PREDISPOSES,Epithelial antibody,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Indicator, Reagent, or Diagnostic Aid",Epithelial antibody Malignant neoplasm of breast
AUGMENTS,"BCAR1 protein, human|BCAR1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","BCAR1 protein, human|BCAR1 Malignant neoplasm of breast"
PREDISPOSES,Vitamin B6 intake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Vitamin B6 intake Malignant neoplasm of breast
AUGMENTS,Fibroblast Growth Factor Receptors,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Biologically Active Substance,Fibroblast Growth Factor Receptors Breast cancer metastatic
AUGMENTS,Estrogen Receptor beta|ESR2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptor beta|ESR2 Malignant neoplasm of breast
AFFECTS,Adenocarcinoma of esophagus,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Adenocarcinoma of esophagus Malignant neoplasm of breast
AFFECTS,Homologous Recombination,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Homologous Recombination Malignant neoplasm of breast
DISRUPTS,RNA,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",RNA Breast cancer metastatic
CAUSES,TP53 gene|TP53,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,TP53 gene|TP53 Breast Carcinoma
PREDISPOSES,hepatocellular carcinoma protein 1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",hepatocellular carcinoma protein 1 Breast cancer metastatic
AFFECTS,RELN gene|RELN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RELN gene|RELN Malignant neoplasm of breast
PREDISPOSES,Urine protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Urine protein Malignant neoplasm of breast
AFFECTS,DNA,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",DNA Breast cancer metastatic
AUGMENTS,Enzymes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Enzyme,Enzymes Malignant neoplasm of breast
AFFECTS,intervention program,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,"Element, Ion, or Isotope",intervention program Familial cancer of breast
DISRUPTS,PTEN gene|PTEN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PTEN gene|PTEN Malignant neoplasm of breast
PREDISPOSES,Total estrogens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Total estrogens Malignant neoplasm of breast
CAUSES,PGR gene|PGR,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Gene or Genome,PGR gene|PGR Carcinoma of Male Breast
PREDISPOSES,CCL20 gene|CCL20,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,CCL20 gene|CCL20 Breast cancer metastatic
PREDISPOSES,ITK gene|ITK,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ITK gene|ITK Malignant neoplasm of breast
AUGMENTS,AR gene|AR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,AR gene|AR Malignant neoplasm of breast
AFFECTS,CD29 Antigen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Immunologic Factor,CD29 Antigen Malignant neoplasm of breast
PREDISPOSES,Forkhead Transcription Factors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Forkhead Transcription Factors Malignant neoplasm of breast
AFFECTS,Estrogen Receptors,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptors Breast Carcinoma
AUGMENTS,Orthologous Gene,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,Gene or Genome,Orthologous Gene Female Breast Carcinoma
PREDISPOSES,NBS1 gene|NBN|NLRP2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NBS1 gene|NBN|NLRP2 Malignant neoplasm of breast
AUGMENTS,Apoptosis Inhibiting Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Apoptosis Inhibiting Proteins Malignant neoplasm of breast
AFFECTS,Food,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Food Malignant neoplasm of breast
AFFECTS,Cervix carcinoma,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Cervix carcinoma Breast Carcinoma
PREDISPOSES,progesterone receptor negative,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,progesterone receptor negative Malignant neoplasm of breast
AUGMENTS,Soybean preparation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Soybean preparation Malignant neoplasm of breast
DISRUPTS,CDC42 gene|CDC42,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CDC42 gene|CDC42 Malignant neoplasm of breast
PREDISPOSES,SENP2 gene|SENP2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SENP2 gene|SENP2 Malignant neoplasm of breast
CAUSES,H2AFX gene|H2AFX,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Gene or Genome,H2AFX gene|H2AFX Sporadic Breast Carcinoma
CAUSES,CDH1 gene|CDH1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CDH1 gene|CDH1 Malignant neoplasm of breast
AUGMENTS,CXCR4 gene|CXCR4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CXCR4 gene|CXCR4 Malignant neoplasm of breast
CAUSES,MSH6 gene|MSH6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MSH6 gene|MSH6 Malignant neoplasm of breast
PREDISPOSES,CCND2 gene|CCND2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CCND2 gene|CCND2 Malignant neoplasm of breast
DISRUPTS,GLS gene|GLS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GLS gene|GLS Malignant neoplasm of breast
PREDISPOSES,TXNIP gene|TXNIP,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,TXNIP gene|TXNIP Noninfiltrating Intraductal Carcinoma
DISRUPTS,MAPK8 gene|MAPK8,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MAPK8 gene|MAPK8 Malignant neoplasm of breast
AUGMENTS,"PER2 protein, mammalian",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","PER2 protein, mammalian Malignant neoplasm of breast"
CAUSES,"RNA, Satellite",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","RNA, Satellite Malignant neoplasm of breast"
CAUSES,CD80 gene|CD80,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CD80 gene|CD80 Malignant neoplasm of breast
AFFECTS,Protein Precursors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Protein Precursors Malignant neoplasm of breast
AUGMENTS,ERBB2 gene|ERBB2,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,ERBB2 gene|ERBB2 Breast Carcinoma
AFFECTS,TAZ gene|TAZ,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TAZ gene|TAZ Malignant neoplasm of breast
AFFECTS,Cancer cachexia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Cancer cachexia Malignant neoplasm of breast
AFFECTS,disease stage,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,disease stage Malignant neoplasm of breast
AFFECTS,BCAR3 gene|BCAR3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BCAR3 gene|BCAR3 Malignant neoplasm of breast
AFFECTS,genetic locus,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,genetic locus Malignant neoplasm of breast
CAUSES,CDKN2A gene|CDKN2A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CDKN2A gene|CDKN2A Malignant neoplasm of breast
AFFECTS,AR gene|AR,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,AR gene|AR Breast cancer metastatic
AUGMENTS,FGFR2 gene|FGFR2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FGFR2 gene|FGFR2 Malignant neoplasm of breast
PREDISPOSES,KLK10 gene|KLK10,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,KLK10 gene|KLK10 Malignant neoplasm of breast
AFFECTS,Oncogene Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Oncogene Proteins Malignant neoplasm of breast
PREDISPOSES,MLL gene|KMT2A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MLL gene|KMT2A Malignant neoplasm of breast
PREDISPOSES,CDH1 gene|CDH1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CDH1 gene|CDH1 Malignant neoplasm of breast
AUGMENTS,Antineoplastic Agents,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Antineoplastic Agents Breast Carcinoma
AFFECTS,TP53 gene|TP53,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,TP53 gene|TP53 Breast Carcinoma
PREDISPOSES,"TNF protein, human|TNF",Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein","TNF protein, human|TNF Breast Carcinoma"
AFFECTS,Mutation,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Mutation Breast Carcinoma
AFFECTS,Lipids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Lipid,Lipids Malignant neoplasm of breast
CAUSES,Epidermal Growth Factor Receptor|EGFR,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Biologically Active Substance,Epidermal Growth Factor Receptor|EGFR Ductal Breast Carcinoma
AFFECTS,Dissection,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Element, Ion, or Isotope",Dissection Breast cancer invasive NOS
PREDISPOSES,Hexachlorobenzene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hazardous or Poisonous Substance,Hexachlorobenzene Malignant neoplasm of breast
AFFECTS,receptor expression,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",receptor expression Malignant neoplasm of breast
PREDISPOSES,Generalized obesity,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Generalized obesity Malignant neoplasm of breast
PREDISPOSES,Malignant disease,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Malignant disease Malignant neoplasm of breast
DISRUPTS,Aromatase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Enzyme,Aromatase Malignant neoplasm of breast
DISRUPTS,Tamoxifen,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Pharmacologic Substance,Tamoxifen Breast cancer recurrent
PREDISPOSES,Mitogen-Activated Protein Kinases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Mitogen-Activated Protein Kinases Malignant neoplasm of breast
PREDISPOSES,DDT (Insecticide),Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,Invertebrate,DDT (Insecticide) Female Breast Carcinoma
PREDISPOSES,Medication use,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,Medication use Malignant neoplasm of breast
PREDISPOSES,Composition,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Element, Ion, or Isotope",Composition Breast cancer recurrent
PREDISPOSES,Depressive disorder,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Depressive disorder Malignant neoplasm of breast
DISRUPTS,SYK gene|SYK,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SYK gene|SYK Malignant neoplasm of breast
CAUSES,Acids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Acids Malignant neoplasm of breast
PREDISPOSES,DHFR gene|DHFR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,DHFR gene|DHFR Malignant neoplasm of breast
DISRUPTS,Genes,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Gene or Genome,Genes Inflammatory Breast Carcinoma
DISRUPTS,IGF1 gene|IGF1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IGF1 gene|IGF1 Malignant neoplasm of breast
PREDISPOSES,"TRIM25 protein, human|TRIM25",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","TRIM25 protein, human|TRIM25 Malignant neoplasm of breast"
PREDISPOSES,Maternal status,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Maternal status Malignant neoplasm of breast
PREDISPOSES,Vascular Endothelial Growth Factor Receptor-1|FLT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Vascular Endothelial Growth Factor Receptor-1|FLT1 Malignant neoplasm of breast
PREDISPOSES,IRS2 gene|IRS2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IRS2 gene|IRS2 Malignant neoplasm of breast
AFFECTS,Fine needle aspiration biopsy,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,"Element, Ion, or Isotope",Fine needle aspiration biopsy Carcinoma of Male Breast
PREDISPOSES,ERBB2 gene|ERBB2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,ERBB2 gene|ERBB2 Breast cancer metastatic
CAUSES,Soy Foods,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Soy Foods Malignant neoplasm of breast
AUGMENTS,MTHFR gene|MTHFR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MTHFR gene|MTHFR Malignant neoplasm of breast
PREDISPOSES,CD40 gene|CD40,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Gene or Genome,CD40 gene|CD40 Sporadic Breast Carcinoma
PREDISPOSES,Acquired Immunodeficiency Syndrome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Acquired Immunodeficiency Syndrome Malignant neoplasm of breast
PREDISPOSES,KISS1 gene|KISS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,KISS1 gene|KISS1 Malignant neoplasm of breast
AUGMENTS,CCNE1 gene|CCNE1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CCNE1 gene|CCNE1 Malignant neoplasm of breast
PREDISPOSES,Tumor Suppressor Genes,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Gene or Genome,Tumor Suppressor Genes Carcinoma of Male Breast
CAUSES,Progesterone,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Hormone,Progesterone Breast Carcinoma
PREDISPOSES,MIRN27A gene|MIR27A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIRN27A gene|MIR27A Malignant neoplasm of breast
AFFECTS,Aberrant DNA Methylation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Aberrant DNA Methylation Malignant neoplasm of breast
AFFECTS,aldehyde dehydrogenases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",aldehyde dehydrogenases Malignant neoplasm of breast
AUGMENTS,"ribosomal protein S6 kinase, 70kD, polypeptide 2|RPS6KB2",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","ribosomal protein S6 kinase, 70kD, polypeptide 2|RPS6KB2 Malignant neoplasm of breast"
AUGMENTS,S100A9 gene|S100A9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,S100A9 gene|S100A9 Malignant neoplasm of breast
AFFECTS,XRCC3 gene|XRCC3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,XRCC3 gene|XRCC3 Malignant neoplasm of breast
PREDISPOSES,Speech reception threshold,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Speech reception threshold Malignant neoplasm of breast
AFFECTS,SOD2 gene|SOD2,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Gene or Genome,SOD2 gene|SOD2 Breast cancer recurrent
AFFECTS,Metaplastic Breast Carcinoma,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Neoplastic Process,"Metaplastic Breast Carcinoma Carcinoma, Ductal, Breast"
PREDISPOSES,Testosterone,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Hormone,Testosterone Breast cancer invasive NOS
AFFECTS,Squamous cell carcinoma,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Squamous cell carcinoma Breast Carcinoma
AFFECTS,Functional disorder,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Functional disorder Malignant neoplasm of breast
AFFECTS,"Biological function, NOS",Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope","Biological function, NOS Breast cancer metastatic"
PREDISPOSES,"Receptors, Progesterone|PGR",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,"Receptors, Progesterone|PGR Malignant neoplasm of breast"
AFFECTS,SMARCE1 gene|SMARCE1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,SMARCE1 gene|SMARCE1 Breast cancer metastatic
AUGMENTS,PTEN gene|PTEN,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Gene or Genome,"PTEN gene|PTEN Carcinoma, Ductal, Breast"
PREDISPOSES,GSTT1 protein|SLC25A4|CD5|IL1RL1|TRAPPC9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",GSTT1 protein|SLC25A4|CD5|IL1RL1|TRAPPC9 Malignant neoplasm of breast
PREDISPOSES,GSTT1 protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",GSTT1 protein Malignant neoplasm of breast
AFFECTS,Microinvasive carcinoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Microinvasive carcinoma Malignant neoplasm of breast
DISRUPTS,Pharmaceutical Preparations,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Pharmacologic Substance,Pharmaceutical Preparations Breast cancer recurrent
AFFECTS,Cell fusion,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Cell fusion Malignant neoplasm of breast
AFFECTS,Invasive Malignant Neoplasm,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Invasive Malignant Neoplasm Malignant neoplasm of breast
AFFECTS,MMP9 gene|MMP9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MMP9 gene|MMP9 Malignant neoplasm of breast
AFFECTS,trastuzumab,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Pharmacologic Substance,trastuzumab Noninfiltrating Intraductal Carcinoma
PREDISPOSES,PGR gene|PGR,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,PGR gene|PGR Breast Carcinoma
PREDISPOSES,Rare Diseases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Rare Diseases Malignant neoplasm of breast
AFFECTS,PGRMC1 gene|PGRMC1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PGRMC1 gene|PGRMC1 Malignant neoplasm of breast
AFFECTS,Supplementation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Supplementation Malignant neoplasm of breast
PREDISPOSES,Alcohol consumption,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Element, Ion, or Isotope",Alcohol consumption Breast cancer recurrent
PREDISPOSES,RNASEL,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",RNASEL Malignant neoplasm of breast
AUGMENTS,"Metals, Heavy",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Metals, Heavy Malignant neoplasm of breast"
CAUSES,Carcinogens,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Hazardous or Poisonous Substance,Carcinogens Breast cancer metastatic
AFFECTS,MIRN223 gene|MIR223,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIRN223 gene|MIR223 Malignant neoplasm of breast
AFFECTS,TERT gene|TERT,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,TERT gene|TERT Breast Carcinoma
PREDISPOSES,Prophylactic immunotherapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Immunologic Factor,Prophylactic immunotherapy Malignant neoplasm of breast
AFFECTS,TP53 gene|TP53,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Gene or Genome,TP53 gene|TP53 Sporadic Breast Carcinoma
CAUSES,RNA I,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",RNA I Malignant neoplasm of breast
AFFECTS,HTATIP2 gene|HTATIP2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HTATIP2 gene|HTATIP2 Malignant neoplasm of breast
PREDISPOSES,IL10 gene|IL10,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IL10 gene|IL10 Malignant neoplasm of breast
PREDISPOSES,cyclooxygenase 2|XK,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",cyclooxygenase 2|XK Malignant neoplasm of breast
DISRUPTS,S-Adenosylmethionine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",S-Adenosylmethionine Malignant neoplasm of breast
PREDISPOSES,LUM gene|LUM,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LUM gene|LUM Malignant neoplasm of breast
COMPLICATES,Extravasation of lymph,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Extravasation of lymph Malignant neoplasm of breast
AFFECTS,CAV1 gene|CAV1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CAV1 gene|CAV1 Malignant neoplasm of breast
CAUSES,PRKDC gene|PRKDC,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PRKDC gene|PRKDC Malignant neoplasm of breast
PREDISPOSES,ABCB1 gene|ABCB1,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,ABCB1 gene|ABCB1 Breast Carcinoma
PREDISPOSES,BAX gene|BAX,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BAX gene|BAX Malignant neoplasm of breast
PREDISPOSES,MIRN21 gene|MIR21,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIRN21 gene|MIR21 Malignant neoplasm of breast
AFFECTS,Cyclooxygenase Inhibitors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Cyclooxygenase Inhibitors Malignant neoplasm of breast
PREDISPOSES,Alcohol interaction,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Alcohol interaction Malignant neoplasm of breast
AFFECTS,"Angiography, Digital Subtraction",Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope","Angiography, Digital Subtraction Noninfiltrating Intraductal Carcinoma"
AFFECTS,CDK2AP1 gene|CDK2AP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CDK2AP1 gene|CDK2AP1 Malignant neoplasm of breast
PREDISPOSES,CD28 gene|CD28,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Gene or Genome,CD28 gene|CD28 Sporadic Breast Carcinoma
PREDISPOSES,Disease Outcome,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Disease or Syndrome,"Disease Outcome Carcinoma, Ductal, Breast"
PREDISPOSES,Primary tumor size,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Primary tumor size Malignant neoplasm of breast
AUGMENTS,Genes,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Gene or Genome,"Genes Carcinoma, Ductal, Breast"
AFFECTS,S100A9 gene|S100A9,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Gene or Genome,S100A9 gene|S100A9 Inflammatory Breast Carcinoma
AFFECTS,breast cancer prevention,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,breast cancer prevention Malignant neoplasm of breast
AFFECTS,TNFRSF1B gene|TNFRSF1B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TNFRSF1B gene|TNFRSF1B Malignant neoplasm of breast
AFFECTS,Inflammatory Breast Carcinoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Inflammatory Breast Carcinoma Malignant neoplasm of breast
DISRUPTS,Aromatase Inhibitors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Aromatase Inhibitors Malignant neoplasm of breast
AUGMENTS,SLC2A1 gene|SLC2A1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SLC2A1 gene|SLC2A1 Malignant neoplasm of breast
AFFECTS,Fertilization in Vitro,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Fertilization in Vitro Malignant neoplasm of breast
AFFECTS,"TERT protein, human|TERT",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","TERT protein, human|TERT Malignant neoplasm of breast"
AFFECTS,Conjugated Equine Estrogens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Conjugated Equine Estrogens Malignant neoplasm of breast
AUGMENTS,steroid sulfate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Steroid,steroid sulfate Malignant neoplasm of breast
AFFECTS,RNA Interference,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",RNA Interference Malignant neoplasm of breast
PREDISPOSES,glutathione S-transferase M1|CHRM1|MRLN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",glutathione S-transferase M1|CHRM1|MRLN Malignant neoplasm of breast
PREDISPOSES,Regional Disease,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Regional Disease Breast cancer metastatic
CAUSES,Total cholesterol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Lipid,Total cholesterol Malignant neoplasm of breast
DISRUPTS,Chlorogenic Acid,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Chemical,Chlorogenic Acid Breast cancer metastatic
PREDISPOSES,AANAT gene|AANAT,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,AANAT gene|AANAT Malignant neoplasm of breast
PREDISPOSES,CD2 gene|CD2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CD2 gene|CD2 Malignant neoplasm of breast
AUGMENTS,TIAM1 gene|TIAM1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TIAM1 gene|TIAM1 Malignant neoplasm of breast
AFFECTS,Examination of breast,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Examination of breast Malignant neoplasm of breast
AFFECTS,Detection,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,"Element, Ion, or Isotope",Detection Contralateral breast cancer
PREDISPOSES,CDKN1C gene|CDKN1C,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CDKN1C gene|CDKN1C Malignant neoplasm of breast
PREDISPOSES,Chemoprevention,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Chemoprevention Malignant neoplasm of breast
AFFECTS,Cosmic Radiation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Cosmic Radiation Malignant neoplasm of breast
AFFECTS,Peptide Hydrolases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Peptide Hydrolases Malignant neoplasm of breast
AFFECTS,zoledronic acid,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Chemical,zoledronic acid Breast cancer metastatic
DISRUPTS,DMBT1 gene|DMBT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,DMBT1 gene|DMBT1 Malignant neoplasm of breast
AFFECTS,Female Breast Carcinoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Female Breast Carcinoma Malignant neoplasm of breast
AUGMENTS,ABCG2 gene|ABCG2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ABCG2 gene|ABCG2 Malignant neoplasm of breast
AFFECTS,Adaptation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Adaptation Malignant neoplasm of breast
DISRUPTS,IGF1R gene|IGF1R,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IGF1R gene|IGF1R Malignant neoplasm of breast
AFFECTS,Adenocarcinoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Adenocarcinoma Malignant neoplasm of breast
AFFECTS,AR gene|AR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,AR gene|AR Malignant neoplasm of breast
AFFECTS,Paget's Disease,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Disease or Syndrome,"Paget's Disease Carcinoma, Ductal, Breast"
AFFECTS,MIRN107 gene|MIR107,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIRN107 gene|MIR107 Malignant neoplasm of breast
AFFECTS,Malignant neoplasm of breast,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Neoplastic Process,Malignant neoplasm of breast Breast cancer recurrent
AFFECTS,Thioctic Acid,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Chemical,Thioctic Acid Breast cancer metastatic
PREDISPOSES,Regulatory Protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Regulatory Protein Malignant neoplasm of breast
PREDISPOSES,"ESR1 protein, human|ESR1",Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein","ESR1 protein, human|ESR1 Breast Carcinoma"
DISRUPTS,"FRAP1 protein, human|MTOR",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","FRAP1 protein, human|MTOR Malignant neoplasm of breast"
CAUSES,tumor growth,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,tumor growth Malignant neoplasm of breast
PREDISPOSES,autoimmune thyroid disease,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,autoimmune thyroid disease Malignant neoplasm of breast
AUGMENTS,Proto-Oncogenes|PGR|PR@|PRH2|TMEM37|ERVK-7|ERVK-8|ERVK-10|ERVK-9|ERVK-21|ERVK-18|ERVK-25|ERVK-24|ERVK-19,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Gene or Genome,Proto-Oncogenes|PGR|PR@|PRH2|TMEM37|ERVK-7|ERVK-8|ERVK-10|ERVK-9|ERVK-21|ERVK-18|ERVK-25|ERVK-24|ERVK-19 Breast cancer invasive NOS
CAUSES,Tumor necrosis factor receptor 11b,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Tumor necrosis factor receptor 11b Malignant neoplasm of breast
PREDISPOSES,Thymine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Thymine Malignant neoplasm of breast
PREDISPOSES,Tumor Markers,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Tumor Markers Breast cancer metastatic
PREDISPOSES,KRT19 gene|KRT19,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Gene or Genome,KRT19 gene|KRT19 Breast cancer invasive NOS
AFFECTS,Radiation therapy,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",Radiation therapy Noninfiltrating Intraductal Carcinoma
AFFECTS,"Receptors, Progesterone|EREG|ESR1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,"Receptors, Progesterone|EREG|ESR1 Malignant neoplasm of breast"
CAUSES,Latent Virus,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Virus,Latent Virus Malignant neoplasm of breast
CAUSES,Malignant neoplasm of breast,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Malignant neoplasm of breast Breast Carcinoma
PREDISPOSES,Folic Acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Folic Acid Malignant neoplasm of breast
PREDISPOSES,Steroid hormone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Steroid hormone Malignant neoplasm of breast
AFFECTS,EVI1 gene|RUNX1|MECOM,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,EVI1 gene|RUNX1|MECOM Malignant neoplasm of breast
PREDISPOSES,Periodontal Diseases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Periodontal Diseases Malignant neoplasm of breast
AUGMENTS,"Receptors, Progesterone|EREG|ESR1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,"Receptors, Progesterone|EREG|ESR1 Malignant neoplasm of breast"
PREDISPOSES,K-ras Oncogene|KRAS,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Gene or Genome,"K-ras Oncogene|KRAS Carcinoma, Ductal, Breast"
AFFECTS,Induction,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Induction Breast cancer metastatic
AFFECTS,Little's Disease,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Little's Disease Malignant neoplasm of breast
PREDISPOSES,Estrogen receptor negative,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen receptor negative Malignant neoplasm of breast
PREDISPOSES,Fatty acid glycerol esters,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Fatty acid glycerol esters Malignant neoplasm of breast
PREDISPOSES,Infiltration,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",Infiltration Noninfiltrating Intraductal Carcinoma
AFFECTS,Small Inducible Cytokine A18|CCL18,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Small Inducible Cytokine A18|CCL18 Malignant neoplasm of breast
AUGMENTS,Antisense RNA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Antisense RNA Malignant neoplasm of breast
AUGMENTS,"Antigens, Fos-Related|FOS",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Immunologic Factor,"Antigens, Fos-Related|FOS Malignant neoplasm of breast"
PREDISPOSES,RFP2 gene|TRIM13,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RFP2 gene|TRIM13 Malignant neoplasm of breast
PREDISPOSES,Green Fluorescent Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Green Fluorescent Proteins Malignant neoplasm of breast
PREDISPOSES,FSIP1 gene|FSIP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FSIP1 gene|FSIP1 Malignant neoplasm of breast
PREDISPOSES,Steroid 17-alpha-monooxygenase|CYP17A1,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,"Element, Ion, or Isotope",Steroid 17-alpha-monooxygenase|CYP17A1 Carcinoma of Male Breast
PREDISPOSES,Estrogen receptor positive,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen receptor positive Breast cancer recurrent
AFFECTS,Malignant neoplasm of lung,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Malignant neoplasm of lung Malignant neoplasm of breast
PREDISPOSES,Chronic inflammation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Chronic inflammation Malignant neoplasm of breast
AFFECTS,UBE2D2 gene|UBE2D2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,UBE2D2 gene|UBE2D2 Malignant neoplasm of breast
CAUSES,TGFB1 gene|TGFB1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TGFB1 gene|TGFB1 Malignant neoplasm of breast
PREDISPOSES,CYP24A1 gene|CYP24A1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CYP24A1 gene|CYP24A1 Malignant neoplasm of breast
PREDISPOSES,Red Meat Consumption,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Element, Ion, or Isotope",Red Meat Consumption Breast cancer invasive NOS
PREDISPOSES,E2F1 gene|E2F1|UBE2L3,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,E2F1 gene|E2F1|UBE2L3 Breast cancer metastatic
PREDISPOSES,"Estrogens, Conjugated (USP)",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,"Estrogens, Conjugated (USP) Malignant neoplasm of breast"
PREDISPOSES,Matrix Metalloproteinases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Matrix Metalloproteinases Malignant neoplasm of breast
PREDISPOSES,CUL5 gene|CUL5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CUL5 gene|CUL5 Malignant neoplasm of breast
AFFECTS,Apocrine adenocarcinoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Apocrine adenocarcinoma Malignant neoplasm of breast
AUGMENTS,FOSL1 gene|FOSL1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FOSL1 gene|FOSL1 Malignant neoplasm of breast
PREDISPOSES,Ribosomal RNA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Ribosomal RNA Malignant neoplasm of breast
DISRUPTS,betulinic acid,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Chemical,betulinic acid Breast cancer metastatic
DISRUPTS,11-beta-Hydroxysteroid Dehydrogenase Type 2|HSD11B2|RNU1-4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",11-beta-Hydroxysteroid Dehydrogenase Type 2|HSD11B2|RNU1-4 Malignant neoplasm of breast
AFFECTS,Implantation procedure,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Implantation procedure Malignant neoplasm of breast
PREDISPOSES,Polycystic Ovary Syndrome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Polycystic Ovary Syndrome Malignant neoplasm of breast
CAUSES,GTPase-Activating Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",GTPase-Activating Proteins Malignant neoplasm of breast
DISRUPTS,ATP8A2 gene|ATP8A2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,ATP8A2 gene|ATP8A2 Breast cancer metastatic
CAUSES,Aromatase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Enzyme,Aromatase Malignant neoplasm of breast
AUGMENTS,estrogens,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Hormone,estrogens estrogen receptor-positive breast cancer
AFFECTS,GTPase-Activating Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",GTPase-Activating Proteins Malignant neoplasm of breast
AFFECTS,Tumor-Associated Process,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Tumor-Associated Process Malignant neoplasm of breast
AFFECTS,"CD69 protein, human|CD69",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CD69 protein, human|CD69 Triple Negative Breast Neoplasms"
COMPLICATES,Hepatolenticular Degeneration,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Hepatolenticular Degeneration Malignant neoplasm of breast
AUGMENTS,LHX1 gene|LHX1,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Gene or Genome,LHX1 gene|LHX1 Breast cancer invasive NOS
AUGMENTS,MIR195 gene|MIR195,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIR195 gene|MIR195 Malignant neoplasm of breast
PREDISPOSES,UGT2B7 gene|UGT2B7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,UGT2B7 gene|UGT2B7 Malignant neoplasm of breast
AUGMENTS,LINC02657 gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LINC02657 gene Malignant neoplasm of breast
AUGMENTS,ZEB1-AS1 gene|ZEB1-AS1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,ZEB1-AS1 gene|ZEB1-AS1 Triple Negative Breast Neoplasms
CAUSES,Substance with phenol structure,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Substance,Substance with phenol structure Malignant neoplasm of breast
AUGMENTS,"TFF1 protein, human|TFF1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","TFF1 protein, human|TFF1 Malignant neoplasm of breast"
PREDISPOSES,SETD3 gene|SETD3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SETD3 gene|SETD3 Malignant neoplasm of breast
CAUSES,GADD45A gene|GADD45A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GADD45A gene|GADD45A Malignant neoplasm of breast
DISRUPTS,LSR gene|LSR,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,LSR gene|LSR Triple Negative Breast Neoplasms
AFFECTS,27-hydroxycholesterol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Lipid,27-hydroxycholesterol Malignant neoplasm of breast
CAUSES,H19 gene|H19|HILS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,H19 gene|H19|HILS1 Malignant neoplasm of breast
PREDISPOSES,Accumulation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Accumulation Malignant neoplasm of breast
PREDISPOSES,Radiopharmaceuticals,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,Radiopharmaceuticals Malignant neoplasm of breast
CAUSES,DNA Minor Groove Binding Agent,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",DNA Minor Groove Binding Agent Malignant neoplasm of breast
CAUSES,Sex Hormone-Binding Globulin,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Hormone,Sex Hormone-Binding Globulin Invasive carcinoma of breast
AFFECTS,GSTT1 gene|GSTT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GSTT1 gene|GSTT1 Malignant neoplasm of breast
AUGMENTS,mullerian-inhibiting hormone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,mullerian-inhibiting hormone Malignant neoplasm of breast
PREDISPOSES,NOP2 gene|NOP2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NOP2 gene|NOP2 Malignant neoplasm of breast
AUGMENTS,E2F3 gene|E2F3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,E2F3 gene|E2F3 Malignant neoplasm of breast
AFFECTS,gamma-linolenic acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,gamma-linolenic acid Malignant neoplasm of breast
PREDISPOSES,PLSCR1 gene|PLSCR1,Basal-Like Breast Carcinoma,0.0039960039960039,Female Breast Cancer,Gene or Genome,PLSCR1 gene|PLSCR1 Basal-Like Breast Carcinoma
AFFECTS,glutathione S-transferase pi|GSTP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",glutathione S-transferase pi|GSTP1 Malignant neoplasm of breast
DISRUPTS,MIR454 gene|MIR454,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,MIR454 gene|MIR454 Triple Negative Breast Neoplasms
AFFECTS,Basaloid squamous cell carcinoma,Basal-Like Breast Carcinoma,0.0039960039960039,Female Breast Cancer,Neoplastic Process,Basaloid squamous cell carcinoma Basal-Like Breast Carcinoma
PREDISPOSES,apolipoprotein D|APOD,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",apolipoprotein D|APOD Breast Carcinoma
AFFECTS,TXNIP gene|TXNIP,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,TXNIP gene|TXNIP Triple Negative Breast Neoplasms
PREDISPOSES,"EIF2C2 protein, human|AGO2",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","EIF2C2 protein, human|AGO2 Malignant neoplasm of breast"
AUGMENTS,S100A14 gene|S100A14,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,S100A14 gene|S100A14 Malignant neoplasm of breast
CAUSES,LINC00261 gene|LINC00261,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LINC00261 gene|LINC00261 Malignant neoplasm of breast
DISRUPTS,Methyl-CpG-Binding Protein 2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Methyl-CpG-Binding Protein 2 Malignant neoplasm of breast
AFFECTS,CTHRC1 gene|CTHRC1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CTHRC1 gene|CTHRC1 Malignant neoplasm of breast
AFFECTS,"POU5F1 protein, human|POU5F1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","POU5F1 protein, human|POU5F1 Malignant neoplasm of breast"
PREDISPOSES,MIR622 gene|MIR622,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,MIR622 gene|MIR622 Breast Carcinoma
AFFECTS,TFEB gene|TFEB,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TFEB gene|TFEB Malignant neoplasm of breast
PREDISPOSES,Aromatase,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Enzyme,Aromatase estrogen receptor-positive breast cancer
AFFECTS,RB1CC1 gene|RB1CC1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RB1CC1 gene|RB1CC1 Malignant neoplasm of breast
AFFECTS,aggressive cancer,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Neoplastic Process,aggressive cancer Triple Negative Breast Neoplasms
PREDISPOSES,LOXL4 gene|LOXL4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LOXL4 gene|LOXL4 Malignant neoplasm of breast
AUGMENTS,"RNA, Messenger",Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","RNA, Messenger Inflammatory Breast Carcinoma"
PREDISPOSES,MIR145 gene|MIR145,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIR145 gene|MIR145 Malignant neoplasm of breast
DISRUPTS,HOPX gene|HOPX,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HOPX gene|HOPX Malignant neoplasm of breast
AFFECTS,TMED3 gene|TMED3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TMED3 gene|TMED3 Malignant neoplasm of breast
PREDISPOSES,GPC1 gene|GPC1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GPC1 gene|GPC1 Malignant neoplasm of breast
CAUSES,RNA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",RNA Malignant neoplasm of breast
AFFECTS,Malignant neoplasm of breast,malignant neoplasm of breast staging,0.0,Female Breast Cancer,Neoplastic Process,Malignant neoplasm of breast malignant neoplasm of breast staging
AFFECTS,NEAT1 gene|NEAT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NEAT1 gene|NEAT1 Malignant neoplasm of breast
AFFECTS,Negative Regulation of S Phase,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Negative Regulation of S Phase Triple Negative Breast Neoplasms
PREDISPOSES,SALL4 gene|SALL4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SALL4 gene|SALL4 Malignant neoplasm of breast
AFFECTS,Immunoregulation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Immunoregulation Malignant neoplasm of breast
CAUSES,IL31 gene|IL31,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,IL31 gene|IL31 Breast Carcinoma
AUGMENTS,fos-related antigen 1|FOS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Immunologic Factor,fos-related antigen 1|FOS Malignant neoplasm of breast
PREDISPOSES,SAMD4A gene|SAMD4A,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,SAMD4A gene|SAMD4A Triple Negative Breast Neoplasms
CAUSES,LINC-ROR gene|LINC-ROR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LINC-ROR gene|LINC-ROR Malignant neoplasm of breast
AFFECTS,Treatment modification,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Treatment modification Malignant neoplasm of breast
PREDISPOSES,SMAD7 gene|SMAD7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SMAD7 gene|SMAD7 Malignant neoplasm of breast
CAUSES,Residual Tumor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Residual Tumor Malignant neoplasm of breast
PREDISPOSES,Low Density Lipoprotein Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Low Density Lipoprotein Receptor Malignant neoplasm of breast
AFFECTS,UGT1A1 gene|UGT1A1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,UGT1A1 gene|UGT1A1 Triple Negative Breast Neoplasms
PREDISPOSES,SKA3 gene|SKA3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SKA3 gene|SKA3 Malignant neoplasm of breast
AFFECTS,Nucleotides,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Nucleotides Malignant neoplasm of breast
PREDISPOSES,HOMER1 gene|HOMER1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HOMER1 gene|HOMER1 Malignant neoplasm of breast
PREDISPOSES,Blood Proteins,malignant neoplasm of breast staging,0.0,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Blood Proteins malignant neoplasm of breast staging
AFFECTS,Hypomethylation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Hypomethylation Malignant neoplasm of breast
AFFECTS,cytokine,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Biologically Active Substance,cytokine Invasive carcinoma of breast
PREDISPOSES,HOTAIR gene|HOTAIR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HOTAIR gene|HOTAIR Malignant neoplasm of breast
CAUSES,fructose,Carcinoma breast stage IV,0.0,Female Breast Cancer,Carbohydrate,fructose Carcinoma breast stage IV
PREDISPOSES,CYFIP1 gene|CYFIP1,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Gene or Genome,CYFIP1 gene|CYFIP1 Sporadic Breast Carcinoma
AFFECTS,HER2-negative breast cancer,Carcinoma breast stage IV,0.0,Female Breast Cancer,"Amino Acid, Peptide, or Protein",HER2-negative breast cancer Carcinoma breast stage IV
AFFECTS,"GPER protein, human|GPER1",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein","GPER protein, human|GPER1 Triple Negative Breast Neoplasms"
AFFECTS,Deubiquitinating Enzymes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Enzyme,Deubiquitinating Enzymes Malignant neoplasm of breast
DISRUPTS,"CRYAB protein, human|CRYAB",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CRYAB protein, human|CRYAB Malignant neoplasm of breast"
AUGMENTS,"YAP1 protein, human|YAP1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","YAP1 protein, human|YAP1 Malignant neoplasm of breast"
AUGMENTS,DSCC1 gene|DSCC1,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,DSCC1 gene|DSCC1 Breast Carcinoma
DISRUPTS,ZEB1 gene|ZEB1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ZEB1 gene|ZEB1 Malignant neoplasm of breast
AFFECTS,Cyclin-Dependent Kinase Inhibitor Proteins,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Cyclin-Dependent Kinase Inhibitor Proteins HER2-positive carcinoma of breast
AUGMENTS,ATXN8OS gene|ATXN8OS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ATXN8OS gene|ATXN8OS Malignant neoplasm of breast
PREDISPOSES,CHPF gene|CHPF,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,CHPF gene|CHPF Breast Carcinoma
AFFECTS,palbociclib,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Pharmacologic Substance,palbociclib Triple Negative Breast Neoplasms
AFFECTS,epithelial to mesenchymal transition,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",epithelial to mesenchymal transition Breast Carcinoma
AUGMENTS,SLC12A8 gene|SLC12A8,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,SLC12A8 gene|SLC12A8 Breast Carcinoma
AFFECTS,thioguanine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",thioguanine Malignant neoplasm of breast
PREDISPOSES,"Receptor, Transforming Growth Factor-beta Type I|TGFBR1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,"Receptor, Transforming Growth Factor-beta Type I|TGFBR1 Malignant neoplasm of breast"
PREDISPOSES,cadmium,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Inorganic Chemical,cadmium Malignant neoplasm of breast
CAUSES,Binding Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Binding Proteins Malignant neoplasm of breast
PREDISPOSES,GOLPH3L gene|GOLPH3L,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GOLPH3L gene|GOLPH3L Malignant neoplasm of breast
DISRUPTS,Cystathionine beta-Synthase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Cystathionine beta-Synthase Malignant neoplasm of breast
AUGMENTS,Genes,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Gene or Genome,Genes Inflammatory Breast Carcinoma
PREDISPOSES,KIF15 gene|KIF15,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,KIF15 gene|KIF15 Triple Negative Breast Neoplasms
AUGMENTS,KIF3B gene|KIF3B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,KIF3B gene|KIF3B Malignant neoplasm of breast
AUGMENTS,DNA Methyltransferase Inhibitor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",DNA Methyltransferase Inhibitor Malignant neoplasm of breast
CAUSES,letrozole,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,letrozole Malignant neoplasm of breast
AFFECTS,Agent,Carcinoma breast stage IV,0.0,Female Breast Cancer,Chemical Viewed Functionally,Agent Carcinoma breast stage IV
AFFECTS,mitogen-activated protein kinase kinase kinase 11,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",mitogen-activated protein kinase kinase kinase 11 Malignant neoplasm of breast
DISRUPTS,KIF3B gene|KIF3B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,KIF3B gene|KIF3B Malignant neoplasm of breast
AUGMENTS,Squalene monooxygenase,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",Squalene monooxygenase Noninfiltrating Intraductal Carcinoma
AUGMENTS,Transforming Growth Factor beta,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Biologically Active Substance,Transforming Growth Factor beta Triple Negative Breast Neoplasms
AFFECTS,Hormone Receptor Positive Breast Carcinoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Hormone Receptor Positive Breast Carcinoma Malignant neoplasm of breast
AFFECTS,"ABCG2 protein, human|ABCG2",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","ABCG2 protein, human|ABCG2 Malignant neoplasm of breast"
PREDISPOSES,Genes,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Gene or Genome,Genes HER2-positive carcinoma of breast
DISRUPTS,ITM2A gene|ITM2A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ITM2A gene|ITM2A Malignant neoplasm of breast
CAUSES,TOX3 gene|TOX3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TOX3 gene|TOX3 Malignant neoplasm of breast
DISRUPTS,MIR22 gene|MIR22,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIR22 gene|MIR22 Malignant neoplasm of breast
DISRUPTS,LINC-ROR gene|LINC-ROR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LINC-ROR gene|LINC-ROR Malignant neoplasm of breast
PREDISPOSES,Alcohol consumption,Recurrent Breast Carcinoma,0.0009990009990009,Recurrent Breast Cancer,"Element, Ion, or Isotope",Alcohol consumption Recurrent Breast Carcinoma
PREDISPOSES,SHISA3 gene|SHISA3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SHISA3 gene|SHISA3 Malignant neoplasm of breast
PREDISPOSES,GSEC gene|GSEC,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,GSEC gene|GSEC Triple Negative Breast Neoplasms
DISRUPTS,ST7-AS1 gene|ST7-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ST7-AS1 gene|ST7-AS1 Malignant neoplasm of breast
AFFECTS,KIAA1109 gene|KIAA1109,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,Gene or Genome,KIAA1109 gene|KIAA1109 Female Breast Carcinoma
PREDISPOSES,ACTL8 gene|ACTL8,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,ACTL8 gene|ACTL8 Triple Negative Breast Neoplasms
AFFECTS,Stimulation procedure,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Stimulation procedure Malignant neoplasm of breast
PREDISPOSES,Epidermal Growth Factor Receptor,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Biologically Active Substance,Epidermal Growth Factor Receptor Triple Negative Breast Neoplasms
AUGMENTS,"RNA, Small Untranslated",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","RNA, Small Untranslated Triple Negative Breast Neoplasms"
AUGMENTS,LGMN gene|LGMN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LGMN gene|LGMN Malignant neoplasm of breast
AFFECTS,SLAMF7 gene|SLAMF7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SLAMF7 gene|SLAMF7 Malignant neoplasm of breast
AUGMENTS,calcium ion,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",calcium ion Malignant neoplasm of breast
PREDISPOSES,Fatty-acid synthase,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Chemical,Fatty-acid synthase Triple Negative Breast Neoplasms
AUGMENTS,SRSF1 gene|SRSF1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,SRSF1 gene|SRSF1 Triple Negative Breast Neoplasms
DISRUPTS,PVR gene|PVR,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,PVR gene|PVR Triple Negative Breast Neoplasms
AUGMENTS,"CD274 protein, human|CD274",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CD274 protein, human|CD274 Malignant neoplasm of breast"
PREDISPOSES,E-Box Elements,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",E-Box Elements Malignant neoplasm of breast
CAUSES,Long Intergenic Non-Protein Coding RNA,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Long Intergenic Non-Protein Coding RNA Triple Negative Breast Neoplasms
AFFECTS,FBXO5 gene|FBXO5,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,FBXO5 gene|FBXO5 Breast Carcinoma
AFFECTS,SRSF1 gene|SRSF1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,SRSF1 gene|SRSF1 Triple Negative Breast Neoplasms
AUGMENTS,CEP55 gene|CEP55,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,CEP55 gene|CEP55 Triple Negative Breast Neoplasms
AFFECTS,Crotoxin,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Chemical,Crotoxin estrogen receptor-positive breast cancer
AFFECTS,Antigen Processing,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Immunologic Factor,Antigen Processing Malignant neoplasm of breast
AFFECTS,DPP4 gene|DPP4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,DPP4 gene|DPP4 Malignant neoplasm of breast
COMPLICATES,Portal Hypertension,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Portal Hypertension Malignant neoplasm of breast
PREDISPOSES,MIR526B gene|MIR526B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIR526B gene|MIR526B Malignant neoplasm of breast
AFFECTS,Biological Processes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Phenomenon or Process,Biological Processes Malignant neoplasm of breast
PREDISPOSES,Heparin Binding Growth Factor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Heparin Binding Growth Factor Malignant neoplasm of breast
PREDISPOSES,EN1 gene|EN1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,EN1 gene|EN1 Malignant neoplasm of breast
AFFECTS,Microcalcification,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Microcalcification Malignant neoplasm of breast
PREDISPOSES,IFI30 gene|IFI30,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IFI30 gene|IFI30 Malignant neoplasm of breast
AFFECTS,EGR1 gene|EGR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,EGR1 gene|EGR1 Malignant neoplasm of breast
AFFECTS,DPP10 gene|DPP10,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,DPP10 gene|DPP10 Malignant neoplasm of breast
AUGMENTS,Glycosphingolipids,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Lipid,Glycosphingolipids Triple Negative Breast Neoplasms
AUGMENTS,ANLN gene|ANLN,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,ANLN gene|ANLN Triple Negative Breast Neoplasms
DISRUPTS,LINC01089 gene|LINC01089,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LINC01089 gene|LINC01089 Malignant neoplasm of breast
PREDISPOSES,SMUG1 gene|SMUG1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SMUG1 gene|SMUG1 Malignant neoplasm of breast
AFFECTS,RNA modification,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",RNA modification Malignant neoplasm of breast
AFFECTS,ataxia telangiectasia mutated protein|ATM,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",ataxia telangiectasia mutated protein|ATM Malignant neoplasm of breast
DISRUPTS,NOL10 gene|NOL10,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NOL10 gene|NOL10 Malignant neoplasm of breast
DISRUPTS,TMEM238L gene|TMEM238L,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TMEM238L gene|TMEM238L Malignant neoplasm of breast
AFFECTS,Drug Combinations,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,Drug Combinations Malignant neoplasm of breast
AUGMENTS,IMPACT gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IMPACT gene Malignant neoplasm of breast
PREDISPOSES,MIR155 gene|MIR155,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIR155 gene|MIR155 Malignant neoplasm of breast
PREDISPOSES,Monocyte Chemoattractant Protein-1,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,"Amino Acid, Peptide, or Protein",Monocyte Chemoattractant Protein-1 Carcinoma of Male Breast
AUGMENTS,TCOF1 gene|TCOF1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,TCOF1 gene|TCOF1 Triple Negative Breast Neoplasms
DISRUPTS,TBX15 gene|TBX15,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TBX15 gene|TBX15 Malignant neoplasm of breast
AFFECTS,MicroRNAs,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",MicroRNAs Noninfiltrating Intraductal Carcinoma
AFFECTS,disorder control (procedure),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,disorder control (procedure) Malignant neoplasm of breast
PREDISPOSES,H1-5 gene|HIST1H1B,Basal-Like Breast Carcinoma,0.0039960039960039,Female Breast Cancer,Gene or Genome,H1-5 gene|HIST1H1B Basal-Like Breast Carcinoma
AFFECTS,tRNA modification,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",tRNA modification Malignant neoplasm of breast
AFFECTS,BRCA1 Mutation,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,BRCA1 Mutation Breast cancer metastatic
DISRUPTS,MIR4521 gene|MIR4521,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIR4521 gene|MIR4521 Malignant neoplasm of breast
PREDISPOSES,lead,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Inorganic Chemical,lead Invasive carcinoma of breast
PREDISPOSES,Polyunsaturated fatty acid intake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Polyunsaturated fatty acid intake Malignant neoplasm of breast
PREDISPOSES,hyaluronic acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,hyaluronic acid Malignant neoplasm of breast
AUGMENTS,LIG1 gene|LIG1|LRIG1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LIG1 gene|LIG1|LRIG1 Malignant neoplasm of breast
PREDISPOSES,ARHGAP9 gene|ARHGAP9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ARHGAP9 gene|ARHGAP9 Malignant neoplasm of breast
AFFECTS,RPS6KA3 gene|RPS6KA3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RPS6KA3 gene|RPS6KA3 Malignant neoplasm of breast
AFFECTS,Matrix Metalloproteinase 11,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Matrix Metalloproteinase 11 HER2-positive carcinoma of breast
AUGMENTS,glucose,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Carbohydrate,glucose Malignant neoplasm of breast
AFFECTS,RTL8C gene|RTL8C,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RTL8C gene|RTL8C Malignant neoplasm of breast
PREDISPOSES,Genes,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,Genes Secondary malignant neoplasm of breast
DISRUPTS,JAM2 gene|JAM2|JAM3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,JAM2 gene|JAM2|JAM3 Malignant neoplasm of breast
PREDISPOSES,progesterone,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Hormone,progesterone Breast Carcinoma
DISRUPTS,SYVN1 gene|SYVN1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SYVN1 gene|SYVN1 Malignant neoplasm of breast
PREDISPOSES,Constitutive skin pigmentation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Constitutive skin pigmentation Malignant neoplasm of breast
PREDISPOSES,Genetic Profile,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Genetic Profile Malignant neoplasm of breast
DISRUPTS,Vitamin D3 Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Vitamin D3 Receptor Malignant neoplasm of breast
PREDISPOSES,MALAT1 gene|MALAT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MALAT1 gene|MALAT1 Malignant neoplasm of breast
DISRUPTS,FAM189A2 gene|FAM189A2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FAM189A2 gene|FAM189A2 Malignant neoplasm of breast
CAUSES,Lipoxygenase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Lipoxygenase Malignant neoplasm of breast
PREDISPOSES,VIRMA gene|VIRMA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,VIRMA gene|VIRMA Malignant neoplasm of breast
DISRUPTS,MRPS30-DT gene|MRPS30-DT,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,MRPS30-DT gene|MRPS30-DT Triple Negative Breast Neoplasms
CAUSES,SOX2 Transcription Factor|SOX2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",SOX2 Transcription Factor|SOX2 Malignant neoplasm of breast
DISRUPTS,HOXC-AS3 gene|HOXC-AS3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HOXC-AS3 gene|HOXC-AS3 Malignant neoplasm of breast
DISRUPTS,LPAR6 gene|LPAR6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LPAR6 gene|LPAR6 Malignant neoplasm of breast
CAUSES,Anti-Bacterial Agents,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical Viewed Functionally,Anti-Bacterial Agents Malignant neoplasm of breast
AFFECTS,"Injections, Intraperitoneal",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Injections, Intraperitoneal Malignant neoplasm of breast"
PREDISPOSES,EIF6 gene|EIF6,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,EIF6 gene|EIF6 Triple Negative Breast Neoplasms
CAUSES,ANKDD1A gene|ANKDD1A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ANKDD1A gene|ANKDD1A Malignant neoplasm of breast
DISRUPTS,MEOX2 gene|MEOX2,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,MEOX2 gene|MEOX2 Breast Carcinoma
PREDISPOSES,MIR660 gene|MIR660,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIR660 gene|MIR660 Malignant neoplasm of breast
AFFECTS,Malignant Neoplasms,Luminal B Breast Carcinoma,0.0,Female Breast Cancer,Neoplastic Process,Malignant Neoplasms Luminal B Breast Carcinoma
AUGMENTS,UHRF1 gene|UHRF1,Invasive Ductal Breast Carcinoma,0.0,Female Breast Cancer,Gene or Genome,UHRF1 gene|UHRF1 Invasive Ductal Breast Carcinoma
PREDISPOSES,mRNA Precursor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",mRNA Precursor Malignant neoplasm of breast
AUGMENTS,"IL22 protein, human|IL22",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","IL22 protein, human|IL22 Malignant neoplasm of breast"
AFFECTS,Homologous Recombination Deficiency,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Homologous Recombination Deficiency Malignant neoplasm of breast
AFFECTS,STAMBPL1 gene|STAMBPL1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,STAMBPL1 gene|STAMBPL1 Malignant neoplasm of breast
DISRUPTS,LINC00472 gene|LINC00472,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LINC00472 gene|LINC00472 Malignant neoplasm of breast
PREDISPOSES,GZMK gene|GZMK,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Gene or Genome,GZMK gene|GZMK estrogen receptor-positive breast cancer
AFFECTS,CDK16 gene|CDK16,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,CDK16 gene|CDK16 Triple Negative Breast Neoplasms
AFFECTS,"RNA, Untranslated",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","RNA, Untranslated Triple Negative Breast Neoplasms"
CAUSES,Indicators,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Indicator, Reagent, or Diagnostic Aid",Indicators Malignant neoplasm of breast
DISRUPTS,Protein p53|TP53,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Protein p53|TP53 Malignant neoplasm of breast
CAUSES,Genes,Carcinoma breast stage IV,0.0,Female Breast Cancer,Gene or Genome,Genes Carcinoma breast stage IV
AFFECTS,Malignant Neoplasms,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Neoplastic Process,Malignant Neoplasms HER2-positive carcinoma of breast
AUGMENTS,ATP6AP2 gene|ATP6AP2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ATP6AP2 gene|ATP6AP2 Malignant neoplasm of breast
AUGMENTS,LMNB1 gene|LMNB1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LMNB1 gene|LMNB1 Malignant neoplasm of breast
CAUSES,Secondary malignant neoplasm of bone,Recurrent Breast Carcinoma,0.0009990009990009,Recurrent Breast Cancer,Neoplastic Process,Secondary malignant neoplasm of bone Recurrent Breast Carcinoma
AUGMENTS,MARK2 gene|MARK2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MARK2 gene|MARK2 Malignant neoplasm of breast
AFFECTS,GATA3 gene|GATA3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GATA3 gene|GATA3 Malignant neoplasm of breast
PREDISPOSES,RBIS gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RBIS gene Malignant neoplasm of breast
AFFECTS,Ovarian Stimulation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Ovarian Stimulation Malignant neoplasm of breast
CAUSES,Mouse mammary tumor virus,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Mouse mammary tumor virus Breast Carcinoma
PREDISPOSES,History of previous events,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Phenomenon or Process,History of previous events Malignant neoplasm of breast
PREDISPOSES,C17orf49 gene|C17orf49,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,C17orf49 gene|C17orf49 Triple Negative Breast Neoplasms
AUGMENTS,MYC gene|MYC,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,MYC gene|MYC Triple Negative Breast Neoplasms
PREDISPOSES,RUNX2 gene|RUNX2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RUNX2 gene|RUNX2 Malignant neoplasm of breast
PREDISPOSES,SNHG14 gene|SNHG14,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SNHG14 gene|SNHG14 Malignant neoplasm of breast
AFFECTS,intracellular protein transport,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",intracellular protein transport Malignant neoplasm of breast
PREDISPOSES,WNT2 gene|WNT2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,WNT2 gene|WNT2 Malignant neoplasm of breast
PREDISPOSES,"Food, Preserved",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,"Food, Preserved Malignant neoplasm of breast"
AFFECTS,Malignant Neoplasms,"Breast Cancer, Familial",0.0,Female Breast Cancer,Neoplastic Process,"Malignant Neoplasms Breast Cancer, Familial"
PREDISPOSES,Elevated Expression,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Elevated Expression Malignant neoplasm of breast
AFFECTS,KIF11 gene|KIF11,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,KIF11 gene|KIF11 Malignant neoplasm of breast
AUGMENTS,Lactic acid dehydrogenase isoenzyme 5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Lactic acid dehydrogenase isoenzyme 5 Malignant neoplasm of breast
AUGMENTS,ANLN gene|ANLN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ANLN gene|ANLN Malignant neoplasm of breast
DISRUPTS,COL11A1 gene|COL11A1,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Gene or Genome,COL11A1 gene|COL11A1 estrogen receptor-positive breast cancer
PREDISPOSES,Melanocyte stimulating hormone,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Hormone,Melanocyte stimulating hormone Secondary malignant neoplasm of breast
PREDISPOSES,ACTA2-AS1 gene|ACTA2-AS1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,ACTA2-AS1 gene|ACTA2-AS1 Triple Negative Breast Neoplasms
CAUSES,"IRS1 protein, human|IRS1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","IRS1 protein, human|IRS1 Malignant neoplasm of breast"
PREDISPOSES,progesterone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,progesterone Malignant neoplasm of breast
AFFECTS,Tumor Necrosis Factor Signaling Process,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Tumor Necrosis Factor Signaling Process Malignant neoplasm of breast
PREDISPOSES,IMPA1 gene|IMPA1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,IMPA1 gene|IMPA1 Triple Negative Breast Neoplasms
AUGMENTS,Long Intergenic Non-Protein Coding RNA,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Long Intergenic Non-Protein Coding RNA Noninfiltrating Intraductal Carcinoma
PREDISPOSES,LINC01194 gene|LINC01194,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,LINC01194 gene|LINC01194 Triple Negative Breast Neoplasms
PREDISPOSES,perfluorooctane sulfonic acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,perfluorooctane sulfonic acid Malignant neoplasm of breast
PREDISPOSES,Sulfonic Acids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Sulfonic Acids Malignant neoplasm of breast
PREDISPOSES,Disease,Refractory Breast Carcinoma,0.0,Other,Disease or Syndrome,Disease Refractory Breast Carcinoma
AFFECTS,New medications,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,New medications Malignant neoplasm of breast
PREDISPOSES,ascorbic acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,ascorbic acid Malignant neoplasm of breast
AFFECTS,Matrix Metalloproteinase 9|MMP9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Matrix Metalloproteinase 9|MMP9 Malignant neoplasm of breast
AFFECTS,Generalized obesity,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Generalized obesity Malignant neoplasm of breast
CAUSES,IMPA1 gene|IMPA1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,IMPA1 gene|IMPA1 Triple Negative Breast Neoplasms
PREDISPOSES,Evaluation and management note:Finding:Point in time:{Setting}:Document:{Provider},Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Evaluation and management note:Finding:Point in time:{Setting}:Document:{Provider} Triple Negative Breast Neoplasms
PREDISPOSES,Membrane Transport Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Membrane Transport Proteins Malignant neoplasm of breast
AFFECTS,E2F6 gene|E2F6,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,E2F6 gene|E2F6 Triple Negative Breast Neoplasms
DISRUPTS,TP53 gene|TP53,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,TP53 gene|TP53 Secondary malignant neoplasm of breast
PREDISPOSES,ACBD3 gene|ACBD3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ACBD3 gene|ACBD3 Malignant neoplasm of breast
AUGMENTS,GAS6-AS1 gene|GAS6-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GAS6-AS1 gene|GAS6-AS1 Malignant neoplasm of breast
PREDISPOSES,SERPINA12 gene|SERPINA12,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,SERPINA12 gene|SERPINA12 Triple Negative Breast Neoplasms
DISRUPTS,SEMA3B-AS1 gene|SEMA3B-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SEMA3B-AS1 gene|SEMA3B-AS1 Malignant neoplasm of breast
PREDISPOSES,SLC3A2 gene|SLC3A2,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,SLC3A2 gene|SLC3A2 Breast Carcinoma
DISRUPTS,RYK gene|RYK,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,RYK gene|RYK Secondary malignant neoplasm of breast
PREDISPOSES,Matrix Metalloproteinase 2|MMP2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Matrix Metalloproteinase 2|MMP2 Malignant neoplasm of breast
CAUSES,FRY gene|FRY,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FRY gene|FRY Malignant neoplasm of breast
AFFECTS,"ITK protein, human|ITK",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","ITK protein, human|ITK Malignant neoplasm of breast"
DISRUPTS,"ERCC5 protein, human|ERCC5",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","ERCC5 protein, human|ERCC5 Malignant neoplasm of breast"
PREDISPOSES,MYCL gene|MYCL,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,MYCL gene|MYCL Triple Negative Breast Neoplasms
AFFECTS,CXCL14 gene|CXCL14,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,CXCL14 gene|CXCL14 Triple Negative Breast Neoplasms
AUGMENTS,AURKB gene|AURKB,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,AURKB gene|AURKB Malignant neoplasm of breast
PREDISPOSES,HSPB2 gene|HSPB2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HSPB2 gene|HSPB2 Malignant neoplasm of breast
AUGMENTS,RECQL4 gene|RECQL4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RECQL4 gene|RECQL4 Malignant neoplasm of breast
PREDISPOSES,EXO1 gene|EXO1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,EXO1 gene|EXO1 Malignant neoplasm of breast
AUGMENTS,Pathogenic Variant,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Virus,Pathogenic Variant Noninfiltrating Intraductal Carcinoma
PREDISPOSES,glutathione S-transferase pi|GSTP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",glutathione S-transferase pi|GSTP1 Malignant neoplasm of breast
PREDISPOSES,LINC00473 gene|LINC00473,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LINC00473 gene|LINC00473 Malignant neoplasm of breast
PREDISPOSES,FOXA1 gene|FOXA1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FOXA1 gene|FOXA1 Malignant neoplasm of breast
PREDISPOSES,glutathione,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",glutathione Malignant neoplasm of breast
PREDISPOSES,ELAVL2 gene|ELAVL2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ELAVL2 gene|ELAVL2 Malignant neoplasm of breast
AFFECTS,Antiplatelet Agents,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical Viewed Functionally,Antiplatelet Agents Malignant neoplasm of breast
AUGMENTS,USP37 gene|USP37,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Gene or Genome,USP37 gene|USP37 estrogen receptor-positive breast cancer
DISRUPTS,PPARA gene|PPARA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PPARA gene|PPARA Malignant neoplasm of breast
AUGMENTS,Vitamin D3 Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Vitamin D3 Receptor Malignant neoplasm of breast
AFFECTS,boswellic acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,boswellic acid Malignant neoplasm of breast
AFFECTS,SOX8 gene|SOX8,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,SOX8 gene|SOX8 Triple Negative Breast Neoplasms
PREDISPOSES,LINC00536 gene|LINC00536,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LINC00536 gene|LINC00536 Malignant neoplasm of breast
PREDISPOSES,CBX3 gene|CBX3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CBX3 gene|CBX3 Malignant neoplasm of breast
PREDISPOSES,Anti-Inflammatory Agents,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical Viewed Functionally,Anti-Inflammatory Agents Malignant neoplasm of breast
AFFECTS,Interventional procedure,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Interventional procedure Malignant neoplasm of breast
PREDISPOSES,SOAT2 gene|SOAT2,Basal-Like Breast Carcinoma,0.0039960039960039,Female Breast Cancer,Gene or Genome,SOAT2 gene|SOAT2 Basal-Like Breast Carcinoma
AFFECTS,FRMD3 gene|FRMD3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FRMD3 gene|FRMD3 Malignant neoplasm of breast
PREDISPOSES,IMPACT gene,contralateral breast cancer,0.0029970029970029,Female Breast Cancer,Gene or Genome,IMPACT gene contralateral breast cancer
CAUSES,SDC1 gene|SDC1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SDC1 gene|SDC1 Malignant neoplasm of breast
AFFECTS,Circulating MicroRNA,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Circulating MicroRNA Breast Carcinoma
PREDISPOSES,TINCR gene|TINCR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TINCR gene|TINCR Malignant neoplasm of breast
CAUSES,MIR497HG gene|MIR497HG,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIR497HG gene|MIR497HG Malignant neoplasm of breast
PREDISPOSES,Responsive Disease,Carcinoma breast stage IV,0.0,Female Breast Cancer,Disease or Syndrome,Responsive Disease Carcinoma breast stage IV
PREDISPOSES,LAPTM5 gene|LAPTM5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LAPTM5 gene|LAPTM5 Malignant neoplasm of breast
DISRUPTS,CLDN6 gene|CLDN6,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,CLDN6 gene|CLDN6 Secondary malignant neoplasm of breast
PREDISPOSES,TAF15 gene|TAF15,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TAF15 gene|TAF15 Malignant neoplasm of breast
AUGMENTS,RHOV gene|RHOV,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,RHOV gene|RHOV Triple Negative Breast Neoplasms
AUGMENTS,Transforming Growth Factor beta,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Transforming Growth Factor beta Malignant neoplasm of breast
DISRUPTS,GABRD gene|GABRD,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GABRD gene|GABRD Malignant neoplasm of breast
AFFECTS,SIRT7 gene|SIRT7,Carcinoma breast stage IV,0.0,Female Breast Cancer,Gene or Genome,SIRT7 gene|SIRT7 Carcinoma breast stage IV
PREDISPOSES,MicroRNAs,Early-Stage Breast Carcinoma,0.0,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",MicroRNAs Early-Stage Breast Carcinoma
PREDISPOSES,Disease/diagnosis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Disease/diagnosis Malignant neoplasm of breast
PREDISPOSES,MYBL2 gene|MYBL2,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,MYBL2 gene|MYBL2 Triple Negative Breast Neoplasms
PREDISPOSES,NOTCH1 gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NOTCH1 gene Malignant neoplasm of breast
AUGMENTS,COMMD3 gene|COMMD3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,COMMD3 gene|COMMD3 Malignant neoplasm of breast
DISRUPTS,NPY1R gene|NPY1R,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NPY1R gene|NPY1R Malignant neoplasm of breast
PREDISPOSES,Sugar-Sweetened Beverages,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Carbohydrate,Sugar-Sweetened Beverages Malignant neoplasm of breast
CAUSES,"herstatin protein, human",Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein","herstatin protein, human Breast Carcinoma"
AUGMENTS,"Adaptor Proteins, Signal Transducing",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","Adaptor Proteins, Signal Transducing Malignant neoplasm of breast"
DISRUPTS,PLPP4 gene|PLPP4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PLPP4 gene|PLPP4 Malignant neoplasm of breast
AUGMENTS,TIPARP gene|TIPARP,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Gene or Genome,TIPARP gene|TIPARP Invasive carcinoma of breast
CAUSES,Estrogen Antagonists,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Estrogen Antagonists Malignant neoplasm of breast
AFFECTS,GJA1 gene|GJA1,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Gene or Genome,GJA1 gene|GJA1 estrogen receptor-positive breast cancer
PREDISPOSES,Pathogenic Variant,contralateral breast cancer,0.0029970029970029,Female Breast Cancer,Virus,Pathogenic Variant contralateral breast cancer
CAUSES,Phytochemicals,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Chemical,Phytochemicals Triple Negative Breast Neoplasms
AFFECTS,C1QL4 gene|C1QL4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,C1QL4 gene|C1QL4 Malignant neoplasm of breast
PREDISPOSES,Food Habits,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Food Habits Malignant neoplasm of breast
AFFECTS,Noninfiltrating Intraductal Carcinoma,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Neoplastic Process,Noninfiltrating Intraductal Carcinoma Triple Negative Breast Neoplasms
CAUSES,progesterone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,progesterone Malignant neoplasm of breast
PREDISPOSES,Heat Shock Protein 27,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Heat Shock Protein 27 Malignant neoplasm of breast
AFFECTS,Sulfhydryl Compounds,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Sulfhydryl Compounds Malignant neoplasm of breast
AUGMENTS,IDO2 gene|IDO2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IDO2 gene|IDO2 Malignant neoplasm of breast
PREDISPOSES,NDC80 gene|NDC80,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NDC80 gene|NDC80 Malignant neoplasm of breast
PREDISPOSES,reproductive hormone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,reproductive hormone Malignant neoplasm of breast
DISRUPTS,ADAR gene|ADAR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ADAR gene|ADAR Malignant neoplasm of breast
AUGMENTS,GPT2 gene,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,GPT2 gene Triple Negative Breast Neoplasms
AUGMENTS,Long Interspersed Nucleotide Element-1,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,"Element, Ion, or Isotope",Long Interspersed Nucleotide Element-1 Inflammatory Breast Carcinoma
DISRUPTS,PTCSC3 gene|PTCSC3,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,PTCSC3 gene|PTCSC3 Triple Negative Breast Neoplasms
PREDISPOSES,SCRIB gene|SCRIB,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,SCRIB gene|SCRIB Secondary malignant neoplasm of breast
DISRUPTS,"CD274 protein, human|CD274",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CD274 protein, human|CD274 Triple Negative Breast Neoplasms"
DISRUPTS,FOXM1 gene|FOXM1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FOXM1 gene|FOXM1 Malignant neoplasm of breast
AFFECTS,Infiltration,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Infiltration Triple Negative Breast Neoplasms
PREDISPOSES,cholesterol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Lipid,cholesterol Malignant neoplasm of breast
AFFECTS,Tumor Microenvironment of Metastasis Density,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Tumor Microenvironment of Metastasis Density Malignant neoplasm of breast
PREDISPOSES,IRF7 gene|IRF7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IRF7 gene|IRF7 Malignant neoplasm of breast
PREDISPOSES,HDAC1 gene|HDAC1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HDAC1 gene|HDAC1 Malignant neoplasm of breast
COMPLICATES,MED1 gene|MED1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MED1 gene|MED1 Malignant neoplasm of breast
AFFECTS,MAPK1 gene|MAPK1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MAPK1 gene|MAPK1 Malignant neoplasm of breast
AFFECTS,Carcinogenesis,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Hazardous or Poisonous Substance,Carcinogenesis estrogen receptor-positive breast cancer
AFFECTS,Multiple tumors,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Neoplastic Process,Multiple tumors Invasive carcinoma of breast
DISRUPTS,ZNF831 gene|ZNF831,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ZNF831 gene|ZNF831 Malignant neoplasm of breast
AUGMENTS,MC1R gene|MC1R,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MC1R gene|MC1R Malignant neoplasm of breast
DISRUPTS,estrogens,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Hormone,estrogens estrogen receptor-positive breast cancer
PREDISPOSES,Non-alcoholic Fatty Liver Disease,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Non-alcoholic Fatty Liver Disease Malignant neoplasm of breast
AUGMENTS,"estrogens, conjugated (USP)",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,"estrogens, conjugated (USP) Malignant neoplasm of breast"
PREDISPOSES,MIR429 gene|MIR429,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,MIR429 gene|MIR429 Triple Negative Breast Neoplasms
AFFECTS,"ATF2 protein, human|ATF2",estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,"Amino Acid, Peptide, or Protein","ATF2 protein, human|ATF2 estrogen receptor-positive breast cancer"
AUGMENTS,FTO gene|FTO,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FTO gene|FTO Malignant neoplasm of breast
CAUSES,trastuzumab deruxtecan,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,trastuzumab deruxtecan Malignant neoplasm of breast
AFFECTS,VIRMA gene|VIRMA,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,VIRMA gene|VIRMA Triple Negative Breast Neoplasms
AFFECTS,KLF5 gene|KLF5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,KLF5 gene|KLF5 Malignant neoplasm of breast
AFFECTS,Screening for malignant neoplasm of breast,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Screening for malignant neoplasm of breast Malignant neoplasm of breast
PREDISPOSES,FAM83D gene|FAM83D,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FAM83D gene|FAM83D Malignant neoplasm of breast
AUGMENTS,RACK1 gene|RACK1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RACK1 gene|RACK1 Malignant neoplasm of breast
PREDISPOSES,A1BG-AS1 gene|A1BG-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,A1BG-AS1 gene|A1BG-AS1 Malignant neoplasm of breast
AFFECTS,ANO6 gene|ANO6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ANO6 gene|ANO6 Malignant neoplasm of breast
DISRUPTS,DNAJB4 gene|DNAJB4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,DNAJB4 gene|DNAJB4 Malignant neoplasm of breast
PREDISPOSES,AFF4 gene|AFF4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,AFF4 gene|AFF4 Malignant neoplasm of breast
AFFECTS,PROS1 gene|PROS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PROS1 gene|PROS1 Malignant neoplasm of breast
PREDISPOSES,testosterone,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Hormone,testosterone Invasive carcinoma of breast
PREDISPOSES,Lesch-Nyhan Syndrome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Lesch-Nyhan Syndrome Malignant neoplasm of breast
DISRUPTS,CAVIN1 gene|CAVIN1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CAVIN1 gene|CAVIN1 Malignant neoplasm of breast
PREDISPOSES,TDRKH-AS1 gene|TDRKH-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TDRKH-AS1 gene|TDRKH-AS1 Malignant neoplasm of breast
AUGMENTS,"IMP3 protein, human",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","IMP3 protein, human Malignant neoplasm of breast"
CAUSES,"MFGE8 protein, human|MFGE8",Invasive Ductal Breast Carcinoma,0.0,Female Breast Cancer,"Amino Acid, Peptide, or Protein","MFGE8 protein, human|MFGE8 Invasive Ductal Breast Carcinoma"
PREDISPOSES,Organic solvent product,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Organic solvent product Malignant neoplasm of breast
PREDISPOSES,TTPAL gene|TTPAL,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TTPAL gene|TTPAL Malignant neoplasm of breast
AFFECTS,FOXK1 gene|FOXK1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FOXK1 gene|FOXK1 Malignant neoplasm of breast
DISRUPTS,MIR205 gene|MIR205,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,MIR205 gene|MIR205 Triple Negative Breast Neoplasms
AFFECTS,Non-alcoholic Fatty Liver Disease,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Non-alcoholic Fatty Liver Disease Malignant neoplasm of breast
CAUSES,Implants,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biomedical or Dental Material,Implants Malignant neoplasm of breast
AFFECTS,FTO gene|FTO,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,FTO gene|FTO Triple Negative Breast Neoplasms
AUGMENTS,GNAO1 gene|GNAO1,Carcinoma breast stage IV,0.0,Female Breast Cancer,Gene or Genome,GNAO1 gene|GNAO1 Carcinoma breast stage IV
PREDISPOSES,FOXQ1 gene|FOXQ1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FOXQ1 gene|FOXQ1 Malignant neoplasm of breast
AUGMENTS,PARK7 gene|PARK7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PARK7 gene|PARK7 Malignant neoplasm of breast
DISRUPTS,PPARGC1B gene|PPARGC1B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PPARGC1B gene|PPARGC1B Malignant neoplasm of breast
PREDISPOSES,TPM2 gene|TPM2,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,TPM2 gene|TPM2 Breast Carcinoma
DISRUPTS,RSRC2 gene|RSRC2,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,RSRC2 gene|RSRC2 Triple Negative Breast Neoplasms
COMPLICATES,Sarcoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Sarcoma Malignant neoplasm of breast
PREDISPOSES,"CD69 protein, human|CD69",Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CD69 protein, human|CD69 Female Breast Carcinoma"
AUGMENTS,Estrogen Receptor alpha,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptor alpha estrogen receptor-positive breast cancer
PREDISPOSES,SIK2 gene|SIK2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SIK2 gene|SIK2 Malignant neoplasm of breast
PREDISPOSES,magnesium cation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",magnesium cation Malignant neoplasm of breast
AFFECTS,Neoplastic Cell Transformation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Neoplastic Cell Transformation Malignant neoplasm of breast
DISRUPTS,MIR205 gene|MIR205,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,MIR205 gene|MIR205 Secondary malignant neoplasm of breast
PREDISPOSES,SLC7A11 gene|SLC7A11,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,SLC7A11 gene|SLC7A11 Triple Negative Breast Neoplasms
AFFECTS,Gene Expression,Carcinoma breast stage IV,0.0,Female Breast Cancer,Gene or Genome,Gene Expression Carcinoma breast stage IV
AFFECTS,MT-RNR1 gene|RNR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MT-RNR1 gene|RNR1 Malignant neoplasm of breast
PREDISPOSES,RAB5A gene|RAB5A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RAB5A gene|RAB5A Malignant neoplasm of breast
PREDISPOSES,CAT gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CAT gene Malignant neoplasm of breast
AUGMENTS,CCDC150 gene|CCDC150,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,CCDC150 gene|CCDC150 Triple Negative Breast Neoplasms
AFFECTS,MXRA5 gene|MXRA5,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,MXRA5 gene|MXRA5 Secondary malignant neoplasm of breast
PREDISPOSES,NF2 gene|NF2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NF2 gene|NF2 Malignant neoplasm of breast
CAUSES,translation factor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",translation factor Malignant neoplasm of breast
DISRUPTS,WWOX gene|WWOX,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,WWOX gene|WWOX Triple Negative Breast Neoplasms
AUGMENTS,EP300 gene|EP300,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,EP300 gene|EP300 Triple Negative Breast Neoplasms
PREDISPOSES,Leucine-Rich Repeat Proteins,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Leucine-Rich Repeat Proteins Triple Negative Breast Neoplasms
COMPLICATES,EYA2 gene|EYA2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,EYA2 gene|EYA2 Malignant neoplasm of breast
PREDISPOSES,PKMYT1 gene|PKMYT1,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,PKMYT1 gene|PKMYT1 Breast Carcinoma
AUGMENTS,ME1 gene|ME1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ME1 gene|ME1 Malignant neoplasm of breast
PREDISPOSES,CACNG4 gene|CACNG4,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,CACNG4 gene|CACNG4 Breast Carcinoma
AFFECTS,obeticholic acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,obeticholic acid Malignant neoplasm of breast
AUGMENTS,CCL20 gene|CCL20,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CCL20 gene|CCL20 Malignant neoplasm of breast
DISRUPTS,MBD2 gene|MBD2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MBD2 gene|MBD2 Malignant neoplasm of breast
AFFECTS,"IL1A protein, human|IL1A",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","IL1A protein, human|IL1A Malignant neoplasm of breast"
AUGMENTS,IL22 gene|IL22,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,IL22 gene|IL22 Triple Negative Breast Neoplasms
AUGMENTS,Human Class I Antigens,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Immunologic Factor,Human Class I Antigens Triple Negative Breast Neoplasms
AFFECTS,DNA Replication,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",DNA Replication Triple Negative Breast Neoplasms
AFFECTS,CCNB1 gene|CCNB1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,CCNB1 gene|CCNB1 Triple Negative Breast Neoplasms
PREDISPOSES,pyruvate dehydrogenase kinase 4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",pyruvate dehydrogenase kinase 4 Malignant neoplasm of breast
AUGMENTS,SLC38A5 gene|SLC38A5,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,SLC38A5 gene|SLC38A5 Triple Negative Breast Neoplasms
PREDISPOSES,FGF11 gene|FGF11,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FGF11 gene|FGF11 Malignant neoplasm of breast
PREDISPOSES,4-aminohippuric acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,4-aminohippuric acid Malignant neoplasm of breast
PREDISPOSES,ZBTB10 gene|ZBTB10,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ZBTB10 gene|ZBTB10 Malignant neoplasm of breast
AFFECTS,Combination Chemotherapy,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Combination Chemotherapy Breast cancer metastatic
AFFECTS,GRB7 gene|GRB7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GRB7 gene|GRB7 Malignant neoplasm of breast
CAUSES,CCL18 gene|CCL18,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,CCL18 gene|CCL18 Breast cancer metastatic
AUGMENTS,EPHA10 gene|EPHA10,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,EPHA10 gene|EPHA10 Malignant neoplasm of breast
PREDISPOSES,Cancer-Predisposing Gene,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Gene or Genome,Cancer-Predisposing Gene Carcinoma of Male Breast
PREDISPOSES,MAP3K1 gene|MAP3K1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MAP3K1 gene|MAP3K1 Malignant neoplasm of breast
DISRUPTS,Estrogens,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Hormone,Estrogens Breast cancer metastatic
PREDISPOSES,CYP1A1 gene|CYP1A1,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Gene or Genome,CYP1A1 gene|CYP1A1 Breast cancer recurrent
AUGMENTS,"WBSCR22 protein, human|BUD23",Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Amino Acid, Peptide, or Protein","WBSCR22 protein, human|BUD23 Breast cancer invasive NOS"
AFFECTS,Environmental Estrogen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Environmental Estrogen Malignant neoplasm of breast
AFFECTS,Renal Cell Carcinoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Renal Cell Carcinoma Malignant neoplasm of breast
AUGMENTS,Oxygen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Oxygen Malignant neoplasm of breast
CAUSES,Enhancer Elements (Genetics),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Enhancer Elements (Genetics) Malignant neoplasm of breast
DISRUPTS,MIRN143 gene|MIR143,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIRN143 gene|MIR143 Malignant neoplasm of breast
AFFECTS,RAD51C gene|RAD51C,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RAD51C gene|RAD51C Malignant neoplasm of breast
CAUSES,AATF gene|AATF,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,AATF gene|AATF Malignant neoplasm of breast
PREDISPOSES,Selective serotonin re-uptake inhibitor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neuroreactive Substance or Biogenic Amine,Selective serotonin re-uptake inhibitor Malignant neoplasm of breast
AFFECTS,PTGS2 gene|PTGS2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,PTGS2 gene|PTGS2 Breast cancer metastatic
PREDISPOSES,8-Oxoguanine DNA Glycosylase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",8-Oxoguanine DNA Glycosylase Malignant neoplasm of breast
AFFECTS,Tumor Suppressor Genes,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,Tumor Suppressor Genes Breast Carcinoma
AUGMENTS,IL18 gene|IL18,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IL18 gene|IL18 Malignant neoplasm of breast
AFFECTS,"Carcinoma, Ductal, Breast",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,"Carcinoma, Ductal, Breast Malignant neoplasm of breast"
AFFECTS,cytotoxicity,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hazardous or Poisonous Substance,cytotoxicity Malignant neoplasm of breast
AUGMENTS,NRIP1 gene|NRIP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NRIP1 gene|NRIP1 Malignant neoplasm of breast
PREDISPOSES,Microtubule-Associated Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Microtubule-Associated Proteins Malignant neoplasm of breast
AUGMENTS,Phosphoglycerate dehydrogenase|PHGDH,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Phosphoglycerate dehydrogenase|PHGDH Malignant neoplasm of breast
CAUSES,Epidermal Growth Factor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Epidermal Growth Factor Malignant neoplasm of breast
AFFECTS,STC1 gene|STC1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,STC1 gene|STC1 Malignant neoplasm of breast
AUGMENTS,Receptor Protein-Tyrosine Kinases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Receptor Protein-Tyrosine Kinases Malignant neoplasm of breast
AFFECTS,Ir Genes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Ir Genes Malignant neoplasm of breast
AFFECTS,Insulin-Like Growth Factor Receptor,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Biologically Active Substance,Insulin-Like Growth Factor Receptor Breast cancer metastatic
PREDISPOSES,ADRA2A gene|ADRA2A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ADRA2A gene|ADRA2A Malignant neoplasm of breast
AFFECTS,Gene Expression Regulation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Gene Expression Regulation Malignant neoplasm of breast
DISRUPTS,"ST13 protein, human|ST13",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","ST13 protein, human|ST13 Malignant neoplasm of breast"
AUGMENTS,FABP5 gene|FABP5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FABP5 gene|FABP5 Malignant neoplasm of breast
PREDISPOSES,Follicle Stimulating Hormone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Follicle Stimulating Hormone Malignant neoplasm of breast
DISRUPTS,PRLR gene|PRLR|PTP4A3,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Gene or Genome,PRLR gene|PRLR|PTP4A3 Breast cancer invasive NOS
PREDISPOSES,GSTA1 gene|GSTA1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GSTA1 gene|GSTA1 Malignant neoplasm of breast
AFFECTS,cytokine,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Biologically Active Substance,cytokine Breast cancer metastatic
AUGMENTS,Oncogenes,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,Oncogenes Breast Carcinoma
PREDISPOSES,Insulin-Like Growth Factor I,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Biologically Active Substance,Insulin-Like Growth Factor I Noninfiltrating Intraductal Carcinoma
CAUSES,Viral Tumor Antigens,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Viral Tumor Antigens Breast Carcinoma
AUGMENTS,Proliferating Cell Nuclear Antigen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Immunologic Factor,Proliferating Cell Nuclear Antigen Malignant neoplasm of breast
AFFECTS,cytokine,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Biologically Active Substance,cytokine Breast cancer invasive NOS
PREDISPOSES,Central Nervous System Agents,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical Viewed Functionally,Central Nervous System Agents Malignant neoplasm of breast
DISRUPTS,Estrogens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Estrogens Malignant neoplasm of breast
CAUSES,Human papillomavirus 16,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Virus,Human papillomavirus 16 Malignant neoplasm of breast
CAUSES,Malignant mixed salivary gland tumor,Cancer en cuirasse,0.0,Female Breast Cancer,Neoplastic Process,Malignant mixed salivary gland tumor Cancer en cuirasse
DISRUPTS,"Receptors, Progesterone",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,"Receptors, Progesterone Malignant neoplasm of breast"
AFFECTS,Human Platelet Antigens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Immunologic Factor,Human Platelet Antigens Malignant neoplasm of breast
CAUSES,reproductive hormone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,reproductive hormone Malignant neoplasm of breast
PREDISPOSES,Alcohol consumption,bilateral breast cancer,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Alcohol consumption bilateral breast cancer
CAUSES,Agent,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Chemical Viewed Functionally,Agent Breast Carcinoma
AUGMENTS,CTTN gene|CTTN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CTTN gene|CTTN Malignant neoplasm of breast
AFFECTS,Atypical proliferation,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",Atypical proliferation Noninfiltrating Intraductal Carcinoma
AFFECTS,Tumor Antigens,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Tumor Antigens Breast Carcinoma
AFFECTS,Polyunsaturated Fatty Acids,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Chemical,Polyunsaturated Fatty Acids Breast Carcinoma
AUGMENTS,CD44 gene|CD44,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,CD44 gene|CD44 Breast Carcinoma
DISRUPTS,Fatty Acids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Fatty Acids Malignant neoplasm of breast
CAUSES,PRLR gene|PRLR|PTP4A3,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,PRLR gene|PRLR|PTP4A3 Breast Carcinoma
PREDISPOSES,LALBA gene|LALBA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LALBA gene|LALBA Malignant neoplasm of breast
CAUSES,Malignant neoplasm of breast,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,Malignant neoplasm of breast Breast cancer invasive NOS
AUGMENTS,"TFF1 protein, human|TFF1",Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein","TFF1 protein, human|TFF1 Breast Carcinoma"
AFFECTS,Epidermal Growth Factor Receptor|EGF,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Epidermal Growth Factor Receptor|EGF Malignant neoplasm of breast
AFFECTS,Caloric Restriction,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Caloric Restriction Malignant neoplasm of breast
CAUSES,Hodgkin Disease,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Disease or Syndrome,Hodgkin Disease Breast Carcinoma
CAUSES,"Carcinogens, Environmental",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hazardous or Poisonous Substance,"Carcinogens, Environmental Malignant neoplasm of breast"
CAUSES,cDNA Library,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",cDNA Library Breast Carcinoma
AUGMENTS,RBBP1L1 Protein|ARID4B,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",RBBP1L1 Protein|ARID4B Breast Carcinoma
AFFECTS,FGF4 gene|FGF4,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,FGF4 gene|FGF4 Breast Carcinoma
PREDISPOSES,Malignant Carcinoid Syndrome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Malignant Carcinoid Syndrome Malignant neoplasm of breast
AFFECTS,Hypolipidemia,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Lipid,Hypolipidemia Breast Carcinoma
CAUSES,Tamoxifen,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Pharmacologic Substance,Tamoxifen Breast Carcinoma
AFFECTS,Hormone manipulation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Hormone manipulation Malignant neoplasm of breast
CAUSES,Transgenes,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,Transgenes Breast Carcinoma
AFFECTS,Estrogen Replacements,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Estrogen Replacements Malignant neoplasm of breast
AFFECTS,ATM gene|ATM,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Gene or Genome,ATM gene|ATM Sporadic Breast Carcinoma
PREDISPOSES,Noninfiltrating Intraductal Carcinoma,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,Noninfiltrating Intraductal Carcinoma Breast cancer invasive NOS
AFFECTS,PPARBP gene|MED1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PPARBP gene|MED1 Malignant neoplasm of breast
AFFECTS,Insulin-Like Growth Factor I,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Biologically Active Substance,Insulin-Like Growth Factor I Breast Carcinoma
CAUSES,whey protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",whey protein Malignant neoplasm of breast
AFFECTS,TP53 gene|TP53,bilateral breast cancer,0.0,Female Breast Cancer,Gene or Genome,TP53 gene|TP53 bilateral breast cancer
AFFECTS,Osteoclastic resorption,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Osteoclastic resorption Malignant neoplasm of breast
CAUSES,SYK gene|SYK,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SYK gene|SYK Malignant neoplasm of breast
AFFECTS,TFF1 gene|TFF1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TFF1 gene|TFF1 Malignant neoplasm of breast
AFFECTS,Postmenopausal Hormone Replacement Therapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Postmenopausal Hormone Replacement Therapy Malignant neoplasm of breast
CAUSES,Tumor Angiogenesis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Tumor Angiogenesis Malignant neoplasm of breast
AUGMENTS,matrix metalloproteinase 26,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Amino Acid, Peptide, or Protein",matrix metalloproteinase 26 Noninfiltrating Intraductal Carcinoma
AUGMENTS,glutathione S-transferase pi|EREG|ESR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",glutathione S-transferase pi|EREG|ESR1 Malignant neoplasm of breast
AFFECTS,Germ-Line Mutation,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,"Element, Ion, or Isotope",Germ-Line Mutation Familial cancer of breast
PREDISPOSES,alpha-Fetoproteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",alpha-Fetoproteins Malignant neoplasm of breast
PREDISPOSES,BIN1 gene|BIN1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BIN1 gene|BIN1 Malignant neoplasm of breast
AUGMENTS,BIRC5 gene|BIRC5,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,BIRC5 gene|BIRC5 Noninfiltrating Intraductal Carcinoma
PREDISPOSES,Encounter due to Unspecified general medical examination,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Encounter due to Unspecified general medical examination Malignant neoplasm of breast
PREDISPOSES,Parkinson Disease,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Parkinson Disease Malignant neoplasm of breast
AFFECTS,CD82 gene|CD82,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,CD82 gene|CD82 Breast cancer metastatic
DISRUPTS,Tumor Suppressor Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Tumor Suppressor Proteins Malignant neoplasm of breast
AFFECTS,TNFSF10 gene|TNFSF10,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TNFSF10 gene|TNFSF10 Malignant neoplasm of breast
CAUSES,Transforming Growth Factor alpha|TGFA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Transforming Growth Factor alpha|TGFA Malignant neoplasm of breast
CAUSES,Tumor Suppressor Genes,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Gene or Genome,Tumor Suppressor Genes Sporadic Breast Carcinoma
AFFECTS,Bone Resorption,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Bone Resorption Malignant neoplasm of breast
AFFECTS,Phytoestrogens,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Hormone,Phytoestrogens Breast cancer recurrent
AUGMENTS,SNCG gene|SNCG,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,SNCG gene|SNCG Breast cancer metastatic
PREDISPOSES,"Fatty Acids, Monounsaturated",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,"Fatty Acids, Monounsaturated Malignant neoplasm of breast"
AFFECTS,H-ras Genes,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Gene or Genome,H-ras Genes Sporadic Breast Carcinoma
CAUSES,Carcinoembryonic Antigen,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Immunologic Factor,Carcinoembryonic Antigen Breast cancer metastatic
AUGMENTS,REL gene|REL,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,REL gene|REL Malignant neoplasm of breast
AFFECTS,Tamoxifen,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,Pharmacologic Substance,Tamoxifen Contralateral breast cancer
CAUSES,"BCAR1 protein, human|BCAR1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","BCAR1 protein, human|BCAR1 Malignant neoplasm of breast"
AUGMENTS,AKT3 gene|AKT3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,AKT3 gene|AKT3 Malignant neoplasm of breast
AFFECTS,Opioid Peptide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Opioid Peptide Malignant neoplasm of breast
AUGMENTS,8-hydroxyguanine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",8-hydroxyguanine Malignant neoplasm of breast
AFFECTS,"Fatty Acids, Omega-6",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,"Fatty Acids, Omega-6 Malignant neoplasm of breast"
AFFECTS,"Anti-Inflammatory Agents, Non-Steroidal",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical Viewed Functionally,"Anti-Inflammatory Agents, Non-Steroidal Malignant neoplasm of breast"
AFFECTS,"Antidepressive Agents, Tricyclic",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical Viewed Functionally,"Antidepressive Agents, Tricyclic Malignant neoplasm of breast"
AFFECTS,LIG4 gene|LIG4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LIG4 gene|LIG4 Malignant neoplasm of breast
DISRUPTS,RNA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",RNA Malignant neoplasm of breast
CAUSES,Antineoplastic Agents,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Antineoplastic Agents Malignant neoplasm of breast
AUGMENTS,SNCG gene|SNCG,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SNCG gene|SNCG Malignant neoplasm of breast
AFFECTS,Tamoxifen,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Pharmacologic Substance,Tamoxifen Breast cancer invasive NOS
DISRUPTS,BRCA2 gene|BRCA2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BRCA2 gene|BRCA2 Malignant neoplasm of breast
PREDISPOSES,Tumor Suppressor Genes,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Gene or Genome,Tumor Suppressor Genes Inflammatory Breast Carcinoma
AFFECTS,BRCA1 Protein|BRCA1,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Gene or Genome,BRCA1 Protein|BRCA1 Sporadic Breast Carcinoma
DISRUPTS,Soy Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Soy Proteins Malignant neoplasm of breast
AFFECTS,"NOS2A protein, human|NOS2",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","NOS2A protein, human|NOS2 Malignant neoplasm of breast"
PREDISPOSES,3' Untranslated Regions,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",3' Untranslated Regions Malignant neoplasm of breast
PREDISPOSES,Carcinoma in Situ,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Carcinoma in Situ Malignant neoplasm of breast
CAUSES,PTEN gene|PTEN,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,Gene or Genome,PTEN gene|PTEN Familial cancer of breast
AFFECTS,Glutathione S-Transferase|SLCO6A1|GSTK1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Glutathione S-Transferase|SLCO6A1|GSTK1 Malignant neoplasm of breast
AFFECTS,"Embolism, Tumor",Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Neoplastic Process,"Embolism, Tumor Inflammatory Breast Carcinoma"
PREDISPOSES,Myocardial Infarction,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Myocardial Infarction Malignant neoplasm of breast
AFFECTS,Pharmaceutical Preparations,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Pharmacologic Substance,Pharmaceutical Preparations Noninfiltrating Intraductal Carcinoma
AFFECTS,Estrogenic effect,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Hormone,Estrogenic effect Breast cancer recurrent
AUGMENTS,FGF3 gene|FGF3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FGF3 gene|FGF3 Malignant neoplasm of breast
DISRUPTS,Eicosapentaenoic Acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Eicosapentaenoic Acid Malignant neoplasm of breast
AFFECTS,Cytokinesis of the fertilized ovum,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Cytokinesis of the fertilized ovum Malignant neoplasm of breast
PREDISPOSES,Fatty-acid synthase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Fatty-acid synthase Malignant neoplasm of breast
PREDISPOSES,Obstruction,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Obstruction Malignant neoplasm of breast
AUGMENTS,Genes,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,Gene or Genome,Genes Female Breast Carcinoma
AFFECTS,Epithelial Cell Proliferation,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Epithelial Cell Proliferation Breast Carcinoma
AFFECTS,Radiation,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Radiation Breast Carcinoma
PREDISPOSES,Monocyte Chemoattractant Protein-1|CCL2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Monocyte Chemoattractant Protein-1|CCL2 Malignant neoplasm of breast
AUGMENTS,Palmitic Acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Palmitic Acid Malignant neoplasm of breast
PREDISPOSES,"STK6 protein, human|AURKA",Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Amino Acid, Peptide, or Protein","STK6 protein, human|AURKA Noninfiltrating Intraductal Carcinoma"
PREDISPOSES,N-6 fatty acid intake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,N-6 fatty acid intake Malignant neoplasm of breast
CAUSES,Malignant neoplasm of prostate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Malignant neoplasm of prostate Malignant neoplasm of breast
AFFECTS,Chronic Disease,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Chronic Disease Malignant neoplasm of breast
PREDISPOSES,Elements,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Elements Malignant neoplasm of breast
PREDISPOSES,TNFSF6 gene|FASLG,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TNFSF6 gene|FASLG Malignant neoplasm of breast
CAUSES,protein tyrosine phosphatase 1B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",protein tyrosine phosphatase 1B Malignant neoplasm of breast
PREDISPOSES,ERBB3 gene|ERBB3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ERBB3 gene|ERBB3 Malignant neoplasm of breast
PREDISPOSES,Testosterone,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Hormone,Testosterone Breast cancer recurrent
AUGMENTS,Estrogen Receptor Modulators,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptor Modulators Malignant neoplasm of breast
DISRUPTS,MERTK gene|MERTK,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MERTK gene|MERTK Malignant neoplasm of breast
CAUSES,Oncogenes,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Gene or Genome,"Oncogenes Carcinoma, Ductal, Breast"
AFFECTS,Chemopreventive Agent,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical Viewed Functionally,Chemopreventive Agent Malignant neoplasm of breast
AFFECTS,Insulin-Like Growth Factor Binding Protein 3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Insulin-Like Growth Factor Binding Protein 3 Malignant neoplasm of breast
DISRUPTS,"RNA, Small Interfering",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","RNA, Small Interfering Malignant neoplasm of breast"
DISRUPTS,Carbon,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Carbon Malignant neoplasm of breast
PREDISPOSES,Conjugated Equine Estrogens,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Hormone,Conjugated Equine Estrogens Breast cancer invasive NOS
AUGMENTS,Carbon,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Carbon Malignant neoplasm of breast
DISRUPTS,Antihormone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Antihormone Malignant neoplasm of breast
CAUSES,HIVEP2 gene|HIVEP2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HIVEP2 gene|HIVEP2 Malignant neoplasm of breast
AFFECTS,Platelet-Derived Growth Factor Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Platelet-Derived Growth Factor Receptor Malignant neoplasm of breast
PREDISPOSES,Non-esterified cholesterol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Lipid,Non-esterified cholesterol Malignant neoplasm of breast
DISRUPTS,Insulin-Like Growth Factor Binding Protein 3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Insulin-Like Growth Factor Binding Protein 3 Malignant neoplasm of breast
AFFECTS,reproductive hormone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,reproductive hormone Malignant neoplasm of breast
PREDISPOSES,IFNG gene|IFNG,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Gene or Genome,IFNG gene|IFNG Sporadic Breast Carcinoma
DISRUPTS,bone morphogenetic protein 2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,bone morphogenetic protein 2 Malignant neoplasm of breast
AUGMENTS,Proto-Oncogene Protein pp60 (c-src)|SRC,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,Proto-Oncogene Protein pp60 (c-src)|SRC Breast Carcinoma
PREDISPOSES,Epidermal Growth Factor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Epidermal Growth Factor Malignant neoplasm of breast
AFFECTS,Specific antibody,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Indicator, Reagent, or Diagnostic Aid",Specific antibody Malignant neoplasm of breast
AUGMENTS,CHEK2 gene|CHEK2,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,Gene or Genome,CHEK2 gene|CHEK2 Female Breast Carcinoma
PREDISPOSES,Receptor Protein-Tyrosine Kinases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Receptor Protein-Tyrosine Kinases Malignant neoplasm of breast
AUGMENTS,CA-125 Antigen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Immunologic Factor,CA-125 Antigen Malignant neoplasm of breast
AFFECTS,Gene Expression,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Gene or Genome,Gene Expression Breast cancer invasive NOS
CAUSES,MTHFR gene|MTHFR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MTHFR gene|MTHFR Malignant neoplasm of breast
PREDISPOSES,Glutathione S-Transferase|SLCO6A1|GSTK1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Glutathione S-Transferase|SLCO6A1|GSTK1 Malignant neoplasm of breast
PREDISPOSES,STK11 gene|STK11,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,STK11 gene|STK11 Malignant neoplasm of breast
AFFECTS,Estrogen Receptors,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptors Breast cancer invasive NOS
AFFECTS,Cell Communication,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,"Element, Ion, or Isotope","Cell Communication Carcinoma, Ductal, Breast"
AFFECTS,ERBB2 gene|ERBB2,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Gene or Genome,ERBB2 gene|ERBB2 Breast cancer recurrent
AUGMENTS,Compound Q,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Compound Q Malignant neoplasm of breast
AUGMENTS,Human Chorionic Gonadotropin,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Human Chorionic Gonadotropin Breast Carcinoma
AFFECTS,protein tyrosine phosphatase 1B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",protein tyrosine phosphatase 1B Malignant neoplasm of breast
PREDISPOSES,HMMR gene|HMMR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HMMR gene|HMMR Malignant neoplasm of breast
PREDISPOSES,TRANSCRIPTION FACTOR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",TRANSCRIPTION FACTOR Malignant neoplasm of breast
PREDISPOSES,OTP gene|OTP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,OTP gene|OTP Malignant neoplasm of breast
AFFECTS,Protein Expression,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Protein Expression Ductal Breast Carcinoma
PREDISPOSES,CYP1B1 gene|CYP1B1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CYP1B1 gene|CYP1B1 Malignant neoplasm of breast
PREDISPOSES,Convenience food,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Convenience food Malignant neoplasm of breast
AFFECTS,"Cations, Divalent",Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope","Cations, Divalent Breast cancer metastatic"
AFFECTS,HMMR gene|HMMR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HMMR gene|HMMR Malignant neoplasm of breast
PREDISPOSES,Molecular Fingerprint of Tumor,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Neoplastic Process,Molecular Fingerprint of Tumor Breast cancer recurrent
AUGMENTS,Cullin Proteins,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Cullin Proteins Noninfiltrating Intraductal Carcinoma
AFFECTS,Carbon,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Carbon Malignant neoplasm of breast
AFFECTS,BRMS1 gene|BRMS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BRMS1 gene|BRMS1 Malignant neoplasm of breast
PREDISPOSES,PLXNB1 gene|PLXNB1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,PLXNB1 gene|PLXNB1 Breast cancer metastatic
AUGMENTS,"SMO protein, human|SMO",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","SMO protein, human|SMO Malignant neoplasm of breast"
AFFECTS,Cell-cell adhesion molecule,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Cell-cell adhesion molecule Breast cancer metastatic
AFFECTS,Apocrine adenocarcinoma,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Apocrine adenocarcinoma Breast Carcinoma
CAUSES,MYB gene|MYB,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,MYB gene|MYB Noninfiltrating Intraductal Carcinoma
AFFECTS,Germ-Line Mutation,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Germ-Line Mutation Breast Carcinoma
AFFECTS,Spontaneous abortion,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Spontaneous abortion Malignant neoplasm of breast
AFFECTS,PLG gene|PLG,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Gene or Genome,PLG gene|PLG Breast cancer invasive NOS
PREDISPOSES,FASTK Gene,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,FASTK Gene Noninfiltrating Intraductal Carcinoma
AUGMENTS,S100A11 gene|S100A11,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,S100A11 gene|S100A11 Malignant neoplasm of breast
AFFECTS,CDC25A gene|CDC25A,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,CDC25A gene|CDC25A Breast cancer metastatic
AUGMENTS,MDM2 gene|MDM2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MDM2 gene|MDM2 Malignant neoplasm of breast
AFFECTS,Chemoprevention,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Chemoprevention Malignant neoplasm of breast
AFFECTS,TP53BP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TP53BP1 Malignant neoplasm of breast
AUGMENTS,Antigens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Immunologic Factor,Antigens Malignant neoplasm of breast
PREDISPOSES,ATM gene|ATM,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,Gene or Genome,ATM gene|ATM Contralateral breast cancer
AFFECTS,Pharmacologic Substance,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,Pharmacologic Substance Malignant neoplasm of breast
PREDISPOSES,ERBB2 gene|ERBB2,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,ERBB2 gene|ERBB2 Noninfiltrating Intraductal Carcinoma
PREDISPOSES,ALCAM gene|ALCAM,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ALCAM gene|ALCAM Malignant neoplasm of breast
CAUSES,SPDEF gene|SPDEF,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SPDEF gene|SPDEF Malignant neoplasm of breast
CAUSES,ESR1 gene|ESR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ESR1 gene|ESR1 Malignant neoplasm of breast
DISRUPTS,CXCR4 gene|CXCR4,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,CXCR4 gene|CXCR4 Breast cancer metastatic
AFFECTS,"Receptors, Steroid",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Steroid,"Receptors, Steroid Malignant neoplasm of breast"
CAUSES,SERPINE1 gene|SERPINE1,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,SERPINE1 gene|SERPINE1 Noninfiltrating Intraductal Carcinoma
CAUSES,Cancer Promoting Genes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Cancer Promoting Genes Malignant neoplasm of breast
PREDISPOSES,"Linoleic Acids, Conjugated",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,"Linoleic Acids, Conjugated Malignant neoplasm of breast"
AFFECTS,CXCL10 gene|CXCL10,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,CXCL10 gene|CXCL10 Breast cancer metastatic
PREDISPOSES,MMP9 gene|MMP9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MMP9 gene|MMP9 Malignant neoplasm of breast
AFFECTS,"TIMP2 protein, human|TIMP2",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","TIMP2 protein, human|TIMP2 Malignant neoplasm of breast"
PREDISPOSES,MAP Kinase Gene,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,MAP Kinase Gene Breast cancer metastatic
AFFECTS,CD44 gene|CD44,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CD44 gene|CD44 Malignant neoplasm of breast
DISRUPTS,Gallic acid,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Chemical,Gallic acid Breast cancer metastatic
AFFECTS,Lipids,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Lipid,Lipids Breast cancer metastatic
DISRUPTS,FBXW7 gene|FBXW7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FBXW7 gene|FBXW7 Malignant neoplasm of breast
PREDISPOSES,hypercholesterolemia,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Lipid,hypercholesterolemia Breast cancer recurrent
AUGMENTS,Functional RNA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Functional RNA Malignant neoplasm of breast
AUGMENTS,COX7A2L gene|COX7A2L,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,COX7A2L gene|COX7A2L Malignant neoplasm of breast
AFFECTS,F3 gene|F3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,F3 gene|F3 Malignant neoplasm of breast
PREDISPOSES,CCL22 gene|CCL22,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CCL22 gene|CCL22 Malignant neoplasm of breast
DISRUPTS,Vascular Endothelial Growth Factor C|VEGFA,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Biologically Active Substance,Vascular Endothelial Growth Factor C|VEGFA Breast cancer metastatic
AFFECTS,Primary carcinoma of the liver cells,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Primary carcinoma of the liver cells Malignant neoplasm of breast
CAUSES,Tumor Suppressor Genes,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,Gene or Genome,Tumor Suppressor Genes Familial cancer of breast
CAUSES,Proto-Oncogene Proteins c-myc|MYC,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Proto-Oncogene Proteins c-myc|MYC Malignant neoplasm of breast
AFFECTS,RNA-Binding Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",RNA-Binding Proteins Malignant neoplasm of breast
AFFECTS,FGF1 gene|FGF1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FGF1 gene|FGF1 Malignant neoplasm of breast
AFFECTS,Alport's syndrome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Alport's syndrome Malignant neoplasm of breast
AFFECTS,ERCC1 gene|ERCC1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,ERCC1 gene|ERCC1 Breast cancer metastatic
AUGMENTS,STAT3 gene|STAT3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,STAT3 gene|STAT3 Malignant neoplasm of breast
PREDISPOSES,Malignant neoplasm of prostate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Malignant neoplasm of prostate Malignant neoplasm of breast
AFFECTS,CASP9 gene|CASP9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CASP9 gene|CASP9 Malignant neoplasm of breast
PREDISPOSES,CCL13 gene|CCL13,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CCL13 gene|CCL13 Malignant neoplasm of breast
AFFECTS,Biogenesis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Biogenesis Malignant neoplasm of breast
AUGMENTS,C-terminal binding protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",C-terminal binding protein Malignant neoplasm of breast
AFFECTS,Immune response,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Immunologic Factor,Immune response Breast cancer metastatic
AFFECTS,Malignant neoplasm of urinary bladder,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Malignant neoplasm of urinary bladder Malignant neoplasm of breast
CAUSES,Polyaromatic hydrocarbon,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Polyaromatic hydrocarbon Breast Carcinoma
AFFECTS,Protein phosphatase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Protein phosphatase Malignant neoplasm of breast
PREDISPOSES,Proto-Oncogene Proteins c-akt|AKT1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,Proto-Oncogene Proteins c-akt|AKT1 Breast cancer metastatic
PREDISPOSES,"Genes, Regulator",Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,"Genes, Regulator Breast Carcinoma"
AFFECTS,Inactivation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Inactivation Malignant neoplasm of breast
PREDISPOSES,Docosahexaenoic Acids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Docosahexaenoic Acids Malignant neoplasm of breast
AFFECTS,CDX2 gene|CDX2,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,CDX2 gene|CDX2 Breast Carcinoma
DISRUPTS,MIRN34A gene|MIR34A,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,MIRN34A gene|MIR34A Breast cancer metastatic
AFFECTS,Inflammation,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,"Element, Ion, or Isotope",Inflammation Inflammatory Breast Carcinoma
AFFECTS,H19 gene|H19|HILS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,H19 gene|H19|HILS1 Malignant neoplasm of breast
AFFECTS,Inflammation,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Inflammation Breast cancer metastatic
AFFECTS,Breast cancer invasive NOS,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Breast cancer invasive NOS Breast cancer metastatic
AUGMENTS,FOXM1 gene|FOXM1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FOXM1 gene|FOXM1 Malignant neoplasm of breast
AFFECTS,"Fatty Acids, Omega-3",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,"Fatty Acids, Omega-3 Malignant neoplasm of breast"
CAUSES,Primary carcinoma of the liver cells,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Primary carcinoma of the liver cells Malignant neoplasm of breast
CAUSES,Membrane Transport Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Membrane Transport Proteins Malignant neoplasm of breast
COMPLICATES,topical application,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",topical application Malignant neoplasm of breast
PREDISPOSES,"KLK5 protein, human|KLK5",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","KLK5 protein, human|KLK5 Malignant neoplasm of breast"
AFFECTS,ESR2 gene|ESR2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ESR2 gene|ESR2 Malignant neoplasm of breast
PREDISPOSES,CCL4 gene|CCL4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CCL4 gene|CCL4 Malignant neoplasm of breast
DISRUPTS,Receptor Protein-Tyrosine Kinases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Receptor Protein-Tyrosine Kinases Malignant neoplasm of breast
DISRUPTS,Oligonucleotides,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Oligonucleotides Malignant neoplasm of breast
DISRUPTS,Antiepileptic Agents,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical Viewed Functionally,Antiepileptic Agents Malignant neoplasm of breast
AFFECTS,"Linoleic Acids, Conjugated",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,"Linoleic Acids, Conjugated Malignant neoplasm of breast"
PREDISPOSES,Progesterone level,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Progesterone level Malignant neoplasm of breast
AFFECTS,zinc-binding protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",zinc-binding protein Malignant neoplasm of breast
AFFECTS,Cell Proliferation,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Element, Ion, or Isotope",Cell Proliferation Breast cancer invasive NOS
AFFECTS,Transcriptional Regulation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Transcriptional Regulation Malignant neoplasm of breast
PREDISPOSES,Epidermal Growth Factor Receptor|EGFR,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Biologically Active Substance,Epidermal Growth Factor Receptor|EGFR Breast cancer invasive NOS
AFFECTS,Thyroid Hormone Receptor Alpha-1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Thyroid Hormone Receptor Alpha-1 Malignant neoplasm of breast
CAUSES,FOXC1 gene|FOXC1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,FOXC1 gene|FOXC1 Breast cancer metastatic
AFFECTS,polycylic aromatic hydrocarbons-DNA adduct,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",polycylic aromatic hydrocarbons-DNA adduct Malignant neoplasm of breast
CAUSES,XRCC1 gene|XRCC1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,XRCC1 gene|XRCC1 Malignant neoplasm of breast
CAUSES,"Neoplastic Syndromes, Hereditary",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,"Neoplastic Syndromes, Hereditary Malignant neoplasm of breast"
CAUSES,APOE gene|APOE,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,APOE gene|APOE Malignant neoplasm of breast
AFFECTS,ATP phosphohydrolase|DNAH8,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",ATP phosphohydrolase|DNAH8 Malignant neoplasm of breast
PREDISPOSES,Metabolic syndrome,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Disease or Syndrome,Metabolic syndrome Breast cancer invasive NOS
AFFECTS,Angiogenesis,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Gene or Genome,Angiogenesis Breast cancer invasive NOS
AFFECTS,CDKN1B gene|CDKN1B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CDKN1B gene|CDKN1B Malignant neoplasm of breast
AFFECTS,Radiofrequency ablation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Radiofrequency ablation Malignant neoplasm of breast
PREDISPOSES,CDC2 gene|CDK1|POLD1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CDC2 gene|CDK1|POLD1 Malignant neoplasm of breast
AUGMENTS,EZH2 gene|EZH2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,EZH2 gene|EZH2 Malignant neoplasm of breast
PREDISPOSES,Apolipoprotein A-I|APOA1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Apolipoprotein A-I|APOA1 Malignant neoplasm of breast
DISRUPTS,CHES1 gene|FOXN3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CHES1 gene|FOXN3 Malignant neoplasm of breast
CAUSES,NES gene|NES,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NES gene|NES Malignant neoplasm of breast
AUGMENTS,S100A8 gene|S100A8,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,S100A8 gene|S100A8 Noninfiltrating Intraductal Carcinoma
CAUSES,Neoplasm progression,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Neoplasm progression Malignant neoplasm of breast
PREDISPOSES,RAD51C gene|RAD51C,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,Gene or Genome,RAD51C gene|RAD51C Familial cancer of breast
AFFECTS,Anti-Anxiety Agents,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical Viewed Functionally,Anti-Anxiety Agents Malignant neoplasm of breast
PREDISPOSES,"Receptors, Progesterone|EREG|ESR1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,"Receptors, Progesterone|EREG|ESR1 Malignant neoplasm of breast"
AFFECTS,Polyunsaturated Fatty Acids,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Chemical,Polyunsaturated Fatty Acids Breast cancer metastatic
PREDISPOSES,P-Glycoprotein,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Amino Acid, Peptide, or Protein",P-Glycoprotein Breast cancer recurrent
AFFECTS,Hormone replacement therapy,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Hormone,Hormone replacement therapy Breast cancer recurrent
PREDISPOSES,Recreation,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Recreation Breast Carcinoma
CAUSES,CDKN1A gene|CDKN1A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CDKN1A gene|CDKN1A Malignant neoplasm of breast
CAUSES,BRCA1 gene|BRCA1,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,BRCA1 gene|BRCA1 Breast Carcinoma
AFFECTS,Estrogen Replacement Therapy,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Hormone,Estrogen Replacement Therapy Breast cancer invasive NOS
PREDISPOSES,LACRT gene|LACRT,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LACRT gene|LACRT Malignant neoplasm of breast
PREDISPOSES,Health promotion behavior,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Health promotion behavior Malignant neoplasm of breast
PREDISPOSES,Binding Protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Binding Protein Malignant neoplasm of breast
PREDISPOSES,"IGFBP2 protein, human|IGFBP2",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","IGFBP2 protein, human|IGFBP2 Malignant neoplasm of breast"
AFFECTS,Excision,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,"Element, Ion, or Isotope","Excision Carcinoma, Ductal, Breast"
PREDISPOSES,somatotropin-binding protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",somatotropin-binding protein Malignant neoplasm of breast
DISRUPTS,Aromatase,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Enzyme,Aromatase Breast Carcinoma
AFFECTS,Mutation,bilateral breast cancer,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Mutation bilateral breast cancer
PREDISPOSES,CCND1 gene|CCND1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CCND1 gene|CCND1 Malignant neoplasm of breast
PREDISPOSES,Serum Albumin,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Body Substance,Serum Albumin Ductal Breast Carcinoma
PREDISPOSES,Antineoplastic Agents,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Antineoplastic Agents Malignant neoplasm of breast
AFFECTS,MMP14 gene|MMP14,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MMP14 gene|MMP14 Malignant neoplasm of breast
AFFECTS,Cell Cycle Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Cell Cycle Proteins Malignant neoplasm of breast
CAUSES,Air Pollution,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Air Pollution Malignant neoplasm of breast
CAUSES,"Carcinoma, Ductal, Breast",Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Neoplastic Process,"Carcinoma, Ductal, Breast Noninfiltrating Intraductal Carcinoma"
AFFECTS,Primary Lesion,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",Primary Lesion Noninfiltrating Intraductal Carcinoma
PREDISPOSES,Punctate calcium deposition,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Punctate calcium deposition Malignant neoplasm of breast
CAUSES,Hodgkin Disease,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Hodgkin Disease Malignant neoplasm of breast
PREDISPOSES,Endotoxins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Endotoxins Malignant neoplasm of breast
AUGMENTS,IRS1 gene|IRS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IRS1 gene|IRS1 Malignant neoplasm of breast
AFFECTS,STN gene|EEF1A2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,STN gene|EEF1A2 Malignant neoplasm of breast
CAUSES,Thyroid Hormones,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Hormone,Thyroid Hormones Breast Carcinoma
PREDISPOSES,Drug Exposure,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,Drug Exposure Malignant neoplasm of breast
AFFECTS,CCL5 gene|CCL5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CCL5 gene|CCL5 Malignant neoplasm of breast
AFFECTS,Nuclear Receptor Gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Nuclear Receptor Gene Malignant neoplasm of breast
PREDISPOSES,Personal Satisfaction,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,"Element, Ion, or Isotope",Personal Satisfaction Familial cancer of breast
CAUSES,Steroidal Estrogen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Steroidal Estrogen Malignant neoplasm of breast
PREDISPOSES,Family history of breast cancer,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,Family history of breast cancer Breast cancer invasive NOS
PREDISPOSES,Rare Diseases,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Disease or Syndrome,Rare Diseases Breast cancer invasive NOS
PREDISPOSES,Telomere Maintenance Gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Telomere Maintenance Gene Malignant neoplasm of breast
AFFECTS,conjugation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",conjugation Malignant neoplasm of breast
DISRUPTS,Sirolimus (substance),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Substance,Sirolimus (substance) Malignant neoplasm of breast
PREDISPOSES,NR3C1 gene|NR3C1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NR3C1 gene|NR3C1 Malignant neoplasm of breast
PREDISPOSES,"Receptors, Progesterone",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,"Receptors, Progesterone Malignant neoplasm of breast"
AUGMENTS,BRCA3 gene|BRCA3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BRCA3 gene|BRCA3 Malignant neoplasm of breast
PREDISPOSES,Red Meat Consumption,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Red Meat Consumption Malignant neoplasm of breast
PREDISPOSES,CSH2 gene|CSH2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CSH2 gene|CSH2 Malignant neoplasm of breast
AFFECTS,Actin bundling protein,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Actin bundling protein Breast cancer metastatic
PREDISPOSES,IL8 gene|CXCL8,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IL8 gene|CXCL8 Malignant neoplasm of breast
AFFECTS,MTHFR gene|MTHFR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MTHFR gene|MTHFR Malignant neoplasm of breast
AUGMENTS,HMGA2 gene|HMGA2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HMGA2 gene|HMGA2 Malignant neoplasm of breast
PREDISPOSES,ribonucleotide reductase M2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",ribonucleotide reductase M2 Malignant neoplasm of breast
PREDISPOSES,Cadmium Compounds,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Cadmium Compounds Malignant neoplasm of breast
AFFECTS,Mutation,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,"Element, Ion, or Isotope",Mutation Female Breast Carcinoma
AUGMENTS,HIF1A gene|HIF1A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HIF1A gene|HIF1A Malignant neoplasm of breast
AFFECTS,Pharmaceutical Preparations,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Pharmacologic Substance,Pharmaceutical Preparations Breast cancer recurrent
PREDISPOSES,Disorder of pregnancy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Disorder of pregnancy Malignant neoplasm of breast
PREDISPOSES,RRM2 gene|RRM2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,RRM2 gene|RRM2 Breast cancer metastatic
AUGMENTS,Sirolimus (substance),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Substance,Sirolimus (substance) Malignant neoplasm of breast
PREDISPOSES,Gene Family,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Gene Family Malignant neoplasm of breast
AFFECTS,MMP11 gene|MMP11,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MMP11 gene|MMP11 Malignant neoplasm of breast
PREDISPOSES,Mammographic microcalcification,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",Mammographic microcalcification Noninfiltrating Intraductal Carcinoma
AUGMENTS,MIRN93 gene|MIR93|MIR9-3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIRN93 gene|MIR93|MIR9-3 Malignant neoplasm of breast
AUGMENTS,Protein p53|TP53,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Protein p53|TP53 Malignant neoplasm of breast
DISRUPTS,Tumor Suppressor Genes,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,Tumor Suppressor Genes Breast Carcinoma
PREDISPOSES,Gonadal Steroid Hormones,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Hormone,Gonadal Steroid Hormones Breast cancer recurrent
AFFECTS,Diffusion,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Diffusion Malignant neoplasm of breast
PREDISPOSES,Co-morbid conditions,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Element, Ion, or Isotope",Co-morbid conditions Breast cancer recurrent
AFFECTS,C-KIT Gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,C-KIT Gene Malignant neoplasm of breast
AUGMENTS,MICE gene,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,MICE gene Noninfiltrating Intraductal Carcinoma
AFFECTS,Angiogenesis,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,Angiogenesis Breast Carcinoma
PREDISPOSES,Alcohol consumption,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Element, Ion, or Isotope",Alcohol consumption Breast cancer invasive NOS
AFFECTS,CHD5 gene|CHD5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CHD5 gene|CHD5 Malignant neoplasm of breast
CAUSES,EGF gene|EGF,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,EGF gene|EGF Malignant neoplasm of breast
AFFECTS,Carcinoma in situ of breast,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,Carcinoma in situ of breast Breast cancer invasive NOS
AFFECTS,"CHEK1 protein, human|CHEK1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CHEK1 protein, human|CHEK1 Malignant neoplasm of breast"
PREDISPOSES,Estrogen effect,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Estrogen effect Malignant neoplasm of breast
DISRUPTS,BRCA1 gene|BRCA1,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Gene or Genome,BRCA1 gene|BRCA1 Sporadic Breast Carcinoma
AFFECTS,ERCC2 gene|ERCC2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ERCC2 gene|ERCC2 Malignant neoplasm of breast
AFFECTS,Disease,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Disease or Syndrome,Disease Carcinoma of Male Breast
AFFECTS,Radiation,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,"Element, Ion, or Isotope",Radiation Contralateral breast cancer
PREDISPOSES,Fluorodeoxyglucose F18,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Carbohydrate,Fluorodeoxyglucose F18 Malignant neoplasm of breast
AFFECTS,CCND1 Gene Amplification,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CCND1 Gene Amplification Malignant neoplasm of breast
AUGMENTS,aldehyde dehydrogenase 1|ALDH1A1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",aldehyde dehydrogenase 1|ALDH1A1 Malignant neoplasm of breast
PREDISPOSES,Membrane Transport Proteins,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Membrane Transport Proteins Contralateral breast cancer
AUGMENTS,Vitamin D,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Vitamin D Malignant neoplasm of breast
PREDISPOSES,Breast arterial calcification,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Breast arterial calcification Malignant neoplasm of breast
AFFECTS,FBXW7 gene|FBXW7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FBXW7 gene|FBXW7 Malignant neoplasm of breast
PREDISPOSES,palmitoleic acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,palmitoleic acid Malignant neoplasm of breast
PREDISPOSES,PROTEIN KINASE,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",PROTEIN KINASE Malignant neoplasm of breast
PREDISPOSES,C14orf166 gene|RTRAF,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,C14orf166 gene|RTRAF Malignant neoplasm of breast
AFFECTS,EGFR Protein Overexpression,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",EGFR Protein Overexpression Malignant neoplasm of breast
AFFECTS,FBXO31 gene|FBXO31,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FBXO31 gene|FBXO31 Malignant neoplasm of breast
PREDISPOSES,FABP4 gene|FABP4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FABP4 gene|FABP4 Malignant neoplasm of breast
PREDISPOSES,GATA3 gene|GATA3,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,GATA3 gene|GATA3 Breast Carcinoma
AFFECTS,Reexcision,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Reexcision Malignant neoplasm of breast
PREDISPOSES,Encounter due to breast augmentation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Encounter due to breast augmentation Malignant neoplasm of breast
AUGMENTS,MAPK12 gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MAPK12 gene Malignant neoplasm of breast
AUGMENTS,tacrolimus binding protein 4|FKBP4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",tacrolimus binding protein 4|FKBP4 Malignant neoplasm of breast
AFFECTS,Signal Transduction Pathways,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Signal Transduction Pathways Breast Carcinoma
AFFECTS,Breast Cancer Model,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Breast Cancer Model Malignant neoplasm of breast
AFFECTS,Ellagic Acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Ellagic Acid Malignant neoplasm of breast
PREDISPOSES,FGFR1 gene|FGFR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FGFR1 gene|FGFR1 Malignant neoplasm of breast
CAUSES,Receptor Protein-Tyrosine Kinases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Receptor Protein-Tyrosine Kinases Malignant neoplasm of breast
CAUSES,BRCA2 gene|BRCA2,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Gene or Genome,BRCA2 gene|BRCA2 Carcinoma of Male Breast
AFFECTS,Cancer Promoting Genes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Cancer Promoting Genes Malignant neoplasm of breast
AFFECTS,"MAPK14 protein, human|MAPK14",Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Amino Acid, Peptide, or Protein","MAPK14 protein, human|MAPK14 Breast cancer invasive NOS"
PREDISPOSES,Estrogen Receptor Status,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptor Status Contralateral breast cancer
PREDISPOSES,Genes,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Gene or Genome,Genes Breast cancer invasive NOS
AUGMENTS,"Fatty Acids, Saturated",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,"Fatty Acids, Saturated Malignant neoplasm of breast"
PREDISPOSES,Onions,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Onions Malignant neoplasm of breast
PREDISPOSES,Androstenedione,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Androstenedione Malignant neoplasm of breast
AFFECTS,ID2 gene|ID2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,ID2 gene|ID2 Breast cancer metastatic
AFFECTS,mannuronic acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,mannuronic acid Malignant neoplasm of breast
PREDISPOSES,KRT19 gene|KRT19,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,KRT19 gene|KRT19 Breast cancer metastatic
AFFECTS,Ectopic Expression,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Ectopic Expression Malignant neoplasm of breast
PREDISPOSES,MFAP5 gene|MFAP5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MFAP5 gene|MFAP5 Malignant neoplasm of breast
AFFECTS,CCL20 gene|CCL20,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CCL20 gene|CCL20 Malignant neoplasm of breast
CAUSES,Vitamin D3 Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Vitamin D3 Receptor Malignant neoplasm of breast
AFFECTS,SDC1 gene|SDC1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SDC1 gene|SDC1 Malignant neoplasm of breast
AFFECTS,gamma-Linolenic Acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,gamma-Linolenic Acid Malignant neoplasm of breast
DISRUPTS,CD44 gene|CD44,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,CD44 gene|CD44 Breast cancer metastatic
CAUSES,Skin Lymphangiosarcoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Skin Lymphangiosarcoma Malignant neoplasm of breast
PREDISPOSES,Coronary heart disease,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Disease or Syndrome,Coronary heart disease Breast cancer invasive NOS
AFFECTS,MAFG gene|MAFG,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,MAFG gene|MAFG Breast Carcinoma
AFFECTS,ADAMTS1 gene|ADAMTS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ADAMTS1 gene|ADAMTS1 Malignant neoplasm of breast
PREDISPOSES,Antigens,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Immunologic Factor,Antigens Breast cancer metastatic
AFFECTS,Malignant Neoplasms,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Neoplastic Process,Malignant Neoplasms Inflammatory Breast Carcinoma
AFFECTS,Antisense RNA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Antisense RNA Malignant neoplasm of breast
PREDISPOSES,Metals,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Metals Malignant neoplasm of breast
AFFECTS,mRNA Expression,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",mRNA Expression Breast Carcinoma
AUGMENTS,SDC1 gene|SDC1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,SDC1 gene|SDC1 Breast cancer metastatic
PREDISPOSES,GLI3 gene|GLI3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GLI3 gene|GLI3 Malignant neoplasm of breast
AFFECTS,Tissue-Specific Gene Expression,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Tissue-Specific Gene Expression Malignant neoplasm of breast
PREDISPOSES,Egg Food Product,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Food,Egg Food Product Breast cancer invasive NOS
AFFECTS,Valproic Acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Valproic Acid Malignant neoplasm of breast
PREDISPOSES,Proto-Oncogene Proteins c-jun|JUN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Proto-Oncogene Proteins c-jun|JUN Malignant neoplasm of breast
AFFECTS,MDM2 gene|MDM2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,MDM2 gene|MDM2 Breast cancer metastatic
PREDISPOSES,Medication use,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Pharmacologic Substance,Medication use Breast cancer invasive NOS
DISRUPTS,"PER2 protein, mammalian",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","PER2 protein, mammalian Malignant neoplasm of breast"
DISRUPTS,MIRN192 gene|MIR192,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIRN192 gene|MIR192 Malignant neoplasm of breast
PREDISPOSES,Extracellular Matrix Proteins,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Extracellular Matrix Proteins Breast cancer metastatic
CAUSES,Vitamins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Vitamins Malignant neoplasm of breast
AUGMENTS,transcription factor PML,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",transcription factor PML Malignant neoplasm of breast
AFFECTS,Carcinosarcoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Carcinosarcoma Malignant neoplasm of breast
PREDISPOSES,Tumor stage,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Tumor stage Malignant neoplasm of breast
PREDISPOSES,Monocyte Chemoattractant Protein-1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Monocyte Chemoattractant Protein-1 Malignant neoplasm of breast
AUGMENTS,Transcription Repressor/Corepressor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Transcription Repressor/Corepressor Malignant neoplasm of breast
AUGMENTS,RUNX2 gene|RUNX2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RUNX2 gene|RUNX2 Malignant neoplasm of breast
PREDISPOSES,APRIN gene|PDS5B,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,APRIN gene|PDS5B Breast cancer metastatic
AUGMENTS,BMX gene|BMX,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BMX gene|BMX Malignant neoplasm of breast
AFFECTS,Mitogen-Activated Protein Kinase 3|MAPK3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Mitogen-Activated Protein Kinase 3|MAPK3 Malignant neoplasm of breast
AFFECTS,Alternative Splicing,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Alternative Splicing Breast cancer metastatic
AFFECTS,GABRA3 gene|GABRA3,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,GABRA3 gene|GABRA3 Triple Negative Breast Neoplasms
PREDISPOSES,Trans Fatty Acids,estrogen receptor-negative breast cancer,0.0,Female Breast Cancer,Chemical,Trans Fatty Acids estrogen receptor-negative breast cancer
AFFECTS,TGFB1 gene|TGFB1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,TGFB1 gene|TGFB1 Triple Negative Breast Neoplasms
PREDISPOSES,Nance-Horan syndrome,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Disease or Syndrome,Nance-Horan syndrome Triple Negative Breast Neoplasms
PREDISPOSES,intrauterine disorder,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,intrauterine disorder Malignant neoplasm of breast
CAUSES,mercury,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Inorganic Chemical,mercury Malignant neoplasm of breast
AUGMENTS,CLDN11 gene|CLDN11,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,CLDN11 gene|CLDN11 Breast Carcinoma
COMPLICATES,Secondary malignant neoplasm of bone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Secondary malignant neoplasm of bone Malignant neoplasm of breast
AFFECTS,MicroRNAs,"Breast Cancer, Familial",0.0,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","MicroRNAs Breast Cancer, Familial"
PREDISPOSES,RHPN1-AS1 gene|RHPN1-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RHPN1-AS1 gene|RHPN1-AS1 Malignant neoplasm of breast
PREDISPOSES,BRCA2 gene|BRCA2,contralateral breast cancer,0.0029970029970029,Female Breast Cancer,Gene or Genome,BRCA2 gene|BRCA2 contralateral breast cancer
PREDISPOSES,opium alkaloids and derivative combination cough suppressants,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",opium alkaloids and derivative combination cough suppressants Malignant neoplasm of breast
AFFECTS,tamoxifen,Early-Stage Breast Carcinoma,0.0,Female Breast Cancer,Pharmacologic Substance,tamoxifen Early-Stage Breast Carcinoma
AFFECTS,letrozole,Early-Stage Breast Carcinoma,0.0,Female Breast Cancer,Pharmacologic Substance,letrozole Early-Stage Breast Carcinoma
AFFECTS,Mutation,contralateral breast cancer,0.0029970029970029,Female Breast Cancer,"Element, Ion, or Isotope",Mutation contralateral breast cancer
AUGMENTS,SIRT4 gene|SIRT4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SIRT4 gene|SIRT4 Malignant neoplasm of breast
PREDISPOSES,TP53,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,TP53 Breast Carcinoma
AFFECTS,MIR221 gene|MIR221,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIR221 gene|MIR221 Malignant neoplasm of breast
AFFECTS,Invasive carcinoma of breast,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Invasive carcinoma of breast Malignant neoplasm of breast
PREDISPOSES,LINC00963 gene|LINC00963,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LINC00963 gene|LINC00963 Malignant neoplasm of breast
DISRUPTS,"TGFB1 protein, human|TGFB1",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein","TGFB1 protein, human|TGFB1 Triple Negative Breast Neoplasms"
PREDISPOSES,MIR221 gene|MIR221,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIR221 gene|MIR221 Malignant neoplasm of breast
PREDISPOSES,BHLHE40-AS1 gene|BHLHE40-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BHLHE40-AS1 gene|BHLHE40-AS1 Malignant neoplasm of breast
PREDISPOSES,SLX4IP gene|SLX4IP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SLX4IP gene|SLX4IP Malignant neoplasm of breast
AFFECTS,MTOR gene|MTOR,Carcinoma breast stage IV,0.0,Female Breast Cancer,Gene or Genome,MTOR gene|MTOR Carcinoma breast stage IV
AFFECTS,SOX21-AS1 gene|SOX21-AS1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,SOX21-AS1 gene|SOX21-AS1 Triple Negative Breast Neoplasms
AFFECTS,Detection,malignant neoplasm of breast staging,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Detection malignant neoplasm of breast staging
PREDISPOSES,STAT1 gene|STAT1,Basal-Like Breast Carcinoma,0.0039960039960039,Female Breast Cancer,Gene or Genome,STAT1 gene|STAT1 Basal-Like Breast Carcinoma
CAUSES,Gonadal Steroid Hormones,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Hormone,Gonadal Steroid Hormones Invasive carcinoma of breast
AFFECTS,Immunohistochemistry,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Indicator, Reagent, or Diagnostic Aid",Immunohistochemistry Malignant neoplasm of breast
AFFECTS,"CISH protein, human|CISH",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CISH protein, human|CISH Malignant neoplasm of breast"
AUGMENTS,NOP2 gene|NOP2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NOP2 gene|NOP2 Malignant neoplasm of breast
DISRUPTS,SNHG3 gene|SNHG3,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,SNHG3 gene|SNHG3 Triple Negative Breast Neoplasms
CAUSES,MDC1 gene|MDC1,Basal-Like Breast Carcinoma,0.0039960039960039,Female Breast Cancer,Gene or Genome,MDC1 gene|MDC1 Basal-Like Breast Carcinoma
PREDISPOSES,FOXP1 gene|FOXP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FOXP1 gene|FOXP1 Malignant neoplasm of breast
PREDISPOSES,UBE2M gene|UBE2M,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,UBE2M gene|UBE2M Malignant neoplasm of breast
AFFECTS,MLKL gene|MLKL,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MLKL gene|MLKL Malignant neoplasm of breast
PREDISPOSES,STAT3 gene|STAT3,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,STAT3 gene|STAT3 Noninfiltrating Intraductal Carcinoma
CAUSES,HER2-positive carcinoma of breast,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",HER2-positive carcinoma of breast Malignant neoplasm of breast
AFFECTS,Hemangiosarcoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Hemangiosarcoma Malignant neoplasm of breast
DISRUPTS,HEXIM1 gene|HEXIM1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,HEXIM1 gene|HEXIM1 Triple Negative Breast Neoplasms
PREDISPOSES,Hormone Receptor Positive,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Hormone Receptor Positive Malignant neoplasm of breast
PREDISPOSES,"Genes, Modifier",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,"Genes, Modifier Malignant neoplasm of breast"
AFFECTS,Proliferation (morphologic abnormality),Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Proliferation (morphologic abnormality) Breast Carcinoma
PREDISPOSES,"WWTR1 protein, human|WWTR1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","WWTR1 protein, human|WWTR1 Malignant neoplasm of breast"
PREDISPOSES,LINC00160 gene|LINC00160,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Gene or Genome,LINC00160 gene|LINC00160 estrogen receptor-positive breast cancer
AFFECTS,KLHL22 gene|KLHL22,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,KLHL22 gene|KLHL22 Malignant neoplasm of breast
AFFECTS,Cytotoxic Chemotherapy,HER2-negative breast cancer,0.0,Female Breast Cancer,Hazardous or Poisonous Substance,Cytotoxic Chemotherapy HER2-negative breast cancer
DISRUPTS,HSP90 Heat-Shock Proteins|HSP90AA1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein",HSP90 Heat-Shock Proteins|HSP90AA1 Triple Negative Breast Neoplasms
AUGMENTS,Long Intergenic Non-Protein Coding RNA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Long Intergenic Non-Protein Coding RNA Malignant neoplasm of breast
PREDISPOSES,Pathogenic,contralateral breast cancer,0.0029970029970029,Female Breast Cancer,Virus,Pathogenic contralateral breast cancer
PREDISPOSES,information seeking,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",information seeking Malignant neoplasm of breast
DISRUPTS,RB1CC1 gene|RB1CC1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RB1CC1 gene|RB1CC1 Malignant neoplasm of breast
AFFECTS,RUNX3 gene|RUNX3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RUNX3 gene|RUNX3 Malignant neoplasm of breast
PREDISPOSES,CXCR2 gene|CXCR2,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,CXCR2 gene|CXCR2 Triple Negative Breast Neoplasms
AUGMENTS,SIRT6 gene|SIRT6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SIRT6 gene|SIRT6 Malignant neoplasm of breast
AFFECTS,Ion Channel,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Ion Channel Malignant neoplasm of breast
AFFECTS,Eukaryotic Initiation Factors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Eukaryotic Initiation Factors Malignant neoplasm of breast
AUGMENTS,SIRT1 gene|SIRT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SIRT1 gene|SIRT1 Malignant neoplasm of breast
DISRUPTS,Reactive Oxygen Species,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Reactive Oxygen Species Malignant neoplasm of breast
AFFECTS,Vitamin D3 24-Hydroxylase|CYP24A1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Vitamin D3 24-Hydroxylase|CYP24A1 Malignant neoplasm of breast
PREDISPOSES,BHLHE40 gene|BHLHE40,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BHLHE40 gene|BHLHE40 Malignant neoplasm of breast
PREDISPOSES,"KRT10 protein, human|KRT10",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","KRT10 protein, human|KRT10 Malignant neoplasm of breast"
AUGMENTS,UBE2D2 gene|UBE2D2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,UBE2D2 gene|UBE2D2 Malignant neoplasm of breast
PREDISPOSES,CST3 gene|CST3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CST3 gene|CST3 Malignant neoplasm of breast
PREDISPOSES,PRS gene|PRS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PRS gene|PRS Malignant neoplasm of breast
PREDISPOSES,C8A gene|C8A,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Gene or Genome,C8A gene|C8A HER2-positive carcinoma of breast
AFFECTS,Radionuclide Imaging,malignant neoplasm of breast staging,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Radionuclide Imaging malignant neoplasm of breast staging
PREDISPOSES,Cancer-Predisposing Gene,"Breast Cancer, Familial",0.0,Female Breast Cancer,Gene or Genome,"Cancer-Predisposing Gene Breast Cancer, Familial"
PREDISPOSES,NEAT1 gene|NEAT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NEAT1 gene|NEAT1 Malignant neoplasm of breast
AFFECTS,steroid glycoside,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Steroid,steroid glycoside Triple Negative Breast Neoplasms
PREDISPOSES,SNAI3 gene|SNAI3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SNAI3 gene|SNAI3 Malignant neoplasm of breast
PREDISPOSES,Vascular Endothelial Growth Factor A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Vascular Endothelial Growth Factor A Malignant neoplasm of breast
PREDISPOSES,FZD7 gene|FZD7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FZD7 gene|FZD7 Malignant neoplasm of breast
COMPLICATES,ZFPM2-AS1 gene|ZFPM2-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ZFPM2-AS1 gene|ZFPM2-AS1 Malignant neoplasm of breast
AFFECTS,Visual Accommodation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Visual Accommodation Malignant neoplasm of breast
COMPLICATES,CTHRC1 gene|CTHRC1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CTHRC1 gene|CTHRC1 Malignant neoplasm of breast
AUGMENTS,UBR1 gene|UBR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,UBR1 gene|UBR1 Malignant neoplasm of breast
PREDISPOSES,"HLA Class I Histocompatibility Antigen, Alpha Chain G",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Immunologic Factor,"HLA Class I Histocompatibility Antigen, Alpha Chain G Malignant neoplasm of breast"
AFFECTS,angiotensin converting enzyme 2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Enzyme,angiotensin converting enzyme 2 Malignant neoplasm of breast
DISRUPTS,"YAP1 protein, human|YAP1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","YAP1 protein, human|YAP1 Malignant neoplasm of breast"
AFFECTS,Lipids,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Lipid,Lipids Breast Carcinoma
DISRUPTS,GPER1 gene|GPER1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GPER1 gene|GPER1 Malignant neoplasm of breast
AFFECTS,JMJD6 gene|JMJD6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,JMJD6 gene|JMJD6 Malignant neoplasm of breast
AFFECTS,"Regulatory Sequences, Nucleic Acid",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,"Regulatory Sequences, Nucleic Acid Malignant neoplasm of breast"
DISRUPTS,PPP2R2B gene|PPP2R2B,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Gene or Genome,PPP2R2B gene|PPP2R2B HER2-positive carcinoma of breast
AFFECTS,Epidermal Growth Factor Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Epidermal Growth Factor Receptor Malignant neoplasm of breast
AFFECTS,HHEX gene|HHEX,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HHEX gene|HHEX Malignant neoplasm of breast
DISRUPTS,ERRFI1 gene|ERRFI1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ERRFI1 gene|ERRFI1 Malignant neoplasm of breast
AUGMENTS,"CD9 protein, human|CD9",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CD9 protein, human|CD9 Malignant neoplasm of breast"
DISRUPTS,ZFAS1 gene|ZFAS1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,ZFAS1 gene|ZFAS1 Triple Negative Breast Neoplasms
PREDISPOSES,"CREB1 protein, human|CREB1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CREB1 protein, human|CREB1 Malignant neoplasm of breast"
AFFECTS,RCC2 gene|RCC2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RCC2 gene|RCC2 Malignant neoplasm of breast
AFFECTS,HER2-targeting Agent,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Amino Acid, Peptide, or Protein",HER2-targeting Agent HER2-positive carcinoma of breast
AFFECTS,Anti-Angiogenesis Effect,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Anti-Angiogenesis Effect Malignant neoplasm of breast
PREDISPOSES,Volatile Organic Compounds,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Chemical,Volatile Organic Compounds Noninfiltrating Intraductal Carcinoma
AUGMENTS,Epidermal Growth Factor Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Epidermal Growth Factor Receptor Malignant neoplasm of breast
DISRUPTS,MST1 gene|MST1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MST1 gene|MST1 Malignant neoplasm of breast
PREDISPOSES,Alcohol dehydrogenase,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Alcohol dehydrogenase Breast Carcinoma
PREDISPOSES,TRIM6 gene|TRIM6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TRIM6 gene|TRIM6 Malignant neoplasm of breast
PREDISPOSES,Tissue Inhibitor of Metalloproteinase-3|TIMP3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Tissue Inhibitor of Metalloproteinase-3|TIMP3 Malignant neoplasm of breast
AUGMENTS,HNF1A-AS1 gene|HNF1A-AS1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,HNF1A-AS1 gene|HNF1A-AS1 Triple Negative Breast Neoplasms
CAUSES,"CD274 protein, human|CD274",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CD274 protein, human|CD274 Malignant neoplasm of breast"
PREDISPOSES,human MUC1 protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",human MUC1 protein Malignant neoplasm of breast
PREDISPOSES,GZMK gene|GZMK,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GZMK gene|GZMK Malignant neoplasm of breast
DISRUPTS,COL10A1 gene|COL10A1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,COL10A1 gene|COL10A1 Malignant neoplasm of breast
CAUSES,IFNG gene|IFNG,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IFNG gene|IFNG Malignant neoplasm of breast
AUGMENTS,Nicotinate-nucleotide pyrophosphorylase (carboxylating),Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Nicotinate-nucleotide pyrophosphorylase (carboxylating) Invasive carcinoma of breast
PREDISPOSES,lipid mediator,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Lipid,lipid mediator Malignant neoplasm of breast
PREDISPOSES,VPS35 gene|VPS35,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,VPS35 gene|VPS35 Malignant neoplasm of breast
PREDISPOSES,TNFRSF11A gene|TNFRSF11A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TNFRSF11A gene|TNFRSF11A Malignant neoplasm of breast
PREDISPOSES,LINC01977 gene|LINC01977,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LINC01977 gene|LINC01977 Malignant neoplasm of breast
AFFECTS,WNT7B gene|WNT7B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,WNT7B gene|WNT7B Malignant neoplasm of breast
AUGMENTS,CYTOR gene|CYTOR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CYTOR gene|CYTOR Malignant neoplasm of breast
PREDISPOSES,Vitamin supplementation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Vitamin supplementation Malignant neoplasm of breast
AFFECTS,MIR31HG gene|MIR31HG,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIR31HG gene|MIR31HG Malignant neoplasm of breast
AUGMENTS,MIR31HG gene|MIR31HG,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIR31HG gene|MIR31HG Malignant neoplasm of breast
AFFECTS,MTERF3 gene|MTERF3,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,MTERF3 gene|MTERF3 Breast Carcinoma
AUGMENTS,GAS5 gene|GAS5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GAS5 gene|GAS5 Malignant neoplasm of breast
CAUSES,estrogen receptor-positive breast cancer,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",estrogen receptor-positive breast cancer Malignant neoplasm of breast
AUGMENTS,GLUCOSE-6-PHOSPHATASE,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Carbohydrate,GLUCOSE-6-PHOSPHATASE Triple Negative Breast Neoplasms
CAUSES,atmospheric pollution,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",atmospheric pollution Malignant neoplasm of breast
AFFECTS,Sphingolipids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Lipid,Sphingolipids Malignant neoplasm of breast
AFFECTS,Pathologic Neovascularization,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Pathologic Neovascularization Triple Negative Breast Neoplasms
AUGMENTS,PFKFB4 gene|PFKFB4,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,PFKFB4 gene|PFKFB4 Triple Negative Breast Neoplasms
AFFECTS,Metastatic malignant neoplasm to brain,Luminal B Breast Carcinoma,0.0,Female Breast Cancer,Neoplastic Process,Metastatic malignant neoplasm to brain Luminal B Breast Carcinoma
CAUSES,Angiogenesis Inhibitors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Angiogenesis Inhibitors Malignant neoplasm of breast
AUGMENTS,FABP4 gene|FABP4,Recurrent Breast Carcinoma,0.0009990009990009,Recurrent Breast Cancer,Gene or Genome,FABP4 gene|FABP4 Recurrent Breast Carcinoma
AFFECTS,Candidate Disease Gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Candidate Disease Gene Malignant neoplasm of breast
AFFECTS,Agent,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemical Viewed Functionally,Agent HER2-positive carcinoma of breast
AFFECTS,Long Intergenic Non-Protein Coding RNA,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Long Intergenic Non-Protein Coding RNA HER2-positive carcinoma of breast
AUGMENTS,TRPV6 gene|TRPV6,Carcinoma breast stage IV,0.0,Female Breast Cancer,Gene or Genome,TRPV6 gene|TRPV6 Carcinoma breast stage IV
PREDISPOSES,MMP11 gene|MMP11,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MMP11 gene|MMP11 Malignant neoplasm of breast
PREDISPOSES,AMD1 gene|AMD1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,AMD1 gene|AMD1 Malignant neoplasm of breast
CAUSES,E2F1 Transcription Factor|E2F1|UBE2L3,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",E2F1 Transcription Factor|E2F1|UBE2L3 Breast Carcinoma
AFFECTS,SOX2 Transcription Factor|SOX2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",SOX2 Transcription Factor|SOX2 Malignant neoplasm of breast
PREDISPOSES,3F8 antibody,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Indicator, Reagent, or Diagnostic Aid",3F8 antibody Malignant neoplasm of breast
PREDISPOSES,"Food, Organic",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,"Food, Organic Malignant neoplasm of breast"
CAUSES,Epstein-Barr virus,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Virus,Epstein-Barr virus Malignant neoplasm of breast
AFFECTS,Breast Cancer Therapeutic Procedure,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Breast Cancer Therapeutic Procedure Breast Carcinoma
AFFECTS,TBX15 gene|TBX15,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TBX15 gene|TBX15 Malignant neoplasm of breast
AUGMENTS,Kynurenine 3-monooxygenase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Kynurenine 3-monooxygenase Malignant neoplasm of breast
DISRUPTS,PIM1 gene|PIM1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PIM1 gene|PIM1 Malignant neoplasm of breast
AFFECTS,Hormone Therapy,Carcinoma breast stage IV,0.0,Female Breast Cancer,Hormone,Hormone Therapy Carcinoma breast stage IV
AFFECTS,AIFM2 gene|AIFM2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,AIFM2 gene|AIFM2 Malignant neoplasm of breast
PREDISPOSES,Trace Elements,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Trace Elements Malignant neoplasm of breast
AUGMENTS,RPPH1 gene|RPPH1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RPPH1 gene|RPPH1 Malignant neoplasm of breast
PREDISPOSES,"protein tyrosine phosphatase, non-receptor type 1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","protein tyrosine phosphatase, non-receptor type 1 Malignant neoplasm of breast"
PREDISPOSES,estrogen use,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,estrogen use Malignant neoplasm of breast
PREDISPOSES,PALB2 gene|PALB2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PALB2 gene|PALB2 Malignant neoplasm of breast
AFFECTS,epithelial to mesenchymal transition,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,"Element, Ion, or Isotope",epithelial to mesenchymal transition Secondary malignant neoplasm of breast
PREDISPOSES,Adverse Event Emergency Room Visit,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Phenomenon or Process,Adverse Event Emergency Room Visit Invasive carcinoma of breast
PREDISPOSES,SNHG3 gene|SNHG3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SNHG3 gene|SNHG3 Malignant neoplasm of breast
AUGMENTS,TUBA4A gene|TUBA4A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TUBA4A gene|TUBA4A Malignant neoplasm of breast
PREDISPOSES,WDR43 gene|WDR43,estrogen receptor-negative breast cancer,0.0,Female Breast Cancer,Gene or Genome,WDR43 gene|WDR43 estrogen receptor-negative breast cancer
PREDISPOSES,AMIGO2 gene|AMIGO2,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Gene or Genome,AMIGO2 gene|AMIGO2 HER2-positive carcinoma of breast
DISRUPTS,SNHG1 gene|SNHG1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SNHG1 gene|SNHG1 Malignant neoplasm of breast
AFFECTS,Intronic Mutation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Intronic Mutation Malignant neoplasm of breast
CAUSES,"Dolichyl-Diphosphooligosaccharide-Protein Glycosyltransferase Subunit 1, human",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","Dolichyl-Diphosphooligosaccharide-Protein Glycosyltransferase Subunit 1, human Malignant neoplasm of breast"
PREDISPOSES,glucose high,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Carbohydrate,glucose high Malignant neoplasm of breast
AFFECTS,Elevation procedure,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Elevation procedure Malignant neoplasm of breast
CAUSES,GATA3 gene|GATA3,Basal-Like Breast Carcinoma,0.0039960039960039,Female Breast Cancer,Gene or Genome,GATA3 gene|GATA3 Basal-Like Breast Carcinoma
PREDISPOSES,TMEM130 gene|TMEM130,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TMEM130 gene|TMEM130 Malignant neoplasm of breast
AFFECTS,Plasma Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Plasma Proteins Malignant neoplasm of breast
PREDISPOSES,RASSF1 gene|RASSF1,"Breast Cancer, Familial",0.0,Female Breast Cancer,Gene or Genome,"RASSF1 gene|RASSF1 Breast Cancer, Familial"
PREDISPOSES,BNIP3 gene|BNIP3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BNIP3 gene|BNIP3 Malignant neoplasm of breast
AFFECTS,fibroblast activation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",fibroblast activation Malignant neoplasm of breast
PREDISPOSES,Elevated Expression,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",Elevated Expression HER2-positive carcinoma of breast
AUGMENTS,COMT gene|COMT,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,COMT gene|COMT Malignant neoplasm of breast
DISRUPTS,PTPN2 gene|PTPN2,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,PTPN2 gene|PTPN2 Triple Negative Breast Neoplasms
AFFECTS,FERMT2 gene|FERMT2,Carcinoma breast stage IV,0.0,Female Breast Cancer,Gene or Genome,FERMT2 gene|FERMT2 Carcinoma breast stage IV
PREDISPOSES,"Receptor Tyrosine-Protein Kinase ErbB-4, human|ERBB4",Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,"Amino Acid, Peptide, or Protein","Receptor Tyrosine-Protein Kinase ErbB-4, human|ERBB4 Inflammatory Breast Carcinoma"
AFFECTS,Aromatase Inhibitors,Malignant neoplasm of female breast,0.0,Female Breast Cancer,Hormone,Aromatase Inhibitors Malignant neoplasm of female breast
AFFECTS,MEG3 gene|MEG3|FAM129B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MEG3 gene|MEG3|FAM129B Malignant neoplasm of breast
AUGMENTS,SHMT2 gene|SHMT2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SHMT2 gene|SHMT2 Malignant neoplasm of breast
PREDISPOSES,EIF3B gene|EIF3B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,EIF3B gene|EIF3B Malignant neoplasm of breast
CAUSES,MIR21 gene|MIR21,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIR21 gene|MIR21 Malignant neoplasm of breast
CAUSES,Suspensions,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Suspensions Malignant neoplasm of breast
AFFECTS,mRNA editing,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",mRNA editing estrogen receptor-positive breast cancer
CAUSES,Transcription Coactivator,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Transcription Coactivator Malignant neoplasm of breast
PREDISPOSES,Lymphatic Invasion,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Lymphatic Invasion Malignant neoplasm of breast
AFFECTS,Precision Medicine,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Precision Medicine Triple Negative Breast Neoplasms
COMPLICATES,Binding Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Binding Proteins Malignant neoplasm of breast
AFFECTS,MicroRNAs,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",MicroRNAs HER2-positive carcinoma of breast
PREDISPOSES,IRAK1 gene|IRAK1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IRAK1 gene|IRAK1 Malignant neoplasm of breast
PREDISPOSES,TSPAN8 gene|TSPAN8,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TSPAN8 gene|TSPAN8 Malignant neoplasm of breast
CAUSES,Genetic Loci,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Genetic Loci Malignant neoplasm of breast
PREDISPOSES,Nicotinate-nucleotide pyrophosphorylase (carboxylating),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Nicotinate-nucleotide pyrophosphorylase (carboxylating) Malignant neoplasm of breast
PREDISPOSES,Confirmation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Confirmation Malignant neoplasm of breast
COMPLICATES,cytokine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,cytokine Malignant neoplasm of breast
AFFECTS,ALDH2 gene|ALDH2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ALDH2 gene|ALDH2 Malignant neoplasm of breast
PREDISPOSES,NTN4 gene|NTN4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NTN4 gene|NTN4 Malignant neoplasm of breast
PREDISPOSES,Tumor necrosis factor receptor 11b,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Tumor necrosis factor receptor 11b Malignant neoplasm of breast
AUGMENTS,CCL18 gene|CCL18,Carcinoma breast stage IV,0.0,Female Breast Cancer,Gene or Genome,CCL18 gene|CCL18 Carcinoma breast stage IV
AUGMENTS,TLN1 gene|TLN1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,TLN1 gene|TLN1 Triple Negative Breast Neoplasms
AUGMENTS,Cell-Free DNA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Cell-Free DNA Malignant neoplasm of breast
AFFECTS,HAUS5 gene|HAUS5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HAUS5 gene|HAUS5 Malignant neoplasm of breast
AFFECTS,LINC01315 gene|LINC01315,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,LINC01315 gene|LINC01315 Triple Negative Breast Neoplasms
AUGMENTS,DLGAP1-AS2 gene|DLGAP1-AS2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,DLGAP1-AS2 gene|DLGAP1-AS2 Malignant neoplasm of breast
AFFECTS,Chromosomal translocation,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,"Element, Ion, or Isotope",Chromosomal translocation Inflammatory Breast Carcinoma
AFFECTS,SOX10 gene|SOX10,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SOX10 gene|SOX10 Malignant neoplasm of breast
DISRUPTS,lipid mediator,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Lipid,lipid mediator Malignant neoplasm of breast
AFFECTS,terminal differentiation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",terminal differentiation Malignant neoplasm of breast
AUGMENTS,UBE2T gene|UBE2T,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,UBE2T gene|UBE2T Malignant neoplasm of breast
AFFECTS,Intraoperative Radiation Therapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Intraoperative Radiation Therapy Malignant neoplasm of breast
PREDISPOSES,GHET1 gene|GHET1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,GHET1 gene|GHET1 Triple Negative Breast Neoplasms
DISRUPTS,PGM5P3-AS1 gene|PGM5P3-AS1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,PGM5P3-AS1 gene|PGM5P3-AS1 Triple Negative Breast Neoplasms
AFFECTS,cancer care,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,cancer care Malignant neoplasm of breast
CAUSES,Hereditary Breast and Ovarian Cancer Syndrome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Hereditary Breast and Ovarian Cancer Syndrome Malignant neoplasm of breast
AFFECTS,ZNF582-DT gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ZNF582-DT gene Malignant neoplasm of breast
PREDISPOSES,EBF1 gene|EBF1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,EBF1 gene|EBF1 Triple Negative Breast Neoplasms
PREDISPOSES,Recurrent infections,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Recurrent infections Malignant neoplasm of breast
PREDISPOSES,CENPW gene|CENPW,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CENPW gene|CENPW Malignant neoplasm of breast
AFFECTS,GP5 gene|GP5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GP5 gene|GP5 Malignant neoplasm of breast
AUGMENTS,CYP2W1 gene|CYP2W1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CYP2W1 gene|CYP2W1 Malignant neoplasm of breast
AFFECTS,Matrix Metalloproteinases,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Matrix Metalloproteinases Inflammatory Breast Carcinoma
AFFECTS,CDK6 gene|CDK6,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Gene or Genome,CDK6 gene|CDK6 Inflammatory Breast Carcinoma
PREDISPOSES,MFNG gene|MFNG,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,MFNG gene|MFNG Triple Negative Breast Neoplasms
PREDISPOSES,"Amino Acids, Branched-Chain",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","Amino Acids, Branched-Chain Malignant neoplasm of breast"
PREDISPOSES,Fast Foods,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Fast Foods Malignant neoplasm of breast
PREDISPOSES,MCM10 gene|MCM10,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MCM10 gene|MCM10 Malignant neoplasm of breast
AFFECTS,"SFN protein, human|SFN",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","SFN protein, human|SFN Malignant neoplasm of breast"
AFFECTS,tao hong si wu decoction,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",tao hong si wu decoction Malignant neoplasm of breast
PREDISPOSES,KDM4A gene|KDM4A,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,KDM4A gene|KDM4A Secondary malignant neoplasm of breast
AFFECTS,FOXF2 gene|FOXF2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FOXF2 gene|FOXF2 Malignant neoplasm of breast
AUGMENTS,CENPW gene|CENPW,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,CENPW gene|CENPW Breast Carcinoma
PREDISPOSES,GJA1 gene|GJA1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GJA1 gene|GJA1 Malignant neoplasm of breast
DISRUPTS,"RNA, Long Untranslated",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","RNA, Long Untranslated Triple Negative Breast Neoplasms"
AUGMENTS,MELK gene|MELK,Basal-Like Breast Carcinoma,0.0039960039960039,Female Breast Cancer,Gene or Genome,MELK gene|MELK Basal-Like Breast Carcinoma
AFFECTS,CASP9 gene|CASP9,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Gene or Genome,CASP9 gene|CASP9 Inflammatory Breast Carcinoma
CAUSES,Phytochemicals,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Phytochemicals Malignant neoplasm of breast
AUGMENTS,PFKFB3 gene|PFKFB3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PFKFB3 gene|PFKFB3 Malignant neoplasm of breast
AFFECTS,Chemicals,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemical,Chemicals HER2-positive carcinoma of breast
COMPLICATES,Acquired Immunodeficiency Syndrome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Acquired Immunodeficiency Syndrome Malignant neoplasm of breast
AFFECTS,Acute infectious disease,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Acute infectious disease Malignant neoplasm of breast
PREDISPOSES,SLC6A14 gene|SLC6A14,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,SLC6A14 gene|SLC6A14 Breast Carcinoma
DISRUPTS,RPS6KB1 gene|RPS6KB1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RPS6KB1 gene|RPS6KB1 Malignant neoplasm of breast
PREDISPOSES,SULT1A1 gene|SULT1A1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SULT1A1 gene|SULT1A1 Malignant neoplasm of breast
PREDISPOSES,medication use,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,medication use Malignant neoplasm of breast
AFFECTS,CUEDC2 gene|CUEDC2,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,CUEDC2 gene|CUEDC2 Triple Negative Breast Neoplasms
CAUSES,estrogens,Advanced breast cancer diagnosis,0.0,Female Breast Cancer,Hormone,estrogens Advanced breast cancer diagnosis
AFFECTS,"LATS1 protein, human|LATS1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","LATS1 protein, human|LATS1 Malignant neoplasm of breast"
DISRUPTS,KIF11 gene|KIF11,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,KIF11 gene|KIF11 Malignant neoplasm of breast
AUGMENTS,IRS2 gene|IRS2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IRS2 gene|IRS2 Malignant neoplasm of breast
AFFECTS,Gene Expression,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,Gene Expression Triple Negative Breast Neoplasms
PREDISPOSES,CHEK2 gene|CHEK2,contralateral breast cancer,0.0029970029970029,Female Breast Cancer,Gene or Genome,CHEK2 gene|CHEK2 contralateral breast cancer
PREDISPOSES,Lymph-vascular invasion,Invasive Ductal Breast Carcinoma,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Lymph-vascular invasion Invasive Ductal Breast Carcinoma
AFFECTS,NR1H3 gene|NR1H3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NR1H3 gene|NR1H3 Malignant neoplasm of breast
PREDISPOSES,"HMGB3 protein, human|HMGB3",Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein","HMGB3 protein, human|HMGB3 Breast Carcinoma"
PREDISPOSES,MTNR1B gene|MTNR1B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MTNR1B gene|MTNR1B Malignant neoplasm of breast
PREDISPOSES,Morbidity - disease rate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Morbidity - disease rate Malignant neoplasm of breast
AFFECTS,"DNA Breaks, Double-Stranded",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","DNA Breaks, Double-Stranded Triple Negative Breast Neoplasms"
AFFECTS,Observation - diagnostic procedure,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Observation - diagnostic procedure Malignant neoplasm of breast
AFFECTS,Female Breast Carcinoma,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Neoplastic Process,Female Breast Carcinoma Carcinoma of Male Breast
AFFECTS,Tumor Microenvironment,Carcinoma breast stage IV,0.0,Female Breast Cancer,Neoplastic Process,Tumor Microenvironment Carcinoma breast stage IV
AFFECTS,Hepatocyte Growth Factor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Hepatocyte Growth Factor Malignant neoplasm of breast
DISRUPTS,SAFB2 gene|SAFB2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SAFB2 gene|SAFB2 Malignant neoplasm of breast
DISRUPTS,MicroRNA 367-3p,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",MicroRNA 367-3p Malignant neoplasm of breast
CAUSES,Substance P Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Substance,Substance P Receptor Malignant neoplasm of breast
CAUSES,Vascular Endothelial Growth Factors|VEGFA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Vascular Endothelial Growth Factors|VEGFA Malignant neoplasm of breast
AFFECTS,PARP9 gene|PARP9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PARP9 gene|PARP9 Malignant neoplasm of breast
PREDISPOSES,Sentinel node (disorder),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Sentinel node (disorder) Malignant neoplasm of breast
AFFECTS,Cancer/Testis Antigen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Cancer/Testis Antigen Malignant neoplasm of breast
PREDISPOSES,DDX3X gene|DDX3X,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Gene or Genome,DDX3X gene|DDX3X Carcinoma of Male Breast
PREDISPOSES,PTPN13 gene|PTPN13,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PTPN13 gene|PTPN13 Malignant neoplasm of breast
AUGMENTS,KAT7 gene|KAT7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,KAT7 gene|KAT7 Malignant neoplasm of breast
AUGMENTS,"RNA, Circular",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","RNA, Circular Triple Negative Breast Neoplasms"
AFFECTS,IMPACT gene,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,IMPACT gene Triple Negative Breast Neoplasms
PREDISPOSES,IGF2BP1 gene|IGF2BP1,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,IGF2BP1 gene|IGF2BP1 Secondary malignant neoplasm of breast
AFFECTS,Degenerative polyarthritis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Degenerative polyarthritis Malignant neoplasm of breast
AFFECTS,PRMT2 gene|PRMT2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PRMT2 gene|PRMT2 Malignant neoplasm of breast
DISRUPTS,PCAT19 gene|PCAT19,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PCAT19 gene|PCAT19 Malignant neoplasm of breast
CAUSES,Genes,Hereditary Breast and Ovarian Cancer Syndrome,0.0,Female Breast Cancer,Gene or Genome,Genes Hereditary Breast and Ovarian Cancer Syndrome
AUGMENTS,SFXN1 gene|SFXN1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SFXN1 gene|SFXN1 Malignant neoplasm of breast
DISRUPTS,glycyrrhetinic acid,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Chemical,glycyrrhetinic acid Secondary malignant neoplasm of breast
AFFECTS,TWIST1 gene|TWIST1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,TWIST1 gene|TWIST1 Triple Negative Breast Neoplasms
AUGMENTS,SFXN2 gene|SFXN2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SFXN2 gene|SFXN2 Malignant neoplasm of breast
AFFECTS,Proliferation (morphologic abnormality),HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",Proliferation (morphologic abnormality) HER2-positive carcinoma of breast
PREDISPOSES,Reproductive tract infection,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Reproductive tract infection Malignant neoplasm of breast
PREDISPOSES,Apolipoprotein A-I,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Apolipoprotein A-I Malignant neoplasm of breast
AUGMENTS,IGF1R gene|IGF1R,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IGF1R gene|IGF1R Malignant neoplasm of breast
AFFECTS,SOX9 gene|SOX9,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,SOX9 gene|SOX9 Triple Negative Breast Neoplasms
PREDISPOSES,ETV7 gene|ETV7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ETV7 gene|ETV7 Malignant neoplasm of breast
AFFECTS,"FRAP1 protein, human|MTOR",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein","FRAP1 protein, human|MTOR Triple Negative Breast Neoplasms"
AFFECTS,New Target Lesion Identification,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",New Target Lesion Identification Malignant neoplasm of breast
PREDISPOSES,SMIM10L2A gene|SMIM10L2A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SMIM10L2A gene|SMIM10L2A Malignant neoplasm of breast
PREDISPOSES,Premenstrual Tension,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Premenstrual Tension Malignant neoplasm of breast
AFFECTS,Malignant neoplasm of breast,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Neoplastic Process,Malignant neoplasm of breast Secondary malignant neoplasm of breast
AFFECTS,"CDK7 protein, human|CDK7",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CDK7 protein, human|CDK7 Triple Negative Breast Neoplasms"
PREDISPOSES,LINC02568 gene|LINC02568,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Gene or Genome,LINC02568 gene|LINC02568 estrogen receptor-positive breast cancer
AFFECTS,Invasive carcinoma of breast,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Neoplastic Process,Invasive carcinoma of breast Noninfiltrating Intraductal Carcinoma
PREDISPOSES,KCNQ1OT1 gene|KCNQ1OT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,KCNQ1OT1 gene|KCNQ1OT1 Malignant neoplasm of breast
PREDISPOSES,ERBB2 gene|ERBB2,Carcinoma breast stage IV,0.0,Female Breast Cancer,Gene or Genome,ERBB2 gene|ERBB2 Carcinoma breast stage IV
PREDISPOSES,Cardiac dysfunction,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Cardiac dysfunction Malignant neoplasm of breast
AUGMENTS,SNHG11 gene|SNHG11,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,SNHG11 gene|SNHG11 Triple Negative Breast Neoplasms
AFFECTS,glucose,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Carbohydrate,glucose Malignant neoplasm of breast
AFFECTS,Mental disorders,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Mental disorders Malignant neoplasm of breast
AUGMENTS,SLC7A11 gene|SLC7A11,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SLC7A11 gene|SLC7A11 Malignant neoplasm of breast
AFFECTS,Tn antigen,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Immunologic Factor,Tn antigen Secondary malignant neoplasm of breast
AFFECTS,TIPARP gene|TIPARP,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,TIPARP gene|TIPARP Triple Negative Breast Neoplasms
PREDISPOSES,"TNK2 protein, human|TNK2",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","TNK2 protein, human|TNK2 Malignant neoplasm of breast"
CAUSES,Lymph Node Metastasis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Lymph Node Metastasis Malignant neoplasm of breast
AFFECTS,glycosylation,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,"Element, Ion, or Isotope",glycosylation Secondary malignant neoplasm of breast
AFFECTS,Indicators,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,"Indicator, Reagent, or Diagnostic Aid",Indicators Secondary malignant neoplasm of breast
AFFECTS,MIR182 gene|MIR182,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIR182 gene|MIR182 Malignant neoplasm of breast
AFFECTS,receptor for advanced glycation endproducts,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",receptor for advanced glycation endproducts Malignant neoplasm of breast
PREDISPOSES,ATP2C1 gene|ATP2C1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ATP2C1 gene|ATP2C1 Malignant neoplasm of breast
PREDISPOSES,malignant disease,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,malignant disease Malignant neoplasm of breast
AFFECTS,Hypofractionated radiation therapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Hypofractionated radiation therapy Malignant neoplasm of breast
PREDISPOSES,FOXA1 gene|FOXA1,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,FOXA1 gene|FOXA1 Secondary malignant neoplasm of breast
PREDISPOSES,postmenopausal syndrome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,postmenopausal syndrome Malignant neoplasm of breast
PREDISPOSES,SIGLEC15 gene|SIGLEC15,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,SIGLEC15 gene|SIGLEC15 Secondary malignant neoplasm of breast
DISRUPTS,MIDEAS gene|ELMSAN1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,MIDEAS gene|ELMSAN1 Triple Negative Breast Neoplasms
AFFECTS,Amino Acids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Amino Acids Malignant neoplasm of breast
AFFECTS,OTUB1 gene|OTUB1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,OTUB1 gene|OTUB1 Malignant neoplasm of breast
AFFECTS,High Density Lipoproteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",High Density Lipoproteins Malignant neoplasm of breast
CAUSES,VEGFA gene|VEGFA,Invasive Ductal Breast Carcinoma,0.0,Female Breast Cancer,Gene or Genome,VEGFA gene|VEGFA Invasive Ductal Breast Carcinoma
PREDISPOSES,LAYN gene|LAYN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LAYN gene|LAYN Malignant neoplasm of breast
AUGMENTS,PIK3CB gene|PIK3CB,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PIK3CB gene|PIK3CB Malignant neoplasm of breast
PREDISPOSES,Genes,Carcinoma breast stage IV,0.0,Female Breast Cancer,Gene or Genome,Genes Carcinoma breast stage IV
PREDISPOSES,RHOT1 gene|RHOT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RHOT1 gene|RHOT1 Malignant neoplasm of breast
AFFECTS,STAT3 gene|STAT3,Carcinoma breast stage IV,0.0,Female Breast Cancer,Gene or Genome,STAT3 gene|STAT3 Carcinoma breast stage IV
PREDISPOSES,UHRF1 gene|UHRF1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,UHRF1 gene|UHRF1 Malignant neoplasm of breast
AUGMENTS,PAXX gene|PAXX,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,PAXX gene|PAXX Triple Negative Breast Neoplasms
PREDISPOSES,Consideration,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Consideration Breast Carcinoma
DISRUPTS,ANXA9 gene|ANXA9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ANXA9 gene|ANXA9 Malignant neoplasm of breast
PREDISPOSES,SF3B1 gene|SF3B1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SF3B1 gene|SF3B1 Malignant neoplasm of breast
AFFECTS,Positive Regulation of Oxidative Stress Process,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",Positive Regulation of Oxidative Stress Process estrogen receptor-positive breast cancer
CAUSES,CERS4 gene|CERS4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CERS4 gene|CERS4 Malignant neoplasm of breast
AFFECTS,"MMP11 protein, human|MMP11",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","MMP11 protein, human|MMP11 Malignant neoplasm of breast"
AUGMENTS,"MAP3K8 protein, human|MAP3K8",Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Amino Acid, Peptide, or Protein","MAP3K8 protein, human|MAP3K8 Noninfiltrating Intraductal Carcinoma"
AUGMENTS,Squalene monooxygenase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Squalene monooxygenase Malignant neoplasm of breast
PREDISPOSES,RIN2 gene|RIN2,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,RIN2 gene|RIN2 Triple Negative Breast Neoplasms
PREDISPOSES,G protein-coupled receptor kinase 4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",G protein-coupled receptor kinase 4 Malignant neoplasm of breast
AUGMENTS,YTHDF1 gene|YTHDF1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,YTHDF1 gene|YTHDF1 Malignant neoplasm of breast
PREDISPOSES,INSM1 gene|INSM1,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,INSM1 gene|INSM1 Breast Carcinoma
PREDISPOSES,"PTGS2 protein, human|PTGS2",Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Amino Acid, Peptide, or Protein","PTGS2 protein, human|PTGS2 Invasive carcinoma of breast"
AFFECTS,AZGP1 gene|AZGP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,AZGP1 gene|AZGP1 Malignant neoplasm of breast
AUGMENTS,CIB1 gene|CIB1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,CIB1 gene|CIB1 Triple Negative Breast Neoplasms
DISRUPTS,NCBP1 gene|NCBP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NCBP1 gene|NCBP1 Malignant neoplasm of breast
CAUSES,NEU1 gene|NEU1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NEU1 gene|NEU1 Malignant neoplasm of breast
PREDISPOSES,ELAVL2 gene|ELAVL2,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,ELAVL2 gene|ELAVL2 Secondary malignant neoplasm of breast
AFFECTS,APOBEC3A gene|APOBEC3A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,APOBEC3A gene|APOBEC3A Malignant neoplasm of breast
DISRUPTS,ROS1 gene|ROS1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,ROS1 gene|ROS1 Triple Negative Breast Neoplasms
AUGMENTS,SNORD49B gene|SNORD49B,Early-Stage Breast Carcinoma,0.0,Female Breast Cancer,Gene or Genome,SNORD49B gene|SNORD49B Early-Stage Breast Carcinoma
PREDISPOSES,Details of education,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Details of education Malignant neoplasm of breast
AFFECTS,MYC gene|MYC,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,MYC gene|MYC Secondary malignant neoplasm of breast
AFFECTS,SIPA1 gene|SIPA1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,SIPA1 gene|SIPA1 Triple Negative Breast Neoplasms
PREDISPOSES,"ORF74 protein, Human herpesvirus 8",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein","ORF74 protein, Human herpesvirus 8 Triple Negative Breast Neoplasms"
AFFECTS,RBM24 gene|RBM24,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,RBM24 gene|RBM24 Triple Negative Breast Neoplasms
PREDISPOSES,FOXO3 gene|FOXO3,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,FOXO3 gene|FOXO3 Triple Negative Breast Neoplasms
AUGMENTS,NT5DC2 gene|NT5DC2,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,NT5DC2 gene|NT5DC2 Triple Negative Breast Neoplasms
PREDISPOSES,CERNA2 gene|CERNA2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CERNA2 gene|CERNA2 Malignant neoplasm of breast
DISRUPTS,PTPRG-AS1 gene|PTPRG-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PTPRG-AS1 gene|PTPRG-AS1 Malignant neoplasm of breast
AFFECTS,Pharmaceutical Preparations,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Pharmacologic Substance,Pharmaceutical Preparations Triple Negative Breast Neoplasms
AUGMENTS,Genes,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,Genes Triple Negative Breast Neoplasms
PREDISPOSES,SF3A2 gene|SF3A2,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,SF3A2 gene|SF3A2 Triple Negative Breast Neoplasms
AUGMENTS,SLC7A11 gene|SLC7A11,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,SLC7A11 gene|SLC7A11 Triple Negative Breast Neoplasms
PREDISPOSES,PDK1 gene|PDK1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PDK1 gene|PDK1 Malignant neoplasm of breast
AFFECTS,Lipidome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Lipid,Lipidome Malignant neoplasm of breast
PREDISPOSES,BAIAP2L1 gene|BAIAP2L1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BAIAP2L1 gene|BAIAP2L1 Malignant neoplasm of breast
AFFECTS,Malignant Neoplasms,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Neoplastic Process,Malignant Neoplasms Secondary malignant neoplasm of breast
AUGMENTS,Cell Cycle Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Cell Cycle Proteins Malignant neoplasm of breast
AFFECTS,Endocrine System Diseases,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Hormone,Endocrine System Diseases HER2-positive carcinoma of breast
AFFECTS,Hormone Receptor,malignant neoplasm of breast staging,0.0,Female Breast Cancer,Hormone,Hormone Receptor malignant neoplasm of breast staging
DISRUPTS,NUDT1 gene|NUDT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NUDT1 gene|NUDT1 Malignant neoplasm of breast
AFFECTS,CONOTRUNCAL ANOMALY FACE SYNDROME,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,CONOTRUNCAL ANOMALY FACE SYNDROME Malignant neoplasm of breast
AFFECTS,Corticotropin-Releasing Hormone,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Hormone,Corticotropin-Releasing Hormone Breast Carcinoma
AFFECTS,receptor for advanced glycation endproducts,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",receptor for advanced glycation endproducts Breast cancer metastatic
CAUSES,Intravascular Metastasis,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Intravascular Metastasis Breast cancer metastatic
CAUSES,MAPK8 gene|MAPK8,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MAPK8 gene|MAPK8 Malignant neoplasm of breast
AFFECTS,CXCL12 gene|CXCL12,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Gene or Genome,"CXCL12 gene|CXCL12 Carcinoma, Ductal, Breast"
AFFECTS,ATF3 gene|ATF3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ATF3 gene|ATF3 Malignant neoplasm of breast
DISRUPTS,BCL-2 Protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",BCL-2 Protein Malignant neoplasm of breast
PREDISPOSES,TRAF4 gene|TRAF4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TRAF4 gene|TRAF4 Malignant neoplasm of breast
AFFECTS,Breast cancer metastatic,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Breast cancer metastatic Malignant neoplasm of breast
DISRUPTS,Estrogen Receptors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptors Malignant neoplasm of breast
PREDISPOSES,Chronic inflammation,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Chronic inflammation Sporadic Breast Carcinoma
PREDISPOSES,EPHA10 gene|EPHA10,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,EPHA10 gene|EPHA10 Malignant neoplasm of breast
CAUSES,STAT3 gene|STAT3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,STAT3 gene|STAT3 Malignant neoplasm of breast
DISRUPTS,"FRAP1 protein, human|MTOR",Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein","FRAP1 protein, human|MTOR Breast cancer metastatic"
PREDISPOSES,"CYP2B6 protein, human|CYP2B6",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CYP2B6 protein, human|CYP2B6 Malignant neoplasm of breast"
DISRUPTS,Selective Estrogen Receptor Modulators,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Selective Estrogen Receptor Modulators Malignant neoplasm of breast
AFFECTS,Transferase Gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Transferase Gene Malignant neoplasm of breast
AFFECTS,DNA repair protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",DNA repair protein Malignant neoplasm of breast
PREDISPOSES,NCOA1 gene|NCOA1,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Gene or Genome,NCOA1 gene|NCOA1 Breast cancer recurrent
CAUSES,SRC gene|SRC,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SRC gene|SRC Malignant neoplasm of breast
CAUSES,Secondary malignant neoplasm of lung,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Secondary malignant neoplasm of lung Malignant neoplasm of breast
AFFECTS,TRANCE protein,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",TRANCE protein Breast Carcinoma
AUGMENTS,AMOT gene|AMOT,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,AMOT gene|AMOT Malignant neoplasm of breast
DISRUPTS,3' Untranslated Regions,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",3' Untranslated Regions Malignant neoplasm of breast
CAUSES,Estrogen Receptor beta|EREG|ESR1,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptor beta|EREG|ESR1 Female Breast Carcinoma
AFFECTS,CYP2C19 gene|CYP2C19,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CYP2C19 gene|CYP2C19 Malignant neoplasm of breast
AUGMENTS,GIT1 gene|GIT1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,GIT1 gene|GIT1 Breast cancer metastatic
CAUSES,Estrogens,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,Hormone,Estrogens Female Breast Carcinoma
PREDISPOSES,25-hydroxyvitamin D,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,25-hydroxyvitamin D Malignant neoplasm of breast
AFFECTS,mdm2 protein|MDM4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",mdm2 protein|MDM4 Malignant neoplasm of breast
AFFECTS,Medroxyprogesterone 17-Acetate,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Hormone,Medroxyprogesterone 17-Acetate Breast cancer metastatic
AFFECTS,Detection,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Element, Ion, or Isotope",Detection Breast cancer invasive NOS
AFFECTS,"Carcinogens, Environmental",Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Hazardous or Poisonous Substance,"Carcinogens, Environmental Carcinoma of Male Breast"
PREDISPOSES,Noninfiltrating Intraductal Carcinoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Noninfiltrating Intraductal Carcinoma Malignant neoplasm of breast
AFFECTS,Breast Microcalcification,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Element, Ion, or Isotope",Breast Microcalcification Breast cancer invasive NOS
PREDISPOSES,HNRPM gene|HNRNPM,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,HNRPM gene|HNRNPM Breast cancer metastatic
PREDISPOSES,PARP1 gene|PARP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PARP1 gene|PARP1 Malignant neoplasm of breast
PREDISPOSES,BIRC7 gene|BIRC7,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,BIRC7 gene|BIRC7 Breast cancer metastatic
DISRUPTS,BCL2L11 gene|BCL2L11,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,BCL2L11 gene|BCL2L11 Breast cancer metastatic
AFFECTS,Squamous cell carcinoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Squamous cell carcinoma Malignant neoplasm of breast
PREDISPOSES,Seafood,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Seafood Malignant neoplasm of breast
PREDISPOSES,Mammographic microcalcification,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Mammographic microcalcification Malignant neoplasm of breast
AUGMENTS,MicroRNAs,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","MicroRNAs Carcinoma, Ductal, Breast"
AFFECTS,"Genes, Suppressor",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,"Genes, Suppressor Malignant neoplasm of breast"
PREDISPOSES,Intercellular adhesion molecule 1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Intercellular adhesion molecule 1 Malignant neoplasm of breast
CAUSES,Colorectal Cancer,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Colorectal Cancer Malignant neoplasm of breast
AFFECTS,S100 Proteins|S100A1|S100B,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Amino Acid, Peptide, or Protein",S100 Proteins|S100A1|S100B Breast cancer invasive NOS
PREDISPOSES,BRCA3 gene|BRCA3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BRCA3 gene|BRCA3 Malignant neoplasm of breast
DISRUPTS,S100A8 gene|S100A8,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,S100A8 gene|S100A8 Malignant neoplasm of breast
PREDISPOSES,Finding of antibody titer,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Indicator, Reagent, or Diagnostic Aid",Finding of antibody titer Malignant neoplasm of breast
AFFECTS,Evolution,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",Evolution Noninfiltrating Intraductal Carcinoma
AFFECTS,MIRN10B gene|MIR10B,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,MIRN10B gene|MIR10B Breast cancer metastatic
PREDISPOSES,CTSL gene|CTSL,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CTSL gene|CTSL Malignant neoplasm of breast
CAUSES,ERBB2 gene|ERBB2,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,ERBB2 gene|ERBB2 Breast Carcinoma
AFFECTS,Malignant Neoplasms,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Neoplastic Process,Malignant Neoplasms Sporadic Breast Carcinoma
AFFECTS,ERBB4 gene|ERBB4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ERBB4 gene|ERBB4 Malignant neoplasm of breast
PREDISPOSES,Selective Estrogen Receptor Modulators,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Selective Estrogen Receptor Modulators Breast cancer invasive NOS
AFFECTS,Serum Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Serum Proteins Malignant neoplasm of breast
DISRUPTS,Genome,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,Genome Breast Carcinoma
AFFECTS,Detection,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",Detection Noninfiltrating Intraductal Carcinoma
AFFECTS,Aromatase Inhibitors,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Hormone,Aromatase Inhibitors Breast cancer metastatic
AUGMENTS,Prostate-Specific Antigen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Immunologic Factor,Prostate-Specific Antigen Malignant neoplasm of breast
AFFECTS,Mitogen-Activated Protein Kinases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Mitogen-Activated Protein Kinases Malignant neoplasm of breast
AFFECTS,ERBB2 gene|ERBB2,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,ERBB2 gene|ERBB2 Breast Carcinoma
AFFECTS,Retinoblastoma Genes,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,Retinoblastoma Genes Breast Carcinoma
CAUSES,leukemia inhibitory factor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,leukemia inhibitory factor Malignant neoplasm of breast
AFFECTS,Phytochemical,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Chemical,Phytochemical Breast cancer metastatic
PREDISPOSES,Lactoylglutathione Lyase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Lactoylglutathione Lyase Malignant neoplasm of breast
CAUSES,BRCA2 gene|BRCA2,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,Gene or Genome,BRCA2 gene|BRCA2 Female Breast Carcinoma
DISRUPTS,TNFSF11 gene|TNFSF11,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TNFSF11 gene|TNFSF11 Malignant neoplasm of breast
AFFECTS,Deletion Mutation,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Deletion Mutation Breast Carcinoma
AFFECTS,Syndrome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Syndrome Malignant neoplasm of breast
AFFECTS,DNA,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",DNA Breast Carcinoma
DISRUPTS,Chemopreventive Agent,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical Viewed Functionally,Chemopreventive Agent Malignant neoplasm of breast
PREDISPOSES,Blind Vision,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Blind Vision Malignant neoplasm of breast
PREDISPOSES,N-Acetylneuraminic Acid,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Chemical,N-Acetylneuraminic Acid Breast Carcinoma
AFFECTS,Malignant Neoplasms,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Neoplastic Process,Malignant Neoplasms Noninfiltrating Intraductal Carcinoma
PREDISPOSES,Milk Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Milk Proteins Malignant neoplasm of breast
AFFECTS,Ductal Carcinoma,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Neoplastic Process,Ductal Carcinoma Noninfiltrating Intraductal Carcinoma
AFFECTS,ASK Gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ASK Gene Malignant neoplasm of breast
CAUSES,Carcinoma,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Neoplastic Process,Carcinoma Carcinoma of Male Breast
PREDISPOSES,CEACAM5 gene|CEACAM5,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,CEACAM5 gene|CEACAM5 Noninfiltrating Intraductal Carcinoma
CAUSES,HPR gene|HPR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HPR gene|HPR Malignant neoplasm of breast
CAUSES,Polyomavirus Middle T Antigens,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Virus,Polyomavirus Middle T Antigens Breast Carcinoma
AFFECTS,trastuzumab,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Pharmacologic Substance,trastuzumab Breast Carcinoma
AUGMENTS,"VEGF protein, human|VEGFA",Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein","VEGF protein, human|VEGFA Breast Carcinoma"
AUGMENTS,sex hormone-binding globulin receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,sex hormone-binding globulin receptor Malignant neoplasm of breast
AFFECTS,Indicators,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Indicator, Reagent, or Diagnostic Aid",Indicators Malignant neoplasm of breast
CAUSES,Tumor Suppressor Genes,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,Tumor Suppressor Genes Breast Carcinoma
AUGMENTS,PBP gene|DOCK3|PEBP1|PKD1|MED1|PPBP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PBP gene|DOCK3|PEBP1|PKD1|MED1|PPBP Malignant neoplasm of breast
PREDISPOSES,Glycoproteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Glycoproteins Malignant neoplasm of breast
PREDISPOSES,National origin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",National origin Malignant neoplasm of breast
CAUSES,Candidate Disease Gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Candidate Disease Gene Malignant neoplasm of breast
CAUSES,Antigens,Breast cancer stage II,0.0,Female Breast Cancer,Immunologic Factor,Antigens Breast cancer stage II
CAUSES,tumor growth,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Neoplastic Process,tumor growth Breast cancer metastatic
PREDISPOSES,alpha-Linolenic Acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,alpha-Linolenic Acid Malignant neoplasm of breast
DISRUPTS,Protease Inhibitor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Enzyme,Protease Inhibitor Malignant neoplasm of breast
CAUSES,Protease Inhibitor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Enzyme,Protease Inhibitor Malignant neoplasm of breast
CAUSES,Cell Cycle Proteins,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Cell Cycle Proteins Breast Carcinoma
AFFECTS,CD4 gene|CD4,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,CD4 gene|CD4 Breast cancer metastatic
AFFECTS,CA-15-3 Antigen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Immunologic Factor,CA-15-3 Antigen Malignant neoplasm of breast
CAUSES,Growth Factor Receptors,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Biologically Active Substance,Growth Factor Receptors Breast Carcinoma
AFFECTS,Endometrial Carcinoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Endometrial Carcinoma Malignant neoplasm of breast
AFFECTS,Vascular Endothelial Growth Factor Receptor-2|VEGFA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Vascular Endothelial Growth Factor Receptor-2|VEGFA Malignant neoplasm of breast
AUGMENTS,riboflavin-binding protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",riboflavin-binding protein Malignant neoplasm of breast
PREDISPOSES,Progesterone increased,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Progesterone increased Malignant neoplasm of breast
CAUSES,Micronutrients,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Micronutrients Malignant neoplasm of breast
AFFECTS,Detection,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Element, Ion, or Isotope",Detection Breast cancer recurrent
AFFECTS,c-myc Proto-Oncogenes|MYC,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,c-myc Proto-Oncogenes|MYC Malignant neoplasm of breast
AFFECTS,Angiogenesis Factor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Angiogenesis Factor Malignant neoplasm of breast
AFFECTS,Epithelial-Stromal Communication,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Epithelial-Stromal Communication Malignant neoplasm of breast
AFFECTS,Immunization,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Immunization Breast Carcinoma
CAUSES,Hydrocarbons,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Hydrocarbons Malignant neoplasm of breast
PREDISPOSES,Oncogene ErbB2|ERBB2|NEU1|NEURL1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Oncogene ErbB2|ERBB2|NEU1|NEURL1 Malignant neoplasm of breast
PREDISPOSES,Preventive Services - Orthodontics,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Phenomenon or Process,Preventive Services - Orthodontics Malignant neoplasm of breast
AUGMENTS,EPSTI1 gene|EPSTI1,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Gene or Genome,EPSTI1 gene|EPSTI1 Breast cancer invasive NOS
AUGMENTS,AKT2 gene|AKT2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,AKT2 gene|AKT2 Malignant neoplasm of breast
AFFECTS,Transgenes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Transgenes Malignant neoplasm of breast
AUGMENTS,Protein Kinase C|PRRT2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Protein Kinase C|PRRT2 Malignant neoplasm of breast
CAUSES,Cyclooxygenase 2 Inhibitors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Cyclooxygenase 2 Inhibitors Malignant neoplasm of breast
AFFECTS,Tamoxifen,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Pharmacologic Substance,Tamoxifen Breast Carcinoma
AFFECTS,Endocrine therapy,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Hormone,Endocrine therapy Breast Carcinoma
AFFECTS,"CBFB protein, human|CBFB|NFYA|NFYB",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CBFB protein, human|CBFB|NFYA|NFYB Malignant neoplasm of breast"
PREDISPOSES,MSN gene|MSN,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,MSN gene|MSN Breast Carcinoma
DISRUPTS,Human Chorionic Gonadotropin|CGA|HTC2|CGB5,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Human Chorionic Gonadotropin|CGA|HTC2|CGB5 Breast Carcinoma
AFFECTS,VEGF gene|VEGFA,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,VEGF gene|VEGFA Breast cancer metastatic
CAUSES,BARD1 gene|BARD1,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,BARD1 gene|BARD1 Breast Carcinoma
CAUSES,"prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase), human",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase), human Malignant neoplasm of breast"
PREDISPOSES,Renal tubular disorder,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Disease or Syndrome,Renal tubular disorder Breast cancer invasive NOS
PREDISPOSES,Dinucleotide Repeats,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Dinucleotide Repeats Malignant neoplasm of breast
DISRUPTS,GADD45A gene|GADD45A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GADD45A gene|GADD45A Malignant neoplasm of breast
AUGMENTS,TSG101 gene|TSG101,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Gene or Genome,TSG101 gene|TSG101 Breast cancer invasive NOS
AFFECTS,progesterone analog,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,progesterone analog Malignant neoplasm of breast
CAUSES,Mouse mammary tumor virus infection,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Mouse mammary tumor virus infection Breast Carcinoma
PREDISPOSES,Abnormal digestive tract function,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Abnormal digestive tract function Malignant neoplasm of breast
CAUSES,"Receptors, Progesterone|PGR",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,"Receptors, Progesterone|PGR Malignant neoplasm of breast"
COMPLICATES,Poland Syndrome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Poland Syndrome Malignant neoplasm of breast
AFFECTS,STK11 gene|STK11,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,STK11 gene|STK11 Malignant neoplasm of breast
AFFECTS,BIN1 gene|BIN1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BIN1 gene|BIN1 Malignant neoplasm of breast
PREDISPOSES,Dopamine Antagonists,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neuroreactive Substance or Biogenic Amine,Dopamine Antagonists Malignant neoplasm of breast
AFFECTS,IL6ST gene|IL6ST,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IL6ST gene|IL6ST Malignant neoplasm of breast
PREDISPOSES,Cell Adhesion Molecules,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Cell Adhesion Molecules Breast Carcinoma
AFFECTS,Hereditary Malignant Neoplasm,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Hereditary Malignant Neoplasm Malignant neoplasm of breast
DISRUPTS,CASP8 gene|CASP8,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CASP8 gene|CASP8 Malignant neoplasm of breast
CAUSES,Vitamin D,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Vitamin D Malignant neoplasm of breast
PREDISPOSES,Pulmonary toxicity,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,Hazardous or Poisonous Substance,Pulmonary toxicity Contralateral breast cancer
PREDISPOSES,IGFBP1 gene|IGFBP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IGFBP1 gene|IGFBP1 Malignant neoplasm of breast
CAUSES,Carcinogenicity,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hazardous or Poisonous Substance,Carcinogenicity Malignant neoplasm of breast
PREDISPOSES,APOE gene|APOE,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,APOE gene|APOE Malignant neoplasm of breast
AUGMENTS,5'-AMP-activated protein kinase,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",5'-AMP-activated protein kinase Breast Carcinoma
DISRUPTS,Transforming Growth Factor beta Receptors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Transforming Growth Factor beta Receptors Malignant neoplasm of breast
PREDISPOSES,syndecan 1 protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",syndecan 1 protein Malignant neoplasm of breast
PREDISPOSES,Recombinant Transforming Growth Factor-Beta 1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Recombinant Transforming Growth Factor-Beta 1 Malignant neoplasm of breast
CAUSES,Carcinoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Carcinoma Malignant neoplasm of breast
PREDISPOSES,RHOC gene|RHOC,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Gene or Genome,RHOC gene|RHOC Inflammatory Breast Carcinoma
CAUSES,Antihypertensive Agents,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical Viewed Functionally,Antihypertensive Agents Malignant neoplasm of breast
AFFECTS,catenin p120(ctn) protein|CTNND1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",catenin p120(ctn) protein|CTNND1 Malignant neoplasm of breast
AUGMENTS,Homologous Gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Homologous Gene Malignant neoplasm of breast
AUGMENTS,PTN gene|PTN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PTN gene|PTN Malignant neoplasm of breast
AFFECTS,SCTR gene|SCTR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SCTR gene|SCTR Malignant neoplasm of breast
PREDISPOSES,Repetitive Region,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Repetitive Region Malignant neoplasm of breast
CAUSES,NBS1 gene|NBN|NLRP2,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,Gene or Genome,NBS1 gene|NBN|NLRP2 Familial cancer of breast
CAUSES,Genes,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,Genes Breast Carcinoma
AUGMENTS,steroid hormone receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,steroid hormone receptor Malignant neoplasm of breast
AFFECTS,Excretory function,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Excretory function Malignant neoplasm of breast
PREDISPOSES,Serum Folate Level,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Body Substance,Serum Folate Level Malignant neoplasm of breast
DISRUPTS,of 3-(4-(4-((1-(2-chlorophenyl)ethoxy)carbonyl amino)-3-methyl-5-isoxazolyl) benzylsulfanyl) propanoic acid,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Chemical,of 3-(4-(4-((1-(2-chlorophenyl)ethoxy)carbonyl amino)-3-methyl-5-isoxazolyl) benzylsulfanyl) propanoic acid Breast cancer metastatic
AFFECTS,Nucleotide Excision Repair,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Nucleotide Excision Repair Malignant neoplasm of breast
PREDISPOSES,Focal Adhesion Protein-Tyrosine Kinases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Focal Adhesion Protein-Tyrosine Kinases Malignant neoplasm of breast
AFFECTS,bone morphogenetic protein 5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,bone morphogenetic protein 5 Malignant neoplasm of breast
CAUSES,Transgenes,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,Transgenes Breast cancer metastatic
PREDISPOSES,Dyslipidemias,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Lipid,Dyslipidemias Malignant neoplasm of breast
AUGMENTS,PROTEIN KINASE|PGR|PR@|PRH2|TMEM37|ERVK-7|ERVK-8|ERVK-10|ERVK-9|ERVK-21|ERVK-18|ERVK-25|ERVK-24|ERVK-19,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Amino Acid, Peptide, or Protein",PROTEIN KINASE|PGR|PR@|PRH2|TMEM37|ERVK-7|ERVK-8|ERVK-10|ERVK-9|ERVK-21|ERVK-18|ERVK-25|ERVK-24|ERVK-19 Breast cancer invasive NOS
DISRUPTS,KL gene|KL,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,KL gene|KL Malignant neoplasm of breast
AFFECTS,nucleic acid inhibitor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,nucleic acid inhibitor Malignant neoplasm of breast
AUGMENTS,Estrogens,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Hormone,Estrogens Sporadic Breast Carcinoma
CAUSES,Breast cancer metastatic,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Breast cancer metastatic Malignant neoplasm of breast
AUGMENTS,Proto-Oncogene Proteins c-akt,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,Proto-Oncogene Proteins c-akt Breast Carcinoma
PREDISPOSES,estrogen receptor gamma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",estrogen receptor gamma Malignant neoplasm of breast
PREDISPOSES,MAPK8 gene|MAPK8,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MAPK8 gene|MAPK8 Malignant neoplasm of breast
AFFECTS,FGFR2 gene|FGFR2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FGFR2 gene|FGFR2 Malignant neoplasm of breast
PREDISPOSES,P-Glycoprotein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",P-Glycoprotein Malignant neoplasm of breast
AFFECTS,sarcoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,sarcoma Malignant neoplasm of breast
AFFECTS,Reactive Oxygen Species,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Reactive Oxygen Species Malignant neoplasm of breast
PREDISPOSES,Protein phosphatase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Protein phosphatase Malignant neoplasm of breast
AFFECTS,CD44 gene|CD44,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,CD44 gene|CD44 Noninfiltrating Intraductal Carcinoma
PREDISPOSES,Transcription Factor 3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Transcription Factor 3 Malignant neoplasm of breast
PREDISPOSES,MAPK12 gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MAPK12 gene Malignant neoplasm of breast
AUGMENTS,S100A2 gene|S100A2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,S100A2 gene|S100A2 Malignant neoplasm of breast
AFFECTS,antiangiogenesis therapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,antiangiogenesis therapy Malignant neoplasm of breast
AFFECTS,Monocyte Chemoattractant Protein-1|CCL2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Monocyte Chemoattractant Protein-1|CCL2 Breast cancer metastatic
CAUSES,Heat Shock Protein 27,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Heat Shock Protein 27 Malignant neoplasm of breast
PREDISPOSES,Transforming Growth Factor Beta 2|NEUROD1|TUBB4B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Transforming Growth Factor Beta 2|NEUROD1|TUBB4B Malignant neoplasm of breast
DISRUPTS,"FRAP1 protein, human|MTOR",Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,"Amino Acid, Peptide, or Protein","FRAP1 protein, human|MTOR Female Breast Carcinoma"
DISRUPTS,KLF9 gene|KLF9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,KLF9 gene|KLF9 Malignant neoplasm of breast
AFFECTS,TNFRSF10B gene|TNFRSF10B,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,TNFRSF10B gene|TNFRSF10B Breast cancer metastatic
AFFECTS,Germ-Line Mutation,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Germ-Line Mutation Breast cancer metastatic
CAUSES,Fibroblast Growth Factor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Fibroblast Growth Factor Malignant neoplasm of breast
CAUSES,Ion Channel,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Ion Channel Malignant neoplasm of breast
AFFECTS,Metabolic syndrome,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Disease or Syndrome,Metabolic syndrome Breast cancer metastatic
AFFECTS,Evolution,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Evolution Malignant neoplasm of breast
DISRUPTS,Promoter Regions (Genetics),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Promoter Regions (Genetics) Malignant neoplasm of breast
PREDISPOSES,Cholesterol levels raised,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Lipid,Cholesterol levels raised Breast cancer recurrent
AFFECTS,Malignant neoplasm of breast,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Neoplastic Process,Malignant neoplasm of breast Inflammatory Breast Carcinoma
AUGMENTS,Protein C Inhibitor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Protein C Inhibitor Malignant neoplasm of breast
AFFECTS,Nicotinamide adenine dinucleotide (NAD),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Nicotinamide adenine dinucleotide (NAD) Malignant neoplasm of breast
DISRUPTS,NR4A1 gene|NR4A1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NR4A1 gene|NR4A1 Malignant neoplasm of breast
CAUSES,TWIST1 gene|TWIST1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TWIST1 gene|TWIST1 Malignant neoplasm of breast
PREDISPOSES,NUCB2 gene|NUCB2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,NUCB2 gene|NUCB2 Breast cancer metastatic
AFFECTS,Risk Reduction,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Risk Reduction Malignant neoplasm of breast
PREDISPOSES,CXCL9 gene|CXCL9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CXCL9 gene|CXCL9 Malignant neoplasm of breast
AFFECTS,IGF1R gene|IGF1R,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IGF1R gene|IGF1R Malignant neoplasm of breast
AFFECTS,GPR116 gene|ADGRF5,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,GPR116 gene|ADGRF5 Breast cancer metastatic
DISRUPTS,Docosahexaenoic Acids,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Chemical,Docosahexaenoic Acids Breast cancer metastatic
DISRUPTS,Protein phosphatase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Protein phosphatase Malignant neoplasm of breast
AFFECTS,Colorectal Cancer,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Colorectal Cancer Malignant neoplasm of breast
AUGMENTS,GIT1 gene|GIT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GIT1 gene|GIT1 Malignant neoplasm of breast
AFFECTS,DNA Adducts,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",DNA Adducts Malignant neoplasm of breast
AFFECTS,chemoprotection,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",chemoprotection Malignant neoplasm of breast
AFFECTS,Radiation therapy,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,"Element, Ion, or Isotope",Radiation therapy Carcinoma of Male Breast
AFFECTS,RGS2 gene|RGS2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RGS2 gene|RGS2 Malignant neoplasm of breast
PREDISPOSES,Reactive Oxygen Species,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Reactive Oxygen Species Malignant neoplasm of breast
AFFECTS,Neoplasm progression,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Neoplasm progression Breast cancer metastatic
AUGMENTS,CLDN2 gene|CLDN2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,CLDN2 gene|CLDN2 Breast cancer metastatic
DISRUPTS,BRMS1 gene|BRMS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BRMS1 gene|BRMS1 Malignant neoplasm of breast
AFFECTS,Acute myocardial infarction,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Acute myocardial infarction Malignant neoplasm of breast
AFFECTS,radiosensitization,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",radiosensitization Malignant neoplasm of breast
PREDISPOSES,CYP2B6 gene|CYP2B6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CYP2B6 gene|CYP2B6 Malignant neoplasm of breast
AUGMENTS,membrane-type 1 matrix metalloproteinase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",membrane-type 1 matrix metalloproteinase Malignant neoplasm of breast
CAUSES,PLAT gene|PLAT,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PLAT gene|PLAT Malignant neoplasm of breast
PREDISPOSES,Estrogen Receptor Status,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,"Amino Acid, Peptide, or Protein","Estrogen Receptor Status Carcinoma, Ductal, Breast"
DISRUPTS,Benzoic Acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Benzoic Acid Malignant neoplasm of breast
AFFECTS,CYC1 gene|CYC1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CYC1 gene|CYC1 Malignant neoplasm of breast
PREDISPOSES,"ABCG2 protein, human|ABCG2",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","ABCG2 protein, human|ABCG2 Malignant neoplasm of breast"
AFFECTS,Thiazolidinediones,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Thiazolidinediones Malignant neoplasm of breast
CAUSES,tumor growth,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,tumor growth Breast Carcinoma
AUGMENTS,calmodulin-dependent protein kinase II|CAMK2G,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",calmodulin-dependent protein kinase II|CAMK2G Malignant neoplasm of breast
AFFECTS,calmodulin-dependent protein kinase II|CAMK2G,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",calmodulin-dependent protein kinase II|CAMK2G Breast cancer metastatic
PREDISPOSES,Oncogenes,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,Oncogenes Breast cancer metastatic
AFFECTS,FGF2 gene|FGF2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FGF2 gene|FGF2 Malignant neoplasm of breast
PREDISPOSES,KRAS gene|KRAS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,KRAS gene|KRAS Malignant neoplasm of breast
AFFECTS,CXCL1 gene|CXCL1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CXCL1 gene|CXCL1 Malignant neoplasm of breast
AUGMENTS,"Amino Acids, Branched-Chain",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","Amino Acids, Branched-Chain Malignant neoplasm of breast"
CAUSES,ALDH1A3 gene|ALDH1A3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ALDH1A3 gene|ALDH1A3 Malignant neoplasm of breast
PREDISPOSES,Prostaglandin-Endoperoxide Synthase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Eicosanoid,Prostaglandin-Endoperoxide Synthase Malignant neoplasm of breast
PREDISPOSES,Arachidonic Acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Arachidonic Acid Malignant neoplasm of breast
AFFECTS,Vitamin D Analog,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Food,Vitamin D Analog Breast cancer metastatic
AUGMENTS,MST1R gene|MST1R,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,MST1R gene|MST1R Breast cancer metastatic
PREDISPOSES,BCL2 gene|BCL2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BCL2 gene|BCL2 Malignant neoplasm of breast
CAUSES,Endogenous Retroviruses,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Virus,Endogenous Retroviruses Malignant neoplasm of breast
AFFECTS,PRLR gene|PRLR|PTP4A3,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,PRLR gene|PRLR|PTP4A3 Breast cancer metastatic
AFFECTS,"ESR1 protein, human|ESR1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","ESR1 protein, human|ESR1 Malignant neoplasm of breast"
PREDISPOSES,PTHLH gene|PTHLH,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PTHLH gene|PTHLH Malignant neoplasm of breast
DISRUPTS,Proto-Oncogene Proteins c-jun|JUN,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,Proto-Oncogene Proteins c-jun|JUN Breast cancer metastatic
PREDISPOSES,GGN gene|GGN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GGN gene|GGN Malignant neoplasm of breast
CAUSES,CLOCK gene|CLOCK,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CLOCK gene|CLOCK Malignant neoplasm of breast
AFFECTS,BCAS3 gene|BCAS3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BCAS3 gene|BCAS3 Malignant neoplasm of breast
AFFECTS,MCM10 gene|MCM10,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MCM10 gene|MCM10 Malignant neoplasm of breast
AFFECTS,Aromatase,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Enzyme,Aromatase Noninfiltrating Intraductal Carcinoma
AUGMENTS,Linoleic Acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Linoleic Acid Malignant neoplasm of breast
DISRUPTS,TRANSCRIPTION FACTOR,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",TRANSCRIPTION FACTOR Breast cancer metastatic
PREDISPOSES,ARNT2 gene|ARNT2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ARNT2 gene|ARNT2 Malignant neoplasm of breast
AFFECTS,lysophosphatidic acid,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Chemical,lysophosphatidic acid Breast cancer metastatic
AUGMENTS,PTK6 gene|PTK6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PTK6 gene|PTK6 Malignant neoplasm of breast
AUGMENTS,ESR1 gene|ESR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ESR1 gene|ESR1 Malignant neoplasm of breast
AUGMENTS,Nuclease Sensitive Element Binding Protein 1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Nuclease Sensitive Element Binding Protein 1 Malignant neoplasm of breast
AUGMENTS,NES gene|NES,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NES gene|NES Malignant neoplasm of breast
AFFECTS,MicroRNAs,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","MicroRNAs Carcinoma, Ductal, Breast"
AUGMENTS,S100A9 gene|S100A9,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,S100A9 gene|S100A9 Noninfiltrating Intraductal Carcinoma
AFFECTS,MIRN205 gene|MIR205,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIRN205 gene|MIR205 Malignant neoplasm of breast
DISRUPTS,Viral Tumor Antigens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Viral Tumor Antigens Malignant neoplasm of breast
PREDISPOSES,SNW1 Gene|SNW1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SNW1 Gene|SNW1 Malignant neoplasm of breast
AUGMENTS,"Carcinogens, Environmental",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hazardous or Poisonous Substance,"Carcinogens, Environmental Malignant neoplasm of breast"
AUGMENTS,RBX1 gene|RBX1,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,RBX1 gene|RBX1 Breast Carcinoma
PREDISPOSES,CEACAM5 gene|CEACAM5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CEACAM5 gene|CEACAM5 Malignant neoplasm of breast
PREDISPOSES,Estrogen Antagonists,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Estrogen Antagonists Malignant neoplasm of breast
DISRUPTS,Cytostatic Agents,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Chemical Viewed Functionally,Cytostatic Agents Breast Carcinoma
AUGMENTS,Vascular Endothelial Growth Factor Receptor-3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Vascular Endothelial Growth Factor Receptor-3 Malignant neoplasm of breast
PREDISPOSES,Heat-Shock Proteins 70|HSPA4,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Heat-Shock Proteins 70|HSPA4 Breast Carcinoma
PREDISPOSES,Carrier of disorder,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Disease or Syndrome,Carrier of disorder Carcinoma of Male Breast
PREDISPOSES,Ions,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Ions Malignant neoplasm of breast
AFFECTS,"Mammary Carcinoma, Human",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,"Mammary Carcinoma, Human Malignant neoplasm of breast"
DISRUPTS,Serine Proteinase Inhibitors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Serine Proteinase Inhibitors Malignant neoplasm of breast
AUGMENTS,Tumor Necrosis Factor Ligand Superfamily Member 6|FAS,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Neoplastic Process,"Tumor Necrosis Factor Ligand Superfamily Member 6|FAS Carcinoma, Ductal, Breast"
PREDISPOSES,Atypical proliferation,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Element, Ion, or Isotope",Atypical proliferation Breast cancer invasive NOS
PREDISPOSES,C-Peptide,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",C-Peptide Breast Carcinoma
AUGMENTS,PTGS2 gene|PTGS2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,PTGS2 gene|PTGS2 Breast cancer metastatic
PREDISPOSES,letrozole,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Pharmacologic Substance,letrozole Breast cancer recurrent
DISRUPTS,Total cholesterol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Lipid,Total cholesterol Malignant neoplasm of breast
AUGMENTS,High Density Lipoprotein Cholesterol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",High Density Lipoprotein Cholesterol Malignant neoplasm of breast
AFFECTS,Multivitamin preparation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Multivitamin preparation Malignant neoplasm of breast
AFFECTS,letrozole,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,letrozole Malignant neoplasm of breast
AFFECTS,ERCC5 gene|ERCC5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ERCC5 gene|ERCC5 Malignant neoplasm of breast
AFFECTS,Non-infiltrating lobular carcinoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Non-infiltrating lobular carcinoma Malignant neoplasm of breast
AFFECTS,Heat-Shock Proteins 70|HSPA4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Heat-Shock Proteins 70|HSPA4 Malignant neoplasm of breast
PREDISPOSES,Growth Factor,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Biologically Active Substance,Growth Factor Breast Carcinoma
AFFECTS,"Transcription, Genetic",Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Gene or Genome,"Transcription, Genetic Breast cancer recurrent"
PREDISPOSES,Eicosapentaenoic Acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Eicosapentaenoic Acid Malignant neoplasm of breast
PREDISPOSES,Adrenal Cortex Hormones,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Adrenal Cortex Hormones Malignant neoplasm of breast
PREDISPOSES,Long chain fatty acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Long chain fatty acid Malignant neoplasm of breast
AUGMENTS,Antibiotics,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Antibiotic,Antibiotics Malignant neoplasm of breast
PREDISPOSES,Specific antigen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Immunologic Factor,Specific antigen Malignant neoplasm of breast
PREDISPOSES,GPR30 gene|GPER1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GPR30 gene|GPER1 Malignant neoplasm of breast
AFFECTS,Detection,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,"Element, Ion, or Isotope",Detection Carcinoma of Male Breast
DISRUPTS,Proto-Oncogene Protein pp60 (c-src)|SRC,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Proto-Oncogene Protein pp60 (c-src)|SRC Malignant neoplasm of breast
AFFECTS,Contralateral breast cancer,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Contralateral breast cancer Malignant neoplasm of breast
AUGMENTS,GDI2 gene|GDI2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GDI2 gene|GDI2 Malignant neoplasm of breast
AFFECTS,Osteogenesis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Osteogenesis Malignant neoplasm of breast
PREDISPOSES,Klinefelter's Syndrome,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Disease or Syndrome,Klinefelter's Syndrome Carcinoma of Male Breast
PREDISPOSES,LIG4 gene|LIG4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LIG4 gene|LIG4 Malignant neoplasm of breast
PREDISPOSES,Hypertension induced by pregnancy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Hypertension induced by pregnancy Malignant neoplasm of breast
PREDISPOSES,APOB gene|APOB,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,APOB gene|APOB Malignant neoplasm of breast
DISRUPTS,Estrogen Receptor beta,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptor beta Malignant neoplasm of breast
CAUSES,Food,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Food Malignant neoplasm of breast
AFFECTS,Neoplasm progression,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Neoplasm progression Breast Carcinoma
AFFECTS,cytokine,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Biologically Active Substance,cytokine Breast cancer recurrent
PREDISPOSES,Vitamin B12 intake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Vitamin B12 intake Malignant neoplasm of breast
DISRUPTS,Proliferating Cell Nuclear Antigen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Immunologic Factor,Proliferating Cell Nuclear Antigen Malignant neoplasm of breast
AUGMENTS,Folic Acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Folic Acid Malignant neoplasm of breast
AUGMENTS,Steroid hormone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Steroid hormone Malignant neoplasm of breast
PREDISPOSES,aldehyde dehydrogenase 1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",aldehyde dehydrogenase 1 Malignant neoplasm of breast
AFFECTS,biological_process,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Phenomenon or Process,biological_process Noninfiltrating Intraductal Carcinoma
PREDISPOSES,TYRP1 gene|TYRP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TYRP1 gene|TYRP1 Malignant neoplasm of breast
CAUSES,Estrogen Receptor alpha,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptor alpha Breast cancer metastatic
PREDISPOSES,HORMONE REPLACEMENT,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,HORMONE REPLACEMENT Malignant neoplasm of breast
PREDISPOSES,Disease,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Disease or Syndrome,Disease Breast cancer metastatic
CAUSES,Transforming Growth Factor beta,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Biologically Active Substance,Transforming Growth Factor beta Breast cancer metastatic
AFFECTS,Residual Cancer,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Residual Cancer Malignant neoplasm of breast
AUGMENTS,Antigens,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Immunologic Factor,Antigens Breast cancer invasive NOS
AFFECTS,"Anti-Inflammatory Agents, Non-Steroidal",Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Chemical Viewed Functionally,"Anti-Inflammatory Agents, Non-Steroidal Breast cancer recurrent"
AUGMENTS,Mixed Function Oxygenases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Mixed Function Oxygenases Malignant neoplasm of breast
AUGMENTS,Protein Family,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Protein Family Malignant neoplasm of breast
PREDISPOSES,MDM4 gene|MDM4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MDM4 gene|MDM4 Malignant neoplasm of breast
PREDISPOSES,Cadmium,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Inorganic Chemical,Cadmium Breast cancer invasive NOS
PREDISPOSES,XRCC5 gene|XRCC5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,XRCC5 gene|XRCC5 Malignant neoplasm of breast
AFFECTS,transduction,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",transduction Malignant neoplasm of breast
AFFECTS,trastuzumab,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Pharmacologic Substance,trastuzumab Breast cancer metastatic
PREDISPOSES,AXILLARY LYMPH NODE METASTASIS,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Neoplastic Process,AXILLARY LYMPH NODE METASTASIS Breast cancer recurrent
PREDISPOSES,Sleep Apnea Syndromes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Sleep Apnea Syndromes Malignant neoplasm of breast
PREDISPOSES,regional differences,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",regional differences Malignant neoplasm of breast
AUGMENTS,Isoenzymes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Enzyme,Isoenzymes Malignant neoplasm of breast
PREDISPOSES,HP gene|HP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HP gene|HP Malignant neoplasm of breast
AFFECTS,Breast cancer invasive NOS,Carcinoma in situ of breast,0.0019980019980019,Female Breast Cancer,Neoplastic Process,Breast cancer invasive NOS Carcinoma in situ of breast
AFFECTS,Second Primary Cancers,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Neoplastic Process,Second Primary Cancers Sporadic Breast Carcinoma
CAUSES,Methionine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Methionine Malignant neoplasm of breast
CAUSES,Localized Malignant Neoplasm,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,Neoplastic Process,Localized Malignant Neoplasm Female Breast Carcinoma
PREDISPOSES,Physical function,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Physical function Malignant neoplasm of breast
AUGMENTS,snail transcription factors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",snail transcription factors Malignant neoplasm of breast
DISRUPTS,claudin 1 protein,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Amino Acid, Peptide, or Protein",claudin 1 protein Breast cancer invasive NOS
AFFECTS,volatile substances,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Substance,volatile substances Breast cancer recurrent
AFFECTS,CDKN2A gene|CDKN2A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CDKN2A gene|CDKN2A Malignant neoplasm of breast
AFFECTS,"Diabetes, Gestational",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Diabetes, Gestational Malignant neoplasm of breast"
AFFECTS,Fine needle aspiration biopsy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Fine needle aspiration biopsy Malignant neoplasm of breast
AFFECTS,Large Neutral Amino Acid-Transporter 1|SLC7A5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Large Neutral Amino Acid-Transporter 1|SLC7A5 Malignant neoplasm of breast
PREDISPOSES,Monomeric GTP-Binding Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Monomeric GTP-Binding Proteins Malignant neoplasm of breast
PREDISPOSES,APEX1 gene|APEX1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,APEX1 gene|APEX1 Malignant neoplasm of breast
PREDISPOSES,Primary disease,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Disease or Syndrome,Primary disease Breast cancer recurrent
CAUSES,Phyllodes Tumor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Phyllodes Tumor Malignant neoplasm of breast
PREDISPOSES,"EZH2 protein, human|EZH2",Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,"Amino Acid, Peptide, or Protein","EZH2 protein, human|EZH2 Inflammatory Breast Carcinoma"
DISRUPTS,Blood Coagulation Factor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Blood Coagulation Factor Malignant neoplasm of breast
PREDISPOSES,Seeks information,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Seeks information Malignant neoplasm of breast
AFFECTS,Malignant neoplasm of breast,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Neoplastic Process,Malignant neoplasm of breast Carcinoma of Male Breast
PREDISPOSES,Adverse event,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Phenomenon or Process,Adverse event Malignant neoplasm of breast
AUGMENTS,FOLR1 gene|FOLR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FOLR1 gene|FOLR1 Malignant neoplasm of breast
PREDISPOSES,IL8RB gene|CXCR2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IL8RB gene|CXCR2 Malignant neoplasm of breast
PREDISPOSES,Inflammation,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Element, Ion, or Isotope",Inflammation Breast cancer invasive NOS
AFFECTS,Aminolevulinic Acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Aminolevulinic Acid Malignant neoplasm of breast
AFFECTS,Diffusion Magnetic Resonance Imaging,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Diffusion Magnetic Resonance Imaging Malignant neoplasm of breast
PREDISPOSES,Hypoglycemic Agents,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical Viewed Functionally,Hypoglycemic Agents Malignant neoplasm of breast
AFFECTS,"Echocardiography, Three-Dimensional",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Echocardiography, Three-Dimensional Malignant neoplasm of breast"
PREDISPOSES,CHEK2 gene|CHEK2,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,Gene or Genome,CHEK2 gene|CHEK2 Familial cancer of breast
AFFECTS,ESTROGEN+PROGESTERONE RECEPTOR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,ESTROGEN+PROGESTERONE RECEPTOR Malignant neoplasm of breast
PREDISPOSES,Hormones,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Hormone,Hormones Sporadic Breast Carcinoma
PREDISPOSES,Alkylating Agents,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical Viewed Functionally,Alkylating Agents Malignant neoplasm of breast
AFFECTS,Prevention,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Element, Ion, or Isotope",Prevention Breast cancer invasive NOS
AFFECTS,breast implant procedure,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biomedical or Dental Material,breast implant procedure Malignant neoplasm of breast
DISRUPTS,Anti-Anxiety Agents,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical Viewed Functionally,Anti-Anxiety Agents Malignant neoplasm of breast
PREDISPOSES,DNA,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",DNA Breast cancer recurrent
AUGMENTS,PVT1 gene|PVT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PVT1 gene|PVT1 Malignant neoplasm of breast
PREDISPOSES,RNA-Binding Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",RNA-Binding Proteins Malignant neoplasm of breast
AFFECTS,Solid tumor,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,Solid tumor Breast cancer invasive NOS
AFFECTS,Homologous Gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Homologous Gene Malignant neoplasm of breast
PREDISPOSES,PTPN1 gene|PTPN1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PTPN1 gene|PTPN1 Malignant neoplasm of breast
PREDISPOSES,Sugar candy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Carbohydrate,Sugar candy Malignant neoplasm of breast
PREDISPOSES,Plasma glucose result,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Body Substance,Plasma glucose result Malignant neoplasm of breast
PREDISPOSES,advanced disease,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,advanced disease Malignant neoplasm of breast
PREDISPOSES,Atypical proliferation,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",Atypical proliferation Noninfiltrating Intraductal Carcinoma
AUGMENTS,SP1 gene|SP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SP1 gene|SP1 Malignant neoplasm of breast
PREDISPOSES,activated RNA polymerase II transcription cofactor 4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",activated RNA polymerase II transcription cofactor 4 Malignant neoplasm of breast
PREDISPOSES,Progesterone Receptor Status,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Hormone,Progesterone Receptor Status Breast cancer invasive NOS
AFFECTS,Anticholesteremic Agents,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical Viewed Functionally,Anticholesteremic Agents Malignant neoplasm of breast
PREDISPOSES,TSC1 gene|TSC1|CCL26,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TSC1 gene|TSC1|CCL26 Malignant neoplasm of breast
CAUSES,Materials,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Substance,Materials Breast cancer metastatic
CAUSES,Pharmaceutical Preparations,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,Pharmaceutical Preparations Malignant neoplasm of breast
PREDISPOSES,"CHEK2 protein, human|CHEK2",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CHEK2 protein, human|CHEK2 Malignant neoplasm of breast"
AFFECTS,Juvenile carcinoma of the breast,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Juvenile carcinoma of the breast Malignant neoplasm of breast
PREDISPOSES,Disease recurrence,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Disease recurrence Malignant neoplasm of breast
AUGMENTS,Collagen Gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Collagen Gene Malignant neoplasm of breast
PREDISPOSES,DNA Excision Repair Protein ERCC-5|ERCC5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",DNA Excision Repair Protein ERCC-5|ERCC5 Malignant neoplasm of breast
PREDISPOSES,XBP1 gene|XBP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,XBP1 gene|XBP1 Malignant neoplasm of breast
AFFECTS,Tumor Burden,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Tumor Burden Malignant neoplasm of breast
AFFECTS,Tumor Immunity,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Tumor Immunity Malignant neoplasm of breast
PREDISPOSES,ERBB2 gene|ERBB2,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Gene or Genome,ERBB2 gene|ERBB2 Breast cancer invasive NOS
AFFECTS,HIF1alpha protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",HIF1alpha protein Malignant neoplasm of breast
AFFECTS,LARP4 gene|LARP4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LARP4 gene|LARP4 Malignant neoplasm of breast
AFFECTS,"RNA, circular",Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","RNA, circular Breast cancer metastatic"
AFFECTS,SMAD4 gene|SMAD4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SMAD4 gene|SMAD4 Malignant neoplasm of breast
CAUSES,Malignant Neoplasms,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Neoplastic Process,Malignant Neoplasms Noninfiltrating Intraductal Carcinoma
CAUSES,"E2F1 protein, human|E2F1|UBE2L3",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","E2F1 protein, human|E2F1|UBE2L3 Malignant neoplasm of breast"
CAUSES,LOXL1-AS1 gene|LOXL1-AS1,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Gene or Genome,LOXL1-AS1 gene|LOXL1-AS1 Invasive carcinoma of breast
AUGMENTS,"2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,"2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid Malignant neoplasm of breast"
AUGMENTS,PAK4 gene|PAK4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PAK4 gene|PAK4 Malignant neoplasm of breast
PREDISPOSES,FAM83H-AS1 gene|FAM83H-AS1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,FAM83H-AS1 gene|FAM83H-AS1 Triple Negative Breast Neoplasms
CAUSES,folic acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,folic acid Malignant neoplasm of breast
AUGMENTS,Protein Isoforms,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Protein Isoforms Malignant neoplasm of breast
PREDISPOSES,"PTGS2 protein, human|PTGS2",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","PTGS2 protein, human|PTGS2 Malignant neoplasm of breast"
AUGMENTS,Phosphoglycerate dehydrogenase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Phosphoglycerate dehydrogenase Malignant neoplasm of breast
AFFECTS,Genome,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,Genome Triple Negative Breast Neoplasms
AUGMENTS,"PKN1 protein, human|PKN1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","PKN1 protein, human|PKN1 Malignant neoplasm of breast"
AFFECTS,ELF5 gene|ELF5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ELF5 gene|ELF5 Malignant neoplasm of breast
AUGMENTS,Mutant Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Mutant Proteins Malignant neoplasm of breast
PREDISPOSES,apolipoprotein D,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",apolipoprotein D Malignant neoplasm of breast
DISRUPTS,TRANSCRIPTION FACTOR,Carcinoma breast stage IV,0.0,Female Breast Cancer,"Element, Ion, or Isotope",TRANSCRIPTION FACTOR Carcinoma breast stage IV
AFFECTS,KISS1R gene|KISS1R,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,KISS1R gene|KISS1R Triple Negative Breast Neoplasms
PREDISPOSES,Genes,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,Genes Noninfiltrating Intraductal Carcinoma
AFFECTS,Sentinel node (disorder),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Sentinel node (disorder) Malignant neoplasm of breast
PREDISPOSES,Insoluble fiber (substance),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Substance,Insoluble fiber (substance) Malignant neoplasm of breast
AFFECTS,Carbon Ion Radiotherapy,Early-Stage Breast Carcinoma,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Carbon Ion Radiotherapy Early-Stage Breast Carcinoma
PREDISPOSES,H19 gene|H19|HILS1,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,H19 gene|H19|HILS1 Breast Carcinoma
AUGMENTS,BCL11A gene|BCL11A,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,BCL11A gene|BCL11A Triple Negative Breast Neoplasms
AFFECTS,PPFIA1 gene|PPFIA1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PPFIA1 gene|PPFIA1 Malignant neoplasm of breast
AUGMENTS,PPFIA1 gene|PPFIA1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PPFIA1 gene|PPFIA1 Malignant neoplasm of breast
DISRUPTS,PARP1 gene|PARP1,Hereditary Breast and Ovarian Cancer Syndrome,0.0,Female Breast Cancer,Gene or Genome,PARP1 gene|PARP1 Hereditary Breast and Ovarian Cancer Syndrome
DISRUPTS,SOX9 gene|SOX9,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,SOX9 gene|SOX9 Noninfiltrating Intraductal Carcinoma
PREDISPOSES,CBR3-AS1 gene|CBR3-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CBR3-AS1 gene|CBR3-AS1 Malignant neoplasm of breast
AFFECTS,Polycystic Ovary Syndrome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Polycystic Ovary Syndrome Malignant neoplasm of breast
AFFECTS,RNF111 gene|RNF111,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RNF111 gene|RNF111 Malignant neoplasm of breast
CAUSES,steroid receptor coactivator AIB1|NCOA3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Steroid,steroid receptor coactivator AIB1|NCOA3 Malignant neoplasm of breast
PREDISPOSES,new information,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",new information Malignant neoplasm of breast
PREDISPOSES,Blood Glucose,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Carbohydrate,Blood Glucose Malignant neoplasm of breast
AFFECTS,S-adenosylmethionine,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",S-adenosylmethionine Triple Negative Breast Neoplasms
CAUSES,Malignant Neoplasms,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Neoplastic Process,Malignant Neoplasms Triple Negative Breast Neoplasms
PREDISPOSES,Polypeptides,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Polypeptides Malignant neoplasm of breast
PREDISPOSES,MNX1-AS1 gene|MNX1-AS1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,MNX1-AS1 gene|MNX1-AS1 Triple Negative Breast Neoplasms
AUGMENTS,N-Myc Downstream Regulated Protein 1|NDRG1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",N-Myc Downstream Regulated Protein 1|NDRG1 Malignant neoplasm of breast
DISRUPTS,Dicarboxylic Acids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Dicarboxylic Acids Malignant neoplasm of breast
CAUSES,ENC1 gene|ENC1,Carcinoma breast stage IV,0.0,Female Breast Cancer,Gene or Genome,ENC1 gene|ENC1 Carcinoma breast stage IV
AFFECTS,NORAD gene|NORAD,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,NORAD gene|NORAD Breast Carcinoma
CAUSES,Mammary Tumorigenesis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Mammary Tumorigenesis Malignant neoplasm of breast
PREDISPOSES,SOX2 Transcription Factor|SOX2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",SOX2 Transcription Factor|SOX2 Malignant neoplasm of breast
AUGMENTS,Genes,estrogen receptor-negative breast cancer,0.0,Female Breast Cancer,Gene or Genome,Genes estrogen receptor-negative breast cancer
PREDISPOSES,MEG3 gene|MEG3|FAM129B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MEG3 gene|MEG3|FAM129B Malignant neoplasm of breast
PREDISPOSES,CA10 gene|CA10,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CA10 gene|CA10 Malignant neoplasm of breast
PREDISPOSES,NME1 gene|NME1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NME1 gene|NME1 Malignant neoplasm of breast
PREDISPOSES,MIR326 gene|MIR326,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIR326 gene|MIR326 Malignant neoplasm of breast
AFFECTS,PART1 gene|PART1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PART1 gene|PART1 Malignant neoplasm of breast
CAUSES,YTHDF3 gene|YTHDF3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,YTHDF3 gene|YTHDF3 Malignant neoplasm of breast
PREDISPOSES,S100A14 gene|S100A14,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,S100A14 gene|S100A14 Malignant neoplasm of breast
PREDISPOSES,TMPRSS13 gene|TMPRSS13,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TMPRSS13 gene|TMPRSS13 Malignant neoplasm of breast
PREDISPOSES,nervous system disorder,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,nervous system disorder Malignant neoplasm of breast
AFFECTS,TRIO gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TRIO gene Malignant neoplasm of breast
PREDISPOSES,HSD17B4 gene|HSD17B4,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Gene or Genome,HSD17B4 gene|HSD17B4 HER2-positive carcinoma of breast
AFFECTS,Carcinoma of Male Breast,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Carcinoma of Male Breast Malignant neoplasm of breast
AUGMENTS,"CCND2 protein, human|CCND2",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CCND2 protein, human|CCND2 Malignant neoplasm of breast"
DISRUPTS,UBR1 gene|UBR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,UBR1 gene|UBR1 Malignant neoplasm of breast
PREDISPOSES,CCR5 gene|CCR5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CCR5 gene|CCR5 Malignant neoplasm of breast
AFFECTS,"Receptor Tyrosine-Protein Kinase ErbB-4, human|ERBB4",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","Receptor Tyrosine-Protein Kinase ErbB-4, human|ERBB4 Malignant neoplasm of breast"
DISRUPTS,CAVIN3 gene|CAVIN3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CAVIN3 gene|CAVIN3 Malignant neoplasm of breast
AFFECTS,epithelial to mesenchymal transition,Carcinoma breast stage IV,0.0,Female Breast Cancer,"Element, Ion, or Isotope",epithelial to mesenchymal transition Carcinoma breast stage IV
AUGMENTS,"TFF1 protein, human|TFF1",estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,"Amino Acid, Peptide, or Protein","TFF1 protein, human|TFF1 estrogen receptor-positive breast cancer"
CAUSES,Neoplasm Metastasis,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Neoplastic Process,Neoplasm Metastasis estrogen receptor-positive breast cancer
AUGMENTS,estrogens,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Hormone,estrogens Triple Negative Breast Neoplasms
AUGMENTS,"WWTR1 protein, human|WWTR1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","WWTR1 protein, human|WWTR1 Malignant neoplasm of breast"
CAUSES,Transforming Growth Factor beta,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Biologically Active Substance,Transforming Growth Factor beta Inflammatory Breast Carcinoma
COMPLICATES,contralateral breast cancer,Right-Sided Breast Neoplasms,0.0,Female Breast Cancer,Neoplastic Process,contralateral breast cancer Right-Sided Breast Neoplasms
PREDISPOSES,PRMT5 gene|PRMT5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PRMT5 gene|PRMT5 Malignant neoplasm of breast
AFFECTS,DNA replication checkpoint,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",DNA replication checkpoint Triple Negative Breast Neoplasms
PREDISPOSES,Fermented Foods,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Fermented Foods Malignant neoplasm of breast
AFFECTS,NF2 gene|NF2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NF2 gene|NF2 Malignant neoplasm of breast
DISRUPTS,PLEKHA7 gene|PLEKHA7,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Gene or Genome,PLEKHA7 gene|PLEKHA7 Inflammatory Breast Carcinoma
AFFECTS,Ultraviolet B radiation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Ultraviolet B radiation Malignant neoplasm of breast
AUGMENTS,STRN3 gene|STRN3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,STRN3 gene|STRN3 Malignant neoplasm of breast
CAUSES,Transcription factor genes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Transcription factor genes Malignant neoplasm of breast
AUGMENTS,ZMYND8 gene|ZMYND8,Refractory Breast Carcinoma,0.0,Other,Gene or Genome,ZMYND8 gene|ZMYND8 Refractory Breast Carcinoma
AUGMENTS,ZEB1 gene|ZEB1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ZEB1 gene|ZEB1 Malignant neoplasm of breast
DISRUPTS,SOX6 gene|SOX6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SOX6 gene|SOX6 Malignant neoplasm of breast
AUGMENTS,RSPO2 gene|RSPO2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RSPO2 gene|RSPO2 Malignant neoplasm of breast
DISRUPTS,PEBP1 gene|PEBP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PEBP1 gene|PEBP1 Malignant neoplasm of breast
PREDISPOSES,RARRES2 gene|RARRES2,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,RARRES2 gene|RARRES2 Breast Carcinoma
AFFECTS,EIF4A1 gene|EIF4A1,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Gene or Genome,EIF4A1 gene|EIF4A1 Invasive carcinoma of breast
DISRUPTS,CA13 gene|CA13,Carcinoma breast stage IV,0.0,Female Breast Cancer,Gene or Genome,CA13 gene|CA13 Carcinoma breast stage IV
AFFECTS,Adverse event,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Phenomenon or Process,Adverse event Malignant neoplasm of breast
PREDISPOSES,FOXK1 gene|FOXK1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FOXK1 gene|FOXK1 Malignant neoplasm of breast
PREDISPOSES,NUP43 gene|NUP43,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NUP43 gene|NUP43 Malignant neoplasm of breast
AFFECTS,MYCN gene|MYCN,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,MYCN gene|MYCN Triple Negative Breast Neoplasms
AFFECTS,tamoxifen,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Pharmacologic Substance,tamoxifen Breast Carcinoma
AFFECTS,HNRNPK gene|HNRNPK,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Gene or Genome,HNRNPK gene|HNRNPK Invasive carcinoma of breast
AUGMENTS,ERRFI1 gene|ERRFI1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,ERRFI1 gene|ERRFI1 Triple Negative Breast Neoplasms
DISRUPTS,STUB1 gene|STUB1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,STUB1 gene|STUB1 Malignant neoplasm of breast
AFFECTS,S100A7 gene|S100A7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,S100A7 gene|S100A7 Malignant neoplasm of breast
PREDISPOSES,Elevated C-reactive protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Elevated C-reactive protein Malignant neoplasm of breast
PREDISPOSES,BTNL9 gene|BTNL9,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,BTNL9 gene|BTNL9 Breast Carcinoma
DISRUPTS,CDC25C gene|CDC25C,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CDC25C gene|CDC25C Malignant neoplasm of breast
AFFECTS,HMGB1 Protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",HMGB1 Protein Malignant neoplasm of breast
DISRUPTS,PDCD4 gene|PDCD4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PDCD4 gene|PDCD4 Malignant neoplasm of breast
DISRUPTS,MDM2 gene|MDM2,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,MDM2 gene|MDM2 Triple Negative Breast Neoplasms
DISRUPTS,PIK3CA gene|PIK3CA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PIK3CA gene|PIK3CA Malignant neoplasm of breast
PREDISPOSES,ZNF132 gene|ZNF132,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ZNF132 gene|ZNF132 Malignant neoplasm of breast
CAUSES,Pathogenic Variant,"Breast Cancer, Familial",0.0,Female Breast Cancer,Virus,"Pathogenic Variant Breast Cancer, Familial"
DISRUPTS,NRBP2 gene|NRBP2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NRBP2 gene|NRBP2 Malignant neoplasm of breast
PREDISPOSES,PCAT1 gene|PCAT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PCAT1 gene|PCAT1 Malignant neoplasm of breast
PREDISPOSES,Disease,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,Disease or Syndrome,Disease Female Breast Carcinoma
PREDISPOSES,Borg Category-Ratio 10 Perceived Exertion Score 5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Borg Category-Ratio 10 Perceived Exertion Score 5 Malignant neoplasm of breast
DISRUPTS,TPT1-AS1 gene|TPT1-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TPT1-AS1 gene|TPT1-AS1 Malignant neoplasm of breast
AFFECTS,KIAA1755 gene|KIAA1755,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,Gene or Genome,KIAA1755 gene|KIAA1755 Female Breast Carcinoma
PREDISPOSES,LINC00467 gene|LINC00467,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LINC00467 gene|LINC00467 Malignant neoplasm of breast
AFFECTS,Hormone Therapy,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Hormone,Hormone Therapy Breast Carcinoma
CAUSES,Homeobox Protein ARX,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Homeobox Protein ARX Malignant neoplasm of breast
DISRUPTS,NORAD gene|NORAD,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NORAD gene|NORAD Malignant neoplasm of breast
PREDISPOSES,HAGLR gene|HAGLR,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,HAGLR gene|HAGLR Triple Negative Breast Neoplasms
PREDISPOSES,Proto-Oncogene Proteins c-sis|PDGFB,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Proto-Oncogene Proteins c-sis|PDGFB Malignant neoplasm of breast
PREDISPOSES,nucleoside diphosphate kinase A|NME1,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Gene or Genome,nucleoside diphosphate kinase A|NME1 Invasive carcinoma of breast
AUGMENTS,LINC00894 gene|LINC00894,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LINC00894 gene|LINC00894 Malignant neoplasm of breast
PREDISPOSES,MIR373 gene|MIR373,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,MIR373 gene|MIR373 Breast Carcinoma
DISRUPTS,BABAM2-AS1 gene,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,BABAM2-AS1 gene Triple Negative Breast Neoplasms
AFFECTS,"Migration, Cell",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Migration, Cell Malignant neoplasm of breast"
PREDISPOSES,CXCL13 gene|CXCL13,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,CXCL13 gene|CXCL13 Breast Carcinoma
AFFECTS,METTL3 gene|METTL3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,METTL3 gene|METTL3 Malignant neoplasm of breast
AFFECTS,Cigarette smoke (substance),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Substance,Cigarette smoke (substance) Malignant neoplasm of breast
CAUSES,Oncogene Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Oncogene Proteins Malignant neoplasm of breast
PREDISPOSES,OVOL1 gene|OVOL1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,OVOL1 gene|OVOL1 Malignant neoplasm of breast
PREDISPOSES,Transforming Growth Factor beta,Carcinoma breast stage IV,0.0,Female Breast Cancer,Biologically Active Substance,Transforming Growth Factor beta Carcinoma breast stage IV
PREDISPOSES,Matrix Metalloproteinase 3,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Matrix Metalloproteinase 3 Breast Carcinoma
PREDISPOSES,PTPN11 gene|PTPN11,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,PTPN11 gene|PTPN11 Triple Negative Breast Neoplasms
AFFECTS,DPP9 gene|DPP9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,DPP9 gene|DPP9 Malignant neoplasm of breast
PREDISPOSES,STAU2 gene|STAU2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,STAU2 gene|STAU2 Malignant neoplasm of breast
DISRUPTS,GATA3 gene|GATA3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GATA3 gene|GATA3 Malignant neoplasm of breast
AFFECTS,OMA1 gene|OMA1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,OMA1 gene|OMA1 Malignant neoplasm of breast
AUGMENTS,IL17RB gene|IL17RB,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IL17RB gene|IL17RB Malignant neoplasm of breast
AFFECTS,Extraction,Carcinoma breast stage IV,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Extraction Carcinoma breast stage IV
AUGMENTS,Protein-Lysine 6-Oxidase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Protein-Lysine 6-Oxidase Malignant neoplasm of breast
AFFECTS,Hypermethylation,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",Hypermethylation estrogen receptor-positive breast cancer
AFFECTS,RABIF gene|RABIF,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,RABIF gene|RABIF Triple Negative Breast Neoplasms
PREDISPOSES,NEIL2 gene|NEIL2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NEIL2 gene|NEIL2 Malignant neoplasm of breast
CAUSES,AKR1C1 gene|AKR1C1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,AKR1C1 gene|AKR1C1 Malignant neoplasm of breast
PREDISPOSES,LINC01094 gene|LINC01094,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LINC01094 gene|LINC01094 Malignant neoplasm of breast
CAUSES,CASQ2 gene|CASQ2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CASQ2 gene|CASQ2 Malignant neoplasm of breast
DISRUPTS,Pharmaceutical Preparations,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Pharmacologic Substance,Pharmaceutical Preparations Triple Negative Breast Neoplasms
AFFECTS,Platinum Compounds,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Platinum Compounds Malignant neoplasm of breast
PREDISPOSES,Raw Foods,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Raw Foods Malignant neoplasm of breast
AUGMENTS,TUBA1C gene|TUBA1C,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TUBA1C gene|TUBA1C Malignant neoplasm of breast
COMPLICATES,LINC02381 gene|LINC02381,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LINC02381 gene|LINC02381 Malignant neoplasm of breast
PREDISPOSES,SH3BGRL gene|SH3BGRL,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,SH3BGRL gene|SH3BGRL Secondary malignant neoplasm of breast
PREDISPOSES,RGMA gene|RGMA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RGMA gene|RGMA Malignant neoplasm of breast
AFFECTS,SEMA6D gene|SEMA6D,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SEMA6D gene|SEMA6D Malignant neoplasm of breast
CAUSES,HSPA5 gene|HSPA5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HSPA5 gene|HSPA5 Malignant neoplasm of breast
PREDISPOSES,Mucin-1 Antigen,Early-Stage Breast Carcinoma,0.0,Female Breast Cancer,Immunologic Factor,Mucin-1 Antigen Early-Stage Breast Carcinoma
PREDISPOSES,BARD1 gene|BARD1,"Breast Cancer, Familial",0.0,Female Breast Cancer,Gene or Genome,"BARD1 gene|BARD1 Breast Cancer, Familial"
DISRUPTS,NDRG2 gene|NDRG2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NDRG2 gene|NDRG2 Malignant neoplasm of breast
PREDISPOSES,FOXP3 gene|FOXP3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FOXP3 gene|FOXP3 Malignant neoplasm of breast
AFFECTS,Cell secretion,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Cell secretion Triple Negative Breast Neoplasms
DISRUPTS,HSPA5 gene|HSPA5,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,HSPA5 gene|HSPA5 Triple Negative Breast Neoplasms
AFFECTS,LPAR6 gene|LPAR6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LPAR6 gene|LPAR6 Malignant neoplasm of breast
AUGMENTS,PELI1 gene|PELI1,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,PELI1 gene|PELI1 Breast Carcinoma
DISRUPTS,KPNA2 gene|KPNA2,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,KPNA2 gene|KPNA2 Secondary malignant neoplasm of breast
PREDISPOSES,ZMIZ2 gene|ZMIZ2,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,ZMIZ2 gene|ZMIZ2 Triple Negative Breast Neoplasms
CAUSES,UBA6-AS1 gene|UBA6-AS1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,UBA6-AS1 gene|UBA6-AS1 Triple Negative Breast Neoplasms
PREDISPOSES,Nutritional status,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Nutritional status Malignant neoplasm of breast
AUGMENTS,MALAT1 gene|MALAT1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,MALAT1 gene|MALAT1 Triple Negative Breast Neoplasms
PREDISPOSES,Insulin-Like Growth Factor Binding Protein 6|IGFBP6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Insulin-Like Growth Factor Binding Protein 6|IGFBP6 Malignant neoplasm of breast
AFFECTS,Cancer-Predisposing Gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Cancer-Predisposing Gene Malignant neoplasm of breast
AUGMENTS,ANKDD1A gene|ANKDD1A,Early-Stage Breast Carcinoma,0.0,Female Breast Cancer,Gene or Genome,ANKDD1A gene|ANKDD1A Early-Stage Breast Carcinoma
AUGMENTS,BNIP3 gene|BNIP3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BNIP3 gene|BNIP3 Malignant neoplasm of breast
PREDISPOSES,Candidate Disease Gene,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,Candidate Disease Gene Secondary malignant neoplasm of breast
AUGMENTS,HCAR1 gene|HCAR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HCAR1 gene|HCAR1 Malignant neoplasm of breast
CAUSES,MED1 gene|MED1,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Gene or Genome,MED1 gene|MED1 estrogen receptor-positive breast cancer
PREDISPOSES,Environmental Estrogen,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Hormone,Environmental Estrogen estrogen receptor-positive breast cancer
CAUSES,PROX1 gene|PROX1,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,PROX1 gene|PROX1 Secondary malignant neoplasm of breast
AFFECTS,Stat3 protein,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Stat3 protein estrogen receptor-positive breast cancer
AFFECTS,ZFR gene|ZFR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ZFR gene|ZFR Malignant neoplasm of breast
AFFECTS,DNMT1 gene|DNMT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,DNMT1 gene|DNMT1 Malignant neoplasm of breast
AFFECTS,RUNX2 gene|RUNX2,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,RUNX2 gene|RUNX2 Secondary malignant neoplasm of breast
AFFECTS,Signal Transduction,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Signal Transduction Triple Negative Breast Neoplasms
DISRUPTS,HSPBP1 gene|HSPBP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HSPBP1 gene|HSPBP1 Malignant neoplasm of breast
AUGMENTS,MSH2 gene|MSH2,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,MSH2 gene|MSH2 Triple Negative Breast Neoplasms
PREDISPOSES,First relationship,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",First relationship Malignant neoplasm of breast
AFFECTS,CDK1 gene|CDK1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CDK1 gene|CDK1 Malignant neoplasm of breast
AFFECTS,tumor suppressor activity,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,tumor suppressor activity Malignant neoplasm of breast
AFFECTS,Acute Promyelocytic Leukemia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Acute Promyelocytic Leukemia Malignant neoplasm of breast
AFFECTS,B3GNT5 gene|B3GNT5,Basal-Like Breast Carcinoma,0.0039960039960039,Female Breast Cancer,Gene or Genome,B3GNT5 gene|B3GNT5 Basal-Like Breast Carcinoma
DISRUPTS,Tumor Suppressor Genes,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,Tumor Suppressor Genes Triple Negative Breast Neoplasms
AFFECTS,LINC00662 gene|LINC00662,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LINC00662 gene|LINC00662 Malignant neoplasm of breast
AUGMENTS,KIF4A gene|KIF4A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,KIF4A gene|KIF4A Malignant neoplasm of breast
CAUSES,Inflammation Mediators,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Inflammation Mediators Malignant neoplasm of breast
PREDISPOSES,LINC01234 gene|LINC01234,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LINC01234 gene|LINC01234 Malignant neoplasm of breast
AFFECTS,Therapeutic immunosuppression,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Therapeutic immunosuppression Triple Negative Breast Neoplasms
PREDISPOSES,RAD51D gene|RAD51D,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RAD51D gene|RAD51D Malignant neoplasm of breast
AUGMENTS,ALYREF gene|ALYREF,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ALYREF gene|ALYREF Malignant neoplasm of breast
PREDISPOSES,perfluorononanoic acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,perfluorononanoic acid Malignant neoplasm of breast
PREDISPOSES,"POSTN protein, human|POSTN",Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein","POSTN protein, human|POSTN Breast Carcinoma"
PREDISPOSES,RAD51B gene|RAD51B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RAD51B gene|RAD51B Malignant neoplasm of breast
AFFECTS,PNO1 gene|PNO1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,PNO1 gene|PNO1 Triple Negative Breast Neoplasms
AUGMENTS,Oncogenes,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,Oncogenes Triple Negative Breast Neoplasms
AFFECTS,PIK3R1 gene|PIK3R1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PIK3R1 gene|PIK3R1 Malignant neoplasm of breast
DISRUPTS,MicroRNAs,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",MicroRNAs Triple Negative Breast Neoplasms
PREDISPOSES,OTUD6A gene|OTUD6A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,OTUD6A gene|OTUD6A Malignant neoplasm of breast
DISRUPTS,MEG3 gene|MEG3|FAM129B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MEG3 gene|MEG3|FAM129B Malignant neoplasm of breast
DISRUPTS,CXCL14 gene|CXCL14,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,CXCL14 gene|CXCL14 Triple Negative Breast Neoplasms
PREDISPOSES,CDKN2A gene|CDKN2A,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,CDKN2A gene|CDKN2A Triple Negative Breast Neoplasms
AFFECTS,Immunoregulation,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",Immunoregulation HER2-positive carcinoma of breast
AFFECTS,Complement System Proteins,Carcinoma breast stage IV,0.0,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Complement System Proteins Carcinoma breast stage IV
PREDISPOSES,Large Neutral Amino Acid-Transporter 1|SLC7A5,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Large Neutral Amino Acid-Transporter 1|SLC7A5 Breast Carcinoma
PREDISPOSES,Serum autoantibodies,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Body Substance,Serum autoantibodies Malignant neoplasm of breast
AUGMENTS,LINC00520 gene|LINC00520,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,LINC00520 gene|LINC00520 Breast Carcinoma
PREDISPOSES,TPD52L2 gene|TPD52L2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TPD52L2 gene|TPD52L2 Malignant neoplasm of breast
CAUSES,Glucosephosphate Dehydrogenase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Glucosephosphate Dehydrogenase Malignant neoplasm of breast
AUGMENTS,ATP6AP1 gene|ATP6AP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ATP6AP1 gene|ATP6AP1 Malignant neoplasm of breast
DISRUPTS,MIR1294 gene|MIR1294,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIR1294 gene|MIR1294 Malignant neoplasm of breast
COMPLICATES,Psychosocial Intervention,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Psychosocial Intervention Malignant neoplasm of breast
AFFECTS,SLC31A1 gene|SLC31A1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SLC31A1 gene|SLC31A1 Malignant neoplasm of breast
PREDISPOSES,RNase P,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",RNase P Triple Negative Breast Neoplasms
DISRUPTS,TGFB2-AS1 gene|TGFB2-AS1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,TGFB2-AS1 gene|TGFB2-AS1 Triple Negative Breast Neoplasms
DISRUPTS,inhibitor-of-apoptosis protein,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein",inhibitor-of-apoptosis protein Triple Negative Breast Neoplasms
AUGMENTS,MYCL gene|MYCL,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,MYCL gene|MYCL Triple Negative Breast Neoplasms
AFFECTS,MDM2 gene|MDM2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MDM2 gene|MDM2 Malignant neoplasm of breast
PREDISPOSES,DIO3OS gene|DIO3OS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,DIO3OS gene|DIO3OS Malignant neoplasm of breast
PREDISPOSES,centromere protein F,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",centromere protein F Malignant neoplasm of breast
PREDISPOSES,N4BP3 gene|N4BP3,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,N4BP3 gene|N4BP3 Secondary malignant neoplasm of breast
PREDISPOSES,SOD2 gene|SOD2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SOD2 gene|SOD2 Malignant neoplasm of breast
PREDISPOSES,ZNF667-AS1 gene|ZNF667-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ZNF667-AS1 gene|ZNF667-AS1 Malignant neoplasm of breast
PREDISPOSES,RECQL5 gene|RECQL5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RECQL5 gene|RECQL5 Malignant neoplasm of breast
DISRUPTS,RBCK1 gene|RBCK1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,RBCK1 gene|RBCK1 Triple Negative Breast Neoplasms
PREDISPOSES,Dietary Fatty Acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Dietary Fatty Acid Malignant neoplasm of breast
DISRUPTS,MIR506 gene|MIR506,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIR506 gene|MIR506 Malignant neoplasm of breast
PREDISPOSES,ZSWIM1 gene|ZSWIM1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ZSWIM1 gene|ZSWIM1 Malignant neoplasm of breast
DISRUPTS,Vascular Endothelial Growth Factors|VEGFA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Vascular Endothelial Growth Factors|VEGFA Malignant neoplasm of breast
AUGMENTS,MIR21 gene|MIR21,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIR21 gene|MIR21 Malignant neoplasm of breast
PREDISPOSES,PALB2 gene|PALB2,contralateral breast cancer,0.0029970029970029,Female Breast Cancer,Gene or Genome,PALB2 gene|PALB2 contralateral breast cancer
PREDISPOSES,Genes,contralateral breast cancer,0.0029970029970029,Female Breast Cancer,Gene or Genome,Genes contralateral breast cancer
PREDISPOSES,MCF2L-AS1 gene|MCF2L-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MCF2L-AS1 gene|MCF2L-AS1 Malignant neoplasm of breast
AFFECTS,Low Dose Radiation Therapy,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Low Dose Radiation Therapy Triple Negative Breast Neoplasms
DISRUPTS,"pregna-4,17-diene-3,16-dione, (17Z)-isomer",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope","pregna-4,17-diene-3,16-dione, (17Z)-isomer Triple Negative Breast Neoplasms"
PREDISPOSES,NR1H3 gene|NR1H3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NR1H3 gene|NR1H3 Malignant neoplasm of breast
PREDISPOSES,Inflammation,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",Inflammation Invasive carcinoma of breast
PREDISPOSES,Aryl Hydrocarbon Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Aryl Hydrocarbon Receptor Malignant neoplasm of breast
PREDISPOSES,ALDH2 gene|ALDH2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ALDH2 gene|ALDH2 Malignant neoplasm of breast
AFFECTS,cytotoxic T-lymphocyte antigen 4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hazardous or Poisonous Substance,cytotoxic T-lymphocyte antigen 4 Malignant neoplasm of breast
AFFECTS,Genes,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,Genes Breast Carcinoma
PREDISPOSES,PCSK1 gene|PCSK1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PCSK1 gene|PCSK1 Malignant neoplasm of breast
AFFECTS,Drug Repositioning,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Pharmacologic Substance,Drug Repositioning Inflammatory Breast Carcinoma
AFFECTS,YBX1 gene|YBX1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,YBX1 gene|YBX1 Malignant neoplasm of breast
AUGMENTS,LINC00536 gene|LINC00536,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LINC00536 gene|LINC00536 Malignant neoplasm of breast
PREDISPOSES,HNF1A gene|HNF1A,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,HNF1A gene|HNF1A Triple Negative Breast Neoplasms
CAUSES,CALML5 gene|CALML5,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Gene or Genome,CALML5 gene|CALML5 HER2-positive carcinoma of breast
AFFECTS,RBCK1 gene|RBCK1,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Gene or Genome,RBCK1 gene|RBCK1 estrogen receptor-positive breast cancer
AUGMENTS,MYO6 gene|MYO6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MYO6 gene|MYO6 Malignant neoplasm of breast
AUGMENTS,Metric (substance),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Substance,Metric (substance) Malignant neoplasm of breast
AUGMENTS,TLE5 gene|AES,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TLE5 gene|AES Malignant neoplasm of breast
PREDISPOSES,HAR1A gene|HAR1A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HAR1A gene|HAR1A Malignant neoplasm of breast
AUGMENTS,TMED3 gene|TMED3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TMED3 gene|TMED3 Malignant neoplasm of breast
AFFECTS,Anaplastic carcinoma,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Anaplastic carcinoma Breast Carcinoma
DISRUPTS,NUMB gene|NUMB,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NUMB gene|NUMB Malignant neoplasm of breast
PREDISPOSES,internal risk factors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",internal risk factors Malignant neoplasm of breast
PREDISPOSES,Fasting blood sugar result,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Carbohydrate,Fasting blood sugar result Malignant neoplasm of breast
PREDISPOSES,CENPL gene|CENPL,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CENPL gene|CENPL Malignant neoplasm of breast
CAUSES,BRCA2 gene|BRCA2,Hereditary Breast and Ovarian Cancer Syndrome,0.0,Female Breast Cancer,Gene or Genome,BRCA2 gene|BRCA2 Hereditary Breast and Ovarian Cancer Syndrome
AFFECTS,Long Intergenic Non-Protein Coding RNA,Carcinoma breast stage IV,0.0,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Long Intergenic Non-Protein Coding RNA Carcinoma breast stage IV
PREDISPOSES,PCAT19 gene|PCAT19,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PCAT19 gene|PCAT19 Malignant neoplasm of breast
PREDISPOSES,Food antioxidant,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Food antioxidant Malignant neoplasm of breast
PREDISPOSES,oleanolic acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,oleanolic acid Malignant neoplasm of breast
DISRUPTS,SLC2A1 gene|SLC2A1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SLC2A1 gene|SLC2A1 Malignant neoplasm of breast
PREDISPOSES,EIF4A3 gene|EIF4A3,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,EIF4A3 gene|EIF4A3 Triple Negative Breast Neoplasms
AFFECTS,Antibody-Drug Conjugates,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,Antibody-Drug Conjugates Malignant neoplasm of breast
PREDISPOSES,SOD1 gene|SOD1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SOD1 gene|SOD1 Malignant neoplasm of breast
PREDISPOSES,"ANGPT1 protein, human|ANGPT1",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein","ANGPT1 protein, human|ANGPT1 Triple Negative Breast Neoplasms"
AFFECTS,Resistance Process,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Phenomenon or Process,Resistance Process Malignant neoplasm of breast
CAUSES,CYP1B1 gene|CYP1B1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CYP1B1 gene|CYP1B1 Malignant neoplasm of breast
PREDISPOSES,Degenerative polyarthritis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Degenerative polyarthritis Malignant neoplasm of breast
CAUSES,Matrix Metalloproteinase 3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Matrix Metalloproteinase 3 Malignant neoplasm of breast
AFFECTS,GPR141 gene|GPR141,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GPR141 gene|GPR141 Malignant neoplasm of breast
DISRUPTS,HFM1 gene|HFM1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HFM1 gene|HFM1 Malignant neoplasm of breast
CAUSES,tamoxifen,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Pharmacologic Substance,tamoxifen estrogen receptor-positive breast cancer
AFFECTS,LGALS3 gene|LGALS3,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,LGALS3 gene|LGALS3 Triple Negative Breast Neoplasms
AFFECTS,Physiologic calcification,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",Physiologic calcification Noninfiltrating Intraductal Carcinoma
DISRUPTS,ZSCAN18 gene|ZSCAN18,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ZSCAN18 gene|ZSCAN18 Malignant neoplasm of breast
DISRUPTS,NNAT gene|NNAT,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Gene or Genome,NNAT gene|NNAT estrogen receptor-positive breast cancer
AFFECTS,Radioimmunotherapy,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Immunologic Factor,Radioimmunotherapy Triple Negative Breast Neoplasms
DISRUPTS,CREBZF gene|CREBZF,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CREBZF gene|CREBZF Malignant neoplasm of breast
DISRUPTS,OTUD1 gene|OTUD1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,OTUD1 gene|OTUD1 Triple Negative Breast Neoplasms
PREDISPOSES,HMMR gene|HMMR,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,HMMR gene|HMMR Secondary malignant neoplasm of breast
AFFECTS,Elements,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Elements Malignant neoplasm of breast
PREDISPOSES,RNA Sequence,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Nucleotide Sequence,RNA Sequence Breast Carcinoma
PREDISPOSES,BCKDK gene|BCKDK,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,BCKDK gene|BCKDK Secondary malignant neoplasm of breast
AFFECTS,Noninfiltrating Intraductal Carcinoma,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Neoplastic Process,Noninfiltrating Intraductal Carcinoma Invasive carcinoma of breast
PREDISPOSES,"Anesthetics, Inhalation",Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,"Element, Ion, or Isotope","Anesthetics, Inhalation Secondary malignant neoplasm of breast"
CAUSES,Tumor Antigens,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Neoplastic Process,Tumor Antigens Triple Negative Breast Neoplasms
AFFECTS,Caffeic Acid Phenethyl Ester,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Caffeic Acid Phenethyl Ester Malignant neoplasm of breast
DISRUPTS,MicroRNAs,Carcinoma breast stage IV,0.0,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",MicroRNAs Carcinoma breast stage IV
PREDISPOSES,INSM1 gene|INSM1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,INSM1 gene|INSM1 Malignant neoplasm of breast
PREDISPOSES,FUNDC2 gene|FUNDC2,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,FUNDC2 gene|FUNDC2 Triple Negative Breast Neoplasms
CAUSES,ubiquitin-protein ligase,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein",ubiquitin-protein ligase Triple Negative Breast Neoplasms
AFFECTS,NOX4 gene|NOX4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NOX4 gene|NOX4 Malignant neoplasm of breast
AFFECTS,Stereotactic Body Radiation Therapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Stereotactic Body Radiation Therapy Malignant neoplasm of breast
AFFECTS,NT5E gene|NT5E,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,NT5E gene|NT5E Triple Negative Breast Neoplasms
AFFECTS,FOXQ1 gene|FOXQ1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FOXQ1 gene|FOXQ1 Malignant neoplasm of breast
AFFECTS,ERBB2 Gene Mutation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ERBB2 Gene Mutation Malignant neoplasm of breast
PREDISPOSES,KLRB1 gene|KLRB1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,KLRB1 gene|KLRB1 Malignant neoplasm of breast
DISRUPTS,YTHDF1 gene|YTHDF1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,YTHDF1 gene|YTHDF1 Malignant neoplasm of breast
CAUSES,MAPK1 gene|MAPK1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MAPK1 gene|MAPK1 Malignant neoplasm of breast
AFFECTS,Transfer RNA,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Transfer RNA Triple Negative Breast Neoplasms
CAUSES,e protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",e protein Malignant neoplasm of breast
AUGMENTS,METTL3 gene|METTL3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,METTL3 gene|METTL3 Malignant neoplasm of breast
PREDISPOSES,Collagen Diseases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Collagen Diseases Malignant neoplasm of breast
AUGMENTS,VIRMA gene|VIRMA,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,VIRMA gene|VIRMA Triple Negative Breast Neoplasms
AUGMENTS,DNAJA1 gene|DNAJA1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,DNAJA1 gene|DNAJA1 Malignant neoplasm of breast
PREDISPOSES,SMAD4 gene|SMAD4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SMAD4 gene|SMAD4 Malignant neoplasm of breast
PREDISPOSES,LRRC37A2 gene|LRRC37A2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LRRC37A2 gene|LRRC37A2 Malignant neoplasm of breast
DISRUPTS,FZD8 gene|FZD8,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FZD8 gene|FZD8 Malignant neoplasm of breast
AFFECTS,Tumor Microenvironment,estrogen receptor-negative breast cancer,0.0,Female Breast Cancer,Neoplastic Process,Tumor Microenvironment estrogen receptor-negative breast cancer
AFFECTS,VASP gene|VASP,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,VASP gene|VASP Secondary malignant neoplasm of breast
PREDISPOSES,Responsive Disease,Early-Stage Breast Carcinoma,0.0,Female Breast Cancer,Disease or Syndrome,Responsive Disease Early-Stage Breast Carcinoma
PREDISPOSES,Nail-Patella Syndrome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Nail-Patella Syndrome Malignant neoplasm of breast
AFFECTS,CREB3L1 gene|CREB3L1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CREB3L1 gene|CREB3L1 Malignant neoplasm of breast
DISRUPTS,H19 gene|H19|HILS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,H19 gene|H19|HILS1 Malignant neoplasm of breast
AUGMENTS,PSME3 gene|PSME3,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,PSME3 gene|PSME3 Triple Negative Breast Neoplasms
PREDISPOSES,MDH2 gene|MDH2,Recurrent Breast Carcinoma,0.0009990009990009,Recurrent Breast Cancer,Gene or Genome,MDH2 gene|MDH2 Recurrent Breast Carcinoma
AFFECTS,PFKP gene|PFKP,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,PFKP gene|PFKP Triple Negative Breast Neoplasms
DISRUPTS,RNF185 gene|RNF185,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RNF185 gene|RNF185 Malignant neoplasm of breast
AFFECTS,Tumor Microenvironment,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Neoplastic Process,Tumor Microenvironment Secondary malignant neoplasm of breast
AFFECTS,RNA I,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",RNA I Triple Negative Breast Neoplasms
CAUSES,Genes,Invasive Ductal Breast Carcinoma,0.0,Female Breast Cancer,Gene or Genome,Genes Invasive Ductal Breast Carcinoma
PREDISPOSES,Oncogene Proteins,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,Oncogene Proteins Triple Negative Breast Neoplasms
PREDISPOSES,PARD3 gene|PARD3,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,PARD3 gene|PARD3 Secondary malignant neoplasm of breast
PREDISPOSES,USP4 gene|USP4,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,USP4 gene|USP4 Secondary malignant neoplasm of breast
AUGMENTS,STING1 gene,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,STING1 gene Triple Negative Breast Neoplasms
PREDISPOSES,mitogen-activated protein kinase p38,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein",mitogen-activated protein kinase p38 Triple Negative Breast Neoplasms
PREDISPOSES,SLC38A3 gene|SLC38A3,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,SLC38A3 gene|SLC38A3 Secondary malignant neoplasm of breast
DISRUPTS,METTL7A gene|METTL7A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,METTL7A gene|METTL7A Malignant neoplasm of breast
PREDISPOSES,"TNF protein, human|TNF",Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,"Amino Acid, Peptide, or Protein","TNF protein, human|TNF Secondary malignant neoplasm of breast"
AFFECTS,ASAH2 gene|ASAH2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ASAH2 gene|ASAH2 Malignant neoplasm of breast
AFFECTS,DCTD gene|DCTD,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,DCTD gene|DCTD Malignant neoplasm of breast
AFFECTS,Malate dehydrogenase (decarboxylating),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Malate dehydrogenase (decarboxylating) Malignant neoplasm of breast
AFFECTS,AICARDI-GOUTIERES SYNDROME,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,AICARDI-GOUTIERES SYNDROME Malignant neoplasm of breast
CAUSES,DNA Sequence,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Nucleotide Sequence,DNA Sequence Malignant neoplasm of breast
AUGMENTS,Protein Kinases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Protein Kinases Malignant neoplasm of breast
AFFECTS,Genes,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,Genes Triple Negative Breast Neoplasms
PREDISPOSES,ST14 gene|ST14,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ST14 gene|ST14 Malignant neoplasm of breast
AFFECTS,RENBP gene|RENBP,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Gene or Genome,RENBP gene|RENBP Inflammatory Breast Carcinoma
PREDISPOSES,Cigarette smoke (substance),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Substance,Cigarette smoke (substance) Malignant neoplasm of breast
AFFECTS,NAT10 gene|NAT10,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NAT10 gene|NAT10 Malignant neoplasm of breast
AUGMENTS,SNORD16 gene|SNORD16,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SNORD16 gene|SNORD16 Malignant neoplasm of breast
AFFECTS,ARID1A gene|ARID1A,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,ARID1A gene|ARID1A Triple Negative Breast Neoplasms
AFFECTS,NUDCD1 gene|NUDCD1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NUDCD1 gene|NUDCD1 Malignant neoplasm of breast
PREDISPOSES,PKD2 gene|PKD2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PKD2 gene|PKD2 Malignant neoplasm of breast
PREDISPOSES,Body composition measure,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Body composition measure Malignant neoplasm of breast
AFFECTS,Neoplastic Cell Transformation,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Neoplastic Process,Neoplastic Cell Transformation Secondary malignant neoplasm of breast
AUGMENTS,ZMIZ1 gene|ZMIZ1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ZMIZ1 gene|ZMIZ1 Malignant neoplasm of breast
PREDISPOSES,Emotional hypersensitivity,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Emotional hypersensitivity Malignant neoplasm of breast
AFFECTS,HER2-positive carcinoma of breast,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",HER2-positive carcinoma of breast Malignant neoplasm of breast
PREDISPOSES,KDM1A gene|KDM1A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,KDM1A gene|KDM1A Malignant neoplasm of breast
AFFECTS,nervous system disorder,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,nervous system disorder Malignant neoplasm of breast
PREDISPOSES,PRMT6 gene|PRMT6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PRMT6 gene|PRMT6 Malignant neoplasm of breast
AFFECTS,YY1 gene|YY1,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,YY1 gene|YY1 Secondary malignant neoplasm of breast
PREDISPOSES,MIRN181A gene|MIR181A2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,MIRN181A gene|MIR181A2 Breast cancer metastatic
PREDISPOSES,Huntington Disease,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Huntington Disease Malignant neoplasm of breast
AFFECTS,Rare Diseases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Rare Diseases Malignant neoplasm of breast
PREDISPOSES,Proteins,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Proteins Breast cancer metastatic
AFFECTS,Leukotrienes,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Eicosanoid,Leukotrienes Ductal Breast Carcinoma
AUGMENTS,Therapeutic agent (substance),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical Viewed Functionally,Therapeutic agent (substance) Malignant neoplasm of breast
PREDISPOSES,BRCA1 gene|BRCA1,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Gene or Genome,BRCA1 gene|BRCA1 Carcinoma of Male Breast
AFFECTS,Ovulation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Ovulation Malignant neoplasm of breast
AFFECTS,Neoplasm Metastasis,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Neoplasm Metastasis Breast Carcinoma
PREDISPOSES,CCAAT-Enhancer-Binding Protein-beta,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",CCAAT-Enhancer-Binding Protein-beta Malignant neoplasm of breast
AFFECTS,ESR1 gene|ESR1,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Gene or Genome,ESR1 gene|ESR1 Carcinoma of Male Breast
PREDISPOSES,FLT1 gene|FLT1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,FLT1 gene|FLT1 Breast cancer metastatic
PREDISPOSES,"CRK protein, human|CRK",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CRK protein, human|CRK Malignant neoplasm of breast"
AUGMENTS,"Progestational Hormones, Synthetic",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,"Progestational Hormones, Synthetic Malignant neoplasm of breast"
PREDISPOSES,CCR5 gene|CCR5,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Gene or Genome,CCR5 gene|CCR5 Breast cancer invasive NOS
CAUSES,HOXD10 gene|HOXD10,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HOXD10 gene|HOXD10 Malignant neoplasm of breast
AFFECTS,Proteins,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Proteins Breast Carcinoma
AFFECTS,KLF8 gene|KLF8,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,KLF8 gene|KLF8 Malignant neoplasm of breast
AFFECTS,Supplementation,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Element, Ion, or Isotope",Supplementation Breast cancer recurrent
PREDISPOSES,methylcobalamin-coenzyme M methyltransferase|EREG|ESR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Enzyme,methylcobalamin-coenzyme M methyltransferase|EREG|ESR1 Malignant neoplasm of breast
PREDISPOSES,Protein Family,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Protein Family Malignant neoplasm of breast
DISRUPTS,"Anti-Inflammatory Agents, Non-Steroidal",Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Chemical Viewed Functionally,"Anti-Inflammatory Agents, Non-Steroidal Breast cancer recurrent"
CAUSES,"TGFB1 protein, human|TGFB1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","TGFB1 protein, human|TGFB1 Malignant neoplasm of breast"
AUGMENTS,MYC Family Genes|MYC,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MYC Family Genes|MYC Malignant neoplasm of breast
AUGMENTS,HSP90 Heat-Shock Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",HSP90 Heat-Shock Proteins Malignant neoplasm of breast
DISRUPTS,mitogen-activated protein kinase p38|CRK|MAPK14|MAPK1|AIMP2|GRAP2|AHSA1|POLDIP2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",mitogen-activated protein kinase p38|CRK|MAPK14|MAPK1|AIMP2|GRAP2|AHSA1|POLDIP2 Breast cancer metastatic
AUGMENTS,Ki antigen|PSME3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Immunologic Factor,Ki antigen|PSME3 Malignant neoplasm of breast
PREDISPOSES,Hormone Receptor,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Hormone,Hormone Receptor Breast cancer metastatic
AFFECTS,IRAK4 gene|IRAK4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IRAK4 gene|IRAK4 Malignant neoplasm of breast
PREDISPOSES,Heart Diseases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Heart Diseases Malignant neoplasm of breast
AUGMENTS,cDNA Library,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",cDNA Library Malignant neoplasm of breast
PREDISPOSES,AXILLARY LYMPH NODE METASTASIS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,AXILLARY LYMPH NODE METASTASIS Malignant neoplasm of breast
PREDISPOSES,tau Proteins|PGR|PR@|PRH2|TMEM37|ERVK-7|ERVK-8|ERVK-10|ERVK-9|ERVK-21|ERVK-18|ERVK-25|ERVK-24|ERVK-19,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",tau Proteins|PGR|PR@|PRH2|TMEM37|ERVK-7|ERVK-8|ERVK-10|ERVK-9|ERVK-21|ERVK-18|ERVK-25|ERVK-24|ERVK-19 Malignant neoplasm of breast
PREDISPOSES,"NAT1 protein, human|NAT1|EIF4G2|SLC6A2|SLC38A3|SLC38A6",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","NAT1 protein, human|NAT1|EIF4G2|SLC6A2|SLC38A3|SLC38A6 Malignant neoplasm of breast"
AFFECTS,low protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",low protein Malignant neoplasm of breast
AFFECTS,C-KIT Mutation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",C-KIT Mutation Malignant neoplasm of breast
AUGMENTS,"TRIP10 protein, human|TRIP10",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","TRIP10 protein, human|TRIP10 Malignant neoplasm of breast"
AFFECTS,SRD5A2 gene|SRD5A2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SRD5A2 gene|SRD5A2 Malignant neoplasm of breast
AFFECTS,Tumor Markers,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Tumor Markers Malignant neoplasm of breast
AUGMENTS,XRCC2 gene|XRCC2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,XRCC2 gene|XRCC2 Malignant neoplasm of breast
PREDISPOSES,CCNA2 gene|CCNA2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CCNA2 gene|CCNA2 Malignant neoplasm of breast
DISRUPTS,MDC1 gene|MDC1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MDC1 gene|MDC1 Malignant neoplasm of breast
AFFECTS,gene polymorphism,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,gene polymorphism Breast Carcinoma
AUGMENTS,TWIST1 gene|TWIST1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,TWIST1 gene|TWIST1 Breast cancer metastatic
PREDISPOSES,"NOS3 protein, human|NOS3",Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein","NOS3 protein, human|NOS3 Breast cancer metastatic"
DISRUPTS,"Anti-Inflammatory Agents, Non-Steroidal",Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Chemical Viewed Functionally,"Anti-Inflammatory Agents, Non-Steroidal Breast cancer invasive NOS"
PREDISPOSES,Effective communication,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Effective communication Malignant neoplasm of breast
PREDISPOSES,Phospholipids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Lipid,Phospholipids Malignant neoplasm of breast
CAUSES,Common Carcinoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Common Carcinoma Malignant neoplasm of breast
DISRUPTS,BRCA2 gene|BRCA2,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Gene or Genome,BRCA2 gene|BRCA2 Sporadic Breast Carcinoma
CAUSES,DNA,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",DNA Sporadic Breast Carcinoma
AFFECTS,peptide hormone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",peptide hormone Malignant neoplasm of breast
AFFECTS,PROTEIN KINASE,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",PROTEIN KINASE Breast Carcinoma
AFFECTS,DNA Sequence,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Nucleotide Sequence,DNA Sequence Malignant neoplasm of breast
DISRUPTS,"SOD2 protein, human|SOD2",Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein","SOD2 protein, human|SOD2 Breast Carcinoma"
COMPLICATES,Neoplasm Metastasis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Neoplasm Metastasis Malignant neoplasm of breast
PREDISPOSES,Exogenous hormones,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Hormone,Exogenous hormones Breast Carcinoma
PREDISPOSES,LMO7 gene|LMO7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LMO7 gene|LMO7 Malignant neoplasm of breast
PREDISPOSES,Antigens,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,Immunologic Factor,Antigens Female Breast Carcinoma
PREDISPOSES,peptide hormone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",peptide hormone Malignant neoplasm of breast
AFFECTS,TP53 gene|TP53,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,TP53 gene|TP53 Noninfiltrating Intraductal Carcinoma
AFFECTS,HOXA1 gene|HOXA1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HOXA1 gene|HOXA1 Malignant neoplasm of breast
AFFECTS,dihydroxy-vitamin D3,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Food,dihydroxy-vitamin D3 Breast Carcinoma
CAUSES,Virus,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Virus,Virus Breast Carcinoma
CAUSES,spasmolytic polypeptide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",spasmolytic polypeptide Malignant neoplasm of breast
AFFECTS,3-hydroxytamoxifen,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Pharmacologic Substance,3-hydroxytamoxifen Breast Carcinoma
PREDISPOSES,Steroid Use,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Steroid,Steroid Use Malignant neoplasm of breast
PREDISPOSES,Low-Density Lipoproteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Low-Density Lipoproteins Malignant neoplasm of breast
PREDISPOSES,ESTROGEN USE,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Hormone,ESTROGEN USE Breast Carcinoma
AFFECTS,Therapeutic Abortion,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Therapeutic Abortion Malignant neoplasm of breast
AUGMENTS,"Fatty Acids, Nonesterified",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,"Fatty Acids, Nonesterified Malignant neoplasm of breast"
AFFECTS,Augmentation mammoplasty,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Augmentation mammoplasty Breast Carcinoma
CAUSES,Malignant neoplasm of breast,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,Neoplastic Process,Malignant neoplasm of breast Contralateral breast cancer
AFFECTS,MICE gene,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,MICE gene Breast Carcinoma
AFFECTS,"Genes, vpr",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,"Genes, vpr Malignant neoplasm of breast"
PREDISPOSES,"Genome, Human",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,"Genome, Human Malignant neoplasm of breast"
PREDISPOSES,mucinous carcinoma-associated antigen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,mucinous carcinoma-associated antigen Malignant neoplasm of breast
PREDISPOSES,Mixed Function Oxygenases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Mixed Function Oxygenases Malignant neoplasm of breast
CAUSES,PCAF gene|KAT2B,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,PCAF gene|KAT2B Breast Carcinoma
AUGMENTS,CCND1 gene|CCND1,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,CCND1 gene|CCND1 Breast Carcinoma
AFFECTS,SHBG gene|SHBG,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SHBG gene|SHBG Malignant neoplasm of breast
AFFECTS,Carcinoembryonic Antigen,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Immunologic Factor,Carcinoembryonic Antigen Noninfiltrating Intraductal Carcinoma
AFFECTS,Ionizing radiation,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,"Element, Ion, or Isotope",Ionizing radiation Carcinoma of Male Breast
CAUSES,Serine Protease,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Enzyme,Serine Protease Breast Carcinoma
CAUSES,SH Protease,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Enzyme,SH Protease Breast Carcinoma
CAUSES,Breast cancer recurrent,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Neoplastic Process,"Breast cancer recurrent Carcinoma, Ductal, Breast"
AFFECTS,3-hydroxytamoxifen,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Pharmacologic Substance,3-hydroxytamoxifen Breast cancer metastatic
CAUSES,Secondary malignant neoplasm of liver,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Secondary malignant neoplasm of liver Malignant neoplasm of breast
CAUSES,cytokine,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Biologically Active Substance,cytokine Breast Carcinoma
CAUSES,Histocompatibility Antigens,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Immunologic Factor,Histocompatibility Antigens Breast Carcinoma
AFFECTS,PGR gene|PGR,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Gene or Genome,PGR gene|PGR Sporadic Breast Carcinoma
CAUSES,Epidermal Growth Factor|EGF,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Biologically Active Substance,Epidermal Growth Factor|EGF Breast Carcinoma
PREDISPOSES,Vascular Endothelial Growth Factor C,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Biologically Active Substance,Vascular Endothelial Growth Factor C Breast cancer metastatic
AUGMENTS,Insulin-Like-Growth Factor I Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Insulin-Like-Growth Factor I Receptor Malignant neoplasm of breast
AUGMENTS,Genes,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Gene or Genome,Genes Breast cancer invasive NOS
AFFECTS,DNA Polymerase I,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",DNA Polymerase I Malignant neoplasm of breast
AUGMENTS,ZNF217 gene|ZNF217,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ZNF217 gene|ZNF217 Malignant neoplasm of breast
PREDISPOSES,riboflavin-binding protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",riboflavin-binding protein Malignant neoplasm of breast
CAUSES,Carcinoma in Situ,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Carcinoma in Situ Malignant neoplasm of breast
AFFECTS,EIF3S6 gene|EIF3E,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,EIF3S6 gene|EIF3E Malignant neoplasm of breast
AFFECTS,SAFB gene|SAFB,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SAFB gene|SAFB Malignant neoplasm of breast
AFFECTS,Angiogenesis,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Gene or Genome,Angiogenesis Inflammatory Breast Carcinoma
CAUSES,Primary Carcinoma,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Primary Carcinoma Breast Carcinoma
PREDISPOSES,Tumor Markers,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Tumor Markers Breast Carcinoma
PREDISPOSES,"EPIDERMAL GROWTH FACTOR, HUMAN",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,"EPIDERMAL GROWTH FACTOR, HUMAN Malignant neoplasm of breast"
PREDISPOSES,Hyperlipidemia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Lipid,Hyperlipidemia Malignant neoplasm of breast
AFFECTS,Germ-Line Mutation,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,"Element, Ion, or Isotope",Germ-Line Mutation Carcinoma of Male Breast
AUGMENTS,MYC gene|MYC,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Gene or Genome,MYC gene|MYC Breast cancer invasive NOS
DISRUPTS,"TACC1 protein, human|TACC1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","TACC1 protein, human|TACC1 Malignant neoplasm of breast"
PREDISPOSES,"Hydrocarbons, Halogenated",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Hydrocarbons, Halogenated Malignant neoplasm of breast"
PREDISPOSES,Genetic syndrome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Genetic syndrome Malignant neoplasm of breast
CAUSES,Hormones,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Hormone,Hormones Noninfiltrating Intraductal Carcinoma
AFFECTS,Pathologic Processes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Phenomenon or Process,Pathologic Processes Malignant neoplasm of breast
AUGMENTS,ELF3 gene|ELF3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ELF3 gene|ELF3 Malignant neoplasm of breast
AFFECTS,PLAUR gene|PLAUR,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,PLAUR gene|PLAUR Breast cancer metastatic
AFFECTS,Thyrotropin-Releasing Hormone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Thyrotropin-Releasing Hormone Malignant neoplasm of breast
PREDISPOSES,AXIN2 gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,AXIN2 gene Malignant neoplasm of breast
AFFECTS,CCL2 gene|CCL2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CCL2 gene|CCL2 Malignant neoplasm of breast
CAUSES,Estrogen Receptor beta|ESR2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptor beta|ESR2 Malignant neoplasm of breast
AFFECTS,bone sialoprotein,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",bone sialoprotein Breast cancer metastatic
DISRUPTS,Thiazolidinediones,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Thiazolidinediones Breast Carcinoma
AUGMENTS,EZH2 gene|EZH2,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,EZH2 gene|EZH2 Noninfiltrating Intraductal Carcinoma
DISRUPTS,antireticular cytotoxic serum,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hazardous or Poisonous Substance,antireticular cytotoxic serum Malignant neoplasm of breast
PREDISPOSES,restriction enzyme,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",restriction enzyme Malignant neoplasm of breast
CAUSES,SEPT9 gene|SEPT9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SEPT9 gene|SEPT9 Malignant neoplasm of breast
CAUSES,Steroids,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Steroid,Steroids Breast Carcinoma
PREDISPOSES,betaIG-H3 protein|TGFBI,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",betaIG-H3 protein|TGFBI Malignant neoplasm of breast
AFFECTS,PTHLH gene|PTHLH,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,PTHLH gene|PTHLH Breast cancer metastatic
CAUSES,T gene,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,T gene Noninfiltrating Intraductal Carcinoma
CAUSES,Vitamin A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Vitamin A Malignant neoplasm of breast
CAUSES,Gonadal Hormones,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Gonadal Hormones Malignant neoplasm of breast
PREDISPOSES,IRS2 gene|IRS2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,IRS2 gene|IRS2 Breast cancer metastatic
AFFECTS,Small RNA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Small RNA Malignant neoplasm of breast
PREDISPOSES,PSIP1 gene|PSIP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PSIP1 gene|PSIP1 Malignant neoplasm of breast
PREDISPOSES,CA9 gene|CA9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CA9 gene|CA9 Malignant neoplasm of breast
CAUSES,Antidepressive Agents,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical Viewed Functionally,Antidepressive Agents Malignant neoplasm of breast
AUGMENTS,IGF2 gene|IGF2,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,IGF2 gene|IGF2 Noninfiltrating Intraductal Carcinoma
PREDISPOSES,SCTR gene|SCTR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SCTR gene|SCTR Malignant neoplasm of breast
CAUSES,Estrogens,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Hormone,Estrogens Sporadic Breast Carcinoma
AFFECTS,"Shc1 protein, mouse|SHC1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","Shc1 protein, mouse|SHC1 Malignant neoplasm of breast"
CAUSES,Environmental Estrogen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Environmental Estrogen Malignant neoplasm of breast
AFFECTS,Selective Estrogen Receptor Modulators,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Selective Estrogen Receptor Modulators Breast cancer metastatic
AFFECTS,PP5 protein-serine-threonine phosphatase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",PP5 protein-serine-threonine phosphatase Malignant neoplasm of breast
PREDISPOSES,Lesion,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",Lesion Noninfiltrating Intraductal Carcinoma
AFFECTS,IGFBP3 gene|IGFBP3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IGFBP3 gene|IGFBP3 Malignant neoplasm of breast
AFFECTS,Vascular Endothelial Growth Factors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Vascular Endothelial Growth Factors Malignant neoplasm of breast
PREDISPOSES,N-3 fatty acid intake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,N-3 fatty acid intake Malignant neoplasm of breast
AFFECTS,cell invasion,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Element, Ion, or Isotope",cell invasion Breast cancer recurrent
CAUSES,TRANCE protein|TNFSF11,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",TRANCE protein|TNFSF11 Malignant neoplasm of breast
AUGMENTS,"Genes, Homeobox|LBX1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,"Genes, Homeobox|LBX1 Malignant neoplasm of breast"
PREDISPOSES,NDRG1 gene|NDRG1,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Gene or Genome,NDRG1 gene|NDRG1 Breast cancer invasive NOS
AFFECTS,Combination Drug Therapy,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Pharmacologic Substance,Combination Drug Therapy Breast cancer metastatic
AFFECTS,Secondary malignant neoplasm of bone,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Secondary malignant neoplasm of bone Breast cancer metastatic
AFFECTS,genetic element,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,genetic element Breast Carcinoma
AFFECTS,"DICER1 protein, human|DICER1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","DICER1 protein, human|DICER1 Malignant neoplasm of breast"
CAUSES,Xanthine Dehydrogenase|XDH,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Xanthine Dehydrogenase|XDH Malignant neoplasm of breast
DISRUPTS,NOTCH1 gene,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Gene or Genome,NOTCH1 gene Breast cancer recurrent
AFFECTS,Cell Adhesion,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Cell Adhesion Malignant neoplasm of breast
AUGMENTS,CCL18 gene|CCL18,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CCL18 gene|CCL18 Malignant neoplasm of breast
AUGMENTS,PTK2B gene|PTK2B,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Gene or Genome,PTK2B gene|PTK2B Breast cancer recurrent
PREDISPOSES,ABCB1 gene|ABCB1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ABCB1 gene|ABCB1 Malignant neoplasm of breast
AFFECTS,Signal Transduction Pathways,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Signal Transduction Pathways Breast cancer metastatic
PREDISPOSES,CCL2 gene|CCL2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,CCL2 gene|CCL2 Breast cancer metastatic
PREDISPOSES,Receptor Protein-Tyrosine Kinases,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Receptor Protein-Tyrosine Kinases Breast cancer invasive NOS
AFFECTS,RGS Proteins|PITX2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",RGS Proteins|PITX2 Malignant neoplasm of breast
AFFECTS,TNFSF11 gene|TNFSF11,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TNFSF11 gene|TNFSF11 Malignant neoplasm of breast
AFFECTS,PRS gene|PRS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PRS gene|PRS Malignant neoplasm of breast
CAUSES,"Receptors, Progesterone|EREG|ESR1",Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Hormone,"Receptors, Progesterone|EREG|ESR1 Breast Carcinoma"
AFFECTS,cell fate determination,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",cell fate determination Malignant neoplasm of breast
AFFECTS,Gene Expression Alteration,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Gene Expression Alteration Malignant neoplasm of breast
AFFECTS,Cessation of life,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Cessation of life Breast Carcinoma
CAUSES,Human Papilloma Virus Vaccine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Virus,Human Papilloma Virus Vaccine Malignant neoplasm of breast
CAUSES,JTB gene|JTB,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,JTB gene|JTB Malignant neoplasm of breast
CAUSES,Process,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Phenomenon or Process,Process Malignant neoplasm of breast
AFFECTS,Protein Overexpression,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Protein Overexpression Breast cancer invasive NOS
PREDISPOSES,Systemic disease,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Systemic disease Malignant neoplasm of breast
PREDISPOSES,Candidate Disease Gene,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,Candidate Disease Gene Breast cancer metastatic
PREDISPOSES,Extravasation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Extravasation Malignant neoplasm of breast
PREDISPOSES,Alkaline phosphatase isoenzyme,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Enzyme,Alkaline phosphatase isoenzyme Breast cancer metastatic
AFFECTS,Hormone Receptor Test,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Hormone Receptor Test Malignant neoplasm of breast
AFFECTS,Interleukin Gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Interleukin Gene Malignant neoplasm of breast
AFFECTS,AXL gene|AXL,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,AXL gene|AXL Malignant neoplasm of breast
AFFECTS,CD100 antigen|SEMA4D,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Immunologic Factor,CD100 antigen|SEMA4D Malignant neoplasm of breast
DISRUPTS,TIAM1 gene|TIAM1,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,TIAM1 gene|TIAM1 Breast Carcinoma
DISRUPTS,Tumor Suppressor Genes,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,Tumor Suppressor Genes Breast cancer metastatic
AFFECTS,ERBB2 gene|ERBB2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,ERBB2 gene|ERBB2 Breast cancer metastatic
PREDISPOSES,Stiff-Person Syndrome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Stiff-Person Syndrome Malignant neoplasm of breast
PREDISPOSES,TAZ gene|TAZ,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TAZ gene|TAZ Malignant neoplasm of breast
DISRUPTS,Ethacrynic Acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Ethacrynic Acid Malignant neoplasm of breast
PREDISPOSES,Sweet's Syndrome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Sweet's Syndrome Malignant neoplasm of breast
PREDISPOSES,Prions,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Prions Malignant neoplasm of breast
AUGMENTS,PTPN12 gene|PTPN12,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PTPN12 gene|PTPN12 Malignant neoplasm of breast
AUGMENTS,"Antigens, CD25",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Immunologic Factor,"Antigens, CD25 Malignant neoplasm of breast"
AFFECTS,PLK1 gene|PLK1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PLK1 gene|PLK1 Malignant neoplasm of breast
AUGMENTS,Fibroblast Growth Factor 1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Fibroblast Growth Factor 1 Malignant neoplasm of breast
AFFECTS,"EPIDERMAL GROWTH FACTOR, HUMAN",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,"EPIDERMAL GROWTH FACTOR, HUMAN Malignant neoplasm of breast"
PREDISPOSES,Intercellular adhesion molecule 1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Intercellular adhesion molecule 1 Breast cancer metastatic
DISRUPTS,5'-AMP-activated protein kinase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",5'-AMP-activated protein kinase Malignant neoplasm of breast
CAUSES,Metals,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Metals Malignant neoplasm of breast
AFFECTS,WT1 gene|WT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,WT1 gene|WT1 Malignant neoplasm of breast
AUGMENTS,BRCA2 gene|BRCA2,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Gene or Genome,BRCA2 gene|BRCA2 Sporadic Breast Carcinoma
PREDISPOSES,MIRN96 gene|MIR96,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,MIRN96 gene|MIR96 Breast cancer metastatic
AFFECTS,PVT1 gene|PVT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PVT1 gene|PVT1 Malignant neoplasm of breast
DISRUPTS,"Receptors, Progesterone|PGR",Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Hormone,"Receptors, Progesterone|PGR Breast Carcinoma"
AUGMENTS,CD47 gene|CD47,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CD47 gene|CD47 Malignant neoplasm of breast
CAUSES,mitogen-activated protein kinase 7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",mitogen-activated protein kinase 7 Malignant neoplasm of breast
AFFECTS,TGFBR2 gene|TGFBR2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,TGFBR2 gene|TGFBR2 Breast cancer metastatic
AFFECTS,Reactive Oxygen Species,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Reactive Oxygen Species Breast cancer metastatic
AFFECTS,"ESR2 protein, human|ESR2",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","ESR2 protein, human|ESR2 Malignant neoplasm of breast"
AFFECTS,CPEB4 gene|CPEB4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CPEB4 gene|CPEB4 Malignant neoplasm of breast
AFFECTS,triplet codon-amino acid adaptor activity,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,"Amino Acid, Peptide, or Protein",triplet codon-amino acid adaptor activity Female Breast Carcinoma
PREDISPOSES,"TGFB1 protein, human|TGFB1",Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein","TGFB1 protein, human|TGFB1 Breast cancer metastatic"
DISRUPTS,Hydroxamic Acids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Hydroxamic Acids Malignant neoplasm of breast
AFFECTS,Tumor necrosis factor receptor 11b,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Tumor necrosis factor receptor 11b Malignant neoplasm of breast
AFFECTS,Phospholipids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Lipid,Phospholipids Malignant neoplasm of breast
AFFECTS,Infrared radiation therapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Infrared radiation therapy Malignant neoplasm of breast
AUGMENTS,"STC1 protein, human|STC1",Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Amino Acid, Peptide, or Protein","STC1 protein, human|STC1 Breast cancer recurrent"
PREDISPOSES,HMGA2 gene|HMGA2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,HMGA2 gene|HMGA2 Breast cancer metastatic
CAUSES,Breast cancer stage III,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Breast cancer stage III Malignant neoplasm of breast
AUGMENTS,Glycerol-3-Phosphate Dehydrogenase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Glycerol-3-Phosphate Dehydrogenase Malignant neoplasm of breast
AFFECTS,Adhesions,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Adhesions Breast cancer metastatic
PREDISPOSES,"MFNG protein, human|MFNG",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","MFNG protein, human|MFNG Malignant neoplasm of breast"
AUGMENTS,Placental Growth Factor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Placental Growth Factor Malignant neoplasm of breast
PREDISPOSES,HGF gene|HGF,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HGF gene|HGF Malignant neoplasm of breast
AUGMENTS,RBBP1L1 Protein|ARID4B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",RBBP1L1 Protein|ARID4B Malignant neoplasm of breast
AFFECTS,TERT gene|TERT,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TERT gene|TERT Malignant neoplasm of breast
AFFECTS,hypercholesterolemia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Lipid,hypercholesterolemia Malignant neoplasm of breast
CAUSES,RETN gene|RETN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RETN gene|RETN Malignant neoplasm of breast
DISRUPTS,LIMK1 gene|LIMK1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LIMK1 gene|LIMK1 Malignant neoplasm of breast
AFFECTS,Mutant Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Mutant Proteins Malignant neoplasm of breast
CAUSES,Dioxygenases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Dioxygenases Malignant neoplasm of breast
CAUSES,RET gene|RET,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,RET gene|RET Breast Carcinoma
AFFECTS,Immunotoxins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Immunotoxins Malignant neoplasm of breast
CAUSES,DNA,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",DNA Familial cancer of breast
CAUSES,NRF1 gene|NRF1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NRF1 gene|NRF1 Malignant neoplasm of breast
PREDISPOSES,"8-oxoguanine-DNA glycosylase, human",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","8-oxoguanine-DNA glycosylase, human Malignant neoplasm of breast"
PREDISPOSES,PCDH10 gene|PCDH10,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PCDH10 gene|PCDH10 Malignant neoplasm of breast
AFFECTS,"NOS3 protein, human|NOS3",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","NOS3 protein, human|NOS3 Malignant neoplasm of breast"
PREDISPOSES,NOTCH1 gene,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Gene or Genome,"NOTCH1 gene Carcinoma, Ductal, Breast"
AFFECTS,CDK4 gene|CDK4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CDK4 gene|CDK4 Malignant neoplasm of breast
CAUSES,Prostaglandins E,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Eicosanoid,Prostaglandins E Malignant neoplasm of breast
CAUSES,CD4 gene|CD4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CD4 gene|CD4 Malignant neoplasm of breast
CAUSES,TOLLIP gene|TOLLIP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TOLLIP gene|TOLLIP Malignant neoplasm of breast
PREDISPOSES,CASP10 gene|CASP10,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CASP10 gene|CASP10 Malignant neoplasm of breast
DISRUPTS,Pharmaceutical Preparations,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Pharmacologic Substance,Pharmaceutical Preparations Breast cancer metastatic
DISRUPTS,CCNB1 gene|CCNB1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CCNB1 gene|CCNB1 Malignant neoplasm of breast
AUGMENTS,BARD1 gene|BARD1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BARD1 gene|BARD1 Malignant neoplasm of breast
AFFECTS,Therapeutic Intervention,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Therapeutic Intervention Breast cancer metastatic
AFFECTS,FOXC1 gene|FOXC1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FOXC1 gene|FOXC1 Malignant neoplasm of breast
CAUSES,Homologous Gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Homologous Gene Malignant neoplasm of breast
AFFECTS,Alternative Therapies,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Alternative Therapies Malignant neoplasm of breast
AFFECTS,"NAT2 protein, human|NAT2",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","NAT2 protein, human|NAT2 Malignant neoplasm of breast"
PREDISPOSES,LTB4R2 gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LTB4R2 gene Malignant neoplasm of breast
AFFECTS,Dopamine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neuroreactive Substance or Biogenic Amine,Dopamine Malignant neoplasm of breast
PREDISPOSES,Insulin-Like Growth-Factor-Binding Proteins|PGR|PR@|PRH2|TMEM37|ERVK-7|ERVK-8|ERVK-10|ERVK-9|ERVK-21|ERVK-18|ERVK-25|ERVK-24|ERVK-19,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Insulin-Like Growth-Factor-Binding Proteins|PGR|PR@|PRH2|TMEM37|ERVK-7|ERVK-8|ERVK-10|ERVK-9|ERVK-21|ERVK-18|ERVK-25|ERVK-24|ERVK-19 Malignant neoplasm of breast
PREDISPOSES,BRCA1 gene|BRCA1,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Gene or Genome,BRCA1 gene|BRCA1 Breast cancer invasive NOS
PREDISPOSES,XPA gene|XPA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,XPA gene|XPA Malignant neoplasm of breast
AFFECTS,NES gene|NES,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NES gene|NES Malignant neoplasm of breast
CAUSES,CDKN1B gene|CDKN1B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CDKN1B gene|CDKN1B Malignant neoplasm of breast
DISRUPTS,MIRN384 gene|MIR384,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIRN384 gene|MIR384 Malignant neoplasm of breast
PREDISPOSES,MAL gene|CD8A|MAL|MKL1|TIRAP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MAL gene|CD8A|MAL|MKL1|TIRAP Malignant neoplasm of breast
DISRUPTS,TRANCE protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",TRANCE protein Malignant neoplasm of breast
CAUSES,Mitogen-Activated Protein Kinases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Mitogen-Activated Protein Kinases Malignant neoplasm of breast
AFFECTS,Hodgkin Disease,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Hodgkin Disease Malignant neoplasm of breast
PREDISPOSES,Candidate Disease Gene,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,Candidate Disease Gene Breast Carcinoma
PREDISPOSES,Estrogen receptor negative,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen receptor negative Noninfiltrating Intraductal Carcinoma
PREDISPOSES,Malnutrition,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Malnutrition Malignant neoplasm of breast
PREDISPOSES,Tumor Antigens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Tumor Antigens Malignant neoplasm of breast
AFFECTS,Transplantation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Transplantation Malignant neoplasm of breast
PREDISPOSES,Insulin-Like Growth Factor I,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Biologically Active Substance,Insulin-Like Growth Factor I Breast Carcinoma
PREDISPOSES,Insulin-Like Growth Factor Binding Protein 3,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Insulin-Like Growth Factor Binding Protein 3 Breast Carcinoma
PREDISPOSES,Tumor Promoters,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,Tumor Promoters Breast cancer invasive NOS
AFFECTS,Indicators,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Indicator, Reagent, or Diagnostic Aid",Indicators Breast cancer invasive NOS
PREDISPOSES,HYAL1 gene|HYAL1,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Gene or Genome,HYAL1 gene|HYAL1 Breast cancer invasive NOS
AFFECTS,Cell division,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Cell division Malignant neoplasm of breast
DISRUPTS,letrozole,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Pharmacologic Substance,letrozole Breast cancer recurrent
AUGMENTS,Genes,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,Genes Breast cancer metastatic
PREDISPOSES,Sexual function,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Sexual function Malignant neoplasm of breast
AFFECTS,Carcinoma in Situ,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Neoplastic Process,Carcinoma in Situ Noninfiltrating Intraductal Carcinoma
PREDISPOSES,MIRN21 gene|MIR21,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Gene or Genome,MIRN21 gene|MIR21 Ductal Breast Carcinoma
PREDISPOSES,Carcinoembryonic Antigen,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Immunologic Factor,Carcinoembryonic Antigen Breast Carcinoma
AUGMENTS,PRL gene|PRL,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PRL gene|PRL Malignant neoplasm of breast
AFFECTS,RARA gene|RARA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RARA gene|RARA Malignant neoplasm of breast
CAUSES,progesterone receptor B|EREG|ESR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,progesterone receptor B|EREG|ESR1 Malignant neoplasm of breast
AFFECTS,biological_process,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Phenomenon or Process,biological_process Malignant neoplasm of breast
AFFECTS,MAP Kinase Gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MAP Kinase Gene Malignant neoplasm of breast
PREDISPOSES,"TGFB1 protein, human|TGFB1",Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Amino Acid, Peptide, or Protein","TGFB1 protein, human|TGFB1 Breast cancer invasive NOS"
CAUSES,E2F1 gene|E2F1|UBE2L3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,E2F1 gene|E2F1|UBE2L3 Malignant neoplasm of breast
AFFECTS,soy protein isolate,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Amino Acid, Peptide, or Protein",soy protein isolate Breast cancer recurrent
PREDISPOSES,"Polycyclic Hydrocarbons, Aromatic",Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,"Element, Ion, or Isotope","Polycyclic Hydrocarbons, Aromatic Carcinoma of Male Breast"
DISRUPTS,ARHI gene|DIRAS3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ARHI gene|DIRAS3 Malignant neoplasm of breast
AFFECTS,Superior Vena Cava Syndrome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Superior Vena Cava Syndrome Malignant neoplasm of breast
PREDISPOSES,S100 Proteins|S100A1|S100B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",S100 Proteins|S100A1|S100B Malignant neoplasm of breast
CAUSES,Precancerous lesions,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Neoplastic Process,Precancerous lesions Ductal Breast Carcinoma
CAUSES,WNT5A gene|WNT5A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,WNT5A gene|WNT5A Malignant neoplasm of breast
AFFECTS,"ESR1 protein, human|ESR1",Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Amino Acid, Peptide, or Protein","ESR1 protein, human|ESR1 Breast cancer invasive NOS"
AUGMENTS,"Ribosomal Protein S6 Kinases, 70-kDa|UBASH3B",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","Ribosomal Protein S6 Kinases, 70-kDa|UBASH3B Malignant neoplasm of breast"
AUGMENTS,Methionine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Methionine Malignant neoplasm of breast
PREDISPOSES,ING1 gene|ING1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ING1 gene|ING1 Malignant neoplasm of breast
DISRUPTS,PRKD1 gene|PRKD1,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Gene or Genome,PRKD1 gene|PRKD1 Breast cancer invasive NOS
AFFECTS,TIAM1 gene|TIAM1,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Gene or Genome,TIAM1 gene|TIAM1 Breast cancer invasive NOS
AUGMENTS,PTEN gene|PTEN,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,PTEN gene|PTEN Noninfiltrating Intraductal Carcinoma
AFFECTS,biological_process,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Phenomenon or Process,biological_process Breast cancer invasive NOS
AFFECTS,Adenoid Cystic Carcinoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Adenoid Cystic Carcinoma Malignant neoplasm of breast
AUGMENTS,MRPS18A gene|MRPS18A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MRPS18A gene|MRPS18A Malignant neoplasm of breast
PREDISPOSES,Vitamin B2 intake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Vitamin B2 intake Malignant neoplasm of breast
PREDISPOSES,ATM gene|ATM,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,Gene or Genome,ATM gene|ATM Female Breast Carcinoma
PREDISPOSES,Mineralocorticoid Receptor|DHCR24,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Mineralocorticoid Receptor|DHCR24 Malignant neoplasm of breast
PREDISPOSES,Antilipemic Agents,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical Viewed Functionally,Antilipemic Agents Malignant neoplasm of breast
AUGMENTS,ITK gene|ITK,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,ITK gene|ITK Breast cancer metastatic
AUGMENTS,CXCL10 gene|CXCL10,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CXCL10 gene|CXCL10 Malignant neoplasm of breast
DISRUPTS,MicroRNAs,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",MicroRNAs Carcinoma of Male Breast
AFFECTS,antibody therapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Indicator, Reagent, or Diagnostic Aid",antibody therapy Malignant neoplasm of breast
AFFECTS,Pancreatic carcinoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Pancreatic carcinoma Malignant neoplasm of breast
PREDISPOSES,KIF4A gene|KIF4A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,KIF4A gene|KIF4A Malignant neoplasm of breast
PREDISPOSES,DNA Repair Gene,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,Gene or Genome,DNA Repair Gene Female Breast Carcinoma
PREDISPOSES,Breast Microcalcification,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Breast Microcalcification Breast Carcinoma
PREDISPOSES,IL1B gene|IL1B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IL1B gene|IL1B Malignant neoplasm of breast
PREDISPOSES,IL4R gene|IL4R,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IL4R gene|IL4R Malignant neoplasm of breast
PREDISPOSES,Enhancing Lesion,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Enhancing Lesion Malignant neoplasm of breast
AUGMENTS,Sulfuric Acid Esters,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Sulfuric Acid Esters Malignant neoplasm of breast
AUGMENTS,CXCL13 gene|CXCL13,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CXCL13 gene|CXCL13 Malignant neoplasm of breast
AFFECTS,Malignant neoplasm of breast,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,Neoplastic Process,Malignant neoplasm of breast Contralateral breast cancer
AUGMENTS,ERBB3 gene|ERBB3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ERBB3 gene|ERBB3 Malignant neoplasm of breast
CAUSES,Amyloid beta-Protein Precursor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Amyloid beta-Protein Precursor Malignant neoplasm of breast
AFFECTS,CAPN9 gene|CAPN9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CAPN9 gene|CAPN9 Malignant neoplasm of breast
AFFECTS,KIAA1199 gene|CEMIP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,KIAA1199 gene|CEMIP Malignant neoplasm of breast
PREDISPOSES,ACE gene|ACE,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ACE gene|ACE Malignant neoplasm of breast
PREDISPOSES,alpha2HS glycoprotein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",alpha2HS glycoprotein Malignant neoplasm of breast
AFFECTS,Microdissection,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Microdissection Malignant neoplasm of breast
PREDISPOSES,VEGF gene|VEGFA,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Gene or Genome,VEGF gene|VEGFA Breast cancer invasive NOS
CAUSES,Malathion,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Malathion Malignant neoplasm of breast
PREDISPOSES,"VEGF protein, human|VEGFA",Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,"Amino Acid, Peptide, or Protein","VEGF protein, human|VEGFA Inflammatory Breast Carcinoma"
PREDISPOSES,Encounter due to breast reduction,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Encounter due to breast reduction Malignant neoplasm of breast
AFFECTS,Detection,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,"Element, Ion, or Isotope",Detection Familial cancer of breast
PREDISPOSES,Elongation Factor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Elongation Factor Malignant neoplasm of breast
AUGMENTS,FOXC1 gene|FOXC1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FOXC1 gene|FOXC1 Malignant neoplasm of breast
PREDISPOSES,H19 gene|H19|HILS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,H19 gene|H19|HILS1 Malignant neoplasm of breast
PREDISPOSES,patient retention,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",patient retention Malignant neoplasm of breast
AFFECTS,USF1 gene|USF1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,USF1 gene|USF1 Malignant neoplasm of breast
DISRUPTS,WWOX gene|WWOX,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,WWOX gene|WWOX Malignant neoplasm of breast
AFFECTS,usnic acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,usnic acid Malignant neoplasm of breast
AFFECTS,Folic Acid Antagonists,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Chemical,Folic Acid Antagonists Breast cancer metastatic
AUGMENTS,toxicant,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hazardous or Poisonous Substance,toxicant Malignant neoplasm of breast
PREDISPOSES,Cacodylic Acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Cacodylic Acid Malignant neoplasm of breast
DISRUPTS,c-myc Genes|MYC,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,c-myc Genes|MYC Malignant neoplasm of breast
PREDISPOSES,"Antirheumatic Drugs, Disease-Modifying",Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Pharmacologic Substance,"Antirheumatic Drugs, Disease-Modifying Breast cancer recurrent"
PREDISPOSES,PTH gene|PTH,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PTH gene|PTH Malignant neoplasm of breast
PREDISPOSES,SDC1 gene|SDC1,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,SDC1 gene|SDC1 Breast Carcinoma
AUGMENTS,TOP2A gene|TOP2A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TOP2A gene|TOP2A Malignant neoplasm of breast
PREDISPOSES,GSTM1 gene|GSTM1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,GSTM1 gene|GSTM1 Breast cancer metastatic
AFFECTS,Estrogen Receptor alpha,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptor alpha Sporadic Breast Carcinoma
PREDISPOSES,Thromboembolic event,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Phenomenon or Process,Thromboembolic event Breast cancer invasive NOS
AFFECTS,G-T mismatch-binding protein|MSH6,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,"Amino Acid, Peptide, or Protein",G-T mismatch-binding protein|MSH6 Sporadic Breast Carcinoma
AFFECTS,Therapeutic Intervention,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Therapeutic Intervention Malignant neoplasm of breast
PREDISPOSES,CYP2D6 gene|CYP2D6,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,CYP2D6 gene|CYP2D6 Breast cancer metastatic
AFFECTS,"PHEMX protein, human|TSPAN32",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","PHEMX protein, human|TSPAN32 Malignant neoplasm of breast"
AFFECTS,Abnormal protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Abnormal protein Malignant neoplasm of breast
COMPLICATES,Malignant meningitis,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Neoplastic Process,"Malignant meningitis Carcinoma, Ductal, Breast"
DISRUPTS,SMAD7 gene|SMAD7,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,SMAD7 gene|SMAD7 Breast cancer metastatic
AFFECTS,"NRIP1 protein, human|NRIP1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","NRIP1 protein, human|NRIP1 Malignant neoplasm of breast"
PREDISPOSES,CD71 antigen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Immunologic Factor,CD71 antigen Malignant neoplasm of breast
DISRUPTS,Factor VIII-Related Antigen,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Immunologic Factor,Factor VIII-Related Antigen Breast cancer metastatic
DISRUPTS,CYGB gene|CYGB,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CYGB gene|CYGB Malignant neoplasm of breast
PREDISPOSES,Food,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Food,Food Breast cancer invasive NOS
AFFECTS,Manual reduction,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Manual reduction Malignant neoplasm of breast
AFFECTS,"EPIDERMAL GROWTH FACTOR, HUMAN|EREG|ESR1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,"EPIDERMAL GROWTH FACTOR, HUMAN|EREG|ESR1 Malignant neoplasm of breast"
AUGMENTS,"RNA, Messenger",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","RNA, Messenger Malignant neoplasm of breast"
AFFECTS,PARVA gene|PARVA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PARVA gene|PARVA Malignant neoplasm of breast
PREDISPOSES,Anthracycline Antibiotics,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Antibiotic,Anthracycline Antibiotics Malignant neoplasm of breast
PREDISPOSES,Pancreatic Polypeptide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Pancreatic Polypeptide Malignant neoplasm of breast
PREDISPOSES,"MPP3 protein, human|MPP3",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","MPP3 protein, human|MPP3 Malignant neoplasm of breast"
AFFECTS,Apolipoprotein A-I,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Apolipoprotein A-I Malignant neoplasm of breast
PREDISPOSES,Taking medication,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,Taking medication Malignant neoplasm of breast
PREDISPOSES,N-Acetylneuraminic Acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,N-Acetylneuraminic Acid Malignant neoplasm of breast
PREDISPOSES,MicroRNAs,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",MicroRNAs Breast cancer invasive NOS
PREDISPOSES,CYP2C8 gene|CYP2C8,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CYP2C8 gene|CYP2C8 Malignant neoplasm of breast
PREDISPOSES,Heat-Shock Proteins 70,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Heat-Shock Proteins 70 Malignant neoplasm of breast
AUGMENTS,bone morphogenetic protein 2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,bone morphogenetic protein 2 Malignant neoplasm of breast
AFFECTS,parathyroid hormone-related protein,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",parathyroid hormone-related protein Breast cancer metastatic
AFFECTS,cell transformation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",cell transformation Malignant neoplasm of breast
AFFECTS,Thyroid Hormone Receptor Beta,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Thyroid Hormone Receptor Beta Malignant neoplasm of breast
PREDISPOSES,Macrophage Activation Syndrome,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",Macrophage Activation Syndrome Invasive carcinoma of breast
PREDISPOSES,"CEACAM5 protein, human|CEACAM5",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CEACAM5 protein, human|CEACAM5 Malignant neoplasm of breast"
AFFECTS,Neurophysiology - biologic function,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Neurophysiology - biologic function Triple Negative Breast Neoplasms
AFFECTS,zoledronic acid,Early-Stage Breast Carcinoma,0.0,Female Breast Cancer,Chemical,zoledronic acid Early-Stage Breast Carcinoma
AFFECTS,Metaplastic carcinoma of breast,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Metaplastic carcinoma of breast Malignant neoplasm of breast
PREDISPOSES,ERBB3 gene|ERBB3,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,ERBB3 gene|ERBB3 Triple Negative Breast Neoplasms
PREDISPOSES,LINC00520 gene|LINC00520,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,LINC00520 gene|LINC00520 Triple Negative Breast Neoplasms
AUGMENTS,TRIP6 gene|TRIP6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TRIP6 gene|TRIP6 Malignant neoplasm of breast
PREDISPOSES,Enzyme Gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Enzyme Gene Malignant neoplasm of breast
PREDISPOSES,Cholesterol hydroxylase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Lipid,Cholesterol hydroxylase Malignant neoplasm of breast
CAUSES,anastrozole,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,anastrozole Malignant neoplasm of breast
PREDISPOSES,MIR182 gene|MIR182,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIR182 gene|MIR182 Malignant neoplasm of breast
PREDISPOSES,COL10A1 gene|COL10A1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,COL10A1 gene|COL10A1 Malignant neoplasm of breast
AFFECTS,ZNF10 gene|ZNF10,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ZNF10 gene|ZNF10 Malignant neoplasm of breast
AFFECTS,KDM5B gene|KDM5B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,KDM5B gene|KDM5B Malignant neoplasm of breast
CAUSES,Genome,"Breast Cancer, Familial",0.0,Female Breast Cancer,Gene or Genome,"Genome Breast Cancer, Familial"
PREDISPOSES,Sex Hormone-Binding Globulin,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Hormone,Sex Hormone-Binding Globulin Noninfiltrating Intraductal Carcinoma
AFFECTS,HMGA2 gene|HMGA2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HMGA2 gene|HMGA2 Malignant neoplasm of breast
AUGMENTS,PAQR4 gene|PAQR4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PAQR4 gene|PAQR4 Malignant neoplasm of breast
AFFECTS,PTTG1 gene|PTTG1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PTTG1 gene|PTTG1 Malignant neoplasm of breast
AFFECTS,Hormones,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Hormone,Hormones Noninfiltrating Intraductal Carcinoma
AUGMENTS,Epidermal Growth Factor Receptor,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Biologically Active Substance,Epidermal Growth Factor Receptor Triple Negative Breast Neoplasms
CAUSES,"Breast Cancer, Familial",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,"Breast Cancer, Familial Malignant neoplasm of breast"
AUGMENTS,ASAP1 gene|ASAP1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,ASAP1 gene|ASAP1 Triple Negative Breast Neoplasms
PREDISPOSES,"Genes, Essential",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,"Genes, Essential Malignant neoplasm of breast"
AUGMENTS,TRPM4 gene|TRPM4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TRPM4 gene|TRPM4 Malignant neoplasm of breast
PREDISPOSES,SNORA71B gene|SNORA71B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SNORA71B gene|SNORA71B Malignant neoplasm of breast
PREDISPOSES,MARS gene|MARS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MARS gene|MARS Malignant neoplasm of breast
CAUSES,Estrogen Receptor beta,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptor beta Malignant neoplasm of breast
AUGMENTS,Positive Transcriptional Elongation Factor B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Positive Transcriptional Elongation Factor B Malignant neoplasm of breast
AUGMENTS,ENO1 gene|ENO1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ENO1 gene|ENO1 Malignant neoplasm of breast
AFFECTS,SCUBE2 gene|SCUBE2,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,SCUBE2 gene|SCUBE2 Triple Negative Breast Neoplasms
AFFECTS,Cell Proliferation,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Cell Proliferation Breast Carcinoma
PREDISPOSES,MKI67 gene|MKI67,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MKI67 gene|MKI67 Malignant neoplasm of breast
PREDISPOSES,"T-Cell Surface Glycoprotein CD4, human|CD4",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","T-Cell Surface Glycoprotein CD4, human|CD4 Malignant neoplasm of breast"
PREDISPOSES,TMEM165 gene|TMEM165,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,TMEM165 gene|TMEM165 Breast Carcinoma
CAUSES,Tumor-Associated Process,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Tumor-Associated Process Malignant neoplasm of breast
PREDISPOSES,CDC2 Protein Kinase|CDK1,Luminal B Breast Carcinoma,0.0,Female Breast Cancer,"Amino Acid, Peptide, or Protein",CDC2 Protein Kinase|CDK1 Luminal B Breast Carcinoma
AUGMENTS,MMP10 gene|MMP10,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Gene or Genome,MMP10 gene|MMP10 estrogen receptor-positive breast cancer
PREDISPOSES,ENC1 gene|ENC1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ENC1 gene|ENC1 Malignant neoplasm of breast
AFFECTS,"AGR3 protein, human|AGR3",estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,"Amino Acid, Peptide, or Protein","AGR3 protein, human|AGR3 estrogen receptor-positive breast cancer"
PREDISPOSES,Smoked food,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Smoked food Malignant neoplasm of breast
AFFECTS,GA-Binding Protein Transcription Factor|GABPA|NFE2L2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",GA-Binding Protein Transcription Factor|GABPA|NFE2L2 Malignant neoplasm of breast
PREDISPOSES,HLCS gene|HLCS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HLCS gene|HLCS Malignant neoplasm of breast
AFFECTS,Functional Food,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Functional Food Triple Negative Breast Neoplasms
AUGMENTS,UNC5B gene|UNC5B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,UNC5B gene|UNC5B Malignant neoplasm of breast
PREDISPOSES,ITPKC gene|ITPKC,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,ITPKC gene|ITPKC Triple Negative Breast Neoplasms
AFFECTS,Stat3 protein,Basal-Like Breast Carcinoma,0.0039960039960039,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Stat3 protein Basal-Like Breast Carcinoma
PREDISPOSES,PART1 gene|PART1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PART1 gene|PART1 Malignant neoplasm of breast
CAUSES,SPRY4-IT1 gene|SPRY4-IT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SPRY4-IT1 gene|SPRY4-IT1 Malignant neoplasm of breast
CAUSES,Extranodal Extension,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Extranodal Extension Malignant neoplasm of breast
AFFECTS,ADAMTS8 gene|ADAMTS8,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ADAMTS8 gene|ADAMTS8 Malignant neoplasm of breast
AFFECTS,Obstruction,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Obstruction Malignant neoplasm of breast
PREDISPOSES,Chronic Obstructive Airway Disease,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Chronic Obstructive Airway Disease Malignant neoplasm of breast
AFFECTS,mammary gland involution,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",mammary gland involution Malignant neoplasm of breast
PREDISPOSES,MIR100HG gene|MIR100HG,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,MIR100HG gene|MIR100HG Triple Negative Breast Neoplasms
AFFECTS,PALB2 gene|PALB2,"Breast Cancer, Familial",0.0,Female Breast Cancer,Gene or Genome,"PALB2 gene|PALB2 Breast Cancer, Familial"
AFFECTS,MIR497 gene|MIR497,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIR497 gene|MIR497 Malignant neoplasm of breast
AFFECTS,YY1 gene|YY1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,YY1 gene|YY1 Triple Negative Breast Neoplasms
CAUSES,"TRIM25 protein, human|TRIM25",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","TRIM25 protein, human|TRIM25 Malignant neoplasm of breast"
DISRUPTS,HAND2-AS1 gene|HAND2-AS1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,HAND2-AS1 gene|HAND2-AS1 Triple Negative Breast Neoplasms
AFFECTS,Expression procedure,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Expression procedure Breast Carcinoma
DISRUPTS,SRCIN1 gene|SRCIN1,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Gene or Genome,SRCIN1 gene|SRCIN1 HER2-positive carcinoma of breast
PREDISPOSES,Eicosanoids,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Eicosanoid,Eicosanoids Breast Carcinoma
PREDISPOSES,Adipose Tissue Deposition,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Adipose Tissue Deposition Malignant neoplasm of breast
AFFECTS,PLEKHA7 gene|PLEKHA7,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Gene or Genome,PLEKHA7 gene|PLEKHA7 Inflammatory Breast Carcinoma
DISRUPTS,CDC25B gene|CDC25B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CDC25B gene|CDC25B Malignant neoplasm of breast
PREDISPOSES,MKI67 gene|MKI67,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Gene or Genome,MKI67 gene|MKI67 Invasive carcinoma of breast
PREDISPOSES,estrogens,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Hormone,estrogens Invasive carcinoma of breast
CAUSES,"RNA, Circular",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","RNA, Circular Triple Negative Breast Neoplasms"
AFFECTS,"Transcription, Genetic",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,"Transcription, Genetic Triple Negative Breast Neoplasms"
PREDISPOSES,HLA-F-AS1 gene|HLA-F-AS1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,HLA-F-AS1 gene|HLA-F-AS1 Triple Negative Breast Neoplasms
AFFECTS,DSCAM-AS1 gene|DSCAM-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,DSCAM-AS1 gene|DSCAM-AS1 Malignant neoplasm of breast
PREDISPOSES,APLN gene|APLN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,APLN gene|APLN Malignant neoplasm of breast
DISRUPTS,RING1 gene|RING1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RING1 gene|RING1 Malignant neoplasm of breast
AFFECTS,K-ras Oncogene|KRAS,Invasive Ductal Breast Carcinoma,0.0,Female Breast Cancer,Gene or Genome,K-ras Oncogene|KRAS Invasive Ductal Breast Carcinoma
AFFECTS,"Metabolic Process, Cellular",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Phenomenon or Process,"Metabolic Process, Cellular Malignant neoplasm of breast"
AFFECTS,EIF3A gene|EIF3A,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Gene or Genome,EIF3A gene|EIF3A Invasive carcinoma of breast
PREDISPOSES,PFKL gene|PFKL,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PFKL gene|PFKL Malignant neoplasm of breast
AFFECTS,Genes,Hereditary Breast and Ovarian Cancer Syndrome,0.0,Female Breast Cancer,Gene or Genome,Genes Hereditary Breast and Ovarian Cancer Syndrome
PREDISPOSES,"Sleep Disorders, Circadian Rhythm",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,"Sleep Disorders, Circadian Rhythm Malignant neoplasm of breast"
DISRUPTS,HMGA2 gene|HMGA2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HMGA2 gene|HMGA2 Malignant neoplasm of breast
AFFECTS,"CD274 protein, human|CD274",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CD274 protein, human|CD274 Malignant neoplasm of breast"
AFFECTS,Chemotherapy Regimen or Agent Combination,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Chemotherapy Regimen or Agent Combination Triple Negative Breast Neoplasms
DISRUPTS,ZEB1 gene|ZEB1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,ZEB1 gene|ZEB1 Triple Negative Breast Neoplasms
PREDISPOSES,Long Interspersed Nucleotide Element-1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Long Interspersed Nucleotide Element-1 Malignant neoplasm of breast
AFFECTS,Heat shock proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Heat shock proteins Malignant neoplasm of breast
PREDISPOSES,Transforming Growth Factor beta,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Biologically Active Substance,Transforming Growth Factor beta Triple Negative Breast Neoplasms
PREDISPOSES,CDKN2B gene|CDKN2B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CDKN2B gene|CDKN2B Malignant neoplasm of breast
AFFECTS,Mutation,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Mutation Triple Negative Breast Neoplasms
AUGMENTS,ACTL8 gene|ACTL8,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,ACTL8 gene|ACTL8 Triple Negative Breast Neoplasms
AUGMENTS,"CD274 protein, human|CD274",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CD274 protein, human|CD274 Triple Negative Breast Neoplasms"
PREDISPOSES,BCL6 gene|BCL6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BCL6 gene|BCL6 Malignant neoplasm of breast
AFFECTS,Dietary Modification,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",Dietary Modification Noninfiltrating Intraductal Carcinoma
AFFECTS,SIRT3 gene|SIRT3,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,SIRT3 gene|SIRT3 Breast Carcinoma
PREDISPOSES,FOXO6 gene|FOXO6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FOXO6 gene|FOXO6 Malignant neoplasm of breast
DISRUPTS,METTL3 gene|METTL3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,METTL3 gene|METTL3 Malignant neoplasm of breast
PREDISPOSES,"STK11 protein, human|STK11",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","STK11 protein, human|STK11 Malignant neoplasm of breast"
AFFECTS,Transforming Growth Factor beta,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Biologically Active Substance,Transforming Growth Factor beta Triple Negative Breast Neoplasms
AUGMENTS,KIF18B gene|KIF18B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,KIF18B gene|KIF18B Malignant neoplasm of breast
PREDISPOSES,PDLIM7 gene|PDLIM7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PDLIM7 gene|PDLIM7 Malignant neoplasm of breast
AUGMENTS,RFX5 gene|RFX5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RFX5 gene|RFX5 Malignant neoplasm of breast
DISRUPTS,PUM1 gene|PUM1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PUM1 gene|PUM1 Malignant neoplasm of breast
AFFECTS,gene interaction,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,gene interaction Malignant neoplasm of breast
PREDISPOSES,prevention effectiveness,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",prevention effectiveness Malignant neoplasm of breast
PREDISPOSES,AFAP1-AS1 gene|AFAP1-AS1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,AFAP1-AS1 gene|AFAP1-AS1 Triple Negative Breast Neoplasms
PREDISPOSES,IMPACT gene,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,IMPACT gene Noninfiltrating Intraductal Carcinoma
AFFECTS,EEF1E1 gene|EEF1E1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,EEF1E1 gene|EEF1E1 Malignant neoplasm of breast
AFFECTS,"CD69 protein, human|CD69",Malignant neoplasm of female breast,0.0,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CD69 protein, human|CD69 Malignant neoplasm of female breast"
CAUSES,HIF1A gene|HIF1A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HIF1A gene|HIF1A Malignant neoplasm of breast
AFFECTS,"Transformation, function",estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope","Transformation, function estrogen receptor-positive breast cancer"
PREDISPOSES,CASC16 gene|CASC16,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CASC16 gene|CASC16 Malignant neoplasm of breast
DISRUPTS,"RNA, Messenger",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","RNA, Messenger Malignant neoplasm of breast"
PREDISPOSES,CDC20 gene|CDC20,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,CDC20 gene|CDC20 Triple Negative Breast Neoplasms
DISRUPTS,multidrug resistance-associated protein 2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",multidrug resistance-associated protein 2 Malignant neoplasm of breast
PREDISPOSES,"CD9 protein, human|CD9",Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CD9 protein, human|CD9 Breast Carcinoma"
DISRUPTS,MIR937 gene|MIR937,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIR937 gene|MIR937 Malignant neoplasm of breast
PREDISPOSES,ERBB2 gene|ERBB2,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Gene or Genome,ERBB2 gene|ERBB2 HER2-positive carcinoma of breast
AUGMENTS,RAD54B gene|RAD54B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RAD54B gene|RAD54B Malignant neoplasm of breast
AFFECTS,"GPER protein, human|GPER1",Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,"Amino Acid, Peptide, or Protein","GPER protein, human|GPER1 Carcinoma of Male Breast"
AFFECTS,LRP6 gene|LRP6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LRP6 gene|LRP6 Malignant neoplasm of breast
PREDISPOSES,Pregnancy-Associated Plasma Protein-A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Pregnancy-Associated Plasma Protein-A Malignant neoplasm of breast
PREDISPOSES,SCUBE2 gene|SCUBE2,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Gene or Genome,SCUBE2 gene|SCUBE2 HER2-positive carcinoma of breast
PREDISPOSES,Physical function,contralateral breast cancer,0.0029970029970029,Female Breast Cancer,"Element, Ion, or Isotope",Physical function contralateral breast cancer
AUGMENTS,MORC2 gene|MORC2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MORC2 gene|MORC2 Malignant neoplasm of breast
CAUSES,G-Protein-Coupled Receptors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",G-Protein-Coupled Receptors Malignant neoplasm of breast
AUGMENTS,GATA3 Transcription Factor|GATA3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",GATA3 Transcription Factor|GATA3 Malignant neoplasm of breast
AUGMENTS,Vascular Endothelial Growth Factor A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Vascular Endothelial Growth Factor A Malignant neoplasm of breast
PREDISPOSES,IL18 gene|IL18,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IL18 gene|IL18 Malignant neoplasm of breast
PREDISPOSES,ABI1 gene|ABI1,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,ABI1 gene|ABI1 Secondary malignant neoplasm of breast
AUGMENTS,"BCAR3 protein, human|BCAR3",Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Amino Acid, Peptide, or Protein","BCAR3 protein, human|BCAR3 Noninfiltrating Intraductal Carcinoma"
AFFECTS,SHARPIN gene|SHARPIN,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,SHARPIN gene|SHARPIN Triple Negative Breast Neoplasms
AFFECTS,Antitumor Response,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Antitumor Response Malignant neoplasm of breast
AFFECTS,"DKK3 protein, human|DKK3",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","DKK3 protein, human|DKK3 Malignant neoplasm of breast"
PREDISPOSES,Matrix Metalloproteinase 13,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Matrix Metalloproteinase 13 Malignant neoplasm of breast
AUGMENTS,LIG3 gene|LIG3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LIG3 gene|LIG3 Malignant neoplasm of breast
AFFECTS,cadmium,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Inorganic Chemical,cadmium Malignant neoplasm of breast
PREDISPOSES,WLS gene|WLS,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Gene or Genome,WLS gene|WLS HER2-positive carcinoma of breast
AFFECTS,Positron-Emission Tomography,Carcinoma breast stage IV,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Positron-Emission Tomography Carcinoma breast stage IV
PREDISPOSES,PLB1 gene|PLB1,estrogen receptor-negative breast cancer,0.0,Female Breast Cancer,Gene or Genome,PLB1 gene|PLB1 estrogen receptor-negative breast cancer
PREDISPOSES,USP41 gene|USP41,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,USP41 gene|USP41 Malignant neoplasm of breast
PREDISPOSES,SP7 gene|SP7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SP7 gene|SP7 Malignant neoplasm of breast
AUGMENTS,"CDK7 protein, human|CDK7",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CDK7 protein, human|CDK7 Malignant neoplasm of breast"
AFFECTS,Oligonucleotides,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Oligonucleotides Secondary malignant neoplasm of breast
DISRUPTS,"CD69 protein, human|CD69",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CD69 protein, human|CD69 Triple Negative Breast Neoplasms"
DISRUPTS,BCL6B gene|BCL6B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BCL6B gene|BCL6B Malignant neoplasm of breast
PREDISPOSES,TWSG1 gene|TWSG1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TWSG1 gene|TWSG1 Malignant neoplasm of breast
AUGMENTS,SPARC gene|SPARC,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SPARC gene|SPARC Malignant neoplasm of breast
AUGMENTS,CTNNB1 gene|CTNNB1,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Gene or Genome,CTNNB1 gene|CTNNB1 Ductal Breast Carcinoma
AFFECTS,BCL6B gene|BCL6B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BCL6B gene|BCL6B Malignant neoplasm of breast
PREDISPOSES,MYD88 gene|MYD88,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MYD88 gene|MYD88 Malignant neoplasm of breast
AFFECTS,Poly-L-lactic acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Poly-L-lactic acid Malignant neoplasm of breast
AFFECTS,Hormone Therapy,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Hormone,Hormone Therapy Triple Negative Breast Neoplasms
PREDISPOSES,"TNFSF13 protein, human|TNFSF13","Breast Cancer, Familial",0.0,Female Breast Cancer,"Amino Acid, Peptide, or Protein","TNFSF13 protein, human|TNFSF13 Breast Cancer, Familial"
CAUSES,"RNA, Long Untranslated",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","RNA, Long Untranslated Malignant neoplasm of breast"
AFFECTS,Estrogen Receptor Modulators,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptor Modulators Malignant neoplasm of breast
PREDISPOSES,Effective Communication,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Effective Communication Malignant neoplasm of breast
DISRUPTS,glucose oxidase,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Carbohydrate,glucose oxidase Triple Negative Breast Neoplasms
PREDISPOSES,MIR10B gene|MIR10B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIR10B gene|MIR10B Malignant neoplasm of breast
AFFECTS,MIR139 gene|MIR139,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,MIR139 gene|MIR139 Triple Negative Breast Neoplasms
AUGMENTS,CDC20 gene|CDC20,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CDC20 gene|CDC20 Malignant neoplasm of breast
AUGMENTS,"CTGF protein, human|CTGF",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CTGF protein, human|CTGF Triple Negative Breast Neoplasms"
AFFECTS,"CD69 protein, human|CD69",Triple-Negative Breast Carcinoma,0.0,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CD69 protein, human|CD69 Triple-Negative Breast Carcinoma"
PREDISPOSES,TPI1 gene|TPI1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TPI1 gene|TPI1 Malignant neoplasm of breast
AFFECTS,Acclimatization,Malignant neoplasm of female breast,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Acclimatization Malignant neoplasm of female breast
AUGMENTS,MKI67 gene|MKI67,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MKI67 gene|MKI67 Malignant neoplasm of breast
CAUSES,TPI1 gene|TPI1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TPI1 gene|TPI1 Malignant neoplasm of breast
AUGMENTS,CDK6 gene|CDK6,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,CDK6 gene|CDK6 Triple Negative Breast Neoplasms
DISRUPTS,MAP1LC3C gene|MAP1LC3C,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,MAP1LC3C gene|MAP1LC3C Triple Negative Breast Neoplasms
PREDISPOSES,Pathogenic Variant,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Virus,Pathogenic Variant estrogen receptor-positive breast cancer
DISRUPTS,Pseudogenes,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,Pseudogenes Triple Negative Breast Neoplasms
PREDISPOSES,TTYH3 gene|TTYH3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TTYH3 gene|TTYH3 Malignant neoplasm of breast
AUGMENTS,cyclooxygenase 2,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",cyclooxygenase 2 Breast Carcinoma
AFFECTS,Proliferation (morphologic abnormality),Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Proliferation (morphologic abnormality) Triple Negative Breast Neoplasms
AFFECTS,HSPG2 gene|HSPG2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HSPG2 gene|HSPG2 Malignant neoplasm of breast
AUGMENTS,LINC01234 gene|LINC01234,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LINC01234 gene|LINC01234 Malignant neoplasm of breast
AUGMENTS,ELP3 gene|ELP3,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,ELP3 gene|ELP3 Triple Negative Breast Neoplasms
PREDISPOSES,Methylation Site,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Methylation Site Breast Carcinoma
AFFECTS,DST gene|DST,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,DST gene|DST Malignant neoplasm of breast
AUGMENTS,CYP2S1 gene|CYP2S1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CYP2S1 gene|CYP2S1 Malignant neoplasm of breast
PREDISPOSES,High glycemic index food,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,High glycemic index food Malignant neoplasm of breast
AUGMENTS,RNA-Binding Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",RNA-Binding Proteins Malignant neoplasm of breast
PREDISPOSES,GTF2H1 gene|GTF2H1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GTF2H1 gene|GTF2H1 Malignant neoplasm of breast
AFFECTS,"Tomography, Emission-Computed",Carcinoma breast stage IV,0.0,Female Breast Cancer,"Element, Ion, or Isotope","Tomography, Emission-Computed Carcinoma breast stage IV"
PREDISPOSES,ULBP2 gene|ULBP2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ULBP2 gene|ULBP2 Malignant neoplasm of breast
AFFECTS,MEF2C gene|MEF2C,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MEF2C gene|MEF2C Malignant neoplasm of breast
CAUSES,Plasma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Body Substance,Plasma Malignant neoplasm of breast
CAUSES,"Mammary Carcinoma, Human",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,"Mammary Carcinoma, Human Malignant neoplasm of breast"
PREDISPOSES,Bioavailable testosterone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Bioavailable testosterone Malignant neoplasm of breast
DISRUPTS,SPOP gene|SPOP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SPOP gene|SPOP Malignant neoplasm of breast
AFFECTS,CUL4B gene|CUL4B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CUL4B gene|CUL4B Malignant neoplasm of breast
AUGMENTS,MMP13 gene|MMP13,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,MMP13 gene|MMP13 Noninfiltrating Intraductal Carcinoma
CAUSES,Anthracycline Antibiotics,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Antibiotic,Anthracycline Antibiotics Malignant neoplasm of breast
PREDISPOSES,TIMM8A gene|TIMM8A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TIMM8A gene|TIMM8A Malignant neoplasm of breast
AFFECTS,"TRIM25 protein, human|TRIM25",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein","TRIM25 protein, human|TRIM25 Triple Negative Breast Neoplasms"
AFFECTS,MicroRNA 205-5p,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",MicroRNA 205-5p Malignant neoplasm of breast
PREDISPOSES,CLIC1 gene|CLIC1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CLIC1 gene|CLIC1 Malignant neoplasm of breast
PREDISPOSES,HSPA8 gene|HSPA8,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,HSPA8 gene|HSPA8 Triple Negative Breast Neoplasms
PREDISPOSES,aflatoxin B1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,aflatoxin B1 Malignant neoplasm of breast
PREDISPOSES,"ZFP36 protein, human|ZFP36",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","ZFP36 protein, human|ZFP36 Malignant neoplasm of breast"
PREDISPOSES,Decreased Expression,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Decreased Expression Malignant neoplasm of breast
PREDISPOSES,ERBB2 gene|ERBB2,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,ERBB2 gene|ERBB2 Secondary malignant neoplasm of breast
AUGMENTS,LINC00473 gene|LINC00473,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LINC00473 gene|LINC00473 Malignant neoplasm of breast
PREDISPOSES,WBP2 gene|WBP2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,WBP2 gene|WBP2 Malignant neoplasm of breast
PREDISPOSES,microphthalmia-associated transcription factor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",microphthalmia-associated transcription factor Malignant neoplasm of breast
PREDISPOSES,WNT9B gene|WNT9B,Triple-Negative Breast Carcinoma,0.0,Female Breast Cancer,Gene or Genome,WNT9B gene|WNT9B Triple-Negative Breast Carcinoma
AFFECTS,Menopausal syndrome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Menopausal syndrome Malignant neoplasm of breast
CAUSES,CXCR4 gene|CXCR4,Carcinoma breast stage IV,0.0,Female Breast Cancer,Gene or Genome,CXCR4 gene|CXCR4 Carcinoma breast stage IV
AFFECTS,testosterone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,testosterone Malignant neoplasm of breast
PREDISPOSES,LINC00667 gene|LINC00667,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LINC00667 gene|LINC00667 Malignant neoplasm of breast
AFFECTS,Mutation Abnormality,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Mutation Abnormality Malignant neoplasm of breast
PREDISPOSES,Animal feed (substance),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Substance,Animal feed (substance) Malignant neoplasm of breast
AUGMENTS,SPON2 gene|SPON2,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,SPON2 gene|SPON2 Triple Negative Breast Neoplasms
AFFECTS,CRABP2 gene|CRABP2,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,CRABP2 gene|CRABP2 Breast Carcinoma
DISRUPTS,BTG4 gene|BTG4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BTG4 gene|BTG4 Malignant neoplasm of breast
DISRUPTS,ZSCAN1 gene|ZSCAN1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ZSCAN1 gene|ZSCAN1 Malignant neoplasm of breast
PREDISPOSES,USP20 gene|USP20,Carcinoma breast stage IV,0.0,Female Breast Cancer,Gene or Genome,USP20 gene|USP20 Carcinoma breast stage IV
PREDISPOSES,AFAP1-AS1 gene|AFAP1-AS1,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,AFAP1-AS1 gene|AFAP1-AS1 Secondary malignant neoplasm of breast
PREDISPOSES,PFKFB3 gene|PFKFB3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PFKFB3 gene|PFKFB3 Malignant neoplasm of breast
PREDISPOSES,treatment options,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",treatment options Malignant neoplasm of breast
DISRUPTS,"CD69 protein, human|CD69",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CD69 protein, human|CD69 Malignant neoplasm of breast"
AFFECTS,MCAM gene|MCAM,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MCAM gene|MCAM Malignant neoplasm of breast
AFFECTS,hydroxybenzoic acid,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Chemical,hydroxybenzoic acid Triple Negative Breast Neoplasms
AFFECTS,Lipoproteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Lipoproteins Malignant neoplasm of breast
CAUSES,Toxin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Toxin Malignant neoplasm of breast
AFFECTS,Immunoregulation,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Immunoregulation Triple Negative Breast Neoplasms
DISRUPTS,Singlet Oxygen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Singlet Oxygen Malignant neoplasm of breast
AFFECTS,Bone Morphogenetic Protein Receptors,Carcinoma breast stage IV,0.0,Female Breast Cancer,Gene or Genome,Bone Morphogenetic Protein Receptors Carcinoma breast stage IV
AUGMENTS,ZNF451 gene|ZNF451,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,ZNF451 gene|ZNF451 Triple Negative Breast Neoplasms
CAUSES,"Genes, env|ERVW-1|ERVK-20|ERVK-18|ERVK-32",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,"Genes, env|ERVW-1|ERVK-20|ERVK-18|ERVK-32 Malignant neoplasm of breast"
CAUSES,RAD52 gene|RAD52,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RAD52 gene|RAD52 Malignant neoplasm of breast
CAUSES,CCR7 gene|CCR7,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,CCR7 gene|CCR7 Breast Carcinoma
PREDISPOSES,CXXC5 gene|CXXC5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CXXC5 gene|CXXC5 Malignant neoplasm of breast
AUGMENTS,TYMSOS gene|TYMSOS,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,TYMSOS gene|TYMSOS Secondary malignant neoplasm of breast
AFFECTS,systemic administration,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",systemic administration HER2-positive carcinoma of breast
AFFECTS,Cancer Relapse,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Cancer Relapse Malignant neoplasm of breast
PREDISPOSES,IMPACT gene,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Gene or Genome,IMPACT gene Invasive carcinoma of breast
PREDISPOSES,Axillary node METASTASIS,Breast cancer stage II,0.0,Female Breast Cancer,Neoplastic Process,Axillary node METASTASIS Breast cancer stage II
DISRUPTS,NR1D1 gene|NR1D1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NR1D1 gene|NR1D1 Malignant neoplasm of breast
CAUSES,Genes,"Breast Cancer, Familial",0.0,Female Breast Cancer,Gene or Genome,"Genes Breast Cancer, Familial"
AFFECTS,anastrozole,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Pharmacologic Substance,anastrozole estrogen receptor-positive breast cancer
AFFECTS,HLA-G gene|HLA-G,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,HLA-G gene|HLA-G Triple Negative Breast Neoplasms
PREDISPOSES,DLGAP5 gene|DLGAP5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,DLGAP5 gene|DLGAP5 Malignant neoplasm of breast
PREDISPOSES,"IL5 protein, human|IL5",HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Amino Acid, Peptide, or Protein","IL5 protein, human|IL5 HER2-positive carcinoma of breast"
AFFECTS,"Transformation, function",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope","Transformation, function Triple Negative Breast Neoplasms"
DISRUPTS,BCPR Gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BCPR Gene Malignant neoplasm of breast
PREDISPOSES,VIRMA gene|VIRMA,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,VIRMA gene|VIRMA Triple Negative Breast Neoplasms
CAUSES,Antigens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Immunologic Factor,Antigens Malignant neoplasm of breast
PREDISPOSES,EZH2 gene|EZH2,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Gene or Genome,EZH2 gene|EZH2 Invasive carcinoma of breast
AFFECTS,BHLHE41 gene|BHLHE41,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,BHLHE41 gene|BHLHE41 Triple Negative Breast Neoplasms
AUGMENTS,medroxyprogesterone acetate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,medroxyprogesterone acetate Malignant neoplasm of breast
AUGMENTS,SHC4 gene|SHC4,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,SHC4 gene|SHC4 Triple Negative Breast Neoplasms
DISRUPTS,USP4 gene|USP4,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,USP4 gene|USP4 Secondary malignant neoplasm of breast
AFFECTS,SRRM4 gene|SRRM4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SRRM4 gene|SRRM4 Malignant neoplasm of breast
DISRUPTS,PTK2 gene|PTK2,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,PTK2 gene|PTK2 Triple Negative Breast Neoplasms
PREDISPOSES,SKP2 gene|SKP2,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,SKP2 gene|SKP2 Triple Negative Breast Neoplasms
PREDISPOSES,USP30 gene|USP30,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,USP30 gene|USP30 Malignant neoplasm of breast
PREDISPOSES,AIMP2 gene|AIMP2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,AIMP2 gene|AIMP2 Malignant neoplasm of breast
CAUSES,FOXO1 gene|FOXO1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,FOXO1 gene|FOXO1 Triple Negative Breast Neoplasms
PREDISPOSES,TWIST1 gene|TWIST1,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,TWIST1 gene|TWIST1 Secondary malignant neoplasm of breast
CAUSES,"PIK3CB protein, human|PIK3CB",Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,"Amino Acid, Peptide, or Protein","PIK3CB protein, human|PIK3CB Secondary malignant neoplasm of breast"
PREDISPOSES,"TLR2 protein, human|TLR2",HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Amino Acid, Peptide, or Protein","TLR2 protein, human|TLR2 HER2-positive carcinoma of breast"
AFFECTS,NSUN2 gene|NSUN2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NSUN2 gene|NSUN2 Malignant neoplasm of breast
PREDISPOSES,FOXA2 gene|FOXA2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FOXA2 gene|FOXA2 Malignant neoplasm of breast
DISRUPTS,FBXO8 gene|FBXO8,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FBXO8 gene|FBXO8 Malignant neoplasm of breast
AUGMENTS,SNORA73B gene|SNORA73B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SNORA73B gene|SNORA73B Malignant neoplasm of breast
AUGMENTS,SCARNA4 gene|SCARNA4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SCARNA4 gene|SCARNA4 Malignant neoplasm of breast
AFFECTS,PLK4 gene|PLK4,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,PLK4 gene|PLK4 Triple Negative Breast Neoplasms
PREDISPOSES,MIR130A gene|MIR130A,malignant neoplasm of breast staging,0.0,Female Breast Cancer,Gene or Genome,MIR130A gene|MIR130A malignant neoplasm of breast staging
CAUSES,"membrane protein, SARS-CoV-2",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein","membrane protein, SARS-CoV-2 Triple Negative Breast Neoplasms"
CAUSES,Mutant Proteins,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Mutant Proteins Triple Negative Breast Neoplasms
AUGMENTS,progesterone,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Hormone,progesterone estrogen receptor-positive breast cancer
AUGMENTS,Protease Inhibitors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Enzyme,Protease Inhibitors Malignant neoplasm of breast
DISRUPTS,RBMS3 gene|RBMS3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RBMS3 gene|RBMS3 Malignant neoplasm of breast
CAUSES,Non-infiltrating lobular carcinoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Non-infiltrating lobular carcinoma Malignant neoplasm of breast
AUGMENTS,SF3A2 gene|SF3A2,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,SF3A2 gene|SF3A2 Triple Negative Breast Neoplasms
PREDISPOSES,COL5A1 gene|COL5A1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,COL5A1 gene|COL5A1 Triple Negative Breast Neoplasms
PREDISPOSES,MTA1 gene|MTA1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,MTA1 gene|MTA1 Triple Negative Breast Neoplasms
DISRUPTS,obeticholic acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,obeticholic acid Malignant neoplasm of breast
DISRUPTS,Hypolipidemic Agents,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Chemical Viewed Functionally,Hypolipidemic Agents Triple Negative Breast Neoplasms
AFFECTS,Cessation of life,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Cessation of life Triple Negative Breast Neoplasms
DISRUPTS,ETNK1 gene|ETNK1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ETNK1 gene|ETNK1 Malignant neoplasm of breast
AFFECTS,Antigens,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Immunologic Factor,Antigens Breast Carcinoma
AFFECTS,Steroids,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Steroid,Steroids Breast Carcinoma
AUGMENTS,Protein Isoforms|PGR|PR@|PRH2|TMEM37|ERVK-7|ERVK-8|ERVK-10|ERVK-9|ERVK-21|ERVK-18|ERVK-25|ERVK-24|ERVK-19,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,"Amino Acid, Peptide, or Protein","Protein Isoforms|PGR|PR@|PRH2|TMEM37|ERVK-7|ERVK-8|ERVK-10|ERVK-9|ERVK-21|ERVK-18|ERVK-25|ERVK-24|ERVK-19 Carcinoma, Ductal, Breast"
DISRUPTS,Folic Acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Folic Acid Malignant neoplasm of breast
PREDISPOSES,protein-tyrosine kinase c-src|SRC,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",protein-tyrosine kinase c-src|SRC Breast cancer metastatic
AFFECTS,Human Papilloma Virus Vaccine,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Virus,Human Papilloma Virus Vaccine Breast Carcinoma
AFFECTS,Testosterone,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Hormone,Testosterone Breast Carcinoma
DISRUPTS,Oncogenes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Oncogenes Malignant neoplasm of breast
DISRUPTS,Bicarbonates,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Bicarbonates Malignant neoplasm of breast
CAUSES,Carcinomatous peritonitis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Carcinomatous peritonitis Malignant neoplasm of breast
PREDISPOSES,RAI3 gene|GPRC5A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RAI3 gene|GPRC5A Malignant neoplasm of breast
DISRUPTS,Metastasis Suppressor Genes,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,Metastasis Suppressor Genes Breast cancer metastatic
PREDISPOSES,VIP gene|VIP,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,Gene or Genome,VIP gene|VIP Female Breast Carcinoma
DISRUPTS,STK11 gene|STK11,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,STK11 gene|STK11 Malignant neoplasm of breast
AUGMENTS,C-Peptide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",C-Peptide Malignant neoplasm of breast
AFFECTS,Carcinogenesis,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Hazardous or Poisonous Substance,Carcinogenesis Breast Carcinoma
PREDISPOSES,IRF2 gene|IRF2,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Gene or Genome,IRF2 gene|IRF2 Breast cancer recurrent
CAUSES,"Embolism, Tumor",Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Neoplastic Process,"Embolism, Tumor Inflammatory Breast Carcinoma"
AUGMENTS,DNA Methyltransferase,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",DNA Methyltransferase Breast Carcinoma
PREDISPOSES,SMAD2 gene|SMAD2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,SMAD2 gene|SMAD2 Breast cancer metastatic
AUGMENTS,Transforming Growth Factor beta,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Biologically Active Substance,Transforming Growth Factor beta Breast cancer metastatic
DISRUPTS,BRCA2|BLID,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,BRCA2|BLID Breast cancer metastatic
PREDISPOSES,neuropeptide Y|NPY,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",neuropeptide Y|NPY Malignant neoplasm of breast
AFFECTS,SMAD2 gene|SMAD2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,SMAD2 gene|SMAD2 Breast cancer metastatic
DISRUPTS,"DNA, Double-Stranded",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","DNA, Double-Stranded Malignant neoplasm of breast"
AFFECTS,SMAD3 gene|SMAD3,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,SMAD3 gene|SMAD3 Breast cancer metastatic
DISRUPTS,HIF1A gene|HIF1A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HIF1A gene|HIF1A Malignant neoplasm of breast
CAUSES,Estrogens,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Hormone,Estrogens Carcinoma of Male Breast
AFFECTS,Systemic disease,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Systemic disease Malignant neoplasm of breast
PREDISPOSES,"Genes, Immunoglobulin",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,"Genes, Immunoglobulin Malignant neoplasm of breast"
AUGMENTS,Progesterone,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Hormone,Progesterone Breast cancer recurrent
AFFECTS,DDX26 gene|INTS6|DDX56,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,DDX26 gene|INTS6|DDX56 Malignant neoplasm of breast
DISRUPTS,ADORA2B gene|ADORA2B,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,ADORA2B gene|ADORA2B Breast cancer metastatic
PREDISPOSES,"Genes, env|ERVW-1|ERVK-20|ERVK-18|ERVK-32",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,"Genes, env|ERVW-1|ERVK-20|ERVK-18|ERVK-32 Malignant neoplasm of breast"
AFFECTS,Oral Solution,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Oral Solution Malignant neoplasm of breast
PREDISPOSES,IGF1R gene|IGF1R,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IGF1R gene|IGF1R Malignant neoplasm of breast
AFFECTS,Mutation,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,"Element, Ion, or Isotope",Mutation Carcinoma of Male Breast
CAUSES,MIRN205 gene|MIR205,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIRN205 gene|MIR205 Malignant neoplasm of breast
PREDISPOSES,Fusion Protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Fusion Protein Malignant neoplasm of breast
CAUSES,Hepatitis C virus,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Virus,Hepatitis C virus Malignant neoplasm of breast
CAUSES,Invasive Carcinoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Invasive Carcinoma Malignant neoplasm of breast
AFFECTS,Eukaryotic Initiation Factor-4E|EIF4E,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Eukaryotic Initiation Factor-4E|EIF4E Malignant neoplasm of breast
AFFECTS,Malignant neoplasm of gastrointestinal tract,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Malignant neoplasm of gastrointestinal tract Malignant neoplasm of breast
AFFECTS,Insulin-Like-Growth Factor I Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Insulin-Like-Growth Factor I Receptor Malignant neoplasm of breast
DISRUPTS,MIRN200B gene|MIR200B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIRN200B gene|MIR200B Malignant neoplasm of breast
AUGMENTS,TP53BP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TP53BP1 Malignant neoplasm of breast
PREDISPOSES,Pharmaceutical Preparations,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,Pharmacologic Substance,Pharmaceutical Preparations Contralateral breast cancer
DISRUPTS,"EZH2 protein, human|EZH2",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","EZH2 protein, human|EZH2 Malignant neoplasm of breast"
AUGMENTS,MMP14 gene|MMP14,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MMP14 gene|MMP14 Malignant neoplasm of breast
PREDISPOSES,"Receptors, Tumor Necrosis Factor, Type II",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,"Receptors, Tumor Necrosis Factor, Type II Malignant neoplasm of breast"
PREDISPOSES,FGF1 gene|FGF1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FGF1 gene|FGF1 Malignant neoplasm of breast
AFFECTS,Lymphatic Diseases,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Disease or Syndrome,Lymphatic Diseases Breast Carcinoma
PREDISPOSES,VEGFC gene|VEGFC,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,VEGFC gene|VEGFC Malignant neoplasm of breast
AFFECTS,Malignant neoplasm of cervix uteri,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Malignant neoplasm of cervix uteri Malignant neoplasm of breast
AFFECTS,DOCK1 gene|DOCK1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,DOCK1 gene|DOCK1 Breast cancer metastatic
PREDISPOSES,MIRN203 gene|MIR203A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIRN203 gene|MIR203A Malignant neoplasm of breast
PREDISPOSES,Promoter Regions (Genetics),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Promoter Regions (Genetics) Malignant neoplasm of breast
CAUSES,Cholesterol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Lipid,Cholesterol Malignant neoplasm of breast
PREDISPOSES,aldehyde dehydrogenase 1|ALDH1A1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",aldehyde dehydrogenase 1|ALDH1A1 Malignant neoplasm of breast
PREDISPOSES,CD29 Antigen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Immunologic Factor,CD29 Antigen Malignant neoplasm of breast
CAUSES,PTHLH gene|PTHLH,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PTHLH gene|PTHLH Malignant neoplasm of breast
AFFECTS,Estrogen Antagonists,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Hormone,Estrogen Antagonists Breast cancer metastatic
AFFECTS,ABCC1 gene|ABCC1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ABCC1 gene|ABCC1 Malignant neoplasm of breast
AFFECTS,Tamoxifen,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Pharmacologic Substance,Tamoxifen Breast cancer metastatic
AUGMENTS,KIF20A gene|KIF20A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,KIF20A gene|KIF20A Malignant neoplasm of breast
DISRUPTS,Glucosephosphate Dehydrogenase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Glucosephosphate Dehydrogenase Malignant neoplasm of breast
AFFECTS,BRCA2 gene|BRCA2,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Gene or Genome,BRCA2 gene|BRCA2 Carcinoma of Male Breast
CAUSES,WBP2 gene|WBP2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,WBP2 gene|WBP2 Malignant neoplasm of breast
DISRUPTS,Regulatory Protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Regulatory Protein Malignant neoplasm of breast
AFFECTS,mdm2 protein|SLURP1,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",mdm2 protein|SLURP1 Breast Carcinoma
CAUSES,Cholangiocarcinoma,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Cholangiocarcinoma Breast Carcinoma
CAUSES,Sex Hormone-Binding Globulin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Sex Hormone-Binding Globulin Malignant neoplasm of breast
AFFECTS,Gene Mutation,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Gene or Genome,Gene Mutation Carcinoma of Male Breast
CAUSES,"12-Hydroxy-5,8,10,14-eicosatetraenoic Acid",Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Chemical,"12-Hydroxy-5,8,10,14-eicosatetraenoic Acid Breast cancer metastatic"
PREDISPOSES,Relationship problems,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Relationship problems Malignant neoplasm of breast
AFFECTS,Secondary malignant neoplasm of axilla,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Secondary malignant neoplasm of axilla Breast Carcinoma
AFFECTS,Malignant disease,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Malignant disease Malignant neoplasm of breast
CAUSES,leukemia,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,leukemia Breast Carcinoma
PREDISPOSES,S-Phase Fraction,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,"Element, Ion, or Isotope",S-Phase Fraction Female Breast Carcinoma
DISRUPTS,sterculic acid,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Chemical,sterculic acid Breast Carcinoma
CAUSES,Aflatoxin B1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Aflatoxin B1 Malignant neoplasm of breast
CAUSES,fibrosarcoma,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,fibrosarcoma Breast Carcinoma
AUGMENTS,Cellular Retinoic Acid Binding Protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Cellular Retinoic Acid Binding Protein Malignant neoplasm of breast
AFFECTS,Cerebellar degeneration,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Cerebellar degeneration Malignant neoplasm of breast
AUGMENTS,Response Elements,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Response Elements Malignant neoplasm of breast
CAUSES,dromostanolone propionate,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",dromostanolone propionate Breast Carcinoma
AFFECTS,Trace Elements,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Trace Elements Malignant neoplasm of breast
AFFECTS,Malignant neoplasm of breast,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,Neoplastic Process,Malignant neoplasm of breast Familial cancer of breast
DISRUPTS,"Linoleic Acids, Conjugated",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,"Linoleic Acids, Conjugated Malignant neoplasm of breast"
AFFECTS,Ductal Breast Carcinoma,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,Neoplastic Process,Ductal Breast Carcinoma Female Breast Carcinoma
AUGMENTS,FGFR1 gene|FGFR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FGFR1 gene|FGFR1 Malignant neoplasm of breast
PREDISPOSES,blood lipid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Lipid,blood lipid Malignant neoplasm of breast
PREDISPOSES,placental protein 11|ENDOU,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",placental protein 11|ENDOU Malignant neoplasm of breast
AFFECTS,PTHLH gene|PTHLH,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PTHLH gene|PTHLH Malignant neoplasm of breast
AFFECTS,BRCA2 gene|BRCA2,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Gene or Genome,BRCA2 gene|BRCA2 Sporadic Breast Carcinoma
COMPLICATES,Pleural effusion disorder,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Pleural effusion disorder Malignant neoplasm of breast
AUGMENTS,NCOA3 gene|NCOA3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NCOA3 gene|NCOA3 Malignant neoplasm of breast
DISRUPTS,Specific antibody,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Indicator, Reagent, or Diagnostic Aid",Specific antibody Malignant neoplasm of breast
DISRUPTS,Sulfhydryl Compounds,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Chemical,Sulfhydryl Compounds Noninfiltrating Intraductal Carcinoma
PREDISPOSES,Carcinogens,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Hazardous or Poisonous Substance,Carcinogens Breast Carcinoma
PREDISPOSES,"Genital Diseases, Female",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,"Genital Diseases, Female Malignant neoplasm of breast"
AUGMENTS,RNA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",RNA Malignant neoplasm of breast
CAUSES,Small T-Antigen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Immunologic Factor,Small T-Antigen Malignant neoplasm of breast
DISRUPTS,NME1 gene|NME1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,NME1 gene|NME1 Breast cancer metastatic
DISRUPTS,Serine Protease,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Enzyme,Serine Protease Malignant neoplasm of breast
CAUSES,Mutagens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hazardous or Poisonous Substance,Mutagens Malignant neoplasm of breast
PREDISPOSES,sarcoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,sarcoma Malignant neoplasm of breast
CAUSES,Prostate-Specific Antigen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Immunologic Factor,Prostate-Specific Antigen Malignant neoplasm of breast
CAUSES,Cyclin Gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Cyclin Gene Malignant neoplasm of breast
DISRUPTS,Immunotoxins,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Chemical,Immunotoxins Breast cancer metastatic
AUGMENTS,RNA,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",RNA Breast Carcinoma
DISRUPTS,Tumor Suppressor Genes,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Gene or Genome,Tumor Suppressor Genes Sporadic Breast Carcinoma
CAUSES,"VEGF protein, human|VEGFA",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","VEGF protein, human|VEGFA Malignant neoplasm of breast"
COMPLICATES,Radiation therapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Radiation therapy Malignant neoplasm of breast
AUGMENTS,NRG1 gene|NRG1,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,NRG1 gene|NRG1 Breast Carcinoma
AUGMENTS,cyclooxygenase 2,Carcinoma in situ of breast,0.0019980019980019,Female Breast Cancer,"Element, Ion, or Isotope",cyclooxygenase 2 Carcinoma in situ of breast
AFFECTS,c-myc Genes|MYC,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,c-myc Genes|MYC Malignant neoplasm of breast
AFFECTS,Nucleic Acids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Nucleic Acids Malignant neoplasm of breast
PREDISPOSES,COMT gene|COMT,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,COMT gene|COMT Malignant neoplasm of breast
AFFECTS,"Genes, Homeobox",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,"Genes, Homeobox Malignant neoplasm of breast"
PREDISPOSES,AR gene|AR,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Gene or Genome,AR gene|AR Carcinoma of Male Breast
CAUSES,SHBG gene|SHBG,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SHBG gene|SHBG Malignant neoplasm of breast
AFFECTS,Gene Amplification,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,Gene Amplification Breast Carcinoma
AFFECTS,Transcriptional Repression,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Transcriptional Repression Malignant neoplasm of breast
PREDISPOSES,LTA gene|LTA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LTA gene|LTA Malignant neoplasm of breast
PREDISPOSES,Nuclear Matrix-Associated Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Nuclear Matrix-Associated Proteins Malignant neoplasm of breast
AFFECTS,Neuropeptide Y Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Neuropeptide Y Receptor Malignant neoplasm of breast
PREDISPOSES,"ESR1 protein, human|ESR1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","ESR1 protein, human|ESR1 Malignant neoplasm of breast"
AFFECTS,Testosterone Propionate,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Hormone,Testosterone Propionate Breast cancer metastatic
AUGMENTS,Peptide Hydrolases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Peptide Hydrolases Malignant neoplasm of breast
AFFECTS,Matrix Metalloproteinases,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Matrix Metalloproteinases Breast cancer metastatic
PREDISPOSES,5-lipoxygenase-activating protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",5-lipoxygenase-activating protein Malignant neoplasm of breast
AFFECTS,Thyroid Diseases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Thyroid Diseases Malignant neoplasm of breast
PREDISPOSES,Tissue-Inhibitor of Metalloproteinase-1|TIMP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Tissue-Inhibitor of Metalloproteinase-1|TIMP1 Malignant neoplasm of breast
PREDISPOSES,VEGF gene|VEGFA,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Gene or Genome,VEGF gene|VEGFA Sporadic Breast Carcinoma
PREDISPOSES,Metalloproteases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Metalloproteases Malignant neoplasm of breast
PREDISPOSES,Fluctuation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Fluctuation Malignant neoplasm of breast
AFFECTS,Diagnostic radiologic examination,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Diagnostic radiologic examination Breast cancer metastatic
AFFECTS,Adhesions,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Adhesions Breast Carcinoma
AFFECTS,EP300 gene|EP300,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Gene or Genome,EP300 gene|EP300 Breast cancer invasive NOS
PREDISPOSES,PTN gene|PTN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PTN gene|PTN Malignant neoplasm of breast
AUGMENTS,Phytoestrogens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Phytoestrogens Malignant neoplasm of breast
AFFECTS,Malignant neoplasm of prostate,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Malignant neoplasm of prostate Breast Carcinoma
CAUSES,Ha-ras Oncogenes,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,Ha-ras Oncogenes Breast Carcinoma
PREDISPOSES,Testicular Diseases,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Disease or Syndrome,Testicular Diseases Carcinoma of Male Breast
PREDISPOSES,"Receptors, Progesterone|PGR",Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Hormone,"Receptors, Progesterone|PGR Breast cancer metastatic"
DISRUPTS,Tissue factor antibody,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Indicator, Reagent, or Diagnostic Aid",Tissue factor antibody Breast cancer metastatic
AFFECTS,Insulin-Like Growth Factor II|CD74|GCNT2|TCN2|VIPR1|TAF8,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Insulin-Like Growth Factor II|CD74|GCNT2|TCN2|VIPR1|TAF8 Malignant neoplasm of breast
PREDISPOSES,"LGALS3BP protein, human|LGALS3BP",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","LGALS3BP protein, human|LGALS3BP Malignant neoplasm of breast"
PREDISPOSES,Vitamin E,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Food,Vitamin E Breast cancer invasive NOS
AFFECTS,Hormone Receptor,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Hormone,Hormone Receptor Breast Carcinoma
AUGMENTS,LGI1 gene|LGI1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LGI1 gene|LGI1 Malignant neoplasm of breast
CAUSES,BMI1 gene|BMI1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BMI1 gene|BMI1 Malignant neoplasm of breast
AFFECTS,SKI gene|SKI,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Gene or Genome,SKI gene|SKI Breast cancer invasive NOS
CAUSES,Functional RNA,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Functional RNA Breast cancer metastatic
PREDISPOSES,TNFSF11 gene|TNFSF11,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,TNFSF11 gene|TNFSF11 Breast cancer metastatic
PREDISPOSES,Encounter due to drug use,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,Encounter due to drug use Malignant neoplasm of breast
PREDISPOSES,"Receptors, Progesterone|EREG|ESR1",Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Hormone,"Receptors, Progesterone|EREG|ESR1 Breast Carcinoma"
PREDISPOSES,Aromatase Inhibitors,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,Hormone,Aromatase Inhibitors Contralateral breast cancer
DISRUPTS,letrozole,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,Pharmacologic Substance,letrozole Contralateral breast cancer
AFFECTS,Estrogens,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Hormone,Estrogens Breast cancer invasive NOS
PREDISPOSES,MCAM gene|MCAM,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MCAM gene|MCAM Malignant neoplasm of breast
CAUSES,SKP2 gene|SKP2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SKP2 gene|SKP2 Malignant neoplasm of breast
AFFECTS,IL2 gene|IL2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IL2 gene|IL2 Malignant neoplasm of breast
AUGMENTS,TP53 gene|TP53,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,TP53 gene|TP53 Noninfiltrating Intraductal Carcinoma
CAUSES,"Histiocytoma, Malignant Fibrous",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,"Histiocytoma, Malignant Fibrous Malignant neoplasm of breast"
AFFECTS,cellular process,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Phenomenon or Process,cellular process Malignant neoplasm of breast
AUGMENTS,ALK gene|ALK,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Gene or Genome,ALK gene|ALK Inflammatory Breast Carcinoma
AFFECTS,Drug resistance,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Pharmacologic Substance,Drug resistance Breast cancer metastatic
AUGMENTS,"Cholesterol, Dietary",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Lipid,"Cholesterol, Dietary Malignant neoplasm of breast"
AFFECTS,HIF1A gene|HIF1A,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,HIF1A gene|HIF1A Noninfiltrating Intraductal Carcinoma
PREDISPOSES,LDL Cholesterol Lipoproteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",LDL Cholesterol Lipoproteins Malignant neoplasm of breast
AUGMENTS,ERBB4 gene|ERBB4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ERBB4 gene|ERBB4 Malignant neoplasm of breast
AFFECTS,Retinoblastoma Genes,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,Retinoblastoma Genes Breast cancer metastatic
PREDISPOSES,Tumor Suppressor Genes,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,Gene or Genome,Tumor Suppressor Genes Familial cancer of breast
AUGMENTS,"DNA, Single-Stranded",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","DNA, Single-Stranded Malignant neoplasm of breast"
AUGMENTS,Estrogens,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Hormone,Estrogens Noninfiltrating Intraductal Carcinoma
AFFECTS,epidermal growth factor receptor VIII,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,epidermal growth factor receptor VIII Malignant neoplasm of breast
AFFECTS,Angiogenesis Inhibitors,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Gene or Genome,Angiogenesis Inhibitors Inflammatory Breast Carcinoma
AFFECTS,GAPD gene|GAPDH,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GAPD gene|GAPDH Malignant neoplasm of breast
AUGMENTS,Oncogene ErbB2|ERBB2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,Oncogene ErbB2|ERBB2 Breast cancer metastatic
PREDISPOSES,Proto-Oncogene Proteins p21(ras),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Proto-Oncogene Proteins p21(ras) Malignant neoplasm of breast
DISRUPTS,protein kinase C zeta,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",protein kinase C zeta Breast cancer metastatic
AUGMENTS,parathyroid hormone-related protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",parathyroid hormone-related protein Malignant neoplasm of breast
PREDISPOSES,CNS disorder,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,CNS disorder Malignant neoplasm of breast
AUGMENTS,BRCA1 gene|BRCA1,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Gene or Genome,BRCA1 gene|BRCA1 Sporadic Breast Carcinoma
DISRUPTS,Cytotoxic T-Lymphocyte-Associated Protein 4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hazardous or Poisonous Substance,Cytotoxic T-Lymphocyte-Associated Protein 4 Malignant neoplasm of breast
AFFECTS,Vitamin D Deficiency,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Food,Vitamin D Deficiency Breast cancer metastatic
PREDISPOSES,APP gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,APP gene Malignant neoplasm of breast
DISRUPTS,Fatty-acid synthase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Fatty-acid synthase Malignant neoplasm of breast
AUGMENTS,IL4 gene|IL4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IL4 gene|IL4 Malignant neoplasm of breast
AFFECTS,KLF8 gene|KLF8,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,KLF8 gene|KLF8 Breast cancer metastatic
AFFECTS,Membrane Proteins,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Membrane Proteins Breast cancer metastatic
AUGMENTS,KNG1 gene|KNG1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,KNG1 gene|KNG1 Malignant neoplasm of breast
AUGMENTS,Fibroblast Growth Factor Receptor 1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Fibroblast Growth Factor Receptor 1 Malignant neoplasm of breast
PREDISPOSES,Acute inflammation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Acute inflammation Malignant neoplasm of breast
PREDISPOSES,Proteins,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Amino Acid, Peptide, or Protein",Proteins Breast cancer recurrent
PREDISPOSES,COX7A2L gene|COX7A2L,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,COX7A2L gene|COX7A2L Malignant neoplasm of breast
AFFECTS,mead acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,mead acid Malignant neoplasm of breast
PREDISPOSES,Metabolic syndrome,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Disease or Syndrome,Metabolic syndrome Breast cancer recurrent
AFFECTS,Protein antigen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Protein antigen Malignant neoplasm of breast
AFFECTS,MIRN182 gene|MIR182,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIRN182 gene|MIR182 Malignant neoplasm of breast
AFFECTS,Sulfonylurea Compounds,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Sulfonylurea Compounds Malignant neoplasm of breast
AFFECTS,bone morphogenetic protein 4,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,bone morphogenetic protein 4 Breast cancer metastatic
DISRUPTS,BMI1 gene|BMI1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BMI1 gene|BMI1 Malignant neoplasm of breast
AFFECTS,Antihypertensive Agents,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical Viewed Functionally,Antihypertensive Agents Malignant neoplasm of breast
CAUSES,Epidermal Growth Factor Receptor|EGFR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Epidermal Growth Factor Receptor|EGFR Malignant neoplasm of breast
PREDISPOSES,apolipoprotein E-2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",apolipoprotein E-2 Malignant neoplasm of breast
PREDISPOSES,Dyslipidemias,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Lipid,Dyslipidemias Inflammatory Breast Carcinoma
AFFECTS,"Cystadenocarcinoma, Serous",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,"Cystadenocarcinoma, Serous Malignant neoplasm of breast"
PREDISPOSES,Inflammatory disorder,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Inflammatory disorder Malignant neoplasm of breast
AUGMENTS,MFAP5 gene|MFAP5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MFAP5 gene|MFAP5 Malignant neoplasm of breast
AFFECTS,Gene Expression,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Gene or Genome,Gene Expression Inflammatory Breast Carcinoma
PREDISPOSES,Disease Progression,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Disease Progression Malignant neoplasm of breast
CAUSES,SMAD3 gene|SMAD3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SMAD3 gene|SMAD3 Malignant neoplasm of breast
AFFECTS,Secretory Carcinoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Secretory Carcinoma Malignant neoplasm of breast
AFFECTS,cilium biogenesis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,cilium biogenesis Malignant neoplasm of breast
PREDISPOSES,Fatty Acid-Binding Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Fatty Acid-Binding Proteins Malignant neoplasm of breast
PREDISPOSES,Benzene,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Hazardous or Poisonous Substance,Benzene Carcinoma of Male Breast
AFFECTS,Tumorigenesis,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,Tumorigenesis Breast cancer metastatic
AFFECTS,KISS1 gene|KISS1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,KISS1 gene|KISS1 Breast cancer metastatic
PREDISPOSES,Sleep Disorders,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Sleep Disorders Malignant neoplasm of breast
AFFECTS,copper-binding protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",copper-binding protein Malignant neoplasm of breast
DISRUPTS,ID2 gene|ID2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ID2 gene|ID2 Malignant neoplasm of breast
CAUSES,MIRN21 gene|MIR21,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIRN21 gene|MIR21 Malignant neoplasm of breast
AFFECTS,Tamoxifen,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Pharmacologic Substance,Tamoxifen Breast cancer recurrent
PREDISPOSES,ARHGEF5 gene|ARHGEF5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ARHGEF5 gene|ARHGEF5 Malignant neoplasm of breast
AFFECTS,SENP2 gene|SENP2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SENP2 gene|SENP2 Malignant neoplasm of breast
DISRUPTS,Fibroblast Growth Factor Receptor 1|FGFR1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Biologically Active Substance,Fibroblast Growth Factor Receptor 1|FGFR1 Breast cancer metastatic
AFFECTS,Thioctic Acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Thioctic Acid Malignant neoplasm of breast
AFFECTS,DNA amplification,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",DNA amplification Malignant neoplasm of breast
AUGMENTS,BCL2 gene|BCL2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BCL2 gene|BCL2 Malignant neoplasm of breast
PREDISPOSES,Transforming Growth Factor beta,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Biologically Active Substance,Transforming Growth Factor beta Breast Carcinoma
PREDISPOSES,Pathogenesis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Pathogenesis Malignant neoplasm of breast
CAUSES,MDM2 gene|MDM2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MDM2 gene|MDM2 Malignant neoplasm of breast
AFFECTS,Carcinogenesis,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Hazardous or Poisonous Substance,Carcinogenesis Inflammatory Breast Carcinoma
AFFECTS,ETS1 gene|ETS1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,ETS1 gene|ETS1 Breast cancer metastatic
PREDISPOSES,Need for isolation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Need for isolation Malignant neoplasm of breast
AFFECTS,Colorectal cancer metastatic,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Colorectal cancer metastatic Breast cancer metastatic
AUGMENTS,E2F4 gene|E2F4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,E2F4 gene|E2F4 Malignant neoplasm of breast
AFFECTS,DMBT1 gene|DMBT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,DMBT1 gene|DMBT1 Malignant neoplasm of breast
AUGMENTS,retinoic acid receptor beta 2,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Chemical,retinoic acid receptor beta 2 Inflammatory Breast Carcinoma
AFFECTS,Phosphoproteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Phosphoproteins Malignant neoplasm of breast
AFFECTS,Cyclic AMP-Responsive DNA-Binding Protein|CAMP,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Cyclic AMP-Responsive DNA-Binding Protein|CAMP Breast cancer metastatic
AFFECTS,attenuation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",attenuation Malignant neoplasm of breast
PREDISPOSES,Insulin-Like Growth Factor Binding Protein 3|IGFBP3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Insulin-Like Growth Factor Binding Protein 3|IGFBP3 Malignant neoplasm of breast
AUGMENTS,GAB2 gene|GAB2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GAB2 gene|GAB2 Malignant neoplasm of breast
CAUSES,Malignant Neoplasms,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,Neoplastic Process,Malignant Neoplasms Female Breast Carcinoma
PREDISPOSES,Tumor Promoters,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Neoplastic Process,Tumor Promoters Inflammatory Breast Carcinoma
PREDISPOSES,BRCA1 Protein|BRCA1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BRCA1 Protein|BRCA1 Malignant neoplasm of breast
DISRUPTS,Progesterone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Progesterone Malignant neoplasm of breast
PREDISPOSES,Transcription Repressor/Corepressor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Transcription Repressor/Corepressor Malignant neoplasm of breast
AFFECTS,Local excision,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",Local excision Noninfiltrating Intraductal Carcinoma
PREDISPOSES,G22P1 gene|XRCC6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,G22P1 gene|XRCC6 Malignant neoplasm of breast
PREDISPOSES,Invasive Lesion,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,"Element, Ion, or Isotope","Invasive Lesion Carcinoma, Ductal, Breast"
AFFECTS,Disease Progression,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Disease Progression Breast cancer metastatic
AFFECTS,"TERT protein, human|TERT","Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,"Amino Acid, Peptide, or Protein","TERT protein, human|TERT Carcinoma, Ductal, Breast"
PREDISPOSES,CBS gene|CBS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CBS gene|CBS Malignant neoplasm of breast
AFFECTS,childhood brain tumor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,childhood brain tumor Malignant neoplasm of breast
AUGMENTS,EEF1A2 gene|EEF1A2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,EEF1A2 gene|EEF1A2 Malignant neoplasm of breast
PREDISPOSES,Gonadal Hormones,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Gonadal Hormones Malignant neoplasm of breast
AFFECTS,SKP2 gene|SKP2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SKP2 gene|SKP2 Malignant neoplasm of breast
AFFECTS,Carcinoma,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Carcinoma Breast Carcinoma
AFFECTS,Malignant neoplasm of breast,bilateral breast cancer,0.0,Female Breast Cancer,Neoplastic Process,Malignant neoplasm of breast bilateral breast cancer
PREDISPOSES,Alcohol consumption,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,"Element, Ion, or Isotope",Alcohol consumption Female Breast Carcinoma
CAUSES,"RNA, Messenger",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","RNA, Messenger Malignant neoplasm of breast"
AFFECTS,Testosterone,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Hormone,Testosterone Breast cancer invasive NOS
PREDISPOSES,GLO1 gene|GLO1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GLO1 gene|GLO1 Malignant neoplasm of breast
PREDISPOSES,GNRHR gene|GNRHR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GNRHR gene|GNRHR Malignant neoplasm of breast
AUGMENTS,"RNA, Messenger","Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","RNA, Messenger Carcinoma, Ductal, Breast"
AUGMENTS,"TACSTD2 protein, human|TACSTD2",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","TACSTD2 protein, human|TACSTD2 Malignant neoplasm of breast"
AUGMENTS,TACSTD2 gene|TACSTD2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TACSTD2 gene|TACSTD2 Malignant neoplasm of breast
AUGMENTS,CXCR3 gene|CXCR3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CXCR3 gene|CXCR3 Malignant neoplasm of breast
PREDISPOSES,Epstein-Barr Virus Infections,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Epstein-Barr Virus Infections Malignant neoplasm of breast
DISRUPTS,Proteins,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,"Amino Acid, Peptide, or Protein","Proteins Carcinoma, Ductal, Breast"
PREDISPOSES,IL23R gene|IL23R,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Gene or Genome,IL23R gene|IL23R Sporadic Breast Carcinoma
AFFECTS,Proteins,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Proteins Breast cancer metastatic
PREDISPOSES,BRCA2 gene|BRCA2,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,Gene or Genome,BRCA2 gene|BRCA2 Contralateral breast cancer
AUGMENTS,MIRN27A gene|MIR27A,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Gene or Genome,MIRN27A gene|MIR27A Breast cancer invasive NOS
PREDISPOSES,AR gene|AR,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Gene or Genome,AR gene|AR Breast cancer recurrent
AFFECTS,vitamin supplement,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,vitamin supplement Malignant neoplasm of breast
PREDISPOSES,RHOC gene|RHOC,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RHOC gene|RHOC Malignant neoplasm of breast
AFFECTS,Ionizing radiation,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",Ionizing radiation Noninfiltrating Intraductal Carcinoma
AFFECTS,Vaccination,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Vaccination Malignant neoplasm of breast
AFFECTS,WNT2 gene|WNT2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,WNT2 gene|WNT2 Malignant neoplasm of breast
CAUSES,Agent,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Chemical Viewed Functionally,Agent Breast cancer metastatic
AUGMENTS,XRCC3 gene|XRCC3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,XRCC3 gene|XRCC3 Malignant neoplasm of breast
PREDISPOSES,DNA Sequence,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Nucleotide Sequence,DNA Sequence Breast Carcinoma
PREDISPOSES,STK11 gene|STK11,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,STK11 gene|STK11 Breast cancer metastatic
AUGMENTS,ADM gene|ADM,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,ADM gene|ADM Breast cancer metastatic
PREDISPOSES,Vascular Endothelial Growth Factor C,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Vascular Endothelial Growth Factor C Malignant neoplasm of breast
PREDISPOSES,Gonadal Steroid Hormones,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Hormone,Gonadal Steroid Hormones Carcinoma of Male Breast
AFFECTS,FOS gene|FOS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FOS gene|FOS Malignant neoplasm of breast
AUGMENTS,MIRN370 gene|MIR370,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIRN370 gene|MIR370 Malignant neoplasm of breast
AFFECTS,mRNA Expression,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",mRNA Expression Breast cancer metastatic
PREDISPOSES,Homologous Gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Homologous Gene Malignant neoplasm of breast
DISRUPTS,Insulin-Like-Growth Factor I Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Insulin-Like-Growth Factor I Receptor Malignant neoplasm of breast
AFFECTS,Prevention,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Prevention Breast cancer metastatic
AFFECTS,Cyclooxygenase 2 Inhibitors,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Element, Ion, or Isotope",Cyclooxygenase 2 Inhibitors Breast cancer recurrent
AUGMENTS,"Receptors, Progesterone|PGR",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,"Receptors, Progesterone|PGR Malignant neoplasm of breast"
PREDISPOSES,Estrogen Receptors,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptors Breast cancer recurrent
PREDISPOSES,IL1A gene|IL1A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IL1A gene|IL1A Malignant neoplasm of breast
DISRUPTS,Transforming Growth Factor beta,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Biologically Active Substance,Transforming Growth Factor beta Breast cancer metastatic
PREDISPOSES,Genes,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,Gene or Genome,Genes Familial cancer of breast
CAUSES,Malignant neoplasm of breast,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Neoplastic Process,Malignant neoplasm of breast Breast cancer recurrent
PREDISPOSES,apolipoprotein E-4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",apolipoprotein E-4 Malignant neoplasm of breast
PREDISPOSES,"Anti-Inflammatory Agents, Non-Steroidal",Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Chemical Viewed Functionally,"Anti-Inflammatory Agents, Non-Steroidal Breast Carcinoma"
PREDISPOSES,letrozole,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,letrozole Malignant neoplasm of breast
AFFECTS,Sirolimus (substance),Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Substance,Sirolimus (substance) Breast Carcinoma
AFFECTS,Cessation of life,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Cessation of life Breast cancer metastatic
PREDISPOSES,proto-oncogene protein c-crk,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,proto-oncogene protein c-crk Malignant neoplasm of breast
CAUSES,Antipsychotic Agents,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical Viewed Functionally,Antipsychotic Agents Malignant neoplasm of breast
CAUSES,Materials,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Substance,Materials Malignant neoplasm of breast
AFFECTS,TCF4 gene|TCF4|TCF7L2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TCF4 gene|TCF4|TCF7L2 Malignant neoplasm of breast
PREDISPOSES,Functional RNA,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,"Element, Ion, or Isotope",Functional RNA Familial cancer of breast
CAUSES,Insulin-Like Growth Factor I|IGF1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Insulin-Like Growth Factor I|IGF1 Malignant neoplasm of breast
PREDISPOSES,Phosphatidylethanolamine Binding Protein|ZHX2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Phosphatidylethanolamine Binding Protein|ZHX2 Malignant neoplasm of breast
CAUSES,Fibroblast Growth Factor 7,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Biologically Active Substance,Fibroblast Growth Factor 7 Breast cancer metastatic
PREDISPOSES,YARS gene|YARS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,YARS gene|YARS Malignant neoplasm of breast
PREDISPOSES,CHEK2 gene|CHEK2,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,Gene or Genome,CHEK2 gene|CHEK2 Female Breast Carcinoma
AFFECTS,calcification,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",calcification Noninfiltrating Intraductal Carcinoma
PREDISPOSES,methionine synthase reductase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",methionine synthase reductase Malignant neoplasm of breast
PREDISPOSES,Carcinoma in Situ,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,Carcinoma in Situ Breast cancer invasive NOS
AFFECTS,Sexual Dysfunction,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Sexual Dysfunction Malignant neoplasm of breast
AFFECTS,MIRN210 gene|MIR210,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIRN210 gene|MIR210 Malignant neoplasm of breast
DISRUPTS,MCAM gene|MCAM,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MCAM gene|MCAM Malignant neoplasm of breast
AUGMENTS,CCL2 gene|CCL2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CCL2 gene|CCL2 Malignant neoplasm of breast
PREDISPOSES,KISS1 gene|KISS1,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Gene or Genome,KISS1 gene|KISS1 Breast cancer invasive NOS
AFFECTS,Dissociation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Dissociation Malignant neoplasm of breast
PREDISPOSES,"PTTG1 protein, human|PTTG1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","PTTG1 protein, human|PTTG1 Malignant neoplasm of breast"
PREDISPOSES,CA-15-3 Antigen,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Immunologic Factor,CA-15-3 Antigen Inflammatory Breast Carcinoma
AFFECTS,Protein Expression,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Protein Expression Breast Carcinoma
PREDISPOSES,"PER2 protein, mammalian",Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Amino Acid, Peptide, or Protein","PER2 protein, mammalian Breast cancer recurrent"
AFFECTS,bilateral breast cancer,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,bilateral breast cancer Malignant neoplasm of breast
PREDISPOSES,Estrogen Receptor Status,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptor Status Breast cancer metastatic
PREDISPOSES,TP53 gene|TP53,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Gene or Genome,TP53 gene|TP53 Inflammatory Breast Carcinoma
AFFECTS,MAPK12 gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MAPK12 gene Malignant neoplasm of breast
AFFECTS,Promoter (Genetics),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Promoter (Genetics) Malignant neoplasm of breast
PREDISPOSES,Single Nucleotide Polymorphism,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Single Nucleotide Polymorphism Contralateral breast cancer
CAUSES,Endometrial Carcinoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Endometrial Carcinoma Malignant neoplasm of breast
AUGMENTS,Aryl Hydrocarbon Receptor|AHR,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Aryl Hydrocarbon Receptor|AHR Breast Carcinoma
AUGMENTS,aldehyde dehydrogenases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",aldehyde dehydrogenases Malignant neoplasm of breast
PREDISPOSES,PTGS2 gene|PTGS2,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,PTGS2 gene|PTGS2 Noninfiltrating Intraductal Carcinoma
AUGMENTS,PROTEIN KINASE|PGR|PR@|PRH2|TMEM37|ERVK-7|ERVK-8|ERVK-10|ERVK-9|ERVK-21|ERVK-18|ERVK-25|ERVK-24|ERVK-19,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",PROTEIN KINASE|PGR|PR@|PRH2|TMEM37|ERVK-7|ERVK-8|ERVK-10|ERVK-9|ERVK-21|ERVK-18|ERVK-25|ERVK-24|ERVK-19 Malignant neoplasm of breast
AUGMENTS,E2F5 gene|E2F5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,E2F5 gene|E2F5 Malignant neoplasm of breast
AFFECTS,Disease,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,Disease or Syndrome,Disease Contralateral breast cancer
DISRUPTS,Fertility Agents,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical Viewed Functionally,Fertility Agents Malignant neoplasm of breast
PREDISPOSES,TOP2A gene|TOP2A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TOP2A gene|TOP2A Malignant neoplasm of breast
PREDISPOSES,CCND1 gene|CCND1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,CCND1 gene|CCND1 Breast cancer metastatic
AFFECTS,disorder control,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,disorder control Malignant neoplasm of breast
PREDISPOSES,PTPRC gene|PTPRC,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PTPRC gene|PTPRC Malignant neoplasm of breast
AFFECTS,CXCL14 gene|CXCL14,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CXCL14 gene|CXCL14 Malignant neoplasm of breast
AUGMENTS,Bone Morphogenetic Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Bone Morphogenetic Proteins Malignant neoplasm of breast
PREDISPOSES,ELK3 gene|ELK3|KCNH8,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Gene or Genome,ELK3 gene|ELK3|KCNH8 Breast cancer invasive NOS
AFFECTS,"Metabolic Detoxication, Drug",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hazardous or Poisonous Substance,"Metabolic Detoxication, Drug Malignant neoplasm of breast"
AFFECTS,Infiltration,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",Infiltration Noninfiltrating Intraductal Carcinoma
AFFECTS,Nuclear Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Nuclear Proteins Malignant neoplasm of breast
AFFECTS,PDCD1 gene|PDCD1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PDCD1 gene|PDCD1 Malignant neoplasm of breast
PREDISPOSES,Peptide YY,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Peptide YY Malignant neoplasm of breast
DISRUPTS,Glucose,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Carbohydrate,Glucose Malignant neoplasm of breast
AFFECTS,Malignant neoplasm of breast,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Neoplastic Process,"Malignant neoplasm of breast Carcinoma, Ductal, Breast"
AFFECTS,PIK3CA gene|PIK3CA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PIK3CA gene|PIK3CA Malignant neoplasm of breast
PREDISPOSES,CUL2 gene|CUL2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CUL2 gene|CUL2 Malignant neoplasm of breast
AFFECTS,"PIK3CA protein, human|PIK3CA",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","PIK3CA protein, human|PIK3CA Malignant neoplasm of breast"
AFFECTS,Lymphocytic infiltration,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Lymphocytic infiltration Malignant neoplasm of breast
AFFECTS,Carbon Dioxide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Carbon Dioxide Malignant neoplasm of breast
PREDISPOSES,CLDN1 gene|CLDN1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CLDN1 gene|CLDN1 Malignant neoplasm of breast
AFFECTS,SIDT1 gene|SIDT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SIDT1 gene|SIDT1 Malignant neoplasm of breast
AFFECTS,Respiration,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Respiration Malignant neoplasm of breast
CAUSES,Minerals,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Minerals Malignant neoplasm of breast
AFFECTS,"Translation, Genetic",Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,"Translation, Genetic Breast cancer metastatic"
AFFECTS,Ablation,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Ablation Breast cancer metastatic
AFFECTS,tacrolimus binding protein 4|FKBP4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",tacrolimus binding protein 4|FKBP4 Malignant neoplasm of breast
DISRUPTS,"FBXW7 protein, human|FBXW7",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","FBXW7 protein, human|FBXW7 Malignant neoplasm of breast"
AUGMENTS,protein kinase C nu|DIO3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",protein kinase C nu|DIO3 Malignant neoplasm of breast
PREDISPOSES,"Genes, Regulator",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,"Genes, Regulator Malignant neoplasm of breast"
DISRUPTS,SFN gene|SFN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SFN gene|SFN Malignant neoplasm of breast
AUGMENTS,B lymphocyte-induced maturation protein 1|PGR|PR@|PRH2|TMEM37|ERVK-7|ERVK-8|ERVK-10|ERVK-9|ERVK-21|ERVK-18|ERVK-25|ERVK-24|ERVK-19,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",B lymphocyte-induced maturation protein 1|PGR|PR@|PRH2|TMEM37|ERVK-7|ERVK-8|ERVK-10|ERVK-9|ERVK-21|ERVK-18|ERVK-25|ERVK-24|ERVK-19 Malignant neoplasm of breast
AFFECTS,Desire for food,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Desire for food Malignant neoplasm of breast
PREDISPOSES,Short Sleeper Syndrome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Short Sleeper Syndrome Malignant neoplasm of breast
DISRUPTS,Matrix Metalloproteinase 9,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Matrix Metalloproteinase 9 Noninfiltrating Intraductal Carcinoma
PREDISPOSES,LINC-ROR gene|LINC-ROR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LINC-ROR gene|LINC-ROR Malignant neoplasm of breast
DISRUPTS,"RNA, Messenger",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","RNA, Messenger Triple Negative Breast Neoplasms"
AUGMENTS,Pharmaceutical Preparations,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Pharmacologic Substance,Pharmaceutical Preparations Inflammatory Breast Carcinoma
AFFECTS,TP53,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Gene or Genome,TP53 Inflammatory Breast Carcinoma
AFFECTS,Breast Microcalcification,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Breast Microcalcification Malignant neoplasm of breast
PREDISPOSES,"CD69 protein, human|CD69",Carcinoma breast stage IV,0.0,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CD69 protein, human|CD69 Carcinoma breast stage IV"
PREDISPOSES,hydroxybenzoic acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,hydroxybenzoic acid Malignant neoplasm of breast
PREDISPOSES,Household composition,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Household composition Malignant neoplasm of breast
AUGMENTS,ELAVL1 gene|ELAVL1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,ELAVL1 gene|ELAVL1 Triple Negative Breast Neoplasms
AFFECTS,MicroRNA 335-5p,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",MicroRNA 335-5p Malignant neoplasm of breast
AUGMENTS,Stat3 protein,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Stat3 protein Triple Negative Breast Neoplasms
PREDISPOSES,"RNA, Long Untranslated",Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","RNA, Long Untranslated Breast Carcinoma"
AUGMENTS,"FRAP1 protein, human|MTOR",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","FRAP1 protein, human|MTOR Malignant neoplasm of breast"
PREDISPOSES,TSIX gene|TSIX,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TSIX gene|TSIX Malignant neoplasm of breast
PREDISPOSES,CCL18 gene|CCL18,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CCL18 gene|CCL18 Malignant neoplasm of breast
CAUSES,"ITK protein, human|ITK",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","ITK protein, human|ITK Malignant neoplasm of breast"
AFFECTS,RPS6KA6 gene|RPS6KA6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RPS6KA6 gene|RPS6KA6 Malignant neoplasm of breast
PREDISPOSES,Growth Hormone Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Growth Hormone Receptor Malignant neoplasm of breast
AFFECTS,elements of cancer genetics risk assessment and counseling,"Breast Cancer, Familial",0.0,Female Breast Cancer,Gene or Genome,"elements of cancer genetics risk assessment and counseling Breast Cancer, Familial"
PREDISPOSES,Clinical information:Finding:Point in time:^Patient:Narrative,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Clinical information:Finding:Point in time:^Patient:Narrative Triple Negative Breast Neoplasms
AUGMENTS,PLSCR1 gene|PLSCR1,Basal-Like Breast Carcinoma,0.0039960039960039,Female Breast Cancer,Gene or Genome,PLSCR1 gene|PLSCR1 Basal-Like Breast Carcinoma
PREDISPOSES,CXXC5 gene|CXXC5,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Gene or Genome,CXXC5 gene|CXXC5 estrogen receptor-positive breast cancer
AUGMENTS,MYH10 gene|MYH10,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MYH10 gene|MYH10 Malignant neoplasm of breast
PREDISPOSES,Single Nucleotide Polymorphism,contralateral breast cancer,0.0029970029970029,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Single Nucleotide Polymorphism contralateral breast cancer
AFFECTS,BRCA1 Gene Mutation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BRCA1 Gene Mutation Malignant neoplasm of breast
CAUSES,Genes,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Gene or Genome,Genes Ductal Breast Carcinoma
PREDISPOSES,DNASE1L2 gene|DNASE1L2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,DNASE1L2 gene|DNASE1L2 Malignant neoplasm of breast
PREDISPOSES,Syndrome,"Breast Cancer, Familial",0.0,Female Breast Cancer,Disease or Syndrome,"Syndrome Breast Cancer, Familial"
AFFECTS,WDR41 gene|WDR41,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,WDR41 gene|WDR41 Triple Negative Breast Neoplasms
PREDISPOSES,NEUROD1 gene|NEUROD1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NEUROD1 gene|NEUROD1 Malignant neoplasm of breast
DISRUPTS,ZNF326 gene|ZNF326,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,ZNF326 gene|ZNF326 Triple Negative Breast Neoplasms
AFFECTS,C5 gene|C5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,C5 gene|C5 Malignant neoplasm of breast
DISRUPTS,"E2F1 protein, human|E2F1|UBE2L3",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","E2F1 protein, human|E2F1|UBE2L3 Malignant neoplasm of breast"
AFFECTS,"Fatty Acids, Essential",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Chemical,"Fatty Acids, Essential Triple Negative Breast Neoplasms"
CAUSES,GAS5 gene|GAS5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GAS5 gene|GAS5 Malignant neoplasm of breast
AFFECTS,TGFB1 gene|TGFB1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TGFB1 gene|TGFB1 Malignant neoplasm of breast
PREDISPOSES,RCC2-AS1 gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RCC2-AS1 gene Malignant neoplasm of breast
PREDISPOSES,SPX gene|SPX,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SPX gene|SPX Malignant neoplasm of breast
DISRUPTS,RNF5 gene|RNF5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RNF5 gene|RNF5 Malignant neoplasm of breast
AFFECTS,Chronic inflammatory disorder,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Chronic inflammatory disorder Malignant neoplasm of breast
PREDISPOSES,Tumor Antigens,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Tumor Antigens Breast Carcinoma
CAUSES,Peptide Hydrolases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Peptide Hydrolases Malignant neoplasm of breast
DISRUPTS,Beta protein,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Beta protein Triple Negative Breast Neoplasms
AFFECTS,AGTR1 gene|AGTR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,AGTR1 gene|AGTR1 Malignant neoplasm of breast
PREDISPOSES,Educational Status,malignant neoplasm of breast staging,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Educational Status malignant neoplasm of breast staging
AFFECTS,LINC01705 gene|LINC01705,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LINC01705 gene|LINC01705 Malignant neoplasm of breast
PREDISPOSES,ATF3 gene|ATF3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ATF3 gene|ATF3 Malignant neoplasm of breast
PREDISPOSES,CONOTRUNCAL ANOMALY FACE SYNDROME,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,CONOTRUNCAL ANOMALY FACE SYNDROME Malignant neoplasm of breast
COMPLICATES,parathyroid hormone,Carcinoma breast stage IV,0.0,Female Breast Cancer,Hormone,parathyroid hormone Carcinoma breast stage IV
CAUSES,PDCD4-AS1 gene|PDCD4-AS1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,PDCD4-AS1 gene|PDCD4-AS1 Triple Negative Breast Neoplasms
PREDISPOSES,MIR30E gene|MIR30E,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIR30E gene|MIR30E Malignant neoplasm of breast
AFFECTS,"SLC6A2 protein, human|SLC6A2",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein","SLC6A2 protein, human|SLC6A2 Triple Negative Breast Neoplasms"
AUGMENTS,cytokine,estrogen receptor-negative breast cancer,0.0,Female Breast Cancer,Biologically Active Substance,cytokine estrogen receptor-negative breast cancer
PREDISPOSES,SETD5 gene|SETD5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SETD5 gene|SETD5 Malignant neoplasm of breast
AFFECTS,CPEB1 gene|CPEB1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CPEB1 gene|CPEB1 Malignant neoplasm of breast
PREDISPOSES,MIR497 gene|MIR497,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIR497 gene|MIR497 Malignant neoplasm of breast
AFFECTS,SYVN1 gene|SYVN1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,SYVN1 gene|SYVN1 Triple Negative Breast Neoplasms
AFFECTS,SOX4 gene|SOX4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SOX4 gene|SOX4 Malignant neoplasm of breast
AFFECTS,CYP27A1 gene|CYP27A1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CYP27A1 gene|CYP27A1 Malignant neoplasm of breast
AUGMENTS,SEMA7A gene|SEMA7A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SEMA7A gene|SEMA7A Malignant neoplasm of breast
AUGMENTS,Hemeproteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Hemeproteins Malignant neoplasm of breast
AFFECTS,Cellular signal transduction,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Cellular signal transduction Malignant neoplasm of breast
PREDISPOSES,FABP7 gene|FABP7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FABP7 gene|FABP7 Malignant neoplasm of breast
AFFECTS,Advanced Breast Carcinoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Advanced Breast Carcinoma Malignant neoplasm of breast
DISRUPTS,ZC3H13 gene|ZC3H13,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ZC3H13 gene|ZC3H13 Malignant neoplasm of breast
AFFECTS,ING4 gene|ING4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ING4 gene|ING4 Malignant neoplasm of breast
CAUSES,GAS6 gene|GAS6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GAS6 gene|GAS6 Malignant neoplasm of breast
AFFECTS,NUDT3 gene|NUDT3,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,NUDT3 gene|NUDT3 Triple Negative Breast Neoplasms
CAUSES,hormone response element,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,hormone response element Malignant neoplasm of breast
AUGMENTS,LINC00511 gene|LINC00511,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LINC00511 gene|LINC00511 Malignant neoplasm of breast
PREDISPOSES,IQGAP1 gene|IQGAP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IQGAP1 gene|IQGAP1 Malignant neoplasm of breast
DISRUPTS,CARNS1 gene|CARNS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CARNS1 gene|CARNS1 Malignant neoplasm of breast
PREDISPOSES,TWIST1 gene|TWIST1,estrogen receptor-negative breast cancer,0.0,Female Breast Cancer,Gene or Genome,TWIST1 gene|TWIST1 estrogen receptor-negative breast cancer
AUGMENTS,IMPACT gene,malignant neoplasm of breast staging,0.0,Female Breast Cancer,Gene or Genome,IMPACT gene malignant neoplasm of breast staging
AFFECTS,HNF1A-AS1 gene|HNF1A-AS1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,HNF1A-AS1 gene|HNF1A-AS1 Triple Negative Breast Neoplasms
DISRUPTS,cyclic compound,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,cyclic compound Malignant neoplasm of breast
AUGMENTS,GFUS gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GFUS gene Malignant neoplasm of breast
PREDISPOSES,TP53,Hereditary Breast and Ovarian Cancer Syndrome,0.0,Female Breast Cancer,Gene or Genome,TP53 Hereditary Breast and Ovarian Cancer Syndrome
AFFECTS,SEMA7A gene|SEMA7A,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Gene or Genome,SEMA7A gene|SEMA7A estrogen receptor-positive breast cancer
AFFECTS,LINC00665 gene|LINC00665,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LINC00665 gene|LINC00665 Malignant neoplasm of breast
AUGMENTS,LINC00665 gene|LINC00665,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LINC00665 gene|LINC00665 Malignant neoplasm of breast
PREDISPOSES,Lupus Coagulation Inhibitor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Lupus Coagulation Inhibitor Malignant neoplasm of breast
AFFECTS,"GAS41 protein, human|YEATS4",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","GAS41 protein, human|YEATS4 Malignant neoplasm of breast"
CAUSES,Epigenome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Epigenome Malignant neoplasm of breast
AUGMENTS,PCAT1 gene|PCAT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PCAT1 gene|PCAT1 Malignant neoplasm of breast
PREDISPOSES,ABCC9 gene|ABCC9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ABCC9 gene|ABCC9 Malignant neoplasm of breast
PREDISPOSES,Piwi-Interacting RNA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Piwi-Interacting RNA Malignant neoplasm of breast
PREDISPOSES,SNHG6 gene|SNHG6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SNHG6 gene|SNHG6 Malignant neoplasm of breast
PREDISPOSES,POU4F1 gene|POU4F1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,POU4F1 gene|POU4F1 Malignant neoplasm of breast
AFFECTS,"PPARGC1B protein, human|PPARGC1B",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","PPARGC1B protein, human|PPARGC1B Malignant neoplasm of breast"
PREDISPOSES,LINC00511 gene|LINC00511,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LINC00511 gene|LINC00511 Malignant neoplasm of breast
CAUSES,MicroRNAs,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",MicroRNAs Triple Negative Breast Neoplasms
AUGMENTS,Matrix Metalloproteinase 9,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Matrix Metalloproteinase 9 Breast Carcinoma
AFFECTS,MIR137 gene|MIR137,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,MIR137 gene|MIR137 Triple Negative Breast Neoplasms
PREDISPOSES,FZD2 gene|FZD2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FZD2 gene|FZD2 Malignant neoplasm of breast
AUGMENTS,NME1 gene|NME1,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,NME1 gene|NME1 Noninfiltrating Intraductal Carcinoma
AUGMENTS,MALAT1 gene|MALAT1,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Gene or Genome,MALAT1 gene|MALAT1 HER2-positive carcinoma of breast
PREDISPOSES,IMPACT gene,Recurrent Breast Carcinoma,0.0009990009990009,Recurrent Breast Cancer,Gene or Genome,IMPACT gene Recurrent Breast Carcinoma
PREDISPOSES,DNAJA1 gene|DNAJA1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,DNAJA1 gene|DNAJA1 Malignant neoplasm of breast
CAUSES,hyaluronic acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,hyaluronic acid Malignant neoplasm of breast
AFFECTS,LRRC3B gene|LRRC3B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LRRC3B gene|LRRC3B Malignant neoplasm of breast
PREDISPOSES,Non-Cancer Related Death,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Non-Cancer Related Death Malignant neoplasm of breast
PREDISPOSES,HSP90AA2P gene|HSP90AA2P,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HSP90AA2P gene|HSP90AA2P Malignant neoplasm of breast
AFFECTS,STAT5A gene|STAT5A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,STAT5A gene|STAT5A Malignant neoplasm of breast
DISRUPTS,"IL5 protein, human|IL5",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","IL5 protein, human|IL5 Malignant neoplasm of breast"
DISRUPTS,FOXP3 gene|FOXP3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FOXP3 gene|FOXP3 Malignant neoplasm of breast
AFFECTS,"WWTR1 protein, human|WWTR1",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein","WWTR1 protein, human|WWTR1 Triple Negative Breast Neoplasms"
PREDISPOSES,CDKL3 gene|CDKL3,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,CDKL3 gene|CDKL3 Triple Negative Breast Neoplasms
COMPLICATES,FBXL16 gene|FBXL16,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FBXL16 gene|FBXL16 Malignant neoplasm of breast
PREDISPOSES,"CD69 protein, human|CD69",Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CD69 protein, human|CD69 Noninfiltrating Intraductal Carcinoma"
AUGMENTS,Primary MicroRNA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Primary MicroRNA Malignant neoplasm of breast
AFFECTS,CDH4 gene|CDH4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CDH4 gene|CDH4 Malignant neoplasm of breast
CAUSES,SEPTIN9 gene|SEPT9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SEPTIN9 gene|SEPT9 Malignant neoplasm of breast
CAUSES,cadmium,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Inorganic Chemical,cadmium Malignant neoplasm of breast
AFFECTS,RUNX2 gene|RUNX2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RUNX2 gene|RUNX2 Malignant neoplasm of breast
CAUSES,Stat3 protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Stat3 protein Malignant neoplasm of breast
PREDISPOSES,Teratogenesis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Teratogenesis Malignant neoplasm of breast
DISRUPTS,ZNF24 gene|ZNF24,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ZNF24 gene|ZNF24 Malignant neoplasm of breast
DISRUPTS,DNA Modification Methylases|DNMT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",DNA Modification Methylases|DNMT1 Malignant neoplasm of breast
AFFECTS,SNAI2 gene|SNAI2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SNAI2 gene|SNAI2 Malignant neoplasm of breast
AFFECTS,H1-5 gene|HIST1H1B,Basal-Like Breast Carcinoma,0.0039960039960039,Female Breast Cancer,Gene or Genome,H1-5 gene|HIST1H1B Basal-Like Breast Carcinoma
PREDISPOSES,STC1 gene|STC1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,STC1 gene|STC1 Malignant neoplasm of breast
CAUSES,Carcinomatosis,Carcinoma breast stage IV,0.0,Female Breast Cancer,Neoplastic Process,Carcinomatosis Carcinoma breast stage IV
PREDISPOSES,TRIM31 gene|TRIM31,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TRIM31 gene|TRIM31 Malignant neoplasm of breast
AFFECTS,Cyclin-Dependent Kinase Inhibitor Proteins,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Cyclin-Dependent Kinase Inhibitor Proteins Triple Negative Breast Neoplasms
DISRUPTS,DNA Modification Methylases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",DNA Modification Methylases Malignant neoplasm of breast
PREDISPOSES,Integral Membrane Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Integral Membrane Proteins Malignant neoplasm of breast
AUGMENTS,cholesterol,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Lipid,cholesterol Triple Negative Breast Neoplasms
AFFECTS,Functional modification,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Functional modification Malignant neoplasm of breast
PREDISPOSES,YAP1 gene|YAP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,YAP1 gene|YAP1 Malignant neoplasm of breast
PREDISPOSES,MCM4 gene|MCM4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MCM4 gene|MCM4 Malignant neoplasm of breast
AUGMENTS,EIF4EBP1 gene|EIF4EBP1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,EIF4EBP1 gene|EIF4EBP1 Triple Negative Breast Neoplasms
PREDISPOSES,Stat3 protein,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Stat3 protein Secondary malignant neoplasm of breast
DISRUPTS,Protein Phosphatase 2A,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Protein Phosphatase 2A Triple Negative Breast Neoplasms
PREDISPOSES,CDK1 gene|CDK1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CDK1 gene|CDK1 Malignant neoplasm of breast
AUGMENTS,Growth Differentiation Factor 15,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Growth Differentiation Factor 15 Malignant neoplasm of breast
AFFECTS,Aryl Hydrocarbon Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Aryl Hydrocarbon Receptor Malignant neoplasm of breast
AFFECTS,Breast Cancer Model,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Neoplastic Process,Breast Cancer Model Triple Negative Breast Neoplasms
AUGMENTS,VEGFA gene|VEGFA,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,VEGFA gene|VEGFA Triple Negative Breast Neoplasms
PREDISPOSES,"Promoter Regions, Genetic",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,"Promoter Regions, Genetic Malignant neoplasm of breast"
AUGMENTS,"Dolichyl-Diphosphooligosaccharide-Protein Glycosyltransferase Subunit 1, human",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","Dolichyl-Diphosphooligosaccharide-Protein Glycosyltransferase Subunit 1, human Malignant neoplasm of breast"
DISRUPTS,SP6 gene|SP6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SP6 gene|SP6 Malignant neoplasm of breast
AUGMENTS,TRIM32 gene|TRIM32,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,TRIM32 gene|TRIM32 Triple Negative Breast Neoplasms
DISRUPTS,ATP11B gene|ATP11B,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,ATP11B gene|ATP11B Secondary malignant neoplasm of breast
DISRUPTS,ATG4A gene|ATG4A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ATG4A gene|ATG4A Malignant neoplasm of breast
AUGMENTS,"TFF3 protein, human|TFF3",Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein","TFF3 protein, human|TFF3 Breast Carcinoma"
AFFECTS,ATP2B1 gene|ATP2B1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ATP2B1 gene|ATP2B1 Malignant neoplasm of breast
AFFECTS,MRPS30-DT gene|MRPS30-DT,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,MRPS30-DT gene|MRPS30-DT Triple Negative Breast Neoplasms
AFFECTS,MIR342 gene|MIR342,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIR342 gene|MIR342 Malignant neoplasm of breast
CAUSES,"BMI1 protein, human|BMI1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","BMI1 protein, human|BMI1 Malignant neoplasm of breast"
PREDISPOSES,STING1 gene,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,STING1 gene Secondary malignant neoplasm of breast
PREDISPOSES,CLTC gene|CLTC,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CLTC gene|CLTC Malignant neoplasm of breast
DISRUPTS,GAS5 gene|GAS5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GAS5 gene|GAS5 Malignant neoplasm of breast
DISRUPTS,WTAP gene|WTAP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,WTAP gene|WTAP Malignant neoplasm of breast
AUGMENTS,PPP1R14C gene|PPP1R14C,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,PPP1R14C gene|PPP1R14C Triple Negative Breast Neoplasms
PREDISPOSES,DSTN gene|DSTN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,DSTN gene|DSTN Malignant neoplasm of breast
AUGMENTS,TRIM28 gene|TRIM28,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,TRIM28 gene|TRIM28 Secondary malignant neoplasm of breast
PREDISPOSES,PSAT1 gene|PSAT1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,PSAT1 gene|PSAT1 Triple Negative Breast Neoplasms
PREDISPOSES,LINC00466 gene|LINC00466,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,LINC00466 gene|LINC00466 Triple Negative Breast Neoplasms
DISRUPTS,NAA25 gene|NAA25,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NAA25 gene|NAA25 Malignant neoplasm of breast
PREDISPOSES,Oncogenes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Oncogenes Malignant neoplasm of breast
DISRUPTS,CD29 Antigen|B3GNT2|B3GNTL1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Immunologic Factor,CD29 Antigen|B3GNT2|B3GNTL1 Triple Negative Breast Neoplasms
DISRUPTS,TLN1 gene|TLN1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,TLN1 gene|TLN1 Triple Negative Breast Neoplasms
PREDISPOSES,Binding Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Binding Proteins Malignant neoplasm of breast
PREDISPOSES,DANCR gene|DANCR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,DANCR gene|DANCR Malignant neoplasm of breast
DISRUPTS,WASF3 gene|WASF3,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,WASF3 gene|WASF3 Secondary malignant neoplasm of breast
PREDISPOSES,DNAJB4 gene|DNAJB4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,DNAJB4 gene|DNAJB4 Malignant neoplasm of breast
AFFECTS,Radiation,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Radiation Triple Negative Breast Neoplasms
PREDISPOSES,ATP6AP2 gene|ATP6AP2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ATP6AP2 gene|ATP6AP2 Malignant neoplasm of breast
AFFECTS,PINK1 gene|PINK1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PINK1 gene|PINK1 Malignant neoplasm of breast
AUGMENTS,AKAP3 gene|AKAP3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,AKAP3 gene|AKAP3 Malignant neoplasm of breast
PREDISPOSES,SETDB1 gene|SETDB1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SETDB1 gene|SETDB1 Malignant neoplasm of breast
PREDISPOSES,KLF8 gene|KLF8,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,KLF8 gene|KLF8 Secondary malignant neoplasm of breast
DISRUPTS,E2F1 gene|E2F1|UBE2L3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,E2F1 gene|E2F1|UBE2L3 Malignant neoplasm of breast
AUGMENTS,NEK2 gene|NEK2,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,NEK2 gene|NEK2 Triple Negative Breast Neoplasms
AFFECTS,MAFG-DT gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MAFG-DT gene Malignant neoplasm of breast
AFFECTS,FOXD3-AS1 gene|FOXD3-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FOXD3-AS1 gene|FOXD3-AS1 Malignant neoplasm of breast
AFFECTS,ADGRF1 gene|ADGRF1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,ADGRF1 gene|ADGRF1 Triple Negative Breast Neoplasms
AUGMENTS,MND1 gene|MND1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MND1 gene|MND1 Malignant neoplasm of breast
AUGMENTS,MAFG-DT gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MAFG-DT gene Malignant neoplasm of breast
AFFECTS,CDK11A gene|CDK11A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CDK11A gene|CDK11A Malignant neoplasm of breast
CAUSES,oleanolic acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,oleanolic acid Malignant neoplasm of breast
AFFECTS,MBNL1-AS1 gene|MBNL1-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MBNL1-AS1 gene|MBNL1-AS1 Malignant neoplasm of breast
AFFECTS,"SDC1 protein, human|SDC1",Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Amino Acid, Peptide, or Protein","SDC1 protein, human|SDC1 Noninfiltrating Intraductal Carcinoma"
PREDISPOSES,LINC02620 gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LINC02620 gene Malignant neoplasm of breast
AFFECTS,Scorpion Venoms,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Scorpion Venoms Malignant neoplasm of breast
PREDISPOSES,Toxic Epidermal Necrolysis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hazardous or Poisonous Substance,Toxic Epidermal Necrolysis Malignant neoplasm of breast
PREDISPOSES,Primary Sj??gren's syndrome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Primary Sj??gren's syndrome Malignant neoplasm of breast
AFFECTS,TRIM4 gene|TRIM4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TRIM4 gene|TRIM4 Malignant neoplasm of breast
CAUSES,MFNG gene|MFNG,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MFNG gene|MFNG Malignant neoplasm of breast
AFFECTS,Disease,Malignant neoplasm of female breast,0.0,Female Breast Cancer,Disease or Syndrome,Disease Malignant neoplasm of female breast
PREDISPOSES,Heat-Shock Proteins 70,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Heat-Shock Proteins 70 Breast Carcinoma
AFFECTS,Angiogenic Process,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Phenomenon or Process,Angiogenic Process Secondary malignant neoplasm of breast
AUGMENTS,MAZ gene|MAZ,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MAZ gene|MAZ Malignant neoplasm of breast
PREDISPOSES,FANCM gene|FANCM,"Breast Cancer, Familial",0.0,Female Breast Cancer,Gene or Genome,"FANCM gene|FANCM Breast Cancer, Familial"
AFFECTS,BIRC5 gene|BIRC5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BIRC5 gene|BIRC5 Malignant neoplasm of breast
DISRUPTS,NR2E1 gene|NR2E1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,NR2E1 gene|NR2E1 Triple Negative Breast Neoplasms
DISRUPTS,TNFRSF9 gene|TNFRSF9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TNFRSF9 gene|TNFRSF9 Malignant neoplasm of breast
PREDISPOSES,NAT10 gene|NAT10,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,NAT10 gene|NAT10 Triple Negative Breast Neoplasms
PREDISPOSES,IGHE gene|IGHE,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IGHE gene|IGHE Malignant neoplasm of breast
COMPLICATES,NUP210 gene|NUP210,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,NUP210 gene|NUP210 Triple Negative Breast Neoplasms
DISRUPTS,MIR409 gene|MIR409,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIR409 gene|MIR409 Malignant neoplasm of breast
CAUSES,CENPK gene|CENPK,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,CENPK gene|CENPK Breast Carcinoma
AFFECTS,Operation on breast,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Operation on breast Malignant neoplasm of breast
PREDISPOSES,TRIO gene,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,TRIO gene Triple Negative Breast Neoplasms
AFFECTS,Positron Emission Tomography and Magnetic Resonance Imaging,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Positron Emission Tomography and Magnetic Resonance Imaging Malignant neoplasm of breast
CAUSES,JMJD6 gene|JMJD6,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,JMJD6 gene|JMJD6 Triple Negative Breast Neoplasms
CAUSES,MCAM gene|MCAM,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MCAM gene|MCAM Malignant neoplasm of breast
PREDISPOSES,UBE2C gene|UBE2C,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,UBE2C gene|UBE2C Malignant neoplasm of breast
AUGMENTS,ROBO3 gene|ROBO3,Basal-Like Breast Carcinoma,0.0039960039960039,Female Breast Cancer,Gene or Genome,ROBO3 gene|ROBO3 Basal-Like Breast Carcinoma
AFFECTS,"TRIM25 protein, human|TRIM25",estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,"Amino Acid, Peptide, or Protein","TRIM25 protein, human|TRIM25 estrogen receptor-positive breast cancer"
AFFECTS,trastuzumab,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Pharmacologic Substance,trastuzumab HER2-positive carcinoma of breast
PREDISPOSES,"GTP-Binding Nuclear Protein Ran, Human",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","GTP-Binding Nuclear Protein Ran, Human Malignant neoplasm of breast"
DISRUPTS,Polypeptides,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Polypeptides Triple Negative Breast Neoplasms
PREDISPOSES,PTPN7 gene|PTPN7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PTPN7 gene|PTPN7 Malignant neoplasm of breast
PREDISPOSES,COL11A1 gene|COL11A1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,COL11A1 gene|COL11A1 Malignant neoplasm of breast
AFFECTS,ELAVL2 gene|ELAVL2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ELAVL2 gene|ELAVL2 Malignant neoplasm of breast
CAUSES,GNG5 gene|GNG5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GNG5 gene|GNG5 Malignant neoplasm of breast
AFFECTS,Acclimatization,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Acclimatization Malignant neoplasm of breast
AFFECTS,ICOS gene|ICOS,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,ICOS gene|ICOS Triple Negative Breast Neoplasms
PREDISPOSES,Neonicotinoid insecticide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Invertebrate,Neonicotinoid insecticide Malignant neoplasm of breast
PREDISPOSES,SYNJ2BP-COX16 gene|SYNJ2BP-COX16,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SYNJ2BP-COX16 gene|SYNJ2BP-COX16 Malignant neoplasm of breast
CAUSES,IL1RN gene|IL1RN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IL1RN gene|IL1RN Malignant neoplasm of breast
AUGMENTS,WFDC21P gene|WFDC21P,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,WFDC21P gene|WFDC21P Triple Negative Breast Neoplasms
AFFECTS,Malignant neoplasm of breast,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Neoplastic Process,Malignant neoplasm of breast HER2-positive carcinoma of breast
AUGMENTS,tamoxifen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,tamoxifen Malignant neoplasm of breast
PREDISPOSES,TBATA gene|TBATA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TBATA gene|TBATA Malignant neoplasm of breast
PREDISPOSES,WNT9B gene|WNT9B,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,WNT9B gene|WNT9B Breast Carcinoma
PREDISPOSES,SAV1 gene|SAV1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SAV1 gene|SAV1 Malignant neoplasm of breast
PREDISPOSES,RNF126 gene|RNF126,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,RNF126 gene|RNF126 Secondary malignant neoplasm of breast
PREDISPOSES,FAC1 protein|PDC,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",FAC1 protein|PDC Malignant neoplasm of breast
AFFECTS,Hormones,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Hormone,Hormones Secondary malignant neoplasm of breast
AFFECTS,DNA Binding Agent,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",DNA Binding Agent Triple Negative Breast Neoplasms
AFFECTS,PFKP gene|PFKP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PFKP gene|PFKP Malignant neoplasm of breast
PREDISPOSES,ADCY5 gene|ADCY5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ADCY5 gene|ADCY5 Malignant neoplasm of breast
DISRUPTS,progesterone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,progesterone Malignant neoplasm of breast
PREDISPOSES,PRDM16 gene|PRDM16,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PRDM16 gene|PRDM16 Malignant neoplasm of breast
AFFECTS,Adult Liver Carcinoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Adult Liver Carcinoma Malignant neoplasm of breast
PREDISPOSES,IGF2BP2 gene|IGF2BP2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IGF2BP2 gene|IGF2BP2 Malignant neoplasm of breast
AUGMENTS,Cancer/Testis Antigen,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Neoplastic Process,Cancer/Testis Antigen Triple Negative Breast Neoplasms
AFFECTS,Adverse reaction to drug,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,Adverse reaction to drug Malignant neoplasm of breast
PREDISPOSES,Lymphatic Invasion,Invasive Ductal Breast Carcinoma,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Lymphatic Invasion Invasive Ductal Breast Carcinoma
AFFECTS,laser irradiation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",laser irradiation Malignant neoplasm of breast
CAUSES,Carbohydrates,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Carbohydrate,Carbohydrates Malignant neoplasm of breast
AFFECTS,Endocrine Disruptors,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Hormone,Endocrine Disruptors estrogen receptor-positive breast cancer
PREDISPOSES,"DNA, Catalytic",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","DNA, Catalytic Malignant neoplasm of breast"
PREDISPOSES,PHGDH gene|PHGDH,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PHGDH gene|PHGDH Malignant neoplasm of breast
CAUSES,Selective Estrogen Receptor Down Regulator,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Selective Estrogen Receptor Down Regulator Malignant neoplasm of breast
AUGMENTS,"PON2 protein, human|PON2",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein","PON2 protein, human|PON2 Triple Negative Breast Neoplasms"
CAUSES,KLF9 gene|KLF9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,KLF9 gene|KLF9 Malignant neoplasm of breast
DISRUPTS,"CD274 protein, human|CD274",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CD274 protein, human|CD274 Malignant neoplasm of breast"
DISRUPTS,RNF43 gene|RNF43,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,RNF43 gene|RNF43 Triple Negative Breast Neoplasms
PREDISPOSES,MIR31HG gene|MIR31HG,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIR31HG gene|MIR31HG Malignant neoplasm of breast
AFFECTS,CLDN4 gene|CLDN4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CLDN4 gene|CLDN4 Malignant neoplasm of breast
AUGMENTS,Estrogen Receptor alpha,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptor alpha Secondary malignant neoplasm of breast
AFFECTS,Malignant neoplasm of endometrium,hereditary breast/ovarian cancer - BRCA1,0.0,Female Breast Cancer,Neoplastic Process,Malignant neoplasm of endometrium hereditary breast/ovarian cancer - BRCA1
PREDISPOSES,CHMP4A gene|CHMP4A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CHMP4A gene|CHMP4A Malignant neoplasm of breast
AFFECTS,PCAT19 gene|PCAT19,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PCAT19 gene|PCAT19 Malignant neoplasm of breast
AFFECTS,Malignant neoplasm of lung,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Neoplastic Process,Malignant neoplasm of lung HER2-positive carcinoma of breast
PREDISPOSES,vitamin E,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,vitamin E Malignant neoplasm of breast
AFFECTS,Very low density lipoprotein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Very low density lipoprotein Malignant neoplasm of breast
AFFECTS,"NEK9 protein, human|NEK9",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","NEK9 protein, human|NEK9 Malignant neoplasm of breast"
PREDISPOSES,PZP gene|PZP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PZP gene|PZP Malignant neoplasm of breast
PREDISPOSES,AEBP1 gene|AEBP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,AEBP1 gene|AEBP1 Malignant neoplasm of breast
AFFECTS,dose-response relationship,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",dose-response relationship Malignant neoplasm of breast
PREDISPOSES,GABRD gene|GABRD,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GABRD gene|GABRD Malignant neoplasm of breast
DISRUPTS,MIR93 gene|MIR93|MIR9-3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIR93 gene|MIR93|MIR9-3 Malignant neoplasm of breast
PREDISPOSES,Antisense RNA,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Antisense RNA Secondary malignant neoplasm of breast
AUGMENTS,RNA,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",RNA Inflammatory Breast Carcinoma
PREDISPOSES,Tn antigen,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Immunologic Factor,Tn antigen Secondary malignant neoplasm of breast
AFFECTS,Apoptosis Inhibiting Proteins,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Apoptosis Inhibiting Proteins Triple Negative Breast Neoplasms
PREDISPOSES,Cell-Free DNA,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Cell-Free DNA Breast Carcinoma
AFFECTS,Structural modification,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Structural modification Malignant neoplasm of breast
DISRUPTS,KRT1 gene|KRT1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,KRT1 gene|KRT1 Triple Negative Breast Neoplasms
DISRUPTS,Long Intergenic Non-Protein Coding RNA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Long Intergenic Non-Protein Coding RNA Malignant neoplasm of breast
AUGMENTS,SOAT1 gene|SOAT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SOAT1 gene|SOAT1 Malignant neoplasm of breast
AFFECTS,bone morphogenesis,Carcinoma breast stage IV,0.0,Female Breast Cancer,Gene or Genome,bone morphogenesis Carcinoma breast stage IV
PREDISPOSES,Proto-Oncogene Proteins p21(ras)|CDKN1A|TCEAL1|NSG1|H3F3AP6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Proto-Oncogene Proteins p21(ras)|CDKN1A|TCEAL1|NSG1|H3F3AP6 Malignant neoplasm of breast
AFFECTS,Cervical Cancer Screening,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Cervical Cancer Screening Breast Carcinoma
AFFECTS,SNHG11 gene|SNHG11,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,SNHG11 gene|SNHG11 Triple Negative Breast Neoplasms
DISRUPTS,Peptides,Carcinoma breast stage IV,0.0,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Peptides Carcinoma breast stage IV
AFFECTS,Malignant neoplasm of breast,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Neoplastic Process,Malignant neoplasm of breast Triple Negative Breast Neoplasms
CAUSES,"RNA, Circular",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","RNA, Circular Malignant neoplasm of breast"
AUGMENTS,CD24 gene|CD24,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CD24 gene|CD24 Malignant neoplasm of breast
AFFECTS,MIR195 gene|MIR195,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIR195 gene|MIR195 Malignant neoplasm of breast
PREDISPOSES,SPATA13 gene|SPATA13,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Gene or Genome,SPATA13 gene|SPATA13 estrogen receptor-positive breast cancer
AFFECTS,"RNA, Untranslated",Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","RNA, Untranslated Inflammatory Breast Carcinoma"
AUGMENTS,Carcinoembryonic Antigen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Immunologic Factor,Carcinoembryonic Antigen Malignant neoplasm of breast
AFFECTS,DNAJB4 gene|DNAJB4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,DNAJB4 gene|DNAJB4 Malignant neoplasm of breast
PREDISPOSES,"IL7 protein, human|IL7",HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Amino Acid, Peptide, or Protein","IL7 protein, human|IL7 HER2-positive carcinoma of breast"
CAUSES,fos-related antigen 1|FOS,Carcinoma breast stage IV,0.0,Female Breast Cancer,Immunologic Factor,fos-related antigen 1|FOS Carcinoma breast stage IV
PREDISPOSES,USP10 gene|USP10,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,USP10 gene|USP10 Triple Negative Breast Neoplasms
PREDISPOSES,Stat3 protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Stat3 protein Malignant neoplasm of breast
AFFECTS,"Administration, Oral",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Administration, Oral Malignant neoplasm of breast"
PREDISPOSES,CKS2 gene|CKS2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CKS2 gene|CKS2 Malignant neoplasm of breast
CAUSES,TIPARP gene|TIPARP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TIPARP gene|TIPARP Malignant neoplasm of breast
CAUSES,CDC2 Protein Kinase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",CDC2 Protein Kinase Malignant neoplasm of breast
CAUSES,LILRB1 gene|LILRB1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LILRB1 gene|LILRB1 Malignant neoplasm of breast
PREDISPOSES,TENM1 gene|TENM1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TENM1 gene|TENM1 Malignant neoplasm of breast
CAUSES,Malignant neoplasm of breast,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Neoplastic Process,Malignant neoplasm of breast Invasive carcinoma of breast
AFFECTS,ULBP2 gene|ULBP2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ULBP2 gene|ULBP2 Malignant neoplasm of breast
CAUSES,PDGFRB gene|PDGFRB,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PDGFRB gene|PDGFRB Malignant neoplasm of breast
AFFECTS,Tumor Suppressor Genes,estrogen receptor-negative breast cancer,0.0,Female Breast Cancer,Gene or Genome,Tumor Suppressor Genes estrogen receptor-negative breast cancer
PREDISPOSES,CHRNA6 gene|CHRNA6,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,CHRNA6 gene|CHRNA6 Breast Carcinoma
PREDISPOSES,LINC-ROR gene|LINC-ROR,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Gene or Genome,LINC-ROR gene|LINC-ROR Invasive carcinoma of breast
PREDISPOSES,GPNMB gene|GPNMB,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GPNMB gene|GPNMB Malignant neoplasm of breast
AUGMENTS,POU4F1 gene|POU4F1,Basal-Like Breast Carcinoma,0.0039960039960039,Female Breast Cancer,Gene or Genome,POU4F1 gene|POU4F1 Basal-Like Breast Carcinoma
PREDISPOSES,BCSC-1 Protein|VWA5A,Carcinoma breast stage IV,0.0,Female Breast Cancer,"Amino Acid, Peptide, or Protein",BCSC-1 Protein|VWA5A Carcinoma breast stage IV
DISRUPTS,FNDC5 gene|FNDC5,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,FNDC5 gene|FNDC5 Secondary malignant neoplasm of breast
AUGMENTS,SNORA73B gene|SNORA73B,Early-Stage Breast Carcinoma,0.0,Female Breast Cancer,Gene or Genome,SNORA73B gene|SNORA73B Early-Stage Breast Carcinoma
AFFECTS,"PIK3CB protein, human|PIK3CB",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein","PIK3CB protein, human|PIK3CB Triple Negative Breast Neoplasms"
PREDISPOSES,paired basic amino acid cleaving enzyme,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",paired basic amino acid cleaving enzyme Malignant neoplasm of breast
AUGMENTS,Hypolipidemic Agents,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical Viewed Functionally,Hypolipidemic Agents Malignant neoplasm of breast
PREDISPOSES,HDAC2 gene|HDAC2,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,HDAC2 gene|HDAC2 Secondary malignant neoplasm of breast
AFFECTS,Cancer Prevention,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Cancer Prevention Malignant neoplasm of breast
AUGMENTS,"BSG protein, human|BSG",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","BSG protein, human|BSG Malignant neoplasm of breast"
AFFECTS,HINT1 gene|HINT1,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,HINT1 gene|HINT1 Breast Carcinoma
PREDISPOSES,LILRB2 gene|LILRB2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LILRB2 gene|LILRB2 Malignant neoplasm of breast
AUGMENTS,pyruvate dehydrogenase kinase 4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",pyruvate dehydrogenase kinase 4 Malignant neoplasm of breast
PREDISPOSES,Low-Density Lipoproteins,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Low-Density Lipoproteins Triple Negative Breast Neoplasms
AFFECTS,"PKN1 protein, human|PKN1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","PKN1 protein, human|PKN1 Malignant neoplasm of breast"
AFFECTS,Estrogen Receptors,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptors Inflammatory Breast Carcinoma
DISRUPTS,cyclooxygenase 2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",cyclooxygenase 2 Breast cancer metastatic
AFFECTS,Binding Protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Binding Protein Malignant neoplasm of breast
AFFECTS,caffeic acid phenethyl ester,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,caffeic acid phenethyl ester Malignant neoplasm of breast
CAUSES,Secondary malignant neoplasm of skin NOS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Secondary malignant neoplasm of skin NOS Malignant neoplasm of breast
PREDISPOSES,"MCL1 protein, human|MCL1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","MCL1 protein, human|MCL1 Malignant neoplasm of breast"
AFFECTS,BUB1 gene|BUB1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BUB1 gene|BUB1 Malignant neoplasm of breast
AUGMENTS,Protein Isoforms|PGR|PR@|PRH2|TMEM37|ERVK-7|ERVK-8|ERVK-10|ERVK-9|ERVK-21|ERVK-18|ERVK-25|ERVK-24|ERVK-19,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Protein Isoforms|PGR|PR@|PRH2|TMEM37|ERVK-7|ERVK-8|ERVK-10|ERVK-9|ERVK-21|ERVK-18|ERVK-25|ERVK-24|ERVK-19 Breast cancer invasive NOS
AUGMENTS,Pharmaceutical Preparations,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Pharmacologic Substance,Pharmaceutical Preparations Breast cancer metastatic
PREDISPOSES,CCAAT-Enhancer-Binding Proteins|EBP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",CCAAT-Enhancer-Binding Proteins|EBP Malignant neoplasm of breast
AFFECTS,Methylation,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",Methylation Noninfiltrating Intraductal Carcinoma
CAUSES,RAD51C gene|RAD51C,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RAD51C gene|RAD51C Malignant neoplasm of breast
PREDISPOSES,FGF10 gene|FGF10,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FGF10 gene|FGF10 Malignant neoplasm of breast
PREDISPOSES,TACC2 gene|TACC2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TACC2 gene|TACC2 Malignant neoplasm of breast
AFFECTS,targeted prevention,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Element, Ion, or Isotope",targeted prevention Breast cancer invasive NOS
AUGMENTS,MicroRNAs,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",MicroRNAs Breast Carcinoma
PREDISPOSES,MIRN23A gene|MIR23A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIRN23A gene|MIR23A Malignant neoplasm of breast
DISRUPTS,Vitamin D,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Food,Vitamin D Noninfiltrating Intraductal Carcinoma
PREDISPOSES,Vegetable Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Vegetable Proteins Malignant neoplasm of breast
AFFECTS,RBM5 gene|RBM5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RBM5 gene|RBM5 Malignant neoplasm of breast
AFFECTS,perfluorooctanoic acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,perfluorooctanoic acid Malignant neoplasm of breast
CAUSES,Genes,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Gene or Genome,Genes Inflammatory Breast Carcinoma
AFFECTS,Docosahexaenoic Acids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Docosahexaenoic Acids Malignant neoplasm of breast
AFFECTS,Agent,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,Chemical Viewed Functionally,Agent Familial cancer of breast
AFFECTS,MIRN326 gene|MIR326,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIRN326 gene|MIR326 Malignant neoplasm of breast
DISRUPTS,SP1 gene|SP1,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Gene or Genome,SP1 gene|SP1 Breast cancer invasive NOS
AFFECTS,Chemotherapeutic agent,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical Viewed Functionally,Chemotherapeutic agent Malignant neoplasm of breast
CAUSES,Carcinogens,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Hazardous or Poisonous Substance,Carcinogens Carcinoma of Male Breast
AUGMENTS,Estrogen Receptor beta,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptor beta Malignant neoplasm of breast
DISRUPTS,SP1 gene|SP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SP1 gene|SP1 Malignant neoplasm of breast
AFFECTS,Excision,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Excision Breast cancer metastatic
PREDISPOSES,Adaptor Signaling Protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Adaptor Signaling Protein Malignant neoplasm of breast
AFFECTS,HOXA9 gene|HOXA9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HOXA9 gene|HOXA9 Malignant neoplasm of breast
DISRUPTS,MIRN195 gene|MIR195,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIRN195 gene|MIR195 Malignant neoplasm of breast
AUGMENTS,XRCC5 gene|XRCC5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,XRCC5 gene|XRCC5 Malignant neoplasm of breast
PREDISPOSES,PAWR gene|PAWR,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Gene or Genome,PAWR gene|PAWR Breast cancer recurrent
AFFECTS,N-Acetylneuraminic Acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,N-Acetylneuraminic Acid Malignant neoplasm of breast
DISRUPTS,Metalloproteases,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Metalloproteases Breast cancer metastatic
AUGMENTS,Radioisotopes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Radioisotopes Malignant neoplasm of breast
CAUSES,Sporadic Breast Carcinoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Sporadic Breast Carcinoma Malignant neoplasm of breast
PREDISPOSES,MYC Family Genes|MYC,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MYC Family Genes|MYC Malignant neoplasm of breast
AUGMENTS,ERBB2 gene|ERBB2,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Gene or Genome,ERBB2 gene|ERBB2 Inflammatory Breast Carcinoma
CAUSES,"EZH2 protein, human|EZH2",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","EZH2 protein, human|EZH2 Malignant neoplasm of breast"
AFFECTS,Developmental Process,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Phenomenon or Process,Developmental Process Malignant neoplasm of breast
AFFECTS,K-ras Oncogene|KRAS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,K-ras Oncogene|KRAS Malignant neoplasm of breast
PREDISPOSES,Transforming Growth Factors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Transforming Growth Factors Malignant neoplasm of breast
PREDISPOSES,Growth Factor Gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Growth Factor Gene Malignant neoplasm of breast
PREDISPOSES,High energy food,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,High energy food Malignant neoplasm of breast
AFFECTS,Malignant transformation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Malignant transformation Malignant neoplasm of breast
PREDISPOSES,Nucleic Acids,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,Nucleic Acids Breast cancer metastatic
COMPLICATES,"Leukemia, Myelocytic, Acute",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,"Leukemia, Myelocytic, Acute Malignant neoplasm of breast"
AFFECTS,Metals,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Metals Malignant neoplasm of breast
AUGMENTS,Soy Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Soy Proteins Malignant neoplasm of breast
DISRUPTS,Serine Proteinase Inhibitors,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Serine Proteinase Inhibitors Noninfiltrating Intraductal Carcinoma
PREDISPOSES,bone sialoprotein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",bone sialoprotein Malignant neoplasm of breast
PREDISPOSES,Maximal Voluntary Ventilation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Maximal Voluntary Ventilation Malignant neoplasm of breast
AUGMENTS,NCOA2 gene|NCOA2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NCOA2 gene|NCOA2 Malignant neoplasm of breast
AFFECTS,Hepatocyte Growth Factor,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Biologically Active Substance,Hepatocyte Growth Factor Breast cancer invasive NOS
AFFECTS,Acylation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Acylation Malignant neoplasm of breast
AFFECTS,Conception,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Conception Malignant neoplasm of breast
AFFECTS,Glucose Transporter,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Carbohydrate,Glucose Transporter Malignant neoplasm of breast
AFFECTS,Drug resistance,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Pharmacologic Substance,Drug resistance Breast Carcinoma
PREDISPOSES,Cesarean section (finding),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Cesarean section (finding) Malignant neoplasm of breast
PREDISPOSES,GSTO2 gene|GSTO2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GSTO2 gene|GSTO2 Malignant neoplasm of breast
AFFECTS,Complement System Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Complement System Proteins Malignant neoplasm of breast
AFFECTS,Estrogen Receptors|EREG|ESR1,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptors|EREG|ESR1 Breast Carcinoma
AFFECTS,"Carcinoma, Cribriform","Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Neoplastic Process,"Carcinoma, Cribriform Carcinoma, Ductal, Breast"
AFFECTS,Endocrine Surgical Procedures,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Hormone,Endocrine Surgical Procedures Breast Carcinoma
PREDISPOSES,PROTEIN INTAKE,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",PROTEIN INTAKE Malignant neoplasm of breast
CAUSES,ras Oncogene,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,ras Oncogene Breast Carcinoma
COMPLICATES,Malignant Neoplasms,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Malignant Neoplasms Breast cancer metastatic
PREDISPOSES,Immunologic Deficiency Syndromes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Immunologic Deficiency Syndromes Malignant neoplasm of breast
DISRUPTS,Estrogenic,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Hormone,Estrogenic Breast Carcinoma
PREDISPOSES,"Markers, DNA",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","Markers, DNA Malignant neoplasm of breast"
CAUSES,Serum,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Body Substance,Serum Breast Carcinoma
AFFECTS,monoclonal antibody CC49,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Indicator, Reagent, or Diagnostic Aid",monoclonal antibody CC49 Malignant neoplasm of breast
AUGMENTS,Fibroblast Growth Factor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Fibroblast Growth Factor Malignant neoplasm of breast
AFFECTS,Radiation,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Element, Ion, or Isotope",Radiation Breast cancer invasive NOS
PREDISPOSES,impaired glucose tolerance,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Carbohydrate,impaired glucose tolerance Malignant neoplasm of breast
CAUSES,leukemia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,leukemia Malignant neoplasm of breast
AFFECTS,Stabilization,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Stabilization Malignant neoplasm of breast
AUGMENTS,ras Oncogene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ras Oncogene Malignant neoplasm of breast
AUGMENTS,N-Acetylneuraminic Acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,N-Acetylneuraminic Acid Malignant neoplasm of breast
AFFECTS,SYK gene|SYK,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SYK gene|SYK Malignant neoplasm of breast
CAUSES,"Estrogens, Catechol",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,"Estrogens, Catechol Malignant neoplasm of breast"
AFFECTS,Metalloproteases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Metalloproteases Malignant neoplasm of breast
PREDISPOSES,Vitamin E intake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Vitamin E intake Malignant neoplasm of breast
AFFECTS,parathyroid hormone-related protein|PTHLH,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",parathyroid hormone-related protein|PTHLH Breast Carcinoma
DISRUPTS,alpha-Linolenic Acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,alpha-Linolenic Acid Malignant neoplasm of breast
AFFECTS,BCAS2 gene|BCAS2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BCAS2 gene|BCAS2 Malignant neoplasm of breast
AFFECTS,Ingestion,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Ingestion Malignant neoplasm of breast
DISRUPTS,P-Glycoprotein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",P-Glycoprotein Malignant neoplasm of breast
PREDISPOSES,Tetranucleotide Repeats,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Tetranucleotide Repeats Malignant neoplasm of breast
AFFECTS,Endometrial adenocarcinoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Endometrial adenocarcinoma Malignant neoplasm of breast
PREDISPOSES,SMAD4 gene|SMAD4,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Gene or Genome,"SMAD4 gene|SMAD4 Carcinoma, Ductal, Breast"
CAUSES,ETS Variant Gene 6 Protein|ETV6,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Gene or Genome,ETS Variant Gene 6 Protein|ETV6 Breast cancer invasive NOS
AFFECTS,parathyroid hormone-related protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",parathyroid hormone-related protein Malignant neoplasm of breast
AFFECTS,Leukemia P388,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Leukemia P388 Breast Carcinoma
AFFECTS,Cardiovascular Diseases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Cardiovascular Diseases Malignant neoplasm of breast
CAUSES,Peptides,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Peptides Malignant neoplasm of breast
PREDISPOSES,Chemotherapeutic agent,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical Viewed Functionally,Chemotherapeutic agent Malignant neoplasm of breast
DISRUPTS,Lymphocyte antigen CD82|CD82,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Immunologic Factor,Lymphocyte antigen CD82|CD82 Malignant neoplasm of breast
AFFECTS,GSTP1 gene|GSTP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GSTP1 gene|GSTP1 Malignant neoplasm of breast
CAUSES,PTEN gene|PTEN,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,PTEN gene|PTEN Breast Carcinoma
AFFECTS,Dissection,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",Dissection Noninfiltrating Intraductal Carcinoma
AFFECTS,Agent,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Chemical Viewed Functionally,Agent Carcinoma of Male Breast
AUGMENTS,Growth Factor Receptors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Growth Factor Receptors Malignant neoplasm of breast
CAUSES,Epidermal Growth Factor Receptor|EGF,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Biologically Active Substance,Epidermal Growth Factor Receptor|EGF Sporadic Breast Carcinoma
CAUSES,Malignant Neoplasms,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Neoplastic Process,Malignant Neoplasms Breast cancer recurrent
DISRUPTS,BCL2 gene|BCL2,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Gene or Genome,"BCL2 gene|BCL2 Carcinoma, Ductal, Breast"
PREDISPOSES,Restriction fragment length polymorphism,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Restriction fragment length polymorphism Malignant neoplasm of breast
CAUSES,Transforming Growth Factor alpha,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Biologically Active Substance,Transforming Growth Factor alpha Breast Carcinoma
PREDISPOSES,Prostaglandins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Eicosanoid,Prostaglandins Malignant neoplasm of breast
AFFECTS,WWOX gene|WWOX,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,WWOX gene|WWOX Malignant neoplasm of breast
PREDISPOSES,Therapeutic agent (substance),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical Viewed Functionally,Therapeutic agent (substance) Malignant neoplasm of breast
DISRUPTS,Selective Estrogen Receptor Modulators,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Selective Estrogen Receptor Modulators Breast cancer invasive NOS
CAUSES,"Cell Transformation, Neoplastic",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,"Cell Transformation, Neoplastic Malignant neoplasm of breast"
DISRUPTS,"PRSS8 protein, human|PRSS8",Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Amino Acid, Peptide, or Protein","PRSS8 protein, human|PRSS8 Breast cancer invasive NOS"
AFFECTS,Axillary Lymph Node Dissection,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,"Element, Ion, or Isotope","Axillary Lymph Node Dissection Carcinoma, Ductal, Breast"
PREDISPOSES,Radioisotopes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Radioisotopes Malignant neoplasm of breast
AFFECTS,Gene Amplification,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,Gene Amplification Breast cancer metastatic
AFFECTS,Gene Mutation,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,Gene or Genome,Gene Mutation Familial cancer of breast
AFFECTS,Pharmaceutical Adjuvants,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Pharmacologic Substance,Pharmaceutical Adjuvants Malignant neoplasm of breast
AUGMENTS,Protein Tyrosine Kinase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Protein Tyrosine Kinase Malignant neoplasm of breast
CAUSES,"Estrogens, Synthetic",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,"Estrogens, Synthetic Malignant neoplasm of breast"
AFFECTS,Growth Factor Receptors,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Biologically Active Substance,Growth Factor Receptors Breast cancer invasive NOS
DISRUPTS,"Linoleic Acids, Conjugated",Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Chemical,"Linoleic Acids, Conjugated Breast Carcinoma"
CAUSES,Mutation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Mutation Malignant neoplasm of breast
CAUSES,ubiquitin-protein ligase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",ubiquitin-protein ligase Malignant neoplasm of breast
CAUSES,Specific antigen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Immunologic Factor,Specific antigen Malignant neoplasm of breast
AUGMENTS,glutathione S-transferase pi,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",glutathione S-transferase pi Malignant neoplasm of breast
AFFECTS,"O-(glucuronic acid 2-sulfate)-(1--3)-O-(2,5)-andydrotalitol 6-sulfate",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,"O-(glucuronic acid 2-sulfate)-(1--3)-O-(2,5)-andydrotalitol 6-sulfate Malignant neoplasm of breast"
AFFECTS,Tumor Suppressor Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Tumor Suppressor Proteins Malignant neoplasm of breast
AFFECTS,"Polymorphism, Genetic",Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Gene or Genome,"Polymorphism, Genetic Sporadic Breast Carcinoma"
AFFECTS,CXCL12 gene|CXCL12,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,CXCL12 gene|CXCL12 Breast cancer metastatic
CAUSES,Fibroblast Growth Factor Receptor 2|FGF7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Fibroblast Growth Factor Receptor 2|FGF7 Malignant neoplasm of breast
PREDISPOSES,STK6 gene|AURKA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,STK6 gene|AURKA Malignant neoplasm of breast
CAUSES,"Regulatory Sequences, Nucleic Acid",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,"Regulatory Sequences, Nucleic Acid Malignant neoplasm of breast"
AUGMENTS,Environmental Estrogen,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,Hormone,Environmental Estrogen Female Breast Carcinoma
PREDISPOSES,Disease,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Disease or Syndrome,Disease Carcinoma of Male Breast
AFFECTS,CDK10 gene|CDK10,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CDK10 gene|CDK10 Malignant neoplasm of breast
DISRUPTS,Protein-tyrosine kinase inhibitor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Protein-tyrosine kinase inhibitor Malignant neoplasm of breast
CAUSES,Fatty-acid synthase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Fatty-acid synthase Malignant neoplasm of breast
CAUSES,Benzene,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Hazardous or Poisonous Substance,Benzene Breast Carcinoma
PREDISPOSES,APC gene|APC,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,APC gene|APC Malignant neoplasm of breast
AUGMENTS,"FOLR1 protein, human|FOLR1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","FOLR1 protein, human|FOLR1 Malignant neoplasm of breast"
PREDISPOSES,HSD17B2 gene|HSD17B2|HSD17B7P2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HSD17B2 gene|HSD17B2|HSD17B7P2 Malignant neoplasm of breast
AFFECTS,Dietary Modification,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,"Element, Ion, or Isotope",Dietary Modification Familial cancer of breast
AFFECTS,Second Primary Cancers,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Second Primary Cancers Malignant neoplasm of breast
PREDISPOSES,Glial Fibrillary Acidic Protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Glial Fibrillary Acidic Protein Malignant neoplasm of breast
CAUSES,Oncogene Proteins,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,Oncogene Proteins Breast Carcinoma
CAUSES,Tumor proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Tumor proteins Malignant neoplasm of breast
PREDISPOSES,CYP2C19 gene|CYP2C19,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CYP2C19 gene|CYP2C19 Malignant neoplasm of breast
AUGMENTS,S-Adenosylmethionine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",S-Adenosylmethionine Malignant neoplasm of breast
AUGMENTS,NCSTN gene|NCSTN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NCSTN gene|NCSTN Malignant neoplasm of breast
CAUSES,Aryl Hydrocarbon Receptor|AHR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Aryl Hydrocarbon Receptor|AHR Malignant neoplasm of breast
PREDISPOSES,DEK gene|DEK,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,DEK gene|DEK Malignant neoplasm of breast
AFFECTS,Long chain fatty acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Long chain fatty acid Malignant neoplasm of breast
PREDISPOSES,ERBB2 gene|ERBB2,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,ERBB2 gene|ERBB2 Breast Carcinoma
AUGMENTS,Heat shock proteins,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Heat shock proteins Breast Carcinoma
AUGMENTS,BCAR1 gene|BCAR1,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,BCAR1 gene|BCAR1 Breast Carcinoma
AUGMENTS,TEK gene|TEK,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,TEK gene|TEK Breast Carcinoma
PREDISPOSES,Sleep Deprivation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Sleep Deprivation Malignant neoplasm of breast
PREDISPOSES,MST1R gene|MST1R,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,MST1R gene|MST1R Breast cancer metastatic
DISRUPTS,ITGA5 gene|ITGA5,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,ITGA5 gene|ITGA5 Breast cancer metastatic
AFFECTS,epithelial cell differentiation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",epithelial cell differentiation Malignant neoplasm of breast
PREDISPOSES,Human Papilloma Virus Vaccine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Virus,Human Papilloma Virus Vaccine Malignant neoplasm of breast
AUGMENTS,VCP gene|VCP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,VCP gene|VCP Malignant neoplasm of breast
AUGMENTS,GLI1 gene|GLI1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GLI1 gene|GLI1 Malignant neoplasm of breast
PREDISPOSES,"PTH protein, human|PTH",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","PTH protein, human|PTH Malignant neoplasm of breast"
DISRUPTS,Genes,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,Genes Breast cancer metastatic
AFFECTS,Carcinoid Tumor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Carcinoid Tumor Malignant neoplasm of breast
PREDISPOSES,High Density Lipoproteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",High Density Lipoproteins Malignant neoplasm of breast
AFFECTS,IL8 gene|CXCL8,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IL8 gene|CXCL8 Malignant neoplasm of breast
PREDISPOSES,Estrogens,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Hormone,Estrogens Breast Carcinoma
PREDISPOSES,DNAJA3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",DNAJA3 Malignant neoplasm of breast
AFFECTS,"progesterone, micronized",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,"progesterone, micronized Malignant neoplasm of breast"
CAUSES,"Carcinoma, Ductal, Breast",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,"Carcinoma, Ductal, Breast Malignant neoplasm of breast"
AFFECTS,Paget's Disease,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Disease or Syndrome,Paget's Disease Breast Carcinoma
CAUSES,"[M]Adenocarcinoma, metastatic, NOS",Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Neoplastic Process,"[M]Adenocarcinoma, metastatic, NOS Inflammatory Breast Carcinoma"
AUGMENTS,"CTTN protein, human|CTTN",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CTTN protein, human|CTTN Malignant neoplasm of breast"
AFFECTS,SNX9 gene|SNX9,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,SNX9 gene|SNX9 Breast cancer metastatic
AUGMENTS,PML gene|PML,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PML gene|PML Malignant neoplasm of breast
AFFECTS,Post-Transcriptional Regulation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Post-Transcriptional Regulation Malignant neoplasm of breast
PREDISPOSES,Epstein-Barr virus DNA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Epstein-Barr virus DNA Malignant neoplasm of breast
PREDISPOSES,Vitamin D Deficiency,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Food,Vitamin D Deficiency Breast cancer metastatic
CAUSES,BRCA2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BRCA2 Malignant neoplasm of breast
CAUSES,MIRN10A gene|MIR10A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIRN10A gene|MIR10A Malignant neoplasm of breast
PREDISPOSES,SULF2 gene|SULF2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SULF2 gene|SULF2 Malignant neoplasm of breast
AFFECTS,Metaplastic carcinoma,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Metaplastic carcinoma Breast Carcinoma
AFFECTS,CD4 gene|CD4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CD4 gene|CD4 Malignant neoplasm of breast
PREDISPOSES,RORA gene|RORA,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,RORA gene|RORA Breast cancer metastatic
CAUSES,"DICER1 protein, human|DICER1","Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,"Amino Acid, Peptide, or Protein","DICER1 protein, human|DICER1 Carcinoma, Ductal, Breast"
AFFECTS,Little's Disease,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Disease or Syndrome,Little's Disease Breast Carcinoma
AUGMENTS,Uridine Diphosphate Sugars,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Carbohydrate,Uridine Diphosphate Sugars Malignant neoplasm of breast
AFFECTS,Functional RNA,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Functional RNA Breast Carcinoma
AFFECTS,Mitogen-Activated Protein Kinase 13|MAPK13,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Mitogen-Activated Protein Kinase 13|MAPK13 Malignant neoplasm of breast
DISRUPTS,9-deoxy-delta-9-prostaglandin D2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Eicosanoid,9-deoxy-delta-9-prostaglandin D2 Breast cancer metastatic
DISRUPTS,EGFR gene|EGFR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,EGFR gene|EGFR Malignant neoplasm of breast
AUGMENTS,"Ribosomal Protein S6 Kinases, 70-kDa",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","Ribosomal Protein S6 Kinases, 70-kDa Malignant neoplasm of breast"
DISRUPTS,bone morphogenetic protein 6,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,bone morphogenetic protein 6 Breast cancer metastatic
PREDISPOSES,Vitamin B1 Intake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Vitamin B1 Intake Malignant neoplasm of breast
DISRUPTS,CDKN1C gene|CDKN1C,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CDKN1C gene|CDKN1C Malignant neoplasm of breast
AFFECTS,TP53 gene|TP53,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,TP53 gene|TP53 Breast cancer metastatic
DISRUPTS,RHOC gene|RHOC,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,RHOC gene|RHOC Breast cancer metastatic
DISRUPTS,LATS2 gene|LATS2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LATS2 gene|LATS2 Malignant neoplasm of breast
PREDISPOSES,RELN gene|RELN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RELN gene|RELN Malignant neoplasm of breast
PREDISPOSES,cytokine,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Biologically Active Substance,cytokine Breast cancer metastatic
AUGMENTS,"PER2 protein, mammalian|PGR|PR@|PRH2|TMEM37|ERVK-7|ERVK-8|ERVK-10|ERVK-9|ERVK-21|ERVK-18|ERVK-25|ERVK-24|ERVK-19",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","PER2 protein, mammalian|PGR|PR@|PRH2|TMEM37|ERVK-7|ERVK-8|ERVK-10|ERVK-9|ERVK-21|ERVK-18|ERVK-25|ERVK-24|ERVK-19 Malignant neoplasm of breast"
AFFECTS,mitochondrial DNA replication,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",mitochondrial DNA replication Malignant neoplasm of breast
AUGMENTS,peptide T amide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",peptide T amide Malignant neoplasm of breast
PREDISPOSES,"HDAC5 protein, human|HDAC5",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","HDAC5 protein, human|HDAC5 Malignant neoplasm of breast"
PREDISPOSES,FYN gene|FYN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FYN gene|FYN Malignant neoplasm of breast
AFFECTS,FOXO3A gene|FOXO3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FOXO3A gene|FOXO3 Malignant neoplasm of breast
AUGMENTS,hepatitis B virus X protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",hepatitis B virus X protein Malignant neoplasm of breast
PREDISPOSES,NOTCH1 gene,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Gene or Genome,NOTCH1 gene Breast cancer invasive NOS
AFFECTS,Estrogens,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Hormone,"Estrogens Carcinoma, Ductal, Breast"
AFFECTS,LAPTM4B gene|LAPTM4B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LAPTM4B gene|LAPTM4B Malignant neoplasm of breast
DISRUPTS,Oncogene ErbB2|ERBB2|NEU1|NEURL1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Oncogene ErbB2|ERBB2|NEU1|NEURL1 Malignant neoplasm of breast
PREDISPOSES,Activated-Leukocyte Cell Adhesion Molecule,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Activated-Leukocyte Cell Adhesion Molecule Malignant neoplasm of breast
DISRUPTS,Fusion Protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Fusion Protein Malignant neoplasm of breast
AUGMENTS,parathyroid hormone-related protein|PTHLH,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",parathyroid hormone-related protein|PTHLH Malignant neoplasm of breast
COMPLICATES,Vitamin D,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Vitamin D Malignant neoplasm of breast
PREDISPOSES,PAWR gene|PAWR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PAWR gene|PAWR Malignant neoplasm of breast
CAUSES,BCL6 gene|BCL6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BCL6 gene|BCL6 Malignant neoplasm of breast
CAUSES,Growth Factor,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Biologically Active Substance,Growth Factor Breast cancer metastatic
PREDISPOSES,ITGB3 gene|ITGB3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ITGB3 gene|ITGB3 Malignant neoplasm of breast
AFFECTS,MIRN423 gene|MIR423,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIRN423 gene|MIR423 Malignant neoplasm of breast
AFFECTS,"Tomography, Emission-Computed",Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope","Tomography, Emission-Computed Breast Carcinoma"
PREDISPOSES,DICER1 gene|DICER1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,DICER1 gene|DICER1 Malignant neoplasm of breast
PREDISPOSES,Peutz-Jeghers Syndrome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Peutz-Jeghers Syndrome Malignant neoplasm of breast
AFFECTS,Pancreatic carcinoma,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Neoplastic Process,"Pancreatic carcinoma Carcinoma, Ductal, Breast"
CAUSES,SYK gene|SYK,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,SYK gene|SYK Breast Carcinoma
PREDISPOSES,HNRPM gene|HNRNPM,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HNRPM gene|HNRNPM Malignant neoplasm of breast
AFFECTS,Pharmaceutical Preparations,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Pharmacologic Substance,Pharmaceutical Preparations Breast cancer invasive NOS
PREDISPOSES,Saethre-Chotzen Syndrome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Saethre-Chotzen Syndrome Malignant neoplasm of breast
AFFECTS,"UBD protein, human|UBD",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","UBD protein, human|UBD Malignant neoplasm of breast"
CAUSES,ERR1 protein|ESRRA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",ERR1 protein|ESRRA Malignant neoplasm of breast
AUGMENTS,Oncogenes,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Gene or Genome,Oncogenes Breast cancer invasive NOS
COMPLICATES,Sterol Regulatory Element Binding Protein 2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Sterol Regulatory Element Binding Protein 2 Malignant neoplasm of breast
AUGMENTS,MMP2 gene|MMP2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MMP2 gene|MMP2 Malignant neoplasm of breast
CAUSES,alpha-Fetoproteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",alpha-Fetoproteins Malignant neoplasm of breast
DISRUPTS,Fusion Protein,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Fusion Protein Breast cancer metastatic
AFFECTS,BLM gene|BLM,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BLM gene|BLM Malignant neoplasm of breast
AFFECTS,DDR2 gene|DDR2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,DDR2 gene|DDR2 Malignant neoplasm of breast
AFFECTS,SMYD3 gene|SMYD3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SMYD3 gene|SMYD3 Malignant neoplasm of breast
AUGMENTS,"HDAC5 protein, human|HDAC5",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","HDAC5 protein, human|HDAC5 Malignant neoplasm of breast"
DISRUPTS,TAZ gene|TAZ,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TAZ gene|TAZ Malignant neoplasm of breast
AFFECTS,ARHI gene|DIRAS3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ARHI gene|DIRAS3 Malignant neoplasm of breast
AFFECTS,CYP2B6 gene|CYP2B6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CYP2B6 gene|CYP2B6 Malignant neoplasm of breast
DISRUPTS,ARHI gene|DIRAS3,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,ARHI gene|DIRAS3 Noninfiltrating Intraductal Carcinoma
PREDISPOSES,participation,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",participation Breast Carcinoma
AFFECTS,Organic solvent product,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Organic solvent product Malignant neoplasm of breast
AFFECTS,Angiogenesis Factor,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,Angiogenesis Factor Noninfiltrating Intraductal Carcinoma
CAUSES,Malignant neoplasm of prostate,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Malignant neoplasm of prostate Breast cancer metastatic
AFFECTS,"Transcription, Genetic",Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,"Transcription, Genetic Breast Carcinoma"
DISRUPTS,High Density Lipoproteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",High Density Lipoproteins Malignant neoplasm of breast
AFFECTS,Monocyte Chemoattractant Protein-1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Monocyte Chemoattractant Protein-1 Malignant neoplasm of breast
PREDISPOSES,"Gene Products, Protein",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,"Gene Products, Protein Malignant neoplasm of breast"
AFFECTS,"Oncogene, RET|RET",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,"Oncogene, RET|RET Malignant neoplasm of breast"
PREDISPOSES,protein kinase D,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Amino Acid, Peptide, or Protein",protein kinase D Breast cancer invasive NOS
AFFECTS,"CHEK1 protein, human|CHEK1",Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CHEK1 protein, human|CHEK1 Breast cancer metastatic"
DISRUPTS,Vitamin E,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Food,Vitamin E Malignant neoplasm of breast
CAUSES,Invasive Carcinoma,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Invasive Carcinoma Breast Carcinoma
AUGMENTS,Nucleolar Organizer Region,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Nucleolar Organizer Region Malignant neoplasm of breast
PREDISPOSES,Hormone level abnormal,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Hormone level abnormal Malignant neoplasm of breast
AFFECTS,monocyte activation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",monocyte activation Malignant neoplasm of breast
CAUSES,retinoic acid receptor alpha,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,retinoic acid receptor alpha Malignant neoplasm of breast
AFFECTS,ERBB2 gene|ERBB2,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,ERBB2 gene|ERBB2 Noninfiltrating Intraductal Carcinoma
CAUSES,Nucleosides,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Nucleosides Malignant neoplasm of breast
AUGMENTS,Myristic Acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Myristic Acid Malignant neoplasm of breast
AUGMENTS,Cell Cycle Checkpoint Genes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Cell Cycle Checkpoint Genes Malignant neoplasm of breast
AUGMENTS,Gonadotropin-Releasing Hormone Analog,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Gonadotropin-Releasing Hormone Analog Malignant neoplasm of breast
PREDISPOSES,NOS3 gene|NOS3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NOS3 gene|NOS3 Malignant neoplasm of breast
PREDISPOSES,Recreation,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",Recreation Noninfiltrating Intraductal Carcinoma
AFFECTS,Malignant neoplasm of thyroid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Malignant neoplasm of thyroid Malignant neoplasm of breast
PREDISPOSES,Alcohol consumption,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Alcohol consumption Breast cancer metastatic
AFFECTS,CD4 gene|CD4,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,CD4 gene|CD4 Breast Carcinoma
PREDISPOSES,Estrogen Receptor beta|ESR2,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,"Amino Acid, Peptide, or Protein","Estrogen Receptor beta|ESR2 Carcinoma, Ductal, Breast"
AFFECTS,Down-Regulation,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",Down-Regulation Noninfiltrating Intraductal Carcinoma
PREDISPOSES,LAPTM4B gene|LAPTM4B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LAPTM4B gene|LAPTM4B Malignant neoplasm of breast
AFFECTS,"PSMD10 protein, human|PSMD10",Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein","PSMD10 protein, human|PSMD10 Breast cancer metastatic"
DISRUPTS,CLDN1 gene|CLDN1,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Gene or Genome,CLDN1 gene|CLDN1 Breast cancer invasive NOS
PREDISPOSES,PRL gene|PRL,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PRL gene|PRL Malignant neoplasm of breast
PREDISPOSES,Sex Hormone-Binding Globulin,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Hormone,Sex Hormone-Binding Globulin Breast cancer invasive NOS
AFFECTS,Liver and Intrahepatic Biliary Tract Carcinoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Liver and Intrahepatic Biliary Tract Carcinoma Malignant neoplasm of breast
DISRUPTS,Cytotoxic agent,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hazardous or Poisonous Substance,Cytotoxic agent Malignant neoplasm of breast
PREDISPOSES,DNAJC27,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",DNAJC27 Malignant neoplasm of breast
AFFECTS,Secondary malignant neoplasm of lymph node,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Secondary malignant neoplasm of lymph node Breast Carcinoma
AFFECTS,Endocrine therapy,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Hormone,Endocrine therapy Inflammatory Breast Carcinoma
PREDISPOSES,TRANSCRIPTION FACTOR,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,"Element, Ion, or Isotope",TRANSCRIPTION FACTOR Inflammatory Breast Carcinoma
CAUSES,RBL2 gene|RBL2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RBL2 gene|RBL2 Malignant neoplasm of breast
PREDISPOSES,MASS LESION,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",MASS LESION Noninfiltrating Intraductal Carcinoma
AFFECTS,"Anesthesia, Conduction",Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Element, Ion, or Isotope","Anesthesia, Conduction Breast cancer recurrent"
PREDISPOSES,TGFBR2 gene|TGFBR2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TGFBR2 gene|TGFBR2 Malignant neoplasm of breast
PREDISPOSES,Sequela of disorder,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Sequela of disorder Malignant neoplasm of breast
AFFECTS,Radiation therapy,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Radiation therapy Breast cancer metastatic
PREDISPOSES,Breast Microcalcification,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",Breast Microcalcification Noninfiltrating Intraductal Carcinoma
AFFECTS,Endocrine Gland Neoplasms,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Endocrine Gland Neoplasms Malignant neoplasm of breast
PREDISPOSES,TRANSCRIPTION FACTOR,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",TRANSCRIPTION FACTOR Breast Carcinoma
CAUSES,Oncogenic Viruses,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Virus,Oncogenic Viruses Malignant neoplasm of breast
CAUSES,Growth Factor Receptors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Growth Factor Receptors Malignant neoplasm of breast
PREDISPOSES,Encounter due to Screening for malignant neoplasm of breast,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,Encounter due to Screening for malignant neoplasm of breast Breast cancer invasive NOS
PREDISPOSES,Infiltration,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,"Element, Ion, or Isotope",Infiltration Inflammatory Breast Carcinoma
AFFECTS,"Metals, Heavy",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Metals, Heavy Malignant neoplasm of breast"
AFFECTS,Glutamic Acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Glutamic Acid Malignant neoplasm of breast
AFFECTS,Fibroblast Growth Factor 7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Fibroblast Growth Factor 7 Malignant neoplasm of breast
AFFECTS,genetic element,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,genetic element Malignant neoplasm of breast
PREDISPOSES,"SBEM protein, human|MUCL1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","SBEM protein, human|MUCL1 Malignant neoplasm of breast"
AUGMENTS,WT1 gene|WT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,WT1 gene|WT1 Malignant neoplasm of breast
AFFECTS,PTGS2 gene|PTGS2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PTGS2 gene|PTGS2 Malignant neoplasm of breast
AFFECTS,CHES1 gene|FOXN3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CHES1 gene|FOXN3 Malignant neoplasm of breast
DISRUPTS,Phospholipids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Lipid,Phospholipids Malignant neoplasm of breast
CAUSES,XRCC5 gene|XRCC5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,XRCC5 gene|XRCC5 Malignant neoplasm of breast
AFFECTS,Candidate Disease Gene|AR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Candidate Disease Gene|AR Malignant neoplasm of breast
AFFECTS,Malignant neoplasm of breast,Carcinoma in situ of breast,0.0019980019980019,Female Breast Cancer,Neoplastic Process,Malignant neoplasm of breast Carcinoma in situ of breast
PREDISPOSES,Placental Hormones,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Placental Hormones Malignant neoplasm of breast
PREDISPOSES,NFKBIA gene|NFKBIA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NFKBIA gene|NFKBIA Malignant neoplasm of breast
AFFECTS,Mutation,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,"Element, Ion, or Isotope",Mutation Inflammatory Breast Carcinoma
AFFECTS,Cholesterol Esters,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Lipid,Cholesterol Esters Malignant neoplasm of breast
AUGMENTS,CYP17A1 gene|CYP17A1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CYP17A1 gene|CYP17A1 Malignant neoplasm of breast
DISRUPTS,TNFRSF1B gene|TNFRSF1B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TNFRSF1B gene|TNFRSF1B Malignant neoplasm of breast
AFFECTS,Morphogenesis,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,Morphogenesis Breast Carcinoma
AUGMENTS,Estrogen-progestin preparation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,Estrogen-progestin preparation Malignant neoplasm of breast
DISRUPTS,CCAAT-Enhancer-Binding Protein-delta,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",CCAAT-Enhancer-Binding Protein-delta Malignant neoplasm of breast
PREDISPOSES,ZNF365 gene|ZNF365,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ZNF365 gene|ZNF365 Malignant neoplasm of breast
PREDISPOSES,LHX1 gene|LHX1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LHX1 gene|LHX1 Malignant neoplasm of breast
PREDISPOSES,ERCC3 gene|ERCC3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ERCC3 gene|ERCC3 Malignant neoplasm of breast
DISRUPTS,RNASE3L gene|DROSHA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,RNASE3L gene|DROSHA Malignant neoplasm of breast
CAUSES,Estrogenic,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Hormone,Estrogenic Breast Carcinoma
AFFECTS,Ductal Carcinoma,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Neoplastic Process,"Ductal Carcinoma Carcinoma, Ductal, Breast"
PREDISPOSES,oncoprotein p21|CDKN1A|SLC12A9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",oncoprotein p21|CDKN1A|SLC12A9 Malignant neoplasm of breast
PREDISPOSES,Single Nucleotide Polymorphism,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Single Nucleotide Polymorphism Breast Carcinoma
AFFECTS,Dietary Modification,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Element, Ion, or Isotope",Dietary Modification Breast cancer recurrent
AFFECTS,Mutagens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hazardous or Poisonous Substance,Mutagens Malignant neoplasm of breast
CAUSES,ETV4 gene|ETV4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ETV4 gene|ETV4 Malignant neoplasm of breast
AFFECTS,Ovulation Induction,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Ovulation Induction Malignant neoplasm of breast
PREDISPOSES,SRC gene|SRC,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Gene or Genome,SRC gene|SRC Breast cancer invasive NOS
PREDISPOSES,FCGR3A gene|FCGR3A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FCGR3A gene|FCGR3A Malignant neoplasm of breast
AFFECTS,S 1 (combination),Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",S 1 (combination) Breast cancer metastatic
PREDISPOSES,CONSTITUTIONAL ORIGIN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",CONSTITUTIONAL ORIGIN Malignant neoplasm of breast
DISRUPTS,Bone Morphogenetic Proteins,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,Bone Morphogenetic Proteins Breast cancer metastatic
AFFECTS,Epstein-Barr Virus Infections,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Epstein-Barr Virus Infections Breast Carcinoma
PREDISPOSES,TRANCE protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",TRANCE protein Malignant neoplasm of breast
PREDISPOSES,Syndrome,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Disease or Syndrome,Syndrome Breast Carcinoma
CAUSES,Angiogenesis Factor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Angiogenesis Factor Malignant neoplasm of breast
PREDISPOSES,PMS2 gene|PMS2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PMS2 gene|PMS2 Malignant neoplasm of breast
AUGMENTS,fatty acid amide hydrolase,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Chemical,fatty acid amide hydrolase Breast cancer invasive NOS
PREDISPOSES,Endocrine System Diseases,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Hormone,Endocrine System Diseases Breast Carcinoma
COMPLICATES,cytokine,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Biologically Active Substance,cytokine Breast cancer metastatic
PREDISPOSES,XRCC1 gene|XRCC1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,XRCC1 gene|XRCC1 Breast cancer metastatic
AFFECTS,Phytoestrogens,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Hormone,Phytoestrogens Breast Carcinoma
PREDISPOSES,ID2 gene|ID2,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,ID2 gene|ID2 Noninfiltrating Intraductal Carcinoma
AFFECTS,LATS1 gene|LATS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LATS1 gene|LATS1 Malignant neoplasm of breast
PREDISPOSES,MDM2 gene|MDM2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,MDM2 gene|MDM2 Breast cancer metastatic
AUGMENTS,ubiquitin-protein ligase,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",ubiquitin-protein ligase Breast cancer metastatic
AFFECTS,HMGN2 Protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",HMGN2 Protein Malignant neoplasm of breast
AFFECTS,Proliferating Cell Nuclear Antigen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Immunologic Factor,Proliferating Cell Nuclear Antigen Malignant neoplasm of breast
CAUSES,"Genome, Human",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,"Genome, Human Malignant neoplasm of breast"
AUGMENTS,GJB2 gene|GJB2,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Gene or Genome,"GJB2 gene|GJB2 Carcinoma, Ductal, Breast"
PREDISPOSES,PTH-Parathyroid hormone level result,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,PTH-Parathyroid hormone level result Malignant neoplasm of breast
AFFECTS,Recurrent Carcinoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Recurrent Carcinoma Malignant neoplasm of breast
AFFECTS,MIRN106A gene|MIR106A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIRN106A gene|MIR106A Malignant neoplasm of breast
AFFECTS,v-myb Genes|MYB,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,v-myb Genes|MYB Malignant neoplasm of breast
AFFECTS,Circadian Rhythm Disorders,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Circadian Rhythm Disorders Malignant neoplasm of breast
AFFECTS,CDK6-associated protein p18,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",CDK6-associated protein p18 Breast cancer metastatic
AFFECTS,ubiquitin-protein ligase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",ubiquitin-protein ligase Malignant neoplasm of breast
AFFECTS,reverse transcription polymerase chain reaction,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",reverse transcription polymerase chain reaction Malignant neoplasm of breast
AUGMENTS,H19 gene|H19|HILS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,H19 gene|H19|HILS1 Malignant neoplasm of breast
PREDISPOSES,"TSLP protein, human|TSLP",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","TSLP protein, human|TSLP Malignant neoplasm of breast"
AFFECTS,Secondary malignant neoplasm of spinal cord,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Secondary malignant neoplasm of spinal cord Malignant neoplasm of breast
PREDISPOSES,bone sialoprotein,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",bone sialoprotein Breast cancer metastatic
AUGMENTS,PIM1 gene|PIM1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PIM1 gene|PIM1 Malignant neoplasm of breast
CAUSES,"Oligonucleotides, Antisense",Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","Oligonucleotides, Antisense Breast cancer metastatic"
AFFECTS,Solvents,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Solvents Malignant neoplasm of breast
AFFECTS,Pancreatic carcinoma,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Neoplastic Process,Pancreatic carcinoma Ductal Breast Carcinoma
PREDISPOSES,centromere protein F,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",centromere protein F Breast cancer metastatic
PREDISPOSES,MIRN133B gene|MIR133B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIRN133B gene|MIR133B Malignant neoplasm of breast
PREDISPOSES,WISP1 gene|WISP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,WISP1 gene|WISP1 Malignant neoplasm of breast
AFFECTS,Paracrine Communication,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Paracrine Communication Malignant neoplasm of breast
PREDISPOSES,LIMS1 gene|LIMS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LIMS1 gene|LIMS1 Malignant neoplasm of breast
AUGMENTS,SIX1 gene|SIX1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SIX1 gene|SIX1 Malignant neoplasm of breast
AFFECTS,SULF1 gene|SULF1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SULF1 gene|SULF1 Malignant neoplasm of breast
AUGMENTS,Dopamine Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neuroreactive Substance or Biogenic Amine,Dopamine Receptor Malignant neoplasm of breast
DISRUPTS,MAGI2-AS3 gene|MAGI2-AS3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MAGI2-AS3 gene|MAGI2-AS3 Malignant neoplasm of breast
PREDISPOSES,Cell-Free DNA,Carcinoma breast stage IV,0.0,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Cell-Free DNA Carcinoma breast stage IV
DISRUPTS,beta-site APP cleaving enzyme 1,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Enzyme,"beta-site APP cleaving enzyme 1 Carcinoma, Ductal, Breast"
AFFECTS,systemic administration,Carcinoma breast stage IV,0.0,Female Breast Cancer,"Element, Ion, or Isotope",systemic administration Carcinoma breast stage IV
PREDISPOSES,Chronic disease,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Chronic disease Malignant neoplasm of breast
AFFECTS,KDM6A gene|KDM6A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,KDM6A gene|KDM6A Malignant neoplasm of breast
AFFECTS,Interferon Signaling Process,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Phenomenon or Process,Interferon Signaling Process Malignant neoplasm of breast
PREDISPOSES,Fibroblast Growth Factor 2|FGF2,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Biologically Active Substance,Fibroblast Growth Factor 2|FGF2 Noninfiltrating Intraductal Carcinoma
PREDISPOSES,UGT1A4 gene|UGT1A4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,UGT1A4 gene|UGT1A4 Malignant neoplasm of breast
AUGMENTS,ATOX1 gene|ATOX1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ATOX1 gene|ATOX1 Malignant neoplasm of breast
AFFECTS,"KISS1R protein, human|KISS1R",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein","KISS1R protein, human|KISS1R Triple Negative Breast Neoplasms"
PREDISPOSES,DNA Repair Gene,Hereditary Breast and Ovarian Cancer Syndrome,0.0,Female Breast Cancer,Gene or Genome,DNA Repair Gene Hereditary Breast and Ovarian Cancer Syndrome
CAUSES,DNA Modification Methylases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",DNA Modification Methylases Malignant neoplasm of breast
AUGMENTS,"Promoter Regions, Genetic",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,"Promoter Regions, Genetic Malignant neoplasm of breast"
PREDISPOSES,GAS1 gene|GAS1,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,GAS1 gene|GAS1 Noninfiltrating Intraductal Carcinoma
AUGMENTS,F2R gene|F2R,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,F2R gene|F2R Noninfiltrating Intraductal Carcinoma
AUGMENTS,LINC00668 gene|LINC00668,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LINC00668 gene|LINC00668 Malignant neoplasm of breast
CAUSES,tumor protein D52|TPD52,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",tumor protein D52|TPD52 Malignant neoplasm of breast
AFFECTS,SH2B3 gene|SH2B3,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,SH2B3 gene|SH2B3 Triple Negative Breast Neoplasms
AUGMENTS,Carcinogens,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Hazardous or Poisonous Substance,Carcinogens Triple Negative Breast Neoplasms
PREDISPOSES,MRTFA gene|MKL1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MRTFA gene|MKL1 Malignant neoplasm of breast
AFFECTS,FDG-Positron Emission Tomography and Computed Tomography Scan,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",FDG-Positron Emission Tomography and Computed Tomography Scan Malignant neoplasm of breast
PREDISPOSES,lead,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Inorganic Chemical,lead Malignant neoplasm of breast
CAUSES,SEPT7 gene|SEPT7,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,SEPT7 gene|SEPT7 Noninfiltrating Intraductal Carcinoma
AUGMENTS,"E2F1 protein, human|E2F1|UBE2L3",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","E2F1 protein, human|E2F1|UBE2L3 Malignant neoplasm of breast"
PREDISPOSES,Apolipoprotein E|APOE,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Apolipoprotein E|APOE Breast Carcinoma
AFFECTS,GATA3 gene|GATA3,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,GATA3 gene|GATA3 Triple Negative Breast Neoplasms
PREDISPOSES,AGO1 gene|AGO1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,AGO1 gene|AGO1 Malignant neoplasm of breast
AFFECTS,Antineoplastic Agents,Carcinoma breast stage IV,0.0,Female Breast Cancer,Neoplastic Process,Antineoplastic Agents Carcinoma breast stage IV
AUGMENTS,CSK gene|CSK,Basal-Like Breast Carcinoma,0.0039960039960039,Female Breast Cancer,Gene or Genome,CSK gene|CSK Basal-Like Breast Carcinoma
PREDISPOSES,"Receptors, Progesterone",Breast cancer stage III,0.0009990009990009,Female Breast Cancer,Hormone,"Receptors, Progesterone Breast cancer stage III"
AFFECTS,Microinvasive tumor,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Neoplastic Process,Microinvasive tumor Noninfiltrating Intraductal Carcinoma
PREDISPOSES,Estrogen Receptors,Breast cancer stage III,0.0009990009990009,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptors Breast cancer stage III
AFFECTS,Estrogen Antagonists,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Hormone,Estrogen Antagonists estrogen receptor-positive breast cancer
PREDISPOSES,ATF4 gene|ATF4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ATF4 gene|ATF4 Malignant neoplasm of breast
AFFECTS,"Genes, Essential",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,"Genes, Essential Malignant neoplasm of breast"
AUGMENTS,PBX1 gene|PBX1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PBX1 gene|PBX1 Malignant neoplasm of breast
AFFECTS,VLDLR gene|VLDLR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,VLDLR gene|VLDLR Malignant neoplasm of breast
DISRUPTS,WNT6 gene|WNT6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,WNT6 gene|WNT6 Malignant neoplasm of breast
AUGMENTS,SIRT3 gene|SIRT3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SIRT3 gene|SIRT3 Malignant neoplasm of breast
PREDISPOSES,TGFB1 gene|TGFB1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TGFB1 gene|TGFB1 Malignant neoplasm of breast
DISRUPTS,ZBTB1 gene|ZBTB1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ZBTB1 gene|ZBTB1 Malignant neoplasm of breast
AFFECTS,CXCR2 gene|CXCR2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CXCR2 gene|CXCR2 Malignant neoplasm of breast
AFFECTS,IQGAP1 gene|IQGAP1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,IQGAP1 gene|IQGAP1 Triple Negative Breast Neoplasms
PREDISPOSES,PSMG3-AS1 gene|PSMG3-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PSMG3-AS1 gene|PSMG3-AS1 Malignant neoplasm of breast
PREDISPOSES,HER2/Neu Positive,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Amino Acid, Peptide, or Protein",HER2/Neu Positive HER2-positive carcinoma of breast
AUGMENTS,FBXW5 gene|FBXW5,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,FBXW5 gene|FBXW5 Breast Carcinoma
AFFECTS,Protein Kinases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Protein Kinases Malignant neoplasm of breast
AFFECTS,EPDR1 gene|EPDR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,EPDR1 gene|EPDR1 Malignant neoplasm of breast
AFFECTS,SPINT1-AS1 gene|SPINT1-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SPINT1-AS1 gene|SPINT1-AS1 Malignant neoplasm of breast
PREDISPOSES,CXCR1 gene|CXCR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CXCR1 gene|CXCR1 Malignant neoplasm of breast
DISRUPTS,MIR26B gene|MIR26B,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,MIR26B gene|MIR26B Triple Negative Breast Neoplasms
AUGMENTS,TUFT1 gene|TUFT1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,TUFT1 gene|TUFT1 Triple Negative Breast Neoplasms
AFFECTS,Alternative Splicing,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Alternative Splicing Invasive carcinoma of breast
AUGMENTS,ZG16B gene|ZG16B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ZG16B gene|ZG16B Malignant neoplasm of breast
DISRUPTS,Photosensitizing Agents,Carcinoma breast stage IV,0.0,Female Breast Cancer,Chemical Viewed Functionally,Photosensitizing Agents Carcinoma breast stage IV
PREDISPOSES,KMT5A gene|KMT5A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,KMT5A gene|KMT5A Malignant neoplasm of breast
AUGMENTS,SNHG7 gene|SNHG7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SNHG7 gene|SNHG7 Malignant neoplasm of breast
DISRUPTS,SETD2 gene|SETD2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SETD2 gene|SETD2 Malignant neoplasm of breast
PREDISPOSES,"BMPR1B protein, human|BMPR1B",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","BMPR1B protein, human|BMPR1B Malignant neoplasm of breast"
PREDISPOSES,PKM gene|PKM,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PKM gene|PKM Malignant neoplasm of breast
AFFECTS,Lymphangiogenesis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Lymphangiogenesis Malignant neoplasm of breast
DISRUPTS,Nucleic Acid Probes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Nucleic Acid Probes Malignant neoplasm of breast
AFFECTS,Germ-Line Mutation,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Germ-Line Mutation Triple Negative Breast Neoplasms
AUGMENTS,MEDAG gene|MEDAG,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MEDAG gene|MEDAG Malignant neoplasm of breast
AFFECTS,MicroRNAs,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",MicroRNAs Inflammatory Breast Carcinoma
DISRUPTS,Protein Quaking,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Protein Quaking Malignant neoplasm of breast
PREDISPOSES,STIP1 gene|STIP1|TFIP11|NECAB1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,STIP1 gene|STIP1|TFIP11|NECAB1 Malignant neoplasm of breast
AFFECTS,Malignant neoplasm of oropharynx,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Malignant neoplasm of oropharynx Malignant neoplasm of breast
AFFECTS,Non-infiltrating lobular carcinoma,Recurrent Breast Carcinoma,0.0009990009990009,Recurrent Breast Cancer,Neoplastic Process,Non-infiltrating lobular carcinoma Recurrent Breast Carcinoma
DISRUPTS,Stat3 protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Stat3 protein Malignant neoplasm of breast
PREDISPOSES,TPX2 gene|TPX2,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,TPX2 gene|TPX2 Triple Negative Breast Neoplasms
PREDISPOSES,IFNGR1 gene|IFNGR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IFNGR1 gene|IFNGR1 Malignant neoplasm of breast
DISRUPTS,VEGFA gene|VEGFA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,VEGFA gene|VEGFA Malignant neoplasm of breast
DISRUPTS,MIR374B gene|MIR374B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIR374B gene|MIR374B Malignant neoplasm of breast
AUGMENTS,AQP3 gene|AQP3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,AQP3 gene|AQP3 Malignant neoplasm of breast
PREDISPOSES,Metric (substance),Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Substance,Metric (substance) Invasive carcinoma of breast
PREDISPOSES,FGD5-AS1 gene|FGD5-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FGD5-AS1 gene|FGD5-AS1 Malignant neoplasm of breast
AUGMENTS,SNHG15 gene|SNHG15,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SNHG15 gene|SNHG15 Malignant neoplasm of breast
AFFECTS,MicroRNA 19B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",MicroRNA 19B Malignant neoplasm of breast
AFFECTS,ZNF213 gene|ZNF213,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,ZNF213 gene|ZNF213 Triple Negative Breast Neoplasms
PREDISPOSES,SRSF1 gene|SRSF1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SRSF1 gene|SRSF1 Malignant neoplasm of breast
PREDISPOSES,FAT3 gene|FAT3,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,FAT3 gene|FAT3 Triple Negative Breast Neoplasms
PREDISPOSES,Low expression,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Low expression Malignant neoplasm of breast
AFFECTS,Tumor Burden,Carcinoma breast stage IV,0.0,Female Breast Cancer,Neoplastic Process,Tumor Burden Carcinoma breast stage IV
CAUSES,Transgenes,Carcinoma breast stage IV,0.0,Female Breast Cancer,Gene or Genome,Transgenes Carcinoma breast stage IV
PREDISPOSES,IL6ST gene|IL6ST,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IL6ST gene|IL6ST Malignant neoplasm of breast
AFFECTS,Cytokinesis,Basal-Like Breast Carcinoma,0.0039960039960039,Female Breast Cancer,Biologically Active Substance,Cytokinesis Basal-Like Breast Carcinoma
AFFECTS,NME1 gene|NME1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,NME1 gene|NME1 Triple Negative Breast Neoplasms
PREDISPOSES,HOXB7 gene|HOXB7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HOXB7 gene|HOXB7 Malignant neoplasm of breast
PREDISPOSES,Dietary carbohydrate intake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Carbohydrate,Dietary carbohydrate intake Malignant neoplasm of breast
AFFECTS,FBXO15 gene|FBXO15,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FBXO15 gene|FBXO15 Malignant neoplasm of breast
AUGMENTS,RNA Polymerase I|ERVW-4,Basal-Like Breast Carcinoma,0.0039960039960039,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",RNA Polymerase I|ERVW-4 Basal-Like Breast Carcinoma
AFFECTS,FGD5-AS1 gene|FGD5-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FGD5-AS1 gene|FGD5-AS1 Malignant neoplasm of breast
AFFECTS,TRAPPC10 gene|TRAPPC10,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,TRAPPC10 gene|TRAPPC10 Breast Carcinoma
AUGMENTS,CT83 gene|CT83,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,CT83 gene|CT83 Triple Negative Breast Neoplasms
DISRUPTS,cytokine,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Biologically Active Substance,cytokine Triple Negative Breast Neoplasms
DISRUPTS,PSMC2 gene|PSMC2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PSMC2 gene|PSMC2 Malignant neoplasm of breast
DISRUPTS,Cell Adhesion Molecules,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Cell Adhesion Molecules Malignant neoplasm of breast
CAUSES,FTO gene|FTO,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FTO gene|FTO Malignant neoplasm of breast
AFFECTS,4-aminohippuric acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,4-aminohippuric acid Malignant neoplasm of breast
PREDISPOSES,PTPRT gene|PTPRT,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PTPRT gene|PTPRT Malignant neoplasm of breast
AFFECTS,Serine-tRNA Ligase|TRNA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Serine-tRNA Ligase|TRNA Malignant neoplasm of breast
DISRUPTS,BRD4 gene|BRD4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BRD4 gene|BRD4 Malignant neoplasm of breast
PREDISPOSES,PDCD11 gene|PDCD11,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,PDCD11 gene|PDCD11 Triple Negative Breast Neoplasms
PREDISPOSES,Genes,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Gene or Genome,Genes Carcinoma of Male Breast
AUGMENTS,AEBP2 gene|AEBP2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,AEBP2 gene|AEBP2 Malignant neoplasm of breast
AUGMENTS,GATA3 gene|GATA3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GATA3 gene|GATA3 Malignant neoplasm of breast
DISRUPTS,HOXA1 gene|HOXA1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,HOXA1 gene|HOXA1 Malignant neoplasm of breast
AFFECTS,DPP8 gene|DPP8,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,DPP8 gene|DPP8 Malignant neoplasm of breast
AFFECTS,ACE2 gene|ACE2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ACE2 gene|ACE2 Malignant neoplasm of breast
PREDISPOSES,PCNT gene|PCNT,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PCNT gene|PCNT Malignant neoplasm of breast
AUGMENTS,TIMM17A gene|TIMM17A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TIMM17A gene|TIMM17A Malignant neoplasm of breast
PREDISPOSES,CXCR5 gene|CXCR5,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,CXCR5 gene|CXCR5 Breast Carcinoma
AFFECTS,DPP7 gene|DPP7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,DPP7 gene|DPP7 Malignant neoplasm of breast
PREDISPOSES,Phytochemical,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Phytochemical Malignant neoplasm of breast
PREDISPOSES,PALB2 gene|PALB2,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Gene or Genome,PALB2 gene|PALB2 Carcinoma of Male Breast
AFFECTS,Lymphocyte antigen CD82|CD82,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Immunologic Factor,Lymphocyte antigen CD82|CD82 Malignant neoplasm of breast
AFFECTS,SMUG1 gene|SMUG1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SMUG1 gene|SMUG1 Malignant neoplasm of breast
PREDISPOSES,SEMA4C gene|SEMA4C,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,SEMA4C gene|SEMA4C Breast Carcinoma
DISRUPTS,SEPTIN9 gene|SEPT9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SEPTIN9 gene|SEPT9 Malignant neoplasm of breast
AUGMENTS,UBQLN1 gene|UBQLN1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,UBQLN1 gene|UBQLN1 Malignant neoplasm of breast
CAUSES,human papillomavirus,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Virus,human papillomavirus Breast Carcinoma
PREDISPOSES,ADAR gene|ADAR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ADAR gene|ADAR Malignant neoplasm of breast
AFFECTS,RBMS3 gene|RBMS3,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,RBMS3 gene|RBMS3 Triple Negative Breast Neoplasms
PREDISPOSES,SOX10 gene|SOX10,Basal-Like Breast Carcinoma,0.0039960039960039,Female Breast Cancer,Gene or Genome,SOX10 gene|SOX10 Basal-Like Breast Carcinoma
PREDISPOSES,Ribosomal Proteins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Ribosomal Proteins Malignant neoplasm of breast
AFFECTS,Interventional procedure,Early-Stage Breast Carcinoma,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Interventional procedure Early-Stage Breast Carcinoma
AFFECTS,Immunohistochemistry,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Indicator, Reagent, or Diagnostic Aid",Immunohistochemistry Breast Carcinoma
DISRUPTS,CDK1 gene|CDK1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CDK1 gene|CDK1 Malignant neoplasm of breast
AFFECTS,Indicators,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Indicator, Reagent, or Diagnostic Aid",Indicators Breast Carcinoma
DISRUPTS,ADAMTS9-AS1 gene|ADAMTS9-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ADAMTS9-AS1 gene|ADAMTS9-AS1 Malignant neoplasm of breast
CAUSES,NAA50 gene|NAA50,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NAA50 gene|NAA50 Malignant neoplasm of breast
AFFECTS,Inflammatory Bowel Diseases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Inflammatory Bowel Diseases Malignant neoplasm of breast
DISRUPTS,FBXL16 gene|FBXL16,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FBXL16 gene|FBXL16 Malignant neoplasm of breast
PREDISPOSES,Triglycerides,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Lipid,Triglycerides estrogen receptor-positive breast cancer
PREDISPOSES,PVT1 gene|PVT1,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,PVT1 gene|PVT1 Breast Carcinoma
DISRUPTS,VIRMA gene|VIRMA,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,VIRMA gene|VIRMA Secondary malignant neoplasm of breast
AUGMENTS,HOTAIR gene|HOTAIR,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,HOTAIR gene|HOTAIR Noninfiltrating Intraductal Carcinoma
PREDISPOSES,MicroRNAs,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",MicroRNAs Triple Negative Breast Neoplasms
CAUSES,LINC00174 gene|LINC00174,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LINC00174 gene|LINC00174 Malignant neoplasm of breast
AFFECTS,Malignant neoplasm of breast,Carcinoma breast stage IV,0.0,Female Breast Cancer,Neoplastic Process,Malignant neoplasm of breast Carcinoma breast stage IV
DISRUPTS,BCLAF1 gene|BCLAF1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BCLAF1 gene|BCLAF1 Malignant neoplasm of breast
PREDISPOSES,NR2F1-AS1 gene|NR2F1-AS1,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,NR2F1-AS1 gene|NR2F1-AS1 Breast Carcinoma
AFFECTS,GNG13 gene|GNG13,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GNG13 gene|GNG13 Malignant neoplasm of breast
AFFECTS,IGLC2 gene|IGLC2,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,IGLC2 gene|IGLC2 Triple Negative Breast Neoplasms
CAUSES,Neoplasm Metastasis,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Neoplastic Process,Neoplasm Metastasis Triple Negative Breast Neoplasms
PREDISPOSES,Food Consumption,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Food Consumption Malignant neoplasm of breast
AFFECTS,"herstatin protein, human",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","herstatin protein, human Malignant neoplasm of breast"
PREDISPOSES,IRAK3 gene|IRAK3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IRAK3 gene|IRAK3 Malignant neoplasm of breast
CAUSES,SLC2A1 gene|SLC2A1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SLC2A1 gene|SLC2A1 Malignant neoplasm of breast
AFFECTS,MicroRNA 1246,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",MicroRNA 1246 Triple Negative Breast Neoplasms
AUGMENTS,WTAP gene|WTAP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,WTAP gene|WTAP Malignant neoplasm of breast
PREDISPOSES,"NOS1 protein, human|NOS1|NANOS1",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein","NOS1 protein, human|NOS1|NANOS1 Triple Negative Breast Neoplasms"
PREDISPOSES,CALCIUM/VITAMIN D,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Food,CALCIUM/VITAMIN D Noninfiltrating Intraductal Carcinoma
PREDISPOSES,CGAS gene|CGAS,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,CGAS gene|CGAS Secondary malignant neoplasm of breast
AUGMENTS,"TNF protein, human|TNF",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","TNF protein, human|TNF Malignant neoplasm of breast"
AFFECTS,Cellular Apoptosis Susceptibility Protein,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Cellular Apoptosis Susceptibility Protein Triple Negative Breast Neoplasms
AFFECTS,carbohydrate analog,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Carbohydrate,carbohydrate analog Malignant neoplasm of breast
DISRUPTS,TRIM72 gene|TRIM72,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TRIM72 gene|TRIM72 Malignant neoplasm of breast
AUGMENTS,Fatty-acid synthase,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Chemical,Fatty-acid synthase Triple Negative Breast Neoplasms
DISRUPTS,MicroRNA 205-5p,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",MicroRNA 205-5p Invasive carcinoma of breast
AUGMENTS,cholesterol,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Lipid,cholesterol estrogen receptor-positive breast cancer
PREDISPOSES,secretory protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",secretory protein Malignant neoplasm of breast
CAUSES,DUSP8 gene|DUSP8,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,DUSP8 gene|DUSP8 Malignant neoplasm of breast
COMPLICATES,Adrenal Gland Hyperfunction,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",Adrenal Gland Hyperfunction estrogen receptor-positive breast cancer
PREDISPOSES,Body position,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Body position Malignant neoplasm of breast
AUGMENTS,PSAT1 gene|PSAT1,Carcinoma breast stage IV,0.0,Female Breast Cancer,Gene or Genome,PSAT1 gene|PSAT1 Carcinoma breast stage IV
AUGMENTS,CCNE1 gene|CCNE1,Basal-Like Breast Carcinoma,0.0039960039960039,Female Breast Cancer,Gene or Genome,CCNE1 gene|CCNE1 Basal-Like Breast Carcinoma
PREDISPOSES,SIN3A gene|SIN3A,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,SIN3A gene|SIN3A Secondary malignant neoplasm of breast
AFFECTS,Malignant neoplasm of breast,Basal-Like Breast Carcinoma,0.0039960039960039,Female Breast Cancer,Neoplastic Process,Malignant neoplasm of breast Basal-Like Breast Carcinoma
PREDISPOSES,MicroRNAs,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",MicroRNAs Secondary malignant neoplasm of breast
AUGMENTS,YTHDF3 gene|YTHDF3,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,YTHDF3 gene|YTHDF3 Triple Negative Breast Neoplasms
PREDISPOSES,"RNA, Long Untranslated",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","RNA, Long Untranslated Malignant neoplasm of breast"
AUGMENTS,PNO1 gene|PNO1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PNO1 gene|PNO1 Malignant neoplasm of breast
AUGMENTS,GSDME gene|GSDME,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GSDME gene|GSDME Malignant neoplasm of breast
AUGMENTS,TRANSCRIPTION FACTOR,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",TRANSCRIPTION FACTOR Triple Negative Breast Neoplasms
AUGMENTS,FERMT1 gene|FERMT1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,FERMT1 gene|FERMT1 Triple Negative Breast Neoplasms
PREDISPOSES,G-Protein-Coupled Receptors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",G-Protein-Coupled Receptors Malignant neoplasm of breast
DISRUPTS,MIR449A gene|MIR449A,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,MIR449A gene|MIR449A Triple Negative Breast Neoplasms
AFFECTS,CDK18 gene|CDK18,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CDK18 gene|CDK18 Malignant neoplasm of breast
PREDISPOSES,Genes,"Breast Cancer, Familial",0.0,Female Breast Cancer,Gene or Genome,"Genes Breast Cancer, Familial"
AUGMENTS,ILF3 gene|ILF3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ILF3 gene|ILF3 Malignant neoplasm of breast
AFFECTS,ROS1 gene|ROS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ROS1 gene|ROS1 Malignant neoplasm of breast
AUGMENTS,CCNA2 gene|CCNA2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CCNA2 gene|CCNA2 Malignant neoplasm of breast
AFFECTS,NSRP1 gene|NSRP1,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,NSRP1 gene|NSRP1 Secondary malignant neoplasm of breast
AFFECTS,SOX13 gene|SOX13,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SOX13 gene|SOX13 Malignant neoplasm of breast
CAUSES,MAFG-DT gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MAFG-DT gene Malignant neoplasm of breast
PREDISPOSES,LINC00665 gene|LINC00665,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,LINC00665 gene|LINC00665 Triple Negative Breast Neoplasms
PREDISPOSES,Long Intergenic Non-Protein Coding RNA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Long Intergenic Non-Protein Coding RNA Malignant neoplasm of breast
AFFECTS,JAG1 gene|JAG1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,JAG1 gene|JAG1 Triple Negative Breast Neoplasms
DISRUPTS,PIEZO1 gene|PIEZO1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PIEZO1 gene|PIEZO1 Malignant neoplasm of breast
AUGMENTS,CHAC1 gene|CHAC1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CHAC1 gene|CHAC1 Malignant neoplasm of breast
AFFECTS,Retinoblastoma Protein|RB1,Carcinoma breast stage IV,0.0,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Retinoblastoma Protein|RB1 Carcinoma breast stage IV
PREDISPOSES,SDC1 gene|SDC1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SDC1 gene|SDC1 Malignant neoplasm of breast
PREDISPOSES,H19 gene|H19|HILS1,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Gene or Genome,H19 gene|H19|HILS1 estrogen receptor-positive breast cancer
DISRUPTS,CDH2 gene|CDH2,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,CDH2 gene|CDH2 Secondary malignant neoplasm of breast
PREDISPOSES,Candidate Disease Gene,"Breast Cancer, Familial",0.0,Female Breast Cancer,Gene or Genome,"Candidate Disease Gene Breast Cancer, Familial"
AFFECTS,SERPINB2 gene|SERPINB2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SERPINB2 gene|SERPINB2 Malignant neoplasm of breast
PREDISPOSES,DST gene|DST,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,DST gene|DST Malignant neoplasm of breast
PREDISPOSES,ISYNA1 gene|ISYNA1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ISYNA1 gene|ISYNA1 Malignant neoplasm of breast
PREDISPOSES,"TLR2 protein, human|TLR2",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","TLR2 protein, human|TLR2 Malignant neoplasm of breast"
AFFECTS,TFE3 gene|TFE3,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,TFE3 gene|TFE3 Secondary malignant neoplasm of breast
PREDISPOSES,"FRAP1 protein, human|MTOR",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein","FRAP1 protein, human|MTOR Triple Negative Breast Neoplasms"
AFFECTS,Vitamin D Analog,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Food,Vitamin D Analog Triple Negative Breast Neoplasms
AFFECTS,ST8SIA6-AS1 gene|ST8SIA6-AS1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,ST8SIA6-AS1 gene|ST8SIA6-AS1 Triple Negative Breast Neoplasms
AFFECTS,Primary Sj??gren's syndrome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Primary Sj??gren's syndrome Malignant neoplasm of breast
AFFECTS,"ERCC5 protein, human|ERCC5",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","ERCC5 protein, human|ERCC5 Malignant neoplasm of breast"
PREDISPOSES,SLC16A3 gene|SLC16A3,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,SLC16A3 gene|SLC16A3 Triple Negative Breast Neoplasms
PREDISPOSES,ELOVL5 gene|ELOVL5,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,ELOVL5 gene|ELOVL5 Secondary malignant neoplasm of breast
PREDISPOSES,Transforming Growth Factor beta Receptors,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Biologically Active Substance,Transforming Growth Factor beta Receptors estrogen receptor-positive breast cancer
DISRUPTS,PTPN18 gene|PTPN18,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,PTPN18 gene|PTPN18 Secondary malignant neoplasm of breast
AFFECTS,SPI1 gene|SPI1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SPI1 gene|SPI1 Malignant neoplasm of breast
PREDISPOSES,SARS1 gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SARS1 gene Malignant neoplasm of breast
AFFECTS,tumor growth,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Neoplastic Process,tumor growth Triple Negative Breast Neoplasms
PREDISPOSES,SEMA3B-AS1 gene|SEMA3B-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SEMA3B-AS1 gene|SEMA3B-AS1 Malignant neoplasm of breast
AFFECTS,Antibody-Drug Conjugates,HER2-negative breast cancer,0.0,Female Breast Cancer,Pharmacologic Substance,Antibody-Drug Conjugates HER2-negative breast cancer
PREDISPOSES,Phytochemicals,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,Phytochemicals Malignant neoplasm of breast
AFFECTS,Chemoimmunotherapy,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Immunologic Factor,Chemoimmunotherapy Triple Negative Breast Neoplasms
AUGMENTS,hla gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,hla gene Malignant neoplasm of breast
CAUSES,testosterone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Hormone,testosterone Malignant neoplasm of breast
AFFECTS,SAA1 gene|SAA1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SAA1 gene|SAA1 Malignant neoplasm of breast
PREDISPOSES,PRSS22 gene|PRSS22,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,PRSS22 gene|PRSS22 Secondary malignant neoplasm of breast
PREDISPOSES,glutamic acid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,glutamic acid Malignant neoplasm of breast
AFFECTS,Thyroid dysfunction,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Thyroid dysfunction Malignant neoplasm of breast
DISRUPTS,"PTK2 protein, human|PTK2",Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,"Amino Acid, Peptide, or Protein","PTK2 protein, human|PTK2 Secondary malignant neoplasm of breast"
PREDISPOSES,Heterogeneous-Nuclear Ribonucleoprotein U,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,Heterogeneous-Nuclear Ribonucleoprotein U Triple Negative Breast Neoplasms
AUGMENTS,MIR217 gene|MIR217,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIR217 gene|MIR217 Malignant neoplasm of breast
CAUSES,TP53 gene|TP53,Carcinoma breast stage IV,0.0,Female Breast Cancer,Gene or Genome,TP53 gene|TP53 Carcinoma breast stage IV
AFFECTS,Circulating MicroRNA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Circulating MicroRNA Malignant neoplasm of breast
PREDISPOSES,Emotional hypersensitivity,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Emotional hypersensitivity Breast Carcinoma
AUGMENTS,USP46 gene|USP46,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,USP46 gene|USP46 Triple Negative Breast Neoplasms
DISRUPTS,BCAR4 gene|BCAR4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,BCAR4 gene|BCAR4 Malignant neoplasm of breast
PREDISPOSES,Genetic Carriers,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Genetic Carriers Malignant neoplasm of breast
PREDISPOSES,TMEM9 gene|TMEM9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TMEM9 gene|TMEM9 Malignant neoplasm of breast
PREDISPOSES,USP10 gene|USP10,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,USP10 gene|USP10 Secondary malignant neoplasm of breast
CAUSES,Neoplastic Cell Transformation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Neoplastic Cell Transformation Malignant neoplasm of breast
PREDISPOSES,Hormone Receptor Positive,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Hormone,Hormone Receptor Positive Invasive carcinoma of breast
AFFECTS,Positive Regulation of Apoptosis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Positive Regulation of Apoptosis Malignant neoplasm of breast
PREDISPOSES,IFNK gene|IFNK,Basal-Like Breast Carcinoma,0.0039960039960039,Female Breast Cancer,Gene or Genome,IFNK gene|IFNK Basal-Like Breast Carcinoma
PREDISPOSES,Surviving free of recurrence of neoplastic disease,contralateral breast cancer,0.0029970029970029,Female Breast Cancer,Neoplastic Process,Surviving free of recurrence of neoplastic disease contralateral breast cancer
PREDISPOSES,IGSF9 gene|IGSF9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IGSF9 gene|IGSF9 Malignant neoplasm of breast
CAUSES,Liver carcinoma,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Neoplastic Process,Liver carcinoma Secondary malignant neoplasm of breast
DISRUPTS,TP53 gene|TP53,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,TP53 gene|TP53 Triple Negative Breast Neoplasms
AFFECTS,omega-3 fatty acids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,omega-3 fatty acids Malignant neoplasm of breast
DISRUPTS,CMTM7 gene|CMTM7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,CMTM7 gene|CMTM7 Malignant neoplasm of breast
PREDISPOSES,"Genes, Duplicate",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,"Genes, Duplicate Malignant neoplasm of breast"
CAUSES,Sphingolipids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Lipid,Sphingolipids Malignant neoplasm of breast
DISRUPTS,GDF2 gene|GDF2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GDF2 gene|GDF2 Malignant neoplasm of breast
PREDISPOSES,ENPP1 gene|ENPP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ENPP1 gene|ENPP1 Malignant neoplasm of breast
AUGMENTS,ANXA1 gene|ANXA1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ANXA1 gene|ANXA1 Malignant neoplasm of breast
CAUSES,fructose,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Carbohydrate,fructose Malignant neoplasm of breast
PREDISPOSES,GLIS3 gene|GLIS3,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,GLIS3 gene|GLIS3 Triple Negative Breast Neoplasms
PREDISPOSES,ABCG1 gene|ABCG1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ABCG1 gene|ABCG1 Malignant neoplasm of breast
AFFECTS,Mucin-1 Antigen,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Immunologic Factor,Mucin-1 Antigen Triple Negative Breast Neoplasms
AFFECTS,"estrogen receptor alpha, human",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","estrogen receptor alpha, human Malignant neoplasm of breast"
PREDISPOSES,DACH1 gene|DACH1,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Gene or Genome,DACH1 gene|DACH1 Carcinoma of Male Breast
DISRUPTS,"DKK3 protein, human|DKK3",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","DKK3 protein, human|DKK3 Malignant neoplasm of breast"
AFFECTS,DPT gene|DPT,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,DPT gene|DPT Malignant neoplasm of breast
PREDISPOSES,CLDN6 gene|CLDN6,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,CLDN6 gene|CLDN6 Breast Carcinoma
PREDISPOSES,"RNA, Circular",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","RNA, Circular Malignant neoplasm of breast"
CAUSES,NORAD gene|NORAD,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,NORAD gene|NORAD Malignant neoplasm of breast
AUGMENTS,LONG INTERGENIC NONCODING RNA PINKY|PNKY,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",LONG INTERGENIC NONCODING RNA PINKY|PNKY Malignant neoplasm of breast
PREDISPOSES,Cancer Vaccines,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Cancer Vaccines Malignant neoplasm of breast
AFFECTS,MIR223 gene|MIR223,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MIR223 gene|MIR223 Malignant neoplasm of breast
AFFECTS,SPARCL1 gene|SPARCL1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SPARCL1 gene|SPARCL1 Malignant neoplasm of breast
AUGMENTS,SFRP2 gene|SFRP2,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Gene or Genome,SFRP2 gene|SFRP2 Noninfiltrating Intraductal Carcinoma
AFFECTS,"YAP1 protein, human|YAP1",Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,"Amino Acid, Peptide, or Protein","YAP1 protein, human|YAP1 Secondary malignant neoplasm of breast"
AUGMENTS,"SFRP1 protein, human|SFRP1",Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Amino Acid, Peptide, or Protein","SFRP1 protein, human|SFRP1 Noninfiltrating Intraductal Carcinoma"
PREDISPOSES,Immunologic Factors,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Immunologic Factor,Immunologic Factors Secondary malignant neoplasm of breast
AFFECTS,TPBG gene|TPBG,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,TPBG gene|TPBG Malignant neoplasm of breast
PREDISPOSES,Estrogen Receptor Status - Clinical Trial Eligibility Criteria,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrogen Receptor Status - Clinical Trial Eligibility Criteria Malignant neoplasm of breast
PREDISPOSES,Pathologic Processes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Phenomenon or Process,Pathologic Processes Malignant neoplasm of breast
AFFECTS,DSCR9 gene|DSCR9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,DSCR9 gene|DSCR9 Malignant neoplasm of breast
CAUSES,"DDIT3 protein, human|DDIT3",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","DDIT3 protein, human|DDIT3 Malignant neoplasm of breast"
AUGMENTS,nerve growth factor,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Biologically Active Substance,nerve growth factor Triple Negative Breast Neoplasms
DISRUPTS,ARHGAP25 gene|ARHGAP25,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ARHGAP25 gene|ARHGAP25 Malignant neoplasm of breast
PREDISPOSES,NLRP12 gene|NLRP12,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,NLRP12 gene|NLRP12 Triple Negative Breast Neoplasms
DISRUPTS,FBXW2 gene|FBXW2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,FBXW2 gene|FBXW2 Malignant neoplasm of breast
PREDISPOSES,"RTN4 protein, human|RTN4",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","RTN4 protein, human|RTN4 Malignant neoplasm of breast"
DISRUPTS,PEDS1 gene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PEDS1 gene Malignant neoplasm of breast
AUGMENTS,IL19 gene|IL19,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,IL19 gene|IL19 Malignant neoplasm of breast
AFFECTS,DNAJB6 gene|DNAJB6,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,DNAJB6 gene|DNAJB6 Triple Negative Breast Neoplasms
PREDISPOSES,UBE3B gene|UBE3B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,UBE3B gene|UBE3B Malignant neoplasm of breast
DISRUPTS,ZNF703 gene|ZNF703,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ZNF703 gene|ZNF703 Malignant neoplasm of breast
AFFECTS,Extraction,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Extraction Malignant neoplasm of breast
DISRUPTS,OTUB1 gene|OTUB1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,OTUB1 gene|OTUB1 Malignant neoplasm of breast
AFFECTS,MAF1 gene|MAF1,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Gene or Genome,MAF1 gene|MAF1 HER2-positive carcinoma of breast
PREDISPOSES,Squalene monooxygenase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Squalene monooxygenase Malignant neoplasm of breast
AFFECTS,"plY protein, Streptococcus pneumoniae",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein","plY protein, Streptococcus pneumoniae Triple Negative Breast Neoplasms"
AFFECTS,Malignant neoplasm of thyroid,estrogen receptor-negative breast cancer,0.0,Female Breast Cancer,Neoplastic Process,Malignant neoplasm of thyroid estrogen receptor-negative breast cancer
PREDISPOSES,KLF5 gene|KLF5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,KLF5 gene|KLF5 Malignant neoplasm of breast
PREDISPOSES,Does ask questions,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Does ask questions Malignant neoplasm of breast
DISRUPTS,zinc pyrithione,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",zinc pyrithione Triple Negative Breast Neoplasms
DISRUPTS,Transgenes,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,Transgenes Secondary malignant neoplasm of breast
DISRUPTS,SFRP2 gene|SFRP2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SFRP2 gene|SFRP2 Malignant neoplasm of breast
DISRUPTS,SOCS3 gene|SOCS3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SOCS3 gene|SOCS3 Malignant neoplasm of breast
AFFECTS,Focal Adhesion Kinase 1,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,"Element, Ion, or Isotope",Focal Adhesion Kinase 1 Secondary malignant neoplasm of breast
PREDISPOSES,KDM2A gene|KDM2A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,KDM2A gene|KDM2A Malignant neoplasm of breast
AFFECTS,SIAE gene|SIAE,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SIAE gene|SIAE Malignant neoplasm of breast
DISRUPTS,secreted frizzled related protein 1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",secreted frizzled related protein 1 Malignant neoplasm of breast
AUGMENTS,LINC02086 gene|LINC02086,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,LINC02086 gene|LINC02086 Malignant neoplasm of breast
AUGMENTS,SERPINA5 gene|SERPINA5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SERPINA5 gene|SERPINA5 Malignant neoplasm of breast
AFFECTS,GRAMD1B gene|GRAMD1B,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,GRAMD1B gene|GRAMD1B Triple Negative Breast Neoplasms
AFFECTS,DACH1 gene|DACH1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,DACH1 gene|DACH1 Malignant neoplasm of breast
AFFECTS,"PIK3CB protein, human|PIK3CB",Carcinoma breast stage IV,0.0,Female Breast Cancer,"Amino Acid, Peptide, or Protein","PIK3CB protein, human|PIK3CB Carcinoma breast stage IV"
PREDISPOSES,GBP1 gene|GBP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,GBP1 gene|GBP1 Malignant neoplasm of breast
PREDISPOSES,MBD4 gene|MBD4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MBD4 gene|MBD4 Malignant neoplasm of breast
AFFECTS,Vitamin supplementation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Vitamin supplementation Malignant neoplasm of breast
AFFECTS,gene therapy,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,gene therapy Triple Negative Breast Neoplasms
AFFECTS,MUTYH Gene Mutation,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MUTYH Gene Mutation Malignant neoplasm of breast
PREDISPOSES,Carcinogens,Basal-Like Breast Carcinoma,0.0039960039960039,Female Breast Cancer,Hazardous or Poisonous Substance,Carcinogens Basal-Like Breast Carcinoma
CAUSES,Malignant neoplasm of thyroid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Malignant neoplasm of thyroid Malignant neoplasm of breast
DISRUPTS,CHD4 gene|CHD4,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,CHD4 gene|CHD4 Triple Negative Breast Neoplasms
PREDISPOSES,SLC7A11 gene|SLC7A11,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SLC7A11 gene|SLC7A11 Malignant neoplasm of breast
AFFECTS,"CREB3L4 protein, human|CREB3L4",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CREB3L4 protein, human|CREB3L4 Triple Negative Breast Neoplasms"
DISRUPTS,NOTCH3 gene,Carcinoma breast stage IV,0.0,Female Breast Cancer,Gene or Genome,NOTCH3 gene Carcinoma breast stage IV
PREDISPOSES,EPYC gene|EPYC,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,EPYC gene|EPYC Breast Carcinoma
CAUSES,EIF4E gene|EIF4E,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,EIF4E gene|EIF4E Malignant neoplasm of breast
AUGMENTS,Stat3 protein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Stat3 protein Malignant neoplasm of breast
AUGMENTS,"DICER1 protein, human|DICER1",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein","DICER1 protein, human|DICER1 Triple Negative Breast Neoplasms"
AUGMENTS,MGP gene|MGP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,MGP gene|MGP Malignant neoplasm of breast
PREDISPOSES,VAMP7 gene|VAMP7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,VAMP7 gene|VAMP7 Malignant neoplasm of breast
PREDISPOSES,"Discharge, body substance",Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Substance,"Discharge, body substance Noninfiltrating Intraductal Carcinoma"
AUGMENTS,QSOX2 gene|QSOX2,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,QSOX2 gene|QSOX2 Triple Negative Breast Neoplasms
AUGMENTS,NUP155 gene|NUP155,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,NUP155 gene|NUP155 Breast Carcinoma
PREDISPOSES,ZNF410 gene|ZNF410,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ZNF410 gene|ZNF410 Malignant neoplasm of breast
AFFECTS,"Culture Media, Conditioned",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Culture Media, Conditioned Malignant neoplasm of breast"
AFFECTS,Luteinizing Hormone-releasing Hormone Agonist,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Hormone,Luteinizing Hormone-releasing Hormone Agonist Carcinoma of Male Breast
PREDISPOSES,Sugars,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Carbohydrate,Sugars Malignant neoplasm of breast
CAUSES,"CDK12 protein, human|CDK12",HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Amino Acid, Peptide, or Protein","CDK12 protein, human|CDK12 HER2-positive carcinoma of breast"
AUGMENTS,MIR190B gene|MIR190B,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Gene or Genome,MIR190B gene|MIR190B estrogen receptor-positive breast cancer
DISRUPTS,Friend Leukemia Integration 1 Transcription Factor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Friend Leukemia Integration 1 Transcription Factor Malignant neoplasm of breast
AUGMENTS,SCARNA4 gene|SCARNA4,Early-Stage Breast Carcinoma,0.0,Female Breast Cancer,Gene or Genome,SCARNA4 gene|SCARNA4 Early-Stage Breast Carcinoma
AUGMENTS,"RAI3 protein, human|GPRC5A",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein","RAI3 protein, human|GPRC5A Triple Negative Breast Neoplasms"
AFFECTS,"PLK1 protein, human|PLK1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","PLK1 protein, human|PLK1 Malignant neoplasm of breast"
PREDISPOSES,JMJD1C gene|JMJD1C,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,JMJD1C gene|JMJD1C Malignant neoplasm of breast
PREDISPOSES,PPP1R21 gene|PPP1R21,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,PPP1R21 gene|PPP1R21 Malignant neoplasm of breast
DISRUPTS,BICD1 gene|BICD1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,BICD1 gene|BICD1 Triple Negative Breast Neoplasms
AUGMENTS,SLC16A3 gene|SLC16A3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,SLC16A3 gene|SLC16A3 Malignant neoplasm of breast
AFFECTS,Hypertensive disease,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Disease or Syndrome,Hypertensive disease Malignant neoplasm of breast
AFFECTS,ANXA9 gene|ANXA9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,ANXA9 gene|ANXA9 Malignant neoplasm of breast
AFFECTS,Gene Mutation,"Breast Cancer, Familial",0.0,Female Breast Cancer,Gene or Genome,"Gene Mutation Breast Cancer, Familial"
PREDISPOSES,EMP2 gene|EMP2,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Gene or Genome,EMP2 gene|EMP2 Triple Negative Breast Neoplasms
PREDISPOSES,NDUFB3|TNFAIP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,NDUFB3|TNFAIP1 Malignant neoplasm of breast
AUGMENTS,RAD51,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",RAD51 Malignant neoplasm of breast
AFFECTS,Topotecan,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Topotecan Malignant neoplasm of breast
PREDISPOSES,ACSL4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",ACSL4 Malignant neoplasm of breast
PREDISPOSES,Body mass index,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Body mass index Malignant neoplasm of breast
AFFECTS,Metabolites,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Metabolites Malignant neoplasm of breast
CAUSES,anthracene,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,anthracene Breast Carcinoma
CAUSES,Methylcholanthrene,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Methylcholanthrene Breast Carcinoma
PREDISPOSES,MTRR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,MTRR Malignant neoplasm of breast
AUGMENTS,MTA2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,MTA2 Malignant neoplasm of breast
AFFECTS,Growth,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Growth Malignant neoplasm of breast
AFFECTS,Pregnancy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Pregnancy Malignant neoplasm of breast
AUGMENTS,DYRK2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",DYRK2 Malignant neoplasm of breast
DISRUPTS,Velcade,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Velcade Malignant neoplasm of breast
PREDISPOSES,lycopene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,lycopene Malignant neoplasm of breast
PREDISPOSES,SMURF1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,SMURF1 Breast cancer metastatic
AFFECTS,polyphenols,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,polyphenols Malignant neoplasm of breast
PREDISPOSES,Obesity,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Obesity Malignant neoplasm of breast
AFFECTS,Etodolac,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Etodolac Malignant neoplasm of breast
AFFECTS,Interleukin-6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Interleukin-6 Malignant neoplasm of breast
PREDISPOSES,Well in self,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Well in self Malignant neoplasm of breast
DISRUPTS,1-Phosphatidylinositol 3-Kinase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",1-Phosphatidylinositol 3-Kinase Malignant neoplasm of breast
AFFECTS,Androgens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Androgens Malignant neoplasm of breast
AUGMENTS,TARBP2,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,TARBP2 Breast Carcinoma
PREDISPOSES,Tobacco smoke,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Tobacco smoke Malignant neoplasm of breast
PREDISPOSES,Annexin A2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Annexin A2 Malignant neoplasm of breast
PREDISPOSES,RAD51,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",RAD51 Malignant neoplasm of breast
PREDISPOSES,GATA3,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",GATA3 Breast Carcinoma
PREDISPOSES,beta-cryptoxanthin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",beta-cryptoxanthin Malignant neoplasm of breast
PREDISPOSES,response,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",response Malignant neoplasm of breast
PREDISPOSES,Physical activity,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Physical activity Malignant neoplasm of breast
AFFECTS,Signal Pathways,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Signal Pathways Malignant neoplasm of breast
AUGMENTS,TARBP2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,TARBP2 Malignant neoplasm of breast
AFFECTS,SELENOP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,SELENOP Malignant neoplasm of breast
AFFECTS,polyphenols,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",polyphenols Breast cancer recurrent
PREDISPOSES,Weight Gain,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Weight Gain Malignant neoplasm of breast
AFFECTS,pleiotropism,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,pleiotropism Malignant neoplasm of breast
CAUSES,Enhancer,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Enhancer Malignant neoplasm of breast
AFFECTS,GATA3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",GATA3 Malignant neoplasm of breast
PREDISPOSES,Prognostic Factor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Prognostic Factor Malignant neoplasm of breast
AFFECTS,kahweol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,kahweol Malignant neoplasm of breast
DISRUPTS,INPP5J,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,INPP5J Malignant neoplasm of breast
PREDISPOSES,heparanase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,heparanase Malignant neoplasm of breast
PREDISPOSES,Fitness,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Fitness Malignant neoplasm of breast
CAUSES,Progestins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Progestins Malignant neoplasm of breast
AUGMENTS,Nitrogen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Nitrogen Malignant neoplasm of breast
PREDISPOSES,Ethanol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Ethanol Malignant neoplasm of breast
AFFECTS,Adiponectin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Adiponectin Malignant neoplasm of breast
PREDISPOSES,CENPN,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",CENPN Breast cancer recurrent
PREDISPOSES,Reproductive History,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Reproductive History Malignant neoplasm of breast
PREDISPOSES,Menopausal Status,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Menopausal Status Malignant neoplasm of breast
AUGMENTS,KISS1R,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",KISS1R Malignant neoplasm of breast
PREDISPOSES,Regular exercise,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Regular exercise Malignant neoplasm of breast
PREDISPOSES,ZNF410,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ZNF410 Malignant neoplasm of breast
PREDISPOSES,Diabetes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Diabetes Malignant neoplasm of breast
PREDISPOSES,Nuts,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Nuts Malignant neoplasm of breast
AFFECTS,Therapeutic procedure,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Therapeutic procedure Malignant neoplasm of breast
AFFECTS,Psychosocial problem,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Psychosocial problem Malignant neoplasm of breast
PREDISPOSES,Red meat,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Red meat Malignant neoplasm of breast
AUGMENTS,Hypothalamic inhibiting factor,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,Hypothalamic inhibiting factor Breast cancer metastatic
PREDISPOSES,Heterocyclic Amines,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Heterocyclic Amines Malignant neoplasm of breast
AFFECTS,Cyclin E,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Cyclin E Malignant neoplasm of breast
PREDISPOSES,Primigravida,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Primigravida Malignant neoplasm of breast
DISRUPTS,Phosphotransferases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Phosphotransferases Malignant neoplasm of breast
CAUSES,Stromal Cell-Derived Factor 1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Stromal Cell-Derived Factor 1 Malignant neoplasm of breast
AFFECTS,Pharmacotherapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Pharmacotherapy Malignant neoplasm of breast
PREDISPOSES,Behavior,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Behavior Malignant neoplasm of breast
DISRUPTS,Isoflavones,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Isoflavones Malignant neoplasm of breast
AFFECTS,Taxotere,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Taxotere Malignant neoplasm of breast
CAUSES,S100A7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",S100A7 Malignant neoplasm of breast
DISRUPTS,Calcium,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Calcium Malignant neoplasm of breast
PREDISPOSES,Antioxidants,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Antioxidants Malignant neoplasm of breast
CAUSES,anthracene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,anthracene Malignant neoplasm of breast
PREDISPOSES,"Receptors, Opioid, delta",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Receptors, Opioid, delta Malignant neoplasm of breast"
CAUSES,Antibodies,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Antibodies Malignant neoplasm of breast
DISRUPTS,AKR1C3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,AKR1C3 Malignant neoplasm of breast
PREDISPOSES,Radial scar,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Radial scar Malignant neoplasm of breast
PREDISPOSES,methyl 4-azidophenylacetimidate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",methyl 4-azidophenylacetimidate Malignant neoplasm of breast
PREDISPOSES,Catechol O-Methyltransferase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Catechol O-Methyltransferase Malignant neoplasm of breast
AFFECTS,dihydroxyacetone sulfate,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",dihydroxyacetone sulfate Breast cancer metastatic
AFFECTS,Estradiol,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Estradiol Breast cancer metastatic
AFFECTS,Apoptosis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Apoptosis Malignant neoplasm of breast
AFFECTS,Taxanes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Taxanes Malignant neoplasm of breast
AFFECTS,fulvestrant,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,fulvestrant Malignant neoplasm of breast
AUGMENTS,BSG,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",BSG Malignant neoplasm of breast
AFFECTS,Neoplasm,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Neoplasm Malignant neoplasm of breast
PREDISPOSES,6-sulfatoxymelatonin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,6-sulfatoxymelatonin Malignant neoplasm of breast
CAUSES,Methylnitrosourea,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Methylnitrosourea Malignant neoplasm of breast
PREDISPOSES,Not significant,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Not significant Malignant neoplasm of breast
DISRUPTS,Citrate,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Citrate Breast Carcinoma
DISRUPTS,RASAL2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",RASAL2 Malignant neoplasm of breast
PREDISPOSES,Genistein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Genistein Malignant neoplasm of breast
CAUSES,"9,10-Dimethyl-1,2-benzanthracene",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","9,10-Dimethyl-1,2-benzanthracene Malignant neoplasm of breast"
AFFECTS,Bilateral salpingectomy with oophorectomy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Bilateral salpingectomy with oophorectomy Malignant neoplasm of breast
PREDISPOSES,Arginine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Arginine Malignant neoplasm of breast
PREDISPOSES,Wine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Wine Malignant neoplasm of breast
AFFECTS,Menopause,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Menopause Malignant neoplasm of breast
PREDISPOSES,Meat,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Meat Malignant neoplasm of breast
PREDISPOSES,Smoking,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Smoking Malignant neoplasm of breast
AFFECTS,sulfuretin,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",sulfuretin Breast cancer metastatic
AFFECTS,Methyltransferase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Methyltransferase Malignant neoplasm of breast
AUGMENTS,HSF1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",HSF1 Malignant neoplasm of breast
CAUSES,Iodine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Iodine Malignant neoplasm of breast
DISRUPTS,Clusterin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Clusterin Malignant neoplasm of breast
AUGMENTS,Dietary Fats,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Dietary Fats Malignant neoplasm of breast
PREDISPOSES,Eosinophilia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Eosinophilia Malignant neoplasm of breast
PREDISPOSES,Insulin Resistance,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Insulin Resistance Malignant neoplasm of breast
AUGMENTS,MAD2L2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,MAD2L2 Malignant neoplasm of breast
AUGMENTS,Urokinase,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Urokinase Breast cancer metastatic
AUGMENTS,erbB-2 Receptor|ERBB2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",erbB-2 Receptor|ERBB2 Malignant neoplasm of breast
AFFECTS,gamma-tocotrienol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",gamma-tocotrienol Malignant neoplasm of breast
AFFECTS,Oxidative Stress,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Oxidative Stress Malignant neoplasm of breast
PREDISPOSES,palm oil,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,palm oil Malignant neoplasm of breast
PREDISPOSES,Tongue feature,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Tongue feature Malignant neoplasm of breast
AFFECTS,Blueberries,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Neoplastic Process,Blueberries Inflammatory Breast Carcinoma
AFFECTS,inhibitors,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",inhibitors Breast cancer metastatic
PREDISPOSES,Triclosan,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Triclosan Malignant neoplasm of breast
PREDISPOSES,Threonine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Threonine Malignant neoplasm of breast
PREDISPOSES,Medical History,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Medical History Malignant neoplasm of breast
PREDISPOSES,Progestins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Progestins Malignant neoplasm of breast
AFFECTS,Genomic Stability,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Genomic Stability Malignant neoplasm of breast
CAUSES,Doxorubicin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Doxorubicin Malignant neoplasm of breast
PREDISPOSES,bevacizumab,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,bevacizumab Malignant neoplasm of breast
PREDISPOSES,Prior Therapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Prior Therapy Malignant neoplasm of breast
AFFECTS,Medical Imaging,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Medical Imaging Malignant neoplasm of breast
AFFECTS,Xenograft procedure,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Xenograft procedure Malignant neoplasm of breast
AFFECTS,Ginkgo biloba extract,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Ginkgo biloba extract Malignant neoplasm of breast
AFFECTS,chemokine receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,chemokine receptor Malignant neoplasm of breast
AFFECTS,Therapeutic procedure,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Therapeutic procedure Breast cancer metastatic
PREDISPOSES,Vimentin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Vimentin Malignant neoplasm of breast
PREDISPOSES,MTR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,MTR Malignant neoplasm of breast
DISRUPTS,Carotenoids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Carotenoids Malignant neoplasm of breast
PREDISPOSES,Oxidoreductase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Oxidoreductase Malignant neoplasm of breast
CAUSES,Baclofen,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Baclofen Breast cancer metastatic
PREDISPOSES,Diphosphonates,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Diphosphonates Malignant neoplasm of breast
PREDISPOSES,Folate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Folate Malignant neoplasm of breast
PREDISPOSES,ORALIT,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ORALIT Malignant neoplasm of breast
PREDISPOSES,Carotenoids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Carotenoids Malignant neoplasm of breast
DISRUPTS,alpha-carotene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",alpha-carotene Malignant neoplasm of breast
CAUSES,"9,10-Dimethyl-1,2-benzanthracene",Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope","9,10-Dimethyl-1,2-benzanthracene Breast Carcinoma"
AFFECTS,Treatment Protocols,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Treatment Protocols Malignant neoplasm of breast
AUGMENTS,DHX9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,DHX9 Malignant neoplasm of breast
PREDISPOSES,Cigarette Smoking,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Cigarette Smoking Malignant neoplasm of breast
PREDISPOSES,stromelysin 3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,stromelysin 3 Malignant neoplasm of breast
PREDISPOSES,Worried,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Worried Malignant neoplasm of breast
PREDISPOSES,Raloxifene Hydrochloride,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,Raloxifene Hydrochloride Breast cancer invasive NOS
AUGMENTS,ANO1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ANO1 Malignant neoplasm of breast
AFFECTS,Diet,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Diet Malignant neoplasm of breast
AFFECTS,Operative Surgical Procedures,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Element, Ion, or Isotope",Operative Surgical Procedures Breast cancer invasive NOS
PREDISPOSES,alpha Tocopherol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",alpha Tocopherol Malignant neoplasm of breast
PREDISPOSES,Carrier status,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Carrier status Malignant neoplasm of breast
DISRUPTS,Doxorubicin,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Doxorubicin Breast Carcinoma
PREDISPOSES,distilled alcoholic beverage,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",distilled alcoholic beverage Malignant neoplasm of breast
PREDISPOSES,Flap Endonuclease-1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Flap Endonuclease-1 Malignant neoplasm of breast
AFFECTS,"Contraceptives, Oral",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Contraceptives, Oral Malignant neoplasm of breast"
PREDISPOSES,Whole milk,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Whole milk Malignant neoplasm of breast
PREDISPOSES,PARITY,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,PARITY Malignant neoplasm of breast
PREDISPOSES,Lymph Node Involvement,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Lymph Node Involvement Malignant neoplasm of breast
PREDISPOSES,Body Weight Changes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Body Weight Changes Malignant neoplasm of breast
PREDISPOSES,osteopontin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,osteopontin Malignant neoplasm of breast
AFFECTS,Progestins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Progestins Malignant neoplasm of breast
PREDISPOSES,Interleukin-4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Interleukin-4 Malignant neoplasm of breast
DISRUPTS,"Ether, Ethyl",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,"Ether, Ethyl Malignant neoplasm of breast"
AFFECTS,humoral defense mechanism (sensu Vertebrata),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,humoral defense mechanism (sensu Vertebrata) Malignant neoplasm of breast
CAUSES,gonadotropin inhibitor,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",gonadotropin inhibitor Breast Carcinoma
PREDISPOSES,Adverse effects,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Adverse effects Malignant neoplasm of breast
AFFECTS,Androgens,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Androgens Breast Carcinoma
PREDISPOSES,High fat diet NOS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",High fat diet NOS Malignant neoplasm of breast
AFFECTS,Polychlorinated Biphenyls,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Polychlorinated Biphenyls Malignant neoplasm of breast
PREDISPOSES,Conflict (Psychology),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Conflict (Psychology) Malignant neoplasm of breast
PREDISPOSES,CYR61,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,CYR61 Breast cancer metastatic
AFFECTS,Childbirth,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Childbirth Malignant neoplasm of breast
PREDISPOSES,Previous pregnancies 2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Previous pregnancies 2 Malignant neoplasm of breast
PREDISPOSES,Infertility,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Infertility Malignant neoplasm of breast
AFFECTS,Proanthocyanidins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Proanthocyanidins Malignant neoplasm of breast
AFFECTS,Chemotherapy-Oncologic Procedure,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Chemotherapy-Oncologic Procedure Malignant neoplasm of breast
AFFECTS,Systemic Therapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Systemic Therapy Malignant neoplasm of breast
AFFECTS,Folate,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Folate Breast Carcinoma
PREDISPOSES,Atypical lobular hyperplasia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Atypical lobular hyperplasia Malignant neoplasm of breast
PREDISPOSES,BCHE|SNORA73A|ENOPH1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,BCHE|SNORA73A|ENOPH1 Malignant neoplasm of breast
AFFECTS,Melatonin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Melatonin Malignant neoplasm of breast
PREDISPOSES,Diet,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Diet Malignant neoplasm of breast
AFFECTS,inhibitors,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",inhibitors Breast Carcinoma
AUGMENTS,Norplant,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Norplant Malignant neoplasm of breast
AFFECTS,Cholecalciferol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Cholecalciferol Malignant neoplasm of breast
CAUSES,inhibitors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",inhibitors Malignant neoplasm of breast
PREDISPOSES,Menopausal symptom,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Menopausal symptom Malignant neoplasm of breast
AFFECTS,inhibitors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",inhibitors Malignant neoplasm of breast
DISRUPTS,E-Cadherin,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,E-Cadherin Breast cancer invasive NOS
DISRUPTS,Galectin 3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Galectin 3 Malignant neoplasm of breast
PREDISPOSES,Hyperinsulinism,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Hyperinsulinism Malignant neoplasm of breast
AFFECTS,Estradiol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Estradiol Malignant neoplasm of breast
CAUSES,Ethylnitrosourea,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Ethylnitrosourea Malignant neoplasm of breast
PREDISPOSES,Beverages,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Beverages Malignant neoplasm of breast
PREDISPOSES,Meat intake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Meat intake Malignant neoplasm of breast
PREDISPOSES,Free estradiol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Free estradiol Malignant neoplasm of breast
AFFECTS,Operative Surgical Procedures,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Operative Surgical Procedures Malignant neoplasm of breast
AUGMENTS,KAT6A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,KAT6A Malignant neoplasm of breast
AFFECTS,Vegetables,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Vegetables Malignant neoplasm of breast
AFFECTS,Genistein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Genistein Malignant neoplasm of breast
CAUSES,Methylnitrosourea,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Methylnitrosourea Breast Carcinoma
PREDISPOSES,Smoker,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Smoker Malignant neoplasm of breast
DISRUPTS,Hydroxyestrones,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Hydroxyestrones Malignant neoplasm of breast
AFFECTS,Dietary Fiber,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Dietary Fiber Malignant neoplasm of breast
CAUSES,Diet,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Diet Malignant neoplasm of breast
CAUSES,Androgens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Androgens Malignant neoplasm of breast
CAUSES,Pesticides,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Pesticides Malignant neoplasm of breast
AFFECTS,Mastectomy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Mastectomy Malignant neoplasm of breast
DISRUPTS,dehydroepiandrosterone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,dehydroepiandrosterone Malignant neoplasm of breast
CAUSES,Paclitaxel,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Paclitaxel Malignant neoplasm of breast
PREDISPOSES,Oils,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Oils Malignant neoplasm of breast
AFFECTS,"9,10-Dimethyl-1,2-benzanthracene",Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope","9,10-Dimethyl-1,2-benzanthracene Breast Carcinoma"
CAUSES,Dactinomycin,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Dactinomycin Breast Carcinoma
AFFECTS,Early Diagnosis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Early Diagnosis Malignant neoplasm of breast
PREDISPOSES,Combined Oral Contraceptives,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Combined Oral Contraceptives Malignant neoplasm of breast
PREDISPOSES,Dietary Fats,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Dietary Fats Malignant neoplasm of breast
AFFECTS,Dysplasia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Dysplasia Malignant neoplasm of breast
PREDISPOSES,Dehydroepiandrosterone Sulfate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Dehydroepiandrosterone Sulfate Malignant neoplasm of breast
AFFECTS,Tetradecanoylphorbol Acetate,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Tetradecanoylphorbol Acetate Breast Carcinoma
PREDISPOSES,PREDICTED,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,PREDICTED Malignant neoplasm of breast
CAUSES,methylurea,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,methylurea Breast Carcinoma
AFFECTS,Birth,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Birth Malignant neoplasm of breast
AUGMENTS,Fibronectins,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Fibronectins Breast Carcinoma
CAUSES,Melatonin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Melatonin Malignant neoplasm of breast
AUGMENTS,Tenascin,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Tenascin Breast Carcinoma
PREDISPOSES,Cholestyramine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Cholestyramine Malignant neoplasm of breast
DISRUPTS,Progestins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Progestins Malignant neoplasm of breast
PREDISPOSES,Ovulatory,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Ovulatory Malignant neoplasm of breast
CAUSES,4'-deoxydoxorubicin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,4'-deoxydoxorubicin Malignant neoplasm of breast
AUGMENTS,Imidazole,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Imidazole Malignant neoplasm of breast
AFFECTS,paracrine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,paracrine Malignant neoplasm of breast
AUGMENTS,"Fats, Unsaturated",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,"Fats, Unsaturated Malignant neoplasm of breast"
AFFECTS,Somatomedins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Somatomedins Malignant neoplasm of breast
PREDISPOSES,Early menarche,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Early menarche Malignant neoplasm of breast
PREDISPOSES,Triceps skin fold thickness,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Triceps skin fold thickness Malignant neoplasm of breast
AFFECTS,Neoplasm,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Neoplasm Breast Carcinoma
AFFECTS,Pregnancy,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Pregnancy Breast Carcinoma
CAUSES,CATHEPSIN D|CTSD,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,CATHEPSIN D|CTSD Malignant neoplasm of breast
PREDISPOSES,"Contraceptives, Oral",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Contraceptives, Oral Malignant neoplasm of breast"
AFFECTS,PNMA3,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,PNMA3 Breast Carcinoma
PREDISPOSES,body mass,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",body mass Malignant neoplasm of breast
PREDISPOSES,Histopathology,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Histopathology Malignant neoplasm of breast
AFFECTS,Fluoroscopy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Fluoroscopy Malignant neoplasm of breast
PREDISPOSES,Cystic Fibrosis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Cystic Fibrosis Malignant neoplasm of breast
AFFECTS,Therapeutic procedure,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Therapeutic procedure Breast Carcinoma
AFFECTS,Alkaline Phosphatase,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Alkaline Phosphatase Breast Carcinoma
AFFECTS,Methoxamine,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Neoplastic Process,Methoxamine Noninfiltrating Intraductal Carcinoma
CAUSES,diphenyl,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,diphenyl Breast Carcinoma
AFFECTS,Relaxin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Relaxin Malignant neoplasm of breast
DISRUPTS,Fucose,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Fucose Breast Carcinoma
CAUSES,Glycol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Glycol Malignant neoplasm of breast
AFFECTS,"Chemotherapy, Adjuvant","Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,"Element, Ion, or Isotope","Chemotherapy, Adjuvant Carcinoma, Ductal, Breast"
AFFECTS,adjuvant therapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",adjuvant therapy Malignant neoplasm of breast
CAUSES,estrophilin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,estrophilin Malignant neoplasm of breast
PREDISPOSES,"Breast Fibrocystic Change, Proliferative Type",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Breast Fibrocystic Change, Proliferative Type Malignant neoplasm of breast"
PREDISPOSES,G-Actin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,G-Actin Malignant neoplasm of breast
AFFECTS,Theophylline,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Theophylline Malignant neoplasm of breast
PREDISPOSES,Androgens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Androgens Malignant neoplasm of breast
AFFECTS,Cisplatin,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Cisplatin Breast cancer metastatic
AUGMENTS,Cyclin D1|LMOD1|BBS9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Cyclin D1|LMOD1|BBS9 Malignant neoplasm of breast
AFFECTS,Aggressive behavior,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Aggressive behavior Malignant neoplasm of breast
AFFECTS,Screening mammography,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Screening mammography Breast Carcinoma
COMPLICATES,Schistosomiasis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Schistosomiasis Malignant neoplasm of breast
AUGMENTS,Gonadorelin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Gonadorelin Malignant neoplasm of breast
AFFECTS,"Chemotherapy, Adjuvant",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Chemotherapy, Adjuvant Malignant neoplasm of breast"
PREDISPOSES,Prolactin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Prolactin Malignant neoplasm of breast
AUGMENTS,Ethanol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Ethanol Malignant neoplasm of breast
PREDISPOSES,Estradiol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Estradiol Malignant neoplasm of breast
PREDISPOSES,Polychlorinated Biphenyls,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,"Element, Ion, or Isotope",Polychlorinated Biphenyls Female Breast Carcinoma
PREDISPOSES,Dietary fat intake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Dietary fat intake Malignant neoplasm of breast
AFFECTS,Brain hemorrhage,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,"Element, Ion, or Isotope","Brain hemorrhage Carcinoma, Ductal, Breast"
AFFECTS,Ethanol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Ethanol Malignant neoplasm of breast
PREDISPOSES,Alleles,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Alleles Breast Carcinoma
AFFECTS,Mammography,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Mammography Malignant neoplasm of breast
DISRUPTS,"(meso-1,2-bis-(2,6-dichloro-4-hydroxyphenyl)ethylenediamine)dichloroplatinum(II)",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","(meso-1,2-bis-(2,6-dichloro-4-hydroxyphenyl)ethylenediamine)dichloroplatinum(II) Malignant neoplasm of breast"
PREDISPOSES,Long menstrual cycle,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Long menstrual cycle Malignant neoplasm of breast
PREDISPOSES,Tobacco,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Tobacco Malignant neoplasm of breast
AFFECTS,"Receptors, Nuclear",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Receptors, Nuclear Malignant neoplasm of breast"
AFFECTS,beta catenin,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Element, Ion, or Isotope",beta catenin Breast cancer invasive NOS
AFFECTS,celecoxib,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,celecoxib Malignant neoplasm of breast
PREDISPOSES,COMT,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,COMT Malignant neoplasm of breast
DISRUPTS,Retinoids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Retinoids Malignant neoplasm of breast
PREDISPOSES,Beer,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Beer Malignant neoplasm of breast
CAUSES,Antioxidants,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Antioxidants Breast Carcinoma
AFFECTS,CAMP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",CAMP Malignant neoplasm of breast
CAUSES,Dietary Fats,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Dietary Fats Malignant neoplasm of breast
AFFECTS,Polyamines,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Polyamines Malignant neoplasm of breast
CAUSES,Silicones,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Silicones Breast Carcinoma
PREDISPOSES,Glycosylated hemoglobin A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Glycosylated hemoglobin A Malignant neoplasm of breast
PREDISPOSES,Ethylene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Ethylene Malignant neoplasm of breast
DISRUPTS,maspin|SERPINB5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,maspin|SERPINB5 Malignant neoplasm of breast
PREDISPOSES,Psychological adjustment,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Psychological adjustment Malignant neoplasm of breast
AFFECTS,diagnostic procedure,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",diagnostic procedure Malignant neoplasm of breast
AFFECTS,APC,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",APC Malignant neoplasm of breast
PREDISPOSES,High weight,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",High weight Malignant neoplasm of breast
AUGMENTS,"Contraceptives, Oral",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Contraceptives, Oral Malignant neoplasm of breast"
PREDISPOSES,Microsatellite Instability,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Microsatellite Instability Malignant neoplasm of breast
PREDISPOSES,Raloxifene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Raloxifene Malignant neoplasm of breast
AFFECTS,Mismatch Repair,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Mismatch Repair Malignant neoplasm of breast
AFFECTS,Urokinase Plasminogen Activator Receptor|PLAU|PRAP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Urokinase Plasminogen Activator Receptor|PLAU|PRAP1 Malignant neoplasm of breast
DISRUPTS,Venoms,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Venoms Malignant neoplasm of breast
PREDISPOSES,Pre-Eclampsia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Pre-Eclampsia Malignant neoplasm of breast
AUGMENTS,Progestins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Progestins Malignant neoplasm of breast
CAUSES,Prolactin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Prolactin Malignant neoplasm of breast
AFFECTS,Curative Surgery,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Curative Surgery Malignant neoplasm of breast
CAUSES,methylurea,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,methylurea Malignant neoplasm of breast
AFFECTS,Dietary intake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Dietary intake Malignant neoplasm of breast
PREDISPOSES,Thromboembolism,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Thromboembolism Malignant neoplasm of breast
DISRUPTS,Genistein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Genistein Malignant neoplasm of breast
AUGMENTS,beta catenin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",beta catenin Malignant neoplasm of breast
PREDISPOSES,Dieldrin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Dieldrin Malignant neoplasm of breast
AUGMENTS,fascin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,fascin Malignant neoplasm of breast
CAUSES,Polychlorinated Biphenyls,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,"Element, Ion, or Isotope",Polychlorinated Biphenyls Female Breast Carcinoma
PREDISPOSES,Sausage,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Sausage Malignant neoplasm of breast
AUGMENTS,cofactor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",cofactor Malignant neoplasm of breast
PREDISPOSES,Dichlorodiphenyl Dichloroethylene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Dichlorodiphenyl Dichloroethylene Malignant neoplasm of breast
CAUSES,Intrinsic factor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Intrinsic factor Malignant neoplasm of breast
PREDISPOSES,GGCT,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,GGCT Malignant neoplasm of breast
CAUSES,Amines,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Neoplastic Process,Amines Ductal Breast Carcinoma
PREDISPOSES,"Etiology, operative procedure, as cause of",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Etiology, operative procedure, as cause of Malignant neoplasm of breast"
AUGMENTS,estrone sulfatase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,estrone sulfatase Malignant neoplasm of breast
PREDISPOSES,Beer intake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Beer intake Malignant neoplasm of breast
AFFECTS,trilostane,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,trilostane Malignant neoplasm of breast
PREDISPOSES,Development of the breasts,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Development of the breasts Malignant neoplasm of breast
AFFECTS,Breast Feeding,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Breast Feeding Malignant neoplasm of breast
CAUSES,B-pyridine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,B-pyridine Malignant neoplasm of breast
PREDISPOSES,Mastodynia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Mastodynia Malignant neoplasm of breast
AFFECTS,NFKB1,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Disease or Syndrome,NFKB1 Sporadic Breast Carcinoma
CAUSES,AROMATICS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,AROMATICS Malignant neoplasm of breast
PREDISPOSES,Symptoms,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Symptoms Malignant neoplasm of breast
PREDISPOSES,KLK14,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,KLK14 Malignant neoplasm of breast
PREDISPOSES,Tocopherols,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Tocopherols Malignant neoplasm of breast
AFFECTS,Permeability,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Permeability Breast cancer metastatic
AUGMENTS,ATP7B,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,ATP7B Breast Carcinoma
DISRUPTS,GGCT,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,GGCT Malignant neoplasm of breast
CAUSES,"2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine",Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope","2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine Breast Carcinoma"
PREDISPOSES,Tryptophan|TYRP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Tryptophan|TYRP1 Malignant neoplasm of breast
PREDISPOSES,"Mastitis, associated with childbirth",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Mastitis, associated with childbirth Malignant neoplasm of breast"
DISRUPTS,SLC19A3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,SLC19A3 Malignant neoplasm of breast
PREDISPOSES,Bone Density,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Bone Density Malignant neoplasm of breast
AFFECTS,ERBB2|NEU1|NEURL1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",ERBB2|NEU1|NEURL1 Malignant neoplasm of breast
AFFECTS,CYR61,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",CYR61 Malignant neoplasm of breast
AFFECTS,Raloxifene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Raloxifene Malignant neoplasm of breast
AFFECTS,LMO4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,LMO4 Malignant neoplasm of breast
DISRUPTS,Peptidyl-Dipeptidase A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Peptidyl-Dipeptidase A Malignant neoplasm of breast
AUGMENTS,Immunologic Adjuvants,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Immunologic Adjuvants Malignant neoplasm of breast
AFFECTS,SNAI3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,SNAI3 Malignant neoplasm of breast
AFFECTS,Diphosphonates,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Diphosphonates Malignant neoplasm of breast
CAUSES,Mammary Neoplasms,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Mammary Neoplasms Malignant neoplasm of breast
DISRUPTS,Soybean Oil,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Soybean Oil Malignant neoplasm of breast
AUGMENTS,PPIG,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,PPIG Malignant neoplasm of breast
CAUSES,"Contraceptives, Oral",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Contraceptives, Oral Malignant neoplasm of breast"
PREDISPOSES,Polychlorinated Biphenyls,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Polychlorinated Biphenyls Malignant neoplasm of breast
AUGMENTS,Somatomedins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Somatomedins Malignant neoplasm of breast
AUGMENTS,11q13,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,11q13 Malignant neoplasm of breast
DISRUPTS,Raloxifene,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,Raloxifene Breast cancer invasive NOS
PREDISPOSES,Somatomedins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Somatomedins Malignant neoplasm of breast
PREDISPOSES,Vegetables,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Vegetables Malignant neoplasm of breast
PREDISPOSES,Chronic Stress,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Chronic Stress Malignant neoplasm of breast
AUGMENTS,PIN1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",PIN1 Malignant neoplasm of breast
DISRUPTS,maspin|SERPINB5,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,maspin|SERPINB5 Breast Carcinoma
PREDISPOSES,Leptin|LEP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Leptin|LEP Malignant neoplasm of breast
AFFECTS,Aneuploidy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Aneuploidy Malignant neoplasm of breast
CAUSES,ERBB2|NEU1|NEURL1,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",ERBB2|NEU1|NEURL1 Breast Carcinoma
PREDISPOSES,Kininogenase|KLK4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Kininogenase|KLK4 Malignant neoplasm of breast
AFFECTS,BONE MASS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",BONE MASS Malignant neoplasm of breast
PREDISPOSES,BIRTHPLACE,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,BIRTHPLACE Malignant neoplasm of breast
PREDISPOSES,Skin problem,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Skin problem Malignant neoplasm of breast
PREDISPOSES,Mammographic breast density,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Mammographic breast density Malignant neoplasm of breast
AFFECTS,Dietary Fats,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Dietary Fats Malignant neoplasm of breast
AFFECTS,mammary gland development,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",mammary gland development Malignant neoplasm of breast
CAUSES,19p13.3,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,19p13.3 Breast Carcinoma
AUGMENTS,Leucine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Leucine Malignant neoplasm of breast
AFFECTS,Magnetic Resonance Imaging,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Magnetic Resonance Imaging Malignant neoplasm of breast
CAUSES,EMSY,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,EMSY Malignant neoplasm of breast
CAUSES,Folate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Folate Malignant neoplasm of breast
CAUSES,Diethylstilbestrol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Diethylstilbestrol Malignant neoplasm of breast
AFFECTS,Normal growth,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Normal growth Malignant neoplasm of breast
PREDISPOSES,Environmental Pollutants,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Environmental Pollutants Malignant neoplasm of breast
PREDISPOSES,stressor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,stressor Malignant neoplasm of breast
DISRUPTS,connexin 26,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",connexin 26 Malignant neoplasm of breast
PREDISPOSES,Stromal Cell-Derived Factor 1|CXCL12,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Stromal Cell-Derived Factor 1|CXCL12 Malignant neoplasm of breast
AFFECTS,Somatomedins,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Somatomedins Breast cancer metastatic
PREDISPOSES,Urokinase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Urokinase Malignant neoplasm of breast
PREDISPOSES,Pollutant,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Pollutant Malignant neoplasm of breast
PREDISPOSES,Gelatinase B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Gelatinase B Malignant neoplasm of breast
DISRUPTS,SPRY2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,SPRY2 Malignant neoplasm of breast
AFFECTS,protective factors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",protective factors Malignant neoplasm of breast
PREDISPOSES,Raloxifene,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,Raloxifene Breast cancer invasive NOS
AFFECTS,Oxidative Stress,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,"Element, Ion, or Isotope",Oxidative Stress Carcinoma of Male Breast
PREDISPOSES,Prenatal Exposure,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Prenatal Exposure Malignant neoplasm of breast
PREDISPOSES,Diastolic blood pressure,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Diastolic blood pressure Malignant neoplasm of breast
CAUSES,Neoplasm,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Neoplasm Malignant neoplasm of breast
PREDISPOSES,Short menstrual cycle,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Short menstrual cycle Malignant neoplasm of breast
PREDISPOSES,Osteoporosis,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,Osteoporosis Breast cancer invasive NOS
PREDISPOSES,Cruciferous Vegetable,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Cruciferous Vegetable Malignant neoplasm of breast
PREDISPOSES,Coffee,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Coffee Malignant neoplasm of breast
PREDISPOSES,Calcium,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Calcium Malignant neoplasm of breast
AFFECTS,Fruit,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Fruit Malignant neoplasm of breast
PREDISPOSES,isoflavonoids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,isoflavonoids Malignant neoplasm of breast
AFFECTS,SLC25A18,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,SLC25A18 Malignant neoplasm of breast
AFFECTS,Juice,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Juice Malignant neoplasm of breast
PREDISPOSES,"Hemoglobin, Glycosylated",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,"Hemoglobin, Glycosylated Malignant neoplasm of breast"
CAUSES,Granulocyte Colony-Stimulating Factor,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,"Element, Ion, or Isotope",Granulocyte Colony-Stimulating Factor Ductal Breast Carcinoma
AFFECTS,Meat,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Meat Malignant neoplasm of breast
PREDISPOSES,Isoleucine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Isoleucine Malignant neoplasm of breast
CAUSES,Carotenoids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Carotenoids Malignant neoplasm of breast
PREDISPOSES,Fat tissue increased,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Fat tissue increased Malignant neoplasm of breast
PREDISPOSES,indole-3-carbinol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,indole-3-carbinol Malignant neoplasm of breast
AUGMENTS,Isoflavones,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Isoflavones Malignant neoplasm of breast
PREDISPOSES,Cyclin D1|LMOD1|BBS9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Cyclin D1|LMOD1|BBS9 Malignant neoplasm of breast
PREDISPOSES,Abruptio Placentae,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Abruptio Placentae Malignant neoplasm of breast
PREDISPOSES,Fruit,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Fruit Malignant neoplasm of breast
PREDISPOSES,Vegetable intake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Vegetable intake Malignant neoplasm of breast
AFFECTS,Postmenopause,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Postmenopause Malignant neoplasm of breast
CAUSES,caveolin 1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,caveolin 1 Malignant neoplasm of breast
CAUSES,Androgen Receptor|AR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Androgen Receptor|AR Malignant neoplasm of breast
PREDISPOSES,Melatonin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Melatonin Malignant neoplasm of breast
PREDISPOSES,Lobular hyperplasia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Lobular hyperplasia Malignant neoplasm of breast
CAUSES,Prolactin|PRL,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Prolactin|PRL Malignant neoplasm of breast
PREDISPOSES,Iron intake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Iron intake Malignant neoplasm of breast
PREDISPOSES,"Hyperparathyroidism, Primary",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Hyperparathyroidism, Primary Malignant neoplasm of breast"
AFFECTS,Magnetic field,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,"Element, Ion, or Isotope",Magnetic field Female Breast Carcinoma
PREDISPOSES,Obesity,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,"Element, Ion, or Isotope",Obesity Inflammatory Breast Carcinoma
CAUSES,sulforafan,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,sulforafan Malignant neoplasm of breast
PREDISPOSES,Hyposensitivity,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Hyposensitivity Malignant neoplasm of breast
PREDISPOSES,decaffeinated coffee,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,decaffeinated coffee Malignant neoplasm of breast
PREDISPOSES,mammaglobin,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",mammaglobin Breast cancer metastatic
AUGMENTS,ADAM12,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ADAM12 Malignant neoplasm of breast
PREDISPOSES,Integrin beta3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Integrin beta3 Malignant neoplasm of breast
AFFECTS,Motility,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Motility Breast cancer metastatic
DISRUPTS,CDV3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,CDV3 Malignant neoplasm of breast
AUGMENTS,SR-2508,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,SR-2508 Malignant neoplasm of breast
PREDISPOSES,Quercetin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Quercetin Malignant neoplasm of breast
DISRUPTS,PBRM1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,PBRM1 Malignant neoplasm of breast
CAUSES,Hydroxymethylglutaryl-CoA Reductase Inhibitors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Hydroxymethylglutaryl-CoA Reductase Inhibitors Malignant neoplasm of breast
AUGMENTS,CISH,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,CISH Malignant neoplasm of breast
PREDISPOSES,Adiponectin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Adiponectin Malignant neoplasm of breast
COMPLICATES,Adverse effects,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Adverse effects Malignant neoplasm of breast
AFFECTS,caspase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,caspase Malignant neoplasm of breast
CAUSES,hemagglutinin I,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,hemagglutinin I Breast Carcinoma
PREDISPOSES,"Menopause, Premature",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,"Menopause, Premature Malignant neoplasm of breast"
DISRUPTS,APOA1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",APOA1 Malignant neoplasm of breast
AFFECTS,Prolactin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Prolactin Malignant neoplasm of breast
AFFECTS,Combined Modality Therapy,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Element, Ion, or Isotope",Combined Modality Therapy Breast cancer recurrent
AFFECTS,beta-adrenergic receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",beta-adrenergic receptor Malignant neoplasm of breast
PREDISPOSES,SLC45A2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",SLC45A2 Malignant neoplasm of breast
DISRUPTS,ERBB2|NEU1|NEURL1,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",ERBB2|NEU1|NEURL1 Breast Carcinoma
PREDISPOSES,Exercise,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Exercise Malignant neoplasm of breast
PREDISPOSES,Biguanides,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Biguanides Malignant neoplasm of breast
PREDISPOSES,KLLN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,KLLN Malignant neoplasm of breast
AFFECTS,MLLT11,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",MLLT11 Breast cancer metastatic
PREDISPOSES,Drink,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Drink Malignant neoplasm of breast
AFFECTS,Indigotindisulfonate Sodium,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Indigotindisulfonate Sodium Malignant neoplasm of breast
AFFECTS,Catechin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Catechin Malignant neoplasm of breast
AFFECTS,Garlic,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Garlic Malignant neoplasm of breast
AFFECTS,"Xeroderma pigmentosum, group C",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Xeroderma pigmentosum, group C Malignant neoplasm of breast"
AFFECTS,Ultrasonography,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Ultrasonography Breast cancer metastatic
AFFECTS,Androgen therapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Androgen therapy Malignant neoplasm of breast
AFFECTS,erlotinib,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",erlotinib Breast cancer metastatic
AFFECTS,Sentinel Lymph Node Mapping,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Sentinel Lymph Node Mapping Malignant neoplasm of breast
PREDISPOSES,RAD50,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,RAD50 Malignant neoplasm of breast
PREDISPOSES,Sedentary,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Sedentary Malignant neoplasm of breast
PREDISPOSES,BLCAP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,BLCAP Malignant neoplasm of breast
AFFECTS,CpG Islands,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",CpG Islands Malignant neoplasm of breast
PREDISPOSES,14q31,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,14q31 Malignant neoplasm of breast
DISRUPTS,Hydroxymethylglutaryl-CoA Reductase Inhibitors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Hydroxymethylglutaryl-CoA Reductase Inhibitors Malignant neoplasm of breast
DISRUPTS,"2,5-dichloro-4-bromophenol",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,"2,5-dichloro-4-bromophenol Malignant neoplasm of breast"
AFFECTS,DUSP4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",DUSP4 Malignant neoplasm of breast
PREDISPOSES,Interleukin-6,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,Interleukin-6 Breast cancer metastatic
PREDISPOSES,Breast tenderness,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Breast tenderness Malignant neoplasm of breast
AFFECTS,gemcitabine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,gemcitabine Malignant neoplasm of breast
AFFECTS,Screening mammography,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Screening mammography Malignant neoplasm of breast
PREDISPOSES,Isoflavones,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Isoflavones Malignant neoplasm of breast
PREDISPOSES,Pumpkin seeds,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Pumpkin seeds Malignant neoplasm of breast
PREDISPOSES,Fruit intake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Fruit intake Malignant neoplasm of breast
PREDISPOSES,Decreased translucency,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Decreased translucency Malignant neoplasm of breast
AFFECTS,atorvastatin,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,atorvastatin Breast Carcinoma
PREDISPOSES,Collagen,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Collagen Breast Carcinoma
AFFECTS,1-Phosphatidylinositol 3-Kinase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",1-Phosphatidylinositol 3-Kinase Malignant neoplasm of breast
PREDISPOSES,Nitrate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Nitrate Malignant neoplasm of breast
AUGMENTS,Angiopoietin-2|ANG,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Angiopoietin-2|ANG Breast Carcinoma
AFFECTS,receptor,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",receptor Breast cancer metastatic
CAUSES,Mucins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Mucins Malignant neoplasm of breast
PREDISPOSES,Folate intake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Folate intake Malignant neoplasm of breast
AFFECTS,Phosphotransferases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Phosphotransferases Malignant neoplasm of breast
AUGMENTS,Flavonoids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Flavonoids Malignant neoplasm of breast
PREDISPOSES,Animal Feed,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Animal Feed Malignant neoplasm of breast
PREDISPOSES,BRD7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",BRD7 Malignant neoplasm of breast
PREDISPOSES,Body mass index,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",Body mass index Noninfiltrating Intraductal Carcinoma
PREDISPOSES,Atypical hyperplasia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Atypical hyperplasia Malignant neoplasm of breast
DISRUPTS,Quercetin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Quercetin Malignant neoplasm of breast
AFFECTS,Obesity,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Obesity Malignant neoplasm of breast
DISRUPTS,BRIP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,BRIP1 Malignant neoplasm of breast
AFFECTS,Hypoxia,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Neoplastic Process,"Hypoxia Carcinoma, Ductal, Breast"
PREDISPOSES,ERBB2|NEU1|NEURL1,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",ERBB2|NEU1|NEURL1 Breast Carcinoma
CAUSES,FOXP3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",FOXP3 Malignant neoplasm of breast
AFFECTS,Serine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Serine Malignant neoplasm of breast
DISRUPTS,lycopene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,lycopene Malignant neoplasm of breast
PREDISPOSES,SRSF1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",SRSF1 Malignant neoplasm of breast
PREDISPOSES,"Nuclear Receptor Subfamily 4, Group A, Member 1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Nuclear Receptor Subfamily 4, Group A, Member 1 Malignant neoplasm of breast"
AUGMENTS,Leptin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Leptin Malignant neoplasm of breast
AFFECTS,"Antibodies, Anti-Idiotypic",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Antibodies, Anti-Idiotypic Malignant neoplasm of breast"
PREDISPOSES,paclitaxel liposome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,paclitaxel liposome Malignant neoplasm of breast
PREDISPOSES,Alleles,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Alleles Malignant neoplasm of breast
PREDISPOSES,"Interferon Alpha, Human|IFNA1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","Interferon Alpha, Human|IFNA1 Malignant neoplasm of breast"
PREDISPOSES,"Insulin, Long-Acting",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Insulin, Long-Acting Malignant neoplasm of breast"
AFFECTS,Prolactin|PRL,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Prolactin|PRL Malignant neoplasm of breast
AFFECTS,"Radiotherapy, Adjuvant",Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,"Element, Ion, or Isotope","Radiotherapy, Adjuvant Contralateral breast cancer"
DISRUPTS,Taxol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Taxol Malignant neoplasm of breast
CAUSES,SPDEF,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",SPDEF Malignant neoplasm of breast
AUGMENTS,S100A4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,S100A4 Malignant neoplasm of breast
AFFECTS,equol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,equol Malignant neoplasm of breast
AFFECTS,VEGFA,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",VEGFA Noninfiltrating Intraductal Carcinoma
PREDISPOSES,BRIP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,BRIP1 Malignant neoplasm of breast
AFFECTS,BEX2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,BEX2 Malignant neoplasm of breast
PREDISPOSES,Atypical antipsychotic,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Atypical antipsychotic Malignant neoplasm of breast
PREDISPOSES,CISH,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,CISH Malignant neoplasm of breast
PREDISPOSES,METHYLATE,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,METHYLATE Malignant neoplasm of breast
CAUSES,GPER1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",GPER1 Malignant neoplasm of breast
PREDISPOSES,NCOA3|ANIB1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",NCOA3|ANIB1 Malignant neoplasm of breast
AFFECTS,Xenograft Model,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Xenograft Model Breast cancer metastatic
PREDISPOSES,Progestins,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Progestins Breast Carcinoma
AFFECTS,Therapeutic procedure,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,"Element, Ion, or Isotope",Therapeutic procedure Inflammatory Breast Carcinoma
PREDISPOSES,response,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",response Breast cancer metastatic
PREDISPOSES,RASSF1A,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,"Element, Ion, or Isotope",RASSF1A Female Breast Carcinoma
PREDISPOSES,Thyrotropin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Thyrotropin Malignant neoplasm of breast
PREDISPOSES,HDAC9,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",HDAC9 Breast cancer metastatic
AFFECTS,Gelatinase A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Gelatinase A Malignant neoplasm of breast
PREDISPOSES,ITGA11,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ITGA11 Malignant neoplasm of breast
PREDISPOSES,TOX3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,TOX3 Malignant neoplasm of breast
PREDISPOSES,Physically active,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Physically active Malignant neoplasm of breast
AFFECTS,Niacinamide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Niacinamide Malignant neoplasm of breast
AFFECTS,epigallocatechin gallate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,epigallocatechin gallate Malignant neoplasm of breast
AFFECTS,Paravertebral anesthesia,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,Paravertebral anesthesia Breast cancer metastatic
AFFECTS,"Psychotherapy, Multiple",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Psychotherapy, Multiple Malignant neoplasm of breast"
PREDISPOSES,Body Weight decreased,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Body Weight decreased Malignant neoplasm of breast
PREDISPOSES,Collagen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Collagen Malignant neoplasm of breast
AFFECTS,fisetin,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",fisetin Breast cancer metastatic
AUGMENTS,GM2A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,GM2A Malignant neoplasm of breast
PREDISPOSES,MIR655,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,MIR655 Malignant neoplasm of breast
AFFECTS,peoniflorin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,peoniflorin Malignant neoplasm of breast
PREDISPOSES,Phosphatidylethanolamine N-Methyltransferase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Phosphatidylethanolamine N-Methyltransferase Malignant neoplasm of breast
DISRUPTS,SPRY1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,SPRY1 Malignant neoplasm of breast
PREDISPOSES,Choline,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Choline Malignant neoplasm of breast
PREDISPOSES,Depressed mood,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Depressed mood Breast cancer metastatic
AUGMENTS,Fibronectins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Fibronectins Malignant neoplasm of breast
CAUSES,Lipopolysaccharides,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Lipopolysaccharides Malignant neoplasm of breast
AFFECTS,Pharmacotherapy,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Pharmacotherapy Breast cancer metastatic
PREDISPOSES,14q24.1,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,"Element, Ion, or Isotope",14q24.1 Female Breast Carcinoma
PREDISPOSES,Cyclophosphamide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Cyclophosphamide Malignant neoplasm of breast
CAUSES,SOAT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,SOAT1 Malignant neoplasm of breast
AFFECTS,HIF1A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",HIF1A Malignant neoplasm of breast
PREDISPOSES,Dietary fiber intake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Dietary fiber intake Malignant neoplasm of breast
PREDISPOSES,PALB2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",PALB2 Malignant neoplasm of breast
PREDISPOSES,Atypical hyperplasia,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Element, Ion, or Isotope",Atypical hyperplasia Breast cancer invasive NOS
PREDISPOSES,ARNTL,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ARNTL Malignant neoplasm of breast
DISRUPTS,PORPHOBILINOGEN SYNTHASE|ALAD,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",PORPHOBILINOGEN SYNTHASE|ALAD Malignant neoplasm of breast
AFFECTS,Histone Deacetylase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Histone Deacetylase Malignant neoplasm of breast
PREDISPOSES,Physical activity,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Element, Ion, or Isotope",Physical activity Breast cancer recurrent
AFFECTS,Tubulin,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Tubulin Breast cancer metastatic
PREDISPOSES,MBTPS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,MBTPS1 Malignant neoplasm of breast
PREDISPOSES,ZNF423,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ZNF423 Malignant neoplasm of breast
PREDISPOSES,6q25.1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,6q25.1 Malignant neoplasm of breast
DISRUPTS,Transcript,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Transcript Malignant neoplasm of breast
PREDISPOSES,TRIM25,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",TRIM25 Breast cancer metastatic
DISRUPTS,MIR520C,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,MIR520C Malignant neoplasm of breast
CAUSES,Tetradecanoylphorbol Acetate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Tetradecanoylphorbol Acetate Malignant neoplasm of breast
PREDISPOSES,C6orf106,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,C6orf106 Malignant neoplasm of breast
DISRUPTS,UBE3A,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",UBE3A Breast cancer metastatic
AFFECTS,Pesticides,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Pesticides Malignant neoplasm of breast
AUGMENTS,Estradiol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Estradiol Malignant neoplasm of breast
DISRUPTS,"Receptors, Interleukin-1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Receptors, Interleukin-1 Malignant neoplasm of breast"
AFFECTS,G0S2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,G0S2 Malignant neoplasm of breast
CAUSES,Phosphoric Monoester Hydrolases,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Phosphoric Monoester Hydrolases Breast cancer metastatic
PREDISPOSES,Death (finding),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Death (finding) Malignant neoplasm of breast
CAUSES,F Factor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,F Factor Malignant neoplasm of breast
PREDISPOSES,"Diabetes Mellitus, Non-Insulin-Dependent",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Diabetes Mellitus, Non-Insulin-Dependent Malignant neoplasm of breast"
PREDISPOSES,TFF3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",TFF3 Malignant neoplasm of breast
CAUSES,Advance,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Advance Malignant neoplasm of breast
AFFECTS,Curcumin,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Curcumin Breast cancer metastatic
AFFECTS,Neoadjuvant Therapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Neoadjuvant Therapy Malignant neoplasm of breast
PREDISPOSES,PLAC1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,PLAC1 Malignant neoplasm of breast
AFFECTS,docetaxel,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,docetaxel Malignant neoplasm of breast
PREDISPOSES,Overweight,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Overweight Malignant neoplasm of breast
DISRUPTS,NF-kappa B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,NF-kappa B Malignant neoplasm of breast
AFFECTS,Zinc,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Zinc Malignant neoplasm of breast
CAUSES,Lymph,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Lymph Malignant neoplasm of breast
AFFECTS,SETD7,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",SETD7 Breast cancer metastatic
AFFECTS,PIP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,PIP Malignant neoplasm of breast
AFFECTS,CYP27A1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",CYP27A1 Malignant neoplasm of breast
AUGMENTS,P2RY6,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",P2RY6 Breast cancer metastatic
CAUSES,MAGI3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,MAGI3 Malignant neoplasm of breast
AFFECTS,diallyl disulfide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,diallyl disulfide Malignant neoplasm of breast
PREDISPOSES,Performance,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Performance Malignant neoplasm of breast
AFFECTS,Dietary Component,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Dietary Component Malignant neoplasm of breast
AFFECTS,Transcript,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Transcript Breast cancer metastatic
PREDISPOSES,Metabolites,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Metabolites Malignant neoplasm of breast
AUGMENTS,stanniocalcin 2,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",stanniocalcin 2 Breast cancer recurrent
DISRUPTS,Paclitaxel,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Paclitaxel Breast cancer metastatic
AUGMENTS,synaptotagmin I|RELA|SYT1|GORASP1|WNK1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",synaptotagmin I|RELA|SYT1|GORASP1|WNK1 Malignant neoplasm of breast
AFFECTS,EPHB2|MAPK1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",EPHB2|MAPK1 Malignant neoplasm of breast
AFFECTS,Soluble ErbB-1|EGFR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Soluble ErbB-1|EGFR Malignant neoplasm of breast
AUGMENTS,CYR61,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",CYR61 Malignant neoplasm of breast
AFFECTS,Primary Neoplasm,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Primary Neoplasm Malignant neoplasm of breast
AUGMENTS,CAMK2B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,CAMK2B Malignant neoplasm of breast
AFFECTS,HOXD10,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,HOXD10 Breast cancer metastatic
AFFECTS,Honey,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Honey Malignant neoplasm of breast
DISRUPTS,Polymerase|ERVK-9|ERVK-19|ERVK-11,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Polymerase|ERVK-9|ERVK-19|ERVK-11 Malignant neoplasm of breast
PREDISPOSES,Synaptophysin|SYP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Synaptophysin|SYP Malignant neoplasm of breast
AFFECTS,ADIPOR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ADIPOR1 Malignant neoplasm of breast
AUGMENTS,ISL1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ISL1 Malignant neoplasm of breast
PREDISPOSES,Interleukin-2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Interleukin-2 Malignant neoplasm of breast
CAUSES,Estradiol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Estradiol Malignant neoplasm of breast
AFFECTS,Granulocyte-Macrophage Colony-Stimulating Factor|CSF2|LAMC2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Granulocyte-Macrophage Colony-Stimulating Factor|CSF2|LAMC2 Breast cancer metastatic
AFFECTS,Gelatinase B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Gelatinase B Malignant neoplasm of breast
AFFECTS,Tocopherols,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Tocopherols Malignant neoplasm of breast
DISRUPTS,Anthocyanins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Anthocyanins Malignant neoplasm of breast
PREDISPOSES,DMXL2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,DMXL2 Malignant neoplasm of breast
AFFECTS,Curcumin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Curcumin Malignant neoplasm of breast
PREDISPOSES,POU5F1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",POU5F1 Malignant neoplasm of breast
PREDISPOSES,Stromal Cell-Derived Factor 1,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Stromal Cell-Derived Factor 1 Breast Carcinoma
AUGMENTS,WBP2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",WBP2 Malignant neoplasm of breast
DISRUPTS,myricetin,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",myricetin Breast cancer metastatic
PREDISPOSES,Ethanol,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,Ethanol Breast cancer invasive NOS
AFFECTS,Ultrasonography,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Ultrasonography Malignant neoplasm of breast
AUGMENTS,PITX2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",PITX2 Malignant neoplasm of breast
AUGMENTS,SUMO1P3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,SUMO1P3 Malignant neoplasm of breast
AFFECTS,Autophagy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Autophagy Malignant neoplasm of breast
DISRUPTS,SOHLH2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",SOHLH2 Breast cancer metastatic
AUGMENTS,Clomiphene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Clomiphene Malignant neoplasm of breast
AFFECTS,discoidin domain receptor 1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,discoidin domain receptor 1 Malignant neoplasm of breast
PREDISPOSES,NEK6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,NEK6 Malignant neoplasm of breast
AFFECTS,O-GlcNAc transferase,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",O-GlcNAc transferase Breast cancer metastatic
AFFECTS,Tea,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Tea Malignant neoplasm of breast
AFFECTS,ACKR3,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",ACKR3 Breast cancer metastatic
AFFECTS,Cisplatin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Cisplatin Malignant neoplasm of breast
AFFECTS,Cisplatin,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Cisplatin Breast Carcinoma
AFFECTS,Dinoprostone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Dinoprostone Malignant neoplasm of breast
PREDISPOSES,Transcriptase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Transcriptase Malignant neoplasm of breast
AFFECTS,Immunity,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Immunity Malignant neoplasm of breast
PREDISPOSES,Reading,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Reading Malignant neoplasm of breast
PREDISPOSES,Tea,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Tea Malignant neoplasm of breast
CAUSES,HRG,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,HRG Malignant neoplasm of breast
DISRUPTS,GATA3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",GATA3 Malignant neoplasm of breast
PREDISPOSES,Thrombosis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Thrombosis Malignant neoplasm of breast
AUGMENTS,FOXA1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",FOXA1 Breast cancer metastatic
DISRUPTS,GAS5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",GAS5 Malignant neoplasm of breast
AUGMENTS,GGN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",GGN Malignant neoplasm of breast
CAUSES,SLC4A7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,SLC4A7 Malignant neoplasm of breast
PREDISPOSES,Crisis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Crisis Malignant neoplasm of breast
AUGMENTS,Calcitriol,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Calcitriol Breast cancer metastatic
PREDISPOSES,RICTOR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,RICTOR Malignant neoplasm of breast
AFFECTS,GACAT3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,GACAT3 Malignant neoplasm of breast
PREDISPOSES,preference,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",preference Breast cancer recurrent
PREDISPOSES,Twin birth,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Twin birth Malignant neoplasm of breast
AUGMENTS,PSMB4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,PSMB4 Malignant neoplasm of breast
AFFECTS,PRMT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,PRMT1 Malignant neoplasm of breast
AFFECTS,gefitinib,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,gefitinib Malignant neoplasm of breast
AFFECTS,RAD51,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",RAD51 Malignant neoplasm of breast
AFFECTS,Cruciferous Vegetable,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Cruciferous Vegetable Malignant neoplasm of breast
DISRUPTS,FBXL14,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,FBXL14 Malignant neoplasm of breast
PREDISPOSES,BDE-99,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,BDE-99 Malignant neoplasm of breast
DISRUPTS,Risedronate,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Risedronate Breast cancer metastatic
PREDISPOSES,"Antibodies, Anti-Idiotypic",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Antibodies, Anti-Idiotypic Malignant neoplasm of breast"
AUGMENTS,recessive allele,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",recessive allele Malignant neoplasm of breast
AUGMENTS,HORMAD1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,HORMAD1 Malignant neoplasm of breast
PREDISPOSES,Habits,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Habits Malignant neoplasm of breast
AFFECTS,EREG|ESR1,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Element, Ion, or Isotope",EREG|ESR1 Breast cancer invasive NOS
AUGMENTS,N-Cadherins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,N-Cadherins Malignant neoplasm of breast
PREDISPOSES,16q12.1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,16q12.1 Malignant neoplasm of breast
PREDISPOSES,Interleukin-6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Interleukin-6 Malignant neoplasm of breast
AUGMENTS,C3|ERVK-2,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",C3|ERVK-2 Noninfiltrating Intraductal Carcinoma
PREDISPOSES,Hypothyroidism,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Hypothyroidism Malignant neoplasm of breast
CAUSES,S100A4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,S100A4 Malignant neoplasm of breast
PREDISPOSES,Prognosis bad,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Prognosis bad Malignant neoplasm of breast
AFFECTS,Cell Cycle,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Cell Cycle Malignant neoplasm of breast
AFFECTS,resveratrol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,resveratrol Malignant neoplasm of breast
PREDISPOSES,ADAM17,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ADAM17 Malignant neoplasm of breast
DISRUPTS,sunflower seed oil,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,sunflower seed oil Malignant neoplasm of breast
PREDISPOSES,Sun Exposure,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Sun Exposure Malignant neoplasm of breast
AUGMENTS,Raloxifene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Raloxifene Malignant neoplasm of breast
AFFECTS,Oils,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Oils Malignant neoplasm of breast
PREDISPOSES,Cytokeratin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Cytokeratin Malignant neoplasm of breast
DISRUPTS,KDM1A,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,KDM1A Breast cancer metastatic
AUGMENTS,Transcript,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Disease or Syndrome,Transcript Carcinoma of Male Breast
CAUSES,Coffee,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Coffee Malignant neoplasm of breast
DISRUPTS,RAP1A|RABGEF1|TERF2IP,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Neoplastic Process,RAP1A|RABGEF1|TERF2IP Noninfiltrating Intraductal Carcinoma
AFFECTS,Mutate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Mutate Malignant neoplasm of breast
AFFECTS,piperine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,piperine Malignant neoplasm of breast
AFFECTS,SPC24,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,SPC24 Malignant neoplasm of breast
AUGMENTS,Tubulin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Tubulin Malignant neoplasm of breast
PREDISPOSES,LSINCT5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,LSINCT5 Malignant neoplasm of breast
CAUSES,decaffeinated coffee,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,decaffeinated coffee Malignant neoplasm of breast
AFFECTS,high-dose chemotherapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",high-dose chemotherapy Malignant neoplasm of breast
PREDISPOSES,Fibrosis,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Neoplastic Process,Fibrosis Noninfiltrating Intraductal Carcinoma
AUGMENTS,Steryl-sulfatase|STS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Steryl-sulfatase|STS Malignant neoplasm of breast
DISRUPTS,Oils,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Oils Malignant neoplasm of breast
PREDISPOSES,Phosphotransferases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Phosphotransferases Malignant neoplasm of breast
PREDISPOSES,LINC00310,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,LINC00310 Malignant neoplasm of breast
PREDISPOSES,Black tea,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Black tea Malignant neoplasm of breast
PREDISPOSES,Premarin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Premarin Malignant neoplasm of breast
AFFECTS,EPHB4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,EPHB4 Malignant neoplasm of breast
CAUSES,EIF4G1,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Neoplastic Process,EIF4G1 Inflammatory Breast Carcinoma
AFFECTS,baicalein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,baicalein Malignant neoplasm of breast
AFFECTS,erbB-2 Receptor|EREG|ESR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",erbB-2 Receptor|EREG|ESR1 Malignant neoplasm of breast
PREDISPOSES,racial differences,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",racial differences Malignant neoplasm of breast
PREDISPOSES,Histologic type,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Histologic type Malignant neoplasm of breast
AFFECTS,Raloxifene,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Raloxifene Breast Carcinoma
PREDISPOSES,CDC16,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,CDC16 Malignant neoplasm of breast
PREDISPOSES,ARHGAP9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",ARHGAP9 Malignant neoplasm of breast
AFFECTS,Metformin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Metformin Malignant neoplasm of breast
AFFECTS,receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,receptor Malignant neoplasm of breast
AFFECTS,Hyperthyroidism,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Hyperthyroidism Malignant neoplasm of breast
PREDISPOSES,Compete,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Compete Contralateral breast cancer
PREDISPOSES,Head circumference,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Head circumference Malignant neoplasm of breast
AFFECTS,cell motility,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",cell motility Malignant neoplasm of breast
AFFECTS,Immunologic Adjuvants,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Immunologic Adjuvants Malignant neoplasm of breast
AFFECTS,ARF6,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",ARF6 Breast cancer metastatic
PREDISPOSES,Alcoholic Beverages,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Alcoholic Beverages Malignant neoplasm of breast
AUGMENTS,Progestins,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Progestins Breast Carcinoma
AFFECTS,NAT1|EIF4G2|SLC6A2|SLC38A3|SLC38A6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",NAT1|EIF4G2|SLC6A2|SLC38A3|SLC38A6 Malignant neoplasm of breast
PREDISPOSES,health-related beliefs,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",health-related beliefs Malignant neoplasm of breast
PREDISPOSES,Hypoxia,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Hypoxia Breast Carcinoma
AFFECTS,ZD 6126,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,ZD 6126 Breast Carcinoma
CAUSES,Mucins,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Neoplastic Process,Mucins Ductal Breast Carcinoma
AUGMENTS,Tyrphostins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Tyrphostins Malignant neoplasm of breast
CAUSES,Organochlorine pesticide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Organochlorine pesticide Malignant neoplasm of breast
PREDISPOSES,Lean body mass,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Lean body mass Breast Carcinoma
DISRUPTS,Somatomedins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Somatomedins Malignant neoplasm of breast
PREDISPOSES,Beta Carotene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Beta Carotene Malignant neoplasm of breast
AFFECTS,Osteoporosis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Osteoporosis Malignant neoplasm of breast
PREDISPOSES,Daily drinker,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Daily drinker Malignant neoplasm of breast
PREDISPOSES,Thinness,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Thinness Malignant neoplasm of breast
AFFECTS,Pain relief,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Pain relief Malignant neoplasm of breast
PREDISPOSES,alpha-carotene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",alpha-carotene Malignant neoplasm of breast
PREDISPOSES,Amitriptyline,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Amitriptyline Malignant neoplasm of breast
AUGMENTS,Polyamines,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Polyamines Malignant neoplasm of breast
PREDISPOSES,Somatomedins,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Somatomedins Breast Carcinoma
AUGMENTS,BNIP3,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",BNIP3 Noninfiltrating Intraductal Carcinoma
PREDISPOSES,"Endometriosis, site unspecified",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Endometriosis, site unspecified Malignant neoplasm of breast"
AFFECTS,Insulin Resistance,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Insulin Resistance Malignant neoplasm of breast
CAUSES,BP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,BP1 Malignant neoplasm of breast
AFFECTS,celecoxib,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,celecoxib Breast Carcinoma
PREDISPOSES,PRSS3P2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,PRSS3P2 Malignant neoplasm of breast
PREDISPOSES,Physical activity,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Element, Ion, or Isotope",Physical activity Breast cancer invasive NOS
PREDISPOSES,leptin receptor|LEPR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",leptin receptor|LEPR Malignant neoplasm of breast
AUGMENTS,Dichlorodiphenyl Dichloroethylene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Dichlorodiphenyl Dichloroethylene Malignant neoplasm of breast
AUGMENTS,sulfotransferase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,sulfotransferase Malignant neoplasm of breast
PREDISPOSES,Ibandronate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Ibandronate Malignant neoplasm of breast
AUGMENTS,RGS17,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,RGS17 Malignant neoplasm of breast
PREDISPOSES,Behavior showing increased motor activity,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Behavior showing increased motor activity Malignant neoplasm of breast
PREDISPOSES,Fever,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Fever Malignant neoplasm of breast
AFFECTS,Anthracyclines,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Anthracyclines Malignant neoplasm of breast
PREDISPOSES,Almond Nut,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Almond Nut Malignant neoplasm of breast
AUGMENTS,FOXL2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,FOXL2 Malignant neoplasm of breast
PREDISPOSES,Enkephalins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Enkephalins Malignant neoplasm of breast
PREDISPOSES,PRKD1,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Element, Ion, or Isotope",PRKD1 Breast cancer invasive NOS
PREDISPOSES,Atypia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Atypia Malignant neoplasm of breast
PREDISPOSES,CD55|TCN2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",CD55|TCN2 Malignant neoplasm of breast
PREDISPOSES,Waist circumference,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Waist circumference Malignant neoplasm of breast
PREDISPOSES,tibolone,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,tibolone Breast Carcinoma
AFFECTS,Diagnostic Neoplasm Staging,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Diagnostic Neoplasm Staging Malignant neoplasm of breast
AFFECTS,Pancreatectomy,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Neoplastic Process,Pancreatectomy Ductal Breast Carcinoma
PREDISPOSES,personal experience,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",personal experience Malignant neoplasm of breast
AFFECTS,Choline,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Choline Malignant neoplasm of breast
AFFECTS,syndecan 2,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",syndecan 2 Breast Carcinoma
CAUSES,Selenium,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Selenium Malignant neoplasm of breast
AFFECTS,Minipill,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Minipill Malignant neoplasm of breast
AFFECTS,Energy Metabolism,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Energy Metabolism Malignant neoplasm of breast
AFFECTS,Sentinel Lymph Node Biopsy,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,"Element, Ion, or Isotope",Sentinel Lymph Node Biopsy Ductal Breast Carcinoma
AUGMENTS,8q24,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,8q24 Malignant neoplasm of breast
PREDISPOSES,Hydroxyestrones,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Hydroxyestrones Malignant neoplasm of breast
PREDISPOSES,Iron,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Iron Malignant neoplasm of breast
PREDISPOSES,DDT,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",DDT Malignant neoplasm of breast
PREDISPOSES,Berries,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Berries Malignant neoplasm of breast
PREDISPOSES,Peptidyl-Dipeptidase A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Peptidyl-Dipeptidase A Malignant neoplasm of breast
PREDISPOSES,binge drinking,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,binge drinking Malignant neoplasm of breast
AUGMENTS,17q12,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,17q12 Malignant neoplasm of breast
PREDISPOSES,Fiber,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Fiber Malignant neoplasm of breast
PREDISPOSES,response,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",response Breast Carcinoma
PREDISPOSES,FCER1A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,FCER1A Malignant neoplasm of breast
CAUSES,Free Radicals,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Free Radicals Malignant neoplasm of breast
PREDISPOSES,Pesticides,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Pesticides Malignant neoplasm of breast
PREDISPOSES,Stearoyl-CoA Desaturase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Stearoyl-CoA Desaturase Malignant neoplasm of breast
AFFECTS,Doxorubicin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Doxorubicin Malignant neoplasm of breast
AUGMENTS,Recombinant Erythropoietin,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,Recombinant Erythropoietin Breast cancer metastatic
PREDISPOSES,Prolactin Receptor|PRLR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Prolactin Receptor|PRLR Malignant neoplasm of breast
AFFECTS,capecitabine,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",capecitabine Breast cancer metastatic
AFFECTS,Tocotrienols,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Tocotrienols Malignant neoplasm of breast
PREDISPOSES,hemiplegia; ascending,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,hemiplegia; ascending Malignant neoplasm of breast
PREDISPOSES,MUTYH,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",MUTYH Malignant neoplasm of breast
PREDISPOSES,Beta-carotene intake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Beta-carotene intake Malignant neoplasm of breast
PREDISPOSES,Pulse vegetables,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Pulse vegetables Malignant neoplasm of breast
AFFECTS,claudin 6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,claudin 6 Malignant neoplasm of breast
AFFECTS,Tretinoin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Tretinoin Malignant neoplasm of breast
AFFECTS,Epirubicin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Epirubicin Malignant neoplasm of breast
AUGMENTS,UQCRFS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,UQCRFS1 Malignant neoplasm of breast
AFFECTS,pterostilbene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,pterostilbene Malignant neoplasm of breast
PREDISPOSES,Duffy blood group phenotype,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Lipid,Duffy blood group phenotype Malignant neoplasm of breast
PREDISPOSES,Asthma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Asthma Malignant neoplasm of breast
PREDISPOSES,Sleep disturbances,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Sleep disturbances Malignant neoplasm of breast
DISRUPTS,argatroban,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",argatroban Breast cancer metastatic
PREDISPOSES,taxane,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,taxane Malignant neoplasm of breast
PREDISPOSES,Osteoporosis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Osteoporosis Malignant neoplasm of breast
PREDISPOSES,HERC4,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Neoplastic Process,"HERC4 Carcinoma, Ductal, Breast"
PREDISPOSES,responsibility,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,responsibility Malignant neoplasm of breast
PREDISPOSES,[X]Unspecified osteoporosis with pathological fracture,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",[X]Unspecified osteoporosis with pathological fracture Malignant neoplasm of breast
AFFECTS,Lectin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Lectin Malignant neoplasm of breast
AUGMENTS,OSU 03012,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,OSU 03012 Malignant neoplasm of breast
PREDISPOSES,Methylenetetrahydrofolate reductase (NADPH)|MTHFR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Methylenetetrahydrofolate reductase (NADPH)|MTHFR Malignant neoplasm of breast
PREDISPOSES,Abdominal obesity,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Abdominal obesity Malignant neoplasm of breast
DISRUPTS,Collagen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Collagen Malignant neoplasm of breast
AFFECTS,Dimethyl Sulfoxide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Dimethyl Sulfoxide Malignant neoplasm of breast
PREDISPOSES,research outcome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",research outcome Malignant neoplasm of breast
PREDISPOSES,Tomatoes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Tomatoes Malignant neoplasm of breast
PREDISPOSES,ID1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",ID1 Breast cancer metastatic
PREDISPOSES,Interstitial Collagenase|MMP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Interstitial Collagenase|MMP1 Malignant neoplasm of breast
AFFECTS,Paclitaxel,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Paclitaxel Malignant neoplasm of breast
PREDISPOSES,APOBEC3A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",APOBEC3A Malignant neoplasm of breast
AFFECTS,Hydroxymethylglutaryl-CoA Reductase Inhibitors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Hydroxymethylglutaryl-CoA Reductase Inhibitors Malignant neoplasm of breast
PREDISPOSES,SULT1A1|SULT1A2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",SULT1A1|SULT1A2 Malignant neoplasm of breast
PREDISPOSES,Breast size,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Breast size Malignant neoplasm of breast
PREDISPOSES,FTO,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",FTO Malignant neoplasm of breast
PREDISPOSES,Breast size,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Breast size Breast Carcinoma
PREDISPOSES,Underweight,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Underweight Malignant neoplasm of breast
AUGMENTS,Adiponectin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Adiponectin Malignant neoplasm of breast
AFFECTS,RNF8,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,RNF8 Malignant neoplasm of breast
DISRUPTS,Botanicals,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Botanicals Malignant neoplasm of breast
PREDISPOSES,SOX2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",SOX2 Malignant neoplasm of breast
PREDISPOSES,KLF4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,KLF4 Malignant neoplasm of breast
PREDISPOSES,Weight fluctuates,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Weight fluctuates Malignant neoplasm of breast
AFFECTS,Carboplatin,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Carboplatin Breast cancer metastatic
PREDISPOSES,Equine laminitis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Equine laminitis Malignant neoplasm of breast
PREDISPOSES,GAL3ST1|SLC35A1|CASZ1|CST12P,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,GAL3ST1|SLC35A1|CASZ1|CST12P Malignant neoplasm of breast
PREDISPOSES,Diethylhexyl Phthalate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Diethylhexyl Phthalate Malignant neoplasm of breast
AFFECTS,Hypoxia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Hypoxia Malignant neoplasm of breast
PREDISPOSES,Lymphedema,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Lymphedema Breast cancer recurrent
AUGMENTS,tibolone,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",tibolone Breast cancer recurrent
AFFECTS,Pharmacotherapy,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Neoplastic Process,Pharmacotherapy Inflammatory Breast Carcinoma
PREDISPOSES,Seizures,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,Seizures Breast cancer invasive NOS
PREDISPOSES,Bendroflumethiazide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Bendroflumethiazide Malignant neoplasm of breast
PREDISPOSES,FLII,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,FLII Malignant neoplasm of breast
PREDISPOSES,aurora kinase,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",aurora kinase Breast cancer metastatic
CAUSES,Insulin|INS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Insulin|INS Malignant neoplasm of breast
PREDISPOSES,KIF4A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",KIF4A Malignant neoplasm of breast
AFFECTS,Ultrasonography,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Neoplastic Process,"Ultrasonography Carcinoma, Ductal, Breast"
PREDISPOSES,Peanut butter,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Peanut butter Malignant neoplasm of breast
PREDISPOSES,Strenuous Exercise,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Strenuous Exercise Malignant neoplasm of breast
PREDISPOSES,Diffuse Scleroderma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Diffuse Scleroderma Malignant neoplasm of breast
PREDISPOSES,Symptoms,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Symptoms Breast Carcinoma
AFFECTS,Diet,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Diet Breast cancer recurrent
DISRUPTS,Gastrin|GAST,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Gastrin|GAST Malignant neoplasm of breast
PREDISPOSES,TLR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,TLR1 Malignant neoplasm of breast
PREDISPOSES,Hypersensitivity,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Hypersensitivity Malignant neoplasm of breast
PREDISPOSES,Organochlorine pesticide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Organochlorine pesticide Malignant neoplasm of breast
AFFECTS,Nephroblastoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Nephroblastoma Malignant neoplasm of breast
PREDISPOSES,Pork,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Pork Malignant neoplasm of breast
PREDISPOSES,Dietary Fiber,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Dietary Fiber Malignant neoplasm of breast
PREDISPOSES,Epithelial hyperplasia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Epithelial hyperplasia Malignant neoplasm of breast
PREDISPOSES,resistin|RETN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",resistin|RETN Malignant neoplasm of breast
DISRUPTS,Curcumin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Curcumin Malignant neoplasm of breast
PREDISPOSES,Vegetables,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Vegetables Breast cancer recurrent
AFFECTS,Reflexology,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Reflexology Malignant neoplasm of breast
AFFECTS,vinorelbine,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",vinorelbine Breast cancer metastatic
PREDISPOSES,Willing,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Willing Malignant neoplasm of breast
AFFECTS,S100A4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,S100A4 Malignant neoplasm of breast
PREDISPOSES,Stress,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Stress Malignant neoplasm of breast
PREDISPOSES,MAP Kinase Kinase Kinase 1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",MAP Kinase Kinase Kinase 1 Malignant neoplasm of breast
AFFECTS,CHD5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",CHD5 Malignant neoplasm of breast
DISRUPTS,Aspirin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Aspirin Malignant neoplasm of breast
PREDISPOSES,CDKN1A|TCEAL1|NSG1|H3F3AP6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",CDKN1A|TCEAL1|NSG1|H3F3AP6 Malignant neoplasm of breast
PREDISPOSES,receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,receptor Malignant neoplasm of breast
PREDISPOSES,Caffeine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Caffeine Malignant neoplasm of breast
AUGMENTS,TWIST2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,TWIST2 Malignant neoplasm of breast
AFFECTS,cyclophosphamide/fluorouracil/methotrexate protocol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,cyclophosphamide/fluorouracil/methotrexate protocol Malignant neoplasm of breast
CAUSES,XRCC6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",XRCC6 Malignant neoplasm of breast
AFFECTS,Mammography,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Neoplastic Process,Mammography Noninfiltrating Intraductal Carcinoma
DISRUPTS,Metformin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Metformin Malignant neoplasm of breast
AFFECTS,Histopathology,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Histopathology Malignant neoplasm of breast
AFFECTS,Androgen Receptor|AR,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,"Element, Ion, or Isotope",Androgen Receptor|AR Carcinoma of Male Breast
AFFECTS,"Diet, Mediterranean",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,"Diet, Mediterranean Malignant neoplasm of breast"
PREDISPOSES,Fish intake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Fish intake Malignant neoplasm of breast
CAUSES,feral,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,feral Malignant neoplasm of breast
PREDISPOSES,5-Alpha reductase inhibitor,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,"Element, Ion, or Isotope",5-Alpha reductase inhibitor Carcinoma of Male Breast
PREDISPOSES,Follistatin,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Follistatin Breast Carcinoma
PREDISPOSES,Inflammatory Response,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Inflammatory Response Malignant neoplasm of breast
AFFECTS,TGFB2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",TGFB2 Malignant neoplasm of breast
PREDISPOSES,Engine Exhaust,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Engine Exhaust Malignant neoplasm of breast
PREDISPOSES,"Receptor, Angiotensin, Type 1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Receptor, Angiotensin, Type 1 Malignant neoplasm of breast"
AFFECTS,Mass Screening,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Mass Screening Malignant neoplasm of breast
AFFECTS,Microsatellite Repeats,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,"Element, Ion, or Isotope","Microsatellite Repeats Carcinoma, Ductal, Breast"
AFFECTS,Sentinel Lymph Node Biopsy,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",Sentinel Lymph Node Biopsy Noninfiltrating Intraductal Carcinoma
PREDISPOSES,Chinese cabbage,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Chinese cabbage Malignant neoplasm of breast
AFFECTS,Screening mammography,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,Screening mammography Breast cancer invasive NOS
PREDISPOSES,Environmental Tobacco Smoke,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Environmental Tobacco Smoke Malignant neoplasm of breast
PREDISPOSES,Defense Mechanisms,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Defense Mechanisms Malignant neoplasm of breast
DISRUPTS,Expressed Sequence Tags,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",Expressed Sequence Tags Noninfiltrating Intraductal Carcinoma
AFFECTS,Hydroxymethylglutaryl-CoA Reductase Inhibitors,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,"Element, Ion, or Isotope",Hydroxymethylglutaryl-CoA Reductase Inhibitors Inflammatory Breast Carcinoma
PREDISPOSES,Red meat intake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Red meat intake Malignant neoplasm of breast
AFFECTS,Skin necrosis,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",Skin necrosis Noninfiltrating Intraductal Carcinoma
PREDISPOSES,SOX10,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",SOX10 Breast Carcinoma
PREDISPOSES,Autoantibodies,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Autoantibodies Breast Carcinoma
PREDISPOSES,Dinoprostone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Dinoprostone Malignant neoplasm of breast
PREDISPOSES,PREDICTED,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,PREDICTED Breast cancer invasive NOS
PREDISPOSES,Vitality,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Vitality Malignant neoplasm of breast
PREDISPOSES,KMT5A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",KMT5A Malignant neoplasm of breast
AFFECTS,bicalutamide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,bicalutamide Malignant neoplasm of breast
AFFECTS,oleuropein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,oleuropein Malignant neoplasm of breast
DISRUPTS,ALKBH3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ALKBH3 Malignant neoplasm of breast
PREDISPOSES,Metformin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Metformin Malignant neoplasm of breast
PREDISPOSES,Cytochrome P-450 CYP1A2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Cytochrome P-450 CYP1A2 Malignant neoplasm of breast
PREDISPOSES,SLC45A2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,SLC45A2 Breast cancer metastatic
AFFECTS,sulfotransferase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,sulfotransferase Malignant neoplasm of breast
AFFECTS,RHBDD1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",RHBDD1 Breast cancer metastatic
AFFECTS,Gelatinase B|PGR|PR@|PRH2|TMEM37|ERVK-7|ERVK-8|ERVK-10|ERVK-9|ERVK-21|ERVK-18|ERVK-25|ERVK-24|ERVK-19,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Gelatinase B|PGR|PR@|PRH2|TMEM37|ERVK-7|ERVK-8|ERVK-10|ERVK-9|ERVK-21|ERVK-18|ERVK-25|ERVK-24|ERVK-19 Malignant neoplasm of breast
PREDISPOSES,tibolone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,tibolone Malignant neoplasm of breast
PREDISPOSES,Adenosis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Adenosis Malignant neoplasm of breast
PREDISPOSES,Discrepancy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Discrepancy Malignant neoplasm of breast
AFFECTS,Needle biopsy procedure,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Needle biopsy procedure Malignant neoplasm of breast
PREDISPOSES,Cyclin-Dependent Kinase 10,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Cyclin-Dependent Kinase 10 Malignant neoplasm of breast
AFFECTS,exemestane,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",exemestane Breast cancer metastatic
PREDISPOSES,Hot flushes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Hot flushes Malignant neoplasm of breast
PREDISPOSES,GGT1|GGTLC5P|GGTLC3|GGT2|GGTLC4P,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,GGT1|GGTLC5P|GGTLC3|GGT2|GGTLC4P Breast Carcinoma
CAUSES,Polychlorinated Biphenyls,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Polychlorinated Biphenyls Malignant neoplasm of breast
AUGMENTS,cyclin D3|CCND3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",cyclin D3|CCND3 Malignant neoplasm of breast
PREDISPOSES,USP11,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,USP11 Malignant neoplasm of breast
CAUSES,Ethanol,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Ethanol Breast cancer metastatic
PREDISPOSES,Aspirin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Aspirin Malignant neoplasm of breast
AFFECTS,Magnetic Resonance,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Magnetic Resonance Malignant neoplasm of breast
DISRUPTS,MAP2K3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,MAP2K3 Malignant neoplasm of breast
PREDISPOSES,P-Cadherin,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,P-Cadherin Breast Carcinoma
AFFECTS,Doxorubicin Hydrochloride,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Doxorubicin Hydrochloride Malignant neoplasm of breast
PREDISPOSES,QUINTILE,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,QUINTILE Malignant neoplasm of breast
PREDISPOSES,Mass of body structure,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Mass of body structure Malignant neoplasm of breast
AUGMENTS,Calcium Channel Blockers,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Calcium Channel Blockers Malignant neoplasm of breast
PREDISPOSES,Strenuous Exercise,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,Strenuous Exercise Breast cancer invasive NOS
PREDISPOSES,receptor activator of NF-kappaB,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,receptor activator of NF-kappaB Malignant neoplasm of breast
PREDISPOSES,Hydroxymethylglutaryl-CoA Reductase Inhibitors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Hydroxymethylglutaryl-CoA Reductase Inhibitors Malignant neoplasm of breast
PREDISPOSES,Exposure to,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Exposure to Malignant neoplasm of breast
DISRUPTS,equol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,equol Malignant neoplasm of breast
DISRUPTS,"2,3-bis(3'-hydroxybenzyl)butyrolactone",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,"2,3-bis(3'-hydroxybenzyl)butyrolactone Malignant neoplasm of breast"
AFFECTS,Cyclophosphamide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Cyclophosphamide Malignant neoplasm of breast
PREDISPOSES,Hydroxymethylglutaryl-CoA Reductase Inhibitors,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,"Element, Ion, or Isotope","Hydroxymethylglutaryl-CoA Reductase Inhibitors Carcinoma, Ductal, Breast"
AFFECTS,Sentinel Lymph Node Biopsy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Sentinel Lymph Node Biopsy Malignant neoplasm of breast
PREDISPOSES,Red breast,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,"Element, Ion, or Isotope",Red breast Inflammatory Breast Carcinoma
AUGMENTS,"Iron, Dietary",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Iron, Dietary Malignant neoplasm of breast"
PREDISPOSES,White bread,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,White bread Malignant neoplasm of breast
PREDISPOSES,Endometrial Hyperplasia,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Lipid,Endometrial Hyperplasia Breast cancer recurrent
PREDISPOSES,"1,4-dioxin",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,"1,4-dioxin Malignant neoplasm of breast"
AFFECTS,Lasofoxifene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Lasofoxifene Malignant neoplasm of breast
AFFECTS,"1,4-dioxin",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,"1,4-dioxin Malignant neoplasm of breast"
PREDISPOSES,MTA2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,MTA2 Malignant neoplasm of breast
AFFECTS,Human Development,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Human Development Malignant neoplasm of breast
PREDISPOSES,Cullin 1|CUL1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,Cullin 1|CUL1 Breast cancer metastatic
PREDISPOSES,erbB-2 Receptor|ERBB2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",erbB-2 Receptor|ERBB2 Breast cancer metastatic
CAUSES,IARS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,IARS Malignant neoplasm of breast
AFFECTS,Proteasome inhibitor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Proteasome inhibitor Malignant neoplasm of breast
AFFECTS,Interleukins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Interleukins Malignant neoplasm of breast
CAUSES,DSCAM-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",DSCAM-AS1 Malignant neoplasm of breast
AFFECTS,ORALIT,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ORALIT Malignant neoplasm of breast
AFFECTS,S100A7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",S100A7 Malignant neoplasm of breast
PREDISPOSES,Trans Fats,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Trans Fats Malignant neoplasm of breast
DISRUPTS,Corticosterone,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Corticosterone Breast cancer metastatic
PREDISPOSES,Tryptophan,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Tryptophan Malignant neoplasm of breast
PREDISPOSES,Alanine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Alanine Malignant neoplasm of breast
PREDISPOSES,Interleukin-8,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,Interleukin-8 Breast cancer metastatic
PREDISPOSES,TBX3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,TBX3 Malignant neoplasm of breast
AFFECTS,Body mass index procedure,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Body mass index procedure Malignant neoplasm of breast
AFFECTS,DANCR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",DANCR Malignant neoplasm of breast
PREDISPOSES,Urokinase|PLAU|PRAP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Urokinase|PLAU|PRAP1 Malignant neoplasm of breast
CAUSES,CYP1B1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",CYP1B1 Malignant neoplasm of breast
PREDISPOSES,survivin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,survivin Malignant neoplasm of breast
PREDISPOSES,Primary idiopathic dilated cardiomyopathy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Primary idiopathic dilated cardiomyopathy Malignant neoplasm of breast
AFFECTS,Polysaccharides,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Polysaccharides Malignant neoplasm of breast
AFFECTS,SNORA7B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,SNORA7B Malignant neoplasm of breast
DISRUPTS,NanoGel,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",NanoGel Breast cancer metastatic
PREDISPOSES,Positive Lymph Node,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Element, Ion, or Isotope",Positive Lymph Node Breast cancer recurrent
AFFECTS,Physiological stress,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Physiological stress Malignant neoplasm of breast
AFFECTS,Anisotropy,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Anisotropy Breast cancer recurrent
PREDISPOSES,Exons,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Exons Malignant neoplasm of breast
AFFECTS,RPE65|UVRAG|TP63|CKAP4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,RPE65|UVRAG|TP63|CKAP4 Malignant neoplasm of breast
AFFECTS,erbB-2 Receptor|ERBB2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",erbB-2 Receptor|ERBB2 Malignant neoplasm of breast
DISRUPTS,erbB-2 Receptor|ERBB2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",erbB-2 Receptor|ERBB2 Malignant neoplasm of breast
AFFECTS,CYP1B1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",CYP1B1 Malignant neoplasm of breast
AFFECTS,Parabens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Parabens Malignant neoplasm of breast
AFFECTS,LINC00968,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,LINC00968 Malignant neoplasm of breast
AUGMENTS,SNHG7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",SNHG7 Malignant neoplasm of breast
AFFECTS,Biopsy,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Element, Ion, or Isotope",Biopsy Breast cancer invasive NOS
PREDISPOSES,CYP1B1,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,"Element, Ion, or Isotope",CYP1B1 Carcinoma of Male Breast
AUGMENTS,PLK1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",PLK1 Malignant neoplasm of breast
PREDISPOSES,GALNT16,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,GALNT16 Malignant neoplasm of breast
AFFECTS,taxane,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,taxane Malignant neoplasm of breast
PREDISPOSES,Red meat,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Element, Ion, or Isotope",Red meat Breast cancer invasive NOS
AFFECTS,Digital mammography,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",Digital mammography Noninfiltrating Intraductal Carcinoma
PREDISPOSES,LINC00460,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,LINC00460 Malignant neoplasm of breast
PREDISPOSES,CUL4B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",CUL4B Malignant neoplasm of breast
AFFECTS,honokiol,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",honokiol Breast cancer metastatic
PREDISPOSES,TUFT1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,TUFT1 Breast cancer metastatic
PREDISPOSES,Insulin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Insulin Malignant neoplasm of breast
PREDISPOSES,Glucocorticoid Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Glucocorticoid Receptor Malignant neoplasm of breast
PREDISPOSES,CCAT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,CCAT1 Malignant neoplasm of breast
DISRUPTS,SCUBE2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",SCUBE2 Malignant neoplasm of breast
PREDISPOSES,"N',N''-diacetylspermine",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,"N',N''-diacetylspermine Malignant neoplasm of breast"
AFFECTS,Leptin|LEP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Leptin|LEP Malignant neoplasm of breast
AFFECTS,Gelatinase A,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Gelatinase A Breast cancer metastatic
AFFECTS,Electromagnetic Energy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Electromagnetic Energy Malignant neoplasm of breast
AFFECTS,Coffee,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Coffee Malignant neoplasm of breast
AFFECTS,NCAPD2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,NCAPD2 Malignant neoplasm of breast
AFFECTS,"Radiotherapy, Adjuvant",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Radiotherapy, Adjuvant Malignant neoplasm of breast"
AFFECTS,ginsenoside M1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",ginsenoside M1 Malignant neoplasm of breast
DISRUPTS,Metformin hydrochloride,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Metformin hydrochloride Malignant neoplasm of breast
PREDISPOSES,Spermine Synthase|SMS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Spermine Synthase|SMS Malignant neoplasm of breast
PREDISPOSES,Hip circumference,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Hip circumference Malignant neoplasm of breast
AUGMENTS,PCB 180,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,PCB 180 Malignant neoplasm of breast
DISRUPTS,silybin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,silybin Malignant neoplasm of breast
AFFECTS,KDM5B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",KDM5B Malignant neoplasm of breast
PREDISPOSES,Flavonoids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Flavonoids Malignant neoplasm of breast
PREDISPOSES,Androgen Receptor|AR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Androgen Receptor|AR Malignant neoplasm of breast
PREDISPOSES,Prognosis good,contralateral breast cancer,0.0029970029970029,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Prognosis good contralateral breast cancer
AFFECTS,Combined Modality Therapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Combined Modality Therapy Malignant neoplasm of breast
AFFECTS,sulforafan,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,sulforafan Malignant neoplasm of breast
CAUSES,Secondary Neoplasm,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Secondary Neoplasm Malignant neoplasm of breast
AUGMENTS,PRNCR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,PRNCR1 Malignant neoplasm of breast
DISRUPTS,everolimus,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Neoplastic Process,everolimus Noninfiltrating Intraductal Carcinoma
PREDISPOSES,Stable weight,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Stable weight Malignant neoplasm of breast
DISRUPTS,ATP8A2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",ATP8A2 Breast cancer metastatic
PREDISPOSES,YAP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",YAP1 Malignant neoplasm of breast
AUGMENTS,CGRRF1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,CGRRF1 Malignant neoplasm of breast
DISRUPTS,ZMYND10,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ZMYND10 Malignant neoplasm of breast
PREDISPOSES,Procedure findings:Finding:Point in time:^Patient:Narrative,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Procedure findings:Finding:Point in time:^Patient:Narrative Malignant neoplasm of breast
AFFECTS,Chemotherapy Regimen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Chemotherapy Regimen Malignant neoplasm of breast
PREDISPOSES,Dense breasts NOS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Dense breasts NOS Malignant neoplasm of breast
PREDISPOSES,Low absolute lymphocyte count,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Low absolute lymphocyte count Malignant neoplasm of breast
PREDISPOSES,clinical aspects,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Immunologic Factor,clinical aspects Triple Negative Breast Neoplasms
AUGMENTS,claudin 4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,claudin 4 Malignant neoplasm of breast
PREDISPOSES,Breast Density,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Breast Density Malignant neoplasm of breast
CAUSES,MK 2206,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",MK 2206 HER2-positive carcinoma of breast
AFFECTS,Breast-Conserving Surgery,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Breast-Conserving Surgery Malignant neoplasm of breast
AFFECTS,Secondary Neoplasm,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Secondary Neoplasm Malignant neoplasm of breast
PREDISPOSES,Menopause Status,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Menopause Status Malignant neoplasm of breast
PREDISPOSES,Exogenous Factors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Exogenous Factors Malignant neoplasm of breast
AFFECTS,Neoplasms,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Neoplasms Malignant neoplasm of breast
PREDISPOSES,Reproductive History,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",Reproductive History Invasive carcinoma of breast
AFFECTS,Histamine H1 Antagonists,contralateral breast cancer,0.0029970029970029,Female Breast Cancer,"Element, Ion, or Isotope",Histamine H1 Antagonists contralateral breast cancer
PREDISPOSES,Family history,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Family history Malignant neoplasm of breast
CAUSES,beta catenin,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",beta catenin Breast Carcinoma
AFFECTS,citronellol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,citronellol Malignant neoplasm of breast
CAUSES,osteopontin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,osteopontin Malignant neoplasm of breast
PREDISPOSES,"ATP Binding Cassette Transporter, Sub-Family G, Member 2|ABCG2",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","ATP Binding Cassette Transporter, Sub-Family G, Member 2|ABCG2 Malignant neoplasm of breast"
DISRUPTS,sulforafan,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,sulforafan Malignant neoplasm of breast
PREDISPOSES,CHEK2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",CHEK2 Malignant neoplasm of breast
CAUSES,Vaccines,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Vaccines Malignant neoplasm of breast
PREDISPOSES,Hypersensitivity,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Immunologic Factor,Hypersensitivity Triple Negative Breast Neoplasms
AFFECTS,Diagnosis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Diagnosis Malignant neoplasm of breast
PREDISPOSES,Discordance,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Discordance Malignant neoplasm of breast
CAUSES,Calcium-Sensing Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Calcium-Sensing Receptor Malignant neoplasm of breast
DISRUPTS,tissue-factor-pathway inhibitor 2|TFPI2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",tissue-factor-pathway inhibitor 2|TFPI2 Malignant neoplasm of breast
PREDISPOSES,neoplasm-associated factor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",neoplasm-associated factor Malignant neoplasm of breast
PREDISPOSES,High Level,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",High Level Triple Negative Breast Neoplasms
PREDISPOSES,Signs and Symptoms,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Signs and Symptoms Malignant neoplasm of breast
PREDISPOSES,Subjective:Finding:Point in time:^Patient:Narrative,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Subjective:Finding:Point in time:^Patient:Narrative Malignant neoplasm of breast
PREDISPOSES,Aggressive behavior,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Aggressive behavior Malignant neoplasm of breast
AFFECTS,Muscle Strength,Malignant neoplasm of female breast,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Muscle Strength Malignant neoplasm of female breast
PREDISPOSES,Quintile,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Quintile Malignant neoplasm of breast
AUGMENTS,FGFR3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,FGFR3 Malignant neoplasm of breast
AFFECTS,Carotenoids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Carotenoids Malignant neoplasm of breast
PREDISPOSES,Stiffness,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Stiffness Malignant neoplasm of breast
PREDISPOSES,Mammographic Breast Density,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Mammographic Breast Density Malignant neoplasm of breast
PREDISPOSES,Physical Inactivity,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Physical Inactivity Malignant neoplasm of breast
DISRUPTS,daunorubicin liposomal,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,daunorubicin liposomal Malignant neoplasm of breast
AFFECTS,bisphenol A,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,"Amino Acid, Peptide, or Protein",bisphenol A estrogen receptor-positive breast cancer
AFFECTS,Pharmacotherapy,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Pharmacotherapy Triple Negative Breast Neoplasms
DISRUPTS,huaier,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,huaier Malignant neoplasm of breast
AFFECTS,Flavonoids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Flavonoids Malignant neoplasm of breast
PREDISPOSES,Increased risk,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Increased risk Malignant neoplasm of breast
PREDISPOSES,concise,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,concise Breast Carcinoma
AUGMENTS,YES1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",YES1 Triple Negative Breast Neoplasms
PREDISPOSES,RUNX1,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Chemical,RUNX1 estrogen receptor-positive breast cancer
AFFECTS,interleukin-10,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",interleukin-10 Malignant neoplasm of breast
PREDISPOSES,Pathologic Response,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Pathologic Response Triple Negative Breast Neoplasms
AUGMENTS,antiporter,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",antiporter HER2-positive carcinoma of breast
PREDISPOSES,Neuropilin-1|NRP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Neuropilin-1|NRP1 Malignant neoplasm of breast
PREDISPOSES,Finding of body mass index,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Finding of body mass index Malignant neoplasm of breast
PREDISPOSES,Fumigant,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Fumigant Malignant neoplasm of breast
PREDISPOSES,Cyclin B1|CCNB1,Luminal B Breast Carcinoma,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Cyclin B1|CCNB1 Luminal B Breast Carcinoma
AFFECTS,calycopterin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,calycopterin Malignant neoplasm of breast
AFFECTS,arctigenin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,arctigenin Malignant neoplasm of breast
PREDISPOSES,Fibrin fragment D,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Fibrin fragment D Malignant neoplasm of breast
DISRUPTS,pristimerin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,pristimerin Malignant neoplasm of breast
PREDISPOSES,Sedentary lifestyle,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Sedentary lifestyle Malignant neoplasm of breast
DISRUPTS,kusunokinin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,kusunokinin Malignant neoplasm of breast
PREDISPOSES,Late Relapse,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Late Relapse Malignant neoplasm of breast
PREDISPOSES,risk factors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",risk factors Malignant neoplasm of breast
PREDISPOSES,TNF wt Allele,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",TNF wt Allele Malignant neoplasm of breast
AFFECTS,Puberty,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Puberty Malignant neoplasm of breast
AFFECTS,magnesium,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",magnesium Malignant neoplasm of breast
AFFECTS,Neoplasms,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Neoplasms Triple Negative Breast Neoplasms
AFFECTS,ergocalciferol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ergocalciferol Malignant neoplasm of breast
PREDISPOSES,Biological Markers,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Biological Markers Malignant neoplasm of breast
PREDISPOSES,naringenin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,naringenin Malignant neoplasm of breast
PREDISPOSES,Flavanones,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Flavanones Malignant neoplasm of breast
CAUSES,wogonin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,wogonin Malignant neoplasm of breast
AFFECTS,Transcript,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Transcript Malignant neoplasm of breast
AFFECTS,podofilox,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,podofilox Malignant neoplasm of breast
PREDISPOSES,Antimalarials,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Antimalarials Malignant neoplasm of breast
PREDISPOSES,sunitinib,Carcinoma breast stage IV,0.0,Female Breast Cancer,"Element, Ion, or Isotope",sunitinib Carcinoma breast stage IV
PREDISPOSES,Hyperthyroidism,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Hyperthyroidism Malignant neoplasm of breast
PREDISPOSES,ACVR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ACVR1 Malignant neoplasm of breast
PREDISPOSES,Androgen Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Androgen Receptor Malignant neoplasm of breast
AFFECTS,Screening procedure,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Screening procedure Malignant neoplasm of breast
AFFECTS,baicalin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,baicalin Malignant neoplasm of breast
DISRUPTS,simvastatin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,simvastatin Malignant neoplasm of breast
PREDISPOSES,Excessive dietary caloric intake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Excessive dietary caloric intake Malignant neoplasm of breast
PREDISPOSES,APOBEC3B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,APOBEC3B Malignant neoplasm of breast
PREDISPOSES,Organophosphate pesticides,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Organophosphate pesticides Malignant neoplasm of breast
PREDISPOSES,water,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,water Malignant neoplasm of breast
PREDISPOSES,Biological Response Modifiers,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Biological Response Modifiers Malignant neoplasm of breast
PREDISPOSES,Trichorhinophalangeal dysplasia type I,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Trichorhinophalangeal dysplasia type I Breast Carcinoma
AFFECTS,Uptake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Uptake Malignant neoplasm of breast
PREDISPOSES,Procedure findings:Finding:Point in time:^Patient:Narrative,Early-Stage Breast Carcinoma,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Procedure findings:Finding:Point in time:^Patient:Narrative Early-Stage Breast Carcinoma
AFFECTS,"Chemotherapy, Adjuvant",Carcinoma breast stage I,0.0,Female Breast Cancer,"Element, Ion, or Isotope","Chemotherapy, Adjuvant Carcinoma breast stage I"
AFFECTS,Oils,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Oils Triple Negative Breast Neoplasms
PREDISPOSES,acetate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",acetate Malignant neoplasm of breast
PREDISPOSES,c-Mer Tyrosine Kinase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",c-Mer Tyrosine Kinase Malignant neoplasm of breast
PREDISPOSES,Moderate risk,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Moderate risk Malignant neoplasm of breast
PREDISPOSES,Present,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Present Malignant neoplasm of breast
CAUSES,Progranulins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Progranulins Malignant neoplasm of breast
AUGMENTS,Thymidylate Synthase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Thymidylate Synthase Malignant neoplasm of breast
CAUSES,Anthracyclines,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Anthracyclines Malignant neoplasm of breast
PREDISPOSES,Hypoxia-Inducible Factor 1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Hypoxia-Inducible Factor 1 Malignant neoplasm of breast
DISRUPTS,cryptotanshinone,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,"Amino Acid, Peptide, or Protein",cryptotanshinone estrogen receptor-positive breast cancer
AFFECTS,Biological Neural Networks,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Biological Neural Networks Breast Carcinoma
PREDISPOSES,mortalin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,mortalin Malignant neoplasm of breast
PREDISPOSES,Zearalenone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Zearalenone Malignant neoplasm of breast
PREDISPOSES,resistin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,resistin Malignant neoplasm of breast
AUGMENTS,bisphenol A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,bisphenol A Malignant neoplasm of breast
PREDISPOSES,lamin B2,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Immunologic Factor,lamin B2 Triple Negative Breast Neoplasms
PREDISPOSES,High Level,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",High Level Malignant neoplasm of breast
AFFECTS,Elasticity Imaging Techniques,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Elasticity Imaging Techniques Malignant neoplasm of breast
AFFECTS,Magnetic Resonance Imaging,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Magnetic Resonance Imaging Triple Negative Breast Neoplasms
AFFECTS,hereditary factors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",hereditary factors Malignant neoplasm of breast
PREDISPOSES,Risk Scores,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Risk Scores Malignant neoplasm of breast
PREDISPOSES,selenium,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,selenium Malignant neoplasm of breast
PREDISPOSES,Uncertainty,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Uncertainty Malignant neoplasm of breast
AFFECTS,aspirin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,aspirin Malignant neoplasm of breast
AFFECTS,Bilateral mastectomy,contralateral breast cancer,0.0029970029970029,Female Breast Cancer,Gene or Genome,Bilateral mastectomy contralateral breast cancer
AFFECTS,Pharmacotherapy,Carcinoma breast stage IV,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Pharmacotherapy Carcinoma breast stage IV
AUGMENTS,iron,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Immunologic Factor,iron Triple Negative Breast Neoplasms
AFFECTS,Lactates,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Lactates estrogen receptor-positive breast cancer
AFFECTS,Neoadjuvant Chemotherapy,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",Neoadjuvant Chemotherapy HER2-positive carcinoma of breast
AFFECTS,Immune Checkpoint Blockade,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Immunologic Factor,Immune Checkpoint Blockade Triple Negative Breast Neoplasms
DISRUPTS,Adiponectin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Adiponectin Malignant neoplasm of breast
PREDISPOSES,"Obesity, Abdominal",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Obesity, Abdominal Malignant neoplasm of breast"
PREDISPOSES,Leisure physical activity,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Leisure physical activity Malignant neoplasm of breast
PREDISPOSES,calcium,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",calcium Malignant neoplasm of breast
DISRUPTS,leptin receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,leptin receptor Malignant neoplasm of breast
PREDISPOSES,Calcium intake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Calcium intake Malignant neoplasm of breast
PREDISPOSES,Hypoxia,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Hypoxia Triple Negative Breast Neoplasms
AFFECTS,hydroxyl group,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",hydroxyl group Malignant neoplasm of breast
CAUSES,Secondary Neoplasm,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Secondary Neoplasm Triple Negative Breast Neoplasms
PREDISPOSES,Ovarian failure,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Ovarian failure Malignant neoplasm of breast
AFFECTS,Immunologic Surveillance,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Chemical,Immunologic Surveillance estrogen receptor-positive breast cancer
AFFECTS,COVID-19,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",COVID-19 Malignant neoplasm of breast
DISRUPTS,Inhibitor,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Inhibitor Triple Negative Breast Neoplasms
CAUSES,Hypoxia-Inducible Factor 1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Hypoxia-Inducible Factor 1 Malignant neoplasm of breast
PREDISPOSES,Zinostatin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Zinostatin Malignant neoplasm of breast
DISRUPTS,ropivacaine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ropivacaine Malignant neoplasm of breast
PREDISPOSES,NF-kappa B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,NF-kappa B Malignant neoplasm of breast
AFFECTS,Body mass index procedure,malignant neoplasm of breast staging,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Body mass index procedure malignant neoplasm of breast staging
PREDISPOSES,Prognostic Factors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Prognostic Factors Malignant neoplasm of breast
AFFECTS,ENTPD1 wt Allele|ENTPD1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",ENTPD1 wt Allele|ENTPD1 Malignant neoplasm of breast
PREDISPOSES,Adrenergic beta-Antagonists,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Adrenergic beta-Antagonists Malignant neoplasm of breast
AFFECTS,ropivacaine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ropivacaine Malignant neoplasm of breast
AFFECTS,Dynamic Contrast-Enhanced Magnetic Resonance Imaging,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Dynamic Contrast-Enhanced Magnetic Resonance Imaging Malignant neoplasm of breast
DISRUPTS,LOC100505851,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,LOC100505851 Malignant neoplasm of breast
PREDISPOSES,LOC105371267,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,LOC105371267 Malignant neoplasm of breast
PREDISPOSES,receptor operated channel,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",receptor operated channel Malignant neoplasm of breast
AFFECTS,Graphene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Graphene Malignant neoplasm of breast
PREDISPOSES,Hydroxymethylglutaryl-CoA reductase,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",Hydroxymethylglutaryl-CoA reductase HER2-positive carcinoma of breast
PREDISPOSES,Thrombophilia,Carcinoma breast stage IV,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Thrombophilia Carcinoma breast stage IV
AFFECTS,Xenograft procedure,Carcinoma breast stage IV,0.0,Female Breast Cancer,Gene or Genome,Xenograft procedure Carcinoma breast stage IV
PREDISPOSES,Full Term Birth,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Full Term Birth Malignant neoplasm of breast
PREDISPOSES,Cerebrovascular accident,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Cerebrovascular accident estrogen receptor-positive breast cancer
PREDISPOSES,Hepatocyte Nuclear Factor 3-alpha|FOXA1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Hepatocyte Nuclear Factor 3-alpha|FOXA1 Malignant neoplasm of breast
PREDISPOSES,Coronary Arteriosclerosis,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",Coronary Arteriosclerosis estrogen receptor-positive breast cancer
AFFECTS,ZBTB7A|AKIRIN2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ZBTB7A|AKIRIN2 Malignant neoplasm of breast
AFFECTS,Diagnosis,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",Diagnosis Noninfiltrating Intraductal Carcinoma
AFFECTS,fluorouracil,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,fluorouracil Malignant neoplasm of breast
AUGMENTS,baicalin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,baicalin Malignant neoplasm of breast
PREDISPOSES,Stress,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,"Element, Ion, or Isotope",Stress Secondary malignant neoplasm of breast
AUGMENTS,Transcript,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Transcript Triple Negative Breast Neoplasms
PREDISPOSES,Problem,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Problem Malignant neoplasm of breast
DISRUPTS,TLR1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",TLR1 Triple Negative Breast Neoplasms
AFFECTS,Endoplasmic Reticulum Stress,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Endoplasmic Reticulum Stress Malignant neoplasm of breast
AFFECTS,COVID-19,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",COVID-19 Breast Carcinoma
AFFECTS,EHD1 wt Allele,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",EHD1 wt Allele Malignant neoplasm of breast
PREDISPOSES,Fiber intake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Fiber intake Malignant neoplasm of breast
AFFECTS,New Diagnosis Procedure,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",New Diagnosis Procedure Malignant neoplasm of breast
CAUSES,ergocalciferol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ergocalciferol Malignant neoplasm of breast
PREDISPOSES,high weight,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",high weight Malignant neoplasm of breast
DISRUPTS,2-(4-morpholinoanilino)-6-cyclohexylaminopurine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,2-(4-morpholinoanilino)-6-cyclohexylaminopurine Malignant neoplasm of breast
AFFECTS,High residue diet,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",High residue diet Malignant neoplasm of breast
DISRUPTS,granzyme B,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,granzyme B Breast Carcinoma
PREDISPOSES,Pathologic Complete Response,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Pathologic Complete Response Triple Negative Breast Neoplasms
PREDISPOSES,CARD.RISK,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",CARD.RISK HER2-positive carcinoma of breast
AFFECTS,liquiritigenin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,liquiritigenin Malignant neoplasm of breast
AFFECTS,Autophagy,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Autophagy Triple Negative Breast Neoplasms
PREDISPOSES,Vital activity,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Vital activity Malignant neoplasm of breast
AFFECTS,oxaliplatin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,oxaliplatin Malignant neoplasm of breast
AFFECTS,doxorubicin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,doxorubicin Malignant neoplasm of breast
DISRUPTS,Agonist,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,"Element, Ion, or Isotope",Agonist Secondary malignant neoplasm of breast
PREDISPOSES,"Obesity, Visceral",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Obesity, Visceral Malignant neoplasm of breast"
PREDISPOSES,Ultrasound scan finding,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Ultrasound scan finding Malignant neoplasm of breast
AFFECTS,tramadol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,tramadol Malignant neoplasm of breast
PREDISPOSES,Life Expectancy Less than Five Years,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Life Expectancy Less than Five Years Malignant neoplasm of breast
DISRUPTS,tegaserod maleate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,tegaserod maleate Malignant neoplasm of breast
PREDISPOSES,Sports,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Sports Malignant neoplasm of breast
PREDISPOSES,Hypoxia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Hypoxia Malignant neoplasm of breast
AFFECTS,Screening mammography,Early-Stage Breast Carcinoma,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Screening mammography Early-Stage Breast Carcinoma
AFFECTS,physiological aspects,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,physiological aspects Malignant neoplasm of breast
AFFECTS,Neoadjuvant Chemotherapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Neoadjuvant Chemotherapy Malignant neoplasm of breast
PREDISPOSES,Keratin-19,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Keratin-19 Malignant neoplasm of breast
AFFECTS,cisplatin,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",cisplatin Triple Negative Breast Neoplasms
PREDISPOSES,Score,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Score Malignant neoplasm of breast
AFFECTS,Metabolism,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Neoplastic Process,Metabolism Ductal Breast Carcinoma
PREDISPOSES,Has difficulty doing (qualifier value),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Has difficulty doing (qualifier value) Malignant neoplasm of breast
AUGMENTS,interleukin-6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",interleukin-6 Malignant neoplasm of breast
AFFECTS,"tropomyosin-related kinase-B, human",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Virus,"tropomyosin-related kinase-B, human Malignant neoplasm of breast"
PREDISPOSES,iron,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",iron Malignant neoplasm of breast
PREDISPOSES,Pediatric Obesity,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Pediatric Obesity Malignant neoplasm of breast
AFFECTS,Hyperactive behavior,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Neoplastic Process,Hyperactive behavior Secondary malignant neoplasm of breast
CAUSES,Players,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Neoplastic Process,Players Secondary malignant neoplasm of breast
AFFECTS,Endoplasmic Reticulum Stress,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Hazardous or Poisonous Substance,Endoplasmic Reticulum Stress Triple Negative Breast Neoplasms
PREDISPOSES,purinoceptor P2X4|P2RX4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,purinoceptor P2X4|P2RX4 Malignant neoplasm of breast
AFFECTS,Magnetic Field Therapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Magnetic Field Therapy Malignant neoplasm of breast
PREDISPOSES,Hypersensitivity,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",Hypersensitivity HER2-positive carcinoma of breast
DISRUPTS,Biological Response Modifiers,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Biological Response Modifiers Triple Negative Breast Neoplasms
AFFECTS,anhydroicaritin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,anhydroicaritin Malignant neoplasm of breast
CAUSES,Adipokines,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Adipokines Malignant neoplasm of breast
PREDISPOSES,Frailty,Locally advanced breast cancer,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Frailty Locally advanced breast cancer
PREDISPOSES,Dietary Habits,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Dietary Habits Malignant neoplasm of breast
PREDISPOSES,"Receptor, PAR-1",Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Gene or Genome,"Receptor, PAR-1 Invasive carcinoma of breast"
PREDISPOSES,dietary fiber intake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",dietary fiber intake Malignant neoplasm of breast
AFFECTS,Diabetes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Diabetes Malignant neoplasm of breast
AFFECTS,Neoadjuvant Chemotherapy,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Neoadjuvant Chemotherapy Triple Negative Breast Neoplasms
AFFECTS,Post-mastectomy radiotherapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Post-mastectomy radiotherapy Malignant neoplasm of breast
PREDISPOSES,Nicotinamide Phosphoribosyltransferase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Nicotinamide Phosphoribosyltransferase Malignant neoplasm of breast
CAUSES,si-wu-tang,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",si-wu-tang Malignant neoplasm of breast
PREDISPOSES,Comorbidity,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,"Element, Ion, or Isotope",Comorbidity Female Breast Carcinoma
AFFECTS,gamma-Secretase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",gamma-Secretase Malignant neoplasm of breast
PREDISPOSES,ergocalciferol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ergocalciferol Malignant neoplasm of breast
CAUSES,Helicobacter pylori,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Neoplastic Process,Helicobacter pylori Inflammatory Breast Carcinoma
PREDISPOSES,SCG2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,SCG2 Malignant neoplasm of breast
PREDISPOSES,Biological Markers,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Biological Markers Triple Negative Breast Neoplasms
DISRUPTS,CD47,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Immunologic Factor,CD47 Triple Negative Breast Neoplasms
AUGMENTS,Aurora Kinase A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Aurora Kinase A Malignant neoplasm of breast
AFFECTS,intrinsic factor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,intrinsic factor Malignant neoplasm of breast
AFFECTS,Claudins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Claudins Malignant neoplasm of breast
AFFECTS,Sleep,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Sleep Malignant neoplasm of breast
CAUSES,catalpol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,catalpol Malignant neoplasm of breast
PREDISPOSES,Mammographic Breast Density,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Mammographic Breast Density Invasive carcinoma of breast
PREDISPOSES,Saturated fat,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Saturated fat Malignant neoplasm of breast
AFFECTS,ESR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",ESR1 Malignant neoplasm of breast
PREDISPOSES,"Diet, Paleolithic",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,"Diet, Paleolithic Malignant neoplasm of breast"
AFFECTS,DNMT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",DNMT1 Malignant neoplasm of breast
DISRUPTS,Inhibitor,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,"Element, Ion, or Isotope",Inhibitor Secondary malignant neoplasm of breast
PREDISPOSES,Parabens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Parabens Malignant neoplasm of breast
PREDISPOSES,adenosine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,adenosine Malignant neoplasm of breast
AFFECTS,pigment epithelium-derived factor,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,"Element, Ion, or Isotope",pigment epithelium-derived factor Secondary malignant neoplasm of breast
DISRUPTS,agonists,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,agonists Malignant neoplasm of breast
AFFECTS,Screening procedure,Early-Stage Breast Carcinoma,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Screening procedure Early-Stage Breast Carcinoma
DISRUPTS,Cerulenin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Cerulenin Malignant neoplasm of breast
PREDISPOSES,Life Expectancy Less than Five Years,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",Life Expectancy Less than Five Years Noninfiltrating Intraductal Carcinoma
AFFECTS,Poly(ADP-ribose) Polymerase Inhibitors,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Virus,Poly(ADP-ribose) Polymerase Inhibitors estrogen receptor-positive breast cancer
AUGMENTS,arsenic trioxide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,arsenic trioxide Malignant neoplasm of breast
DISRUPTS,Liposomes,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Neoplastic Process,Liposomes Secondary malignant neoplasm of breast
AFFECTS,Diagnosis,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Diagnosis Triple Negative Breast Neoplasms
AFFECTS,metformin,Carcinoma breast stage IV,0.0,Female Breast Cancer,"Element, Ion, or Isotope",metformin Carcinoma breast stage IV
DISRUPTS,tiliroside,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",tiliroside Triple Negative Breast Neoplasms
PREDISPOSES,Programmed cell death ligand 1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Programmed cell death ligand 1 Malignant neoplasm of breast
AUGMENTS,Hypoxia Inducible Factor Family,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Hypoxia Inducible Factor Family Malignant neoplasm of breast
DISRUPTS,genistein,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",genistein Triple Negative Breast Neoplasms
PREDISPOSES,ESR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",ESR1 Malignant neoplasm of breast
PREDISPOSES,choline,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",choline Malignant neoplasm of breast
PREDISPOSES,Catechols,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Catechols Malignant neoplasm of breast
AFFECTS,AXL,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",AXL Triple Negative Breast Neoplasms
PREDISPOSES,Metabolic marker,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Pharmacologic Substance,Metabolic marker estrogen receptor-positive breast cancer
AFFECTS,beta-arrestin 1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",beta-arrestin 1 Malignant neoplasm of breast
AFFECTS,Prolactin Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Prolactin Receptor Malignant neoplasm of breast
PREDISPOSES,green tea extract,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",green tea extract Malignant neoplasm of breast
DISRUPTS,eriocalyxin B,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Neoplastic Process,eriocalyxin B Secondary malignant neoplasm of breast
PREDISPOSES,Biological Factors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Biological Factors Malignant neoplasm of breast
PREDISPOSES,dietary fat intake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",dietary fat intake Malignant neoplasm of breast
PREDISPOSES,Senility,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Senility Malignant neoplasm of breast
AFFECTS,toosendanin,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",toosendanin Triple Negative Breast Neoplasms
AFFECTS,Lactates,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Lactates Malignant neoplasm of breast
PREDISPOSES,clinical aspects,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",clinical aspects Malignant neoplasm of breast
DISRUPTS,eltrombopag,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Neoplastic Process,eltrombopag Secondary malignant neoplasm of breast
AFFECTS,factor VII,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,factor VII Malignant neoplasm of breast
AFFECTS,collagen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",collagen Malignant neoplasm of breast
PREDISPOSES,Obesity,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,"Element, Ion, or Isotope",Obesity Secondary malignant neoplasm of breast
PREDISPOSES,COG2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,COG2 Malignant neoplasm of breast
AFFECTS,Ultrasonography,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Ultrasonography Breast Carcinoma
AFFECTS,Salpingo-oophorectomy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Salpingo-oophorectomy Malignant neoplasm of breast
AFFECTS,Immune checkpoint inhibitor therapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Immunologic Factor,Immune checkpoint inhibitor therapy Malignant neoplasm of breast
AFFECTS,Lactates,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Neoplastic Process,Lactates Inflammatory Breast Carcinoma
DISRUPTS,Nicotinamide Phosphoribosyltransferase,Carcinoma breast stage IV,0.0,Female Breast Cancer,Gene or Genome,Nicotinamide Phosphoribosyltransferase Carcinoma breast stage IV
AFFECTS,TYMS|PYCARD,Carcinoma breast stage IV,0.0,Female Breast Cancer,Gene or Genome,TYMS|PYCARD Carcinoma breast stage IV
AFFECTS,Fibronectins,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Neoplastic Process,Fibronectins Secondary malignant neoplasm of breast
PREDISPOSES,Life Expectancy Less than Ten Years,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Life Expectancy Less than Ten Years Malignant neoplasm of breast
PREDISPOSES,Severe (severity modifier),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Severe (severity modifier) Malignant neoplasm of breast
CAUSES,Neoplasms,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Neoplasms Malignant neoplasm of breast
CAUSES,arsenic,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,arsenic Malignant neoplasm of breast
PREDISPOSES,ROR2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ROR2 Malignant neoplasm of breast
AFFECTS,Peripheral Nerve Sheath Neoplasm,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Immunologic Factor,Peripheral Nerve Sheath Neoplasm Triple Negative Breast Neoplasms
PREDISPOSES,"2,3-bis(3'-hydroxybenzyl)butyrolactone",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,"2,3-bis(3'-hydroxybenzyl)butyrolactone Malignant neoplasm of breast"
PREDISPOSES,Biological Markers,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Immunologic Factor,Biological Markers Secondary malignant neoplasm of breast
DISRUPTS,doxorubicin,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Neoplastic Process,doxorubicin Secondary malignant neoplasm of breast
AUGMENTS,Inhibitor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Inhibitor Malignant neoplasm of breast
CAUSES,Inflammasomes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Inflammasomes Malignant neoplasm of breast
PREDISPOSES,leptin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,leptin Malignant neoplasm of breast
PREDISPOSES,zinc,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",zinc Malignant neoplasm of breast
PREDISPOSES,Metabolite,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Metabolite Malignant neoplasm of breast
AFFECTS,alpha Catenin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",alpha Catenin Malignant neoplasm of breast
AFFECTS,Obesity,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Chemical,Obesity estrogen receptor-positive breast cancer
AFFECTS,Cell Growth,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Cell Growth Malignant neoplasm of breast
AUGMENTS,interleukin-6,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",interleukin-6 Breast Carcinoma
PREDISPOSES,Protons,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Protons Malignant neoplasm of breast
PREDISPOSES,Performance,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Neoplastic Process,Performance Invasive carcinoma of breast
AFFECTS,zoledronate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,zoledronate Malignant neoplasm of breast
PREDISPOSES,Caspase-1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Caspase-1 Malignant neoplasm of breast
DISRUPTS,astragaloside IV,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,astragaloside IV Malignant neoplasm of breast
PREDISPOSES,mammaglobin,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,mammaglobin Breast Carcinoma
AFFECTS,Secondary Neoplasm,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,"Element, Ion, or Isotope",Secondary Neoplasm Carcinoma of Male Breast
AUGMENTS,Ferritin Light Chain,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Ferritin Light Chain Malignant neoplasm of breast
PREDISPOSES,beta catenin,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Immunologic Factor,beta catenin Secondary malignant neoplasm of breast
AFFECTS,Mitosis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Mitosis Malignant neoplasm of breast
PREDISPOSES,risk factors,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,"Element, Ion, or Isotope",risk factors Carcinoma of Male Breast
AFFECTS,metformin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,metformin Malignant neoplasm of breast
AFFECTS,euphorbia factor L1,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,"Element, Ion, or Isotope",euphorbia factor L1 Secondary malignant neoplasm of breast
AFFECTS,ketamine,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",ketamine Triple Negative Breast Neoplasms
PREDISPOSES,1-Phosphatidylinositol 3-Kinase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",1-Phosphatidylinositol 3-Kinase Malignant neoplasm of breast
DISRUPTS,andrographolide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,andrographolide Malignant neoplasm of breast
DISRUPTS,Flavonoids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Flavonoids Malignant neoplasm of breast
AFFECTS,signaling cascade,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein",signaling cascade Triple Negative Breast Neoplasms
AFFECTS,Phosphates,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Phosphates Triple Negative Breast Neoplasms
PREDISPOSES,Obesity,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Chemical,Obesity estrogen receptor-positive breast cancer
DISRUPTS,Sesquiterpenes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Sesquiterpenes Malignant neoplasm of breast
AFFECTS,Vacuum assisted biopsy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Vacuum assisted biopsy Malignant neoplasm of breast
DISRUPTS,MIR223 wt Allele,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",MIR223 wt Allele Malignant neoplasm of breast
CAUSES,taxane,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,taxane Malignant neoplasm of breast
AFFECTS,Inhibitor,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,"Element, Ion, or Isotope",Inhibitor Secondary malignant neoplasm of breast
DISRUPTS,hydroxypropylbetadex (0.58-0.68 MS),Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",hydroxypropylbetadex (0.58-0.68 MS) Triple Negative Breast Neoplasms
CAUSES,chelidonine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,chelidonine Malignant neoplasm of breast
DISRUPTS,raloxifene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,raloxifene Malignant neoplasm of breast
PREDISPOSES,Chlordan,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Chlordan Malignant neoplasm of breast
PREDISPOSES,Shift worker,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Shift worker Malignant neoplasm of breast
AFFECTS,"Stress, Psychological",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Stress, Psychological Malignant neoplasm of breast"
PREDISPOSES,calcifediol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,calcifediol Malignant neoplasm of breast
PREDISPOSES,Low Level,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,"Element, Ion, or Isotope",Low Level Female Breast Carcinoma
AFFECTS,HSP90 Inhibitor,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",HSP90 Inhibitor Triple Negative Breast Neoplasms
AFFECTS,Equilibrium,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Equilibrium Malignant neoplasm of breast
AFFECTS,Proliferative vitreoretinopathy,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Proliferative vitreoretinopathy Triple Negative Breast Neoplasms
AFFECTS,Complementary therapies,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Complementary therapies Malignant neoplasm of breast
DISRUPTS,Nicotinamide Phosphoribosyltransferase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Nicotinamide Phosphoribosyltransferase Malignant neoplasm of breast
PREDISPOSES,clinical aspects,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",clinical aspects HER2-positive carcinoma of breast
AFFECTS,icariin,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",icariin Triple Negative Breast Neoplasms
CAUSES,Oxidoreductase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Oxidoreductase Malignant neoplasm of breast
PREDISPOSES,Personal status - Adopted,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Personal status - Adopted Malignant neoplasm of breast
DISRUPTS,Tea Extract,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Tea Extract Malignant neoplasm of breast
PREDISPOSES,Ubiquitin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Ubiquitin Malignant neoplasm of breast
PREDISPOSES,Healthy Lifestyle,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Healthy Lifestyle Malignant neoplasm of breast
PREDISPOSES,Clinical Significance,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",Clinical Significance Noninfiltrating Intraductal Carcinoma
AFFECTS,Secondary Neoplasm,Carcinoma breast stage IV,0.0,Female Breast Cancer,Gene or Genome,Secondary Neoplasm Carcinoma breast stage IV
AFFECTS,Menarche,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Menarche Malignant neoplasm of breast
AFFECTS,ABCB1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",ABCB1 Malignant neoplasm of breast
PREDISPOSES,Performance,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Performance Triple Negative Breast Neoplasms
PREDISPOSES,Obesity,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,"Element, Ion, or Isotope",Obesity Carcinoma of Male Breast
AFFECTS,baicalein,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",baicalein Triple Negative Breast Neoplasms
DISRUPTS,thiostrepton,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",thiostrepton Triple Negative Breast Neoplasms
AFFECTS,"Diabetes Mellitus, Non-Insulin-Dependent",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Diabetes Mellitus, Non-Insulin-Dependent Malignant neoplasm of breast"
PREDISPOSES,Progranulins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Progranulins Malignant neoplasm of breast
PREDISPOSES,Personal Behavior,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Personal Behavior Malignant neoplasm of breast
PREDISPOSES,Nitric Oxide Synthase Type II,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Nitric Oxide Synthase Type II Breast cancer metastatic
DISRUPTS,FAS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",FAS Malignant neoplasm of breast
AFFECTS,Motility,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Motility Malignant neoplasm of breast
AFFECTS,PAK1|PKN1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",PAK1|PKN1 Malignant neoplasm of breast
AFFECTS,Methotrexate,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Methotrexate Breast cancer metastatic
AUGMENTS,Adenosine A1 Receptor|ADORA1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Adenosine A1 Receptor|ADORA1 Malignant neoplasm of breast
AFFECTS,Mammary Neoplasms,Carcinoma in situ of breast,0.0019980019980019,Female Breast Cancer,Neoplastic Process,Mammary Neoplasms Carcinoma in situ of breast
PREDISPOSES,DNMT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",DNMT1 Malignant neoplasm of breast
PREDISPOSES,Estrone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Estrone Malignant neoplasm of breast
DISRUPTS,indole-3-carbinol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,indole-3-carbinol Malignant neoplasm of breast
DISRUPTS,bortezomib,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,bortezomib Malignant neoplasm of breast
AFFECTS,survivin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,survivin Malignant neoplasm of breast
AFFECTS,Connexins,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Connexins Breast cancer metastatic
AFFECTS,Interleukin-17,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Interleukin-17 Malignant neoplasm of breast
CAUSES,MMP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,MMP Malignant neoplasm of breast
AUGMENTS,PITPNM1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",PITPNM1 Breast cancer metastatic
AFFECTS,CIP2A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,CIP2A Malignant neoplasm of breast
PREDISPOSES,mammaglobin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,mammaglobin Malignant neoplasm of breast
AUGMENTS,BST2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,BST2 Malignant neoplasm of breast
PREDISPOSES,ethnic differences,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",ethnic differences Malignant neoplasm of breast
AFFECTS,Free Radicals,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Free Radicals Malignant neoplasm of breast
CAUSES,Catenins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Catenins Malignant neoplasm of breast
AFFECTS,nitidine chloride,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",nitidine chloride Malignant neoplasm of breast
AUGMENTS,KIFC1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,KIFC1 Malignant neoplasm of breast
PREDISPOSES,PSMB6|YY1|DLL1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",PSMB6|YY1|DLL1 Malignant neoplasm of breast
DISRUPTS,cilostazol,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",cilostazol Breast cancer metastatic
AFFECTS,UBE2N,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",UBE2N Breast cancer metastatic
AFFECTS,STMN1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,STMN1 Malignant neoplasm of breast
PREDISPOSES,IQGAP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",IQGAP1 Malignant neoplasm of breast
DISRUPTS,profilin 1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,profilin 1 Malignant neoplasm of breast
AFFECTS,KISS1R,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",KISS1R Malignant neoplasm of breast
CAUSES,Neuromedin U|NMU,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Neuromedin U|NMU Malignant neoplasm of breast
PREDISPOSES,Pain,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Pain Malignant neoplasm of breast
PREDISPOSES,MIR98,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",MIR98 Breast cancer metastatic
PREDISPOSES,erbB-2 Receptor|ERBB2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",erbB-2 Receptor|ERBB2 Malignant neoplasm of breast
AUGMENTS,CENPA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,CENPA Malignant neoplasm of breast
DISRUPTS,isoliquiritigenin,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",isoliquiritigenin Breast cancer metastatic
DISRUPTS,Centchroman,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Centchroman Breast cancer metastatic
PREDISPOSES,RASAL2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",RASAL2 Malignant neoplasm of breast
AUGMENTS,Estradiol,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Estradiol Breast cancer metastatic
DISRUPTS,dihydroxyacetone sulfate,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",dihydroxyacetone sulfate Breast cancer metastatic
CAUSES,PALB2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",PALB2 Malignant neoplasm of breast
PREDISPOSES,Leisure Time,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Leisure Time Malignant neoplasm of breast
PREDISPOSES,Estriol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Estriol Malignant neoplasm of breast
AFFECTS,Cyclophosphamide,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Cyclophosphamide Breast Carcinoma
AUGMENTS,Diethylstilbestrol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Diethylstilbestrol Malignant neoplasm of breast
PREDISPOSES,Thymidylate Synthase,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Neoplastic Process,Thymidylate Synthase Sporadic Breast Carcinoma
PREDISPOSES,Cyclin D1|CCND1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Cyclin D1|CCND1 Malignant neoplasm of breast
AFFECTS,Urokinase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Urokinase Malignant neoplasm of breast
DISRUPTS,Orosomucoid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Orosomucoid Malignant neoplasm of breast
PREDISPOSES,CTCF,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,CTCF Malignant neoplasm of breast
CAUSES,Leptin|LEP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Leptin|LEP Malignant neoplasm of breast
DISRUPTS,Phosphotransferases,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Phosphotransferases Breast cancer metastatic
AUGMENTS,estrone sulfate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",estrone sulfate Malignant neoplasm of breast
PREDISPOSES,Glutamate Carboxypeptidase II,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Glutamate Carboxypeptidase II Malignant neoplasm of breast
AUGMENTS,KISS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",KISS1 Malignant neoplasm of breast
PREDISPOSES,KLF5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",KLF5 Malignant neoplasm of breast
PREDISPOSES,Supraventricular arrhythmia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Supraventricular arrhythmia Malignant neoplasm of breast
DISRUPTS,PFN1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,PFN1 Malignant neoplasm of breast
AFFECTS,Sodium Selenite,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Sodium Selenite Malignant neoplasm of breast
AFFECTS,GRHL3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,GRHL3 Malignant neoplasm of breast
DISRUPTS,1-Phosphatidylinositol 4-Kinase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",1-Phosphatidylinositol 4-Kinase Malignant neoplasm of breast
AUGMENTS,PELP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,PELP1 Malignant neoplasm of breast
PREDISPOSES,SOX11,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Neoplastic Process,SOX11 Noninfiltrating Intraductal Carcinoma
AUGMENTS,Interleukin 4 Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Interleukin 4 Receptor Malignant neoplasm of breast
AUGMENTS,CMA1|SLC16A1|MCAT|MCTS1,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,CMA1|SLC16A1|MCAT|MCTS1 Breast Carcinoma
AFFECTS,Isoflavones,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Isoflavones Malignant neoplasm of breast
PREDISPOSES,Polysaccharides,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Polysaccharides Malignant neoplasm of breast
DISRUPTS,gamma-secretase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",gamma-secretase Malignant neoplasm of breast
PREDISPOSES,Carboxypeptidase U,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Carboxypeptidase U Malignant neoplasm of breast
AFFECTS,Neoplasm,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Disease or Syndrome,Neoplasm Sporadic Breast Carcinoma
AFFECTS,Epinephrine,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Epinephrine Breast Carcinoma
PREDISPOSES,Reserpine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Reserpine Malignant neoplasm of breast
AFFECTS,Aspartic Endopeptidases,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Aspartic Endopeptidases Breast cancer metastatic
CAUSES,chromosome 17q,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",chromosome 17q Malignant neoplasm of breast
PREDISPOSES,Milk intake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Milk intake Malignant neoplasm of breast
PREDISPOSES,Fibrosis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Fibrosis Malignant neoplasm of breast
AUGMENTS,Caseins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Caseins Malignant neoplasm of breast
AFFECTS,Menstrual cycle,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Menstrual cycle Malignant neoplasm of breast
AUGMENTS,Androgens,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Androgens Breast Carcinoma
PREDISPOSES,Reserpine,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Reserpine Breast Carcinoma
AFFECTS,Circadian Rhythms,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Circadian Rhythms Malignant neoplasm of breast
CAUSES,retinol acetate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",retinol acetate Malignant neoplasm of breast
PREDISPOSES,Selenium intake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Selenium intake Malignant neoplasm of breast
CAUSES,Vinyl Chloride,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Vinyl Chloride Breast Carcinoma
PREDISPOSES,N-acetyltransferase 1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,N-acetyltransferase 1 Malignant neoplasm of breast
CAUSES,retinyl methyl ether,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",retinyl methyl ether Malignant neoplasm of breast
PREDISPOSES,Interleukin-13,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Interleukin-13 Malignant neoplasm of breast
AFFECTS,inhibitors,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",inhibitors Noninfiltrating Intraductal Carcinoma
AUGMENTS,GPER1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",GPER1 Malignant neoplasm of breast
AFFECTS,Xeroradiography,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,"Element, Ion, or Isotope",Xeroradiography Female Breast Carcinoma
AFFECTS,Bread,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Bread Malignant neoplasm of breast
PREDISPOSES,leptin receptor|LEP,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Hormone,leptin receptor|LEP Sporadic Breast Carcinoma
DISRUPTS,Cyclin E,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Cyclin E Malignant neoplasm of breast
CAUSES,Metabolites,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Metabolites Malignant neoplasm of breast
PREDISPOSES,"Puberty, Female",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Puberty, Female Malignant neoplasm of breast"
PREDISPOSES,valyl-valyl-valine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,valyl-valyl-valine Malignant neoplasm of breast
AUGMENTS,20q13.2,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,20q13.2 Breast Carcinoma
PREDISPOSES,LOX,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,LOX Malignant neoplasm of breast
AFFECTS,Somatotropin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Somatotropin Malignant neoplasm of breast
PREDISPOSES,BONE MASS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",BONE MASS Malignant neoplasm of breast
AUGMENTS,Urokinase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Urokinase Malignant neoplasm of breast
PREDISPOSES,No past history,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",No past history Malignant neoplasm of breast
PREDISPOSES,Molecular Abnormality,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Molecular Abnormality Malignant neoplasm of breast
PREDISPOSES,Indoles,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Indoles Malignant neoplasm of breast
AFFECTS,Estradiol,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Estradiol Breast Carcinoma
AUGMENTS,Cadherins,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Neoplastic Process,Cadherins Noninfiltrating Intraductal Carcinoma
AFFECTS,Biopsy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Biopsy Malignant neoplasm of breast
AUGMENTS,Melatonin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Melatonin Malignant neoplasm of breast
CAUSES,Retroviridae,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Retroviridae Malignant neoplasm of breast
PREDISPOSES,EYA2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,EYA2 Breast cancer metastatic
AFFECTS,Pill,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Pill Malignant neoplasm of breast
PREDISPOSES,Reproductive History,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Element, Ion, or Isotope",Reproductive History Breast cancer invasive NOS
AFFECTS,Hyaluronan,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Hyaluronan Malignant neoplasm of breast
AFFECTS,Aromatic Amines,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Aromatic Amines Malignant neoplasm of breast
DISRUPTS,Dietary Fats,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Dietary Fats Malignant neoplasm of breast
AFFECTS,Neoplasm,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,Neoplasm Breast cancer invasive NOS
PREDISPOSES,CA1|S100A10,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,CA1|S100A10 Malignant neoplasm of breast
AFFECTS,Binding Sites,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Binding Sites Malignant neoplasm of breast
CAUSES,Urea,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Urea Breast Carcinoma
AFFECTS,Melatonin,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Melatonin Breast Carcinoma
DISRUPTS,Fenretinide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Fenretinide Malignant neoplasm of breast
AFFECTS,Arginine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Arginine Malignant neoplasm of breast
PREDISPOSES,Sterility,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Sterility Malignant neoplasm of breast
CAUSES,Benzanthracenes,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Benzanthracenes Breast Carcinoma
AFFECTS,Absolute Alcohol,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,"Element, Ion, or Isotope",Absolute Alcohol Female Breast Carcinoma
PREDISPOSES,Polyunsaturated fat intake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Polyunsaturated fat intake Malignant neoplasm of breast
DISRUPTS,Polyamines,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Polyamines Malignant neoplasm of breast
AUGMENTS,PHENYL,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,PHENYL Breast Carcinoma
AFFECTS,adjuvant therapy,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Element, Ion, or Isotope",adjuvant therapy Breast cancer recurrent
CAUSES,Estrone,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Estrone Breast Carcinoma
PREDISPOSES,hormonal changes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,hormonal changes Malignant neoplasm of breast
AFFECTS,Fluorouracil,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Fluorouracil Malignant neoplasm of breast
PREDISPOSES,TAG 12,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",TAG 12 Malignant neoplasm of breast
AFFECTS,Term pregnancy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Term pregnancy Malignant neoplasm of breast
PREDISPOSES,Alkaline Phosphatase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Enzyme,Alkaline Phosphatase Malignant neoplasm of breast
PREDISPOSES,Alkaline Phosphatase,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Alkaline Phosphatase Breast Carcinoma
CAUSES,Advance,Breast cancer stage II,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Advance Breast cancer stage II
PREDISPOSES,Athletics,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Athletics Malignant neoplasm of breast
PREDISPOSES,Height / growth measure,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Height / growth measure Malignant neoplasm of breast
PREDISPOSES,ARGINASE,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,ARGINASE Breast Carcinoma
PREDISPOSES,Seizures,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Seizures Malignant neoplasm of breast
AFFECTS,Pharmacotherapy,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Pharmacotherapy Breast Carcinoma
AFFECTS,Testicular Neoplasms,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Testicular Neoplasms Malignant neoplasm of breast
AFFECTS,Mammography,Breast Mucinous Carcinoma,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Mammography Breast Mucinous Carcinoma
AFFECTS,Haloperidol,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Haloperidol Breast Carcinoma
AFFECTS,Hysterectomy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Hysterectomy Malignant neoplasm of breast
AFFECTS,Ovariectomy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Ovariectomy Malignant neoplasm of breast
AUGMENTS,Prolactin,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Prolactin Breast Carcinoma
CAUSES,Neuromedin U|NMU,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Neuromedin U|NMU Breast Carcinoma
COMPLICATES,"Liver Failure, Acute",Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope","Liver Failure, Acute Breast Carcinoma"
AFFECTS,Ovariectomy,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Ovariectomy Breast Carcinoma
DISRUPTS,Monoterpenes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Monoterpenes Malignant neoplasm of breast
AUGMENTS,Hydrocortisone,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Hydrocortisone Breast Carcinoma
AFFECTS,melanoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,melanoma Malignant neoplasm of breast
AFFECTS,Neurotropism,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Neurotropism Breast Carcinoma
PREDISPOSES,2-hydroxyestrone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,2-hydroxyestrone Malignant neoplasm of breast
AFFECTS,Aminoglutethimide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Aminoglutethimide Malignant neoplasm of breast
AFFECTS,Antipyrine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Antipyrine Malignant neoplasm of breast
AFFECTS,Levamisole,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Levamisole Malignant neoplasm of breast
AUGMENTS,transglutaminase 1,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,transglutaminase 1 Breast Carcinoma
AFFECTS,Hydrocortisone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Hydrocortisone Malignant neoplasm of breast
AUGMENTS,Goserelin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Goserelin Malignant neoplasm of breast
PREDISPOSES,Visual impairment,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Visual impairment Malignant neoplasm of breast
AFFECTS,Scanning,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Scanning Malignant neoplasm of breast
PREDISPOSES,Introns,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Introns Malignant neoplasm of breast
DISRUPTS,Flutamide,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Flutamide Breast Carcinoma
AUGMENTS,CATHEPSIN D|CTSD,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,CATHEPSIN D|CTSD Breast Carcinoma
PREDISPOSES,Dichlorodiphenyl Dichloroethylene,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,"Element, Ion, or Isotope",Dichlorodiphenyl Dichloroethylene Female Breast Carcinoma
CAUSES,Acetyltransferase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Acetyltransferase Malignant neoplasm of breast
PREDISPOSES,"(meso-1,2-bis-(2,6-dichloro-4-hydroxyphenyl)ethylenediamine)dichloroplatinum(II)",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","(meso-1,2-bis-(2,6-dichloro-4-hydroxyphenyl)ethylenediamine)dichloroplatinum(II) Malignant neoplasm of breast"
CAUSES,Mixture,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Mixture Malignant neoplasm of breast
PREDISPOSES,Date of birth,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Date of birth Malignant neoplasm of breast
PREDISPOSES,Short stature,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Short stature Malignant neoplasm of breast
AFFECTS,Cyclin D1|CCND1,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Cyclin D1|CCND1 Sporadic Breast Carcinoma
AFFECTS,Magnetic Resonance Spectroscopy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Magnetic Resonance Spectroscopy Malignant neoplasm of breast
PREDISPOSES,Phenothiazines,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Phenothiazines Malignant neoplasm of breast
CAUSES,Vegetable Oils,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Vegetable Oils Malignant neoplasm of breast
AUGMENTS,6-pyruvoyltetrahydropterin synthase|SLC25A3|REG1A|PTPRU,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",6-pyruvoyltetrahydropterin synthase|SLC25A3|REG1A|PTPRU Malignant neoplasm of breast
PREDISPOSES,Beans,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Beans Malignant neoplasm of breast
AFFECTS,Integrins,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Integrins Breast Carcinoma
COMPLICATES,Pathological fracture,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Pathological fracture Malignant neoplasm of breast
PREDISPOSES,Nulliparous,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Nulliparous Malignant neoplasm of breast
PREDISPOSES,Mean blood pressure,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Mean blood pressure Malignant neoplasm of breast
AUGMENTS,glypican 3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,glypican 3 Malignant neoplasm of breast
CAUSES,"Smoking, Passive",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,"Smoking, Passive Malignant neoplasm of breast"
PREDISPOSES,NAT2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",NAT2 Malignant neoplasm of breast
AFFECTS,Ultraviolet Rays,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Ultraviolet Rays Malignant neoplasm of breast
AUGMENTS,GRB7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,GRB7 Malignant neoplasm of breast
PREDISPOSES,Premature Birth,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Premature Birth Malignant neoplasm of breast
AUGMENTS,Mitogens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Mitogens Malignant neoplasm of breast
PREDISPOSES,Fibroadenoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Fibroadenoma Malignant neoplasm of breast
CAUSES,"Receptors, Nuclear",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Receptors, Nuclear Malignant neoplasm of breast"
PREDISPOSES,Cytochrome P450 3A4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Cytochrome P450 3A4 Malignant neoplasm of breast
AUGMENTS,estriol 3-sulfate,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",estriol 3-sulfate Breast Carcinoma
DISRUPTS,Disintegrins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Disintegrins Malignant neoplasm of breast
AFFECTS,Pre-Eclampsia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Pre-Eclampsia Malignant neoplasm of breast
CAUSES,Dichlorodiphenyl Dichloroethylene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Dichlorodiphenyl Dichloroethylene Malignant neoplasm of breast
DISRUPTS,Endostatins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Endostatins Malignant neoplasm of breast
PREDISPOSES,"Encounter due to prophylactic surgery, unspecified",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Encounter due to prophylactic surgery, unspecified Malignant neoplasm of breast"
AFFECTS,Scanning,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Neoplastic Process,Scanning Inflammatory Breast Carcinoma
PREDISPOSES,psychological stressor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,psychological stressor Malignant neoplasm of breast
AUGMENTS,Depo-Provera,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Depo-Provera Malignant neoplasm of breast
PREDISPOSES,"Stress, acute",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Stress, acute Malignant neoplasm of breast"
CAUSES,3MC,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,3MC Breast Carcinoma
AFFECTS,Methylcholanthrene,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Methylcholanthrene Breast Carcinoma
AFFECTS,Ibuprofen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Ibuprofen Malignant neoplasm of breast
DISRUPTS,Beta Carotene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Beta Carotene Malignant neoplasm of breast
CAUSES,"2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein","2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine Malignant neoplasm of breast"
CAUSES,ESRRA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",ESRRA Malignant neoplasm of breast
AFFECTS,specific immunity,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Pharmacologic Substance,specific immunity Breast Carcinoma
AUGMENTS,Androgen Receptor|AR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Androgen Receptor|AR Malignant neoplasm of breast
PREDISPOSES,Gelatinase A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Gelatinase A Malignant neoplasm of breast
AFFECTS,Therapeutic procedure,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",Therapeutic procedure Noninfiltrating Intraductal Carcinoma
AFFECTS,Kininogenase|KLK4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Kininogenase|KLK4 Malignant neoplasm of breast
CAUSES,ZHX2,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",ZHX2 Breast Carcinoma
CAUSES,PIK3CA|PIK3CB|PIK3CD|PIK3CG,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",PIK3CA|PIK3CB|PIK3CD|PIK3CG Breast Carcinoma
PREDISPOSES,Telomerase,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Telomerase Breast Carcinoma
AFFECTS,COMT,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,COMT Malignant neoplasm of breast
PREDISPOSES,Cysteine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Cysteine Malignant neoplasm of breast
CAUSES,Guanosine Triphosphate Phosphohydrolases,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Neoplastic Process,Guanosine Triphosphate Phosphohydrolases Inflammatory Breast Carcinoma
PREDISPOSES,Apple,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Apple Malignant neoplasm of breast
PREDISPOSES,Female genital tract problem,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Female genital tract problem Malignant neoplasm of breast
PREDISPOSES,Embolism,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Embolism Malignant neoplasm of breast
DISRUPTS,ADAM23,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ADAM23 Malignant neoplasm of breast
PREDISPOSES,CANADIAN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,CANADIAN Malignant neoplasm of breast
PREDISPOSES,Mass in breast,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Mass in breast Malignant neoplasm of breast
PREDISPOSES,Lignans,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Lignans Malignant neoplasm of breast
DISRUPTS,Prolactin,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Prolactin Breast Carcinoma
AFFECTS,Mammary Neoplasms,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Mammary Neoplasms Malignant neoplasm of breast
PREDISPOSES,Creatinine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Creatinine Malignant neoplasm of breast
PREDISPOSES,Receptiveness,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Receptiveness Malignant neoplasm of breast
PREDISPOSES,IGKV2D-40,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,IGKV2D-40 Malignant neoplasm of breast
CAUSES,Methylcholanthrene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Methylcholanthrene Malignant neoplasm of breast
DISRUPTS,WNT7B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",WNT7B Malignant neoplasm of breast
AFFECTS,Therapeutic procedure,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,"Element, Ion, or Isotope",Therapeutic procedure Contralateral breast cancer
PREDISPOSES,Synucleins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Synucleins Malignant neoplasm of breast
CAUSES,CDKN1A|TCEAL1|NSG1|H3F3AP6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",CDKN1A|TCEAL1|NSG1|H3F3AP6 Malignant neoplasm of breast
AFFECTS,Androgen therapy,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Androgen therapy Breast Carcinoma
AFFECTS,death receptor-4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",death receptor-4 Malignant neoplasm of breast
AFFECTS,Iodides,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Iodides Malignant neoplasm of breast
PREDISPOSES,Paroxysmal atrial tachycardia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Paroxysmal atrial tachycardia Malignant neoplasm of breast
PREDISPOSES,Hyperglycemia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Hyperglycemia Malignant neoplasm of breast
DISRUPTS,Thrombospondin 1|THBS1|CRISP2|PRSS55,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Thrombospondin 1|THBS1|CRISP2|PRSS55 Breast Carcinoma
PREDISPOSES,Increase in blood pressure,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Lipid,Increase in blood pressure Malignant neoplasm of breast
DISRUPTS,AKR1C1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",AKR1C1 Malignant neoplasm of breast
AUGMENTS,EVL,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,EVL Malignant neoplasm of breast
PREDISPOSES,"Contraceptives, Oral",Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope","Contraceptives, Oral Breast Carcinoma"
AUGMENTS,Fibrin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Fibrin Malignant neoplasm of breast
AFFECTS,CHEST PATHOLOGY,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,CHEST PATHOLOGY Breast cancer invasive NOS
PREDISPOSES,WNT7B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",WNT7B Malignant neoplasm of breast
CAUSES,Spray,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Spray Malignant neoplasm of breast
AUGMENTS,N-Cadherins,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,N-Cadherins Breast Carcinoma
AFFECTS,Dairy Products,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Dairy Products Malignant neoplasm of breast
PREDISPOSES,SLC25A18,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,SLC25A18 Malignant neoplasm of breast
AUGMENTS,Transcript,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Transcript Malignant neoplasm of breast
PREDISPOSES,Climacteric discomfort,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Climacteric discomfort Malignant neoplasm of breast
PREDISPOSES,Valine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Valine Malignant neoplasm of breast
AFFECTS,Microdochectomy,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Neoplastic Process,Microdochectomy Noninfiltrating Intraductal Carcinoma
AFFECTS,Molecular Chaperones,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Molecular Chaperones Malignant neoplasm of breast
AFFECTS,Integrins,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Integrins Breast cancer metastatic
PREDISPOSES,Prolactin level,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Prolactin level Malignant neoplasm of breast
DISRUPTS,ADRA1D,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ADRA1D Malignant neoplasm of breast
AFFECTS,Pregnanes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Pregnanes Malignant neoplasm of breast
AUGMENTS,Valine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Valine Malignant neoplasm of breast
PREDISPOSES,PRL increased,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",PRL increased Malignant neoplasm of breast
AFFECTS,Molecular Target,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Molecular Target Malignant neoplasm of breast
PREDISPOSES,Tocotrienols,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Tocotrienols Malignant neoplasm of breast
AFFECTS,Biopsy,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Biopsy Breast Carcinoma
PREDISPOSES,E-Cadherin,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Neoplastic Process,E-Cadherin Inflammatory Breast Carcinoma
DISRUPTS,allyl sulfide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,allyl sulfide Malignant neoplasm of breast
PREDISPOSES,CYP1B1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",CYP1B1 Malignant neoplasm of breast
AUGMENTS,Tetanus Vaccine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Tetanus Vaccine Malignant neoplasm of breast
CAUSES,Biological Models,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Biological Models Malignant neoplasm of breast
AFFECTS,Mouse Pancreatic Intraepithelial Neoplasia-1B,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Mouse Pancreatic Intraepithelial Neoplasia-1B Breast Carcinoma
PREDISPOSES,Lymph Node Involvement,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Element, Ion, or Isotope",Lymph Node Involvement Breast cancer invasive NOS
PREDISPOSES,Betaine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Betaine Malignant neoplasm of breast
PREDISPOSES,gamma-Glutamyl Hydrolase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",gamma-Glutamyl Hydrolase Malignant neoplasm of breast
AFFECTS,Integrins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Integrins Malignant neoplasm of breast
PREDISPOSES,Disclosure,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Disclosure Malignant neoplasm of breast
AUGMENTS,SIRT7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",SIRT7 Malignant neoplasm of breast
PREDISPOSES,Tea intake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Tea intake Malignant neoplasm of breast
PREDISPOSES,CATHEPSIN D|CTSD,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,CATHEPSIN D|CTSD Malignant neoplasm of breast
CAUSES,Diethylstilbestrol,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Diethylstilbestrol Breast Carcinoma
AUGMENTS,Pesticides,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Pesticides Malignant neoplasm of breast
CAUSES,Detectors,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Detectors Breast Carcinoma
PREDISPOSES,prolylarginine|ABL2|RERE,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,prolylarginine|ABL2|RERE Malignant neoplasm of breast
AFFECTS,Insulin|INS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Insulin|INS Malignant neoplasm of breast
PREDISPOSES,PARP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",PARP1 Malignant neoplasm of breast
PREDISPOSES,Cortisol level,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Cortisol level Malignant neoplasm of breast
AFFECTS,NEK3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,NEK3 Malignant neoplasm of breast
AFFECTS,Thrombospondin 1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Thrombospondin 1 Breast cancer metastatic
CAUSES,Aldosterone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Aldosterone Malignant neoplasm of breast
PREDISPOSES,saturated fat,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",saturated fat Malignant neoplasm of breast
PREDISPOSES,FANCA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",FANCA Malignant neoplasm of breast
CAUSES,Cyproterone Acetate,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Cyproterone Acetate Breast Carcinoma
PREDISPOSES,Development of the breasts,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Lipid,Development of the breasts Breast cancer recurrent
CAUSES,PIN1,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,"Element, Ion, or Isotope",PIN1 Sporadic Breast Carcinoma
DISRUPTS,Alpha tocopheryl succinate,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Alpha tocopheryl succinate Breast Carcinoma
PREDISPOSES,Obesity,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Element, Ion, or Isotope",Obesity Breast cancer invasive NOS
AFFECTS,Guanosine Triphosphate Phosphohydrolases,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Neoplastic Process,Guanosine Triphosphate Phosphohydrolases Inflammatory Breast Carcinoma
PREDISPOSES,Alar,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Alar Malignant neoplasm of breast
PREDISPOSES,estradiol-17 beta-glucuronide,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,"Element, Ion, or Isotope",estradiol-17 beta-glucuronide Female Breast Carcinoma
AFFECTS,"Receptors, Notch",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Receptors, Notch Malignant neoplasm of breast"
AFFECTS,Thymidine Phosphorylase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Thymidine Phosphorylase Malignant neoplasm of breast
CAUSES,Study models,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Study models Malignant neoplasm of breast
AFFECTS,Hyperthyroidism,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Hyperthyroidism Breast Carcinoma
PREDISPOSES,SLC25A4|CD5|IL1RL1|TRAPPC9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",SLC25A4|CD5|IL1RL1|TRAPPC9 Malignant neoplasm of breast
AFFECTS,erlotinib,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,erlotinib Malignant neoplasm of breast
AFFECTS,Aging,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Aging Malignant neoplasm of breast
DISRUPTS,lapatinib,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Neoplastic Process,lapatinib Noninfiltrating Intraductal Carcinoma
AUGMENTS,Androgens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Androgens Malignant neoplasm of breast
AUGMENTS,Telomerase,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,Telomerase Breast cancer invasive NOS
PREDISPOSES,JAG2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",JAG2 Breast cancer metastatic
DISRUPTS,PARP1|COL11A2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",PARP1|COL11A2 Malignant neoplasm of breast
PREDISPOSES,CD27,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Disease or Syndrome,CD27 Sporadic Breast Carcinoma
PREDISPOSES,Vanadium,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Vanadium Malignant neoplasm of breast
AUGMENTS,SPN|DEAF1|PPP1R9B,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,SPN|DEAF1|PPP1R9B Breast Carcinoma
PREDISPOSES,Sex Behavior,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Sex Behavior Malignant neoplasm of breast
CAUSES,TWSG1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",TWSG1 Malignant neoplasm of breast
PREDISPOSES,Development of the breasts,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Element, Ion, or Isotope",Development of the breasts Breast cancer invasive NOS
AUGMENTS,PIK3R1,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",PIK3R1 Breast Carcinoma
AFFECTS,CD24,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",CD24 Breast Carcinoma
AFFECTS,dehydroepiandrosterone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,dehydroepiandrosterone Malignant neoplasm of breast
AFFECTS,Levonorgestrel,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Levonorgestrel Breast cancer recurrent
DISRUPTS,Epicatechin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Epicatechin Malignant neoplasm of breast
PREDISPOSES,SH3KBP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,SH3KBP1 Malignant neoplasm of breast
AFFECTS,Double Strand Break Repair,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Double Strand Break Repair Malignant neoplasm of breast
AFFECTS,SLC9A3R1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,SLC9A3R1 Malignant neoplasm of breast
AFFECTS,Homeostasis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Homeostasis Malignant neoplasm of breast
PREDISPOSES,2q35,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,2q35 Malignant neoplasm of breast
AFFECTS,Cell physiology,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Cell physiology Malignant neoplasm of breast
AFFECTS,Sphingosine-1-Phosphate Receptors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Sphingosine-1-Phosphate Receptors Malignant neoplasm of breast
AFFECTS,Nicotinic Receptors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Nicotinic Receptors Malignant neoplasm of breast
PREDISPOSES,Insulin|INS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Insulin|INS Malignant neoplasm of breast
PREDISPOSES,8q24,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Disease or Syndrome,8q24 Sporadic Breast Carcinoma
AFFECTS,src-Family Kinases|SRC,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",src-Family Kinases|SRC Malignant neoplasm of breast
PREDISPOSES,Microsatellite Repeats,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Microsatellite Repeats Malignant neoplasm of breast
CAUSES,B3GNT2|B3GNTL1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",B3GNT2|B3GNTL1 Breast cancer metastatic
CAUSES,FRAGMENTS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,FRAGMENTS Malignant neoplasm of breast
PREDISPOSES,FOXA1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",FOXA1 Malignant neoplasm of breast
AFFECTS,WWP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,WWP1 Malignant neoplasm of breast
PREDISPOSES,"Calcium, Dietary",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Calcium, Dietary Malignant neoplasm of breast"
AUGMENTS,Calgranulin B|S100A9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Calgranulin B|S100A9 Malignant neoplasm of breast
PREDISPOSES,BRAZILIAN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,BRAZILIAN Malignant neoplasm of breast
AFFECTS,Adenosine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Adenosine Malignant neoplasm of breast
PREDISPOSES,6q22.33,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,6q22.33 Malignant neoplasm of breast
AUGMENTS,NF-kappa B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,NF-kappa B Malignant neoplasm of breast
AFFECTS,brightness,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,brightness Malignant neoplasm of breast
CAUSES,SPN|DEAF1|PPP1R9B,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,SPN|DEAF1|PPP1R9B Breast Carcinoma
AFFECTS,FHL1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,FHL1 Malignant neoplasm of breast
AFFECTS,Leptin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Leptin Malignant neoplasm of breast
AFFECTS,Sodium Valproate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Carbohydrate,Sodium Valproate Malignant neoplasm of breast
AUGMENTS,RPE65|UVRAG|TP63|CKAP4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,RPE65|UVRAG|TP63|CKAP4 Malignant neoplasm of breast
CAUSES,Somatomedins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Somatomedins Malignant neoplasm of breast
AUGMENTS,Enhancer,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Enhancer Malignant neoplasm of breast
PREDISPOSES,cadherin 5,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",cadherin 5 Breast cancer metastatic
AFFECTS,METHYLATE,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,METHYLATE Malignant neoplasm of breast
AUGMENTS,1-Phosphatidylinositol 3-Kinase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",1-Phosphatidylinositol 3-Kinase Malignant neoplasm of breast
CAUSES,SNAI2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,SNAI2 Malignant neoplasm of breast
PREDISPOSES,patient family history,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,"Element, Ion, or Isotope",patient family history Familial cancer of breast
PREDISPOSES,"Receptors, Cytoplasmic",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Receptors, Cytoplasmic Malignant neoplasm of breast"
PREDISPOSES,MS4A1|BBS9|IGKV7-3|SPANXB1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",MS4A1|BBS9|IGKV7-3|SPANXB1 Malignant neoplasm of breast
PREDISPOSES,Very high,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Very high Malignant neoplasm of breast
AFFECTS,Paraffin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Paraffin Malignant neoplasm of breast
PREDISPOSES,5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase Malignant neoplasm of breast
PREDISPOSES,RAB1B,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",RAB1B Breast cancer metastatic
AUGMENTS,PYRUVATE CARBOXYLASE|PC,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",PYRUVATE CARBOXYLASE|PC Malignant neoplasm of breast
AUGMENTS,Annexin A1|ANXA1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Annexin A1|ANXA1 Malignant neoplasm of breast
AUGMENTS,IL18,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",IL18 Malignant neoplasm of breast
PREDISPOSES,Arthralgia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Arthralgia Malignant neoplasm of breast
AFFECTS,PIAS1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",PIAS1 Breast cancer metastatic
AFFECTS,Chemotaxis,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Chemotaxis Breast Carcinoma
AFFECTS,treatment method,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",treatment method Malignant neoplasm of breast
PREDISPOSES,betaine-homocysteine methyltransferase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",betaine-homocysteine methyltransferase Malignant neoplasm of breast
AFFECTS,CYP4Z1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,CYP4Z1 Malignant neoplasm of breast
AUGMENTS,PRICKLE1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,PRICKLE1 Malignant neoplasm of breast
AUGMENTS,saturated fat,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",saturated fat Malignant neoplasm of breast
PREDISPOSES,IGF2BP2|IMMP2L|SPPL3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",IGF2BP2|IMMP2L|SPPL3 Malignant neoplasm of breast
AFFECTS,furanodiene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,furanodiene Malignant neoplasm of breast
AFFECTS,Androgen Receptor|AR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Androgen Receptor|AR Malignant neoplasm of breast
CAUSES,2q33,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,2q33 Malignant neoplasm of breast
AUGMENTS,IL33,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,IL33 Malignant neoplasm of breast
DISRUPTS,OTUD1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,OTUD1 Breast cancer metastatic
DISRUPTS,Neurofibromin 2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Neurofibromin 2 Malignant neoplasm of breast
PREDISPOSES,Annexin A3|ANXA3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Annexin A3|ANXA3 Malignant neoplasm of breast
AUGMENTS,galangin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,galangin Malignant neoplasm of breast
AUGMENTS,PALB2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",PALB2 Malignant neoplasm of breast
DISRUPTS,tubeimoside I,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",tubeimoside I Breast cancer metastatic
DISRUPTS,Sulindac,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Sulindac Malignant neoplasm of breast
AFFECTS,PAQR3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,PAQR3 Malignant neoplasm of breast
AUGMENTS,Biological Response Modifiers,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Biological Response Modifiers Malignant neoplasm of breast
AFFECTS,Pyrimidine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Pyrimidine Malignant neoplasm of breast
AFFECTS,SOX17,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,SOX17 Malignant neoplasm of breast
AFFECTS,myristoylated alanine-rich C kinase substrate,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",myristoylated alanine-rich C kinase substrate Breast Carcinoma
AFFECTS,IKBKB,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",IKBKB Breast cancer metastatic
PREDISPOSES,Osteopenia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Osteopenia Malignant neoplasm of breast
PREDISPOSES,RHOBTB2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,RHOBTB2 Malignant neoplasm of breast
PREDISPOSES,SYF2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,SYF2 Malignant neoplasm of breast
AFFECTS,Enhancer,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Enhancer Malignant neoplasm of breast
PREDISPOSES,CTSO,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,CTSO Malignant neoplasm of breast
AFFECTS,PK 11195,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,PK 11195 Malignant neoplasm of breast
PREDISPOSES,NEUROD1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",NEUROD1 Malignant neoplasm of breast
DISRUPTS,Diphosphonates,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Diphosphonates Breast cancer recurrent
AUGMENTS,KDM6A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",KDM6A Malignant neoplasm of breast
AFFECTS,butylbenzyl phthalate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,butylbenzyl phthalate Malignant neoplasm of breast
CAUSES,Prolactin,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Prolactin Breast Carcinoma
DISRUPTS,Recombinant Interferon-gamma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Recombinant Interferon-gamma Malignant neoplasm of breast
DISRUPTS,BRD7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",BRD7 Malignant neoplasm of breast
DISRUPTS,Myosin Light Chain Kinase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Myosin Light Chain Kinase Malignant neoplasm of breast
AFFECTS,Pain relief,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Pain relief Breast cancer metastatic
AFFECTS,Magnetic field,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Magnetic field Malignant neoplasm of breast
DISRUPTS,Curcumin,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Curcumin Breast cancer metastatic
AFFECTS,Treatment Protocols,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Element, Ion, or Isotope",Treatment Protocols Breast cancer invasive NOS
DISRUPTS,cyclopamine,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",cyclopamine Breast cancer metastatic
PREDISPOSES,GABPA|NFE2L2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",GABPA|NFE2L2 Malignant neoplasm of breast
DISRUPTS,GTF2H1|SQSTM1|KHDRBS1|NUP62|DCTN4,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",GTF2H1|SQSTM1|KHDRBS1|NUP62|DCTN4 Breast cancer metastatic
AFFECTS,sphingosine 1-phosphate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",sphingosine 1-phosphate Malignant neoplasm of breast
AFFECTS,Iodine-131,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Iodine-131 Malignant neoplasm of breast
AFFECTS,Morphine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Morphine Malignant neoplasm of breast
DISRUPTS,Triazoles,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Triazoles Malignant neoplasm of breast
DISRUPTS,ADAMTS18,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",ADAMTS18 Breast cancer metastatic
PREDISPOSES,Birth length,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Birth length Malignant neoplasm of breast
PREDISPOSES,beta catenin,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",beta catenin Breast cancer metastatic
CAUSES,Helminths,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Helminths Malignant neoplasm of breast
CAUSES,RAB11FIP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,RAB11FIP1 Malignant neoplasm of breast
AFFECTS,molecular chaperone GRP78,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",molecular chaperone GRP78 Malignant neoplasm of breast
AFFECTS,TCP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,TCP1 Malignant neoplasm of breast
PREDISPOSES,EHMT2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,EHMT2 Malignant neoplasm of breast
DISRUPTS,MST1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",MST1 Malignant neoplasm of breast
PREDISPOSES,ZEB2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",ZEB2 Breast cancer metastatic
CAUSES,NF-kappa B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,NF-kappa B Malignant neoplasm of breast
PREDISPOSES,pertuzumab,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,pertuzumab Malignant neoplasm of breast
AFFECTS,Nelfinavir,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Nelfinavir Malignant neoplasm of breast
DISRUPTS,cucurbitacin B,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",cucurbitacin B Breast cancer metastatic
PREDISPOSES,imbalance,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Disease or Syndrome,imbalance Carcinoma of Male Breast
PREDISPOSES,Hypogonadism,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Hypogonadism Malignant neoplasm of breast
DISRUPTS,WBP2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",WBP2 Malignant neoplasm of breast
CAUSES,ERBB2|NEU1|NEURL1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",ERBB2|NEU1|NEURL1 Malignant neoplasm of breast
AFFECTS,Atenolol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Atenolol Malignant neoplasm of breast
PREDISPOSES,ERBB2|NEU1|NEURL1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",ERBB2|NEU1|NEURL1 Malignant neoplasm of breast
PREDISPOSES,Mammographic breast density,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Amino Acid, Peptide, or Protein",Mammographic breast density Breast cancer recurrent
AUGMENTS,STX3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,STX3 Malignant neoplasm of breast
PREDISPOSES,Methylene blue,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Methylene blue Malignant neoplasm of breast
AUGMENTS,EIF4G2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",EIF4G2 Malignant neoplasm of breast
PREDISPOSES,epigallocatechin gallate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,epigallocatechin gallate Malignant neoplasm of breast
AFFECTS,Mammary Neoplasms,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Mammary Neoplasms Breast cancer metastatic
DISRUPTS,HIF1A,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",HIF1A Breast cancer metastatic
PREDISPOSES,exemestane,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,exemestane Malignant neoplasm of breast
AUGMENTS,BCYRN1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,BCYRN1 Malignant neoplasm of breast
PREDISPOSES,SRPK1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",SRPK1 Breast cancer metastatic
PREDISPOSES,capecitabine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,capecitabine Malignant neoplasm of breast
PREDISPOSES,Body Weight decreased,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Element, Ion, or Isotope",Body Weight decreased Breast cancer recurrent
AFFECTS,Calcitriol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Calcitriol Malignant neoplasm of breast
PREDISPOSES,Biological Factors,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Element, Ion, or Isotope",Biological Factors Breast cancer recurrent
AFFECTS,Neprilysin,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,Neprilysin Breast cancer invasive NOS
AUGMENTS,EIF4G1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,EIF4G1 Malignant neoplasm of breast
AFFECTS,resistin|RETN,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",resistin|RETN Breast cancer metastatic
AFFECTS,Monoclonal Antibodies,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Monoclonal Antibodies Malignant neoplasm of breast
PREDISPOSES,Cereals,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Cereals Malignant neoplasm of breast
AFFECTS,NF-kappa B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,NF-kappa B Malignant neoplasm of breast
AUGMENTS,Estradiol,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Neoplastic Process,Estradiol Noninfiltrating Intraductal Carcinoma
DISRUPTS,TCF4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,TCF4 Malignant neoplasm of breast
PREDISPOSES,UGT2B4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,UGT2B4 Malignant neoplasm of breast
AUGMENTS,IQUB,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,IQUB Malignant neoplasm of breast
AFFECTS,SYVN1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",SYVN1 Malignant neoplasm of breast
CAUSES,"Sponges, Gauze",Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,"Sponges, Gauze Breast Carcinoma"
AFFECTS,KLF5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",KLF5 Malignant neoplasm of breast
DISRUPTS,LIMK2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",LIMK2 Malignant neoplasm of breast
AFFECTS,Luciferases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Luciferases Malignant neoplasm of breast
CAUSES,PCDH17,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,PCDH17 Malignant neoplasm of breast
PREDISPOSES,DLG5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,DLG5 Malignant neoplasm of breast
DISRUPTS,Quercetin,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Quercetin Breast cancer metastatic
PREDISPOSES,CDK14,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,CDK14 Malignant neoplasm of breast
PREDISPOSES,Does stand,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Does stand Malignant neoplasm of breast
AFFECTS,BIBR 1532,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,BIBR 1532 Malignant neoplasm of breast
CAUSES,extracellular signal-regulated kinase 3|MAPK6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",extracellular signal-regulated kinase 3|MAPK6 Malignant neoplasm of breast
AFFECTS,PKM,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",PKM Malignant neoplasm of breast
AFFECTS,Endopeptidases|ERVK-7|ERVK-8|ERVK-10|ERVK-9|ERVK-21|ERVK-18|ERVK-25|ERVK-24|ERVK-19,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Endopeptidases|ERVK-7|ERVK-8|ERVK-10|ERVK-9|ERVK-21|ERVK-18|ERVK-25|ERVK-24|ERVK-19 Malignant neoplasm of breast
AFFECTS,RNF5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",RNF5 Malignant neoplasm of breast
PREDISPOSES,SPRY4-IT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",SPRY4-IT1 Malignant neoplasm of breast
AFFECTS,Alkaloids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Alkaloids Malignant neoplasm of breast
PREDISPOSES,ADAM12,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",ADAM12 Breast cancer metastatic
AFFECTS,LINC01116,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,LINC01116 Malignant neoplasm of breast
DISRUPTS,OIP5-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",OIP5-AS1 Malignant neoplasm of breast
DISRUPTS,polyphenols,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",polyphenols Breast cancer metastatic
AFFECTS,Blue light,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Blue light Malignant neoplasm of breast
AFFECTS,MIR195,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",MIR195 Malignant neoplasm of breast
PREDISPOSES,phenyl ether,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,phenyl ether Malignant neoplasm of breast
PREDISPOSES,Heparitin Sulfate,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,"Element, Ion, or Isotope","Heparitin Sulfate Carcinoma, Ductal, Breast"
CAUSES,Study models,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Element, Ion, or Isotope",Study models Breast cancer recurrent
AFFECTS,Hesperidin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Hesperidin Malignant neoplasm of breast
DISRUPTS,PDK4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,PDK4 Malignant neoplasm of breast
PREDISPOSES,Garlic,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Garlic Malignant neoplasm of breast
AFFECTS,Multiple Myeloma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Multiple Myeloma Malignant neoplasm of breast
AFFECTS,Anesthesia procedures,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Element, Ion, or Isotope",Anesthesia procedures Breast cancer recurrent
PREDISPOSES,Soybeans,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Soybeans Malignant neoplasm of breast
PREDISPOSES,Cyclical mastalgia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Cyclical mastalgia Malignant neoplasm of breast
DISRUPTS,PIK3CA|PIK3CB|PIK3CD|PIK3CG,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",PIK3CA|PIK3CB|PIK3CD|PIK3CG Breast cancer metastatic
PREDISPOSES,Yogurt,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Yogurt Malignant neoplasm of breast
PREDISPOSES,UGT8,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,UGT8 Malignant neoplasm of breast
AUGMENTS,PSMD2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,PSMD2 Malignant neoplasm of breast
PREDISPOSES,GSTM2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,GSTM2 Malignant neoplasm of breast
AFFECTS,chemokine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,chemokine Malignant neoplasm of breast
CAUSES,src-Family Kinases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",src-Family Kinases Malignant neoplasm of breast
PREDISPOSES,Chicken Meat,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Chicken Meat Malignant neoplasm of breast
AUGMENTS,S100A7,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",S100A7 Noninfiltrating Intraductal Carcinoma
AUGMENTS,CD24,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",CD24 Malignant neoplasm of breast
PREDISPOSES,CYTH3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,CYTH3 Malignant neoplasm of breast
AFFECTS,Interleukin-2,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,"Element, Ion, or Isotope","Interleukin-2 Carcinoma, Ductal, Breast"
DISRUPTS,2-chloroethyl ethyl sulfide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,2-chloroethyl ethyl sulfide Malignant neoplasm of breast
AFFECTS,Flavonols,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Flavonols Malignant neoplasm of breast
CAUSES,Alcoholic Beverages,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Alcoholic Beverages Malignant neoplasm of breast
PREDISPOSES,Depressed mood,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Depressed mood Malignant neoplasm of breast
AFFECTS,ZFHX3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ZFHX3 Malignant neoplasm of breast
PREDISPOSES,CD247,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,CD247 Malignant neoplasm of breast
PREDISPOSES,Measles-Mumps-Rubella Vaccine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Measles-Mumps-Rubella Vaccine Malignant neoplasm of breast
PREDISPOSES,agonists,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,agonists Malignant neoplasm of breast
PREDISPOSES,PIP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,PIP Malignant neoplasm of breast
AFFECTS,Loss of Heterozygosity,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Loss of Heterozygosity Malignant neoplasm of breast
PREDISPOSES,Smoke,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Smoke Malignant neoplasm of breast
DISRUPTS,WWOX,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Element, Ion, or Isotope",WWOX Breast cancer invasive NOS
AFFECTS,polymorphic microsatellite markers,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",polymorphic microsatellite markers Malignant neoplasm of breast
AFFECTS,Menstrual cycle,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Element, Ion, or Isotope",Menstrual cycle Breast cancer recurrent
AFFECTS,Reliance,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Reliance Malignant neoplasm of breast
PREDISPOSES,PSYCHIATRIC HISTORY,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Element, Ion, or Isotope",PSYCHIATRIC HISTORY Breast cancer invasive NOS
PREDISPOSES,Histamine H2 Antagonists,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Histamine H2 Antagonists Malignant neoplasm of breast
AFFECTS,interleukin-23,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",interleukin-23 Malignant neoplasm of breast
PREDISPOSES,Acetaminophen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Acetaminophen Malignant neoplasm of breast
AFFECTS,Diphosphonates,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Diphosphonates Breast cancer metastatic
CAUSES,benzanthracene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,benzanthracene Malignant neoplasm of breast
PREDISPOSES,BP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,BP1 Malignant neoplasm of breast
AFFECTS,adjuvant therapy,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,"Element, Ion, or Isotope",adjuvant therapy Contralateral breast cancer
PREDISPOSES,Strenuous Exercise,Carcinoma in situ of breast,0.0019980019980019,Female Breast Cancer,Neoplastic Process,Strenuous Exercise Carcinoma in situ of breast
AFFECTS,Gel,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Gel Malignant neoplasm of breast
PREDISPOSES,"Insulin, Glargine, Human",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Insulin, Glargine, Human Malignant neoplasm of breast"
PREDISPOSES,Zinc,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Zinc Malignant neoplasm of breast
DISRUPTS,IL13Ralpha2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",IL13Ralpha2 Breast cancer metastatic
PREDISPOSES,Ataxia Telangiectasia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Ataxia Telangiectasia Malignant neoplasm of breast
AFFECTS,Analgesics,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Analgesics Breast cancer recurrent
AFFECTS,Insulin Receptor|INSR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Insulin Receptor|INSR Malignant neoplasm of breast
AFFECTS,Calcium Channel Blockers,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Calcium Channel Blockers Malignant neoplasm of breast
PREDISPOSES,alcohol effect,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",alcohol effect Malignant neoplasm of breast
PREDISPOSES,Female Homosexuality,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Female Homosexuality Malignant neoplasm of breast
PREDISPOSES,delta-hexachlorocyclohexane,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",delta-hexachlorocyclohexane Malignant neoplasm of breast
PREDISPOSES,Manganese Superoxide Dismutase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Manganese Superoxide Dismutase Malignant neoplasm of breast
PREDISPOSES,DPF3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,DPF3 Malignant neoplasm of breast
PREDISPOSES,Cytochrome P-450 CYP1A1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Cytochrome P-450 CYP1A1 Malignant neoplasm of breast
PREDISPOSES,Personality Traits,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Personality Traits Malignant neoplasm of breast
PREDISPOSES,Paraoxonase 1|PON1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Paraoxonase 1|PON1 Malignant neoplasm of breast
AFFECTS,Hydroxyestrones,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,Hydroxyestrones Breast cancer invasive NOS
PREDISPOSES,checkpoint kinase 2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",checkpoint kinase 2 Malignant neoplasm of breast
PREDISPOSES,HSD11B1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,HSD11B1 Malignant neoplasm of breast
AUGMENTS,Tenascin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Tenascin Malignant neoplasm of breast
PREDISPOSES,CXC Chemokines,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,CXC Chemokines Malignant neoplasm of breast
AFFECTS,Simvastatin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Simvastatin Malignant neoplasm of breast
AFFECTS,bevacizumab,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",bevacizumab Breast cancer metastatic
CAUSES,Ethanol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Ethanol Malignant neoplasm of breast
PREDISPOSES,Moderate Exercise,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Moderate Exercise Malignant neoplasm of breast
AFFECTS,Uniparental Disomy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Uniparental Disomy Malignant neoplasm of breast
PREDISPOSES,Rubidium,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Rubidium Malignant neoplasm of breast
PREDISPOSES,19p13.1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,19p13.1 Malignant neoplasm of breast
PREDISPOSES,Plasminogen Activator Inhibitor 1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Plasminogen Activator Inhibitor 1 Malignant neoplasm of breast
PREDISPOSES,Sitting height,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Sitting height Malignant neoplasm of breast
AUGMENTS,E2F3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",E2F3 Malignant neoplasm of breast
CAUSES,polyphenols,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,polyphenols Malignant neoplasm of breast
PREDISPOSES,6/4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,6/4 Malignant neoplasm of breast
AFFECTS,capecitabine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,capecitabine Malignant neoplasm of breast
AFFECTS,Pregnancy,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Element, Ion, or Isotope",Pregnancy Breast cancer recurrent
PREDISPOSES,Metric,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Metric Malignant neoplasm of breast
AUGMENTS,Insulin|INS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Insulin|INS Malignant neoplasm of breast
PREDISPOSES,CpG Islands,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",CpG Islands Malignant neoplasm of breast
AFFECTS,RABGEF1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,RABGEF1 Malignant neoplasm of breast
PREDISPOSES,Behavior,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Behavior Familial cancer of breast
AFFECTS,Thromboembolism,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Thromboembolism Malignant neoplasm of breast
PREDISPOSES,response,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Element, Ion, or Isotope",response Breast cancer invasive NOS
PREDISPOSES,NBN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",NBN Malignant neoplasm of breast
PREDISPOSES,HFE,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",HFE Malignant neoplasm of breast
AFFECTS,Chemotherapy-Oncologic Procedure,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Chemotherapy-Oncologic Procedure Breast cancer metastatic
AFFECTS,Enrich,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Enrich Malignant neoplasm of breast
PREDISPOSES,Nipple discharge NOS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Nipple discharge NOS Malignant neoplasm of breast
PREDISPOSES,Symptoms,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,Symptoms Breast cancer invasive NOS
AFFECTS,Histopathology,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,Histopathology Breast cancer invasive NOS
AFFECTS,Neutropenia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Neutropenia Malignant neoplasm of breast
PREDISPOSES,Asthenia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Asthenia Malignant neoplasm of breast
CAUSES,Nicotine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Nicotine Malignant neoplasm of breast
CAUSES,Cyclin D1|CCND1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Cyclin D1|CCND1 Malignant neoplasm of breast
AFFECTS,Pharmacotherapy,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,Pharmacotherapy Breast cancer invasive NOS
PREDISPOSES,Physical activity,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Physical activity Sporadic Breast Carcinoma
PREDISPOSES,NANOG,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,NANOG Malignant neoplasm of breast
PREDISPOSES,Breastfeeding performance,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Breastfeeding performance Malignant neoplasm of breast
PREDISPOSES,Overweight,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Neoplastic Process,Overweight Inflammatory Breast Carcinoma
PREDISPOSES,Depressive Symptoms,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Depressive Symptoms Malignant neoplasm of breast
AFFECTS,Anorexia Nervosa,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Anorexia Nervosa Malignant neoplasm of breast
CAUSES,crocetin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,crocetin Malignant neoplasm of breast
AFFECTS,delphinidin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,delphinidin Malignant neoplasm of breast
PREDISPOSES,Common wart,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Common wart Malignant neoplasm of breast
PREDISPOSES,LAPTM4B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",LAPTM4B Malignant neoplasm of breast
AUGMENTS,COPS5,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,COPS5 Breast Carcinoma
PREDISPOSES,"Breast Feeding, Exclusive",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,"Breast Feeding, Exclusive Malignant neoplasm of breast"
AFFECTS,everolimus,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,everolimus Malignant neoplasm of breast
AFFECTS,Xenograft Model,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Xenograft Model Malignant neoplasm of breast
PREDISPOSES,Stress,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Element, Ion, or Isotope",Stress Breast cancer invasive NOS
AFFECTS,Breast neoplasm screening,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Breast neoplasm screening Malignant neoplasm of breast
AFFECTS,Multiple alleles,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Multiple alleles Malignant neoplasm of breast
PREDISPOSES,Deficient knowledge,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Deficient knowledge Malignant neoplasm of breast
AFFECTS,Taurine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Taurine Malignant neoplasm of breast
PREDISPOSES,Menopausal Status,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Element, Ion, or Isotope",Menopausal Status Breast cancer invasive NOS
PREDISPOSES,Benzodiazepines,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Benzodiazepines Malignant neoplasm of breast
DISRUPTS,LINC01585,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,LINC01585 Malignant neoplasm of breast
PREDISPOSES,Natural Products,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Natural Products Malignant neoplasm of breast
PREDISPOSES,Physical activity,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,"Element, Ion, or Isotope",Physical activity Carcinoma of Male Breast
PREDISPOSES,Ibuprofen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Ibuprofen Malignant neoplasm of breast
PREDISPOSES,Prognostic Factor,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Prognostic Factor Breast cancer metastatic
AFFECTS,Verbal,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Verbal Malignant neoplasm of breast
PREDISPOSES,Hot water,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Hot water Malignant neoplasm of breast
AFFECTS,Methotrexate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Methotrexate Malignant neoplasm of breast
PREDISPOSES,Consanguinity,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Consanguinity Malignant neoplasm of breast
AFFECTS,Verbal,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Verbal Breast cancer recurrent
CAUSES,TBX3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,TBX3 Malignant neoplasm of breast
PREDISPOSES,Multiple Sclerosis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Multiple Sclerosis Malignant neoplasm of breast
PREDISPOSES,"Obesity, Morbid",Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Element, Ion, or Isotope","Obesity, Morbid Breast cancer recurrent"
AUGMENTS,F2RL1|NR1I2|SLC52A1,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Neoplastic Process,F2RL1|NR1I2|SLC52A1 Noninfiltrating Intraductal Carcinoma
CAUSES,Arginine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Arginine Malignant neoplasm of breast
PREDISPOSES,Rheumatoid Arthritis,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Rheumatoid Arthritis Breast cancer recurrent
PREDISPOSES,NFKB1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,NFKB1 Malignant neoplasm of breast
PREDISPOSES,GHRL,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,GHRL Malignant neoplasm of breast
PREDISPOSES,Animal fat,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Animal fat Malignant neoplasm of breast
AFFECTS,peroxiredoxin I|EREG|ESR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",peroxiredoxin I|EREG|ESR1 Malignant neoplasm of breast
PREDISPOSES,GHSR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,GHSR Malignant neoplasm of breast
AUGMENTS,Estrone sulfotransferase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Estrone sulfotransferase Malignant neoplasm of breast
CAUSES,Recombinant Interferon-gamma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Recombinant Interferon-gamma Malignant neoplasm of breast
DISRUPTS,Diphosphonates,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Diphosphonates Malignant neoplasm of breast
PREDISPOSES,Breasts asymmetrical,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Breasts asymmetrical Malignant neoplasm of breast
CAUSES,Interleukin-2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Interleukin-2 Malignant neoplasm of breast
AFFECTS,HSD17B6,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",HSD17B6 Breast cancer metastatic
PREDISPOSES,Positive Lymph Node,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Positive Lymph Node Malignant neoplasm of breast
AFFECTS,Steryl-sulfatase|STS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Steryl-sulfatase|STS Malignant neoplasm of breast
PREDISPOSES,Systemic Scleroderma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Systemic Scleroderma Malignant neoplasm of breast
AFFECTS,density,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",density Malignant neoplasm of breast
PREDISPOSES,Life Style,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Life Style Malignant neoplasm of breast
PREDISPOSES,PIWIL2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,PIWIL2 Malignant neoplasm of breast
PREDISPOSES,ANLN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",ANLN Malignant neoplasm of breast
PREDISPOSES,ethnic,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ethnic Malignant neoplasm of breast
PREDISPOSES,Gynecomastia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Gynecomastia Malignant neoplasm of breast
AUGMENTS,WWC1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,WWC1 Malignant neoplasm of breast
PREDISPOSES,Adverse effects,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Lipid,Adverse effects Breast cancer recurrent
AFFECTS,pertuzumab,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,pertuzumab Malignant neoplasm of breast
AFFECTS,Whole-Brain Radiotherapy,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Whole-Brain Radiotherapy Breast cancer metastatic
PREDISPOSES,Perceived comfort level,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Perceived comfort level Malignant neoplasm of breast
AUGMENTS,phenylpyruvate tautomerase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,phenylpyruvate tautomerase Malignant neoplasm of breast
PREDISPOSES,FANCM,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",FANCM Malignant neoplasm of breast
DISRUPTS,tibolone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,tibolone Malignant neoplasm of breast
PREDISPOSES,chemokine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,chemokine Malignant neoplasm of breast
PREDISPOSES,Obesity,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Element, Ion, or Isotope",Obesity Breast cancer recurrent
AUGMENTS,CCAT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,CCAT1 Malignant neoplasm of breast
PREDISPOSES,Levonorgestrel,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Levonorgestrel Malignant neoplasm of breast
AFFECTS,Mimicry,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Mimicry Malignant neoplasm of breast
AFFECTS,Operative Surgical Procedures,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,"Element, Ion, or Isotope","Operative Surgical Procedures Carcinoma, Ductal, Breast"
DISRUPTS,1-Phosphatidylinositol 3-Kinase|PI3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",1-Phosphatidylinositol 3-Kinase|PI3 Malignant neoplasm of breast
DISRUPTS,Vaccines,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Vaccines Malignant neoplasm of breast
AFFECTS,Sclerosis,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Neoplastic Process,Sclerosis Noninfiltrating Intraductal Carcinoma
DISRUPTS,flavan-3-ol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,flavan-3-ol Malignant neoplasm of breast
DISRUPTS,Lignans,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Lignans Malignant neoplasm of breast
PREDISPOSES,Galectin 3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Galectin 3 Malignant neoplasm of breast
PREDISPOSES,PARK7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",PARK7 Malignant neoplasm of breast
AUGMENTS,alpha Tocopherol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",alpha Tocopherol Malignant neoplasm of breast
PREDISPOSES,Calcium Channel Blockers,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Calcium Channel Blockers Malignant neoplasm of breast
AFFECTS,Lignans,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Lignans Malignant neoplasm of breast
PREDISPOSES,Bleomycin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Bleomycin Malignant neoplasm of breast
AFFECTS,Coronary Arteriosclerosis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Coronary Arteriosclerosis Malignant neoplasm of breast
PREDISPOSES,Alcoholic Beverages,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Lipid,Alcoholic Beverages Breast cancer recurrent
CAUSES,Neoplasm,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Neoplasm Breast Carcinoma
AFFECTS,KDM4A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",KDM4A Malignant neoplasm of breast
DISRUPTS,"7,3'-dihydroxy-4'-methoxyisoflavone",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,"7,3'-dihydroxy-4'-methoxyisoflavone Malignant neoplasm of breast"
AFFECTS,Cerebrovascular accident,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Cerebrovascular accident Malignant neoplasm of breast
DISRUPTS,inhibitors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",inhibitors Malignant neoplasm of breast
PREDISPOSES,MDM4,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,MDM4 Breast cancer metastatic
PREDISPOSES,KPNA2,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,KPNA2 Breast cancer invasive NOS
PREDISPOSES,Positive Finding,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Positive Finding Malignant neoplasm of breast
AUGMENTS,MFG,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,MFG Malignant neoplasm of breast
PREDISPOSES,Diethylstilbestrol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Diethylstilbestrol Malignant neoplasm of breast
PREDISPOSES,desires,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,desires Malignant neoplasm of breast
AUGMENTS,Prolactin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Prolactin Malignant neoplasm of breast
CAUSES,bufadienolide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,bufadienolide Malignant neoplasm of breast
AUGMENTS,PGK1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",PGK1 Malignant neoplasm of breast
DISRUPTS,ZNHIT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ZNHIT1 Malignant neoplasm of breast
AFFECTS,SEMA3C,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,SEMA3C Malignant neoplasm of breast
AFFECTS,beta catenin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",beta catenin Malignant neoplasm of breast
AFFECTS,ginsenoside Rk1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ginsenoside Rk1 Malignant neoplasm of breast
DISRUPTS,Pimozide,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Pimozide Breast cancer metastatic
AFFECTS,ZNF423,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ZNF423 Malignant neoplasm of breast
AFFECTS,Antidiabetics,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Antidiabetics Malignant neoplasm of breast
AFFECTS,Adriamycin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Adriamycin Malignant neoplasm of breast
DISRUPTS,caveolin 1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",caveolin 1 Breast cancer metastatic
AFFECTS,ZNHIT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ZNHIT1 Malignant neoplasm of breast
PREDISPOSES,SNHG7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",SNHG7 Malignant neoplasm of breast
AUGMENTS,MALAT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",MALAT1 Malignant neoplasm of breast
AFFECTS,SOX8,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",SOX8 Malignant neoplasm of breast
PREDISPOSES,Myocardial Ischemia,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Lipid,Myocardial Ischemia Breast cancer recurrent
AFFECTS,phthalates,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,phthalates Malignant neoplasm of breast
PREDISPOSES,Phosphoric Monoester Hydrolases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Phosphoric Monoester Hydrolases Malignant neoplasm of breast
AFFECTS,Leucine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Leucine Malignant neoplasm of breast
AFFECTS,ERBB2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",ERBB2 Malignant neoplasm of breast
DISRUPTS,shikonin,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",shikonin Breast cancer metastatic
DISRUPTS,NFE2L3,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",NFE2L3 Breast cancer metastatic
PREDISPOSES,lysyllysine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,lysyllysine Malignant neoplasm of breast
AFFECTS,G3BP2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,G3BP2 Malignant neoplasm of breast
AUGMENTS,CBX2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,CBX2 Malignant neoplasm of breast
DISRUPTS,Interleukin-4,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,"Element, Ion, or Isotope",Interleukin-4 Inflammatory Breast Carcinoma
PREDISPOSES,PPM1D,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,PPM1D Malignant neoplasm of breast
CAUSES,Mitomycin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Mitomycin Malignant neoplasm of breast
DISRUPTS,Luteolin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Luteolin Malignant neoplasm of breast
AFFECTS,cell motility,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Element, Ion, or Isotope",cell motility Breast cancer invasive NOS
CAUSES,Xenobiotics,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Xenobiotics Malignant neoplasm of breast
AFFECTS,Liposomes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Liposomes Malignant neoplasm of breast
DISRUPTS,Natural Products,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Natural Products Malignant neoplasm of breast
PREDISPOSES,Phenols,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Phenols Malignant neoplasm of breast
PREDISPOSES,preference,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,preference Malignant neoplasm of breast
AUGMENTS,PIK3R1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",PIK3R1 Malignant neoplasm of breast
AFFECTS,LINC00339,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,LINC00339 Malignant neoplasm of breast
AFFECTS,VIRMA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",VIRMA Malignant neoplasm of breast
PREDISPOSES,VIRMA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",VIRMA Malignant neoplasm of breast
PREDISPOSES,Compete,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Compete Malignant neoplasm of breast
AFFECTS,"3,4-Methylenedioxyamphetamine",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,"3,4-Methylenedioxyamphetamine Malignant neoplasm of breast"
AFFECTS,Bariatric Surgery,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Element, Ion, or Isotope",Bariatric Surgery Breast cancer recurrent
PREDISPOSES,Integrin alphaVbeta3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Integrin alphaVbeta3 Malignant neoplasm of breast
AFFECTS,IDO1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",IDO1 Breast cancer metastatic
DISRUPTS,PIK3CA|PIK3CB|PIK3CD|PIK3CG,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",PIK3CA|PIK3CB|PIK3CD|PIK3CG Malignant neoplasm of breast
AFFECTS,kaempferol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,kaempferol Malignant neoplasm of breast
AFFECTS,Nephroblastoma,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Nephroblastoma Breast cancer metastatic
AFFECTS,Diphenylamine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Diphenylamine Malignant neoplasm of breast
AFFECTS,anillin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,anillin Malignant neoplasm of breast
DISRUPTS,Phosphoric Monoester Hydrolases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Phosphoric Monoester Hydrolases Malignant neoplasm of breast
AFFECTS,Poly(ADP-ribose) Polymerases|WDTC1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Poly(ADP-ribose) Polymerases|WDTC1 Malignant neoplasm of breast
AFFECTS,FBXL19-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",FBXL19-AS1 Malignant neoplasm of breast
AFFECTS,Treatment Protocols,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Treatment Protocols Breast cancer metastatic
AUGMENTS,Polychlorinated Biphenyls,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Polychlorinated Biphenyls Malignant neoplasm of breast
PREDISPOSES,gadoterate meglumine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,gadoterate meglumine Malignant neoplasm of breast
PREDISPOSES,PCB 138,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,PCB 138 Malignant neoplasm of breast
PREDISPOSES,SLC4A11,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,SLC4A11 Malignant neoplasm of breast
PREDISPOSES,UDP-Glucuronosyltransferase 1A1|SLC45A2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",UDP-Glucuronosyltransferase 1A1|SLC45A2 Malignant neoplasm of breast
AFFECTS,Pigment,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Pigment Malignant neoplasm of breast
PREDISPOSES,Formance,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Formance Malignant neoplasm of breast
PREDISPOSES,FAS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",FAS Malignant neoplasm of breast
AFFECTS,hippo signaling,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein",hippo signaling Triple Negative Breast Neoplasms
AFFECTS,cholecalciferol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,cholecalciferol Malignant neoplasm of breast
AFFECTS,Albendazole,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Albendazole Malignant neoplasm of breast
PREDISPOSES,Activator,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Activator Malignant neoplasm of breast
AUGMENTS,Interleukin-17,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Interleukin-17 Malignant neoplasm of breast
AFFECTS,Hydrogel,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Hydrogel Breast cancer metastatic
AFFECTS,Glioblastoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Glioblastoma Malignant neoplasm of breast
AUGMENTS,RASAL2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",RASAL2 Malignant neoplasm of breast
DISRUPTS,small molecule,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",small molecule Breast cancer metastatic
AFFECTS,Profilins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Profilins Malignant neoplasm of breast
AFFECTS,HAND2-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",HAND2-AS1 Malignant neoplasm of breast
PREDISPOSES,Pre-op diagnosis,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",Pre-op diagnosis Noninfiltrating Intraductal Carcinoma
PREDISPOSES,HSPA5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",HSPA5 Malignant neoplasm of breast
PREDISPOSES,Letter:Finding:Point in time:{Setting}:Document:{Provider},Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Letter:Finding:Point in time:{Setting}:Document:{Provider} Malignant neoplasm of breast
AFFECTS,rosemary extract,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",rosemary extract Triple Negative Breast Neoplasms
AFFECTS,Integrin alpha3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Integrin alpha3 Malignant neoplasm of breast
PREDISPOSES,socioeconomic differences,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",socioeconomic differences Malignant neoplasm of breast
AFFECTS,epigallocatechin gallate,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",epigallocatechin gallate Triple Negative Breast Neoplasms
DISRUPTS,Adriamycin,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Adriamycin Triple Negative Breast Neoplasms
PREDISPOSES,Underlying,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Underlying Malignant neoplasm of breast
AFFECTS,Microsatellite Instability,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Microsatellite Instability Triple Negative Breast Neoplasms
PREDISPOSES,prolactin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,prolactin Malignant neoplasm of breast
DISRUPTS,mica,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",mica Triple Negative Breast Neoplasms
AFFECTS,paclitaxel,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,paclitaxel Malignant neoplasm of breast
AFFECTS,leptin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,leptin Malignant neoplasm of breast
AFFECTS,"Chemotherapy, Adjuvant",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein","Chemotherapy, Adjuvant Triple Negative Breast Neoplasms"
AFFECTS,inhibitors,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",inhibitors Triple Negative Breast Neoplasms
PREDISPOSES,ATM,contralateral breast cancer,0.0029970029970029,Female Breast Cancer,Gene or Genome,ATM contralateral breast cancer
AUGMENTS,glypican 4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,glypican 4 Malignant neoplasm of breast
PREDISPOSES,Adipokines,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Adipokines Malignant neoplasm of breast
PREDISPOSES,Lectin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Lectin Malignant neoplasm of breast
AFFECTS,CTCb regimen,Carcinoma breast stage IV,0.0,Female Breast Cancer,Gene or Genome,CTCb regimen Carcinoma breast stage IV
AFFECTS,lumican,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,lumican Malignant neoplasm of breast
DISRUPTS,doxorubicin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,doxorubicin Malignant neoplasm of breast
PREDISPOSES,SOAT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,SOAT1 Malignant neoplasm of breast
AFFECTS,tissue-factor-pathway inhibitor 2|TFPI2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",tissue-factor-pathway inhibitor 2|TFPI2 Malignant neoplasm of breast
PREDISPOSES,Marital Status,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,"Element, Ion, or Isotope",Marital Status Female Breast Carcinoma
AUGMENTS,MYC,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",MYC Triple Negative Breast Neoplasms
PREDISPOSES,SLCO6A1|GSTK1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",SLCO6A1|GSTK1 Malignant neoplasm of breast
PREDISPOSES,interleukin-4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",interleukin-4 Malignant neoplasm of breast
AFFECTS,BET Inhibitor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",BET Inhibitor Malignant neoplasm of breast
PREDISPOSES,Diagnostic Factor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Diagnostic Factor Malignant neoplasm of breast
DISRUPTS,Integrin alpha5,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Integrin alpha5 Triple Negative Breast Neoplasms
DISRUPTS,lovastatin,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",lovastatin Triple Negative Breast Neoplasms
CAUSES,receptor,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",receptor Triple Negative Breast Neoplasms
AFFECTS,Equol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Equol Malignant neoplasm of breast
AUGMENTS,hexane,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,hexane Malignant neoplasm of breast
PREDISPOSES,Account number:Identifier:Point in time:^Patient:Nominal,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Account number:Identifier:Point in time:^Patient:Nominal Malignant neoplasm of breast
CAUSES,bisphenol A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,bisphenol A Malignant neoplasm of breast
PREDISPOSES,FZR1 wt Allele|CDH1,"Breast Cancer, Familial",0.0,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","FZR1 wt Allele|CDH1 Breast Cancer, Familial"
AUGMENTS,FGFR1 wt Allele|FGFR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",FGFR1 wt Allele|FGFR1 Malignant neoplasm of breast
PREDISPOSES,Abnormal metabolism,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Abnormal metabolism Malignant neoplasm of breast
AFFECTS,aquaporin 7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,aquaporin 7 Malignant neoplasm of breast
PREDISPOSES,Herbicides,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Herbicides Malignant neoplasm of breast
PREDISPOSES,caspase-3|CASP3,Luminal B Breast Carcinoma,0.0,Female Breast Cancer,"Element, Ion, or Isotope",caspase-3|CASP3 Luminal B Breast Carcinoma
PREDISPOSES,Pivot,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Pivot Malignant neoplasm of breast
CAUSES,erastin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,erastin Malignant neoplasm of breast
DISRUPTS,acetylglucosamine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,acetylglucosamine Malignant neoplasm of breast
DISRUPTS,purpurin 18,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",purpurin 18 Triple Negative Breast Neoplasms
PREDISPOSES,hesperetin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,hesperetin Malignant neoplasm of breast
PREDISPOSES,Geldanamycin Analogue,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Geldanamycin Analogue Malignant neoplasm of breast
PREDISPOSES,Flavonols,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Flavonols Malignant neoplasm of breast
AFFECTS,Dysbiosis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Dysbiosis Malignant neoplasm of breast
PREDISPOSES,Therapeutic Effect,malignant neoplasm of breast staging,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Therapeutic Effect malignant neoplasm of breast staging
DISRUPTS,aspirin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,aspirin Malignant neoplasm of breast
PREDISPOSES,Diphosphonates,Early-Stage Breast Carcinoma,0.0,Female Breast Cancer,Neoplastic Process,Diphosphonates Early-Stage Breast Carcinoma
PREDISPOSES,ethanol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ethanol Malignant neoplasm of breast
PREDISPOSES,MIR22 wt Allele,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",MIR22 wt Allele Malignant neoplasm of breast
AFFECTS,arbutin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,arbutin Malignant neoplasm of breast
PREDISPOSES,Diet high in saturated fats,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Diet high in saturated fats Malignant neoplasm of breast
CAUSES,aspirin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,aspirin Malignant neoplasm of breast
PREDISPOSES,FOSL1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,FOSL1 Malignant neoplasm of breast
PREDISPOSES,CD8A wt Allele|CD8A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",CD8A wt Allele|CD8A Malignant neoplasm of breast
AUGMENTS,sunitinib,Carcinoma breast stage IV,0.0,Female Breast Cancer,"Element, Ion, or Isotope",sunitinib Carcinoma breast stage IV
DISRUPTS,brazilin,Carcinoma breast stage IV,0.0,Female Breast Cancer,"Element, Ion, or Isotope",brazilin Carcinoma breast stage IV
CAUSES,prolactin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,prolactin Malignant neoplasm of breast
PREDISPOSES,leptin,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,"Element, Ion, or Isotope",leptin Female Breast Carcinoma
PREDISPOSES,TT genotype,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,TT genotype Malignant neoplasm of breast
AUGMENTS,Vitronectin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Vitronectin Malignant neoplasm of breast
AFFECTS,CYP27B1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,CYP27B1 Malignant neoplasm of breast
PREDISPOSES,diethylstilbestrol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,diethylstilbestrol Malignant neoplasm of breast
DISRUPTS,Biological Response Modifiers,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Biological Response Modifiers Malignant neoplasm of breast
AFFECTS,Sphingomyelins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Sphingomyelins Malignant neoplasm of breast
PREDISPOSES,melatonin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,melatonin Malignant neoplasm of breast
CAUSES,Sleeve,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Sleeve Malignant neoplasm of breast
AFFECTS,Rheumatoid Arthritis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Rheumatoid Arthritis Malignant neoplasm of breast
PREDISPOSES,Cyclin-Dependent Kinase Inhibitor p16|CDKN2A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Cyclin-Dependent Kinase Inhibitor p16|CDKN2A Malignant neoplasm of breast
AUGMENTS,periodate-oxidized adenosine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,periodate-oxidized adenosine Malignant neoplasm of breast
AUGMENTS,Nicotinamide Phosphoribosyltransferase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Nicotinamide Phosphoribosyltransferase Malignant neoplasm of breast
DISRUPTS,Erythropoietin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Erythropoietin Malignant neoplasm of breast
AFFECTS,Breast Imaging Reporting and Data System,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Breast Imaging Reporting and Data System Malignant neoplasm of breast
AUGMENTS,DNMT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",DNMT1 Malignant neoplasm of breast
AFFECTS,Diagnosis,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,"Element, Ion, or Isotope",Diagnosis Female Breast Carcinoma
AFFECTS,ciclesonide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ciclesonide Malignant neoplasm of breast
PREDISPOSES,cisplatin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,cisplatin Malignant neoplasm of breast
DISRUPTS,paclitaxel,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,paclitaxel Malignant neoplasm of breast
PREDISPOSES,Ryanodine Receptor 3|RYR3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Ryanodine Receptor 3|RYR3 Malignant neoplasm of breast
PREDISPOSES,patient characteristics,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",patient characteristics Malignant neoplasm of breast
PREDISPOSES,Weight decreased,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Weight decreased Malignant neoplasm of breast
AFFECTS,amygdalin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,amygdalin Malignant neoplasm of breast
PREDISPOSES,Copy Number Polymorphism,"Breast Cancer, Familial",0.0,Female Breast Cancer,"Element, Ion, or Isotope","Copy Number Polymorphism Breast Cancer, Familial"
DISRUPTS,SOY ISOFLAVONES,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",SOY ISOFLAVONES Malignant neoplasm of breast
PREDISPOSES,verteporfin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,verteporfin Malignant neoplasm of breast
CAUSES,butein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,butein Malignant neoplasm of breast
DISRUPTS,si-wu-tang,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",si-wu-tang Triple Negative Breast Neoplasms
AFFECTS,Bilateral mastectomy,Unilateral Breast Carcinoma,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Bilateral mastectomy Unilateral Breast Carcinoma
AFFECTS,paclitaxel,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",paclitaxel Triple Negative Breast Neoplasms
DISRUPTS,Diphosphonates,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Neoplastic Process,Diphosphonates Invasive carcinoma of breast
CAUSES,interleukin-10,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,"Element, Ion, or Isotope",interleukin-10 Inflammatory Breast Carcinoma
AFFECTS,COVID-19,Early-Stage Breast Carcinoma,0.0,Female Breast Cancer,"Element, Ion, or Isotope",COVID-19 Early-Stage Breast Carcinoma
PREDISPOSES,CCL5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",CCL5 Malignant neoplasm of breast
AFFECTS,Pain relief,Early-Stage Breast Carcinoma,0.0,Female Breast Cancer,Neoplastic Process,Pain relief Early-Stage Breast Carcinoma
PREDISPOSES,Procedure findings:Finding:Point in time:^Patient:Narrative,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Procedure findings:Finding:Point in time:^Patient:Narrative Breast Carcinoma
CAUSES,Connexin 43|GJA1,Carcinoma breast stage IV,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Connexin 43|GJA1 Carcinoma breast stage IV
CAUSES,pristane,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,pristane Breast Carcinoma
DISRUPTS,ruthenium,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ruthenium Malignant neoplasm of breast
DISRUPTS,tripterine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,tripterine Malignant neoplasm of breast
PREDISPOSES,Health behavior,"Breast Cancer, Familial",0.0,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","Health behavior Breast Cancer, Familial"
PREDISPOSES,paclitaxel,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,paclitaxel Malignant neoplasm of breast
AUGMENTS,Phosphatidylinositide 3-Kinase Inhibitor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Phosphatidylinositide 3-Kinase Inhibitor Malignant neoplasm of breast
PREDISPOSES,Basis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Basis Malignant neoplasm of breast
PREDISPOSES,High Level,Carcinoma breast stage IV,0.0,Female Breast Cancer,Gene or Genome,High Level Carcinoma breast stage IV
PREDISPOSES,Gamma-glutamyl transferase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Gamma-glutamyl transferase Malignant neoplasm of breast
AFFECTS,Discoidin Domain Receptor 1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Discoidin Domain Receptor 1 Malignant neoplasm of breast
AUGMENTS,polyphenols,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,polyphenols Malignant neoplasm of breast
AFFECTS,Photochemotherapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Photochemotherapy Malignant neoplasm of breast
PREDISPOSES,Diuretics,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Diuretics Malignant neoplasm of breast
DISRUPTS,Transcript,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Transcript Triple Negative Breast Neoplasms
PREDISPOSES,arsenic,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,arsenic Malignant neoplasm of breast
AFFECTS,Pills,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Pills Malignant neoplasm of breast
AFFECTS,antagonists,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",antagonists Malignant neoplasm of breast
AFFECTS,paracrine,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",paracrine Triple Negative Breast Neoplasms
AFFECTS,Ferroptosis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Ferroptosis Malignant neoplasm of breast
AFFECTS,Central Serous Chorioretinopathy,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Neoplastic Process,Central Serous Chorioretinopathy Triple Negative Breast Neoplasms
AFFECTS,triclosan,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,triclosan Malignant neoplasm of breast
PREDISPOSES,Cyclin E,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Cyclin E Malignant neoplasm of breast
PREDISPOSES,Pathologic Complete Response,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Pathologic Complete Response Malignant neoplasm of breast
DISRUPTS,paclitaxel,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",paclitaxel Triple Negative Breast Neoplasms
PREDISPOSES,Tobacco smoking behavior,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Tobacco smoking behavior Malignant neoplasm of breast
DISRUPTS,sirolimus,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",sirolimus Malignant neoplasm of breast
PREDISPOSES,Brominated Diphenyl Ethers,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Brominated Diphenyl Ethers Malignant neoplasm of breast
AUGMENTS,Flap Endonuclease-1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Flap Endonuclease-1 Malignant neoplasm of breast
PREDISPOSES,>40 years,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,>40 years Malignant neoplasm of breast
PREDISPOSES,Cyclin-Dependent Kinases,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Cyclin-Dependent Kinases Triple Negative Breast Neoplasms
DISRUPTS,niclosamide,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",niclosamide HER2-positive carcinoma of breast
PREDISPOSES,beta catenin,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",beta catenin Triple Negative Breast Neoplasms
AFFECTS,Pyroptosis,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Pyroptosis Triple Negative Breast Neoplasms
AFFECTS,LOC105371267,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,LOC105371267 Malignant neoplasm of breast
DISRUPTS,ITGA2B wt Allele|ITGA2B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",ITGA2B wt Allele|ITGA2B Malignant neoplasm of breast
PREDISPOSES,phthalates,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,phthalates Malignant neoplasm of breast
AFFECTS,Neoplasm,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Neoplasm Breast cancer metastatic
PREDISPOSES,CATHEPSIN D,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,CATHEPSIN D Malignant neoplasm of breast
PREDISPOSES,Possible,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Possible Malignant neoplasm of breast
AFFECTS,AZD4547,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,AZD4547 Malignant neoplasm of breast
AFFECTS,GANT 61,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,GANT 61 Malignant neoplasm of breast
AFFECTS,Body mass index procedure,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",Body mass index procedure Invasive carcinoma of breast
DISRUPTS,Liposomes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Liposomes Malignant neoplasm of breast
PREDISPOSES,Immunologic Adjuvants,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",Immunologic Adjuvants Noninfiltrating Intraductal Carcinoma
PREDISPOSES,Decreased translucency,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",Decreased translucency Noninfiltrating Intraductal Carcinoma
PREDISPOSES,Performance,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Performance Breast Carcinoma
AFFECTS,astaxanthin,Carcinoma breast stage IV,0.0,Female Breast Cancer,"Element, Ion, or Isotope",astaxanthin Carcinoma breast stage IV
AUGMENTS,Hypoxia-Inducible Factor 1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Immunologic Factor,Hypoxia-Inducible Factor 1 Triple Negative Breast Neoplasms
CAUSES,Hydrogel,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Hydrogel Malignant neoplasm of breast
PREDISPOSES,Resistance,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Resistance Malignant neoplasm of breast
PREDISPOSES,AMACR wt Allele,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,"Element, Ion, or Isotope",AMACR wt Allele Female Breast Carcinoma
PREDISPOSES,AA genotype,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,AA genotype Malignant neoplasm of breast
AFFECTS,N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide Malignant neoplasm of breast
AFFECTS,Genomic Instability,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Genomic Instability Malignant neoplasm of breast
PREDISPOSES,endosulfine,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",endosulfine Triple Negative Breast Neoplasms
CAUSES,erbB-2 Receptor|ERBB2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",erbB-2 Receptor|ERBB2 Malignant neoplasm of breast
AFFECTS,COVID-19,malignant neoplasm of breast staging,0.0,Female Breast Cancer,"Element, Ion, or Isotope",COVID-19 malignant neoplasm of breast staging
PREDISPOSES,brazilian,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,brazilian Malignant neoplasm of breast
AFFECTS,Inhibitor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Inhibitor Malignant neoplasm of breast
PREDISPOSES,Healthy Lifestyle,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Neoplastic Process,Healthy Lifestyle Noninfiltrating Intraductal Carcinoma
AFFECTS,choline,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",choline Malignant neoplasm of breast
PREDISPOSES,Procedure findings:Finding:Point in time:^Patient:Narrative,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",Procedure findings:Finding:Point in time:^Patient:Narrative Noninfiltrating Intraductal Carcinoma
AUGMENTS,fluvastatin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,fluvastatin Malignant neoplasm of breast
PREDISPOSES,interleukin-6,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,"Element, Ion, or Isotope",interleukin-6 Secondary malignant neoplasm of breast
PREDISPOSES,Immune,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Immune Malignant neoplasm of breast
PREDISPOSES,"Sleep Apnea, Obstructive",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Sleep Apnea, Obstructive Malignant neoplasm of breast"
PREDISPOSES,HMMR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",HMMR Malignant neoplasm of breast
PREDISPOSES,1 time,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",1 time Malignant neoplasm of breast
PREDISPOSES,Tea without milk,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Tea without milk Malignant neoplasm of breast
PREDISPOSES,Infantile Neuroaxonal Dystrophy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Infantile Neuroaxonal Dystrophy Malignant neoplasm of breast
CAUSES,doxorubicin liposome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,doxorubicin liposome Malignant neoplasm of breast
DISRUPTS,sigma-2 receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,sigma-2 receptor Malignant neoplasm of breast
PREDISPOSES,False Positive,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,False Positive Malignant neoplasm of breast
PREDISPOSES,Multifactorial,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Multifactorial Malignant neoplasm of breast
AFFECTS,Post-mastectomy radiotherapy,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Post-mastectomy radiotherapy Triple Negative Breast Neoplasms
AFFECTS,"Antibodies, Bispecific",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope","Antibodies, Bispecific Triple Negative Breast Neoplasms"
AUGMENTS,CCL3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,CCL3 Malignant neoplasm of breast
PREDISPOSES,Basis,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Basis Triple Negative Breast Neoplasms
PREDISPOSES,MIR191 wt Allele,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",MIR191 wt Allele Malignant neoplasm of breast
PREDISPOSES,Monoclonal Antibodies,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Monoclonal Antibodies Malignant neoplasm of breast
DISRUPTS,fluoxetine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,fluoxetine Malignant neoplasm of breast
AFFECTS,canagliflozin,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,canagliflozin Breast Carcinoma
DISRUPTS,catalpol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,catalpol Malignant neoplasm of breast
PREDISPOSES,Score,Early-Stage Breast Carcinoma,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Score Early-Stage Breast Carcinoma
PREDISPOSES,Transsexual (finding),Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,"Element, Ion, or Isotope",Transsexual (finding) Secondary malignant neoplasm of breast
AFFECTS,Antioxidants,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Antioxidants Malignant neoplasm of breast
AFFECTS,Anabolism,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Anabolism Triple Negative Breast Neoplasms
AFFECTS,Estrus,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Estrus estrogen receptor-positive breast cancer
DISRUPTS,diltiazem,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Neoplastic Process,diltiazem Secondary malignant neoplasm of breast
DISRUPTS,resveratrol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,resveratrol Malignant neoplasm of breast
DISRUPTS,Emodin,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Neoplastic Process,Emodin Secondary malignant neoplasm of breast
PREDISPOSES,Clinical Significance,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Immunologic Factor,Clinical Significance Triple Negative Breast Neoplasms
AUGMENTS,N-acetyltransferase 1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,N-acetyltransferase 1 Malignant neoplasm of breast
PREDISPOSES,water channel,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",water channel Malignant neoplasm of breast
PREDISPOSES,Risk Scores,contralateral breast cancer,0.0029970029970029,Female Breast Cancer,Gene or Genome,Risk Scores contralateral breast cancer
PREDISPOSES,Present,Carcinoma breast stage IV,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Present Carcinoma breast stage IV
DISRUPTS,1-Phosphatidylinositol 3-Kinase,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",1-Phosphatidylinositol 3-Kinase HER2-positive carcinoma of breast
AFFECTS,"neoisoliquiritin, (E)-isomer",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","neoisoliquiritin, (E)-isomer Malignant neoplasm of breast"
PREDISPOSES,Phosphotransferases,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Phosphotransferases Triple Negative Breast Neoplasms
AFFECTS,Cell Cycle Arrest,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Cell Cycle Arrest Malignant neoplasm of breast
PREDISPOSES,arginylproline|ABL2|RERE,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,arginylproline|ABL2|RERE Malignant neoplasm of breast
AFFECTS,Tripe,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Tripe Malignant neoplasm of breast
AFFECTS,Candidiasis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Candidiasis Malignant neoplasm of breast
AFFECTS,Treatment Protocols,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",Treatment Protocols HER2-positive carcinoma of breast
PREDISPOSES,Neuregulin 1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Neuregulin 1 Malignant neoplasm of breast
DISRUPTS,LBH589,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,LBH589 Malignant neoplasm of breast
PREDISPOSES,Histone H3 Lysine 27,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Histone H3 Lysine 27 Malignant neoplasm of breast
PREDISPOSES,Low Level,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Low Level Malignant neoplasm of breast
AFFECTS,paclitaxel,Carcinoma breast stage IV,0.0,Female Breast Cancer,"Element, Ion, or Isotope",paclitaxel Carcinoma breast stage IV
PREDISPOSES,ANTXR1 wt Allele|ATR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",ANTXR1 wt Allele|ATR Malignant neoplasm of breast
CAUSES,ROS1 wt Allele|ROS1,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",ROS1 wt Allele|ROS1 estrogen receptor-positive breast cancer
AFFECTS,Mitophagy,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Mitophagy Triple Negative Breast Neoplasms
AFFECTS,chaperone-mediated autophagy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,chaperone-mediated autophagy Malignant neoplasm of breast
PREDISPOSES,Dairy Products,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Dairy Products Malignant neoplasm of breast
AFFECTS,Neoadjuvant Therapy,Early-Stage Breast Carcinoma,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Neoadjuvant Therapy Early-Stage Breast Carcinoma
AFFECTS,Anxiety,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Anxiety Malignant neoplasm of breast
PREDISPOSES,stanniocalcin 2|STC2,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Disease or Syndrome,stanniocalcin 2|STC2 Carcinoma of Male Breast
CAUSES,Secondary Neoplasm,Carcinoma breast stage IV,0.0,Female Breast Cancer,Gene or Genome,Secondary Neoplasm Carcinoma breast stage IV
DISRUPTS,F-Actin,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Neoplastic Process,F-Actin Secondary malignant neoplasm of breast
PREDISPOSES,Vegetarian diet,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Vegetarian diet Malignant neoplasm of breast
CAUSES,Biological Response Modifiers,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Biological Response Modifiers Malignant neoplasm of breast
PREDISPOSES,estradiol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,estradiol Malignant neoplasm of breast
PREDISPOSES,MYC,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",MYC Triple Negative Breast Neoplasms
DISRUPTS,polyphenols,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,polyphenols Malignant neoplasm of breast
PREDISPOSES,Marital Status,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Marital Status Triple Negative Breast Neoplasms
PREDISPOSES,CARD.RISK,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",CARD.RISK Malignant neoplasm of breast
PREDISPOSES,kaempferol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,kaempferol Malignant neoplasm of breast
PREDISPOSES,dydrogesterone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,dydrogesterone Malignant neoplasm of breast
AFFECTS,Inflammatory Response,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Inflammatory Response Malignant neoplasm of breast
DISRUPTS,Luteolin,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Luteolin Triple Negative Breast Neoplasms
AFFECTS,Magnetic Resonance Imaging,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Magnetic Resonance Imaging Breast Carcinoma
CAUSES,copper,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",copper Malignant neoplasm of breast
PREDISPOSES,Negative Surgical Margin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Negative Surgical Margin Malignant neoplasm of breast
AUGMENTS,Agonist,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Agonist Malignant neoplasm of breast
AFFECTS,stanniocalcin 2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,stanniocalcin 2 Malignant neoplasm of breast
CAUSES,Methylnitrosourea,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Methylnitrosourea estrogen receptor-positive breast cancer
AFFECTS,Pharmacotherapy,HER2-negative breast cancer,0.0,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Pharmacotherapy HER2-negative breast cancer
PREDISPOSES,16 alpha-hydroxyestrone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",16 alpha-hydroxyestrone Malignant neoplasm of breast
PREDISPOSES,hydrocortisone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,hydrocortisone Malignant neoplasm of breast
AFFECTS,oxybenzone,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",oxybenzone Triple Negative Breast Neoplasms
PREDISPOSES,Menstrual period late,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Menstrual period late Malignant neoplasm of breast
AFFECTS,Pediatric Obesity,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Pediatric Obesity Malignant neoplasm of breast
PREDISPOSES,lysine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,lysine Malignant neoplasm of breast
PREDISPOSES,Psoriasis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Psoriasis Malignant neoplasm of breast
DISRUPTS,DEGS1 wt Allele|DEGS1,Carcinoma breast stage IV,0.0,Female Breast Cancer,Gene or Genome,DEGS1 wt Allele|DEGS1 Carcinoma breast stage IV
AFFECTS,Pharmacotherapy,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,"Element, Ion, or Isotope",Pharmacotherapy Female Breast Carcinoma
AFFECTS,polyphyllin D,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",polyphyllin D Triple Negative Breast Neoplasms
AFFECTS,tocopherol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,tocopherol Malignant neoplasm of breast
PREDISPOSES,olive oil,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,olive oil Malignant neoplasm of breast
CAUSES,Poly(ADP-ribose) Polymerase Inhibitors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Poly(ADP-ribose) Polymerase Inhibitors Malignant neoplasm of breast
AFFECTS,Parafibromin|CDC73,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Parafibromin|CDC73 Malignant neoplasm of breast
AFFECTS,Neoadjuvant Therapy,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",Neoadjuvant Therapy HER2-positive carcinoma of breast
AFFECTS,Ligands,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Ligands Triple Negative Breast Neoplasms
AFFECTS,CD69,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",CD69 Malignant neoplasm of breast
PREDISPOSES,Life Expectancy Less than Five Years,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",Life Expectancy Less than Five Years Invasive carcinoma of breast
DISRUPTS,Phenols,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Phenols Malignant neoplasm of breast
PREDISPOSES,"Toll-Like Receptor 1, human|TLR1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Toll-Like Receptor 1, human|TLR1 Malignant neoplasm of breast"
PREDISPOSES,Biological Markers,Stage 0 Breast Carcinoma,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Biological Markers Stage 0 Breast Carcinoma
AFFECTS,Ketogenic Diet,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Ketogenic Diet Malignant neoplasm of breast
AFFECTS,Cell Survival,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Cell Survival Malignant neoplasm of breast
AFFECTS,OLT1177,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",OLT1177 Triple Negative Breast Neoplasms
AUGMENTS,beta catenin,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",beta catenin Triple Negative Breast Neoplasms
AFFECTS,quercetin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,quercetin Malignant neoplasm of breast
AFFECTS,Secondary Neoplasm,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Secondary Neoplasm Triple Negative Breast Neoplasms
AFFECTS,Cardiorespiratory Fitness,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Cardiorespiratory Fitness Malignant neoplasm of breast
PREDISPOSES,STMN1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",STMN1 Triple Negative Breast Neoplasms
PREDISPOSES,Waist Circumference,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Waist Circumference Malignant neoplasm of breast
AFFECTS,olaparib,Carcinoma breast stage IV,0.0,Female Breast Cancer,"Element, Ion, or Isotope",olaparib Carcinoma breast stage IV
PREDISPOSES,Mammographic Breast Density,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Mammographic Breast Density Sporadic Breast Carcinoma
PREDISPOSES,1+,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,1+ Malignant neoplasm of breast
AFFECTS,Ferroptosis,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Ferroptosis Triple Negative Breast Neoplasms
AFFECTS,CELSR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,CELSR1 Malignant neoplasm of breast
PREDISPOSES,Rhythm,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Rhythm Malignant neoplasm of breast
PREDISPOSES,Thrombospondin 1,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",Thrombospondin 1 HER2-positive carcinoma of breast
AFFECTS,Dormancy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Dormancy Malignant neoplasm of breast
PREDISPOSES,lutein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,lutein Malignant neoplasm of breast
AFFECTS,Diagnosis,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",Diagnosis Invasive carcinoma of breast
AFFECTS,Mouse Model,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Mouse Model Malignant neoplasm of breast
AFFECTS,Cell Death,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Cell Death Malignant neoplasm of breast
DISRUPTS,idebenone,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",idebenone Triple Negative Breast Neoplasms
AFFECTS,"Tenascin, human|TNC|TNNC1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,"Tenascin, human|TNC|TNNC1 Malignant neoplasm of breast"
AFFECTS,Poly(ADP-ribose) Polymerase Inhibitors,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Poly(ADP-ribose) Polymerase Inhibitors Triple Negative Breast Neoplasms
PREDISPOSES,TLR2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,TLR2 Malignant neoplasm of breast
AFFECTS,ezetimibe,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Neoplastic Process,ezetimibe Secondary malignant neoplasm of breast
AUGMENTS,Follistatin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Follistatin Malignant neoplasm of breast
PREDISPOSES,mitochondrial calcium uniporter,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",mitochondrial calcium uniporter Malignant neoplasm of breast
DISRUPTS,ononin,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",ononin Triple Negative Breast Neoplasms
DISRUPTS,tanshinone II A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",tanshinone II A Malignant neoplasm of breast
AFFECTS,PGR|PR@|PRH2|TMEM37|ERVK-7|ERVK-8|ERVK-10|ERVK-9|ERVK-21|ERVK-18|ERVK-25|ERVK-24|ERVK-19,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,"Element, Ion, or Isotope",PGR|PR@|PRH2|TMEM37|ERVK-7|ERVK-8|ERVK-10|ERVK-9|ERVK-21|ERVK-18|ERVK-25|ERVK-24|ERVK-19 Inflammatory Breast Carcinoma
AFFECTS,oncostatin M receptor|OSMR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,oncostatin M receptor|OSMR Malignant neoplasm of breast
AFFECTS,Anthocyanins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Anthocyanins Malignant neoplasm of breast
PREDISPOSES,Insulin used,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Insulin used Malignant neoplasm of breast
CAUSES,resveratrol,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Neoplastic Process,resveratrol Noninfiltrating Intraductal Carcinoma
AFFECTS,CA2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,CA2 Malignant neoplasm of breast
PREDISPOSES,Adenosine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Adenosine Malignant neoplasm of breast
PREDISPOSES,Cardiovascular morbidity,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Cardiovascular morbidity Malignant neoplasm of breast
PREDISPOSES,IKZF2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,IKZF2 Malignant neoplasm of breast
DISRUPTS,Interleukin-24,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Interleukin-24 Malignant neoplasm of breast
AFFECTS,Neoplasm,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Neoplastic Process,Neoplasm Noninfiltrating Intraductal Carcinoma
CAUSES,Acrylamide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Acrylamide Malignant neoplasm of breast
DISRUPTS,KDM5B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",KDM5B Malignant neoplasm of breast
AFFECTS,"Menopause, Premature",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,"Menopause, Premature Malignant neoplasm of breast"
PREDISPOSES,CETN1,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",CETN1 Breast cancer recurrent
AFFECTS,Aging,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Aging Breast Carcinoma
AFFECTS,Combined Modality Therapy,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Combined Modality Therapy Breast cancer metastatic
PREDISPOSES,GATA3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",GATA3 Malignant neoplasm of breast
PREDISPOSES,Selenium,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Selenium Malignant neoplasm of breast
PREDISPOSES,Menstrual migraine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Menstrual migraine Malignant neoplasm of breast
PREDISPOSES,Eclampsia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Eclampsia Malignant neoplasm of breast
CAUSES,APOBEC3B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,APOBEC3B Malignant neoplasm of breast
PREDISPOSES,Immunologic Adjuvants,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Immunologic Adjuvants Malignant neoplasm of breast
CAUSES,Whole Cell Vaccine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Whole Cell Vaccine Malignant neoplasm of breast
PREDISPOSES,XBP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",XBP1 Malignant neoplasm of breast
AFFECTS,Calcium,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Calcium Malignant neoplasm of breast
PREDISPOSES,Cytochrome P-450 CYP1A1|CYP2B6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Cytochrome P-450 CYP1A1|CYP2B6 Malignant neoplasm of breast
AUGMENTS,MAP3K3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,MAP3K3 Malignant neoplasm of breast
AFFECTS,UDP-Glucuronosyltransferase 1A1|SLC45A2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",UDP-Glucuronosyltransferase 1A1|SLC45A2 Malignant neoplasm of breast
AFFECTS,NANOG,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",NANOG Breast cancer metastatic
CAUSES,TISSUE TRANSGLUTAMINASE,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",TISSUE TRANSGLUTAMINASE Malignant neoplasm of breast
AFFECTS,TLR3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",TLR3 Malignant neoplasm of breast
PREDISPOSES,Quinones,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Quinones Malignant neoplasm of breast
PREDISPOSES,Progestins,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,Progestins Breast cancer invasive NOS
PREDISPOSES,[D]Nausea and vomiting NOS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",[D]Nausea and vomiting NOS Malignant neoplasm of breast
AFFECTS,JAG1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",JAG1 Malignant neoplasm of breast
CAUSES,8q22,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,8q22 Breast cancer invasive NOS
DISRUPTS,Deferoxamine,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Deferoxamine Breast Carcinoma
CAUSES,Specimen from breast,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Specimen from breast Malignant neoplasm of breast
PREDISPOSES,MIR27B,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",MIR27B Breast cancer metastatic
AFFECTS,"9,10-Dimethyl-1,2-benzanthracene",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","9,10-Dimethyl-1,2-benzanthracene Malignant neoplasm of breast"
CAUSES,RUNX1|MECOM,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",RUNX1|MECOM Malignant neoplasm of breast
AFFECTS,ANKRD12|ANKRD11,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ANKRD12|ANKRD11 Malignant neoplasm of breast
AUGMENTS,Interleukin-8,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Interleukin-8 Malignant neoplasm of breast
CAUSES,RHOBTB2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,RHOBTB2 Malignant neoplasm of breast
DISRUPTS,Paclitaxel,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Paclitaxel Malignant neoplasm of breast
DISRUPTS,ID1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",ID1 Breast cancer metastatic
AUGMENTS,Leptin|LEP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Leptin|LEP Malignant neoplasm of breast
AFFECTS,Transferase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Transferase Malignant neoplasm of breast
AFFECTS,Quantitative Trait Loci,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Quantitative Trait Loci Malignant neoplasm of breast
CAUSES,MRPS30,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",MRPS30 Malignant neoplasm of breast
PREDISPOSES,Annexin A2|ANXA2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Annexin A2|ANXA2 Breast cancer metastatic
CAUSES,Endostatins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Endostatins Malignant neoplasm of breast
AUGMENTS,SH3KBP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,SH3KBP1 Malignant neoplasm of breast
PREDISPOSES,Nitrite,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Nitrite Malignant neoplasm of breast
AUGMENTS,ARF6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ARF6 Malignant neoplasm of breast
AFFECTS,Extracellular Signal Regulated Kinases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Extracellular Signal Regulated Kinases Malignant neoplasm of breast
AFFECTS,Immunoglobulin G,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Immunoglobulin G Malignant neoplasm of breast
PREDISPOSES,TG,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,TG Malignant neoplasm of breast
PREDISPOSES,Antiperspirants,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Antiperspirants Malignant neoplasm of breast
PREDISPOSES,Leptin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Leptin Malignant neoplasm of breast
AFFECTS,asparaginylendopeptidase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,asparaginylendopeptidase Malignant neoplasm of breast
AUGMENTS,20q,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,20q Malignant neoplasm of breast
CAUSES,Interleukin 7 Receptor|IL7R,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Interleukin 7 Receptor|IL7R Malignant neoplasm of breast
PREDISPOSES,Livebirth,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Livebirth Malignant neoplasm of breast
DISRUPTS,BMPR1B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",BMPR1B Malignant neoplasm of breast
AFFECTS,Laminin Receptor,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Laminin Receptor Breast Carcinoma
AFFECTS,Magnetic Resonance Imaging,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",Magnetic Resonance Imaging Noninfiltrating Intraductal Carcinoma
PREDISPOSES,ACR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ACR Malignant neoplasm of breast
AFFECTS,Metabolic Rates,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Metabolic Rates Malignant neoplasm of breast
AFFECTS,CATHEPSIN D|CTSD,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",CATHEPSIN D|CTSD Breast cancer metastatic
AFFECTS,"Antibodies, Anti-Idiotypic",Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope","Antibodies, Anti-Idiotypic Breast cancer metastatic"
AFFECTS,Carotenoids,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Carotenoids Breast cancer recurrent
CAUSES,Fibroadenoma,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Fibroadenoma Breast Carcinoma
AFFECTS,Estrous Cycle,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Estrous Cycle Malignant neoplasm of breast
PREDISPOSES,Irregular menstrual cycle NOS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Irregular menstrual cycle NOS Malignant neoplasm of breast
AFFECTS,"Pregnancy, Multiple",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Pregnancy, Multiple Malignant neoplasm of breast"
AFFECTS,fulvestrant,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",fulvestrant Breast cancer metastatic
PREDISPOSES,HSD17B4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",HSD17B4 Malignant neoplasm of breast
PREDISPOSES,Nifedipine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Nifedipine Malignant neoplasm of breast
AFFECTS,Mechanics,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Mechanics Malignant neoplasm of breast
PREDISPOSES,Body mass index,Carcinoma in situ of breast,0.0019980019980019,Female Breast Cancer,"Element, Ion, or Isotope",Body mass index Carcinoma in situ of breast
AUGMENTS,LRRC32,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,LRRC32 Malignant neoplasm of breast
AFFECTS,Signal Pathways,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Signal Pathways Breast cancer metastatic
DISRUPTS,salinomycin,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,salinomycin Breast Carcinoma
AFFECTS,Reconstructive Surgical Procedures,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Reconstructive Surgical Procedures Malignant neoplasm of breast
PREDISPOSES,GALNT14,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",GALNT14 Breast cancer metastatic
CAUSES,Cadherins,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Disease or Syndrome,Cadherins Sporadic Breast Carcinoma
DISRUPTS,Manganese Superoxide Dismutase,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Manganese Superoxide Dismutase Breast Carcinoma
DISRUPTS,Tretinoin,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Tretinoin Breast Carcinoma
PREDISPOSES,Para 2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Para 2 Malignant neoplasm of breast
AFFECTS,Cake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Cake Malignant neoplasm of breast
AFFECTS,Dessert,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Dessert Malignant neoplasm of breast
AFFECTS,Trihalomethanes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Trihalomethanes Malignant neoplasm of breast
AUGMENTS,ZNF121,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ZNF121 Malignant neoplasm of breast
AFFECTS,Paraffin,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Neoplastic Process,Paraffin Ductal Breast Carcinoma
CAUSES,Retroviridae,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Retroviridae Breast Carcinoma
PREDISPOSES,Cytologic finding,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Cytologic finding Malignant neoplasm of breast
PREDISPOSES,GATA3,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",GATA3 Breast cancer metastatic
AFFECTS,Etoposide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Etoposide Malignant neoplasm of breast
PREDISPOSES,Collagen,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,"Element, Ion, or Isotope",Collagen Ductal Breast Carcinoma
PREDISPOSES,activity level,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",activity level Malignant neoplasm of breast
AFFECTS,Biological Factors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Biological Factors Malignant neoplasm of breast
AFFECTS,Trans-Activators,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Trans-Activators Malignant neoplasm of breast
PREDISPOSES,Athletic Training,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Athletic Training Malignant neoplasm of breast
PREDISPOSES,Aromatic Amines,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Aromatic Amines Malignant neoplasm of breast
DISRUPTS,Androgens,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Androgens Breast Carcinoma
PREDISPOSES,alpha-Lactalbumin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",alpha-Lactalbumin Malignant neoplasm of breast
AUGMENTS,Prolactin Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Prolactin Receptor Malignant neoplasm of breast
AFFECTS,Operative Surgical Procedures,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Operative Surgical Procedures Breast Carcinoma
PREDISPOSES,Photosensitivity,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Photosensitivity Malignant neoplasm of breast
AFFECTS,Electromagnetic Fields,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Electromagnetic Fields Malignant neoplasm of breast
AUGMENTS,Phosphotransferases,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Phosphotransferases Breast Carcinoma
COMPLICATES,Hypercalcemia,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Hypercalcemia Breast cancer metastatic
AUGMENTS,receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,receptor Malignant neoplasm of breast
AFFECTS,onapristone,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,onapristone Breast Carcinoma
AFFECTS,Paraffin,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,Paraffin Breast cancer invasive NOS
DISRUPTS,Monoclonal Antibodies,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Monoclonal Antibodies Breast Carcinoma
PREDISPOSES,Debrisoquin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Debrisoquin Malignant neoplasm of breast
AFFECTS,Gonadorelin|GNRH1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Gonadorelin|GNRH1 Malignant neoplasm of breast
CAUSES,Urea,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Urea Malignant neoplasm of breast
CAUSES,"9,10-Dimethyl-1,2-benzanthracene",Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Element, Ion, or Isotope","9,10-Dimethyl-1,2-benzanthracene Breast cancer recurrent"
CAUSES,Dimethyl Sulfoxide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Dimethyl Sulfoxide Malignant neoplasm of breast
PREDISPOSES,beta-hexachlorocyclohexane,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",beta-hexachlorocyclohexane Malignant neoplasm of breast
AFFECTS,Gamma-glutamyl transferase,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Gamma-glutamyl transferase Breast Carcinoma
DISRUPTS,Interferons,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Interferons Breast Carcinoma
AFFECTS,Bromocriptine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Bromocriptine Malignant neoplasm of breast
AUGMENTS,methylurea,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,methylurea Malignant neoplasm of breast
PREDISPOSES,Prognostic Factor,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Prognostic Factor Breast cancer recurrent
AUGMENTS,"9,10-Dimethyl-1,2-benzanthracene",Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope","9,10-Dimethyl-1,2-benzanthracene Breast Carcinoma"
PREDISPOSES,PIP,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",PIP Breast cancer metastatic
AFFECTS,Wound Healing,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Wound Healing Malignant neoplasm of breast
PREDISPOSES,High income,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",High income Malignant neoplasm of breast
PREDISPOSES,Lutein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Lutein Malignant neoplasm of breast
AFFECTS,X-Pro dipeptidase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,X-Pro dipeptidase Malignant neoplasm of breast
PREDISPOSES,New finding,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",New finding Malignant neoplasm of breast
PREDISPOSES,Obesity,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Obesity Breast Carcinoma
AFFECTS,CATHEPSIN D|CTSD,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,CATHEPSIN D|CTSD Malignant neoplasm of breast
PREDISPOSES,tissue-factor-pathway inhibitor 2|PPP5C|TFPI2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",tissue-factor-pathway inhibitor 2|PPP5C|TFPI2 Malignant neoplasm of breast
PREDISPOSES,Fever,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Disease or Syndrome,Fever Carcinoma of Male Breast
PREDISPOSES,regular physical activity,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",regular physical activity Malignant neoplasm of breast
PREDISPOSES,NBEAL2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,NBEAL2 Malignant neoplasm of breast
PREDISPOSES,C2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,C2 Malignant neoplasm of breast
CAUSES,BUB1B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,BUB1B Malignant neoplasm of breast
DISRUPTS,Glucagon|GCG,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Glucagon|GCG Breast Carcinoma
AUGMENTS,MFT 279,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,MFT 279 Breast Carcinoma
DISRUPTS,receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,receptor Malignant neoplasm of breast
CAUSES,Estradiol,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Estradiol Breast Carcinoma
PREDISPOSES,GATA5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,GATA5 Malignant neoplasm of breast
DISRUPTS,folligen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,folligen Malignant neoplasm of breast
AUGMENTS,Cyclin D1|CCND1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Cyclin D1|CCND1 Malignant neoplasm of breast
PREDISPOSES,sodium-iodide symporter,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",sodium-iodide symporter Malignant neoplasm of breast
PREDISPOSES,Prolactin|PRL,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Prolactin|PRL Malignant neoplasm of breast
AFFECTS,Indomethacin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Indomethacin Malignant neoplasm of breast
PREDISPOSES,Increased body mass index,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Increased body mass index Malignant neoplasm of breast
CAUSES,Integrins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Integrins Malignant neoplasm of breast
CAUSES,Insulin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Insulin Malignant neoplasm of breast
AUGMENTS,Decapeptyl,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Decapeptyl Malignant neoplasm of breast
CAUSES,Radium,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Radium Malignant neoplasm of breast
PREDISPOSES,Interstitial Collagenase,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Element, Ion, or Isotope",Interstitial Collagenase Breast cancer invasive NOS
AFFECTS,Allelic Imbalance,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Neoplastic Process,Allelic Imbalance Noninfiltrating Intraductal Carcinoma
PREDISPOSES,Polyamines,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Polyamines Malignant neoplasm of breast
CAUSES,Genistein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Genistein Malignant neoplasm of breast
AFFECTS,Electromagnetic Energy,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Electromagnetic Energy Breast Carcinoma
AUGMENTS,checkpoint kinase 2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",checkpoint kinase 2 Malignant neoplasm of breast
PREDISPOSES,Passive smoker,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Passive smoker Malignant neoplasm of breast
PREDISPOSES,Hypokinesia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Hypokinesia Malignant neoplasm of breast
AFFECTS,Aspirin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Aspirin Malignant neoplasm of breast
AFFECTS,Psychometrics,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Psychometrics Malignant neoplasm of breast
AFFECTS,I Kappa B-Alpha,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,"Element, Ion, or Isotope",I Kappa B-Alpha Sporadic Breast Carcinoma
DISRUPTS,Antioxidants,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Antioxidants Malignant neoplasm of breast
AFFECTS,Triethylenemelamine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Triethylenemelamine Malignant neoplasm of breast
AFFECTS,Lymphoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Lymphoma Malignant neoplasm of breast
AFFECTS,Chromosome abnormality,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Element, Ion, or Isotope",Chromosome abnormality Breast cancer invasive NOS
DISRUPTS,Kininogenase|KLK4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Kininogenase|KLK4 Malignant neoplasm of breast
PREDISPOSES,CLARITY,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,CLARITY Malignant neoplasm of breast
CAUSES,Retroviral Vector,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Retroviral Vector Breast Carcinoma
PREDISPOSES,Saturated fat intake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Saturated fat intake Malignant neoplasm of breast
PREDISPOSES,"N,N-dimethyl-4-anisidine",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,"N,N-dimethyl-4-anisidine Malignant neoplasm of breast"
PREDISPOSES,skills,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,skills Malignant neoplasm of breast
AUGMENTS,EMSY,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Disease or Syndrome,EMSY Sporadic Breast Carcinoma
PREDISPOSES,Reproductive Behavior,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Reproductive Behavior Malignant neoplasm of breast
PREDISPOSES,Venous Thrombosis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Venous Thrombosis Malignant neoplasm of breast
AFFECTS,Quantitative Trait Loci,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Quantitative Trait Loci Breast Carcinoma
PREDISPOSES,Prempro,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Prempro Malignant neoplasm of breast
DISRUPTS,maspin|SERPINB5,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",maspin|SERPINB5 Breast cancer metastatic
CAUSES,Dehydroepiandrosterone Sulfate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Dehydroepiandrosterone Sulfate Malignant neoplasm of breast
AUGMENTS,Phosphotransferases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Phosphotransferases Malignant neoplasm of breast
PREDISPOSES,Retinoids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Retinoids Malignant neoplasm of breast
DISRUPTS,ID-1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ID-1 Malignant neoplasm of breast
PREDISPOSES,MPO,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,MPO Malignant neoplasm of breast
PREDISPOSES,Soy bean product,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Soy bean product Malignant neoplasm of breast
CAUSES,Angiogenic Switch,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Angiogenic Switch Breast Carcinoma
PREDISPOSES,ID1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ID1 Malignant neoplasm of breast
CAUSES,Cryptococcus,Cancer en cuirasse,0.0,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Cryptococcus Cancer en cuirasse
AFFECTS,Infertility,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Infertility Malignant neoplasm of breast
DISRUPTS,EEF1B2P2|BHLHE22,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,EEF1B2P2|BHLHE22 Malignant neoplasm of breast
PREDISPOSES,Decreased density,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Decreased density Malignant neoplasm of breast
AUGMENTS,apomucin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,apomucin Malignant neoplasm of breast
DISRUPTS,NELFB,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,NELFB Malignant neoplasm of breast
CAUSES,receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,receptor Malignant neoplasm of breast
AFFECTS,Granulocyte Colony-Stimulating Factor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Granulocyte Colony-Stimulating Factor Malignant neoplasm of breast
PREDISPOSES,MFG,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,MFG Malignant neoplasm of breast
AFFECTS,Catechol O-Methyltransferase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Catechol O-Methyltransferase Malignant neoplasm of breast
PREDISPOSES,Hyperprolactinemia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Hyperprolactinemia Malignant neoplasm of breast
AFFECTS,Estradiol,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Disease or Syndrome,Estradiol Sporadic Breast Carcinoma
CAUSES,Lignans,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Lignans Malignant neoplasm of breast
AFFECTS,lariciresinol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,lariciresinol Malignant neoplasm of breast
PREDISPOSES,Raloxifene,Carcinoma in situ of breast,0.0019980019980019,Female Breast Cancer,Neoplastic Process,Raloxifene Carcinoma in situ of breast
PREDISPOSES,Anovulatory,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Anovulatory Malignant neoplasm of breast
PREDISPOSES,Sore to touch,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Sore to touch Malignant neoplasm of breast
PREDISPOSES,Gegenhalten,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Gegenhalten Malignant neoplasm of breast
AUGMENTS,pleiotrophin|PTN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",pleiotrophin|PTN Malignant neoplasm of breast
DISRUPTS,epigallocatechin gallate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,epigallocatechin gallate Malignant neoplasm of breast
AFFECTS,beta catenin,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,"Element, Ion, or Isotope","beta catenin Carcinoma, Ductal, Breast"
AFFECTS,WISP2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,WISP2 Malignant neoplasm of breast
PREDISPOSES,Endopeptidases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Endopeptidases Malignant neoplasm of breast
AFFECTS,anti-apoptosis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",anti-apoptosis Malignant neoplasm of breast
AFFECTS,Environmental stimuli,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Environmental stimuli Breast cancer metastatic
DISRUPTS,Asparagine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Asparagine Malignant neoplasm of breast
DISRUPTS,Steryl-sulfatase|STS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Steryl-sulfatase|STS Malignant neoplasm of breast
CAUSES,Cytochrome P450 3A4|CYP3A4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Cytochrome P450 3A4|CYP3A4 Malignant neoplasm of breast
AFFECTS,polyphenols,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",polyphenols Breast cancer metastatic
CAUSES,Breast Cyst,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Breast Cyst Malignant neoplasm of breast
PREDISPOSES,Mannose Binding Lectin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Mannose Binding Lectin Malignant neoplasm of breast
AUGMENTS,Stanolone,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Neoplastic Process,Stanolone Noninfiltrating Intraductal Carcinoma
CAUSES,YBX1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",YBX1 Malignant neoplasm of breast
PREDISPOSES,ghrelin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ghrelin Malignant neoplasm of breast
PREDISPOSES,Ovarian Cysts,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Ovarian Cysts Malignant neoplasm of breast
DISRUPTS,Thrombospondins,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Thrombospondins Breast Carcinoma
PREDISPOSES,Catecholamines,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Catecholamines Malignant neoplasm of breast
CAUSES,Oxytocinase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Oxytocinase Malignant neoplasm of breast
CAUSES,Isoflavones,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Isoflavones Malignant neoplasm of breast
PREDISPOSES,Encounter due to puberty,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Encounter due to puberty Malignant neoplasm of breast
AUGMENTS,TSPYL5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,TSPYL5 Malignant neoplasm of breast
PREDISPOSES,SIPA1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",SIPA1 Malignant neoplasm of breast
PREDISPOSES,PPAR gamma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",PPAR gamma Malignant neoplasm of breast
AFFECTS,Operative Surgical Procedures,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Operative Surgical Procedures Breast cancer metastatic
PREDISPOSES,Walking,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Walking Malignant neoplasm of breast
PREDISPOSES,ABCC11,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ABCC11 Malignant neoplasm of breast
DISRUPTS,"Antibodies, Anti-Idiotypic",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Antibodies, Anti-Idiotypic Malignant neoplasm of breast"
AFFECTS,Thrombolytic Therapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Thrombolytic Therapy Malignant neoplasm of breast
PREDISPOSES,14q24.1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,14q24.1 Malignant neoplasm of breast
CAUSES,NRP2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,NRP2 Malignant neoplasm of breast
PREDISPOSES,MTNR1A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,MTNR1A Malignant neoplasm of breast
PREDISPOSES,MTNR1B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",MTNR1B Malignant neoplasm of breast
PREDISPOSES,Titanium,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Titanium Malignant neoplasm of breast
AUGMENTS,mTOR Inhibitor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",mTOR Inhibitor Malignant neoplasm of breast
PREDISPOSES,Acetyltransferase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Acetyltransferase Malignant neoplasm of breast
CAUSES,Metformin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Metformin Malignant neoplasm of breast
PREDISPOSES,SULT1A1|SULT1A1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",SULT1A1|SULT1A1 Malignant neoplasm of breast
PREDISPOSES,Potato,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Potato Malignant neoplasm of breast
PREDISPOSES,Breast tenderness,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,Breast tenderness Breast cancer invasive NOS
PREDISPOSES,Autoimmune thyroiditis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Autoimmune thyroiditis Malignant neoplasm of breast
AUGMENTS,OPN1LW|CRCP|RAB11FIP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,OPN1LW|CRCP|RAB11FIP1 Malignant neoplasm of breast
PREDISPOSES,PREDICTED,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Neoplastic Process,PREDICTED Noninfiltrating Intraductal Carcinoma
AFFECTS,Interleukin-15,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Interleukin-15 Malignant neoplasm of breast
AUGMENTS,NEK8,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,NEK8 Malignant neoplasm of breast
CAUSES,Cigarette smoke,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Cigarette smoke Malignant neoplasm of breast
DISRUPTS,Sulfatases|ARSH,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Sulfatases|ARSH Malignant neoplasm of breast
AFFECTS,PALB2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",PALB2 Malignant neoplasm of breast
PREDISPOSES,CCDC88A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,CCDC88A Malignant neoplasm of breast
AFFECTS,Retinoids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Retinoids Malignant neoplasm of breast
PREDISPOSES,Diabetes Mellitus,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Diabetes Mellitus Malignant neoplasm of breast
AFFECTS,Somatomedins,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,Somatomedins Breast cancer invasive NOS
AFFECTS,Phototherapy,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Phototherapy Breast Carcinoma
AUGMENTS,Granulocyte Colony-Stimulating Factor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Granulocyte Colony-Stimulating Factor Malignant neoplasm of breast
AUGMENTS,UTS2R|SLC14A2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,UTS2R|SLC14A2 Malignant neoplasm of breast
AFFECTS,Compete,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Compete Malignant neoplasm of breast
PREDISPOSES,Magnesium,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Magnesium Malignant neoplasm of breast
AUGMENTS,Calgranulin A|S100A8,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Calgranulin A|S100A8 Malignant neoplasm of breast
AFFECTS,Cytochrome P450,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Cytochrome P450 Malignant neoplasm of breast
PREDISPOSES,ETV4,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,ETV4 Breast cancer metastatic
PREDISPOSES,Minisatellite Repeats,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Minisatellite Repeats Malignant neoplasm of breast
AFFECTS,PPAR gamma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",PPAR gamma Malignant neoplasm of breast
AUGMENTS,S100A1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",S100A1 Malignant neoplasm of breast
PREDISPOSES,Niacin intake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Niacin intake Malignant neoplasm of breast
AUGMENTS,SIX1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,SIX1 Breast cancer metastatic
PREDISPOSES,Arrestins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Arrestins Malignant neoplasm of breast
AFFECTS,BACH1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",BACH1 Breast cancer metastatic
CAUSES,PHB2|SIL1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,PHB2|SIL1 Malignant neoplasm of breast
CAUSES,Advance,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,Advance Breast cancer invasive NOS
AFFECTS,VEGFA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",VEGFA Malignant neoplasm of breast
PREDISPOSES,SLX4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,SLX4 Malignant neoplasm of breast
CAUSES,Tetradecanoylphorbol Acetate,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Tetradecanoylphorbol Acetate Breast Carcinoma
PREDISPOSES,Catechol O-Methyltransferase|EREG|ESR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Catechol O-Methyltransferase|EREG|ESR1 Malignant neoplasm of breast
PREDISPOSES,MRE11,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",MRE11 Breast cancer recurrent
PREDISPOSES,Methyltransferase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Methyltransferase Malignant neoplasm of breast
DISRUPTS,hesperetin,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,hesperetin Breast Carcinoma
PREDISPOSES,BRIP1,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Disease or Syndrome,BRIP1 Carcinoma of Male Breast
AUGMENTS,ING5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ING5 Malignant neoplasm of breast
COMPLICATES,Angioendotheliomatosis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Angioendotheliomatosis Malignant neoplasm of breast
AFFECTS,"2,3-bis(3'-hydroxybenzyl)butyrolactone",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,"2,3-bis(3'-hydroxybenzyl)butyrolactone Malignant neoplasm of breast"
AFFECTS,Paclitaxel,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Paclitaxel Breast cancer metastatic
PREDISPOSES,RPRD1B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,RPRD1B Malignant neoplasm of breast
AFFECTS,XPO5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,XPO5 Malignant neoplasm of breast
AFFECTS,Therapeutic procedure,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,"Element, Ion, or Isotope",Therapeutic procedure Ductal Breast Carcinoma
AFFECTS,Natural menopause,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Natural menopause Malignant neoplasm of breast
AUGMENTS,sphingosine kinase-1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",sphingosine kinase-1 Malignant neoplasm of breast
AFFECTS,NKD1,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Neoplastic Process,"NKD1 Carcinoma, Ductal, Breast"
CAUSES,ERBB2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",ERBB2 Malignant neoplasm of breast
CAUSES,benzyl isothiocyanate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,benzyl isothiocyanate Malignant neoplasm of breast
PREDISPOSES,Oxides,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Oxides Malignant neoplasm of breast
AFFECTS,ABCB10,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ABCB10 Malignant neoplasm of breast
AFFECTS,shikonin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,shikonin Malignant neoplasm of breast
AFFECTS,KLF4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,KLF4 Malignant neoplasm of breast
DISRUPTS,fucoidan,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,fucoidan Malignant neoplasm of breast
AFFECTS,Cyclin E,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Element, Ion, or Isotope",Cyclin E Breast cancer invasive NOS
PREDISPOSES,"Lupus Erythematosus, Systemic",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Lupus Erythematosus, Systemic Malignant neoplasm of breast"
AFFECTS,NBAT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,NBAT1 Malignant neoplasm of breast
PREDISPOSES,SULF2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",SULF2 Malignant neoplasm of breast
DISRUPTS,arctigenin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,arctigenin Malignant neoplasm of breast
AFFECTS,xanthohumol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,xanthohumol Malignant neoplasm of breast
AFFECTS,Interstitial Collagenase,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,Interstitial Collagenase Breast cancer metastatic
DISRUPTS,BVES,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",BVES Malignant neoplasm of breast
AFFECTS,POU5F1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",POU5F1 Malignant neoplasm of breast
AUGMENTS,MSI2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,MSI2 Malignant neoplasm of breast
PREDISPOSES,ANXA3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ANXA3 Malignant neoplasm of breast
DISRUPTS,curcumol,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",curcumol Breast cancer metastatic
AFFECTS,Transferrin,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Transferrin Breast cancer metastatic
PREDISPOSES,Phosphotransferases,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Phosphotransferases Breast cancer metastatic
PREDISPOSES,pomegranate juice,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,pomegranate juice Malignant neoplasm of breast
PREDISPOSES,YAP1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",YAP1 Breast cancer metastatic
PREDISPOSES,ITGB1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ITGB1 Malignant neoplasm of breast
AFFECTS,discoidin domain receptor 2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",discoidin domain receptor 2 Breast cancer metastatic
PREDISPOSES,Complement 3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Complement 3 Malignant neoplasm of breast
PREDISPOSES,HVCN1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,HVCN1 Malignant neoplasm of breast
PREDISPOSES,IGKV6D-21,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",IGKV6D-21 Malignant neoplasm of breast
AFFECTS,Fertility,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Fertility Malignant neoplasm of breast
PREDISPOSES,Tenascin|TNC,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Neoplastic Process,"Tenascin|TNC Carcinoma, Ductal, Breast"
AUGMENTS,C1GALT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,C1GALT1 Malignant neoplasm of breast
AFFECTS,Bone remodeling,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Bone remodeling Malignant neoplasm of breast
AFFECTS,caveolin 1|CA5A|CAV2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,caveolin 1|CA5A|CAV2 Malignant neoplasm of breast
PREDISPOSES,Lactate,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Lactate Breast cancer metastatic
PREDISPOSES,Diabetes,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,"Element, Ion, or Isotope",Diabetes Inflammatory Breast Carcinoma
DISRUPTS,bakuchiol,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",bakuchiol Breast cancer metastatic
AFFECTS,TFF3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",TFF3 Malignant neoplasm of breast
AFFECTS,pregnane X receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,pregnane X receptor Malignant neoplasm of breast
AUGMENTS,MT2A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,MT2A Malignant neoplasm of breast
AFFECTS,isoalantolactone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,isoalantolactone Malignant neoplasm of breast
AFFECTS,LEF1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",LEF1 Breast cancer metastatic
CAUSES,Raloxifene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Raloxifene Malignant neoplasm of breast
AFFECTS,HIST2H2AC,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,HIST2H2AC Malignant neoplasm of breast
AFFECTS,Fluoxetine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Fluoxetine Malignant neoplasm of breast
DISRUPTS,sinomenine hydrochloride,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",sinomenine hydrochloride Breast cancer metastatic
PREDISPOSES,Interleukin-17,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Interleukin-17 Malignant neoplasm of breast
DISRUPTS,TARDBP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,TARDBP Malignant neoplasm of breast
PREDISPOSES,exemestane,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,exemestane Breast cancer invasive NOS
PREDISPOSES,ADAM33,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ADAM33 Malignant neoplasm of breast
AFFECTS,Pharmacotherapy,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Neoplastic Process,"Pharmacotherapy Carcinoma, Ductal, Breast"
AFFECTS,HOTAIR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",HOTAIR Malignant neoplasm of breast
PREDISPOSES,VTCN1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,VTCN1 Malignant neoplasm of breast
AFFECTS,FCRL3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,FCRL3 Malignant neoplasm of breast
AUGMENTS,PARP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",PARP1 Malignant neoplasm of breast
AUGMENTS,Interleukin-1 beta,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Interleukin-1 beta Malignant neoplasm of breast
DISRUPTS,"Antibodies, Anti-Idiotypic",Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope","Antibodies, Anti-Idiotypic Breast cancer metastatic"
AFFECTS,SHARPIN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,SHARPIN Malignant neoplasm of breast
CAUSES,methyl 4-azidophenylacetimidate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",methyl 4-azidophenylacetimidate Malignant neoplasm of breast
AFFECTS,Polycomb,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Polycomb Breast Carcinoma
DISRUPTS,S1PR2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,S1PR2 Malignant neoplasm of breast
AFFECTS,SP7,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,SP7 Breast cancer metastatic
AUGMENTS,CD44,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",CD44 Malignant neoplasm of breast
PREDISPOSES,RNU4-2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,RNU4-2 Malignant neoplasm of breast
AUGMENTS,meleagrin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,meleagrin Malignant neoplasm of breast
PREDISPOSES,Brown rice,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Brown rice Malignant neoplasm of breast
AUGMENTS,Phosphoric Monoester Hydrolases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Phosphoric Monoester Hydrolases Malignant neoplasm of breast
AUGMENTS,Transcriptase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Transcriptase Malignant neoplasm of breast
AFFECTS,salinomycin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,salinomycin Malignant neoplasm of breast
PREDISPOSES,ANKLE1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ANKLE1 Malignant neoplasm of breast
PREDISPOSES,skills,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",skills Familial cancer of breast
AUGMENTS,sigma-1 receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,sigma-1 receptor Malignant neoplasm of breast
PREDISPOSES,MAPT,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,MAPT Malignant neoplasm of breast
CAUSES,Polysaccharides,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Polysaccharides Malignant neoplasm of breast
DISRUPTS,TGFBR1,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Element, Ion, or Isotope",TGFBR1 Breast cancer invasive NOS
PREDISPOSES,sphingosine kinase-1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",sphingosine kinase-1 Malignant neoplasm of breast
AFFECTS,Ischemia,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,Ischemia Breast cancer invasive NOS
PREDISPOSES,S100A4,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",S100A4 Breast cancer metastatic
AFFECTS,Stem cell transplant,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Stem cell transplant Malignant neoplasm of breast
AFFECTS,BRD7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",BRD7 Malignant neoplasm of breast
AFFECTS,Therapeutic procedure,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,"Element, Ion, or Isotope",Therapeutic procedure Carcinoma of Male Breast
AFFECTS,Multiple malignancy,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,"Element, Ion, or Isotope",Multiple malignancy Ductal Breast Carcinoma
AFFECTS,SUCLA2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,SUCLA2 Malignant neoplasm of breast
CAUSES,Neoplasm,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,"Element, Ion, or Isotope",Neoplasm Carcinoma of Male Breast
AFFECTS,CDCA7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,CDCA7 Malignant neoplasm of breast
DISRUPTS,diallyl disulfide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,diallyl disulfide Malignant neoplasm of breast
AUGMENTS,Relaxin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Relaxin Malignant neoplasm of breast
PREDISPOSES,GEN1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,GEN1 Malignant neoplasm of breast
PREDISPOSES,4-chlorophenyl methyl sulfide,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,"Element, Ion, or Isotope",4-chlorophenyl methyl sulfide Contralateral breast cancer
PREDISPOSES,Difficulty sleeping,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Difficulty sleeping Malignant neoplasm of breast
AUGMENTS,PRI-2191,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",PRI-2191 Breast cancer metastatic
AFFECTS,Collagen,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Collagen Breast Carcinoma
AUGMENTS,Toremifene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Toremifene Malignant neoplasm of breast
CAUSES,Dietary Component,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Dietary Component Malignant neoplasm of breast
PREDISPOSES,Interleukin-1 beta,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Interleukin-1 beta Malignant neoplasm of breast
AFFECTS,Isoprostanes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Isoprostanes Malignant neoplasm of breast
DISRUPTS,WWC1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,WWC1 Malignant neoplasm of breast
DISRUPTS,phenidone,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,phenidone Breast Carcinoma
DISRUPTS,MALAT1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",MALAT1 Breast cancer metastatic
AFFECTS,fibulin-3,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",fibulin-3 Breast cancer metastatic
AFFECTS,Chitosan,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Chitosan Malignant neoplasm of breast
CAUSES,ZEB1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",ZEB1 Malignant neoplasm of breast
DISRUPTS,"9,10-Dimethyl-1,2-benzanthracene",Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope","9,10-Dimethyl-1,2-benzanthracene Breast Carcinoma"
PREDISPOSES,LGALSL,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,LGALSL Malignant neoplasm of breast
AFFECTS,aloperine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,aloperine Malignant neoplasm of breast
AFFECTS,Hydrogels,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Hydrogels Malignant neoplasm of breast
PREDISPOSES,Adverse effects,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Element, Ion, or Isotope",Adverse effects Breast cancer invasive NOS
AUGMENTS,Estradiol,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Estradiol Breast Carcinoma
PREDISPOSES,Test Result,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Body Substance,Test Result Malignant neoplasm of breast
AFFECTS,Fibrosis,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Fibrosis Breast cancer metastatic
PREDISPOSES,Membrane receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Membrane receptor Malignant neoplasm of breast
DISRUPTS,Glycine Hydroxymethyltransferase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Glycine Hydroxymethyltransferase Malignant neoplasm of breast
PREDISPOSES,beta catenin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",beta catenin Malignant neoplasm of breast
DISRUPTS,Luteolin,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Luteolin Breast cancer metastatic
AUGMENTS,TLN2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,TLN2 Malignant neoplasm of breast
PREDISPOSES,erbB-2 Receptor|EREG|ESR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",erbB-2 Receptor|EREG|ESR1 Malignant neoplasm of breast
DISRUPTS,Gelatinase B,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Gelatinase B Breast cancer metastatic
PREDISPOSES,midkine|MDK,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,midkine|MDK Malignant neoplasm of breast
PREDISPOSES,pregnane X receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,pregnane X receptor Malignant neoplasm of breast
PREDISPOSES,Cigarette Smoking,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",Cigarette Smoking Noninfiltrating Intraductal Carcinoma
DISRUPTS,BITTER MELON,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,BITTER MELON Malignant neoplasm of breast
AFFECTS,crystalloid,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Neoplastic Process,crystalloid Noninfiltrating Intraductal Carcinoma
AFFECTS,BP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,BP1 Malignant neoplasm of breast
PREDISPOSES,CHI3L2,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,CHI3L2 Breast cancer invasive NOS
CAUSES,3MC,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,3MC Malignant neoplasm of breast
PREDISPOSES,TMEM25,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,TMEM25 Malignant neoplasm of breast
AFFECTS,CD247,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,CD247 Malignant neoplasm of breast
DISRUPTS,YAP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",YAP1 Malignant neoplasm of breast
AFFECTS,Cyclin D1|CCND1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Cyclin D1|CCND1 Malignant neoplasm of breast
PREDISPOSES,Axillary Lymph Node Involvement,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Element, Ion, or Isotope",Axillary Lymph Node Involvement Breast cancer invasive NOS
AFFECTS,CATHEPSIN D|CTSD,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,CATHEPSIN D|CTSD Breast Carcinoma
PREDISPOSES,Skim milk,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Skim milk Malignant neoplasm of breast
PREDISPOSES,Symptoms,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Symptoms Breast cancer recurrent
PREDISPOSES,Atypical lobular hyperplasia,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Atypical lobular hyperplasia Breast Carcinoma
PREDISPOSES,personal responsibility,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",personal responsibility Malignant neoplasm of breast
PREDISPOSES,beta-hexachlorocyclohexane,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Disease or Syndrome,beta-hexachlorocyclohexane Breast Carcinoma
AFFECTS,Growth,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Biologically Active Substance,Growth Breast Carcinoma
AFFECTS,RHCE|FIP1L1,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,RHCE|FIP1L1 Breast cancer invasive NOS
PREDISPOSES,Ischemic stroke,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Ischemic stroke Malignant neoplasm of breast
PREDISPOSES,CD27,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,CD27 Malignant neoplasm of breast
PREDISPOSES,SALL2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,SALL2 Malignant neoplasm of breast
PREDISPOSES,cathepsin K|CTSK,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,cathepsin K|CTSK Malignant neoplasm of breast
AFFECTS,paxillin|PXN,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",paxillin|PXN Breast cancer metastatic
DISRUPTS,Metformin,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Metformin Breast Carcinoma
AFFECTS,CTHRC1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",CTHRC1 Malignant neoplasm of breast
PREDISPOSES,CTHRC1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",CTHRC1 Breast cancer metastatic
CAUSES,Hydroxyl Radical,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Neoplastic Process,"Hydroxyl Radical Carcinoma, Ductal, Breast"
PREDISPOSES,Depo-Provera,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Depo-Provera Malignant neoplasm of breast
PREDISPOSES,Ductal Breast Hyperplasia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Ductal Breast Hyperplasia Malignant neoplasm of breast
AFFECTS,prednisolone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,prednisolone Malignant neoplasm of breast
PREDISPOSES,5-hydroxymethyl-2'-deoxyuridine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,5-hydroxymethyl-2'-deoxyuridine Malignant neoplasm of breast
AFFECTS,Diabetic Retinopathy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Diabetic Retinopathy Malignant neoplasm of breast
PREDISPOSES,APC,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",APC Malignant neoplasm of breast
AFFECTS,ERBB2|NEU1|NEURL1,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",ERBB2|NEU1|NEURL1 Noninfiltrating Intraductal Carcinoma
PREDISPOSES,Aspirin,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Aspirin Breast Carcinoma
CAUSES,Dairy Products,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Dairy Products Malignant neoplasm of breast
PREDISPOSES,PAX2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,PAX2 Malignant neoplasm of breast
DISRUPTS,Paclitaxel,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Paclitaxel Breast Carcinoma
PREDISPOSES,OR10J3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,OR10J3 Malignant neoplasm of breast
AFFECTS,Therapeutic regimen,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Element, Ion, or Isotope",Therapeutic regimen Breast cancer invasive NOS
AUGMENTS,CYP1B1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",CYP1B1 Malignant neoplasm of breast
AFFECTS,Allelic Imbalance,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Allelic Imbalance Malignant neoplasm of breast
DISRUPTS,2-hydroxyestrone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,2-hydroxyestrone Malignant neoplasm of breast
AFFECTS,Early Diagnosis,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Element, Ion, or Isotope",Early Diagnosis Breast cancer invasive NOS
PREDISPOSES,Lobular Neoplasia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Lobular Neoplasia Malignant neoplasm of breast
AFFECTS,Ultrasonography,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Neoplastic Process,Ultrasonography Noninfiltrating Intraductal Carcinoma
DISRUPTS,small molecule,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Element, Ion, or Isotope",small molecule Breast cancer invasive NOS
AFFECTS,Noscapine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Noscapine Malignant neoplasm of breast
AFFECTS,S100A6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,S100A6 Malignant neoplasm of breast
AUGMENTS,VEGFA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",VEGFA Malignant neoplasm of breast
PREDISPOSES,response,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Element, Ion, or Isotope",response Breast cancer recurrent
PREDISPOSES,SLCO1B1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",SLCO1B1 Malignant neoplasm of breast
PREDISPOSES,Systemic Therapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Systemic Therapy Malignant neoplasm of breast
AFFECTS,osteopontin,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",osteopontin Breast cancer metastatic
CAUSES,Zeranol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Zeranol Malignant neoplasm of breast
PREDISPOSES,ZNF365,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",ZNF365 Malignant neoplasm of breast
PREDISPOSES,Leg length,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Leg length Malignant neoplasm of breast
PREDISPOSES,Worried,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Worried Breast cancer recurrent
PREDISPOSES,Calgranulin B|S100A9,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Calgranulin B|S100A9 Breast cancer metastatic
AFFECTS,B3GNT2|B3GNTL1,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Element, Ion, or Isotope",B3GNT2|B3GNTL1 Breast cancer invasive NOS
PREDISPOSES,coping resources,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,coping resources Malignant neoplasm of breast
AUGMENTS,DDX5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",DDX5 Malignant neoplasm of breast
AFFECTS,ORAI1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ORAI1 Malignant neoplasm of breast
AFFECTS,Creatinine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Creatinine Malignant neoplasm of breast
AFFECTS,Interleukin-17,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Interleukin-17 Breast cancer metastatic
DISRUPTS,osteopontin,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",osteopontin Breast cancer metastatic
AFFECTS,Therapeutic procedure,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Element, Ion, or Isotope",Therapeutic procedure Breast cancer invasive NOS
AUGMENTS,Free Radicals,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Free Radicals Malignant neoplasm of breast
AFFECTS,Berberine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Berberine Malignant neoplasm of breast
DISRUPTS,AG 14361,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,AG 14361 Malignant neoplasm of breast
AFFECTS,Amenorrhea,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Amenorrhea Malignant neoplasm of breast
AFFECTS,Fluoxetine,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Fluoxetine Breast cancer metastatic
PREDISPOSES,Oral form estradiol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Oral form estradiol Malignant neoplasm of breast
PREDISPOSES,"Diabetes Mellitus, Non-Insulin-Dependent",Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,"Element, Ion, or Isotope","Diabetes Mellitus, Non-Insulin-Dependent Female Breast Carcinoma"
CAUSES,beta Sitosterol,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Disease or Syndrome,beta Sitosterol Breast Carcinoma
PREDISPOSES,Estradiol acetate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Estradiol acetate Malignant neoplasm of breast
AFFECTS,KDM3A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,KDM3A Malignant neoplasm of breast
PREDISPOSES,May-Hegglin anomaly,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",May-Hegglin anomaly Malignant neoplasm of breast
CAUSES,crocin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,crocin Malignant neoplasm of breast
AFFECTS,meningioma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,meningioma Malignant neoplasm of breast
AFFECTS,Deferoxamine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Deferoxamine Malignant neoplasm of breast
PREDISPOSES,Bread,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Bread Malignant neoplasm of breast
AFFECTS,Rifabutin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Rifabutin Malignant neoplasm of breast
PREDISPOSES,"Diabetes Mellitus, Insulin-Dependent",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Diabetes Mellitus, Insulin-Dependent Malignant neoplasm of breast"
PREDISPOSES,XIST,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,XIST Malignant neoplasm of breast
AFFECTS,Glucocorticoids,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Glucocorticoids Breast cancer recurrent
PREDISPOSES,Arsenic,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Arsenic Malignant neoplasm of breast
PREDISPOSES,oncostatin M|OSM,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",oncostatin M|OSM Breast cancer metastatic
PREDISPOSES,Not significant,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Neoplastic Process,Not significant Noninfiltrating Intraductal Carcinoma
PREDISPOSES,ERBB2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",ERBB2 Malignant neoplasm of breast
PREDISPOSES,Fertility problem,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Fertility problem Malignant neoplasm of breast
PREDISPOSES,Hyperparathyroidism,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Hyperparathyroidism Malignant neoplasm of breast
AUGMENTS,household cleaner,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,household cleaner Malignant neoplasm of breast
PREDISPOSES,Behavior,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Behavior Breast cancer recurrent
AFFECTS,Breast surgery,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Breast surgery Malignant neoplasm of breast
AFFECTS,Ethanol Metabolism,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Ethanol Metabolism Malignant neoplasm of breast
AFFECTS,acadesine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,acadesine Malignant neoplasm of breast
CAUSES,NR4A2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,NR4A2 Malignant neoplasm of breast
AFFECTS,Insulin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Insulin Malignant neoplasm of breast
PREDISPOSES,Malaise,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Malaise Malignant neoplasm of breast
PREDISPOSES,SPSB1,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",SPSB1 Breast cancer recurrent
CAUSES,Cytochrome P450,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Cytochrome P450 Malignant neoplasm of breast
AFFECTS,Ligands,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Ligands Malignant neoplasm of breast
AFFECTS,Cookie and/or cracker,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Cookie and/or cracker Malignant neoplasm of breast
CAUSES,Heregulin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Heregulin Malignant neoplasm of breast
PREDISPOSES,Kininogenase|KLK4,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Kininogenase|KLK4 Breast Carcinoma
PREDISPOSES,Uterine hemorrhage,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Uterine hemorrhage Malignant neoplasm of breast
AFFECTS,Clinical Protocols,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Clinical Protocols Malignant neoplasm of breast
PREDISPOSES,Beef,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Beef Malignant neoplasm of breast
AFFECTS,Saponins,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Saponins Breast cancer metastatic
PREDISPOSES,Plasminogen Activator Inhibitor 1|SERPINE1|SERPINB2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Plasminogen Activator Inhibitor 1|SERPINE1|SERPINB2 Malignant neoplasm of breast
DISRUPTS,Saponins,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Saponins Breast cancer metastatic
PREDISPOSES,Maximum,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Maximum Malignant neoplasm of breast
AUGMENTS,versican|VCAN,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,versican|VCAN Breast cancer metastatic
AFFECTS,Glucocorticoids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Glucocorticoids Malignant neoplasm of breast
PREDISPOSES,Unreported,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Unreported Malignant neoplasm of breast
PREDISPOSES,SGCB|APOBEC3B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,SGCB|APOBEC3B Malignant neoplasm of breast
CAUSES,4-hydroxy-2-nonenal,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",4-hydroxy-2-nonenal Malignant neoplasm of breast
DISRUPTS,"Contraceptives, Oral",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Contraceptives, Oral Malignant neoplasm of breast"
PREDISPOSES,PROCR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,PROCR Malignant neoplasm of breast
PREDISPOSES,SELPLG,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,SELPLG Malignant neoplasm of breast
PREDISPOSES,Mammographic breast density,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Mammographic breast density Contralateral breast cancer
PREDISPOSES,8-oxo-7-hydrodeoxyguanosine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,8-oxo-7-hydrodeoxyguanosine Malignant neoplasm of breast
AFFECTS,Carboplatin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Carboplatin Malignant neoplasm of breast
PREDISPOSES,DAND5,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",DAND5 Breast cancer metastatic
PREDISPOSES,loss; bone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",loss; bone Malignant neoplasm of breast
DISRUPTS,lobaplatin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,lobaplatin Malignant neoplasm of breast
PREDISPOSES,arginylarginine|ABL2|RERE,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,arginylarginine|ABL2|RERE Malignant neoplasm of breast
PREDISPOSES,Toll-like receptor 9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Toll-like receptor 9 Malignant neoplasm of breast
AFFECTS,Neoplasm,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Disease or Syndrome,Neoplasm Ductal Breast Carcinoma
AFFECTS,Atypical lobular hyperplasia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Atypical lobular hyperplasia Malignant neoplasm of breast
AFFECTS,kinase inhibitor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",kinase inhibitor Malignant neoplasm of breast
PREDISPOSES,Not significant,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Not significant Contralateral breast cancer
PREDISPOSES,Hemoglobin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Hemoglobin Malignant neoplasm of breast
AFFECTS,Propranolol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Propranolol Malignant neoplasm of breast
AFFECTS,Cosmetic surgery,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,"Element, Ion, or Isotope",Cosmetic surgery Familial cancer of breast
CAUSES,NF-kappa B,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Neoplastic Process,NF-kappa B Noninfiltrating Intraductal Carcinoma
AFFECTS,Mammaplasty,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Mammaplasty Malignant neoplasm of breast
AFFECTS,Fat graft,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Fat graft Breast cancer metastatic
PREDISPOSES,Initiative - finding,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Initiative - finding Malignant neoplasm of breast
CAUSES,Iron,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Iron Malignant neoplasm of breast
PREDISPOSES,Calcium Channel Blockers,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Calcium Channel Blockers Breast Carcinoma
AFFECTS,Adverse effects,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Adverse effects Malignant neoplasm of breast
AFFECTS,Injectables,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Injectables Malignant neoplasm of breast
AFFECTS,Local Anesthetics,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Local Anesthetics Malignant neoplasm of breast
AFFECTS,Puberty,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Puberty Familial cancer of breast
AFFECTS,"Absorptiometry, Photon",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,"Absorptiometry, Photon Malignant neoplasm of breast"
PREDISPOSES,Osteocalcin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Osteocalcin Malignant neoplasm of breast
DISRUPTS,Alendronate,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Alendronate Contralateral breast cancer
PREDISPOSES,KDM4A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",KDM4A Malignant neoplasm of breast
PREDISPOSES,phthalate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,phthalate Malignant neoplasm of breast
AUGMENTS,TINCR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",TINCR Malignant neoplasm of breast
PREDISPOSES,DDT EXPOSURE,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",DDT EXPOSURE Malignant neoplasm of breast
CAUSES,Benzanthracenes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Benzanthracenes Malignant neoplasm of breast
AFFECTS,Vimentin|VIM,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Vimentin|VIM Malignant neoplasm of breast
PREDISPOSES,PIK3CA|PIK3CB|PIK3CD|PIK3CG,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",PIK3CA|PIK3CB|PIK3CD|PIK3CG Breast cancer metastatic
AUGMENTS,phospholipase C beta2|NEUROD1|TUBB4B,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",phospholipase C beta2|NEUROD1|TUBB4B Noninfiltrating Intraductal Carcinoma
PREDISPOSES,ATG9A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ATG9A Malignant neoplasm of breast
PREDISPOSES,MUTYH,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,"Element, Ion, or Isotope",MUTYH Carcinoma of Male Breast
PREDISPOSES,Morphine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Morphine Malignant neoplasm of breast
PREDISPOSES,LINC00339,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,LINC00339 Malignant neoplasm of breast
DISRUPTS,MKNK1,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Neoplastic Process,MKNK1 Noninfiltrating Intraductal Carcinoma
AUGMENTS,nicotinamide phosphoribosyltransferase|NAMPT,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",nicotinamide phosphoribosyltransferase|NAMPT Malignant neoplasm of breast
DISRUPTS,VEGFA,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",VEGFA Noninfiltrating Intraductal Carcinoma
AUGMENTS,HOXA1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",HOXA1 Malignant neoplasm of breast
AFFECTS,Fluphenazine Hydrochloride,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Fluphenazine Hydrochloride Malignant neoplasm of breast
AFFECTS,Naloxone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Naloxone Malignant neoplasm of breast
DISRUPTS,Glucosides,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Glucosides Malignant neoplasm of breast
AFFECTS,FOXP4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,FOXP4 Malignant neoplasm of breast
PREDISPOSES,Antibodies,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Antibodies Malignant neoplasm of breast
AUGMENTS,FOXP4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,FOXP4 Malignant neoplasm of breast
AUGMENTS,SNORA7B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,SNORA7B Malignant neoplasm of breast
AFFECTS,Magnesium,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Magnesium Malignant neoplasm of breast
AFFECTS,CASC9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,CASC9 Malignant neoplasm of breast
AUGMENTS,beta catenin,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",beta catenin Breast cancer metastatic
PREDISPOSES,LINC01857,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,LINC01857 Malignant neoplasm of breast
AFFECTS,Tissue Model,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Tissue Model Breast cancer metastatic
AFFECTS,Schizophrenia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Schizophrenia Malignant neoplasm of breast
PREDISPOSES,CASC9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,CASC9 Malignant neoplasm of breast
AFFECTS,glycogen synthase kinase 3 beta,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",glycogen synthase kinase 3 beta Malignant neoplasm of breast
AFFECTS,NR0B1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,NR0B1 Malignant neoplasm of breast
DISRUPTS,schisandrin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,schisandrin Malignant neoplasm of breast
AFFECTS,Treatment Protocols,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,"Element, Ion, or Isotope",Treatment Protocols Contralateral breast cancer
AUGMENTS,SIRT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",SIRT1 Malignant neoplasm of breast
PREDISPOSES,racial differences,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Element, Ion, or Isotope",racial differences Breast cancer invasive NOS
AUGMENTS,COPB2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,COPB2 Malignant neoplasm of breast
PREDISPOSES,Binding Sites,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Binding Sites Breast cancer metastatic
PREDISPOSES,tropomyosin-4|TPM4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,tropomyosin-4|TPM4 Malignant neoplasm of breast
AFFECTS,KDM1A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",KDM1A Malignant neoplasm of breast
DISRUPTS,saikosaponin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,saikosaponin Malignant neoplasm of breast
AUGMENTS,RHPN1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,RHPN1 Malignant neoplasm of breast
AUGMENTS,LINC00460,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,LINC00460 Malignant neoplasm of breast
PREDISPOSES,RASSF1A|RASSF1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",RASSF1A|RASSF1 Malignant neoplasm of breast
AFFECTS,SATB1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",SATB1 Breast cancer metastatic
PREDISPOSES,ENOLASE,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ENOLASE Malignant neoplasm of breast
PREDISPOSES,ACSF3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ACSF3 Malignant neoplasm of breast
PREDISPOSES,NCK1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,NCK1 Malignant neoplasm of breast
AFFECTS,ENO1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",ENO1 Malignant neoplasm of breast
PREDISPOSES,BODY HEIGHT:LENGTH:POINT IN TIME:^PATIENT:QUANTITATIVE,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",BODY HEIGHT:LENGTH:POINT IN TIME:^PATIENT:QUANTITATIVE Malignant neoplasm of breast
PREDISPOSES,mastitis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,mastitis Malignant neoplasm of breast
PREDISPOSES,PCB 153,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,PCB 153 Malignant neoplasm of breast
PREDISPOSES,STIM2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",STIM2 Breast cancer metastatic
PREDISPOSES,NBEAL1,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",NBEAL1 Familial cancer of breast
AUGMENTS,PCB 153,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,PCB 153 Malignant neoplasm of breast
DISRUPTS,acetylacetone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,acetylacetone Malignant neoplasm of breast
PREDISPOSES,CYP24A1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",CYP24A1 Malignant neoplasm of breast
PREDISPOSES,ADCY4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ADCY4 Malignant neoplasm of breast
PREDISPOSES,AZIN2|GADL1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,AZIN2|GADL1 Malignant neoplasm of breast
PREDISPOSES,PCB 118,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,PCB 118 Malignant neoplasm of breast
DISRUPTS,caspase-8|CASP8,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",caspase-8|CASP8 Malignant neoplasm of breast
AFFECTS,Electromagnetic Energy,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,"Element, Ion, or Isotope",Electromagnetic Energy Contralateral breast cancer
PREDISPOSES,PALB2,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,Gene or Genome,PALB2 Familial cancer of breast
AFFECTS,Neuropathy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Neuropathy Malignant neoplasm of breast
DISRUPTS,C11orf74|C17orf49,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",C11orf74|C17orf49 Malignant neoplasm of breast
PREDISPOSES,Biological Markers,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Virus,Biological Markers estrogen receptor-positive breast cancer
AFFECTS,regulatory loop,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",regulatory loop Malignant neoplasm of breast
AFFECTS,Enrich (product),Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,"Element, Ion, or Isotope",Enrich (product) Inflammatory Breast Carcinoma
AFFECTS,CGRRF1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,CGRRF1 Malignant neoplasm of breast
DISRUPTS,PPAR gamma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",PPAR gamma Malignant neoplasm of breast
CAUSES,NAMPT,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,NAMPT Malignant neoplasm of breast
AUGMENTS,PRDM2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,PRDM2 Malignant neoplasm of breast
AUGMENTS,Thrombospondin 1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Thrombospondin 1 Breast cancer metastatic
CAUSES,MIR223 wt Allele,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",MIR223 wt Allele Malignant neoplasm of breast
PREDISPOSES,Nuclear Receptor Coactivator 3|NCOA3|ANIB1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Nuclear Receptor Coactivator 3|NCOA3|ANIB1 Malignant neoplasm of breast
AFFECTS,MAP2K4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,MAP2K4 Malignant neoplasm of breast
PREDISPOSES,blood test result,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Body Substance,blood test result Malignant neoplasm of breast
CAUSES,quinoline,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,quinoline Malignant neoplasm of breast
PREDISPOSES,Deoxyuridine,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",Deoxyuridine HER2-positive carcinoma of breast
PREDISPOSES,High Confidence,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",High Confidence Malignant neoplasm of breast
PREDISPOSES,Biological Markers,Carcinoma breast stage IV,0.0,Female Breast Cancer,Gene or Genome,Biological Markers Carcinoma breast stage IV
AUGMENTS,thrombin,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Neoplastic Process,thrombin Noninfiltrating Intraductal Carcinoma
PREDISPOSES,prasterone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,prasterone Malignant neoplasm of breast
AUGMENTS,thymoquinone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,thymoquinone Malignant neoplasm of breast
CAUSES,Cyclin D1,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Cyclin D1 Breast Carcinoma
PREDISPOSES,Biological Markers,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",Biological Markers Noninfiltrating Intraductal Carcinoma
AFFECTS,melatonin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,melatonin Malignant neoplasm of breast
AFFECTS,Diagnostic Imaging,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Diagnostic Imaging Breast Carcinoma
PREDISPOSES,Prognosis bad,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Prognosis bad Triple Negative Breast Neoplasms
CAUSES,Adriamycin,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",Adriamycin HER2-positive carcinoma of breast
PREDISPOSES,Primigravida,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Neoplastic Process,Primigravida Inflammatory Breast Carcinoma
PREDISPOSES,Binge Drinking,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Binge Drinking Malignant neoplasm of breast
PREDISPOSES,IGFBP7|SFPQ,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,"Amino Acid, Peptide, or Protein",IGFBP7|SFPQ estrogen receptor-positive breast cancer
DISRUPTS,Small Molecule,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Small Molecule Malignant neoplasm of breast
AFFECTS,platinum,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Immunologic Factor,platinum Triple Negative Breast Neoplasms
DISRUPTS,pioglitazone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,pioglitazone Malignant neoplasm of breast
CAUSES,gonadorelin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,gonadorelin Malignant neoplasm of breast
DISRUPTS,rhein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,rhein Malignant neoplasm of breast
PREDISPOSES,Profilin 2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Profilin 2 Malignant neoplasm of breast
AFFECTS,Hypersensitivity,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Immunologic Factor,Hypersensitivity Triple Negative Breast Neoplasms
PREDISPOSES,Mitotic Activity,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",Mitotic Activity Invasive carcinoma of breast
PREDISPOSES,LMNB1,Luminal B Breast Carcinoma,0.0,Female Breast Cancer,"Element, Ion, or Isotope",LMNB1 Luminal B Breast Carcinoma
CAUSES,ESM1 wt Allele,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",ESM1 wt Allele Breast Carcinoma
PREDISPOSES,Cereal intake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Cereal intake Malignant neoplasm of breast
PREDISPOSES,Extensive Necrosis,Basal-Like Breast Carcinoma,0.0039960039960039,Female Breast Cancer,"Element, Ion, or Isotope",Extensive Necrosis Basal-Like Breast Carcinoma
PREDISPOSES,quercetin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,quercetin Malignant neoplasm of breast
PREDISPOSES,TMPO wt Allele,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",TMPO wt Allele Malignant neoplasm of breast
PREDISPOSES,risk factors,Carcinoma breast stage IV,0.0,Female Breast Cancer,Gene or Genome,risk factors Carcinoma breast stage IV
PREDISPOSES,CD163,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,CD163 Malignant neoplasm of breast
AFFECTS,Neurosurgical Procedures,Carcinoma breast stage IV,0.0,Female Breast Cancer,Gene or Genome,Neurosurgical Procedures Carcinoma breast stage IV
PREDISPOSES,LMNB1,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",LMNB1 HER2-positive carcinoma of breast
PREDISPOSES,3-methylquercetin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,3-methylquercetin Malignant neoplasm of breast
AUGMENTS,Transcript,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Transcript estrogen receptor-positive breast cancer
PREDISPOSES,Industrial fungicide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Industrial fungicide Malignant neoplasm of breast
AFFECTS,Biological Factors,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Biological Factors Triple Negative Breast Neoplasms
PREDISPOSES,Negative,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",Negative HER2-positive carcinoma of breast
PREDISPOSES,TAC,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,TAC Malignant neoplasm of breast
PREDISPOSES,Alleles,"Breast Cancer, Familial",0.0,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","Alleles Breast Cancer, Familial"
AFFECTS,cyclophosphamide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,cyclophosphamide Malignant neoplasm of breast
CAUSES,WWOX wt Allele,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",WWOX wt Allele Malignant neoplasm of breast
CAUSES,Androgen Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Androgen Receptor Malignant neoplasm of breast
PREDISPOSES,Illness (finding),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Illness (finding) Malignant neoplasm of breast
AFFECTS,Glucocorticoid Receptor,Basal-Like Breast Carcinoma,0.0039960039960039,Female Breast Cancer,"Element, Ion, or Isotope",Glucocorticoid Receptor Basal-Like Breast Carcinoma
PREDISPOSES,Hyperphagia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Hyperphagia Malignant neoplasm of breast
AFFECTS,Synthetic glucocorticoid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Synthetic glucocorticoid Malignant neoplasm of breast
PREDISPOSES,Family history,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",Family history Invasive carcinoma of breast
CAUSES,doxorubicin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,doxorubicin Malignant neoplasm of breast
PREDISPOSES,Family history,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Family history Breast Carcinoma
CAUSES,Benzo(a)pyrene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Benzo(a)pyrene Malignant neoplasm of breast
PREDISPOSES,"Diabetes Mellitus, Non-Insulin-Dependent",estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope","Diabetes Mellitus, Non-Insulin-Dependent estrogen receptor-positive breast cancer"
DISRUPTS,Aurora Kinase A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Aurora Kinase A Malignant neoplasm of breast
PREDISPOSES,Transferrin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Transferrin Malignant neoplasm of breast
CAUSES,Deodorants,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Deodorants Malignant neoplasm of breast
CAUSES,beta catenin,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",beta catenin Triple Negative Breast Neoplasms
AUGMENTS,Alleles,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Alleles Malignant neoplasm of breast
CAUSES,Copy Number Polymorphism,"Breast Cancer, Familial",0.0,Female Breast Cancer,"Element, Ion, or Isotope","Copy Number Polymorphism Breast Cancer, Familial"
AFFECTS,Color doppler ultrasound,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Color doppler ultrasound Malignant neoplasm of breast
DISRUPTS,osthol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,osthol Malignant neoplasm of breast
CAUSES,Cathepsin L,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Neoplastic Process,Cathepsin L Inflammatory Breast Carcinoma
AFFECTS,osthol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,osthol Malignant neoplasm of breast
AFFECTS,PARP inhibitor therapy,Carcinoma breast stage IV,0.0,Female Breast Cancer,Gene or Genome,PARP inhibitor therapy Carcinoma breast stage IV
DISRUPTS,Inhibitor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Inhibitor Malignant neoplasm of breast
DISRUPTS,thymoquinone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,thymoquinone Malignant neoplasm of breast
AFFECTS,Insulin Receptor,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Insulin Receptor Triple Negative Breast Neoplasms
AFFECTS,estradiol,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",estradiol HER2-positive carcinoma of breast
CAUSES,saffron extract,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,saffron extract Malignant neoplasm of breast
PREDISPOSES,beta-2 Microglobulin,Carcinoma breast stage IV,0.0,Female Breast Cancer,Gene or Genome,beta-2 Microglobulin Carcinoma breast stage IV
PREDISPOSES,small size,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",small size Malignant neoplasm of breast
PREDISPOSES,Smoking,contralateral breast cancer,0.0029970029970029,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Smoking contralateral breast cancer
PREDISPOSES,Alleles,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Alleles Triple Negative Breast Neoplasms
AFFECTS,Aquaporin 1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Aquaporin 1 Triple Negative Breast Neoplasms
PREDISPOSES,2 times,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,2 times Malignant neoplasm of breast
PREDISPOSES,interleukin-10,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",interleukin-10 Triple Negative Breast Neoplasms
AFFECTS,Botanical,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Botanical Malignant neoplasm of breast
PREDISPOSES,research results,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,research results Malignant neoplasm of breast
AFFECTS,Childbirth,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",Childbirth HER2-positive carcinoma of breast
PREDISPOSES,bisphenol A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,bisphenol A Malignant neoplasm of breast
PREDISPOSES,UGT1A7 wt Allele,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",UGT1A7 wt Allele Malignant neoplasm of breast
AFFECTS,Modest-Temperature Hyperthermia,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Modest-Temperature Hyperthermia Triple Negative Breast Neoplasms
PREDISPOSES,Artificially Sweetened Beverages,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Artificially Sweetened Beverages Malignant neoplasm of breast
PREDISPOSES,Mood:-:Point in time:^Patient:-,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Mood:-:Point in time:^Patient:- Malignant neoplasm of breast
AFFECTS,jolkinolide B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,jolkinolide B Malignant neoplasm of breast
PREDISPOSES,Dietary Intake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Dietary Intake Malignant neoplasm of breast
PREDISPOSES,Smoke Exposure,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Smoke Exposure Malignant neoplasm of breast
CAUSES,pyridine,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,pyridine Breast Carcinoma
AFFECTS,cyclin B2,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",cyclin B2 Triple Negative Breast Neoplasms
AFFECTS,Xenograft procedure,Luminal B Breast Carcinoma,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Xenograft procedure Luminal B Breast Carcinoma
PREDISPOSES,Copy Number Polymorphism,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Copy Number Polymorphism Malignant neoplasm of breast
AFFECTS,Stilbenes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Stilbenes Malignant neoplasm of breast
PREDISPOSES,Biological Markers,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",Biological Markers Invasive carcinoma of breast
AFFECTS,Intravenous therapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Intravenous therapy Malignant neoplasm of breast
AFFECTS,caveolin 1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,caveolin 1 Malignant neoplasm of breast
DISRUPTS,Oils,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Oils Triple Negative Breast Neoplasms
PREDISPOSES,Breast Density,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",Breast Density Invasive carcinoma of breast
PREDISPOSES,Coronary Arteriosclerosis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Coronary Arteriosclerosis Malignant neoplasm of breast
PREDISPOSES,Normal weight,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Normal weight Malignant neoplasm of breast
PREDISPOSES,Periodontitis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Periodontitis Malignant neoplasm of breast
PREDISPOSES,Response to treatment,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Response to treatment Malignant neoplasm of breast
PREDISPOSES,Parity,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Parity estrogen receptor-positive breast cancer
CAUSES,mortalin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,mortalin Malignant neoplasm of breast
AFFECTS,Hypersensitivity,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Hypersensitivity Malignant neoplasm of breast
AFFECTS,tanshinol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,tanshinol Malignant neoplasm of breast
DISRUPTS,sinomenine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,sinomenine Malignant neoplasm of breast
PREDISPOSES,TSHZ1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,TSHZ1 Malignant neoplasm of breast
DISRUPTS,Taxol,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Taxol Triple Negative Breast Neoplasms
AFFECTS,estradiol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,estradiol Malignant neoplasm of breast
PREDISPOSES,Very Important,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,"Element, Ion, or Isotope",Very Important Female Breast Carcinoma
AFFECTS,"Receptors, KIR2DL4",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Receptors, KIR2DL4 Malignant neoplasm of breast"
PREDISPOSES,Rhythm,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Hazardous or Poisonous Substance,Rhythm Triple Negative Breast Neoplasms
PREDISPOSES,CDC42,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Chemical,CDC42 estrogen receptor-positive breast cancer
DISRUPTS,PDE5A wt Allele|PDE5A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",PDE5A wt Allele|PDE5A Malignant neoplasm of breast
AFFECTS,Pregnancy,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Pregnancy Triple Negative Breast Neoplasms
AFFECTS,inermin,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",inermin Triple Negative Breast Neoplasms
AFFECTS,Therapeutic procedure,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Immunologic Factor,Therapeutic procedure Secondary malignant neoplasm of breast
AUGMENTS,Sulfatases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Sulfatases Malignant neoplasm of breast
CAUSES,diallyl trisulfide,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Neoplastic Process,diallyl trisulfide Noninfiltrating Intraductal Carcinoma
AFFECTS,Alleles,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Alleles Malignant neoplasm of breast
AFFECTS,corynoline,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",corynoline Triple Negative Breast Neoplasms
PREDISPOSES,urokinase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,urokinase Malignant neoplasm of breast
DISRUPTS,Micelles,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Neoplastic Process,Micelles Secondary malignant neoplasm of breast
DISRUPTS,cytochrome b561,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,cytochrome b561 Malignant neoplasm of breast
PREDISPOSES,File Being Validated,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,File Being Validated Malignant neoplasm of breast
AUGMENTS,docetaxel,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,docetaxel Malignant neoplasm of breast
AFFECTS,eribulin,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",eribulin Triple Negative Breast Neoplasms
DISRUPTS,fulvestrant,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,"Amino Acid, Peptide, or Protein",fulvestrant estrogen receptor-positive breast cancer
PREDISPOSES,4 times,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,4 times Malignant neoplasm of breast
AFFECTS,EGF,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",EGF Malignant neoplasm of breast
AUGMENTS,MRPS7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,MRPS7 Malignant neoplasm of breast
AFFECTS,sirolimus,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",sirolimus Malignant neoplasm of breast
AUGMENTS,Androgen Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Androgen Receptor Malignant neoplasm of breast
PREDISPOSES,homocysteine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,homocysteine Malignant neoplasm of breast
PREDISPOSES,Calcinosis universalis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Calcinosis universalis Malignant neoplasm of breast
AFFECTS,GLI1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",GLI1 Triple Negative Breast Neoplasms
AFFECTS,carbidopa,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,"Amino Acid, Peptide, or Protein",carbidopa estrogen receptor-positive breast cancer
AFFECTS,heparanase,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",heparanase Triple Negative Breast Neoplasms
PREDISPOSES,MUC1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",MUC1 Malignant neoplasm of breast
AFFECTS,Lipopolysaccharides,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Lipopolysaccharides estrogen receptor-positive breast cancer
AUGMENTS,lidocaine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,lidocaine Malignant neoplasm of breast
AFFECTS,Early Diagnosis,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Early Diagnosis Breast Carcinoma
PREDISPOSES,ZNF217,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",ZNF217 Malignant neoplasm of breast
CAUSES,Ligands,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Ligands Malignant neoplasm of breast
CAUSES,Mevalonate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Mevalonate Malignant neoplasm of breast
AFFECTS,Immunogenic Cell Death,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Immunogenic Cell Death Malignant neoplasm of breast
AFFECTS,Metabolite,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Metabolite Malignant neoplasm of breast
AUGMENTS,Inhibitor,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Inhibitor Triple Negative Breast Neoplasms
CAUSES,BARRIER,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,BARRIER Breast Carcinoma
CAUSES,Basis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Basis Malignant neoplasm of breast
PREDISPOSES,Biological Markers,Early-Stage Breast Carcinoma,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Biological Markers Early-Stage Breast Carcinoma
AFFECTS,dihydrotanshinone I,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,dihydrotanshinone I Malignant neoplasm of breast
PREDISPOSES,aspirin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,aspirin Malignant neoplasm of breast
DISRUPTS,Low-Dose Aspirin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Low-Dose Aspirin Malignant neoplasm of breast
PREDISPOSES,health knowledge,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,health knowledge Malignant neoplasm of breast
DISRUPTS,panobinostat,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,panobinostat Malignant neoplasm of breast
AFFECTS,arsenic,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,arsenic Malignant neoplasm of breast
AFFECTS,ENOLASE,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ENOLASE Malignant neoplasm of breast
PREDISPOSES,Biological Markers,HER2-negative breast cancer,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Biological Markers HER2-negative breast cancer
PREDISPOSES,perfluorooctanoate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,perfluorooctanoate Malignant neoplasm of breast
PREDISPOSES,thiamine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,thiamine Malignant neoplasm of breast
PREDISPOSES,birth control pill use,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",birth control pill use Malignant neoplasm of breast
AFFECTS,Differential Diagnosis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Differential Diagnosis Malignant neoplasm of breast
AFFECTS,sauchinone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,sauchinone Malignant neoplasm of breast
AFFECTS,Targeted Therapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Targeted Therapy Malignant neoplasm of breast
PREDISPOSES,MVP wt Allele|RPSA|LRP1|PTPRA|MVP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",MVP wt Allele|RPSA|LRP1|PTPRA|MVP Malignant neoplasm of breast
CAUSES,CBFB|NFYA|NFYB,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",CBFB|NFYA|NFYB Malignant neoplasm of breast
AUGMENTS,caspase-3,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",caspase-3 Triple Negative Breast Neoplasms
AFFECTS,Energy Balance,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Immunologic Factor,Energy Balance Triple Negative Breast Neoplasms
PREDISPOSES,Improved,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Improved Malignant neoplasm of breast
PREDISPOSES,Leisure behavior,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Leisure behavior Malignant neoplasm of breast
DISRUPTS,cyclic guanosine monophosphate-adenosine monophosphate,Carcinoma breast stage IV,0.0,Female Breast Cancer,Gene or Genome,cyclic guanosine monophosphate-adenosine monophosphate Carcinoma breast stage IV
PREDISPOSES,Biological Markers,estrogen receptor-negative breast cancer,0.0,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Biological Markers estrogen receptor-negative breast cancer
CAUSES,Cobalt dichloride,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Cobalt dichloride Triple Negative Breast Neoplasms
AUGMENTS,Hexokinase 1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Hexokinase 1 Malignant neoplasm of breast
AFFECTS,Metabolic Profile,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Metabolic Profile Malignant neoplasm of breast
AUGMENTS,Hexokinase 2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Hexokinase 2 Malignant neoplasm of breast
CAUSES,Pyrenes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Pyrenes Malignant neoplasm of breast
AFFECTS,fruit extracts,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,fruit extracts Malignant neoplasm of breast
CAUSES,Players,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Players Triple Negative Breast Neoplasms
AFFECTS,Liposomes,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Liposomes Triple Negative Breast Neoplasms
AUGMENTS,histone deacetylase 2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,histone deacetylase 2 Malignant neoplasm of breast
PREDISPOSES,Immune,HER2-negative breast cancer,0.0,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Immune HER2-negative breast cancer
AFFECTS,Ferritin Light Chain,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Ferritin Light Chain Malignant neoplasm of breast
PREDISPOSES,Hypothalamic inhibiting factor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Hypothalamic inhibiting factor Malignant neoplasm of breast
AFFECTS,Triple Negative Breast Neoplasms,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Triple Negative Breast Neoplasms Malignant neoplasm of breast
AFFECTS,xiaoyaosan,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,xiaoyaosan Malignant neoplasm of breast
PREDISPOSES,Gravidity,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Gravidity Malignant neoplasm of breast
AFFECTS,cytochrome b561,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,cytochrome b561 Malignant neoplasm of breast
PREDISPOSES,Obesity,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Immunologic Factor,Obesity Triple Negative Breast Neoplasms
CAUSES,Suppressor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Suppressor Malignant neoplasm of breast
CAUSES,agonists,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,agonists Malignant neoplasm of breast
COMPLICATES,Thrombotic Microangiopathies,Carcinoma breast stage IV,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Thrombotic Microangiopathies Carcinoma breast stage IV
AFFECTS,Dynamic Contrast-Enhanced Magnetic Resonance Imaging,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Dynamic Contrast-Enhanced Magnetic Resonance Imaging Breast Carcinoma
AFFECTS,Alkaloids,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Alkaloids Breast Carcinoma
DISRUPTS,pristane,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,pristane Malignant neoplasm of breast
AFFECTS,Ginsenosides,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Ginsenosides Malignant neoplasm of breast
AFFECTS,ethanol,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",ethanol HER2-positive carcinoma of breast
PREDISPOSES,40-49,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,40-49 Malignant neoplasm of breast
CAUSES,interleukin-6|IL6,Invasive Ductal Breast Carcinoma,0.0,Female Breast Cancer,"Element, Ion, or Isotope",interleukin-6|IL6 Invasive Ductal Breast Carcinoma
PREDISPOSES,"Interleukin-16, human",HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","Interleukin-16, human HER2-positive carcinoma of breast"
DISRUPTS,polyphyllin II,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",polyphyllin II Malignant neoplasm of breast
AFFECTS,mahanine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,mahanine Malignant neoplasm of breast
AFFECTS,doxorubicin,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",doxorubicin Triple Negative Breast Neoplasms
AFFECTS,Perimenopause,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Perimenopause Malignant neoplasm of breast
CAUSES,FZR1 wt Allele|CDH1,"Breast Cancer, Familial",0.0,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","FZR1 wt Allele|CDH1 Breast Cancer, Familial"
DISRUPTS,interleukin-6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",interleukin-6 Malignant neoplasm of breast
DISRUPTS,CXCL8,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein",CXCL8 Triple Negative Breast Neoplasms
PREDISPOSES,Hemoglobin,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Neoplastic Process,Hemoglobin Noninfiltrating Intraductal Carcinoma
AUGMENTS,chemokine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,chemokine Malignant neoplasm of breast
CAUSES,butylbenzyl phthalate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,butylbenzyl phthalate Malignant neoplasm of breast
DISRUPTS,"Receptors, Opioid, kappa",estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Hormone,"Receptors, Opioid, kappa estrogen receptor-positive breast cancer"
AFFECTS,AMACR wt Allele,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",AMACR wt Allele Malignant neoplasm of breast
AFFECTS,Endometriosis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Endometriosis Malignant neoplasm of breast
PREDISPOSES,ESR1,malignant neoplasm of breast staging,0.0,Female Breast Cancer,"Element, Ion, or Isotope",ESR1 malignant neoplasm of breast staging
CAUSES,Tobacco,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Tobacco Malignant neoplasm of breast
PREDISPOSES,Tea,Breast cancer stage II,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Tea Breast cancer stage II
AFFECTS,Pivot,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Neoplastic Process,Pivot Secondary malignant neoplasm of breast
PREDISPOSES,erbB-2 Receptor|ERBB2,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",erbB-2 Receptor|ERBB2 Invasive carcinoma of breast
PREDISPOSES,Score,Recurrent Breast Carcinoma,0.0009990009990009,Recurrent Breast Cancer,"Element, Ion, or Isotope",Score Recurrent Breast Carcinoma
PREDISPOSES,Carney Complex,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Carney Complex Malignant neoplasm of breast
PREDISPOSES,"interleukin-1, beta",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","interleukin-1, beta Malignant neoplasm of breast"
DISRUPTS,pimozide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,pimozide Malignant neoplasm of breast
AFFECTS,Movement,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Movement Malignant neoplasm of breast
AFFECTS,Androgen Receptor,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Androgen Receptor Triple Negative Breast Neoplasms
AFFECTS,Patient Derived Xenograft,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Patient Derived Xenograft Malignant neoplasm of breast
PREDISPOSES,Male-to-female transsexual (finding),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Male-to-female transsexual (finding) Malignant neoplasm of breast
PREDISPOSES,Autoantibodies,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Autoantibodies Malignant neoplasm of breast
PREDISPOSES,claudin 3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,claudin 3 Malignant neoplasm of breast
PREDISPOSES,doxorubicin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,doxorubicin Malignant neoplasm of breast
PREDISPOSES,Inhibitor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Inhibitor Malignant neoplasm of breast
AFFECTS,humanin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,humanin Malignant neoplasm of breast
DISRUPTS,metformin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,metformin Malignant neoplasm of breast
AFFECTS,scopolamine,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Neoplastic Process,scopolamine Secondary malignant neoplasm of breast
AFFECTS,Upstaging,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Neoplastic Process,Upstaging Noninfiltrating Intraductal Carcinoma
AFFECTS,Neoadjuvant Therapy,bilateral breast cancer,0.0,Female Breast Cancer,Gene or Genome,Neoadjuvant Therapy bilateral breast cancer
AFFECTS,Neoadjuvant Therapy,Luminal B Breast Carcinoma,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Neoadjuvant Therapy Luminal B Breast Carcinoma
DISRUPTS,taurine,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Neoplastic Process,taurine Secondary malignant neoplasm of breast
AFFECTS,Multiple Sclerosis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Multiple Sclerosis Malignant neoplasm of breast
AFFECTS,Targeted Therapy,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",Targeted Therapy HER2-positive carcinoma of breast
PREDISPOSES,Trichorhinophalangeal dysplasia type I,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Trichorhinophalangeal dysplasia type I Triple Negative Breast Neoplasms
AFFECTS,Bee Venoms,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Bee Venoms Malignant neoplasm of breast
CAUSES,ESR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",ESR1 Malignant neoplasm of breast
DISRUPTS,Urolithin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Urolithin Malignant neoplasm of breast
PREDISPOSES,Protective Factors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Protective Factors Malignant neoplasm of breast
PREDISPOSES,Tissue texture abnormality,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Tissue texture abnormality Malignant neoplasm of breast
PREDISPOSES,Basal Diet,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Basal Diet Malignant neoplasm of breast
PREDISPOSES,phosphatidylinositols,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,phosphatidylinositols Malignant neoplasm of breast
AFFECTS,Folliculin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Folliculin Malignant neoplasm of breast
PREDISPOSES,Nitric Oxide Synthase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Nitric Oxide Synthase Malignant neoplasm of breast
AUGMENTS,20q13,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,20q13 Malignant neoplasm of breast
AUGMENTS,TBX2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,TBX2 Malignant neoplasm of breast
AFFECTS,FAS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",FAS Malignant neoplasm of breast
AUGMENTS,TIMM50,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,TIMM50 Malignant neoplasm of breast
AFFECTS,Stromelysin 1|MMP3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Stromelysin 1|MMP3 Malignant neoplasm of breast
AFFECTS,Integrin alpha4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Integrin alpha4 Malignant neoplasm of breast
AFFECTS,intraoperative radiotherapy,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Element, Ion, or Isotope",intraoperative radiotherapy Breast cancer recurrent
AFFECTS,Menopause,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,"Element, Ion, or Isotope",Menopause Female Breast Carcinoma
DISRUPTS,BRMS1L,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",BRMS1L Breast cancer metastatic
PREDISPOSES,11q13,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,11q13 Malignant neoplasm of breast
CAUSES,Cyclin D1|LMOD1|BBS9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Cyclin D1|LMOD1|BBS9 Malignant neoplasm of breast
PREDISPOSES,cyclin A1|CCNA1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",cyclin A1|CCNA1 Malignant neoplasm of breast
AUGMENTS,Pollutant,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Pollutant Malignant neoplasm of breast
AFFECTS,tangeretin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,tangeretin Malignant neoplasm of breast
AUGMENTS,Glutamine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Glutamine Malignant neoplasm of breast
AFFECTS,Heregulin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Heregulin Malignant neoplasm of breast
DISRUPTS,beta catenin,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",beta catenin Breast cancer metastatic
AFFECTS,STF,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,STF Malignant neoplasm of breast
AUGMENTS,SLC39A6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,SLC39A6 Malignant neoplasm of breast
AFFECTS,Annexin A1|ANXA1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Annexin A1|ANXA1 Malignant neoplasm of breast
AFFECTS,Organized pneumonia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Organized pneumonia Malignant neoplasm of breast
CAUSES,Methotrexate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Methotrexate Malignant neoplasm of breast
AFFECTS,IFNB1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,IFNB1 Malignant neoplasm of breast
DISRUPTS,VEGFA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",VEGFA Malignant neoplasm of breast
PREDISPOSES,Interleukin-18,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Interleukin-18 Malignant neoplasm of breast
AFFECTS,"Receptors, Opioid, delta",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Receptors, Opioid, delta Malignant neoplasm of breast"
AUGMENTS,Androgen Receptor|AR,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Androgen Receptor|AR Breast Carcinoma
CAUSES,Pads,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Neoplastic Process,Pads Noninfiltrating Intraductal Carcinoma
AFFECTS,Hypoxia,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Hypoxia Breast cancer metastatic
AFFECTS,Autophagy,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Autophagy Breast cancer metastatic
PREDISPOSES,Genuineness,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Genuineness Malignant neoplasm of breast
AUGMENTS,BAG3,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,BAG3 Breast Carcinoma
AUGMENTS,SNAI1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,SNAI1 Breast cancer metastatic
DISRUPTS,Endopeptidases|ERVK-7|ERVK-8|ERVK-10|ERVK-9|ERVK-21|ERVK-18|ERVK-25|ERVK-24|ERVK-19,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Endopeptidases|ERVK-7|ERVK-8|ERVK-10|ERVK-9|ERVK-21|ERVK-18|ERVK-25|ERVK-24|ERVK-19 Malignant neoplasm of breast
DISRUPTS,NOP14,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,NOP14 Malignant neoplasm of breast
AFFECTS,Rectal hemorrhage,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Rectal hemorrhage Malignant neoplasm of breast
PREDISPOSES,Activins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Activins Malignant neoplasm of breast
PREDISPOSES,WRAP53,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,WRAP53 Malignant neoplasm of breast
CAUSES,Environmental Pollutants,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Environmental Pollutants Malignant neoplasm of breast
AFFECTS,SNAI1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,SNAI1 Breast cancer metastatic
PREDISPOSES,TRIM62,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,TRIM62 Malignant neoplasm of breast
AFFECTS,Wound Healing,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Disease or Syndrome,Wound Healing Sporadic Breast Carcinoma
DISRUPTS,ERBB2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",ERBB2 Malignant neoplasm of breast
AUGMENTS,osteoblast cadherin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,osteoblast cadherin Malignant neoplasm of breast
PREDISPOSES,Congestive heart failure,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Congestive heart failure Malignant neoplasm of breast
PREDISPOSES,octylphenol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,octylphenol Malignant neoplasm of breast
AFFECTS,ADGRF5,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,ADGRF5 Breast cancer metastatic
AFFECTS,Salts,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Salts Breast Carcinoma
PREDISPOSES,FH: Father NOS,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,Neoplastic Process,FH: Father NOS Familial cancer of breast
AFFECTS,carnosol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,carnosol Malignant neoplasm of breast
DISRUPTS,"1,4-dioxin",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,"1,4-dioxin Malignant neoplasm of breast"
PREDISPOSES,icariin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,icariin Malignant neoplasm of breast
DISRUPTS,MIR200A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",MIR200A Malignant neoplasm of breast
DISRUPTS,PIK3R1|PIK3R2|ARHGEF7|CBFA2T2|PPP1R13B|PPP1R12C,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,PIK3R1|PIK3R2|ARHGEF7|CBFA2T2|PPP1R13B|PPP1R12C Breast cancer metastatic
PREDISPOSES,Physical activity decreased,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Physical activity decreased Malignant neoplasm of breast
DISRUPTS,anthracene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,anthracene Malignant neoplasm of breast
PREDISPOSES,Acetate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Acetate Malignant neoplasm of breast
DISRUPTS,retinyl methyl ether,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",retinyl methyl ether Malignant neoplasm of breast
AFFECTS,PIK3CA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",PIK3CA Malignant neoplasm of breast
AFFECTS,Estrone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Estrone Malignant neoplasm of breast
PREDISPOSES,High Vegetable Diet,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",High Vegetable Diet Malignant neoplasm of breast
AFFECTS,Levodopa,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Levodopa Breast Carcinoma
AFFECTS,receptor,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,receptor Breast Carcinoma
AFFECTS,Gin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Gin Malignant neoplasm of breast
AFFECTS,Clomiphene,bilateral breast cancer,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Clomiphene bilateral breast cancer
AUGMENTS,mammaglobin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,mammaglobin Malignant neoplasm of breast
AUGMENTS,Diphosphonates,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Diphosphonates Malignant neoplasm of breast
PREDISPOSES,glycosyltransferase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",glycosyltransferase Malignant neoplasm of breast
AFFECTS,Brachytherapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Brachytherapy Malignant neoplasm of breast
AFFECTS,Nifedipine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Nifedipine Malignant neoplasm of breast
AFFECTS,Dichlorodiphenyl Dichloroethylene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Dichlorodiphenyl Dichloroethylene Malignant neoplasm of breast
AFFECTS,ukrain,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ukrain Malignant neoplasm of breast
AFFECTS,Cyclin D1|LMOD1|BBS9,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Cyclin D1|LMOD1|BBS9 Breast Carcinoma
AFFECTS,TARBP2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",TARBP2 Breast cancer metastatic
AFFECTS,MAPKAP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,MAPKAP1 Malignant neoplasm of breast
PREDISPOSES,Edema,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Edema Malignant neoplasm of breast
AUGMENTS,ERBB2|NEU1|NEURL1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",ERBB2|NEU1|NEURL1 Malignant neoplasm of breast
PREDISPOSES,Voluntary,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Voluntary Malignant neoplasm of breast
DISRUPTS,Sulfones,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Sulfones Breast Carcinoma
CAUSES,Herpesviridae,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Herpesviridae Malignant neoplasm of breast
CAUSES,Microsatellite Repeats,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Microsatellite Repeats Breast Carcinoma
AUGMENTS,Z-alpha-chlorochalcone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Z-alpha-chlorochalcone Malignant neoplasm of breast
AFFECTS,R-38486,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,R-38486 Malignant neoplasm of breast
AFFECTS,Cyclophosphamide,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Cyclophosphamide Breast cancer metastatic
AUGMENTS,Carotenoids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Carotenoids Malignant neoplasm of breast
PREDISPOSES,MENSTRUAL STATUS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",MENSTRUAL STATUS Malignant neoplasm of breast
AFFECTS,Common Neoplasm,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Common Neoplasm Malignant neoplasm of breast
PREDISPOSES,Menopausal Status,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,"Element, Ion, or Isotope",Menopausal Status Contralateral breast cancer
AUGMENTS,Mechlorethamine,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Mechlorethamine Breast Carcinoma
PREDISPOSES,Goiter,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Goiter Breast Carcinoma
AFFECTS,OK-432,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,OK-432 Malignant neoplasm of breast
PREDISPOSES,Tall stature,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Tall stature Malignant neoplasm of breast
PREDISPOSES,dehydroepiandrosterone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,dehydroepiandrosterone Malignant neoplasm of breast
AUGMENTS,Esters,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Esters Breast Carcinoma
PREDISPOSES,Atrophic,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Atrophic Malignant neoplasm of breast
PREDISPOSES,Excessive self-esteem,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Excessive self-esteem Malignant neoplasm of breast
PREDISPOSES,Confident,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Confident Malignant neoplasm of breast
DISRUPTS,Dinoprost,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Dinoprost Breast Carcinoma
AUGMENTS,FGF4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",FGF4 Malignant neoplasm of breast
PREDISPOSES,Fibrosing adenosis,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,Fibrosing adenosis Breast cancer invasive NOS
AUGMENTS,Epoprostenol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Epoprostenol Malignant neoplasm of breast
AFFECTS,Pregnancy review,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Pregnancy review Malignant neoplasm of breast
AFFECTS,Zuclomiphene,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Zuclomiphene Breast Carcinoma
DISRUPTS,EMD 16795,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,EMD 16795 Malignant neoplasm of breast
AFFECTS,Silicones,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Silicones Malignant neoplasm of breast
AFFECTS,ergocornine,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,ergocornine Breast Carcinoma
CAUSES,Cisplatin,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Cisplatin Breast Carcinoma
CAUSES,2-Acetylaminofluorene,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,2-Acetylaminofluorene Breast Carcinoma
CAUSES,Retinoids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Retinoids Malignant neoplasm of breast
AFFECTS,Microsatellite Repeats,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Microsatellite Repeats Malignant neoplasm of breast
PREDISPOSES,Adipositas,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Adipositas Malignant neoplasm of breast
AFFECTS,Drink,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Drink Malignant neoplasm of breast
CAUSES,Neoplasm,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Neoplastic Process,Neoplasm Noninfiltrating Intraductal Carcinoma
AFFECTS,TP73|ARHGAP24,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Neoplastic Process,TP73|ARHGAP24 Inflammatory Breast Carcinoma
AFFECTS,thermography,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,thermography Malignant neoplasm of breast
CAUSES,Calcium Glucarate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Calcium Glucarate Malignant neoplasm of breast
PREDISPOSES,Psychological Impact,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Psychological Impact Malignant neoplasm of breast
PREDISPOSES,p65|RELA|SYT1|GORASP1|WNK1,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",p65|RELA|SYT1|GORASP1|WNK1 Breast Carcinoma
AFFECTS,Dietary Fats,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Dietary Fats Breast Carcinoma
AFFECTS,Microsatellite Instability,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Microsatellite Instability Malignant neoplasm of breast
PREDISPOSES,2-chloroethyl ethyl sulfide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,2-chloroethyl ethyl sulfide Malignant neoplasm of breast
PREDISPOSES,Jogging,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Jogging Malignant neoplasm of breast
PREDISPOSES,Pregnenes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Pregnenes Malignant neoplasm of breast
AFFECTS,casein kinase II,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",casein kinase II Malignant neoplasm of breast
PREDISPOSES,Overweight,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Overweight Breast Carcinoma
AFFECTS,8-hydroxy-2'-deoxyguanosine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",8-hydroxy-2'-deoxyguanosine Malignant neoplasm of breast
AFFECTS,Integrin alphaV,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Integrin alphaV Malignant neoplasm of breast
CAUSES,Meat,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Meat Malignant neoplasm of breast
AFFECTS,Neoplasm,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Disease or Syndrome,"Neoplasm Carcinoma, Ductal, Breast"
PREDISPOSES,ERBB2|NEU1|NEURL1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",ERBB2|NEU1|NEURL1 Breast cancer metastatic
AFFECTS,SLC39A6,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",SLC39A6 Breast cancer metastatic
AFFECTS,Diet,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Diet Breast Carcinoma
CAUSES,Pollutant,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Pollutant Malignant neoplasm of breast
PREDISPOSES,Menopausal hot flushes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Menopausal hot flushes Malignant neoplasm of breast
CAUSES,Amphiregulin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Amphiregulin Malignant neoplasm of breast
AFFECTS,"Diagnosis, Computer-Assisted",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Diagnosis, Computer-Assisted Malignant neoplasm of breast"
DISRUPTS,estrone sulfatase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,estrone sulfatase Malignant neoplasm of breast
PREDISPOSES,ABL2|RERE,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ABL2|RERE Malignant neoplasm of breast
DISRUPTS,Selenium,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Selenium Breast Carcinoma
CAUSES,Ethylnitrosourea,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Ethylnitrosourea Breast Carcinoma
CAUSES,"N,N-dimethyl-4-anisidine",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,"N,N-dimethyl-4-anisidine Malignant neoplasm of breast"
AFFECTS,Surgical biopsy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Surgical biopsy Malignant neoplasm of breast
PREDISPOSES,Technetium Tc 99m Sestamibi,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,Technetium Tc 99m Sestamibi Breast cancer invasive NOS
CAUSES,Hexestrol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Hexestrol Malignant neoplasm of breast
AFFECTS,stanniocalcin 2|STC2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,stanniocalcin 2|STC2 Malignant neoplasm of breast
PREDISPOSES,Early menarche,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,"Element, Ion, or Isotope",Early menarche Female Breast Carcinoma
AFFECTS,"Receptor, Melatonin, MT1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,"Receptor, Melatonin, MT1 Malignant neoplasm of breast"
PREDISPOSES,Mitotic Activity,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Mitotic Activity Malignant neoplasm of breast
DISRUPTS,Alpha heavy chain,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Alpha heavy chain Malignant neoplasm of breast
PREDISPOSES,"1,2-dibromo-3-chloropropane",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,"1,2-dibromo-3-chloropropane Malignant neoplasm of breast"
PREDISPOSES,Slow acetylator status,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Slow acetylator status Malignant neoplasm of breast
AFFECTS,Ibandronate,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Ibandronate Breast cancer metastatic
AFFECTS,Therapeutic regimen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Therapeutic regimen Malignant neoplasm of breast
DISRUPTS,ATP12A|HK1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ATP12A|HK1 Malignant neoplasm of breast
PREDISPOSES,PGR|PR@|PRH2|TMEM37|ERVK-7|ERVK-8|ERVK-10|ERVK-9|ERVK-21|ERVK-18|ERVK-25|ERVK-24|ERVK-19,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",PGR|PR@|PRH2|TMEM37|ERVK-7|ERVK-8|ERVK-10|ERVK-9|ERVK-21|ERVK-18|ERVK-25|ERVK-24|ERVK-19 Malignant neoplasm of breast
CAUSES,P-Cadherin,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Neoplastic Process,P-Cadherin Noninfiltrating Intraductal Carcinoma
PREDISPOSES,Prenatal Exposure,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Prenatal Exposure Breast Carcinoma
AFFECTS,BAG1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,BAG1 Malignant neoplasm of breast
AFFECTS,adjuvant therapy,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",adjuvant therapy Breast cancer metastatic
PREDISPOSES,Phosphorylcholine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Phosphorylcholine Malignant neoplasm of breast
PREDISPOSES,Dydrogesterone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Dydrogesterone Malignant neoplasm of breast
AUGMENTS,Calgranulin B,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Neoplastic Process,Calgranulin B Noninfiltrating Intraductal Carcinoma
PREDISPOSES,SPOCK2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,SPOCK2 Malignant neoplasm of breast
AFFECTS,RUNX3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",RUNX3 Malignant neoplasm of breast
PREDISPOSES,8q24,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,8q24 Malignant neoplasm of breast
DISRUPTS,Folate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Folate Malignant neoplasm of breast
AFFECTS,cold temperature,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,cold temperature Breast Carcinoma
AFFECTS,helicase|HFM1,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",helicase|HFM1 Familial cancer of breast
AFFECTS,Fanconi's Anemia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Fanconi's Anemia Malignant neoplasm of breast
PREDISPOSES,Atypia,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Atypia Breast Carcinoma
CAUSES,TNF,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,"Element, Ion, or Isotope",TNF Familial cancer of breast
PREDISPOSES,RANTES|CCL5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",RANTES|CCL5 Malignant neoplasm of breast
PREDISPOSES,Recombinant Interleukin-8|CXCL8,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Recombinant Interleukin-8|CXCL8 Malignant neoplasm of breast
PREDISPOSES,Angiotensin Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Angiotensin Receptor Malignant neoplasm of breast
AFFECTS,E-Cadherin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,E-Cadherin Malignant neoplasm of breast
AUGMENTS,Apigenin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Apigenin Malignant neoplasm of breast
PREDISPOSES,AROMATICS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,AROMATICS Malignant neoplasm of breast
AFFECTS,tanshinone II A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",tanshinone II A Malignant neoplasm of breast
PREDISPOSES,"Puberty, Precocious",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,"Puberty, Precocious Malignant neoplasm of breast"
AUGMENTS,Estrone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Estrone Malignant neoplasm of breast
AUGMENTS,Oxidoreductase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Oxidoreductase Malignant neoplasm of breast
PREDISPOSES,Delayed menopause,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Delayed menopause Malignant neoplasm of breast
AFFECTS,PPAR gamma|PPARG,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",PPAR gamma|PPARG Malignant neoplasm of breast
AFFECTS,ASAP1|MYCBPAP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",ASAP1|MYCBPAP Malignant neoplasm of breast
AFFECTS,Glycol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Glycol Malignant neoplasm of breast
CAUSES,PARP1,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",PARP1 Breast Carcinoma
DISRUPTS,polyphenon E,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,polyphenon E Malignant neoplasm of breast
AUGMENTS,Activins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Activins Malignant neoplasm of breast
AFFECTS,"Plants, Edible",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,"Plants, Edible Malignant neoplasm of breast"
DISRUPTS,Analgesics,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Analgesics Malignant neoplasm of breast
AUGMENTS,Disintegrins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Disintegrins Malignant neoplasm of breast
PREDISPOSES,prohibitin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,prohibitin Malignant neoplasm of breast
AFFECTS,Phosphatidylinositols,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Phosphatidylinositols Breast cancer metastatic
AUGMENTS,Paclitaxel,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Paclitaxel Malignant neoplasm of breast
PREDISPOSES,leucylproline,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,leucylproline Malignant neoplasm of breast
PREDISPOSES,Connexins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Connexins Malignant neoplasm of breast
PREDISPOSES,podocalyxin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,podocalyxin Malignant neoplasm of breast
AUGMENTS,ERbetacx,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,ERbetacx Breast cancer invasive NOS
AFFECTS,"Receptors, Cell Surface",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Receptors, Cell Surface Malignant neoplasm of breast"
AFFECTS,GSDME,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",GSDME Malignant neoplasm of breast
PREDISPOSES,Norgestrel,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Norgestrel Malignant neoplasm of breast
AFFECTS,Amphiregulin|AREG,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Amphiregulin|AREG Malignant neoplasm of breast
PREDISPOSES,Body mass index,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Body mass index Breast Carcinoma
CAUSES,RAD50,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",RAD50 Familial cancer of breast
CAUSES,Alleles,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Alleles Malignant neoplasm of breast
AFFECTS,EGLN2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,EGLN2 Malignant neoplasm of breast
AUGMENTS,CD24,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",CD24 Noninfiltrating Intraductal Carcinoma
AFFECTS,IFI27|PSMD9|SSSCA1|DCTN6|TMED7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,IFI27|PSMD9|SSSCA1|DCTN6|TMED7 Malignant neoplasm of breast
AFFECTS,anti-apoptosis,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",anti-apoptosis Breast Carcinoma
AFFECTS,CTCFL,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,CTCFL Malignant neoplasm of breast
AFFECTS,LIN28A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,LIN28A Malignant neoplasm of breast
PREDISPOSES,Simvastatin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Simvastatin Malignant neoplasm of breast
PREDISPOSES,CD70,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Disease or Syndrome,CD70 Sporadic Breast Carcinoma
AUGMENTS,Janus kinase 2|JAK2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Janus kinase 2|JAK2 Malignant neoplasm of breast
PREDISPOSES,MS2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,MS2 Malignant neoplasm of breast
PREDISPOSES,Histologic type,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Element, Ion, or Isotope",Histologic type Breast cancer invasive NOS
DISRUPTS,RUNX2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",RUNX2 Malignant neoplasm of breast
PREDISPOSES,nuclear receptor coactivator 1|SRC,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",nuclear receptor coactivator 1|SRC Breast cancer metastatic
DISRUPTS,Liposomes,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Liposomes Breast cancer metastatic
AUGMENTS,KDM8,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,KDM8 Malignant neoplasm of breast
CAUSES,Disulfiram,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Disulfiram Malignant neoplasm of breast
PREDISPOSES,LBX1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",LBX1 Malignant neoplasm of breast
AUGMENTS,IDO1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,IDO1 Malignant neoplasm of breast
PREDISPOSES,healthful behavior,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,healthful behavior Malignant neoplasm of breast
AFFECTS,"2,5-dichloro-4-bromophenol",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,"2,5-dichloro-4-bromophenol Malignant neoplasm of breast"
AUGMENTS,RUNX2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",RUNX2 Malignant neoplasm of breast
AFFECTS,Lemon extract,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Lemon extract Malignant neoplasm of breast
PREDISPOSES,invariant chain|CD74,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",invariant chain|CD74 Malignant neoplasm of breast
CAUSES,survivin,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Neoplastic Process,survivin Noninfiltrating Intraductal Carcinoma
AUGMENTS,Introns,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Introns Malignant neoplasm of breast
PREDISPOSES,FAN1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,FAN1 Malignant neoplasm of breast
PREDISPOSES,FOXC1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",FOXC1 Malignant neoplasm of breast
CAUSES,Aluminum,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Aluminum Malignant neoplasm of breast
CAUSES,RBBP7,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Neoplastic Process,RBBP7 Noninfiltrating Intraductal Carcinoma
PREDISPOSES,quinoxaline,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,quinoxaline Malignant neoplasm of breast
PREDISPOSES,YBX1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,YBX1 Breast cancer metastatic
DISRUPTS,isoflavonoids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,isoflavonoids Malignant neoplasm of breast
AUGMENTS,"Receptors, Nuclear",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Receptors, Nuclear Malignant neoplasm of breast"
AUGMENTS,CYP2S1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",CYP2S1 Malignant neoplasm of breast
AFFECTS,Fenretinide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Fenretinide Malignant neoplasm of breast
PREDISPOSES,AUSTRALIAN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,AUSTRALIAN Malignant neoplasm of breast
PREDISPOSES,UTS2R|SLC14A2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,UTS2R|SLC14A2 Malignant neoplasm of breast
AUGMENTS,RAD51,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",RAD51 Breast Carcinoma
AUGMENTS,NRDC,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,NRDC Malignant neoplasm of breast
AFFECTS,S100A1|S100B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",S100A1|S100B Malignant neoplasm of breast
CAUSES,Field crops,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Field crops Malignant neoplasm of breast
AFFECTS,Core needle biopsy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Core needle biopsy Malignant neoplasm of breast
PREDISPOSES,NOV,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",NOV Breast cancer metastatic
AFFECTS,Mammary Neoplasms,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Neoplastic Process,Mammary Neoplasms Sporadic Breast Carcinoma
DISRUPTS,NCOA7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,NCOA7 Malignant neoplasm of breast
DISRUPTS,beta catenin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",beta catenin Malignant neoplasm of breast
AFFECTS,Metabolic Marker,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Metabolic Marker Malignant neoplasm of breast
CAUSES,CBX7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",CBX7 Malignant neoplasm of breast
PREDISPOSES,caveolin 1,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Neoplastic Process,caveolin 1 Noninfiltrating Intraductal Carcinoma
PREDISPOSES,BEX2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,BEX2 Malignant neoplasm of breast
AFFECTS,Growth,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Biologically Active Substance,Growth Breast cancer metastatic
AFFECTS,SOX18,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,SOX18 Malignant neoplasm of breast
AFFECTS,intraoperative radiotherapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",intraoperative radiotherapy Malignant neoplasm of breast
AUGMENTS,ATP2B2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ATP2B2 Malignant neoplasm of breast
PREDISPOSES,KIT,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",KIT Malignant neoplasm of breast
PREDISPOSES,RAD51B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",RAD51B Malignant neoplasm of breast
PREDISPOSES,ESR2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",ESR2 Malignant neoplasm of breast
AFFECTS,diindolylmethane,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,diindolylmethane Malignant neoplasm of breast
AFFECTS,S Phase Arrest,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",S Phase Arrest Malignant neoplasm of breast
CAUSES,MALAT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",MALAT1 Malignant neoplasm of breast
DISRUPTS,ASAP1|MYCBPAP,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,ASAP1|MYCBPAP Breast cancer metastatic
AUGMENTS,Gelsolin|GSN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Gelsolin|GSN Malignant neoplasm of breast
CAUSES,Primary Neoplasm,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Primary Neoplasm Breast cancer metastatic
AFFECTS,aurora kinase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",aurora kinase Malignant neoplasm of breast
PREDISPOSES,CRY1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,CRY1 Malignant neoplasm of breast
AFFECTS,CIP2A,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,CIP2A Breast Carcinoma
AUGMENTS,Berberine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Berberine Malignant neoplasm of breast
AFFECTS,Vimentin,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,Vimentin Breast cancer invasive NOS
AFFECTS,IL2-inducible T-cell kinase|ITK|SLC22A3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",IL2-inducible T-cell kinase|ITK|SLC22A3 Malignant neoplasm of breast
DISRUPTS,KIF11,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",KIF11 Malignant neoplasm of breast
DISRUPTS,ATG4B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ATG4B Malignant neoplasm of breast
AFFECTS,Chloroquine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Chloroquine Malignant neoplasm of breast
PREDISPOSES,TMEM88,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,TMEM88 Malignant neoplasm of breast
DISRUPTS,Cysteine,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,Cysteine Breast cancer metastatic
AFFECTS,CDKN1A|TCEAL1|NSG1|H3F3AP6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",CDKN1A|TCEAL1|NSG1|H3F3AP6 Malignant neoplasm of breast
PREDISPOSES,SFRP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",SFRP1 Malignant neoplasm of breast
PREDISPOSES,PFN1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,PFN1 Malignant neoplasm of breast
PREDISPOSES,Diphosphonates,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Diphosphonates Contralateral breast cancer
PREDISPOSES,Overweight,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Disease or Syndrome,Overweight Carcinoma of Male Breast
AFFECTS,Collagen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Collagen Malignant neoplasm of breast
AUGMENTS,PARK7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",PARK7 Malignant neoplasm of breast
PREDISPOSES,molybdenum disulfide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,molybdenum disulfide Malignant neoplasm of breast
AUGMENTS,OIP5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,OIP5 Malignant neoplasm of breast
PREDISPOSES,CHEST PATHOLOGY,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,CHEST PATHOLOGY Malignant neoplasm of breast
AFFECTS,oleocanthal,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,oleocanthal Malignant neoplasm of breast
AFFECTS,Neuromedin U|NMU,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Neuromedin U|NMU Malignant neoplasm of breast
AUGMENTS,Angiopoietin-2|ANGPT2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Angiopoietin-2|ANGPT2 Malignant neoplasm of breast
AFFECTS,DEAE-Dextran,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,DEAE-Dextran Malignant neoplasm of breast
DISRUPTS,Disaccharides,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Disaccharides Malignant neoplasm of breast
PREDISPOSES,LEPR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",LEPR Malignant neoplasm of breast
AUGMENTS,ESR2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",ESR2 Malignant neoplasm of breast
AFFECTS,docetaxel,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",docetaxel Breast cancer metastatic
PREDISPOSES,Reproductive History,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,"Element, Ion, or Isotope",Reproductive History Contralateral breast cancer
AUGMENTS,PIK3CA|PIK3CB|PIK3CD|PIK3CG,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",PIK3CA|PIK3CB|PIK3CD|PIK3CG Malignant neoplasm of breast
AFFECTS,dieckol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,dieckol Malignant neoplasm of breast
DISRUPTS,Lovastatin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Lovastatin Malignant neoplasm of breast
AFFECTS,Therapeutic Touch,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Therapeutic Touch Breast cancer metastatic
PREDISPOSES,Smoking Status,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Smoking Status Malignant neoplasm of breast
DISRUPTS,Phenformin,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Phenformin Breast cancer metastatic
AFFECTS,2-cyclopentyl-5-(5-isoquinolylsulfonyl)-6-nitro-1H-benzo(D)imidazole,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,2-cyclopentyl-5-(5-isoquinolylsulfonyl)-6-nitro-1H-benzo(D)imidazole Malignant neoplasm of breast
AFFECTS,Taxanes,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Taxanes Breast cancer metastatic
PREDISPOSES,teleocalcin,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",teleocalcin Breast cancer recurrent
AFFECTS,ligustilide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ligustilide Malignant neoplasm of breast
PREDISPOSES,TNFAIP8L3,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",TNFAIP8L3 Breast cancer metastatic
PREDISPOSES,LGR5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,LGR5 Malignant neoplasm of breast
AFFECTS,matrine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,matrine Malignant neoplasm of breast
AFFECTS,CCR7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,CCR7 Malignant neoplasm of breast
CAUSES,Glucuronosyltransferase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Glucuronosyltransferase Malignant neoplasm of breast
AUGMENTS,interleukin-17E,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",interleukin-17E Malignant neoplasm of breast
PREDISPOSES,MAGEA2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,MAGEA2 Malignant neoplasm of breast
DISRUPTS,Somatostatin Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Somatostatin Receptor Malignant neoplasm of breast
AUGMENTS,SLC9A3R1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,SLC9A3R1 Malignant neoplasm of breast
PREDISPOSES,RCCD1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,RCCD1 Malignant neoplasm of breast
DISRUPTS,NBAT1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",NBAT1 Breast cancer metastatic
AUGMENTS,Neuropilin-1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Neuropilin-1 Malignant neoplasm of breast
PREDISPOSES,"kallikrein 5, human",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,"kallikrein 5, human Malignant neoplasm of breast"
AFFECTS,Endothelin-1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Endothelin-1 Malignant neoplasm of breast
AFFECTS,Ethanol,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,Ethanol Breast cancer invasive NOS
AFFECTS,NSUN2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",NSUN2 Malignant neoplasm of breast
PREDISPOSES,Lysine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Lysine Malignant neoplasm of breast
AFFECTS,Cadherins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Cadherins Malignant neoplasm of breast
DISRUPTS,MTA3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,MTA3 Malignant neoplasm of breast
PREDISPOSES,Trichloroethylene,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Disease or Syndrome,Trichloroethylene Carcinoma of Male Breast
AFFECTS,Non-alcoholic fatty liver,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Non-alcoholic fatty liver Malignant neoplasm of breast
PREDISPOSES,Age at menarche,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Age at menarche Malignant neoplasm of breast
PREDISPOSES,Sleep behavior finding,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Sleep behavior finding Malignant neoplasm of breast
AFFECTS,NOD2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,NOD2 Malignant neoplasm of breast
AFFECTS,receptor,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Element, Ion, or Isotope",receptor Breast cancer invasive NOS
PREDISPOSES,GSTM3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,GSTM3 Malignant neoplasm of breast
PREDISPOSES,SIRT7,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",SIRT7 Breast cancer metastatic
CAUSES,Neoplasm,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,"Element, Ion, or Isotope",Neoplasm Female Breast Carcinoma
DISRUPTS,Aptamer,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Aptamer Breast cancer metastatic
PREDISPOSES,FABP4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",FABP4 Malignant neoplasm of breast
AUGMENTS,E2F7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,E2F7 Malignant neoplasm of breast
CAUSES,Hydroxyestrones,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Hydroxyestrones Malignant neoplasm of breast
AFFECTS,KRT5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,KRT5 Malignant neoplasm of breast
AUGMENTS,Isoprostanes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Isoprostanes Malignant neoplasm of breast
PREDISPOSES,Coffee intake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Coffee intake Malignant neoplasm of breast
AUGMENTS,Choline,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Choline Malignant neoplasm of breast
DISRUPTS,WWOX,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,WWOX Breast cancer metastatic
AUGMENTS,PPM1D,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,PPM1D Malignant neoplasm of breast
DISRUPTS,GATA4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,GATA4 Malignant neoplasm of breast
AFFECTS,everolimus,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",everolimus Breast cancer metastatic
DISRUPTS,decorin|DCN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,decorin|DCN Malignant neoplasm of breast
PREDISPOSES,Dessert,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Dessert Malignant neoplasm of breast
AUGMENTS,PHF5A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,PHF5A Malignant neoplasm of breast
PREDISPOSES,ITGA2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ITGA2 Malignant neoplasm of breast
AFFECTS,thymoquinone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,thymoquinone Malignant neoplasm of breast
AFFECTS,cucurbitacin B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,cucurbitacin B Malignant neoplasm of breast
AFFECTS,dronedarone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,dronedarone Malignant neoplasm of breast
AFFECTS,Menarche,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Menarche Breast Carcinoma
DISRUPTS,kaempferol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,kaempferol Malignant neoplasm of breast
PREDISPOSES,"Encounter due to prophylactic surgery, unspecified",Familial cancer of breast,0.0039960039960039,Female Breast Cancer,"Element, Ion, or Isotope","Encounter due to prophylactic surgery, unspecified Familial cancer of breast"
CAUSES,zileuton,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,zileuton Breast Carcinoma
AUGMENTS,APC,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,"Element, Ion, or Isotope",APC Inflammatory Breast Carcinoma
AUGMENTS,Stanolone,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Stanolone Breast Carcinoma
CAUSES,Loops,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Loops Malignant neoplasm of breast
DISRUPTS,Fibronectins,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Fibronectins Breast cancer metastatic
DISRUPTS,Ceramides,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Ceramides Malignant neoplasm of breast
AFFECTS,"Spectroscopy, Nuclear Magnetic Resonance",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Spectroscopy, Nuclear Magnetic Resonance Malignant neoplasm of breast"
PREDISPOSES,ANAPC15,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ANAPC15 Malignant neoplasm of breast
AFFECTS,lapatinib,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,lapatinib Malignant neoplasm of breast
PREDISPOSES,UGT1A6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,UGT1A6 Malignant neoplasm of breast
AUGMENTS,Integrins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Integrins Malignant neoplasm of breast
AFFECTS,Emodin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Emodin Malignant neoplasm of breast
AFFECTS,Raloxifene,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,Raloxifene Breast cancer invasive NOS
PREDISPOSES,Fasting,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Fasting Malignant neoplasm of breast
AFFECTS,TOB1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,TOB1 Malignant neoplasm of breast
PREDISPOSES,Fatty fish,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Fatty fish Malignant neoplasm of breast
PREDISPOSES,caveolin 1,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",caveolin 1 Breast cancer recurrent
DISRUPTS,Endopeptidases,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Endopeptidases Breast Carcinoma
AFFECTS,Osteoporosis,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Osteoporosis Breast Carcinoma
PREDISPOSES,Phenelzine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Phenelzine Malignant neoplasm of breast
PREDISPOSES,"Oral Contraceptives, Low-Dose",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Oral Contraceptives, Low-Dose Malignant neoplasm of breast"
PREDISPOSES,Nortriptyline,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Nortriptyline Malignant neoplasm of breast
PREDISPOSES,Overweight,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Overweight Breast cancer recurrent
PREDISPOSES,Diet,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Diet Breast Carcinoma
PREDISPOSES,Overoptimism,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Overoptimism Malignant neoplasm of breast
PREDISPOSES,Nonpuerperal mastitis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Nonpuerperal mastitis Malignant neoplasm of breast
PREDISPOSES,Behavioral change,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Behavioral change Malignant neoplasm of breast
PREDISPOSES,Smoking,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,"Element, Ion, or Isotope",Smoking Female Breast Carcinoma
PREDISPOSES,Alkaline Phosphatase,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Enzyme,Alkaline Phosphatase Breast cancer recurrent
PREDISPOSES,RFC1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,RFC1 Malignant neoplasm of breast
PREDISPOSES,Health-related behavior,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Health-related behavior Malignant neoplasm of breast
CAUSES,Androgen Receptor|AR,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",Androgen Receptor|AR Noninfiltrating Intraductal Carcinoma
DISRUPTS,phenylalanyl-glycyl-valyl-statyl-alanyl-phenylalanine methyl ester,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",phenylalanyl-glycyl-valyl-statyl-alanyl-phenylalanine methyl ester Breast cancer metastatic
AFFECTS,Gonadotropins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Gonadotropins Malignant neoplasm of breast
DISRUPTS,bexarotene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,bexarotene Malignant neoplasm of breast
AFFECTS,Diastasis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Diastasis Malignant neoplasm of breast
PREDISPOSES,Diabetes type,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Diabetes type Malignant neoplasm of breast
AFFECTS,Ataxia Telangiectasia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Ataxia Telangiectasia Malignant neoplasm of breast
PREDISPOSES,TMEM131L,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,TMEM131L Malignant neoplasm of breast
PREDISPOSES,16q12,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,16q12 Malignant neoplasm of breast
PREDISPOSES,Macrophage Colony-Stimulating Factor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Macrophage Colony-Stimulating Factor Malignant neoplasm of breast
PREDISPOSES,Goserelin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Goserelin Malignant neoplasm of breast
PREDISPOSES,Biotinidase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Biotinidase Malignant neoplasm of breast
PREDISPOSES,UBE2S,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,UBE2S Malignant neoplasm of breast
AFFECTS,Mastectomy,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Neoplastic Process,Mastectomy Noninfiltrating Intraductal Carcinoma
AFFECTS,Vincristine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Vincristine Malignant neoplasm of breast
PREDISPOSES,Dietary Supplements,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Dietary Supplements Malignant neoplasm of breast
AFFECTS,Valine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Valine Malignant neoplasm of breast
PREDISPOSES,Excessive weight gain,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Excessive weight gain Malignant neoplasm of breast
PREDISPOSES,Drinking pattern,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Drinking pattern Malignant neoplasm of breast
AFFECTS,Prunes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Prunes Malignant neoplasm of breast
AFFECTS,Cosmetic procedure,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Cosmetic procedure Malignant neoplasm of breast
AFFECTS,Autoimmune hypothyroidism,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Autoimmune hypothyroidism Malignant neoplasm of breast
PREDISPOSES,Alcoholic Beverages,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,"Element, Ion, or Isotope",Alcoholic Beverages Female Breast Carcinoma
PREDISPOSES,VASOMOTOR SYMPTOM,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,VASOMOTOR SYMPTOM Breast cancer invasive NOS
AUGMENTS,epigallocatechin gallate,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,epigallocatechin gallate Breast Carcinoma
AFFECTS,agonists,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,agonists Malignant neoplasm of breast
AFFECTS,tipifarnib,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,tipifarnib Malignant neoplasm of breast
AFFECTS,Activins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Activins Malignant neoplasm of breast
AFFECTS,MUC4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,MUC4 Malignant neoplasm of breast
CAUSES,PALB2,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,Gene or Genome,PALB2 Familial cancer of breast
AFFECTS,lapatinib,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",lapatinib Breast cancer metastatic
PREDISPOSES,Interleukin-8,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Interleukin-8 Malignant neoplasm of breast
CAUSES,trichostatin A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,trichostatin A Malignant neoplasm of breast
PREDISPOSES,KLK5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",KLK5 Malignant neoplasm of breast
PREDISPOSES,deceased,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,deceased Malignant neoplasm of breast
PREDISPOSES,cyclin-dependent kinase 2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",cyclin-dependent kinase 2 Malignant neoplasm of breast
PREDISPOSES,overdiagnosis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,overdiagnosis Malignant neoplasm of breast
AUGMENTS,NR5A2|P2RX5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,NR5A2|P2RX5 Malignant neoplasm of breast
PREDISPOSES,Diabetes Mellitus,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,"Element, Ion, or Isotope",Diabetes Mellitus Female Breast Carcinoma
PREDISPOSES,KRT20|C17orf97,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",KRT20|C17orf97 Malignant neoplasm of breast
DISRUPTS,zeaxanthin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,zeaxanthin Malignant neoplasm of breast
AUGMENTS,heparanase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,heparanase Malignant neoplasm of breast
CAUSES,CD40 Ligand|CD40LG,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",CD40 Ligand|CD40LG Malignant neoplasm of breast
CAUSES,interleukin-19,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",interleukin-19 Malignant neoplasm of breast
PREDISPOSES,Calgranulin A|S100A8,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Calgranulin A|S100A8 Breast cancer metastatic
AFFECTS,Physical therapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Physical therapy Malignant neoplasm of breast
PREDISPOSES,"Muscular Dystrophy, Facioscapulohumeral",bilateral breast cancer,0.0,Female Breast Cancer,"Element, Ion, or Isotope","Muscular Dystrophy, Facioscapulohumeral bilateral breast cancer"
PREDISPOSES,Instability,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Instability Malignant neoplasm of breast
AFFECTS,Diabetes Mellitus,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Diabetes Mellitus Malignant neoplasm of breast
AFFECTS,KIF2A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,KIF2A Malignant neoplasm of breast
AFFECTS,Apoptosis,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Apoptosis Breast Carcinoma
PREDISPOSES,AKR1C4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,AKR1C4 Malignant neoplasm of breast
CAUSES,ABCC10,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ABCC10 Malignant neoplasm of breast
PREDISPOSES,CCDC91,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,CCDC91 Malignant neoplasm of breast
AFFECTS,MT1A|MT1B|MT1E|MT1F|MT1G|MT1H|MT1JP|MT1M|MT1L|MT1X|MTNR1A|ALG1|MT1IP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,MT1A|MT1B|MT1E|MT1F|MT1G|MT1H|MT1JP|MT1M|MT1L|MT1X|MTNR1A|ALG1|MT1IP Malignant neoplasm of breast
AFFECTS,psychological distress,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,psychological distress Malignant neoplasm of breast
PREDISPOSES,PALB2,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,"Element, Ion, or Isotope",PALB2 Female Breast Carcinoma
PREDISPOSES,Insulin,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Element, Ion, or Isotope",Insulin Breast cancer invasive NOS
CAUSES,Alcohol products,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Alcohol products Malignant neoplasm of breast
PREDISPOSES,Mammography abnormal,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Mammography abnormal Malignant neoplasm of breast
PREDISPOSES,Copper,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Copper Malignant neoplasm of breast
AFFECTS,germin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,germin Malignant neoplasm of breast
PREDISPOSES,Smoking,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Neoplastic Process,Smoking Inflammatory Breast Carcinoma
AUGMENTS,Hyaluronan,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Hyaluronan Malignant neoplasm of breast
PREDISPOSES,diindolylmethane,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,diindolylmethane Malignant neoplasm of breast
PREDISPOSES,Sleeplessness,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Sleeplessness Malignant neoplasm of breast
AUGMENTS,Soluble ErbB-1|EGFR,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,"Element, Ion, or Isotope",Soluble ErbB-1|EGFR Inflammatory Breast Carcinoma
AFFECTS,Silence,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Silence Malignant neoplasm of breast
PREDISPOSES,PELP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,PELP1 Malignant neoplasm of breast
AFFECTS,Fertility care,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Fertility care Malignant neoplasm of breast
AFFECTS,Urokinase,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Urokinase Breast cancer metastatic
PREDISPOSES,Rye flour,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Rye flour Malignant neoplasm of breast
AUGMENTS,Clusterin|CLU,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Clusterin|CLU Malignant neoplasm of breast
PREDISPOSES,regular physical activity,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Element, Ion, or Isotope",regular physical activity Breast cancer recurrent
AFFECTS,Mitotic/Spindle Checkpoint,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Mitotic/Spindle Checkpoint Malignant neoplasm of breast
DISRUPTS,claudin 6,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,claudin 6 Breast Carcinoma
AUGMENTS,NEK2,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,"Element, Ion, or Isotope","NEK2 Carcinoma, Ductal, Breast"
PREDISPOSES,Somatotropin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Somatotropin Malignant neoplasm of breast
PREDISPOSES,Glutamate-Cysteine Ligase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Glutamate-Cysteine Ligase Malignant neoplasm of breast
PREDISPOSES,PERP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,PERP Malignant neoplasm of breast
AFFECTS,Mammaplasty,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Element, Ion, or Isotope",Mammaplasty Breast cancer recurrent
PREDISPOSES,Mammographic breast density,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Mammographic breast density Breast cancer invasive NOS
AFFECTS,Autoimmunity,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Autoimmunity Malignant neoplasm of breast
AFFECTS,Sunlight,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Sunlight Malignant neoplasm of breast
AFFECTS,PARD6A|PWAR6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,PARD6A|PWAR6 Malignant neoplasm of breast
AFFECTS,cardanol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,cardanol Malignant neoplasm of breast
AUGMENTS,None|SLC16A3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",None|SLC16A3 Malignant neoplasm of breast
AFFECTS,Corn Oil,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Corn Oil Malignant neoplasm of breast
AUGMENTS,Zinc,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,"Element, Ion, or Isotope","Zinc Carcinoma, Ductal, Breast"
AUGMENTS,UCA1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,UCA1 Malignant neoplasm of breast
AFFECTS,Non-Viral Vector,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Non-Viral Vector Malignant neoplasm of breast
AFFECTS,aglepristone,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,aglepristone Breast Carcinoma
AFFECTS,White bread,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,White bread Malignant neoplasm of breast
PREDISPOSES,Disability NOS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Disability NOS Malignant neoplasm of breast
DISRUPTS,"Calcium, Dietary",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Calcium, Dietary Malignant neoplasm of breast"
PREDISPOSES,Interleukin-18,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Interleukin-18 Breast Carcinoma
PREDISPOSES,chemokine receptor,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",chemokine receptor Breast cancer metastatic
AUGMENTS,Integrin alphaV,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Integrin alphaV Malignant neoplasm of breast
AFFECTS,PROX1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,PROX1 Breast cancer metastatic
AUGMENTS,Dioxins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Dioxins Malignant neoplasm of breast
AFFECTS,cisplatin/cyclophosphamide/etoposide protocol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,cisplatin/cyclophosphamide/etoposide protocol Malignant neoplasm of breast
DISRUPTS,PINX1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",PINX1 Breast cancer metastatic
AFFECTS,BST2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,BST2 Malignant neoplasm of breast
DISRUPTS,Ethanol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Ethanol Malignant neoplasm of breast
DISRUPTS,Tryptophan,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Tryptophan Malignant neoplasm of breast
AFFECTS,Baresthesia,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Baresthesia Breast cancer metastatic
PREDISPOSES,Taurine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Taurine Malignant neoplasm of breast
CAUSES,LPO,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,LPO Malignant neoplasm of breast
PREDISPOSES,Amphiregulin|AREG,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Amphiregulin|AREG Malignant neoplasm of breast
AFFECTS,RPS6KA1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,RPS6KA1 Malignant neoplasm of breast
PREDISPOSES,Peroxisome Proliferator-Activated Receptors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Peroxisome Proliferator-Activated Receptors Malignant neoplasm of breast
PREDISPOSES,Vimentin|VIM,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Vimentin|VIM Malignant neoplasm of breast
PREDISPOSES,GAS5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",GAS5 Malignant neoplasm of breast
AFFECTS,COPS5,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Neoplastic Process,COPS5 Noninfiltrating Intraductal Carcinoma
CAUSES,ZNF350,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ZNF350 Malignant neoplasm of breast
PREDISPOSES,Air Pollutants,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Air Pollutants Malignant neoplasm of breast
PREDISPOSES,"Hyperostosis, Diffuse Idiopathic Skeletal",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,"Hyperostosis, Diffuse Idiopathic Skeletal Malignant neoplasm of breast"
DISRUPTS,celecoxib,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,celecoxib Malignant neoplasm of breast
PREDISPOSES,CD151,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",CD151 Breast cancer metastatic
PREDISPOSES,Fenretinide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Fenretinide Malignant neoplasm of breast
AFFECTS,Immunomodulators,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Immunomodulators Malignant neoplasm of breast
PREDISPOSES,ADA,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,ADA Breast Carcinoma
PREDISPOSES,HADHA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,HADHA Malignant neoplasm of breast
PREDISPOSES,N-acetyltransferase 1|EREG|ESR1,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,"Element, Ion, or Isotope",N-acetyltransferase 1|EREG|ESR1 Carcinoma of Male Breast
AFFECTS,Antiplatelet therapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Antiplatelet therapy Malignant neoplasm of breast
AFFECTS,TIMELESS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,TIMELESS Malignant neoplasm of breast
PREDISPOSES,Annexin A2|ANXA2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Annexin A2|ANXA2 Malignant neoplasm of breast
PREDISPOSES,Work stress,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Work stress Malignant neoplasm of breast
PREDISPOSES,RHBDD1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,RHBDD1 Malignant neoplasm of breast
AFFECTS,Heparan Sulfate Proteoglycan|HSPG2|SDC2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Heparan Sulfate Proteoglycan|HSPG2|SDC2 Malignant neoplasm of breast
CAUSES,LAMTOR5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,LAMTOR5 Malignant neoplasm of breast
AFFECTS,MALAT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",MALAT1 Malignant neoplasm of breast
AUGMENTS,PGD,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,PGD Malignant neoplasm of breast
COMPLICATES,"Diabetes Mellitus, Non-Insulin-Dependent",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Diabetes Mellitus, Non-Insulin-Dependent Malignant neoplasm of breast"
PREDISPOSES,Liver Cirrhosis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Liver Cirrhosis Malignant neoplasm of breast
AFFECTS,Brain Neoplasms,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Brain Neoplasms Malignant neoplasm of breast
PREDISPOSES,Oranges,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Oranges Malignant neoplasm of breast
PREDISPOSES,Edema,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Neoplastic Process,Edema Inflammatory Breast Carcinoma
PREDISPOSES,SESTAMIBI,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,SESTAMIBI Malignant neoplasm of breast
DISRUPTS,Aspirin,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Aspirin Breast cancer metastatic
AFFECTS,Lamins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Lamins Malignant neoplasm of breast
PREDISPOSES,Body mass index,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Element, Ion, or Isotope",Body mass index Breast cancer invasive NOS
DISRUPTS,LINC00518,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,LINC00518 Malignant neoplasm of breast
AUGMENTS,DDT,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",DDT Malignant neoplasm of breast
PREDISPOSES,Overweight,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,Overweight Breast cancer invasive NOS
PREDISPOSES,thrombospondin 4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,thrombospondin 4 Malignant neoplasm of breast
AFFECTS,Histone Deacetylase Inhibitor,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Histone Deacetylase Inhibitor Breast cancer metastatic
DISRUPTS,AQP3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",AQP3 Malignant neoplasm of breast
DISRUPTS,ranolazine,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",ranolazine Breast cancer metastatic
AFFECTS,KIF4A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",KIF4A Malignant neoplasm of breast
DISRUPTS,exemestane,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,exemestane Malignant neoplasm of breast
AFFECTS,Repeat Surgery,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",Repeat Surgery Noninfiltrating Intraductal Carcinoma
PREDISPOSES,PIP5K1C,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Neoplastic Process,"PIP5K1C Carcinoma, Ductal, Breast"
AFFECTS,Luteolin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Luteolin Malignant neoplasm of breast
AFFECTS,SOCS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,SOCS1 Malignant neoplasm of breast
DISRUPTS,AQP5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,AQP5 Malignant neoplasm of breast
PREDISPOSES,ENPP2|SMG1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ENPP2|SMG1 Malignant neoplasm of breast
AUGMENTS,FTO,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",FTO Malignant neoplasm of breast
PREDISPOSES,PDLIM2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,PDLIM2 Malignant neoplasm of breast
AFFECTS,Supportive care,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,Supportive care Breast cancer metastatic
DISRUPTS,RBMS3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",RBMS3 Malignant neoplasm of breast
DISRUPTS,VIPR1,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",VIPR1 Breast Carcinoma
DISRUPTS,triptolide,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",triptolide Breast cancer metastatic
AFFECTS,targeting,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Neoplastic Process,"targeting Carcinoma, Ductal, Breast"
DISRUPTS,Metformin,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Metformin Breast cancer metastatic
PREDISPOSES,Phosphorus,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Phosphorus Malignant neoplasm of breast
PREDISPOSES,Rosacea,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Rosacea Malignant neoplasm of breast
AUGMENTS,PUF60,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,PUF60 Malignant neoplasm of breast
AFFECTS,YAP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",YAP1 Malignant neoplasm of breast
AFFECTS,"1,2-dilinolenoyl-3-(4-aminobutyryl)propane-1,2,3-triol",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,"1,2-dilinolenoyl-3-(4-aminobutyryl)propane-1,2,3-triol Malignant neoplasm of breast"
DISRUPTS,oncostatin M|OSM,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,oncostatin M|OSM Malignant neoplasm of breast
AFFECTS,Dexamethasone,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Dexamethasone Breast cancer metastatic
PREDISPOSES,Phthalimides,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Phthalimides Malignant neoplasm of breast
DISRUPTS,HDAC9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,HDAC9 Malignant neoplasm of breast
AFFECTS,VIM,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,VIM Malignant neoplasm of breast
PREDISPOSES,CISH,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,CISH Breast cancer invasive NOS
AFFECTS,Honey bee venom,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Honey bee venom Breast Carcinoma
AFFECTS,C-Phycocyanin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,C-Phycocyanin Malignant neoplasm of breast
AUGMENTS,NEAT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",NEAT1 Malignant neoplasm of breast
AFFECTS,ATP-Binding Cassette Transporters|ATP8A2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",ATP-Binding Cassette Transporters|ATP8A2 Malignant neoplasm of breast
PREDISPOSES,SNHG1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",SNHG1 Malignant neoplasm of breast
AFFECTS,Anaplasia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Anaplasia Malignant neoplasm of breast
PREDISPOSES,ABCA1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ABCA1 Malignant neoplasm of breast
CAUSES,Cytochrome P-450 CYP1A1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Cytochrome P-450 CYP1A1 Malignant neoplasm of breast
PREDISPOSES,Hyperglycemia,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Hyperglycemia Breast cancer recurrent
PREDISPOSES,MDM4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",MDM4 Malignant neoplasm of breast
PREDISPOSES,E-Cadherin|CDH1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",E-Cadherin|CDH1 Malignant neoplasm of breast
AFFECTS,Pollutant,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Pollutant Malignant neoplasm of breast
AFFECTS,Chinese herbal medicine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Chinese herbal medicine Malignant neoplasm of breast
PREDISPOSES,TIMM13,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,TIMM13 Malignant neoplasm of breast
DISRUPTS,Cyclin-Dependent Kinase Inhibitor 2A|CDK4,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",Cyclin-Dependent Kinase Inhibitor 2A|CDK4 Noninfiltrating Intraductal Carcinoma
AFFECTS,silybin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,silybin Malignant neoplasm of breast
AUGMENTS,PCB 138,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,PCB 138 Malignant neoplasm of breast
PREDISPOSES,CYP2C8,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",CYP2C8 Malignant neoplasm of breast
AFFECTS,Phenols,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Phenols Malignant neoplasm of breast
AFFECTS,TRIM44,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,TRIM44 Malignant neoplasm of breast
DISRUPTS,Quinoxalines,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Quinoxalines Malignant neoplasm of breast
PREDISPOSES,PXDNL,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,PXDNL Malignant neoplasm of breast
AFFECTS,TUFT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",TUFT1 Malignant neoplasm of breast
AFFECTS,Silence,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Silence Breast cancer metastatic
AFFECTS,Premenopause,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Neoplastic Process,Premenopause Noninfiltrating Intraductal Carcinoma
PREDISPOSES,PTP4A3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",PTP4A3 Malignant neoplasm of breast
PREDISPOSES,CDK12,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",CDK12 Malignant neoplasm of breast
PREDISPOSES,JPH1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,JPH1 Malignant neoplasm of breast
PREDISPOSES,UBE2V1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",UBE2V1 Breast cancer metastatic
AFFECTS,Chalcone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Chalcone Malignant neoplasm of breast
AFFECTS,everolimus,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Neoplastic Process,everolimus Noninfiltrating Intraductal Carcinoma
CAUSES,ethylene oxide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ethylene oxide Malignant neoplasm of breast
AFFECTS,FAM53A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,FAM53A Malignant neoplasm of breast
AFFECTS,Microbicides,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Microbicides Malignant neoplasm of breast
AUGMENTS,paclitaxel,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",paclitaxel Triple Negative Breast Neoplasms
PREDISPOSES,HULC,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,HULC Malignant neoplasm of breast
AFFECTS,silence,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",silence Triple Negative Breast Neoplasms
PREDISPOSES,Promoter,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Promoter Malignant neoplasm of breast
PREDISPOSES,"nuclear receptor subfamily 1, group H, member 2",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","nuclear receptor subfamily 1, group H, member 2 Malignant neoplasm of breast"
DISRUPTS,MIR30A wt Allele,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",MIR30A wt Allele Malignant neoplasm of breast
PREDISPOSES,ABCB1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",ABCB1 Malignant neoplasm of breast
DISRUPTS,ibrutinib,Carcinoma breast stage IV,0.0,Female Breast Cancer,"Element, Ion, or Isotope",ibrutinib Carcinoma breast stage IV
AUGMENTS,Ubiquitin,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Hazardous or Poisonous Substance,Ubiquitin Triple Negative Breast Neoplasms
CAUSES,Copy Number Polymorphism,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Copy Number Polymorphism Triple Negative Breast Neoplasms
DISRUPTS,"Antibodies, Blocking",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,"Antibodies, Blocking Malignant neoplasm of breast"
PREDISPOSES,TT genotype,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",TT genotype Triple Negative Breast Neoplasms
PREDISPOSES,29+,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Neoplastic Process,29+ Invasive carcinoma of breast
AFFECTS,Polyunsaturated fat,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Polyunsaturated fat Malignant neoplasm of breast
AFFECTS,Patient Derived Xenograft,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Patient Derived Xenograft Triple Negative Breast Neoplasms
AFFECTS,olaparib,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",olaparib Triple Negative Breast Neoplasms
AFFECTS,Contrast enhanced spectral mammography,malignant neoplasm of breast staging,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Contrast enhanced spectral mammography malignant neoplasm of breast staging
CAUSES,SFN,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",SFN Noninfiltrating Intraductal Carcinoma
AUGMENTS,Transcriptome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Transcriptome Malignant neoplasm of breast
DISRUPTS,Macrolides,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Macrolides Malignant neoplasm of breast
PREDISPOSES,Rheumatoid Arthritis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Rheumatoid Arthritis Malignant neoplasm of breast
AFFECTS,fiber,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",fiber Malignant neoplasm of breast
PREDISPOSES,CD44,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,"Element, Ion, or Isotope",CD44 Inflammatory Breast Carcinoma
PREDISPOSES,Iodides,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Iodides Malignant neoplasm of breast
AUGMENTS,prolactin,Triple-Negative Breast Carcinoma,0.0,Female Breast Cancer,Neoplastic Process,prolactin Triple-Negative Breast Carcinoma
AFFECTS,subharmonic imaging,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",subharmonic imaging Breast Carcinoma
DISRUPTS,OSW 1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",OSW 1 Triple Negative Breast Neoplasms
AFFECTS,Second line treatment,Carcinoma breast stage IV,0.0,Female Breast Cancer,Neoplastic Process,Second line treatment Carcinoma breast stage IV
AUGMENTS,Suppressor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Suppressor Malignant neoplasm of breast
AUGMENTS,methanol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,methanol Malignant neoplasm of breast
PREDISPOSES,FOSB,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",FOSB Triple Negative Breast Neoplasms
PREDISPOSES,Postmenopausal state,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Postmenopausal state Malignant neoplasm of breast
PREDISPOSES,Procedure findings:Finding:Point in time:^Patient:Narrative,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Procedure findings:Finding:Point in time:^Patient:Narrative Triple Negative Breast Neoplasms
PREDISPOSES,risk factors,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",risk factors Invasive carcinoma of breast
PREDISPOSES,Cadherins,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Neoplastic Process,Cadherins Noninfiltrating Intraductal Carcinoma
AFFECTS,Magnetic resonance imaging of breast,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Magnetic resonance imaging of breast Malignant neoplasm of breast
PREDISPOSES,Flavanol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Flavanol Malignant neoplasm of breast
PREDISPOSES,Epigallocatechin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Epigallocatechin Malignant neoplasm of breast
PREDISPOSES,apigenin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,apigenin Malignant neoplasm of breast
PREDISPOSES,AGR2,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,"Amino Acid, Peptide, or Protein",AGR2 estrogen receptor-positive breast cancer
PREDISPOSES,Epicatechin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Epicatechin Malignant neoplasm of breast
PREDISPOSES,P-Cadherin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,P-Cadherin Malignant neoplasm of breast
PREDISPOSES,Easy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Easy Malignant neoplasm of breast
CAUSES,CTBP1-AS2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",CTBP1-AS2 Malignant neoplasm of breast
AFFECTS,silence,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,silence Malignant neoplasm of breast
PREDISPOSES,Caffeinated coffee,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Caffeinated coffee Malignant neoplasm of breast
PREDISPOSES,5-methyltetrahydrofolate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,5-methyltetrahydrofolate Malignant neoplasm of breast
PREDISPOSES,Hypertrophy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Hypertrophy Malignant neoplasm of breast
DISRUPTS,lapatinib,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",lapatinib HER2-positive carcinoma of breast
CAUSES,rucaparib,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",rucaparib Triple Negative Breast Neoplasms
AFFECTS,cisplatin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,cisplatin Malignant neoplasm of breast
AFFECTS,Kynurenine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Kynurenine Malignant neoplasm of breast
CAUSES,mTOR Inhibitor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",mTOR Inhibitor Malignant neoplasm of breast
PREDISPOSES,Biological Markers,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,"Element, Ion, or Isotope",Biological Markers Female Breast Carcinoma
PREDISPOSES,Crown-Like Structures of the Breast,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",Crown-Like Structures of the Breast Invasive carcinoma of breast
CAUSES,NMU,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",NMU Malignant neoplasm of breast
DISRUPTS,xanthomicrol,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",xanthomicrol Triple Negative Breast Neoplasms
PREDISPOSES,Crown-Like Structures of the Breast,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Crown-Like Structures of the Breast Malignant neoplasm of breast
PREDISPOSES,"Receptors, Adrenergic, beta-1|ADRB1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Receptors, Adrenergic, beta-1|ADRB1 Malignant neoplasm of breast"
AFFECTS,polyphenols,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",polyphenols HER2-positive carcinoma of breast
AFFECTS,rasagiline,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,rasagiline Malignant neoplasm of breast
DISRUPTS,cisplatin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,cisplatin Malignant neoplasm of breast
CAUSES,Neutrons,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Neutrons Breast Carcinoma
PREDISPOSES,Dietary Alcohol,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",Dietary Alcohol Invasive carcinoma of breast
PREDISPOSES,mannose receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,mannose receptor Malignant neoplasm of breast
AFFECTS,gemcitabine,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",gemcitabine Triple Negative Breast Neoplasms
COMPLICATES,Obesity,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Obesity Malignant neoplasm of breast
AFFECTS,Pulmonary Metastasectomy,Carcinoma breast stage IV,0.0,Female Breast Cancer,Gene or Genome,Pulmonary Metastasectomy Carcinoma breast stage IV
PREDISPOSES,ATM,Hereditary Breast and Ovarian Cancer Syndrome,0.0,Female Breast Cancer,Neoplastic Process,ATM Hereditary Breast and Ovarian Cancer Syndrome
AFFECTS,Neoplasms by Site,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Neoplasms by Site Triple Negative Breast Neoplasms
AFFECTS,Systemic Therapy,Locally advanced breast cancer,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Systemic Therapy Locally advanced breast cancer
AFFECTS,honokiol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,honokiol Malignant neoplasm of breast
PREDISPOSES,Low BMI,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Low BMI Malignant neoplasm of breast
PREDISPOSES,ethanol,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,ethanol Breast Carcinoma
CAUSES,pembrolizumab,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,pembrolizumab Malignant neoplasm of breast
AFFECTS,CHAF1A wt Allele|KAT2B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",CHAF1A wt Allele|KAT2B Malignant neoplasm of breast
PREDISPOSES,High birth weight,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",High birth weight Malignant neoplasm of breast
PREDISPOSES,Mean score,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",Mean score Invasive carcinoma of breast
AUGMENTS,water channel,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",water channel Malignant neoplasm of breast
AFFECTS,vinorelbine,Carcinoma breast stage IV,0.0,Female Breast Cancer,"Element, Ion, or Isotope",vinorelbine Carcinoma breast stage IV
CAUSES,Cytochrome P450|CYP2B6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Cytochrome P450|CYP2B6 Malignant neoplasm of breast
PREDISPOSES,DEGS1 wt Allele|DEGS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",DEGS1 wt Allele|DEGS1 Malignant neoplasm of breast
PREDISPOSES,Atypical hyperplasia,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Atypical hyperplasia Breast Carcinoma
AFFECTS,Second line treatment,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Neoplastic Process,Second line treatment HER2-positive carcinoma of breast
PREDISPOSES,Biological Markers,malignant neoplasm of breast staging,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Biological Markers malignant neoplasm of breast staging
CAUSES,Reactive Nitrogen Species,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Reactive Nitrogen Species Malignant neoplasm of breast
AUGMENTS,Programmed cell death ligand 1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Programmed cell death ligand 1 Triple Negative Breast Neoplasms
DISRUPTS,MIR506 wt Allele,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",MIR506 wt Allele Triple Negative Breast Neoplasms
DISRUPTS,NF-kappa B,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",NF-kappa B Triple Negative Breast Neoplasms
AFFECTS,bisphenol A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,bisphenol A Malignant neoplasm of breast
AFFECTS,lutein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,lutein Malignant neoplasm of breast
CAUSES,voacamine,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,voacamine Breast Carcinoma
AFFECTS,directive therapy,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",directive therapy Noninfiltrating Intraductal Carcinoma
AFFECTS,"3,3'-diindolylmethane",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,"3,3'-diindolylmethane Malignant neoplasm of breast"
DISRUPTS,Interferon-alpha,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Interferon-alpha Triple Negative Breast Neoplasms
AFFECTS,Biological Response Modifiers,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Virus,Biological Response Modifiers estrogen receptor-positive breast cancer
PREDISPOSES,Imbalance,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Imbalance Malignant neoplasm of breast
AUGMENTS,Chlorpyrifos,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Chlorpyrifos Malignant neoplasm of breast
AFFECTS,Treatment Protocols,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",Treatment Protocols estrogen receptor-positive breast cancer
DISRUPTS,Androgen Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Androgen Receptor Malignant neoplasm of breast
AFFECTS,Xenobiotics,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Xenobiotics Malignant neoplasm of breast
PREDISPOSES,Interstitial Collagenase,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Interstitial Collagenase Breast Carcinoma
PREDISPOSES,Proton Pump Inhibitors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Proton Pump Inhibitors Malignant neoplasm of breast
PREDISPOSES,Increased prolactin level,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",Increased prolactin level Invasive carcinoma of breast
AFFECTS,PET/CT scan,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",PET/CT scan Malignant neoplasm of breast
AUGMENTS,UBA5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,UBA5 Malignant neoplasm of breast
AUGMENTS,DEAD Box Helicase p68|DDX5|KHDRBS1|POLD3|GATAD2B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",DEAD Box Helicase p68|DDX5|KHDRBS1|POLD3|GATAD2B Malignant neoplasm of breast
AUGMENTS,rutecarpine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,rutecarpine Malignant neoplasm of breast
CAUSES,bruceine D,Carcinoma breast stage IV,0.0,Female Breast Cancer,"Element, Ion, or Isotope",bruceine D Carcinoma breast stage IV
PREDISPOSES,ovary; insufficiency,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",ovary; insufficiency Malignant neoplasm of breast
DISRUPTS,ZBTB7A|AKIRIN2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ZBTB7A|AKIRIN2 Malignant neoplasm of breast
DISRUPTS,Hydroxymethylglutaryl-CoA Reductase Inhibitors,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Hydroxymethylglutaryl-CoA Reductase Inhibitors Triple Negative Breast Neoplasms
AUGMENTS,MCM3AP-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",MCM3AP-AS1 Malignant neoplasm of breast
AFFECTS,Metronomic Chemotherapy,Carcinoma breast stage IV,0.0,Female Breast Cancer,Gene or Genome,Metronomic Chemotherapy Carcinoma breast stage IV
DISRUPTS,kinase inhibitor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",kinase inhibitor Malignant neoplasm of breast
CAUSES,Adriamycin,Carcinoma breast stage IV,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Adriamycin Carcinoma breast stage IV
AFFECTS,Mammaplasty,Stage 0 Breast Carcinoma,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Mammaplasty Stage 0 Breast Carcinoma
DISRUPTS,aspirin,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Neoplastic Process,aspirin Secondary malignant neoplasm of breast
AFFECTS,oleyloxyethylphosphorylcholine,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,oleyloxyethylphosphorylcholine Breast Carcinoma
PREDISPOSES,Overdiagnosis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Overdiagnosis Malignant neoplasm of breast
DISRUPTS,erbB-2 Receptor|ERBB2,Recurrent Breast Carcinoma,0.0009990009990009,Recurrent Breast Cancer,"Element, Ion, or Isotope",erbB-2 Receptor|ERBB2 Recurrent Breast Carcinoma
PREDISPOSES,"leptin receptor, human|LEPR",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Virus,"leptin receptor, human|LEPR Malignant neoplasm of breast"
AFFECTS,FGFR4,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",FGFR4 Triple Negative Breast Neoplasms
AFFECTS,atezolizumab,Locally advanced breast cancer,0.0,Female Breast Cancer,"Element, Ion, or Isotope",atezolizumab Locally advanced breast cancer
PREDISPOSES,Parity,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Parity Malignant neoplasm of breast
DISRUPTS,limonin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,limonin Malignant neoplasm of breast
AFFECTS,Ultrasound Tomography,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Ultrasound Tomography Breast Carcinoma
PREDISPOSES,Parallel,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Parallel Malignant neoplasm of breast
PREDISPOSES,ergocalciferol,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Neoplastic Process,ergocalciferol Invasive carcinoma of breast
COMPLICATES,Lymphedema,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Lymphedema Malignant neoplasm of breast
AUGMENTS,interleukin-21,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",interleukin-21 Malignant neoplasm of breast
PREDISPOSES,Low health literacy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Low health literacy Malignant neoplasm of breast
DISRUPTS,genistein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,genistein Malignant neoplasm of breast
AFFECTS,TIMM8A,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Immunologic Factor,TIMM8A Triple Negative Breast Neoplasms
PREDISPOSES,Free triiodothyronine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Free triiodothyronine Malignant neoplasm of breast
AFFECTS,Targeted Therapy,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Targeted Therapy Triple Negative Breast Neoplasms
PREDISPOSES,Male fertility,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Male fertility Malignant neoplasm of breast
AFFECTS,Uptake,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",Uptake Invasive carcinoma of breast
DISRUPTS,exenatide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,exenatide Malignant neoplasm of breast
PREDISPOSES,"Mortality, Premature",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Mortality, Premature Malignant neoplasm of breast"
CAUSES,"Receptor, PAR-1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,"Receptor, PAR-1 Malignant neoplasm of breast"
PREDISPOSES,asparaginylendopeptidase,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Neoplastic Process,asparaginylendopeptidase Secondary malignant neoplasm of breast
PREDISPOSES,CD44,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,"Element, Ion, or Isotope",CD44 Secondary malignant neoplasm of breast
AFFECTS,prolactin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,prolactin Malignant neoplasm of breast
PREDISPOSES,Asbestos,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Asbestos Malignant neoplasm of breast
PREDISPOSES,somatostatin receptor 1|SSTR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,somatostatin receptor 1|SSTR1 Malignant neoplasm of breast
DISRUPTS,TIMM8A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",TIMM8A Malignant neoplasm of breast
PREDISPOSES,Blood group AB,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,"Element, Ion, or Isotope",Blood group AB Carcinoma of Male Breast
PREDISPOSES,Cooking Practices,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Cooking Practices Malignant neoplasm of breast
PREDISPOSES,Mean score,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Mean score Malignant neoplasm of breast
PREDISPOSES,Dysbiosis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Dysbiosis Malignant neoplasm of breast
AFFECTS,Alkaloids,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Immunologic Factor,Alkaloids Triple Negative Breast Neoplasms
PREDISPOSES,Chemokine CXCL12,Carcinoma breast stage IV,0.0,Female Breast Cancer,Gene or Genome,Chemokine CXCL12 Carcinoma breast stage IV
PREDISPOSES,Oral intake,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Virus,Oral intake estrogen receptor-positive breast cancer
PREDISPOSES,AMACR wt Allele,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",AMACR wt Allele Malignant neoplasm of breast
PREDISPOSES,calreticulin,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,calreticulin Breast Carcinoma
PREDISPOSES,NU 7441,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Immunologic Factor,NU 7441 Triple Negative Breast Neoplasms
PREDISPOSES,Prognostic Factors,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,"Element, Ion, or Isotope",Prognostic Factors Secondary malignant neoplasm of breast
AUGMENTS,Purinoceptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Purinoceptor Malignant neoplasm of breast
DISRUPTS,sorafenib,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,sorafenib Malignant neoplasm of breast
CAUSES,trichloroethylene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,trichloroethylene Malignant neoplasm of breast
DISRUPTS,nesiritide|NPPB,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,nesiritide|NPPB Breast Carcinoma
PREDISPOSES,isoleucylvaline,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,isoleucylvaline Malignant neoplasm of breast
AFFECTS,Histone Demethylases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Histone Demethylases Malignant neoplasm of breast
AFFECTS,Therapeutic procedure,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Therapeutic procedure Triple Negative Breast Neoplasms
AFFECTS,maintenance of pluripotency,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",maintenance of pluripotency Malignant neoplasm of breast
DISRUPTS,MIR382 wt Allele,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",MIR382 wt Allele Malignant neoplasm of breast
CAUSES,trichostatin A,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",trichostatin A Triple Negative Breast Neoplasms
AFFECTS,selenium,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,selenium Malignant neoplasm of breast
AFFECTS,Flash,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Flash Malignant neoplasm of breast
AFFECTS,Autophagy,Carcinoma breast stage IV,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Autophagy Carcinoma breast stage IV
DISRUPTS,sauchinone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,sauchinone Malignant neoplasm of breast
AFFECTS,"interleukin-1, beta",Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,"Element, Ion, or Isotope","interleukin-1, beta Inflammatory Breast Carcinoma"
PREDISPOSES,Prolactin Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Prolactin Receptor Malignant neoplasm of breast
PREDISPOSES,interleukin-6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",interleukin-6 Malignant neoplasm of breast
DISRUPTS,parecoxib sodium,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",parecoxib sodium HER2-positive carcinoma of breast
PREDISPOSES,Vigorous physical activity,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Vigorous physical activity Malignant neoplasm of breast
PREDISPOSES,Biomodulin T,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Biomodulin T Breast Carcinoma
PREDISPOSES,Vigorous physical activity,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Virus,Vigorous physical activity estrogen receptor-positive breast cancer
AFFECTS,Ocular Cicatricial Pemphigoid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Ocular Cicatricial Pemphigoid Malignant neoplasm of breast
DISRUPTS,Chalcone,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Chalcone Breast Carcinoma
AFFECTS,Psychosocial procedure,Early-Stage Breast Carcinoma,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Psychosocial procedure Early-Stage Breast Carcinoma
DISRUPTS,hydrochloride,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",hydrochloride Triple Negative Breast Neoplasms
AFFECTS,Neoadjuvant Systemic Therapy,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",Neoadjuvant Systemic Therapy Noninfiltrating Intraductal Carcinoma
PREDISPOSES,Anthropometric Measures:-:Point in time:^Patient:-,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Anthropometric Measures:-:Point in time:^Patient:- Malignant neoplasm of breast
CAUSES,triclosan,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,triclosan Malignant neoplasm of breast
PREDISPOSES,Luteolin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Luteolin Malignant neoplasm of breast
AFFECTS,sirolimus,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",sirolimus Invasive carcinoma of breast
AFFECTS,Adrenergic beta-Antagonists,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Adrenergic beta-Antagonists Malignant neoplasm of breast
AFFECTS,morusin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,morusin Malignant neoplasm of breast
DISRUPTS,quinacrine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,quinacrine Malignant neoplasm of breast
AFFECTS,polyphenols,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",polyphenols Triple Negative Breast Neoplasms
PREDISPOSES,Challenge:Type:Point in time:^Patient:Nominal,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Challenge:Type:Point in time:^Patient:Nominal Malignant neoplasm of breast
AFFECTS,Emodin,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Neoplastic Process,Emodin Secondary malignant neoplasm of breast
PREDISPOSES,Angiotensin II receptor antagonist,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Angiotensin II receptor antagonist Malignant neoplasm of breast
PREDISPOSES,propofol,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Neoplastic Process,propofol Secondary malignant neoplasm of breast
AFFECTS,pirarubicin,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",pirarubicin Triple Negative Breast Neoplasms
PREDISPOSES,Trichorhinophalangeal dysplasia type I,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,"Element, Ion, or Isotope",Trichorhinophalangeal dysplasia type I Female Breast Carcinoma
AUGMENTS,Adrenergic beta-Antagonists,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Adrenergic beta-Antagonists Malignant neoplasm of breast
DISRUPTS,beta-Glucans,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",beta-Glucans Malignant neoplasm of breast
AFFECTS,rebastinib,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",rebastinib Triple Negative Breast Neoplasms
CAUSES,zoledronate,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",zoledronate Triple Negative Breast Neoplasms
AFFECTS,berberine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,berberine Malignant neoplasm of breast
AFFECTS,Synapsin I,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Synapsin I Triple Negative Breast Neoplasms
AFFECTS,interleukin-8,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",interleukin-8 Malignant neoplasm of breast
PREDISPOSES,thymidine kinase 1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",thymidine kinase 1 Triple Negative Breast Neoplasms
CAUSES,metformin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,metformin Malignant neoplasm of breast
AFFECTS,formononetin,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",formononetin Triple Negative Breast Neoplasms
PREDISPOSES,leptin receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,leptin receptor Malignant neoplasm of breast
PREDISPOSES,Dried fruit intake,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Pharmacologic Substance,Dried fruit intake estrogen receptor-positive breast cancer
PREDISPOSES,Raw vegetable,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Raw vegetable Malignant neoplasm of breast
PREDISPOSES,Inflammatory Response,Invasive Ductal Breast Carcinoma,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Inflammatory Response Invasive Ductal Breast Carcinoma
CAUSES,polyphyllin II,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",polyphyllin II Malignant neoplasm of breast
CAUSES,SB 203580,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,SB 203580 Malignant neoplasm of breast
DISRUPTS,hydnocarpin,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",hydnocarpin Triple Negative Breast Neoplasms
PREDISPOSES,Decreasing,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Decreasing Malignant neoplasm of breast
AFFECTS,venetoclax,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,venetoclax Malignant neoplasm of breast
DISRUPTS,doxorubicin,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",doxorubicin Triple Negative Breast Neoplasms
PREDISPOSES,Chest asymmetry,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Chest asymmetry Malignant neoplasm of breast
AUGMENTS,Androgens,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Androgens estrogen receptor-positive breast cancer
CAUSES,takinib,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,takinib Malignant neoplasm of breast
PREDISPOSES,Proteome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Proteome Malignant neoplasm of breast
PREDISPOSES,ABCB1,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",ABCB1 HER2-positive carcinoma of breast
PREDISPOSES,"Diet, Western",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,"Diet, Western Malignant neoplasm of breast"
AFFECTS,directive therapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",directive therapy Malignant neoplasm of breast
PREDISPOSES,Carney Complex,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Carney Complex Breast Carcinoma
AUGMENTS,factor XIII,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,factor XIII Malignant neoplasm of breast
AFFECTS,Breast-Conserving Surgery,Locally advanced breast cancer,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Breast-Conserving Surgery Locally advanced breast cancer
AFFECTS,momordicoside K,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,momordicoside K Malignant neoplasm of breast
AFFECTS,Soybeans,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Soybeans Malignant neoplasm of breast
AFFECTS,ezrin,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",ezrin Triple Negative Breast Neoplasms
AFFECTS,Androgen Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Androgen Receptor Malignant neoplasm of breast
PREDISPOSES,Reproductive History,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Reproductive History Breast Carcinoma
AFFECTS,Viscosity,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Viscosity Breast Carcinoma
AFFECTS,PDZK1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",PDZK1 Malignant neoplasm of breast
PREDISPOSES,tibolone,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,tibolone Breast cancer invasive NOS
CAUSES,CpG Islands,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",CpG Islands Malignant neoplasm of breast
DISRUPTS,PARP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",PARP1 Malignant neoplasm of breast
PREDISPOSES,Soy Milk,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Soy Milk Malignant neoplasm of breast
AFFECTS,TRPM7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,TRPM7 Malignant neoplasm of breast
AFFECTS,Neuregulin 1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Neuregulin 1 Malignant neoplasm of breast
PREDISPOSES,GSTO2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",GSTO2 Malignant neoplasm of breast
PREDISPOSES,LECT2,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",LECT2 Breast cancer recurrent
AFFECTS,p-hydroxycinnamaldehyde,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,p-hydroxycinnamaldehyde Malignant neoplasm of breast
AUGMENTS,maspin|SERPINB5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,maspin|SERPINB5 Malignant neoplasm of breast
AUGMENTS,arginylarginine|ABL2|RERE,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,arginylarginine|ABL2|RERE Malignant neoplasm of breast
CAUSES,Biosensors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Biosensors Malignant neoplasm of breast
PREDISPOSES,FOXD3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",FOXD3 Malignant neoplasm of breast
AFFECTS,ARF6,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,ARF6 Breast cancer invasive NOS
AFFECTS,GPER1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",GPER1 Malignant neoplasm of breast
PREDISPOSES,arsenite,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,arsenite Malignant neoplasm of breast
AFFECTS,catalpol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,catalpol Malignant neoplasm of breast
DISRUPTS,pigment epithelium-derived factor,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",pigment epithelium-derived factor Breast cancer metastatic
PREDISPOSES,Health behavior,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Health behavior Malignant neoplasm of breast
DISRUPTS,NFKB1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,NFKB1 Malignant neoplasm of breast
CAUSES,mammaglobin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,mammaglobin Malignant neoplasm of breast
DISRUPTS,Angiotensin II Type 1 Receptor Blockers,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Angiotensin II Type 1 Receptor Blockers Malignant neoplasm of breast
DISRUPTS,LIN28A,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",LIN28A Breast cancer metastatic
AFFECTS,Diet good,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Diet good Malignant neoplasm of breast
AUGMENTS,p21-activated kinase 1|CDKN1A|TCEAL1|NSG1|H3F3AP6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",p21-activated kinase 1|CDKN1A|TCEAL1|NSG1|H3F3AP6 Malignant neoplasm of breast
DISRUPTS,BMP4|BMP4,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",BMP4|BMP4 Breast cancer metastatic
AFFECTS,Signal Pathways,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Signal Pathways Breast Carcinoma
AFFECTS,YBX1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",YBX1 Malignant neoplasm of breast
DISRUPTS,deferiprone,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,deferiprone Breast Carcinoma
AUGMENTS,Genistein,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Genistein Breast Carcinoma
PREDISPOSES,3/4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,3/4 Malignant neoplasm of breast
PREDISPOSES,FOXP2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",FOXP2 Breast cancer metastatic
PREDISPOSES,Smoking,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Disease or Syndrome,Smoking Sporadic Breast Carcinoma
AUGMENTS,WWTR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",WWTR1 Malignant neoplasm of breast
AUGMENTS,Tungsten,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Tungsten Breast cancer metastatic
PREDISPOSES,Botanicals,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Botanicals Malignant neoplasm of breast
DISRUPTS,RAB22A,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",RAB22A Breast cancer metastatic
DISRUPTS,docetaxel,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",docetaxel Breast cancer metastatic
PREDISPOSES,Heme,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Heme Malignant neoplasm of breast
DISRUPTS,fraxetin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,fraxetin Malignant neoplasm of breast
AUGMENTS,Animal fat,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Animal fat Malignant neoplasm of breast
CAUSES,GATA3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",GATA3 Malignant neoplasm of breast
CAUSES,Molecular Chaperones,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Molecular Chaperones Malignant neoplasm of breast
AFFECTS,lard,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,lard Malignant neoplasm of breast
CAUSES,Neoplasm,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Disease or Syndrome,"Neoplasm Carcinoma, Ductal, Breast"
PREDISPOSES,Pteridines,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Pteridines Malignant neoplasm of breast
PREDISPOSES,Hemorrhage,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Hemorrhage Malignant neoplasm of breast
AFFECTS,PCSK6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,PCSK6 Malignant neoplasm of breast
CAUSES,Reserpine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Reserpine Malignant neoplasm of breast
AFFECTS,Interleukin-6,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,"Element, Ion, or Isotope",Interleukin-6 Inflammatory Breast Carcinoma
PREDISPOSES,Positive Test Result,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Body Substance,Positive Test Result Malignant neoplasm of breast
AFFECTS,Estriol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Estriol Malignant neoplasm of breast
AFFECTS,Selenium,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Selenium Malignant neoplasm of breast
AFFECTS,Nitric Oxide,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Neoplastic Process,Nitric Oxide Ductal Breast Carcinoma
CAUSES,Study models,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Study models Breast Carcinoma
DISRUPTS,FABP7|MAS1L,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,FABP7|MAS1L Malignant neoplasm of breast
DISRUPTS,Flap Endonuclease-1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Flap Endonuclease-1 Malignant neoplasm of breast
CAUSES,Gastrointestinal Neoplasms,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Gastrointestinal Neoplasms Breast Carcinoma
PREDISPOSES,E-Cadherin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,E-Cadherin Malignant neoplasm of breast
CAUSES,thymalfasin,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,thymalfasin Breast Carcinoma
PREDISPOSES,Progestogen only oral contraceptive,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Progestogen only oral contraceptive Malignant neoplasm of breast
CAUSES,Vegetables,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Vegetables Malignant neoplasm of breast
AFFECTS,Technetium Tc 99m Sestamibi,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Technetium Tc 99m Sestamibi Malignant neoplasm of breast
CAUSES,Potato,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Potato Malignant neoplasm of breast
AUGMENTS,Integrin beta3|EEF1B2P2|BHLHE22,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Integrin beta3|EEF1B2P2|BHLHE22 Breast cancer metastatic
AUGMENTS,NLRP3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",NLRP3 Malignant neoplasm of breast
PREDISPOSES,Gynecomastia,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Disease or Syndrome,Gynecomastia Carcinoma of Male Breast
AFFECTS,Fluorouracil,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Fluorouracil Breast cancer metastatic
AFFECTS,Mammary Neoplasms,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Mammary Neoplasms Breast Carcinoma
AUGMENTS,Arginine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Arginine Malignant neoplasm of breast
PREDISPOSES,family background,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",family background Malignant neoplasm of breast
PREDISPOSES,Antispasmodics,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Antispasmodics Malignant neoplasm of breast
CAUSES,Chromosome 11 Short Arm,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Chromosome 11 Short Arm Malignant neoplasm of breast
AFFECTS,Caffeine,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Caffeine Breast Carcinoma
PREDISPOSES,Hydralazine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Hydralazine Malignant neoplasm of breast
PREDISPOSES,Skin problem,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Skin problem Breast Carcinoma
AFFECTS,cell motility,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Disease or Syndrome,cell motility Breast Carcinoma
AFFECTS,Intraductal Hyperplasia,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",Intraductal Hyperplasia Noninfiltrating Intraductal Carcinoma
AFFECTS,Fibroadenoma,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Fibroadenoma Breast Carcinoma
AFFECTS,Buserelin,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Buserelin Breast Carcinoma
CAUSES,benzanthracene,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,benzanthracene Breast Carcinoma
PREDISPOSES,CHEST PATHOLOGY,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,CHEST PATHOLOGY Breast cancer invasive NOS
AFFECTS,Thiotepa,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Thiotepa Malignant neoplasm of breast
CAUSES,"Milk, Human",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,"Milk, Human Malignant neoplasm of breast"
PREDISPOSES,Fibronectins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Fibronectins Malignant neoplasm of breast
AFFECTS,Mitoxantrone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Mitoxantrone Malignant neoplasm of breast
DISRUPTS,Peanut Agglutinin,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Neoplastic Process,"Peanut Agglutinin Carcinoma, Ductal, Breast"
PREDISPOSES,PREMARIN USE,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",PREMARIN USE Malignant neoplasm of breast
PREDISPOSES,Androsterone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Androsterone Malignant neoplasm of breast
DISRUPTS,limonene,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,limonene Breast Carcinoma
PREDISPOSES,erbB-2 Receptor|EGFR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",erbB-2 Receptor|EGFR Malignant neoplasm of breast
PREDISPOSES,Histologic type,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Histologic type Breast Carcinoma
DISRUPTS,Angiostatins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Angiostatins Malignant neoplasm of breast
PREDISPOSES,Leucine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Leucine Malignant neoplasm of breast
AUGMENTS,rac-PK beta|AKT2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",rac-PK beta|AKT2 Malignant neoplasm of breast
DISRUPTS,Immunoconjugates,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Immunoconjugates Malignant neoplasm of breast
DISRUPTS,NME2,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,NME2 Breast Carcinoma
AFFECTS,Fetal Growth,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Fetal Growth Malignant neoplasm of breast
AUGMENTS,formestane,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,formestane Malignant neoplasm of breast
AFFECTS,Equine laminitis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Equine laminitis Malignant neoplasm of breast
PREDISPOSES,HSPB8,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,HSPB8 Malignant neoplasm of breast
PREDISPOSES,Androgens,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Androgens Breast Carcinoma
AUGMENTS,Telomerase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Telomerase Malignant neoplasm of breast
PREDISPOSES,perlecan,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,perlecan Malignant neoplasm of breast
CAUSES,Amphiregulin|AREG,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Amphiregulin|AREG Malignant neoplasm of breast
AUGMENTS,Cyclin D1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Cyclin D1 Malignant neoplasm of breast
CAUSES,Study models,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Element, Ion, or Isotope",Study models Breast cancer invasive NOS
PREDISPOSES,Interleukin-18,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Interleukin-18 Breast cancer metastatic
PREDISPOSES,Brain Neoplasms,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Brain Neoplasms Malignant neoplasm of breast
AFFECTS,Cytochrome P-450 CYP1A1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Cytochrome P-450 CYP1A1 Malignant neoplasm of breast
PREDISPOSES,Therapy responder,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Therapy responder Malignant neoplasm of breast
AFFECTS,NF-kappa B,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Disease or Syndrome,NF-kappa B Sporadic Breast Carcinoma
PREDISPOSES,Punctate inner choroidopathy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Punctate inner choroidopathy Malignant neoplasm of breast
AUGMENTS,resveratrol,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,resveratrol Breast Carcinoma
AUGMENTS,17q23,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,17q23 Malignant neoplasm of breast
AFFECTS,sphingosine kinase-1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",sphingosine kinase-1 Malignant neoplasm of breast
AFFECTS,Endopeptidases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Endopeptidases Malignant neoplasm of breast
AFFECTS,Environmental Pollutants,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Environmental Pollutants Malignant neoplasm of breast
PREDISPOSES,Brain hemorrhage,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Brain hemorrhage Malignant neoplasm of breast
AFFECTS,Molecular Pathology,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,"Element, Ion, or Isotope","Molecular Pathology Carcinoma, Ductal, Breast"
PREDISPOSES,Thrombus,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Thrombus Malignant neoplasm of breast
PREDISPOSES,response,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,"Element, Ion, or Isotope",response Inflammatory Breast Carcinoma
DISRUPTS,Serpins,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Serpins Breast Carcinoma
PREDISPOSES,Uterine activity,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Uterine activity Malignant neoplasm of breast
PREDISPOSES,Carotene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Carotene Malignant neoplasm of breast
AUGMENTS,Transcript,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Neoplastic Process,Transcript Noninfiltrating Intraductal Carcinoma
AFFECTS,fulvestrant,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,fulvestrant Breast Carcinoma
CAUSES,Colony-Stimulating Factors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Colony-Stimulating Factors Malignant neoplasm of breast
PREDISPOSES,Isothiocyanates,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Isothiocyanates Malignant neoplasm of breast
PREDISPOSES,Fanconi's Anemia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Fanconi's Anemia Malignant neoplasm of breast
PREDISPOSES,LRRC15,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,LRRC15 Breast Carcinoma
AFFECTS,Angiotensinogen|AGT,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Angiotensinogen|AGT Malignant neoplasm of breast
AUGMENTS,4-nonylphenol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,4-nonylphenol Malignant neoplasm of breast
AUGMENTS,P-Selectin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,P-Selectin Malignant neoplasm of breast
AFFECTS,CLSPN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,CLSPN Malignant neoplasm of breast
AFFECTS,Doxazosin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Doxazosin Malignant neoplasm of breast
AFFECTS,LZTS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,LZTS1 Malignant neoplasm of breast
AUGMENTS,Fibrinogen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Fibrinogen Malignant neoplasm of breast
CAUSES,adduct,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",adduct Malignant neoplasm of breast
AFFECTS,tomography,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",tomography Malignant neoplasm of breast
PREDISPOSES,Clusterin|CLU,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Clusterin|CLU Malignant neoplasm of breast
PREDISPOSES,Acne,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Acne Malignant neoplasm of breast
PREDISPOSES,Wine intake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Wine intake Malignant neoplasm of breast
PREDISPOSES,Coumestrol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Coumestrol Malignant neoplasm of breast
CAUSES,Lymphoid neoplasm,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Lymphoid neoplasm Malignant neoplasm of breast
PREDISPOSES,"Xeroderma pigmentosum, group C",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Xeroderma pigmentosum, group C Malignant neoplasm of breast"
AUGMENTS,Membrane receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Membrane receptor Malignant neoplasm of breast
AFFECTS,Pulmonary Embolism,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Pulmonary Embolism Malignant neoplasm of breast
AFFECTS,E2F4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",E2F4 Malignant neoplasm of breast
CAUSES,Mucinous Neoplasm,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,"Element, Ion, or Isotope","Mucinous Neoplasm Carcinoma, Ductal, Breast"
PREDISPOSES,Paroxetine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Paroxetine Malignant neoplasm of breast
PREDISPOSES,PSMA5|AP5Z1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,PSMA5|AP5Z1 Malignant neoplasm of breast
CAUSES,Neoplasm,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Disease or Syndrome,Neoplasm Ductal Breast Carcinoma
PREDISPOSES,Body mass index,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Body mass index Sporadic Breast Carcinoma
AFFECTS,CXCR4 Receptors|CXCR4,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",CXCR4 Receptors|CXCR4 Breast cancer metastatic
DISRUPTS,Farnesyl Transferase Inhibitor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Farnesyl Transferase Inhibitor Malignant neoplasm of breast
CAUSES,Ethylene Oxide,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Ethylene Oxide Breast Carcinoma
DISRUPTS,Cysteine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Cysteine Malignant neoplasm of breast
AFFECTS,Complex Extracts,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Complex Extracts Breast Carcinoma
AFFECTS,Biopsy,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Biopsy Breast cancer metastatic
AFFECTS,Quercetin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Quercetin Malignant neoplasm of breast
PREDISPOSES,IL6R,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,IL6R Malignant neoplasm of breast
AFFECTS,Stromal Cell-Derived Factor 1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Stromal Cell-Derived Factor 1 Breast cancer metastatic
AFFECTS,SULT1A1|SLC45A2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",SULT1A1|SLC45A2 Malignant neoplasm of breast
AFFECTS,Ethylene Oxide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Ethylene Oxide Malignant neoplasm of breast
CAUSES,BEX2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,BEX2 Malignant neoplasm of breast
DISRUPTS,semapimod,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",semapimod Breast cancer metastatic
PREDISPOSES,polyphenols,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,polyphenols Malignant neoplasm of breast
CAUSES,Hamartoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Hamartoma Malignant neoplasm of breast
CAUSES,Plasmin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Plasmin Malignant neoplasm of breast
AFFECTS,Tobacco smoke,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Tobacco smoke Malignant neoplasm of breast
AFFECTS,Mammaplasty,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Element, Ion, or Isotope",Mammaplasty Breast cancer invasive NOS
PREDISPOSES,PES1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,PES1 Malignant neoplasm of breast
PREDISPOSES,INPPL1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,INPPL1 Malignant neoplasm of breast
AFFECTS,KLLN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,KLLN Malignant neoplasm of breast
AUGMENTS,PIWIL1,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,PIWIL1 Breast Carcinoma
CAUSES,PGR|PR@|PRH2|TMEM37|ERVK-7|ERVK-8|ERVK-10|ERVK-9|ERVK-21|ERVK-18|ERVK-25|ERVK-24|ERVK-19,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",PGR|PR@|PRH2|TMEM37|ERVK-7|ERVK-8|ERVK-10|ERVK-9|ERVK-21|ERVK-18|ERVK-25|ERVK-24|ERVK-19 Malignant neoplasm of breast
PREDISPOSES,chemokine,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",chemokine Breast cancer metastatic
PREDISPOSES,CYP3A5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,CYP3A5 Malignant neoplasm of breast
AFFECTS,adjuvant therapy,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,"Element, Ion, or Isotope","adjuvant therapy Carcinoma, Ductal, Breast"
PREDISPOSES,"Medical care, unspecified",Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Gene or Genome,"Medical care, unspecified Carcinoma of Male Breast"
PREDISPOSES,TWIST2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,TWIST2 Malignant neoplasm of breast
AUGMENTS,NAT1|EIF4G2|SLC6A2|SLC38A3|SLC38A6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",NAT1|EIF4G2|SLC6A2|SLC38A3|SLC38A6 Malignant neoplasm of breast
PREDISPOSES,ADIPOQ,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ADIPOQ Malignant neoplasm of breast
AFFECTS,ZNF703,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ZNF703 Malignant neoplasm of breast
AUGMENTS,Progestins,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,Progestins Breast cancer invasive NOS
AFFECTS,PELP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,PELP1 Malignant neoplasm of breast
CAUSES,Phosphotransferases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Phosphotransferases Malignant neoplasm of breast
PREDISPOSES,Annexin A6|ANXA6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Annexin A6|ANXA6 Malignant neoplasm of breast
AUGMENTS,thymidine kinase 1,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,"Element, Ion, or Isotope","thymidine kinase 1 Carcinoma, Ductal, Breast"
PREDISPOSES,Chromosome 10 Short Arm,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Chromosome 10 Short Arm Malignant neoplasm of breast
AFFECTS,CD24,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,"Element, Ion, or Isotope","CD24 Carcinoma, Ductal, Breast"
PREDISPOSES,butylbenzyl phthalate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,butylbenzyl phthalate Malignant neoplasm of breast
AFFECTS,Plasminogen Activator Inhibitor 1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Plasminogen Activator Inhibitor 1 Malignant neoplasm of breast
PREDISPOSES,SIX1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,SIX1 Breast cancer metastatic
PREDISPOSES,Dipyridamole,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Disease or Syndrome,Dipyridamole Sporadic Breast Carcinoma
AFFECTS,PARD6A|PWAR6,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",PARD6A|PWAR6 Breast cancer metastatic
PREDISPOSES,TUBB4A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,TUBB4A Malignant neoplasm of breast
AFFECTS,plumbagin,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",plumbagin Breast cancer metastatic
DISRUPTS,SIX1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",SIX1 Malignant neoplasm of breast
PREDISPOSES,6-bromo-2-naphthyl sulfate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",6-bromo-2-naphthyl sulfate Malignant neoplasm of breast
DISRUPTS,beta catenin,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Element, Ion, or Isotope",beta catenin Breast cancer invasive NOS
CAUSES,IFI27|PSMD9|SSSCA1|DCTN6|TMED7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,IFI27|PSMD9|SSSCA1|DCTN6|TMED7 Malignant neoplasm of breast
AFFECTS,Cyclin-Dependent Kinase 4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Cyclin-Dependent Kinase 4 Malignant neoplasm of breast
DISRUPTS,FOXO3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",FOXO3 Malignant neoplasm of breast
AFFECTS,corrigendum,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,corrigendum Malignant neoplasm of breast
PREDISPOSES,Beta-glucuronidase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Beta-glucuronidase Malignant neoplasm of breast
AFFECTS,CLDND1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,CLDND1 Malignant neoplasm of breast
AFFECTS,Dietary Supplements,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Dietary Supplements Malignant neoplasm of breast
AFFECTS,plumbagin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,plumbagin Malignant neoplasm of breast
AUGMENTS,SNHG12,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,SNHG12 Malignant neoplasm of breast
AUGMENTS,Ceruloplasmin|CP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Ceruloplasmin|CP Malignant neoplasm of breast
PREDISPOSES,interleukin-22,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",interleukin-22 Malignant neoplasm of breast
PREDISPOSES,SOX17,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,SOX17 Malignant neoplasm of breast
PREDISPOSES,Pyruvate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Pyruvate Malignant neoplasm of breast
PREDISPOSES,MC1R,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",MC1R Malignant neoplasm of breast
AUGMENTS,Signaling Molecule,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Signaling Molecule Malignant neoplasm of breast
PREDISPOSES,Dichlorodiphenyldichloroethane,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Dichlorodiphenyldichloroethane Malignant neoplasm of breast
AFFECTS,Dexamethasone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Dexamethasone Malignant neoplasm of breast
AFFECTS,MSI2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,MSI2 Malignant neoplasm of breast
CAUSES,Diethylstilbestrol,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Neoplastic Process,Diethylstilbestrol Noninfiltrating Intraductal Carcinoma
CAUSES,IL33,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,IL33 Malignant neoplasm of breast
AFFECTS,TRPV4,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",TRPV4 Breast cancer metastatic
AFFECTS,Berries,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Berries Malignant neoplasm of breast
AUGMENTS,Margarine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Margarine Malignant neoplasm of breast
AFFECTS,ABCB6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ABCB6 Malignant neoplasm of breast
PREDISPOSES,NUP155,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",NUP155 Malignant neoplasm of breast
PREDISPOSES,atorvastatin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,atorvastatin Malignant neoplasm of breast
PREDISPOSES,Signaling Molecule,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Signaling Molecule Malignant neoplasm of breast
DISRUPTS,kinase inhibitor,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,kinase inhibitor Breast cancer metastatic
AFFECTS,Adenomatous Polyposis Coli,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Adenomatous Polyposis Coli Malignant neoplasm of breast
AFFECTS,Glioma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Glioma Malignant neoplasm of breast
DISRUPTS,UBE3A,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,UBE3A Breast cancer invasive NOS
AFFECTS,NUMB,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",NUMB Malignant neoplasm of breast
AFFECTS,liraglutide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,liraglutide Malignant neoplasm of breast
PREDISPOSES,Mammography finding,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Mammography finding Malignant neoplasm of breast
PREDISPOSES,Thiamine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Thiamine Malignant neoplasm of breast
AFFECTS,TARDBP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,TARDBP Malignant neoplasm of breast
CAUSES,Zinc,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Zinc Malignant neoplasm of breast
AFFECTS,PIWIL1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,PIWIL1 Malignant neoplasm of breast
AUGMENTS,MMP,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,MMP Breast cancer invasive NOS
AFFECTS,Hyperinsulinism,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Hyperinsulinism Breast cancer metastatic
DISRUPTS,KLF17,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,KLF17 Malignant neoplasm of breast
AUGMENTS,SHARPIN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,SHARPIN Malignant neoplasm of breast
PREDISPOSES,DACT2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,DACT2 Malignant neoplasm of breast
PREDISPOSES,APBA3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,APBA3 Malignant neoplasm of breast
PREDISPOSES,Late pregnancy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Late pregnancy Malignant neoplasm of breast
AFFECTS,jatrophone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,jatrophone Malignant neoplasm of breast
AFFECTS,CISH,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Neoplastic Process,CISH Noninfiltrating Intraductal Carcinoma
AUGMENTS,PPM1D,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,PPM1D Breast Carcinoma
COMPLICATES,Fibrosing adenosis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Fibrosing adenosis Malignant neoplasm of breast
AFFECTS,BCYRN1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,BCYRN1 Malignant neoplasm of breast
PREDISPOSES,nucleolin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,nucleolin Malignant neoplasm of breast
PREDISPOSES,caveolin 1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,caveolin 1 Malignant neoplasm of breast
AFFECTS,Anaphylaxis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Anaphylaxis Malignant neoplasm of breast
CAUSES,Parabens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Parabens Malignant neoplasm of breast
DISRUPTS,ARRDC3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ARRDC3 Malignant neoplasm of breast
AFFECTS,SENP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,SENP1 Malignant neoplasm of breast
AFFECTS,grasp,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,grasp Malignant neoplasm of breast
PREDISPOSES,CCR7,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",CCR7 Breast cancer metastatic
AFFECTS,Esters,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Esters Malignant neoplasm of breast
DISRUPTS,Manganese Superoxide Dismutase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Manganese Superoxide Dismutase Malignant neoplasm of breast
PREDISPOSES,Lasso,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Lasso Malignant neoplasm of breast
PREDISPOSES,PIK3R1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,PIK3R1 Breast cancer metastatic
AFFECTS,uptake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",uptake Malignant neoplasm of breast
AFFECTS,Collagen Type IV,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Collagen Type IV Malignant neoplasm of breast
AFFECTS,Recombinant Interferon-gamma|IFNG,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Recombinant Interferon-gamma|IFNG Malignant neoplasm of breast
PREDISPOSES,ADH1C|ADH5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ADH1C|ADH5 Malignant neoplasm of breast
PREDISPOSES,PARP9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",PARP9 Malignant neoplasm of breast
AUGMENTS,ATF4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ATF4 Malignant neoplasm of breast
AFFECTS,Taxol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Taxol Malignant neoplasm of breast
AFFECTS,"Receptors, LH",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Receptors, LH Malignant neoplasm of breast"
AUGMENTS,Liposomes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Liposomes Malignant neoplasm of breast
PREDISPOSES,Tobacco use,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Element, Ion, or Isotope",Tobacco use Breast cancer recurrent
AFFECTS,N NOS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,N NOS Malignant neoplasm of breast
AFFECTS,Sentinel Lymph Node Biopsy,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Element, Ion, or Isotope",Sentinel Lymph Node Biopsy Breast cancer recurrent
AFFECTS,wogonin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,wogonin Malignant neoplasm of breast
PREDISPOSES,Glutamine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Glutamine Malignant neoplasm of breast
AFFECTS,Embryonic Development,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Embryonic Development Malignant neoplasm of breast
AUGMENTS,Tobacco smoke,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Tobacco smoke Malignant neoplasm of breast
PREDISPOSES,pentabromodiphenyl ether,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,pentabromodiphenyl ether Malignant neoplasm of breast
AFFECTS,OIP5-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",OIP5-AS1 Malignant neoplasm of breast
AFFECTS,Dietary Oils,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Dietary Oils Malignant neoplasm of breast
AFFECTS,NF-kappa B,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",NF-kappa B Breast cancer metastatic
PREDISPOSES,Rest,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Rest Malignant neoplasm of breast
CAUSES,Black tea,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Black tea Malignant neoplasm of breast
PREDISPOSES,response,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",response Noninfiltrating Intraductal Carcinoma
PREDISPOSES,norethindrone acetate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",norethindrone acetate Malignant neoplasm of breast
AFFECTS,IQGAP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",IQGAP1 Malignant neoplasm of breast
CAUSES,Oxytocin,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Oxytocin Breast Carcinoma
PREDISPOSES,Galactosamine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Galactosamine Malignant neoplasm of breast
AFFECTS,NAMPT,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,NAMPT Malignant neoplasm of breast
DISRUPTS,Homeo Box Sequence,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Homeo Box Sequence Malignant neoplasm of breast
AFFECTS,Early Diagnosis,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",Early Diagnosis Noninfiltrating Intraductal Carcinoma
AFFECTS,Apoptosis,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Apoptosis Sporadic Breast Carcinoma
PREDISPOSES,Chromosome 15 Short Arm,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Chromosome 15 Short Arm Malignant neoplasm of breast
CAUSES,Superoxides,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Superoxides Malignant neoplasm of breast
PREDISPOSES,PIP,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,PIP Breast Carcinoma
DISRUPTS,Immunoglobulin Fc Fragments,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,Immunoglobulin Fc Fragments Breast cancer metastatic
DISRUPTS,vigilin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,vigilin Malignant neoplasm of breast
AFFECTS,PTPN13,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,PTPN13 Malignant neoplasm of breast
CAUSES,FADS2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,FADS2 Malignant neoplasm of breast
AFFECTS,Fish Oils,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Fish Oils Breast cancer metastatic
DISRUPTS,Antibodies,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Antibodies Malignant neoplasm of breast
AFFECTS,Atypical hyperplasia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Atypical hyperplasia Malignant neoplasm of breast
AFFECTS,stromelysin 3,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,stromelysin 3 Breast Carcinoma
AFFECTS,FMO5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,FMO5 Malignant neoplasm of breast
AFFECTS,Endostatins,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Endostatins Breast Carcinoma
AFFECTS,Loss of Heterozygosity,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Loss of Heterozygosity Breast Carcinoma
PREDISPOSES,Optimistic,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Optimistic Malignant neoplasm of breast
PREDISPOSES,Adrenergic Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Adrenergic Receptor Malignant neoplasm of breast
AUGMENTS,SULT1A1|SULT1A1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",SULT1A1|SULT1A1 Malignant neoplasm of breast
PREDISPOSES,Lecithin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Lecithin Malignant neoplasm of breast
PREDISPOSES,BONE MASS,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Element, Ion, or Isotope",BONE MASS Breast cancer invasive NOS
PREDISPOSES,celecoxib,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,celecoxib Malignant neoplasm of breast
PREDISPOSES,CAMP,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,CAMP Breast cancer metastatic
PREDISPOSES,FOXM1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",FOXM1 Malignant neoplasm of breast
AFFECTS,Freund's Adjuvant,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Freund's Adjuvant Breast Carcinoma
PREDISPOSES,Low Birth Weights,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Low Birth Weights Malignant neoplasm of breast
PREDISPOSES,Rh Factors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Rh Factors Malignant neoplasm of breast
PREDISPOSES,SSM,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,SSM Breast Carcinoma
PREDISPOSES,"Contraceptives, Oral",bilateral breast cancer,0.0,Female Breast Cancer,"Element, Ion, or Isotope","Contraceptives, Oral bilateral breast cancer"
AFFECTS,Contraceptive methods,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Contraceptive methods Malignant neoplasm of breast
PREDISPOSES,NAMPT,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,NAMPT Malignant neoplasm of breast
DISRUPTS,MIR519D,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Disease or Syndrome,MIR519D Carcinoma of Male Breast
PREDISPOSES,Puberty stage,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Puberty stage Malignant neoplasm of breast
PREDISPOSES,Butter,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Butter Malignant neoplasm of breast
PREDISPOSES,Vegetable Oils,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Vegetable Oils Malignant neoplasm of breast
PREDISPOSES,Speaking,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Speaking Malignant neoplasm of breast
PREDISPOSES,Weakly positive,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Weakly positive Malignant neoplasm of breast
AFFECTS,adjuvant therapy,Breast cancer stage II,0.0,Female Breast Cancer,"Element, Ion, or Isotope",adjuvant therapy Breast cancer stage II
PREDISPOSES,"Breast Fibrocystic Change, Proliferative Type",Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope","Breast Fibrocystic Change, Proliferative Type Breast Carcinoma"
PREDISPOSES,poor health,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,poor health Malignant neoplasm of breast
AFFECTS,nimesulide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,nimesulide Malignant neoplasm of breast
AFFECTS,Flavones,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Flavones Malignant neoplasm of breast
AFFECTS,Magnetic Resonance Imaging,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Element, Ion, or Isotope",Magnetic Resonance Imaging Breast cancer invasive NOS
CAUSES,tibolone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,tibolone Malignant neoplasm of breast
PREDISPOSES,Short Tandem Repeat Polymorphism,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Short Tandem Repeat Polymorphism Malignant neoplasm of breast
PREDISPOSES,ADRB3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ADRB3 Malignant neoplasm of breast
AFFECTS,Magnetic Resonance Spectroscopy,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Magnetic Resonance Spectroscopy Breast Carcinoma
AFFECTS,Biopsy,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",Biopsy Noninfiltrating Intraductal Carcinoma
PREDISPOSES,Ill-at-ease,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Ill-at-ease Malignant neoplasm of breast
DISRUPTS,pterostilbene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,pterostilbene Malignant neoplasm of breast
AUGMENTS,PKP3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,PKP3 Malignant neoplasm of breast
PREDISPOSES,Ethanol,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Ethanol Breast cancer metastatic
PREDISPOSES,Cadherins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Cadherins Malignant neoplasm of breast
AUGMENTS,Acetaldehyde,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Acetaldehyde Malignant neoplasm of breast
PREDISPOSES,ezrin|EZR,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,ezrin|EZR Breast cancer invasive NOS
AFFECTS,Silence,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Neoplastic Process,Silence Noninfiltrating Intraductal Carcinoma
PREDISPOSES,Asleep,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Asleep Malignant neoplasm of breast
PREDISPOSES,Obesity,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,"Element, Ion, or Isotope",Obesity Female Breast Carcinoma
PREDISPOSES,Interleukin-17,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Interleukin-17 Sporadic Breast Carcinoma
DISRUPTS,Gelatinase B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Gelatinase B Malignant neoplasm of breast
PREDISPOSES,LPCAT3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,LPCAT3 Malignant neoplasm of breast
AFFECTS,Therapeutic procedure,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Element, Ion, or Isotope",Therapeutic procedure Breast cancer recurrent
DISRUPTS,CALML3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,CALML3 Malignant neoplasm of breast
PREDISPOSES,ODAM,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ODAM Malignant neoplasm of breast
PREDISPOSES,MRE11,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,MRE11 Malignant neoplasm of breast
AUGMENTS,RPS6KB1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",RPS6KB1 Malignant neoplasm of breast
AFFECTS,Macrophage Chemotactic Factors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Macrophage Chemotactic Factors Malignant neoplasm of breast
AFFECTS,butein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,butein Malignant neoplasm of breast
PREDISPOSES,heparanase,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",heparanase Breast cancer metastatic
PREDISPOSES,estrone sulfate,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Element, Ion, or Isotope",estrone sulfate Breast cancer invasive NOS
DISRUPTS,atovaquone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,atovaquone Malignant neoplasm of breast
DISRUPTS,CYP24A1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",CYP24A1 Malignant neoplasm of breast
AFFECTS,Chemokine (C-X-C Motif) Ligand 1|CXCL1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Chemokine (C-X-C Motif) Ligand 1|CXCL1 Malignant neoplasm of breast
CAUSES,Estradiol,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Disease or Syndrome,Estradiol Carcinoma of Male Breast
AFFECTS,Computed Tomographic Colonography,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Computed Tomographic Colonography Breast cancer metastatic
PREDISPOSES,VASOMOTOR SYMPTOM,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,VASOMOTOR SYMPTOM Malignant neoplasm of breast
AFFECTS,osteopontin,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,osteopontin Breast cancer invasive NOS
PREDISPOSES,cadherin 5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,cadherin 5 Malignant neoplasm of breast
DISRUPTS,Connexin 43,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Connexin 43 Malignant neoplasm of breast
PREDISPOSES,Fruit intake,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Element, Ion, or Isotope",Fruit intake Breast cancer recurrent
DISRUPTS,Interleukin-12,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Interleukin-12 Breast cancer metastatic
PREDISPOSES,ADAM29,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ADAM29 Malignant neoplasm of breast
PREDISPOSES,Estradiol + norethindrone acetate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Estradiol + norethindrone acetate Malignant neoplasm of breast
AUGMENTS,GAL3ST1|SLC35A1|CASZ1|CST12P,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,GAL3ST1|SLC35A1|CASZ1|CST12P Malignant neoplasm of breast
AFFECTS,Chemotherapy-Oncologic Procedure,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,"Element, Ion, or Isotope","Chemotherapy-Oncologic Procedure Carcinoma, Ductal, Breast"
PREDISPOSES,EMSY,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,EMSY Malignant neoplasm of breast
PREDISPOSES,Atypical hyperplasia,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",Atypical hyperplasia Noninfiltrating Intraductal Carcinoma
PREDISPOSES,Dinoprost,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Dinoprost Malignant neoplasm of breast
AFFECTS,"Chemotherapy, Adjuvant",Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,"Element, Ion, or Isotope","Chemotherapy, Adjuvant Carcinoma of Male Breast"
PREDISPOSES,Insulin Resistance,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Element, Ion, or Isotope",Insulin Resistance Breast cancer recurrent
PREDISPOSES,Cytokeratin 18,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Cytokeratin 18 Malignant neoplasm of breast
PREDISPOSES,Interstitial Collagenase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Interstitial Collagenase Malignant neoplasm of breast
PREDISPOSES,Nickel,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Nickel Malignant neoplasm of breast
AFFECTS,Breast Feeding,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Disease or Syndrome,Breast Feeding Inflammatory Breast Carcinoma
CAUSES,BCCIP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,BCCIP Malignant neoplasm of breast
PREDISPOSES,CHI3L1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,CHI3L1 Malignant neoplasm of breast
AFFECTS,Somatostatin analog|SST,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Somatostatin analog|SST Breast Carcinoma
CAUSES,Interferon Type II|IFNG,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Interferon Type II|IFNG Malignant neoplasm of breast
PREDISPOSES,IL1RN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",IL1RN Malignant neoplasm of breast
AFFECTS,Cyclin D1|CCND1,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Cyclin D1|CCND1 Breast Carcinoma
AFFECTS,"Breast Fibrocystic Change, Proliferative Type",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Breast Fibrocystic Change, Proliferative Type Malignant neoplasm of breast"
PREDISPOSES,S100A4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,S100A4 Malignant neoplasm of breast
CAUSES,sake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,sake Malignant neoplasm of breast
PREDISPOSES,Xq25,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Xq25 Malignant neoplasm of breast
PREDISPOSES,Infectious Mononucleosis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Infectious Mononucleosis Malignant neoplasm of breast
AUGMENTS,Oils,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Oils Malignant neoplasm of breast
PREDISPOSES,EGFL7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,EGFL7 Malignant neoplasm of breast
AUGMENTS,PROM1,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Neoplastic Process,PROM1 Ductal Breast Carcinoma
AFFECTS,DCSTAMP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,DCSTAMP Malignant neoplasm of breast
PREDISPOSES,gefitinib,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,gefitinib Malignant neoplasm of breast
AFFECTS,GLIS3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",GLIS3 Malignant neoplasm of breast
PREDISPOSES,Water,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Water Malignant neoplasm of breast
PREDISPOSES,perfluorooctane sulfonate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",perfluorooctane sulfonate Malignant neoplasm of breast
PREDISPOSES,Riboflavin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Riboflavin Malignant neoplasm of breast
PREDISPOSES,Alcoholic Beverages,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Element, Ion, or Isotope",Alcoholic Beverages Breast cancer invasive NOS
PREDISPOSES,Infant feeding method NOS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Infant feeding method NOS Malignant neoplasm of breast
PREDISPOSES,Weight Gain,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Weight Gain Breast cancer recurrent
PREDISPOSES,DMD|BEST1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,DMD|BEST1 Malignant neoplasm of breast
AFFECTS,Wine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Wine Malignant neoplasm of breast
COMPLICATES,Metaplasia,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Neoplastic Process,"Metaplasia Carcinoma, Ductal, Breast"
PREDISPOSES,Aldehydes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Aldehydes Malignant neoplasm of breast
AFFECTS,Biopsy,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,"Element, Ion, or Isotope",Biopsy Carcinoma of Male Breast
PREDISPOSES,Estradiol,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Estradiol Breast Carcinoma
AFFECTS,phenethyl isothiocyanate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",phenethyl isothiocyanate Malignant neoplasm of breast
AFFECTS,Black tea,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Black tea Malignant neoplasm of breast
PREDISPOSES,Performance,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Performance Breast cancer recurrent
CAUSES,oridonin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,oridonin Malignant neoplasm of breast
CAUSES,EREG|ESR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",EREG|ESR1 Malignant neoplasm of breast
DISRUPTS,Alleles,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Alleles Malignant neoplasm of breast
PREDISPOSES,Poultry Meat,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Poultry Meat Malignant neoplasm of breast
AFFECTS,Mammography,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,Mammography Breast cancer invasive NOS
AFFECTS,Cognitive Therapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Cognitive Therapy Malignant neoplasm of breast
AFFECTS,high-dose chemotherapy,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",high-dose chemotherapy Breast cancer metastatic
CAUSES,Oxytocin Receptor|OXTR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Oxytocin Receptor|OXTR Malignant neoplasm of breast
PREDISPOSES,S100A1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",S100A1 Malignant neoplasm of breast
PREDISPOSES,Does hit,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Does hit Breast Carcinoma
AFFECTS,Iodine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Iodine Malignant neoplasm of breast
AUGMENTS,pigment epithelium-derived factor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",pigment epithelium-derived factor Malignant neoplasm of breast
PREDISPOSES,Diphosphonates,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,Diphosphonates Breast cancer invasive NOS
DISRUPTS,SOSTDC1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,SOSTDC1 Malignant neoplasm of breast
PREDISPOSES,Catechin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Catechin Malignant neoplasm of breast
PREDISPOSES,Night sweats,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Night sweats Malignant neoplasm of breast
DISRUPTS,Flavones,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Flavones Malignant neoplasm of breast
AFFECTS,hydroxytyrosol,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,hydroxytyrosol Breast Carcinoma
AUGMENTS,REXO1|ZFP42,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,REXO1|ZFP42 Malignant neoplasm of breast
PREDISPOSES,VEGFA,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",VEGFA Breast cancer metastatic
AFFECTS,Night Nurse,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Night Nurse Malignant neoplasm of breast
AUGMENTS,NEK2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",NEK2 Malignant neoplasm of breast
PREDISPOSES,Female,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Female Malignant neoplasm of breast
PREDISPOSES,Body Weight decreased,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Body Weight decreased Breast Carcinoma
PREDISPOSES,Cerebrovascular accident,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Cerebrovascular accident Malignant neoplasm of breast
PREDISPOSES,"Powerlessness, low",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Powerlessness, low Malignant neoplasm of breast"
AFFECTS,Pregnancy,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,Gene or Genome,Pregnancy Familial cancer of breast
PREDISPOSES,Atypical lobular hyperplasia,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Element, Ion, or Isotope",Atypical lobular hyperplasia Breast cancer invasive NOS
DISRUPTS,Endothelin Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Endothelin Receptor Malignant neoplasm of breast
PREDISPOSES,Polymerase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Polymerase Malignant neoplasm of breast
PREDISPOSES,Mammographic breast density,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Mammographic breast density Inflammatory Breast Carcinoma
DISRUPTS,Lasofoxifene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Lasofoxifene Malignant neoplasm of breast
AFFECTS,Mammography,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Mammography Breast Carcinoma
AFFECTS,Estrus,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Estrus Malignant neoplasm of breast
PREDISPOSES,Analgesics,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Analgesics Malignant neoplasm of breast
AFFECTS,Adenosine Triphosphate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Adenosine Triphosphate Malignant neoplasm of breast
AUGMENTS,Mitoxantrone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Mitoxantrone Malignant neoplasm of breast
DISRUPTS,protopanaxadiol,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",protopanaxadiol Breast cancer metastatic
AFFECTS,CDCA4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,CDCA4 Malignant neoplasm of breast
PREDISPOSES,SDCBP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,SDCBP Malignant neoplasm of breast
PREDISPOSES,no positive axillary nodes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",no positive axillary nodes Malignant neoplasm of breast
PREDISPOSES,Gout,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Gout Malignant neoplasm of breast
PREDISPOSES,Tyrosine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Tyrosine Malignant neoplasm of breast
AFFECTS,Acetaminophen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Acetaminophen Malignant neoplasm of breast
PREDISPOSES,TRIM33,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,TRIM33 Malignant neoplasm of breast
AUGMENTS,SLC50A1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,SLC50A1 Malignant neoplasm of breast
AFFECTS,FUT2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,FUT2 Malignant neoplasm of breast
AFFECTS,LINC01638,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,LINC01638 Malignant neoplasm of breast
AUGMENTS,PIMREG,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,PIMREG Malignant neoplasm of breast
DISRUPTS,Interleukin-17,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,"Element, Ion, or Isotope",Interleukin-17 Inflammatory Breast Carcinoma
AFFECTS,strictinin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,strictinin Malignant neoplasm of breast
AFFECTS,phenyl ether,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,phenyl ether Malignant neoplasm of breast
PREDISPOSES,SLC50A1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,SLC50A1 Malignant neoplasm of breast
PREDISPOSES,ezrin|EZR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ezrin|EZR Malignant neoplasm of breast
AUGMENTS,beta catenin|CTNNB1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",beta catenin|CTNNB1 Malignant neoplasm of breast
AFFECTS,Coal,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Coal Malignant neoplasm of breast
AFFECTS,RNF115,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,RNF115 Malignant neoplasm of breast
DISRUPTS,S100B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",S100B Malignant neoplasm of breast
PREDISPOSES,HCP5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,HCP5 Malignant neoplasm of breast
DISRUPTS,nitric oxide receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,nitric oxide receptor Malignant neoplasm of breast
AFFECTS,RUSC1-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",RUSC1-AS1 Malignant neoplasm of breast
AUGMENTS,Glucocorticoids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Glucocorticoids Malignant neoplasm of breast
DISRUPTS,TFF3,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",TFF3 Breast Carcinoma
AUGMENTS,HOTAIR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",HOTAIR Malignant neoplasm of breast
PREDISPOSES,PCB 180,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,PCB 180 Malignant neoplasm of breast
AFFECTS,Gold,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Gold Malignant neoplasm of breast
AFFECTS,Energy Balance,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Energy Balance Malignant neoplasm of breast
PREDISPOSES,HAX1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",HAX1 Breast cancer metastatic
CAUSES,angiotensin II,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",angiotensin II Malignant neoplasm of breast
DISRUPTS,cedrelone,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",cedrelone Triple Negative Breast Neoplasms
PREDISPOSES,Flavones,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Flavones Malignant neoplasm of breast
CAUSES,Catechol O-Methyltransferase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Catechol O-Methyltransferase Malignant neoplasm of breast
AFFECTS,Phototherapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Phototherapy Malignant neoplasm of breast
AFFECTS,Neoadjuvant Therapy,Breast cancer stage III,0.0009990009990009,Female Breast Cancer,"Element, Ion, or Isotope",Neoadjuvant Therapy Breast cancer stage III
AFFECTS,Nicotinamide Phosphoribosyltransferase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Nicotinamide Phosphoribosyltransferase Malignant neoplasm of breast
AFFECTS,punicalagin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,punicalagin Malignant neoplasm of breast
AFFECTS,Late menarche,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Late menarche Malignant neoplasm of breast
DISRUPTS,STARD8,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",STARD8 Triple Negative Breast Neoplasms
AFFECTS,Cream,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Cream Malignant neoplasm of breast
CAUSES,chalcomoracin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,chalcomoracin Malignant neoplasm of breast
AFFECTS,Hexokinase 2|HK2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Hexokinase 2|HK2 Malignant neoplasm of breast
PREDISPOSES,insulin detemir,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",insulin detemir Malignant neoplasm of breast
AFFECTS,Prophylactic treatment,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Prophylactic treatment Malignant neoplasm of breast
AFFECTS,Fibromyalgia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Fibromyalgia Malignant neoplasm of breast
PREDISPOSES,compromise,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Neoplastic Process,compromise Noninfiltrating Intraductal Carcinoma
AFFECTS,"Sleep Apnea, Obstructive",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Sleep Apnea, Obstructive Malignant neoplasm of breast"
PREDISPOSES,Chlorpyrifos,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Chlorpyrifos Malignant neoplasm of breast
CAUSES,CCL5,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",CCL5 Invasive carcinoma of breast
AFFECTS,CTCb regimen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",CTCb regimen Malignant neoplasm of breast
AUGMENTS,Phosphoric Monoester Hydrolases,Carcinoma breast stage IV,0.0,Female Breast Cancer,Gene or Genome,Phosphoric Monoester Hydrolases Carcinoma breast stage IV
PREDISPOSES,aluminum,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,aluminum Malignant neoplasm of breast
AFFECTS,SLCO6A1|GSTK1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",SLCO6A1|GSTK1 Malignant neoplasm of breast
PREDISPOSES,risk factors,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,"Element, Ion, or Isotope",risk factors Inflammatory Breast Carcinoma
AFFECTS,Prolactin Receptor,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Prolactin Receptor Triple Negative Breast Neoplasms
PREDISPOSES,Polybrominated Biphenyls,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Polybrominated Biphenyls Malignant neoplasm of breast
PREDISPOSES,Primary care provider:Identifier:Point in time:Provider:Nominal,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Primary care provider:Identifier:Point in time:Provider:Nominal Malignant neoplasm of breast
DISRUPTS,limited use,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",limited use Malignant neoplasm of breast
PREDISPOSES,betaine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,betaine Malignant neoplasm of breast
PREDISPOSES,risk factors,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,"Element, Ion, or Isotope",risk factors Sporadic Breast Carcinoma
AFFECTS,Multiparametric Magnetic Resonance Imaging,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Multiparametric Magnetic Resonance Imaging Malignant neoplasm of breast
AFFECTS,Pharmacotherapy,Luminal B Breast Carcinoma,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Pharmacotherapy Luminal B Breast Carcinoma
AFFECTS,Lyophilized powder,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Lyophilized powder Malignant neoplasm of breast
AFFECTS,genistein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,genistein Malignant neoplasm of breast
AFFECTS,removal technique,Stage IV Inflammatory Breast Carcinoma,0.0,Female Breast Cancer,Gene or Genome,removal technique Stage IV Inflammatory Breast Carcinoma
AFFECTS,glycerin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,glycerin Malignant neoplasm of breast
CAUSES,acetylcysteine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,acetylcysteine Malignant neoplasm of breast
PREDISPOSES,Biological Markers,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,"Element, Ion, or Isotope",Biological Markers Inflammatory Breast Carcinoma
AFFECTS,CXCL1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",CXCL1 Malignant neoplasm of breast
CAUSES,interleukin-6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",interleukin-6 Malignant neoplasm of breast
AFFECTS,Biological Response Modifiers,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Biological Response Modifiers Triple Negative Breast Neoplasms
CAUSES,Interferons,Basal-Like Breast Carcinoma,0.0039960039960039,Female Breast Cancer,"Element, Ion, or Isotope",Interferons Basal-Like Breast Carcinoma
PREDISPOSES,"Scoliosis, unspecified",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Scoliosis, unspecified Malignant neoplasm of breast"
AFFECTS,erbB-2 Receptor|ERBB2,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",erbB-2 Receptor|ERBB2 HER2-positive carcinoma of breast
DISRUPTS,MIR451A wt Allele,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",MIR451A wt Allele Malignant neoplasm of breast
AFFECTS,Pharmacotherapy,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",Pharmacotherapy HER2-positive carcinoma of breast
AFFECTS,leptin,Carcinoma breast stage IV,0.0,Female Breast Cancer,"Element, Ion, or Isotope",leptin Carcinoma breast stage IV
CAUSES,Biopolymers,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Biopolymers Malignant neoplasm of breast
AUGMENTS,folate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,folate Malignant neoplasm of breast
DISRUPTS,Luteolin,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",Luteolin HER2-positive carcinoma of breast
CAUSES,Piperlongumine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Piperlongumine Malignant neoplasm of breast
DISRUPTS,thidiazuron,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,thidiazuron Malignant neoplasm of breast
AUGMENTS,methylate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,methylate Malignant neoplasm of breast
AFFECTS,Neoplasms by Site,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Neoplasms by Site Malignant neoplasm of breast
PREDISPOSES,Behaviorial Habits,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Behaviorial Habits Malignant neoplasm of breast
CAUSES,mitoxantrone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,mitoxantrone Malignant neoplasm of breast
DISRUPTS,Polysaccharides,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Polysaccharides Malignant neoplasm of breast
AFFECTS,Systemic Therapy,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",Systemic Therapy HER2-positive carcinoma of breast
PREDISPOSES,B3GNT2|B3GNTL1,Carcinoma breast stage IV,0.0,Female Breast Cancer,"Element, Ion, or Isotope",B3GNT2|B3GNTL1 Carcinoma breast stage IV
PREDISPOSES,Thymidylate Synthase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Thymidylate Synthase Malignant neoplasm of breast
AFFECTS,Screening mammography,malignant neoplasm of breast staging,0.0,Female Breast Cancer,Neoplastic Process,Screening mammography malignant neoplasm of breast staging
AFFECTS,Mouse Model,Basal-Like Breast Carcinoma,0.0039960039960039,Female Breast Cancer,"Element, Ion, or Isotope",Mouse Model Basal-Like Breast Carcinoma
AFFECTS,sanguinarine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,sanguinarine Malignant neoplasm of breast
PREDISPOSES,Clinical Significance,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Clinical Significance Breast Carcinoma
PREDISPOSES,Breast size,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",Breast size Invasive carcinoma of breast
CAUSES,Triple Negative Breast Neoplasms,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Triple Negative Breast Neoplasms Malignant neoplasm of breast
AUGMENTS,Profilin 2,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Profilin 2 Triple Negative Breast Neoplasms
PREDISPOSES,Performance,Recurrent Breast Carcinoma,0.0009990009990009,Recurrent Breast Cancer,Neoplastic Process,Performance Recurrent Breast Carcinoma
DISRUPTS,dendrophenol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,dendrophenol Malignant neoplasm of breast
AFFECTS,Hydrogel,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Hydrogel Triple Negative Breast Neoplasms
DISRUPTS,"Receptors, Opioid, kappa",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Receptors, Opioid, kappa Malignant neoplasm of breast"
PREDISPOSES,Physical stress,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Physical stress Malignant neoplasm of breast
AFFECTS,metoclopramide,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",metoclopramide Triple Negative Breast Neoplasms
AFFECTS,tripterine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,tripterine Malignant neoplasm of breast
AFFECTS,Cell Cycle Checkpoints,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Cell Cycle Checkpoints Malignant neoplasm of breast
AFFECTS,Inhibitor,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Inhibitor Triple Negative Breast Neoplasms
AFFECTS,Reaching,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Reaching Malignant neoplasm of breast
DISRUPTS,Antibodies,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",Antibodies HER2-positive carcinoma of breast
PREDISPOSES,Cytochrome P-450 CYP1A1|CYP19A1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Cytochrome P-450 CYP1A1|CYP19A1 Malignant neoplasm of breast
AFFECTS,Monoclonal Antibodies,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",Monoclonal Antibodies HER2-positive carcinoma of breast
DISRUPTS,melatonin,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",melatonin Triple Negative Breast Neoplasms
AFFECTS,docetaxel,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",docetaxel Triple Negative Breast Neoplasms
AUGMENTS,nucleolin,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",nucleolin Triple Negative Breast Neoplasms
AFFECTS,"Benzimidazole derivatives, antinematodal",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope","Benzimidazole derivatives, antinematodal Triple Negative Breast Neoplasms"
PREDISPOSES,Moderate risk,contralateral breast cancer,0.0029970029970029,Female Breast Cancer,Gene or Genome,Moderate risk contralateral breast cancer
PREDISPOSES,peroxiredoxin I,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,peroxiredoxin I Malignant neoplasm of breast
AUGMENTS,calreticulin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,calreticulin Malignant neoplasm of breast
DISRUPTS,piperine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,piperine Malignant neoplasm of breast
PREDISPOSES,Cultured Milk Products,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Cultured Milk Products Malignant neoplasm of breast
PREDISPOSES,Biological Response Modifiers,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Biological Response Modifiers Triple Negative Breast Neoplasms
CAUSES,Hesperidin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Hesperidin Malignant neoplasm of breast
CAUSES,Copy Number Polymorphism,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Copy Number Polymorphism Malignant neoplasm of breast
CAUSES,Matrix,Triple-Negative Breast Carcinoma,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Matrix Triple-Negative Breast Carcinoma
PREDISPOSES,cannabinoid receptor,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,"Element, Ion, or Isotope",cannabinoid receptor Secondary malignant neoplasm of breast
PREDISPOSES,LRP6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",LRP6 Malignant neoplasm of breast
PREDISPOSES,Very rare,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Very rare Malignant neoplasm of breast
AUGMENTS,CBR3-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",CBR3-AS1 Malignant neoplasm of breast
PREDISPOSES,VEGFA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",VEGFA Malignant neoplasm of breast
PREDISPOSES,LGALS3BP,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",LGALS3BP HER2-positive carcinoma of breast
PREDISPOSES,Abnormality,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Abnormality Malignant neoplasm of breast
CAUSES,SARS-CoV-2 P.1 variant,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,"Element, Ion, or Isotope",SARS-CoV-2 P.1 variant Secondary malignant neoplasm of breast
AFFECTS,Inhibitor,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,Inhibitor Breast Carcinoma
DISRUPTS,oleuropein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,oleuropein Malignant neoplasm of breast
AFFECTS,Pharmacotherapy,contralateral breast cancer,0.0029970029970029,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Pharmacotherapy contralateral breast cancer
PREDISPOSES,erbB-2 Receptor|ERBB2,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",erbB-2 Receptor|ERBB2 Breast Carcinoma
PREDISPOSES,Histological type,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Histological type Malignant neoplasm of breast
AUGMENTS,BACH1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",BACH1 Triple Negative Breast Neoplasms
AFFECTS,monooxyethylene trimethylolpropane tristearate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,monooxyethylene trimethylolpropane tristearate Malignant neoplasm of breast
AUGMENTS,interferon type II,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",interferon type II Malignant neoplasm of breast
AFFECTS,calcitriol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,calcitriol Malignant neoplasm of breast
AFFECTS,tanshinone,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,"Element, Ion, or Isotope",tanshinone Female Breast Carcinoma
DISRUPTS,anhydroicaritin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,anhydroicaritin Malignant neoplasm of breast
PREDISPOSES,interleukin-10,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",interleukin-10 Malignant neoplasm of breast
AFFECTS,Agonist,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Agonist Malignant neoplasm of breast
AFFECTS,kinase targeted therapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",kinase targeted therapy Malignant neoplasm of breast
DISRUPTS,Inhibitor,Carcinoma breast stage IV,0.0,Female Breast Cancer,Gene or Genome,Inhibitor Carcinoma breast stage IV
DISRUPTS,Histone deacetylase inhibitor,Basal-Like Breast Carcinoma,0.0039960039960039,Female Breast Cancer,"Element, Ion, or Isotope",Histone deacetylase inhibitor Basal-Like Breast Carcinoma
AUGMENTS,perilipin 2,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",perilipin 2 Triple Negative Breast Neoplasms
PREDISPOSES,estradiol high,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",estradiol high Malignant neoplasm of breast
AFFECTS,Immune Checkpoint Inhibitors,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Immunologic Factor,Immune Checkpoint Inhibitors Triple Negative Breast Neoplasms
DISRUPTS,dinaciclib,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,dinaciclib Malignant neoplasm of breast
PREDISPOSES,cholecalciferol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,cholecalciferol Malignant neoplasm of breast
PREDISPOSES,MAP Kinase Kinase 5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",MAP Kinase Kinase 5 Malignant neoplasm of breast
AFFECTS,Mouse Model,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Mouse Model Triple Negative Breast Neoplasms
PREDISPOSES,Incomplete penetrance,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Incomplete penetrance Malignant neoplasm of breast
AFFECTS,pioglitazone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,pioglitazone Malignant neoplasm of breast
AFFECTS,quercetin,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",quercetin Triple Negative Breast Neoplasms
AUGMENTS,Hydrogel,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Hydrogel Malignant neoplasm of breast
AUGMENTS,Hypothalamic inhibiting factor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Hypothalamic inhibiting factor Malignant neoplasm of breast
AFFECTS,aucubin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,aucubin Malignant neoplasm of breast
DISRUPTS,Citrates,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Citrates Malignant neoplasm of breast
CAUSES,Cyclin D1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Cyclin D1 Malignant neoplasm of breast
AFFECTS,ethanol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ethanol Malignant neoplasm of breast
PREDISPOSES,Copy Number Polymorphism,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Copy Number Polymorphism Triple Negative Breast Neoplasms
DISRUPTS,polyethylene glycols,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,polyethylene glycols Malignant neoplasm of breast
DISRUPTS,Ryanodine Receptor 2,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Ryanodine Receptor 2 Triple Negative Breast Neoplasms
PREDISPOSES,Breast Measurement,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Breast Measurement Malignant neoplasm of breast
PREDISPOSES,Negative,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Negative Malignant neoplasm of breast
DISRUPTS,plumbagin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,plumbagin Malignant neoplasm of breast
AFFECTS,MYC,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",MYC Malignant neoplasm of breast
PREDISPOSES,erbB-2 Receptor|ERBB2,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",erbB-2 Receptor|ERBB2 HER2-positive carcinoma of breast
PREDISPOSES,Hypoxia,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Neoplastic Process,Hypoxia Noninfiltrating Intraductal Carcinoma
AFFECTS,Free Energy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Free Energy Malignant neoplasm of breast
AFFECTS,Inhibitor,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Pharmacologic Substance,Inhibitor estrogen receptor-positive breast cancer
AUGMENTS,Parafibromin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Parafibromin Malignant neoplasm of breast
AFFECTS,Osteoporosis,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Neoplastic Process,Osteoporosis Secondary malignant neoplasm of breast
CAUSES,Histone deacetylase inhibitor|HDAC9,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Histone deacetylase inhibitor|HDAC9 Triple Negative Breast Neoplasms
DISRUPTS,Plasmids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Plasmids Malignant neoplasm of breast
PREDISPOSES,SOY ISOFLAVONES,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",SOY ISOFLAVONES Malignant neoplasm of breast
DISRUPTS,Vimentin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Vimentin Malignant neoplasm of breast
PREDISPOSES,Clusterin,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Neoplastic Process,Clusterin Invasive carcinoma of breast
PREDISPOSES,Hydroxymethylglutaryl-CoA reductase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Hydroxymethylglutaryl-CoA reductase Malignant neoplasm of breast
PREDISPOSES,Light Exercise,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Light Exercise Malignant neoplasm of breast
PREDISPOSES,Drinker,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Drinker Malignant neoplasm of breast
AUGMENTS,CREB1,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,"Element, Ion, or Isotope",CREB1 Secondary malignant neoplasm of breast
AFFECTS,bufalin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,bufalin Malignant neoplasm of breast
AFFECTS,"Alanine Aminotransferase 1, human",Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,"Element, Ion, or Isotope","Alanine Aminotransferase 1, human Secondary malignant neoplasm of breast"
PREDISPOSES,cytidylyl-3'-5'-guanosine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,cytidylyl-3'-5'-guanosine Malignant neoplasm of breast
PREDISPOSES,Snacks,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Snacks Malignant neoplasm of breast
AFFECTS,First line treatment,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",First line treatment Triple Negative Breast Neoplasms
DISRUPTS,glabridin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,glabridin Malignant neoplasm of breast
PREDISPOSES,Toothache,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Toothache Malignant neoplasm of breast
PREDISPOSES,Increased risk,contralateral breast cancer,0.0029970029970029,Female Breast Cancer,"Element, Ion, or Isotope",Increased risk contralateral breast cancer
DISRUPTS,quercetin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,quercetin Malignant neoplasm of breast
PREDISPOSES,caveolin 1,contralateral breast cancer,0.0029970029970029,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",caveolin 1 contralateral breast cancer
PREDISPOSES,Global Longitudinal Strain,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Global Longitudinal Strain Malignant neoplasm of breast
AFFECTS,Neoadjuvant Chemotherapy,Luminal B Breast Carcinoma,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Neoadjuvant Chemotherapy Luminal B Breast Carcinoma
PREDISPOSES,Coherent,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Coherent Malignant neoplasm of breast
AUGMENTS,ethanol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ethanol Malignant neoplasm of breast
AFFECTS,Neoadjuvant Chemotherapy,HER2-negative breast cancer,0.0,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Neoadjuvant Chemotherapy HER2-negative breast cancer
PREDISPOSES,Patient age,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Patient age Triple Negative Breast Neoplasms
AFFECTS,Natural Products,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Natural Products Malignant neoplasm of breast
DISRUPTS,dihydroartemisinin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,dihydroartemisinin Malignant neoplasm of breast
AFFECTS,Luteolin,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Luteolin Triple Negative Breast Neoplasms
PREDISPOSES,Severe (severity modifier),Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Neoplastic Process,Severe (severity modifier) Secondary malignant neoplasm of breast
DISRUPTS,disulfiram,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Neoplastic Process,disulfiram Secondary malignant neoplasm of breast
PREDISPOSES,Immune Tolerance,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,Immune Tolerance Secondary malignant neoplasm of breast
PREDISPOSES,Menstrual status:Type:Point in time:^Patient:Nominal:Stated,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Menstrual status:Type:Point in time:^Patient:Nominal:Stated Malignant neoplasm of breast
AFFECTS,Neoadjuvant Chemotherapy,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",Neoadjuvant Chemotherapy Invasive carcinoma of breast
AUGMENTS,Parafibromin|CDC73,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Parafibromin|CDC73 Malignant neoplasm of breast
DISRUPTS,euphorbia factor L1,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,"Element, Ion, or Isotope",euphorbia factor L1 Secondary malignant neoplasm of breast
AFFECTS,Mammary Neoplasms,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Hazardous or Poisonous Substance,Mammary Neoplasms Triple Negative Breast Neoplasms
DISRUPTS,Micelles,Carcinoma breast stage IV,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Micelles Carcinoma breast stage IV
DISRUPTS,platinum,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Immunologic Factor,platinum Triple Negative Breast Neoplasms
PREDISPOSES,CD160,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,CD160 Malignant neoplasm of breast
AFFECTS,Polygenic Traits,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Polygenic Traits Malignant neoplasm of breast
AFFECTS,Basis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Basis Malignant neoplasm of breast
PREDISPOSES,graphdiyne,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,graphdiyne Malignant neoplasm of breast
AFFECTS,Obesity,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Immunologic Factor,Obesity Triple Negative Breast Neoplasms
AFFECTS,Biological Response Modifiers,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,"Element, Ion, or Isotope",Biological Response Modifiers Inflammatory Breast Carcinoma
AFFECTS,Hippo Signaling Pathway,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Hippo Signaling Pathway Malignant neoplasm of breast
AFFECTS,beta sitosterol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",beta sitosterol Malignant neoplasm of breast
PREDISPOSES,ZNF148,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ZNF148 Malignant neoplasm of breast
PREDISPOSES,Possible,estrogen receptor-negative breast cancer,0.0,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Possible estrogen receptor-negative breast cancer
DISRUPTS,quercetin,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,quercetin Breast Carcinoma
PREDISPOSES,Clinical Significance,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Clinical Significance Malignant neoplasm of breast
AFFECTS,DHP107,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,DHP107 Malignant neoplasm of breast
PREDISPOSES,FZR1 wt Allele|CDH1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",FZR1 wt Allele|CDH1 Malignant neoplasm of breast
PREDISPOSES,interleukin-1 alpha,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",interleukin-1 alpha Malignant neoplasm of breast
PREDISPOSES,Cheese intake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Cheese intake Malignant neoplasm of breast
AFFECTS,Origin of Life,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Origin of Life Malignant neoplasm of breast
AFFECTS,tyrosine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",tyrosine Malignant neoplasm of breast
DISRUPTS,dasatinib,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",dasatinib Triple Negative Breast Neoplasms
AFFECTS,Immunogenic Cell Death,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Immunogenic Cell Death Triple Negative Breast Neoplasms
AFFECTS,Carboplatin/Etoposide/Melphalan Regimen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Carboplatin/Etoposide/Melphalan Regimen Malignant neoplasm of breast
PREDISPOSES,Pubertal,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Pubertal Malignant neoplasm of breast
PREDISPOSES,Hypoxia,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Neoplastic Process,Hypoxia Secondary malignant neoplasm of breast
AFFECTS,phosphatidylethanolamines,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,"Amino Acid, Peptide, or Protein",phosphatidylethanolamines estrogen receptor-positive breast cancer
AFFECTS,Phosphoric Monoester Hydrolases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Phosphoric Monoester Hydrolases Malignant neoplasm of breast
DISRUPTS,Withanolides,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Withanolides Triple Negative Breast Neoplasms
AFFECTS,Triterpenes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Triterpenes Malignant neoplasm of breast
DISRUPTS,cyanidin 3-O-glucoside,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,cyanidin 3-O-glucoside Malignant neoplasm of breast
PREDISPOSES,equol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,equol Malignant neoplasm of breast
PREDISPOSES,OGG1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",OGG1 Malignant neoplasm of breast
AFFECTS,Hypoxia-Inducible Factor 1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Hypoxia-Inducible Factor 1 Breast cancer metastatic
AFFECTS,Ultrasonography,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,Ultrasonography Breast cancer invasive NOS
AFFECTS,DYRK2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",DYRK2 Malignant neoplasm of breast
AFFECTS,Mitomycin,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Mitomycin Breast cancer metastatic
AFFECTS,miltefosine,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,miltefosine Breast Carcinoma
AFFECTS,FOXA1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",FOXA1 Malignant neoplasm of breast
AFFECTS,Heparitin Sulfate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Heparitin Sulfate Malignant neoplasm of breast
AUGMENTS,Collagen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Collagen Malignant neoplasm of breast
DISRUPTS,PSD4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,PSD4 Malignant neoplasm of breast
PREDISPOSES,Gamma synuclein|SNCG,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Gamma synuclein|SNCG Malignant neoplasm of breast
AFFECTS,camalexin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,camalexin Malignant neoplasm of breast
PREDISPOSES,CUL3,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",CUL3 Breast cancer metastatic
AFFECTS,Streams,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Streams Malignant neoplasm of breast
PREDISPOSES,TOX3,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Disease or Syndrome,TOX3 Carcinoma of Male Breast
PREDISPOSES,Annexin A2,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,Annexin A2 Breast cancer invasive NOS
AUGMENTS,ORAI3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ORAI3 Malignant neoplasm of breast
AFFECTS,fluvastatin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,fluvastatin Malignant neoplasm of breast
AUGMENTS,KDM6B,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,KDM6B Breast cancer invasive NOS
AUGMENTS,TRPV6,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",TRPV6 Breast Carcinoma
PREDISPOSES,bexarotene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,bexarotene Malignant neoplasm of breast
AUGMENTS,RAC-Alpha Serine/Threonine Kinase|AKT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",RAC-Alpha Serine/Threonine Kinase|AKT1 Malignant neoplasm of breast
CAUSES,dihydroceramide desaturase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,dihydroceramide desaturase Malignant neoplasm of breast
PREDISPOSES,CIP2A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,CIP2A Malignant neoplasm of breast
DISRUPTS,Creatinine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Creatinine Malignant neoplasm of breast
DISRUPTS,Stearates,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Stearates Breast cancer metastatic
CAUSES,PIK3CA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",PIK3CA Malignant neoplasm of breast
CAUSES,Ubiquitin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Ubiquitin Malignant neoplasm of breast
AFFECTS,Angiotensin II Type 1 Receptor Blockers,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Angiotensin II Type 1 Receptor Blockers Malignant neoplasm of breast
AFFECTS,anthracene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,anthracene Malignant neoplasm of breast
PREDISPOSES,RBBP8,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,RBBP8 Malignant neoplasm of breast
AFFECTS,Beverages,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Beverages Malignant neoplasm of breast
AFFECTS,Fat graft,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Fat graft Malignant neoplasm of breast
AFFECTS,Benzimidazoles,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Benzimidazoles Malignant neoplasm of breast
AFFECTS,lysophosphatidylethanolamine,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Neoplastic Process,"lysophosphatidylethanolamine Carcinoma, Ductal, Breast"
PREDISPOSES,Does hit,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Does hit Malignant neoplasm of breast
DISRUPTS,Flavonoids,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Flavonoids Breast cancer metastatic
AUGMENTS,osteoblast cadherin,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Neoplastic Process,osteoblast cadherin Noninfiltrating Intraductal Carcinoma
PREDISPOSES,HOXD@,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",HOXD@ Breast cancer metastatic
AFFECTS,TFF3,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",TFF3 Breast Carcinoma
PREDISPOSES,Lovastatin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Lovastatin Malignant neoplasm of breast
PREDISPOSES,EPHB2|MAPK1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",EPHB2|MAPK1 Malignant neoplasm of breast
AFFECTS,GTF2H1|SQSTM1|KHDRBS1|NUP62|DCTN4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",GTF2H1|SQSTM1|KHDRBS1|NUP62|DCTN4 Malignant neoplasm of breast
PREDISPOSES,APOA1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",APOA1 Malignant neoplasm of breast
PREDISPOSES,genistin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,genistin Malignant neoplasm of breast
AUGMENTS,GRPR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,GRPR Malignant neoplasm of breast
AFFECTS,TRIM62,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,TRIM62 Malignant neoplasm of breast
AFFECTS,tipifarnib,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,tipifarnib Breast Carcinoma
AFFECTS,Autophagy,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Autophagy Breast Carcinoma
PREDISPOSES,LRIG1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,LRIG1 Breast cancer metastatic
DISRUPTS,erlotinib,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,erlotinib Malignant neoplasm of breast
AFFECTS,Dimethyl sulfone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Dimethyl sulfone Malignant neoplasm of breast
DISRUPTS,Acetate,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Acetate Breast cancer metastatic
AUGMENTS,Thrombospondin 1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Thrombospondin 1 Malignant neoplasm of breast
AUGMENTS,Proline,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Proline Malignant neoplasm of breast
PREDISPOSES,icaritin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,icaritin Malignant neoplasm of breast
PREDISPOSES,Biopsy finding,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Biopsy finding Malignant neoplasm of breast
AUGMENTS,GFRA1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,GFRA1 Malignant neoplasm of breast
PREDISPOSES,Prolactin|PRL,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Prolactin|PRL Breast Carcinoma
AFFECTS,CDKN1A|TCEAL1|NSG1|H3F3AP6,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",CDKN1A|TCEAL1|NSG1|H3F3AP6 Breast Carcinoma
CAUSES,dehydroepiandrosterone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,dehydroepiandrosterone Malignant neoplasm of breast
AFFECTS,formononetin,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",formononetin Breast cancer metastatic
AUGMENTS,8q22,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,8q22 Malignant neoplasm of breast
PREDISPOSES,Ataxia Telangiectasia,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,"Element, Ion, or Isotope",Ataxia Telangiectasia Female Breast Carcinoma
PREDISPOSES,Stress,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Stress Breast Carcinoma
DISRUPTS,retinyl methyl ether,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",retinyl methyl ether Breast Carcinoma
PREDISPOSES,Negative Finding,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Negative Finding Malignant neoplasm of breast
AFFECTS,Aneuploidy,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Neoplastic Process,"Aneuploidy Carcinoma, Ductal, Breast"
AFFECTS,"technetium Tc 99m 1,2-bis(bis(2-ethoxyethyl)phosphino)ethane",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,"technetium Tc 99m 1,2-bis(bis(2-ethoxyethyl)phosphino)ethane Malignant neoplasm of breast"
AUGMENTS,Ethinyl Estradiol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Ethinyl Estradiol Malignant neoplasm of breast
AUGMENTS,E-Selectin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,E-Selectin Malignant neoplasm of breast
AFFECTS,"Fruit, Citrus",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,"Fruit, Citrus Malignant neoplasm of breast"
AUGMENTS,ETV4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",ETV4 Malignant neoplasm of breast
AUGMENTS,Plasminogen Activator Inhibitor 1|SERPINE1|SERPINB2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Plasminogen Activator Inhibitor 1|SERPINE1|SERPINB2 Malignant neoplasm of breast
DISRUPTS,Glutaminase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Glutaminase Malignant neoplasm of breast
AFFECTS,Cheese,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Cheese Malignant neoplasm of breast
PREDISPOSES,Androgenic precursors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Androgenic precursors Malignant neoplasm of breast
AFFECTS,Aminoglutethimide,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Disease or Syndrome,Aminoglutethimide Carcinoma of Male Breast
PREDISPOSES,Monoclonal Antibodies,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Monoclonal Antibodies Breast Carcinoma
PREDISPOSES,Relate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Relate Malignant neoplasm of breast
PREDISPOSES,Histological finding,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Histological finding Malignant neoplasm of breast
AFFECTS,Prednisone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Prednisone Malignant neoplasm of breast
CAUSES,Prolactin|PRL,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Prolactin|PRL Breast Carcinoma
DISRUPTS,Caffeine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Caffeine Malignant neoplasm of breast
PREDISPOSES,Hyperplasia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Hyperplasia Malignant neoplasm of breast
PREDISPOSES,Smoking History,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Smoking History Malignant neoplasm of breast
PREDISPOSES,Sialyltransferases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Sialyltransferases Malignant neoplasm of breast
AUGMENTS,CATHEPSIN D|CTSD,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",CATHEPSIN D|CTSD Breast cancer metastatic
CAUSES,Monoclonal Antibodies,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Monoclonal Antibodies Malignant neoplasm of breast
CAUSES,Polymerase,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Polymerase Breast Carcinoma
CAUSES,Dietary Fiber,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Dietary Fiber Malignant neoplasm of breast
AUGMENTS,Insulin Receptor|INSR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Insulin Receptor|INSR Malignant neoplasm of breast
PREDISPOSES,Non-smoker,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Non-smoker Malignant neoplasm of breast
DISRUPTS,Estradiol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Estradiol Malignant neoplasm of breast
AFFECTS,Fluphenazine Hydrochloride,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Fluphenazine Hydrochloride Breast Carcinoma
CAUSES,Lymphoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Lymphoma Malignant neoplasm of breast
PREDISPOSES,NODULAR DENSITY,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",NODULAR DENSITY Malignant neoplasm of breast
CAUSES,Study models,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,"Element, Ion, or Isotope",Study models Ductal Breast Carcinoma
AUGMENTS,Glucagon,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Glucagon Breast Carcinoma
AUGMENTS,Insulin,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,Insulin Breast Carcinoma
AFFECTS,Autologous bone marrow transplant,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Autologous bone marrow transplant Malignant neoplasm of breast
AFFECTS,beta-Chemokines,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Disease or Syndrome,beta-Chemokines Breast Carcinoma
CAUSES,PIN1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",PIN1 Malignant neoplasm of breast
CAUSES,Signaling Molecule,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Signaling Molecule Malignant neoplasm of breast
AFFECTS,Microsatellite Instability,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Disease or Syndrome,Microsatellite Instability Sporadic Breast Carcinoma
PREDISPOSES,Laminin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Laminin Malignant neoplasm of breast
AFFECTS,Raw vegetable,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Raw vegetable Malignant neoplasm of breast
PREDISPOSES,Transferase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Transferase Malignant neoplasm of breast
AUGMENTS,CDKN2A|CDKN2D|F9|REG1A|IL23A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",CDKN2A|CDKN2D|F9|REG1A|IL23A Malignant neoplasm of breast
DISRUPTS,Inositol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Inositol Malignant neoplasm of breast
PREDISPOSES,SULT1A1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",SULT1A1 Malignant neoplasm of breast
DISRUPTS,Inositol,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Inositol Breast Carcinoma
AFFECTS,Differential Diagnosis,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Differential Diagnosis Breast Carcinoma
DISRUPTS,PRMT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,PRMT1 Malignant neoplasm of breast
AFFECTS,Folate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Folate Malignant neoplasm of breast
AFFECTS,Aneuploidy,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Aneuploidy Breast Carcinoma
PREDISPOSES,Mitogens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Mitogens Malignant neoplasm of breast
DISRUPTS,Bilirubin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Bilirubin Malignant neoplasm of breast
CAUSES,cyclin E2|CCNE2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",cyclin E2|CCNE2 Malignant neoplasm of breast
AFFECTS,SPARC,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",SPARC Malignant neoplasm of breast
AFFECTS,ID-1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ID-1 Malignant neoplasm of breast
DISRUPTS,Globo-H,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Globo-H Malignant neoplasm of breast
AFFECTS,Metformin,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Neoplastic Process,Metformin Noninfiltrating Intraductal Carcinoma
AUGMENTS,Platinum,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Platinum Malignant neoplasm of breast
AFFECTS,EGb 761,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,EGb 761 Malignant neoplasm of breast
CAUSES,celecoxib,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,celecoxib Malignant neoplasm of breast
AFFECTS,Nulliparity,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Nulliparity Malignant neoplasm of breast
CAUSES,B-pyridine,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,B-pyridine Breast Carcinoma
PREDISPOSES,Meal pattern NOS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Meal pattern NOS Malignant neoplasm of breast
PREDISPOSES,Diastasis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Diastasis Malignant neoplasm of breast
PREDISPOSES,Fumarate Hydratase|FH,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Fumarate Hydratase|FH Malignant neoplasm of breast
AFFECTS,Vidal,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Vidal Malignant neoplasm of breast
AFFECTS,E-Cadherin|EREG|ESR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",E-Cadherin|EREG|ESR1 Malignant neoplasm of breast
PREDISPOSES,Fluoxetine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Fluoxetine Malignant neoplasm of breast
AFFECTS,ERA-923,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,ERA-923 Breast Carcinoma
AUGMENTS,CD151,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,CD151 Malignant neoplasm of breast
AUGMENTS,Tretinoin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Tretinoin Malignant neoplasm of breast
AFFECTS,Multiparity,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Multiparity Malignant neoplasm of breast
AUGMENTS,Tankyrase|TNKS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Tankyrase|TNKS Malignant neoplasm of breast
AFFECTS,Beans,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Beans Malignant neoplasm of breast
PREDISPOSES,integrin-linked kinase,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",integrin-linked kinase Breast cancer metastatic
CAUSES,Tea,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Tea Malignant neoplasm of breast
PREDISPOSES,zeaxanthin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,zeaxanthin Malignant neoplasm of breast
PREDISPOSES,Smoking,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Smoking Familial cancer of breast
PREDISPOSES,CD109,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,CD109 Breast Carcinoma
AFFECTS,ERBB2|NEU1|NEURL1,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",ERBB2|NEU1|NEURL1 Breast Carcinoma
CAUSES,SRC,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",SRC Breast Carcinoma
CAUSES,Heterocyclic Amines,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Heterocyclic Amines Malignant neoplasm of breast
CAUSES,Aromatic Amines,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Aromatic Amines Malignant neoplasm of breast
AFFECTS,TBX3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,TBX3 Malignant neoplasm of breast
PREDISPOSES,IFI27|PSMD9|SSSCA1|DCTN6|TMED7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,IFI27|PSMD9|SSSCA1|DCTN6|TMED7 Malignant neoplasm of breast
AFFECTS,Integrin alpha6beta1,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Integrin alpha6beta1 Breast Carcinoma
AUGMENTS,Angiopoietin-2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Angiopoietin-2 Breast cancer metastatic
CAUSES,LMO4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,LMO4 Malignant neoplasm of breast
PREDISPOSES,Fetus size,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Fetus size Malignant neoplasm of breast
AUGMENTS,ERbetacx,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Neoplastic Process,ERbetacx Noninfiltrating Intraductal Carcinoma
AFFECTS,multicatalytic endopeptidase complex,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,multicatalytic endopeptidase complex Breast cancer metastatic
PREDISPOSES,Abnormal result,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Abnormal result Malignant neoplasm of breast
AFFECTS,p21-activated kinase 1|CDKN1A|TCEAL1|NSG1|H3F3AP6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",p21-activated kinase 1|CDKN1A|TCEAL1|NSG1|H3F3AP6 Malignant neoplasm of breast
PREDISPOSES,WISP2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,WISP2 Malignant neoplasm of breast
AUGMENTS,WWP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,WWP1 Malignant neoplasm of breast
DISRUPTS,Water,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Water Malignant neoplasm of breast
PREDISPOSES,Eating habit,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Eating habit Malignant neoplasm of breast
PREDISPOSES,alanylalanine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,alanylalanine Malignant neoplasm of breast
AFFECTS,MUC5B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,MUC5B Malignant neoplasm of breast
AFFECTS,Cyclophosphamide,Breast cancer stage II,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Cyclophosphamide Breast cancer stage II
PREDISPOSES,"Nuclear Receptor Subfamily 4, Group A, Member 1",Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Element, Ion, or Isotope","Nuclear Receptor Subfamily 4, Group A, Member 1 Breast cancer recurrent"
PREDISPOSES,Bloody nipple discharge,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Bloody nipple discharge Malignant neoplasm of breast
PREDISPOSES,trans-resveratrol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",trans-resveratrol Malignant neoplasm of breast
AUGMENTS,phospholipase C beta2|NEUROD1|TUBB4B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",phospholipase C beta2|NEUROD1|TUBB4B Malignant neoplasm of breast
AFFECTS,Cytochrome P-450 CYP2D6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Cytochrome P-450 CYP2D6 Malignant neoplasm of breast
CAUSES,Prolactin Receptor|PRLR,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,Prolactin Receptor|PRLR Breast cancer metastatic
PREDISPOSES,Cyclin D1|CCND1,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Element, Ion, or Isotope",Cyclin D1|CCND1 Breast cancer invasive NOS
PREDISPOSES,ADIPOR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ADIPOR1 Malignant neoplasm of breast
AFFECTS,Bone remodeling,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Bone remodeling Breast cancer metastatic
AUGMENTS,ADRA1D,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ADRA1D Malignant neoplasm of breast
AFFECTS,Hypoxia,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Hypoxia Breast Carcinoma
AFFECTS,Pharmacotherapy,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Neoplastic Process,Pharmacotherapy Noninfiltrating Intraductal Carcinoma
PREDISPOSES,osteopontin,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",osteopontin Breast cancer metastatic
AFFECTS,N-Cadherins,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",N-Cadherins Breast cancer metastatic
PREDISPOSES,LSP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",LSP1 Malignant neoplasm of breast
AFFECTS,Stromal hyperplasia,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Stromal hyperplasia Breast Carcinoma
AUGMENTS,UNC45A,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",UNC45A Breast cancer metastatic
PREDISPOSES,CISH,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,"Element, Ion, or Isotope",CISH Female Breast Carcinoma
AUGMENTS,IGF1R,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",IGF1R Malignant neoplasm of breast
AFFECTS,artesunate,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,artesunate Breast Carcinoma
PREDISPOSES,Adrenergic beta-Antagonists,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Element, Ion, or Isotope",Adrenergic beta-Antagonists Breast cancer recurrent
AUGMENTS,Selectins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Selectins Malignant neoplasm of breast
PREDISPOSES,Paraffin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Paraffin Malignant neoplasm of breast
AFFECTS,heparanase,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",heparanase Breast cancer metastatic
AFFECTS,"Calcium, Dietary",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Calcium, Dietary Malignant neoplasm of breast"
DISRUPTS,denbinobin,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",denbinobin Breast cancer metastatic
PREDISPOSES,Proline,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Proline Malignant neoplasm of breast
DISRUPTS,FAT4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,FAT4 Malignant neoplasm of breast
PREDISPOSES,prophylactics use,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",prophylactics use Malignant neoplasm of breast
AFFECTS,HDAC9,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",HDAC9 Breast cancer metastatic
PREDISPOSES,Ethanol,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Ethanol Contralateral breast cancer
PREDISPOSES,COPS5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,COPS5 Malignant neoplasm of breast
AFFECTS,KDM1B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,KDM1B Malignant neoplasm of breast
PREDISPOSES,Cigarette Smoking,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,"Element, Ion, or Isotope",Cigarette Smoking Contralateral breast cancer
AUGMENTS,CBX1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,CBX1 Malignant neoplasm of breast
AFFECTS,metabolic abnormality assessment,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",metabolic abnormality assessment Malignant neoplasm of breast
AFFECTS,Metabolism,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Metabolism Malignant neoplasm of breast
AUGMENTS,UHRF1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",UHRF1 Malignant neoplasm of breast
AFFECTS,asparaginylendopeptidase,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",asparaginylendopeptidase Breast cancer metastatic
DISRUPTS,Transcript,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Neoplastic Process,Transcript Noninfiltrating Intraductal Carcinoma
PREDISPOSES,p21-activated kinase 1|CDKN1A|TCEAL1|NSG1|H3F3AP6,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Amino Acid, Peptide, or Protein",p21-activated kinase 1|CDKN1A|TCEAL1|NSG1|H3F3AP6 Breast cancer recurrent
PREDISPOSES,UHRF1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",UHRF1 Malignant neoplasm of breast
AUGMENTS,heparanase|HPSE,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,heparanase|HPSE Breast cancer metastatic
PREDISPOSES,NUCB2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,NUCB2 Breast cancer metastatic
PREDISPOSES,Keratin,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Keratin Breast Carcinoma
PREDISPOSES,PER1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,PER1 Malignant neoplasm of breast
PREDISPOSES,Polyethylene Glycols,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Polyethylene Glycols Malignant neoplasm of breast
CAUSES,flavanone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,flavanone Malignant neoplasm of breast
PREDISPOSES,Acetaldehyde,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Acetaldehyde Malignant neoplasm of breast
AUGMENTS,SLC2A1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",SLC2A1 Malignant neoplasm of breast
PREDISPOSES,Physiologic Responses,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Physiologic Responses Malignant neoplasm of breast
PREDISPOSES,SMYD2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",SMYD2 Malignant neoplasm of breast
AFFECTS,Dimethylformamide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Dimethylformamide Malignant neoplasm of breast
CAUSES,Systemic poison,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Systemic poison Malignant neoplasm of breast
AFFECTS,Hydroxymethylglutaryl-CoA Reductase Inhibitors,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Element, Ion, or Isotope",Hydroxymethylglutaryl-CoA Reductase Inhibitors Breast cancer recurrent
AFFECTS,Stereotactic radiotherapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Stereotactic radiotherapy Malignant neoplasm of breast
PREDISPOSES,lard,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,lard Malignant neoplasm of breast
AFFECTS,Angiotensins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Angiotensins Malignant neoplasm of breast
AFFECTS,Nicotine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Nicotine Malignant neoplasm of breast
DISRUPTS,osthol,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",osthol Breast cancer metastatic
AFFECTS,ginkgetin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ginkgetin Malignant neoplasm of breast
CAUSES,HOXD13,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,HOXD13 Breast cancer invasive NOS
AFFECTS,diallyl trisulfide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,diallyl trisulfide Malignant neoplasm of breast
AUGMENTS,citrate lyase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,citrate lyase Malignant neoplasm of breast
AFFECTS,Pharmacotherapy,Breast cancer stage III,0.0009990009990009,Female Breast Cancer,Gene or Genome,Pharmacotherapy Breast cancer stage III
DISRUPTS,PPP2R1A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,PPP2R1A Malignant neoplasm of breast
AFFECTS,ADIPOR2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ADIPOR2 Malignant neoplasm of breast
PREDISPOSES,Interleukin-1 alpha,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Interleukin-1 alpha Malignant neoplasm of breast
PREDISPOSES,MMP12,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,MMP12 Malignant neoplasm of breast
DISRUPTS,DANCR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",DANCR Malignant neoplasm of breast
PREDISPOSES,baicalein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,baicalein Malignant neoplasm of breast
AFFECTS,Benzodiazepines,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Benzodiazepines Malignant neoplasm of breast
DISRUPTS,Neprilysin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Neprilysin Malignant neoplasm of breast
CAUSES,WBP2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",WBP2 Malignant neoplasm of breast
DISRUPTS,Anthocyanins,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Anthocyanins Breast cancer metastatic
AFFECTS,Mesothelioma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Mesothelioma Malignant neoplasm of breast
AFFECTS,Lipopolysaccharides,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Lipopolysaccharides Breast cancer metastatic
PREDISPOSES,"Dysplasia, fibrous",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Dysplasia, fibrous Malignant neoplasm of breast"
AFFECTS,SYNJ2BP,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",SYNJ2BP Breast cancer metastatic
AFFECTS,phenylpyruvate tautomerase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,phenylpyruvate tautomerase Malignant neoplasm of breast
AFFECTS,Camellia sinensis extract,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Camellia sinensis extract Malignant neoplasm of breast
DISRUPTS,SRCIN1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",SRCIN1 Malignant neoplasm of breast
PREDISPOSES,"Receptors, Calcium-Sensing",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Receptors, Calcium-Sensing Malignant neoplasm of breast"
AFFECTS,17beta-HSD 7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,17beta-HSD 7 Malignant neoplasm of breast
DISRUPTS,PNPLA2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,PNPLA2 Malignant neoplasm of breast
AFFECTS,L-2-amino-4-phosphonobutyrate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",L-2-amino-4-phosphonobutyrate Malignant neoplasm of breast
PREDISPOSES,RUNX2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",RUNX2 Breast cancer metastatic
AFFECTS,Mitosis,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Neoplastic Process,Mitosis Inflammatory Breast Carcinoma
AFFECTS,Riluzole,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Riluzole Malignant neoplasm of breast
AFFECTS,Androgens,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Neoplastic Process,Androgens Noninfiltrating Intraductal Carcinoma
AFFECTS,Tiron,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Tiron Breast Carcinoma
AFFECTS,sorafenib,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,sorafenib Malignant neoplasm of breast
AUGMENTS,Paclitaxel,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Paclitaxel Breast cancer metastatic
AFFECTS,Cytochrome P-450 CYP2E1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Cytochrome P-450 CYP2E1 Malignant neoplasm of breast
AFFECTS,Dendritic Cell Vaccine,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Dendritic Cell Vaccine Breast cancer metastatic
AUGMENTS,cyclin B2|CCNB2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",cyclin B2|CCNB2 Malignant neoplasm of breast
PREDISPOSES,receptor,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",receptor Breast cancer metastatic
AUGMENTS,atamestane,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,atamestane Malignant neoplasm of breast
PREDISPOSES,N-(4-aminophenethyl)spiroperidol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,N-(4-aminophenethyl)spiroperidol Malignant neoplasm of breast
PREDISPOSES,GACAT3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,GACAT3 Malignant neoplasm of breast
AUGMENTS,Aspartate Transaminase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Aspartate Transaminase Malignant neoplasm of breast
AUGMENTS,UBAP2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,UBAP2 Malignant neoplasm of breast
DISRUPTS,Bombesin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Bombesin Malignant neoplasm of breast
PREDISPOSES,BRIP1,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",BRIP1 Familial cancer of breast
AUGMENTS,indole,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,indole Malignant neoplasm of breast
AUGMENTS,AKTIP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",AKTIP Malignant neoplasm of breast
AUGMENTS,LMO4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,LMO4 Malignant neoplasm of breast
PREDISPOSES,SIRT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",SIRT1 Malignant neoplasm of breast
PREDISPOSES,JAG1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",JAG1 Malignant neoplasm of breast
AFFECTS,FOXM1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",FOXM1 Malignant neoplasm of breast
AUGMENTS,Acetylcysteine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Acetylcysteine Malignant neoplasm of breast
CAUSES,Diet,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Neoplastic Process,Diet Noninfiltrating Intraductal Carcinoma
AFFECTS,fisetin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,fisetin Malignant neoplasm of breast
PREDISPOSES,chemokine receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,chemokine receptor Malignant neoplasm of breast
AFFECTS,rhodioloside,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,rhodioloside Malignant neoplasm of breast
AUGMENTS,HOXB5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,HOXB5 Malignant neoplasm of breast
AFFECTS,Nitric Oxide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Nitric Oxide Malignant neoplasm of breast
PREDISPOSES,YBX1,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Element, Ion, or Isotope",YBX1 Breast cancer invasive NOS
AFFECTS,proteomic profiling,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,proteomic profiling Malignant neoplasm of breast
AFFECTS,Mastectomy,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Mastectomy Breast cancer metastatic
AFFECTS,SNAI1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",SNAI1 Malignant neoplasm of breast
PREDISPOSES,MFAP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,MFAP1 Malignant neoplasm of breast
AFFECTS,Hyperinsulinism,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Hyperinsulinism Malignant neoplasm of breast
AUGMENTS,MTDH,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",MTDH Malignant neoplasm of breast
PREDISPOSES,Diabetic,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Diabetic Malignant neoplasm of breast
DISRUPTS,Genistein,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Genistein Breast Carcinoma
PREDISPOSES,CD24,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",CD24 Breast Carcinoma
PREDISPOSES,Breast hyperplasia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Breast hyperplasia Malignant neoplasm of breast
PREDISPOSES,mixed drink,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",mixed drink Malignant neoplasm of breast
AFFECTS,Thrombospondin 1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Thrombospondin 1 Malignant neoplasm of breast
CAUSES,Diet,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Diet Breast Carcinoma
AFFECTS,CYP2A6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,CYP2A6 Malignant neoplasm of breast
AFFECTS,Wound Healing,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Wound Healing Breast Carcinoma
CAUSES,Depo-Provera,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Depo-Provera Breast Carcinoma
PREDISPOSES,Hydrocortisone,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Neoplastic Process,Hydrocortisone Noninfiltrating Intraductal Carcinoma
AFFECTS,Hydroxymethylglutaryl-CoA Reductase Inhibitors,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Hydroxymethylglutaryl-CoA Reductase Inhibitors Breast Carcinoma
AFFECTS,Violence,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Violence Malignant neoplasm of breast
PREDISPOSES,Methotrexate,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Methotrexate Breast cancer recurrent
PREDISPOSES,BP3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,BP3 Malignant neoplasm of breast
AFFECTS,Permeability,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Neoplastic Process,Permeability Noninfiltrating Intraductal Carcinoma
AFFECTS,CISH,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,CISH Malignant neoplasm of breast
AFFECTS,SULT1A1|SULT1A1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",SULT1A1|SULT1A1 Malignant neoplasm of breast
AFFECTS,tibolone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,tibolone Malignant neoplasm of breast
PREDISPOSES,Menopausal Status,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",Menopausal Status Noninfiltrating Intraductal Carcinoma
AFFECTS,SFRP2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",SFRP2 Malignant neoplasm of breast
AUGMENTS,SLC13A2|SLC13A5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,SLC13A2|SLC13A5 Malignant neoplasm of breast
AFFECTS,bone metabolism,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",bone metabolism Breast cancer metastatic
PREDISPOSES,Androgens,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Neoplastic Process,Androgens Noninfiltrating Intraductal Carcinoma
AFFECTS,Lactate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Lactate Malignant neoplasm of breast
AFFECTS,telomerase activity,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",telomerase activity Noninfiltrating Intraductal Carcinoma
AFFECTS,Seasoning,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Seasoning Malignant neoplasm of breast
PREDISPOSES,Atypia,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,Atypia Breast cancer invasive NOS
PREDISPOSES,Test Result,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,Body Substance,Test Result Familial cancer of breast
PREDISPOSES,Pathologic stage,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Pathologic stage Malignant neoplasm of breast
AFFECTS,Janus kinase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Janus kinase Malignant neoplasm of breast
PREDISPOSES,B VARIANT NOS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",B VARIANT NOS Malignant neoplasm of breast
DISRUPTS,CDKN1A|TCEAL1|NSG1|H3F3AP6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",CDKN1A|TCEAL1|NSG1|H3F3AP6 Malignant neoplasm of breast
PREDISPOSES,Shock,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Shock Malignant neoplasm of breast
CAUSES,Antioxidants,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Antioxidants Malignant neoplasm of breast
PREDISPOSES,Gonadorelin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Gonadorelin Malignant neoplasm of breast
CAUSES,Gelatinase B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Gelatinase B Malignant neoplasm of breast
AUGMENTS,VEGFA,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Element, Ion, or Isotope",VEGFA Breast cancer recurrent
AUGMENTS,MED28,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Neoplastic Process,MED28 Noninfiltrating Intraductal Carcinoma
DISRUPTS,Selenium,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Selenium Malignant neoplasm of breast
PREDISPOSES,Immunoglobulin A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Immunoglobulin A Malignant neoplasm of breast
AUGMENTS,MED28,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,MED28 Malignant neoplasm of breast
PREDISPOSES,claudin 6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,claudin 6 Malignant neoplasm of breast
AUGMENTS,PLEKHF1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,PLEKHF1 Malignant neoplasm of breast
PREDISPOSES,Associated symptom,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Associated symptom Malignant neoplasm of breast
PREDISPOSES,2q34,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,2q34 Malignant neoplasm of breast
AFFECTS,fucoidan,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,fucoidan Malignant neoplasm of breast
AFFECTS,5-7-oxo-zeaenol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,5-7-oxo-zeaenol Malignant neoplasm of breast
AUGMENTS,EGFR|ENAH,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",EGFR|ENAH Malignant neoplasm of breast
AUGMENTS,coactivator-associated arginine methyltransferase 1|CARM1,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Element, Ion, or Isotope",coactivator-associated arginine methyltransferase 1|CARM1 Breast cancer invasive NOS
AFFECTS,ACKR3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ACKR3 Malignant neoplasm of breast
AUGMENTS,Chloroquine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Chloroquine Malignant neoplasm of breast
PREDISPOSES,Does play,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Does play Malignant neoplasm of breast
AFFECTS,Weight maintenance regimen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Weight maintenance regimen Malignant neoplasm of breast
AFFECTS,RAP1GDS1|KIFAP3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,RAP1GDS1|KIFAP3 Malignant neoplasm of breast
PREDISPOSES,LPO,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,LPO Malignant neoplasm of breast
PREDISPOSES,PIP,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Neoplastic Process,PIP Ductal Breast Carcinoma
PREDISPOSES,proneurotensin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,proneurotensin Malignant neoplasm of breast
PREDISPOSES,Dehydroepiandrosterone Sulfate,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Element, Ion, or Isotope",Dehydroepiandrosterone Sulfate Breast cancer invasive NOS
AUGMENTS,EGb 761,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,EGb 761 Malignant neoplasm of breast
AUGMENTS,mortalin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,mortalin Malignant neoplasm of breast
DISRUPTS,CACNA1A,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",CACNA1A Breast cancer metastatic
AFFECTS,osteopontin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,osteopontin Malignant neoplasm of breast
AUGMENTS,XIST,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,XIST Malignant neoplasm of breast
CAUSES,CISH,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,CISH Malignant neoplasm of breast
AFFECTS,Interleukin-6|IL6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Interleukin-6|IL6 Malignant neoplasm of breast
AFFECTS,COX5B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,COX5B Malignant neoplasm of breast
AFFECTS,AHNAK,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,AHNAK Malignant neoplasm of breast
PREDISPOSES,no positive axillary nodes,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Element, Ion, or Isotope",no positive axillary nodes Breast cancer recurrent
PREDISPOSES,chitotriosidase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,chitotriosidase Malignant neoplasm of breast
AFFECTS,PROSTATE SPECIFIC,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",PROSTATE SPECIFIC Malignant neoplasm of breast
AFFECTS,Adjuvant response,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Adjuvant response Malignant neoplasm of breast
PREDISPOSES,E-Cadherin,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,E-Cadherin Breast cancer invasive NOS
AFFECTS,Platinum salt,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Platinum salt Malignant neoplasm of breast
CAUSES,Insulin Receptor|INSR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Insulin Receptor|INSR Malignant neoplasm of breast
PREDISPOSES,CREB3L1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,CREB3L1 Malignant neoplasm of breast
DISRUPTS,Melatonin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Melatonin Malignant neoplasm of breast
AUGMENTS,Interleukin-6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Interleukin-6 Malignant neoplasm of breast
AFFECTS,Fibroadenoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Fibroadenoma Malignant neoplasm of breast
AFFECTS,FANCM,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",FANCM Malignant neoplasm of breast
PREDISPOSES,6/6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,6/6 Malignant neoplasm of breast
AUGMENTS,Thyroxine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Thyroxine Malignant neoplasm of breast
AFFECTS,Gastrin|GAST,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Gastrin|GAST Malignant neoplasm of breast
PREDISPOSES,Peanuts - dietary,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Peanuts - dietary Malignant neoplasm of breast
DISRUPTS,EREG|ESR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",EREG|ESR1 Malignant neoplasm of breast
AFFECTS,Acetate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Acetate Malignant neoplasm of breast
AUGMENTS,IFI27|PSMD9|SSSCA1|DCTN6|TMED7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,IFI27|PSMD9|SSSCA1|DCTN6|TMED7 Malignant neoplasm of breast
CAUSES,Compete,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Compete Malignant neoplasm of breast
PREDISPOSES,Crystallins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Crystallins Malignant neoplasm of breast
PREDISPOSES,MSX2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,MSX2 Malignant neoplasm of breast
AUGMENTS,YBX1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",YBX1 Malignant neoplasm of breast
PREDISPOSES,valdecoxib,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,valdecoxib Malignant neoplasm of breast
DISRUPTS,Mitomycin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Mitomycin Malignant neoplasm of breast
PREDISPOSES,PRRT2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",PRRT2 Malignant neoplasm of breast
AUGMENTS,EGFL7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,EGFL7 Malignant neoplasm of breast
AUGMENTS,beta catenin,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,"Element, Ion, or Isotope","beta catenin Carcinoma, Ductal, Breast"
DISRUPTS,LRRC3B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",LRRC3B Malignant neoplasm of breast
AUGMENTS,Nitric Oxide Synthase Type II,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Nitric Oxide Synthase Type II Malignant neoplasm of breast
AUGMENTS,Thromboplastin,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,Thromboplastin Breast cancer invasive NOS
PREDISPOSES,CD24,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",CD24 Malignant neoplasm of breast
PREDISPOSES,BMP1|PRCP|PGPEP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,BMP1|PRCP|PGPEP1 Malignant neoplasm of breast
DISRUPTS,baicalein,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",baicalein Breast cancer metastatic
PREDISPOSES,PFAS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,PFAS Malignant neoplasm of breast
PREDISPOSES,Diet,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,Diet Breast cancer invasive NOS
AFFECTS,tibolone,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",tibolone Breast cancer recurrent
PREDISPOSES,collagenase 3|PGR|PR@|PRH2|TMEM37|ERVK-7|ERVK-8|ERVK-10|ERVK-9|ERVK-21|ERVK-18|ERVK-25|ERVK-24|ERVK-19,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",collagenase 3|PGR|PR@|PRH2|TMEM37|ERVK-7|ERVK-8|ERVK-10|ERVK-9|ERVK-21|ERVK-18|ERVK-25|ERVK-24|ERVK-19 Malignant neoplasm of breast
AFFECTS,Histopathology,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Histopathology Breast Carcinoma
AFFECTS,Chondroitin Sulfates,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Chondroitin Sulfates Breast cancer metastatic
PREDISPOSES,Cholecalciferol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Cholecalciferol Malignant neoplasm of breast
DISRUPTS,phenethyl isothiocyanate,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",phenethyl isothiocyanate Breast Carcinoma
DISRUPTS,CYLD,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,CYLD Malignant neoplasm of breast
AFFECTS,TBX3,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,TBX3 Breast cancer invasive NOS
DISRUPTS,gefitinib,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",gefitinib Breast cancer metastatic
CAUSES,Oxytocin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Oxytocin Malignant neoplasm of breast
PREDISPOSES,Ferritin level,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Ferritin level Malignant neoplasm of breast
PREDISPOSES,Norethindrone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Norethindrone Malignant neoplasm of breast
AFFECTS,DACH1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",DACH1 Malignant neoplasm of breast
PREDISPOSES,Hyperinsulinism,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Hyperinsulinism Breast cancer metastatic
AFFECTS,Venous Thrombosis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Venous Thrombosis Malignant neoplasm of breast
AUGMENTS,WWOX,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",WWOX Malignant neoplasm of breast
PREDISPOSES,USH2A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,USH2A Malignant neoplasm of breast
PREDISPOSES,Cigarette smoke,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Cigarette smoke Malignant neoplasm of breast
PREDISPOSES,NET1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,NET1 Malignant neoplasm of breast
AFFECTS,MXD1|MAD1L1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,MXD1|MAD1L1 Malignant neoplasm of breast
DISRUPTS,Flavonols,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Flavonols Malignant neoplasm of breast
COMPLICATES,Pancreatic leak,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,"Element, Ion, or Isotope",Pancreatic leak Ductal Breast Carcinoma
AFFECTS,Bilateral oophorectomy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Bilateral oophorectomy Malignant neoplasm of breast
AFFECTS,Depo-Provera,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Depo-Provera Malignant neoplasm of breast
AFFECTS,Neck Neoplasms,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Neck Neoplasms Malignant neoplasm of breast
AUGMENTS,gamma-Glutamyl Hydrolase,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Element, Ion, or Isotope",gamma-Glutamyl Hydrolase Breast cancer invasive NOS
DISRUPTS,CATALASE,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,CATALASE Breast cancer invasive NOS
PREDISPOSES,Leeks (dietary),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Leeks (dietary) Malignant neoplasm of breast
AFFECTS,Vasospasm,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Neoplastic Process,Vasospasm Noninfiltrating Intraductal Carcinoma
AFFECTS,Biological Response Modifiers,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Biological Response Modifiers Malignant neoplasm of breast
DISRUPTS,Micellar Paclitaxel,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Micellar Paclitaxel Malignant neoplasm of breast
CAUSES,Oxalates,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Oxalates Malignant neoplasm of breast
PREDISPOSES,MED19,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,MED19 Malignant neoplasm of breast
PREDISPOSES,Performance,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,Performance Breast cancer invasive NOS
PREDISPOSES,ECT2,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,ECT2 Breast cancer invasive NOS
PREDISPOSES,LINC00461,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,LINC00461 Malignant neoplasm of breast
PREDISPOSES,USP1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",USP1 Breast cancer metastatic
AFFECTS,DKK1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,DKK1 Malignant neoplasm of breast
PREDISPOSES,PIP5K1C,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,PIP5K1C Malignant neoplasm of breast
AFFECTS,Feeding and dietary regimes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Feeding and dietary regimes Malignant neoplasm of breast
AFFECTS,ENPP2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ENPP2 Malignant neoplasm of breast
PREDISPOSES,BITTER MELON FRUIT,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,BITTER MELON FRUIT Malignant neoplasm of breast
PREDISPOSES,PVR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",PVR Malignant neoplasm of breast
PREDISPOSES,Juice,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Juice Malignant neoplasm of breast
PREDISPOSES,Glucocorticoids,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Glucocorticoids Breast cancer metastatic
DISRUPTS,LRP6,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,LRP6 Breast cancer metastatic
CAUSES,Relapse,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Relapse Malignant neoplasm of breast
AFFECTS,cyclin-dependent kinase inhibitor 1B|CDKN1B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",cyclin-dependent kinase inhibitor 1B|CDKN1B Malignant neoplasm of breast
DISRUPTS,Natural Products,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Element, Ion, or Isotope",Natural Products Breast cancer recurrent
DISRUPTS,Interleukin-6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Interleukin-6 Malignant neoplasm of breast
PREDISPOSES,Paraoxonase 1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Paraoxonase 1 Malignant neoplasm of breast
DISRUPTS,Interleukin-1 beta,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Interleukin-1 beta Malignant neoplasm of breast
AFFECTS,ZEB2-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",ZEB2-AS1 Malignant neoplasm of breast
PREDISPOSES,CKS2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",CKS2 Malignant neoplasm of breast
DISRUPTS,beta-elemene,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",beta-elemene Breast cancer metastatic
DISRUPTS,mammaglobin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,mammaglobin Malignant neoplasm of breast
PREDISPOSES,lipocalin 1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,lipocalin 1 Malignant neoplasm of breast
PREDISPOSES,caspase-8|CASP8,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",caspase-8|CASP8 Malignant neoplasm of breast
AUGMENTS,IL17F,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,IL17F Malignant neoplasm of breast
DISRUPTS,claudin 6,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",claudin 6 Breast cancer metastatic
AFFECTS,Gangliosides,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Gangliosides Malignant neoplasm of breast
AUGMENTS,AFAP1L2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,AFAP1L2 Malignant neoplasm of breast
DISRUPTS,Doxorubicin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Doxorubicin Malignant neoplasm of breast
AFFECTS,AMD3465,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",AMD3465 Breast cancer metastatic
AFFECTS,CCAT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,CCAT1 Malignant neoplasm of breast
AFFECTS,shogaol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,shogaol Malignant neoplasm of breast
CAUSES,1-(2-(4-aminophenyl)ethyl)-4-(3-trifluoromethylphenyl)piperazine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,1-(2-(4-aminophenyl)ethyl)-4-(3-trifluoromethylphenyl)piperazine Malignant neoplasm of breast
PREDISPOSES,"Osteoporosis, Postmenopausal",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Osteoporosis, Postmenopausal Malignant neoplasm of breast"
PREDISPOSES,Translocase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Translocase Malignant neoplasm of breast
CAUSES,Collagen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Collagen Malignant neoplasm of breast
AUGMENTS,EZR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,EZR Malignant neoplasm of breast
PREDISPOSES,Monoacylglycerol Lipases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Monoacylglycerol Lipases Malignant neoplasm of breast
PREDISPOSES,ABRAXAS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ABRAXAS1 Malignant neoplasm of breast
AFFECTS,HULC,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,HULC Malignant neoplasm of breast
PREDISPOSES,PARITY,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Neoplastic Process,PARITY Noninfiltrating Intraductal Carcinoma
PREDISPOSES,Proanthocyanidins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Proanthocyanidins Malignant neoplasm of breast
PREDISPOSES,Anthocyanidins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Anthocyanidins Malignant neoplasm of breast
AUGMENTS,26S proteasome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,26S proteasome Malignant neoplasm of breast
DISRUPTS,LINC00665,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",LINC00665 Malignant neoplasm of breast
AFFECTS,Enrich (product),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Enrich (product) Malignant neoplasm of breast
DISRUPTS,"interleukin-1, beta",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","interleukin-1, beta Malignant neoplasm of breast"
AFFECTS,rucaparib,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",rucaparib Triple Negative Breast Neoplasms
AFFECTS,fucoidan,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",fucoidan Triple Negative Breast Neoplasms
AUGMENTS,Thromboplastin,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Neoplastic Process,Thromboplastin Noninfiltrating Intraductal Carcinoma
AFFECTS,ROR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ROR1 Malignant neoplasm of breast
AUGMENTS,CpG Islands,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",CpG Islands Malignant neoplasm of breast
DISRUPTS,chloroxoquinoline,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Neoplastic Process,chloroxoquinoline Invasive carcinoma of breast
PREDISPOSES,bis(4-hydroxyphenyl)sulfone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,bis(4-hydroxyphenyl)sulfone Malignant neoplasm of breast
PREDISPOSES,ZFP36L1|BRF1|MST1L,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",ZFP36L1|BRF1|MST1L Malignant neoplasm of breast
DISRUPTS,Hydrogel,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Hydrogel Malignant neoplasm of breast
AFFECTS,nobiletin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,nobiletin Malignant neoplasm of breast
AFFECTS,CALCIUM HOMEOSTASIS,Carcinoma breast stage IV,0.0,Female Breast Cancer,"Element, Ion, or Isotope",CALCIUM HOMEOSTASIS Carcinoma breast stage IV
AFFECTS,Targeted Therapy,Carcinoma breast stage IV,0.0,Female Breast Cancer,Gene or Genome,Targeted Therapy Carcinoma breast stage IV
DISRUPTS,Aptamer,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Aptamer Malignant neoplasm of breast
AFFECTS,Xenograft type of graft,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Xenograft type of graft Malignant neoplasm of breast
PREDISPOSES,Risk Behavior,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Risk Behavior Malignant neoplasm of breast
AFFECTS,Graft acceptance,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Graft acceptance Triple Negative Breast Neoplasms
DISRUPTS,marizomib,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",marizomib Triple Negative Breast Neoplasms
AFFECTS,ergocalciferol,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",ergocalciferol Triple Negative Breast Neoplasms
PREDISPOSES,Transcriptome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Transcriptome Malignant neoplasm of breast
PREDISPOSES,AGR2,estrogen receptor-negative breast cancer,0.0,Female Breast Cancer,"Amino Acid, Peptide, or Protein",AGR2 estrogen receptor-negative breast cancer
DISRUPTS,DLG3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,DLG3 Malignant neoplasm of breast
AFFECTS,Mevalonate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Mevalonate Malignant neoplasm of breast
PREDISPOSES,dinoprost,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,dinoprost Malignant neoplasm of breast
PREDISPOSES,Epicatechin-3-Gallate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Epicatechin-3-Gallate Malignant neoplasm of breast
PREDISPOSES,Pathologic Response,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Pathologic Response Malignant neoplasm of breast
PREDISPOSES,PROM1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",PROM1 Triple Negative Breast Neoplasms
AFFECTS,Contralateral Prophylactic Mastectomy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Contralateral Prophylactic Mastectomy Malignant neoplasm of breast
AFFECTS,Androgen Receptor,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Pharmacologic Substance,Androgen Receptor Carcinoma of Male Breast
AFFECTS,Xenograft Model,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Hazardous or Poisonous Substance,Xenograft Model Triple Negative Breast Neoplasms
AFFECTS,Cytologic atypia,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Disease or Syndrome,Cytologic atypia Sporadic Breast Carcinoma
AFFECTS,platinum,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",platinum Malignant neoplasm of breast
CAUSES,cyclophosphamide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,cyclophosphamide Malignant neoplasm of breast
DISRUPTS,DNMT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",DNMT1 Malignant neoplasm of breast
PREDISPOSES,Unlikely,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Unlikely Malignant neoplasm of breast
PREDISPOSES,CXCL2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,CXCL2 Malignant neoplasm of breast
AFFECTS,cyclovirobuxine D,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,cyclovirobuxine D Malignant neoplasm of breast
AFFECTS,Salts,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Salts Malignant neoplasm of breast
PREDISPOSES,Fluid intake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Fluid intake Malignant neoplasm of breast
AFFECTS,Periodontitis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Periodontitis Malignant neoplasm of breast
DISRUPTS,Ganetespib,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",Ganetespib HER2-positive carcinoma of breast
AFFECTS,Phosphoinositide Phosphatases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Phosphoinositide Phosphatases Malignant neoplasm of breast
AFFECTS,Mastectomy,Stage IV Inflammatory Breast Carcinoma,0.0,Female Breast Cancer,Gene or Genome,Mastectomy Stage IV Inflammatory Breast Carcinoma
PREDISPOSES,Iodides,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Neoplastic Process,Iodides Invasive carcinoma of breast
DISRUPTS,ciclesonide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ciclesonide Malignant neoplasm of breast
PREDISPOSES,Breast normal,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Neoplastic Process,Breast normal Invasive carcinoma of breast
AFFECTS,Neoadjuvant Systemic Therapy,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",Neoadjuvant Systemic Therapy HER2-positive carcinoma of breast
PREDISPOSES,Ferritin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Ferritin Malignant neoplasm of breast
PREDISPOSES,Red Meat,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Red Meat Malignant neoplasm of breast
CAUSES,heparanase,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Neoplastic Process,heparanase Inflammatory Breast Carcinoma
PREDISPOSES,Patient age,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Patient age Malignant neoplasm of breast
AFFECTS,Digital Mammography,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",Digital Mammography Noninfiltrating Intraductal Carcinoma
PREDISPOSES,No effect,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",No effect Malignant neoplasm of breast
DISRUPTS,Insulin Receptor,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Insulin Receptor Triple Negative Breast Neoplasms
CAUSES,leptin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,leptin Malignant neoplasm of breast
PREDISPOSES,EPHA2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,EPHA2 Malignant neoplasm of breast
AFFECTS,rutin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,rutin Malignant neoplasm of breast
PREDISPOSES,Decreasing,Basal-Like Breast Carcinoma,0.0039960039960039,Female Breast Cancer,"Element, Ion, or Isotope",Decreasing Basal-Like Breast Carcinoma
AFFECTS,MLN4924,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,MLN4924 Malignant neoplasm of breast
AFFECTS,Cyclin-Dependent Kinase 4,Carcinoma breast stage IV,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Cyclin-Dependent Kinase 4 Carcinoma breast stage IV
PREDISPOSES,Ataxia Telangiectasia,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Ataxia Telangiectasia Breast Carcinoma
PREDISPOSES,Pathologic Complete Response,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",Pathologic Complete Response HER2-positive carcinoma of breast
AFFECTS,"Neoplasm, Residual",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Neoplasm, Residual Malignant neoplasm of breast"
DISRUPTS,Glucocorticoid Receptor,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Glucocorticoid Receptor Triple Negative Breast Neoplasms
PREDISPOSES,Transferrin,estrogen receptor-negative breast cancer,0.0,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Transferrin estrogen receptor-negative breast cancer
PREDISPOSES,other medicated shampoos in ATC,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",other medicated shampoos in ATC Triple Negative Breast Neoplasms
DISRUPTS,Nicotinamide Phosphoribosyltransferase,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Immunologic Factor,Nicotinamide Phosphoribosyltransferase Triple Negative Breast Neoplasms
AUGMENTS,FGFR1 wt Allele|FGFR1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",FGFR1 wt Allele|FGFR1 Triple Negative Breast Neoplasms
PREDISPOSES,Medical record number:ID:Pt:^Patient:Nom,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Medical record number:ID:Pt:^Patient:Nom Malignant neoplasm of breast
PREDISPOSES,Interleukin-12 Subunit p35,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Interleukin-12 Subunit p35 Malignant neoplasm of breast
AFFECTS,Dovitinib,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Dovitinib Triple Negative Breast Neoplasms
AFFECTS,physiological aspects,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",physiological aspects Triple Negative Breast Neoplasms
PREDISPOSES,Possible,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Possible Breast Carcinoma
AFFECTS,cell cycle regulator,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",cell cycle regulator Triple Negative Breast Neoplasms
PREDISPOSES,CBR3-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",CBR3-AS1 Malignant neoplasm of breast
AUGMENTS,Luteolin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Luteolin Malignant neoplasm of breast
DISRUPTS,MEG3|FAM129B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",MEG3|FAM129B Malignant neoplasm of breast
PREDISPOSES,Recurrent pregnancy loss,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Recurrent pregnancy loss Malignant neoplasm of breast
PREDISPOSES,Disaccharides,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Disaccharides Malignant neoplasm of breast
CAUSES,ACTG2 wt Allele,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",ACTG2 wt Allele Malignant neoplasm of breast
AFFECTS,Cell Growth,Early-Stage Breast Carcinoma,0.0,Female Breast Cancer,Biologically Active Substance,Cell Growth Early-Stage Breast Carcinoma
PREDISPOSES,COVID-19,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",COVID-19 Malignant neoplasm of breast
PREDISPOSES,Fibrillar Collagen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Fibrillar Collagen Malignant neoplasm of breast
AUGMENTS,Phosphotransferases,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Phosphotransferases Triple Negative Breast Neoplasms
PREDISPOSES,collagen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",collagen Malignant neoplasm of breast
AFFECTS,REPLETE,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,REPLETE Malignant neoplasm of breast
AUGMENTS,SMYD3,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",SMYD3 Breast Carcinoma
AUGMENTS,Alkaloids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Alkaloids Malignant neoplasm of breast
AFFECTS,Whole Grains,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Whole Grains Malignant neoplasm of breast
DISRUPTS,ergocalciferol,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Neoplastic Process,ergocalciferol Secondary malignant neoplasm of breast
DISRUPTS,Limonins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Limonins Malignant neoplasm of breast
AFFECTS,ipatasertib,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",ipatasertib Triple Negative Breast Neoplasms
CAUSES,genistein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,genistein Malignant neoplasm of breast
DISRUPTS,rosuvastatin,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",rosuvastatin Triple Negative Breast Neoplasms
AFFECTS,Reproductive Behavior,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Reproductive Behavior Malignant neoplasm of breast
PREDISPOSES,Biological Markers,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Biological Markers Breast Carcinoma
AUGMENTS,estradiol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,estradiol Malignant neoplasm of breast
PREDISPOSES,1 time,Luminal B Breast Carcinoma,0.0,Female Breast Cancer,"Element, Ion, or Isotope",1 time Luminal B Breast Carcinoma
AFFECTS,paclitaxel liposome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,paclitaxel liposome Malignant neoplasm of breast
AFFECTS,imipramine,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,"Amino Acid, Peptide, or Protein",imipramine estrogen receptor-positive breast cancer
PREDISPOSES,AMACR wt Allele,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",AMACR wt Allele Invasive carcinoma of breast
PREDISPOSES,limited use,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",limited use Malignant neoplasm of breast
AUGMENTS,cyclin B2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",cyclin B2 Malignant neoplasm of breast
PREDISPOSES,ATM,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",ATM Malignant neoplasm of breast
PREDISPOSES,Individual Exposure,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Individual Exposure Malignant neoplasm of breast
PREDISPOSES,Experimental Result,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Experimental Result Malignant neoplasm of breast
PREDISPOSES,Pneumocystis jiroveci pneumonia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Pneumocystis jiroveci pneumonia Malignant neoplasm of breast
AFFECTS,ginsenoside Rg3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ginsenoside Rg3 Malignant neoplasm of breast
AFFECTS,Antioxidants,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",Antioxidants HER2-positive carcinoma of breast
PREDISPOSES,skill,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,skill Malignant neoplasm of breast
AUGMENTS,alpha Karyopherins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",alpha Karyopherins Malignant neoplasm of breast
PREDISPOSES,Anthropometric Measures:-:Point in time:^Patient:-,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Anthropometric Measures:-:Point in time:^Patient:- Triple Negative Breast Neoplasms
PREDISPOSES,TaqI POLYMORPHISM,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",TaqI POLYMORPHISM Malignant neoplasm of breast
AFFECTS,inhibitors,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",inhibitors HER2-positive carcinoma of breast
PREDISPOSES,Pathologic Response,Locally advanced breast cancer,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Pathologic Response Locally advanced breast cancer
AUGMENTS,RET,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",RET Breast Carcinoma
AFFECTS,Contrast used,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Contrast used Malignant neoplasm of breast
PREDISPOSES,clopidogrel,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,clopidogrel Malignant neoplasm of breast
AUGMENTS,"3,3'-diindolylmethane",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,"3,3'-diindolylmethane Malignant neoplasm of breast"
DISRUPTS,Alkaloids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Alkaloids Malignant neoplasm of breast
DISRUPTS,vemurafenib,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,vemurafenib Malignant neoplasm of breast
PREDISPOSES,Histone deacetylase inhibitor,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,"Element, Ion, or Isotope",Histone deacetylase inhibitor Secondary malignant neoplasm of breast
AUGMENTS,ezrin,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Neoplastic Process,ezrin Secondary malignant neoplasm of breast
AUGMENTS,beta-2 Adrenergic Receptors,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein",beta-2 Adrenergic Receptors Triple Negative Breast Neoplasms
AFFECTS,lycorine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,lycorine Malignant neoplasm of breast
PREDISPOSES,Performance,Carcinoma breast stage IV,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Performance Carcinoma breast stage IV
AFFECTS,Operative Surgical Procedures,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",Operative Surgical Procedures HER2-positive carcinoma of breast
CAUSES,Mucosa-Associated Lymphoid Tissue Lymphoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Mucosa-Associated Lymphoid Tissue Lymphoma Malignant neoplasm of breast
CAUSES,mannose,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,mannose Malignant neoplasm of breast
PREDISPOSES,MTOR wt Allele,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",MTOR wt Allele Malignant neoplasm of breast
PREDISPOSES,"Alanine Aminotransferase 1, human",Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,"Element, Ion, or Isotope","Alanine Aminotransferase 1, human Secondary malignant neoplasm of breast"
DISRUPTS,KMT2A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",KMT2A Malignant neoplasm of breast
PREDISPOSES,20-40 years,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",20-40 years Malignant neoplasm of breast
CAUSES,Retinoblastoma,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Retinoblastoma Malignant neoplasm of breast
AFFECTS,Treatment Protocols,Luminal B Breast Carcinoma,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Treatment Protocols Luminal B Breast Carcinoma
PREDISPOSES,Diesel Exhaust,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Diesel Exhaust Malignant neoplasm of breast
PREDISPOSES,Problem,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Neoplastic Process,Problem Secondary malignant neoplasm of breast
CAUSES,BARRIER,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,BARRIER Malignant neoplasm of breast
DISRUPTS,taxifolin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,taxifolin Malignant neoplasm of breast
AFFECTS,macroautophagy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,macroautophagy Malignant neoplasm of breast
DISRUPTS,Androgen Receptor,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Androgen Receptor Triple Negative Breast Neoplasms
PREDISPOSES,Increased risk,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Increased risk Triple Negative Breast Neoplasms
DISRUPTS,cinobufagin,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",cinobufagin Triple Negative Breast Neoplasms
PREDISPOSES,Increased size (finding),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Increased size (finding) Malignant neoplasm of breast
AFFECTS,CD103|ITGAE,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,CD103|ITGAE Malignant neoplasm of breast
PREDISPOSES,risk factors,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",risk factors Noninfiltrating Intraductal Carcinoma
AUGMENTS,brusatol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,brusatol Malignant neoplasm of breast
PREDISPOSES,Hepatitis C,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Hepatitis C Malignant neoplasm of breast
AFFECTS,Menopause,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Menopause estrogen receptor-positive breast cancer
DISRUPTS,Suppressor,Carcinoma breast stage IV,0.0,Female Breast Cancer,Gene or Genome,Suppressor Carcinoma breast stage IV
DISRUPTS,bruceine A,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Neoplastic Process,bruceine A Secondary malignant neoplasm of breast
AFFECTS,pimavanserin tartrate,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",pimavanserin tartrate Triple Negative Breast Neoplasms
AFFECTS,Histone deacetylase inhibitor|HDAC9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Histone deacetylase inhibitor|HDAC9 Malignant neoplasm of breast
AFFECTS,hydroxypropylbetadex (0.58-0.68 MS),Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",hydroxypropylbetadex (0.58-0.68 MS) Triple Negative Breast Neoplasms
DISRUPTS,Piperlongumine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Piperlongumine Malignant neoplasm of breast
PREDISPOSES,Immune,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Immune Triple Negative Breast Neoplasms
AFFECTS,Diagnosis,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,"Element, Ion, or Isotope",Diagnosis Inflammatory Breast Carcinoma
AFFECTS,Anoikis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Anoikis Malignant neoplasm of breast
PREDISPOSES,Dichloroethylenes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Dichloroethylenes Malignant neoplasm of breast
PREDISPOSES,Not significant,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Neoplastic Process,Not significant Invasive carcinoma of breast
AFFECTS,paraffin,Invasive Ductal Breast Carcinoma,0.0,Female Breast Cancer,Hormone,paraffin Invasive Ductal Breast Carcinoma
AUGMENTS,multicatalytic endopeptidase complex,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",multicatalytic endopeptidase complex Malignant neoplasm of breast
AFFECTS,Screening mammography,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",Screening mammography Noninfiltrating Intraductal Carcinoma
AFFECTS,thyme oil,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,thyme oil Malignant neoplasm of breast
AFFECTS,maduramicin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,maduramicin Malignant neoplasm of breast
AUGMENTS,cholecalciferol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,cholecalciferol Malignant neoplasm of breast
PREDISPOSES,Present,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Present Triple Negative Breast Neoplasms
PREDISPOSES,fiber,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",fiber Malignant neoplasm of breast
CAUSES,Bacteroides fragilis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Bacteroides fragilis Malignant neoplasm of breast
AFFECTS,epiberberine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,epiberberine Malignant neoplasm of breast
PREDISPOSES,Benign foot rot,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Benign foot rot Malignant neoplasm of breast
PREDISPOSES,Bloody nipple discharge,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",Bloody nipple discharge Noninfiltrating Intraductal Carcinoma
DISRUPTS,decanoylcarnitine,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",decanoylcarnitine Triple Negative Breast Neoplasms
COMPLICATES,Fibrous Dysplasia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Fibrous Dysplasia Malignant neoplasm of breast
AFFECTS,tegafur,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,tegafur Malignant neoplasm of breast
DISRUPTS,Xenobiotics,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Xenobiotics Malignant neoplasm of breast
PREDISPOSES,Signs and Symptoms,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Signs and Symptoms Triple Negative Breast Neoplasms
PREDISPOSES,Score,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",Score Noninfiltrating Intraductal Carcinoma
PREDISPOSES,Multiple Sclerosis,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",Multiple Sclerosis estrogen receptor-positive breast cancer
AFFECTS,NF-kappa B,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",NF-kappa B HER2-positive carcinoma of breast
PREDISPOSES,Increased risk,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Increased risk estrogen receptor-positive breast cancer
PREDISPOSES,"Receptor, Melatonin, MT1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,"Receptor, Melatonin, MT1 Malignant neoplasm of breast"
PREDISPOSES,Behavior,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,Behavior Breast cancer invasive NOS
PREDISPOSES,Warfarin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Warfarin Malignant neoplasm of breast
AFFECTS,MAD2L1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,MAD2L1 Malignant neoplasm of breast
AFFECTS,Deoxycytidine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Deoxycytidine Malignant neoplasm of breast
AUGMENTS,phosphatidylinositol 3-kinase gamma,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Element, Ion, or Isotope",phosphatidylinositol 3-kinase gamma Breast cancer invasive NOS
AFFECTS,Fluorouracil,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Fluorouracil Breast Carcinoma
PREDISPOSES,PITPNM1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,PITPNM1 Malignant neoplasm of breast
AFFECTS,Psoralens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Psoralens Malignant neoplasm of breast
AUGMENTS,BRD4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",BRD4 Malignant neoplasm of breast
AUGMENTS,Janus kinase 1|JAK1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Janus kinase 1|JAK1 Malignant neoplasm of breast
DISRUPTS,exemestane,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,exemestane Breast cancer invasive NOS
PREDISPOSES,invariant chain|CD74,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",invariant chain|CD74 Breast cancer metastatic
AFFECTS,helicase|HFM1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,helicase|HFM1 Malignant neoplasm of breast
AFFECTS,GPR161,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,GPR161 Malignant neoplasm of breast
DISRUPTS,Brain-Derived Neurotrophic Factor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Brain-Derived Neurotrophic Factor Malignant neoplasm of breast
DISRUPTS,SOD3,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",SOD3 Breast cancer metastatic
AFFECTS,Blood flow,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Blood flow Malignant neoplasm of breast
DISRUPTS,Pyrones,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Pyrones Malignant neoplasm of breast
PREDISPOSES,SIX2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",SIX2 Breast cancer metastatic
PREDISPOSES,TUNAR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,TUNAR Malignant neoplasm of breast
DISRUPTS,andrographolide,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",andrographolide Breast cancer metastatic
PREDISPOSES,HOXB13,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,HOXB13 Malignant neoplasm of breast
AFFECTS,UBE2I,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,UBE2I Malignant neoplasm of breast
CAUSES,chymotrypsin A,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,chymotrypsin A Breast Carcinoma
CAUSES,Spironolactone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Spironolactone Malignant neoplasm of breast
AFFECTS,Ceramides,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Neoplastic Process,"Ceramides Carcinoma, Ductal, Breast"
DISRUPTS,Nitric Oxide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Nitric Oxide Malignant neoplasm of breast
DISRUPTS,Adriamycin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Adriamycin Malignant neoplasm of breast
AUGMENTS,ATP6V1C1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",ATP6V1C1 Breast cancer metastatic
AFFECTS,Therapeutic procedure,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,"Element, Ion, or Isotope",Therapeutic procedure Familial cancer of breast
AFFECTS,Red meat,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Red meat Malignant neoplasm of breast
AUGMENTS,Iron,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Iron Malignant neoplasm of breast
AUGMENTS,MAGEC2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",MAGEC2 Breast cancer metastatic
PREDISPOSES,Thiopurine S-Methyltransferase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Thiopurine S-Methyltransferase Malignant neoplasm of breast
PREDISPOSES,ATP1B2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ATP1B2 Malignant neoplasm of breast
PREDISPOSES,NANOG,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",NANOG Breast cancer metastatic
AFFECTS,Pteridines,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Pteridines Malignant neoplasm of breast
AFFECTS,combretastatin A-4 disodium phosphate,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",combretastatin A-4 disodium phosphate Breast Carcinoma
PREDISPOSES,Chronic heart failure,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Chronic heart failure Malignant neoplasm of breast
DISRUPTS,Ro 48-8071,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Ro 48-8071 Malignant neoplasm of breast
PREDISPOSES,TAAR5|NR2E3,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",TAAR5|NR2E3 Breast cancer metastatic
PREDISPOSES,Placebos,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Placebos Malignant neoplasm of breast
AFFECTS,SOX2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",SOX2 Malignant neoplasm of breast
AFFECTS,Oxidoreductase,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Oxidoreductase Breast Carcinoma
AFFECTS,GAD2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,GAD2 Malignant neoplasm of breast
AFFECTS,Galactosyltransferases,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Galactosyltransferases Breast Carcinoma
AFFECTS,proteomic profiling,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Neoplastic Process,"proteomic profiling Carcinoma, Ductal, Breast"
AFFECTS,Gynecologic Surgical Procedures,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Gynecologic Surgical Procedures Malignant neoplasm of breast
DISRUPTS,beta-cryptoxanthin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",beta-cryptoxanthin Malignant neoplasm of breast
AUGMENTS,NDP,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Neoplastic Process,NDP Noninfiltrating Intraductal Carcinoma
CAUSES,Multiple Myeloma,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Multiple Myeloma Breast Carcinoma
AFFECTS,Norepinephrine,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Norepinephrine Breast Carcinoma
PREDISPOSES,"Tuberculosis, Pulmonary",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Tuberculosis, Pulmonary Malignant neoplasm of breast"
AUGMENTS,Retinoid X Receptors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Retinoid X Receptors Malignant neoplasm of breast
AUGMENTS,Prolactin|PRL,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Prolactin|PRL Breast Carcinoma
PREDISPOSES,Integrin beta3|ITGB3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Integrin beta3|ITGB3 Malignant neoplasm of breast
PREDISPOSES,Calcitonin Receptor|CALCR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Calcitonin Receptor|CALCR Malignant neoplasm of breast
AFFECTS,Prolactin|PRL,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Prolactin|PRL Breast Carcinoma
AFFECTS,Leucovorin,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Leucovorin Breast cancer metastatic
AFFECTS,MLLT11,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,MLLT11 Malignant neoplasm of breast
DISRUPTS,Aspirin,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Aspirin Breast Carcinoma
AFFECTS,particle,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,particle Malignant neoplasm of breast
AUGMENTS,6p12,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,6p12 Breast Carcinoma
AFFECTS,E-Cadherin,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",E-Cadherin Breast cancer metastatic
CAUSES,Endobronchial metastases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Endobronchial metastases Malignant neoplasm of breast
AFFECTS,Fibrinogen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Fibrinogen Malignant neoplasm of breast
CAUSES,Fruit,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Fruit Malignant neoplasm of breast
DISRUPTS,IGFBP7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,IGFBP7 Malignant neoplasm of breast
AFFECTS,Diabetes Insipidus,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Diabetes Insipidus Malignant neoplasm of breast
PREDISPOSES,Free Radicals,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Free Radicals Malignant neoplasm of breast
PREDISPOSES,SLOPE,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,SLOPE Malignant neoplasm of breast
AFFECTS,Calcitonin,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Calcitonin Breast cancer metastatic
AFFECTS,Adrenalectomy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Adrenalectomy Malignant neoplasm of breast
AFFECTS,Adriamycin,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Adriamycin Breast cancer metastatic
CAUSES,16 alpha-hydroxyestrone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Amino Acid, Peptide, or Protein",16 alpha-hydroxyestrone Malignant neoplasm of breast
DISRUPTS,Estriol,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Estriol Breast Carcinoma
CAUSES,Large Cell Lymphoblastic Lymphoma,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Large Cell Lymphoblastic Lymphoma Breast Carcinoma
PREDISPOSES,Caseins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Caseins Malignant neoplasm of breast
PREDISPOSES,Orchitis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Orchitis Malignant neoplasm of breast
AUGMENTS,FCE 21336,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,FCE 21336 Breast Carcinoma
PREDISPOSES,TAG 12,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Element, Ion, or Isotope",TAG 12 Breast cancer recurrent
PREDISPOSES,Body measure result,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Body Substance,Body measure result Malignant neoplasm of breast
CAUSES,Idarubicin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Idarubicin Malignant neoplasm of breast
PREDISPOSES,alpha-Lactalbumin,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",alpha-Lactalbumin Breast Carcinoma
PREDISPOSES,Fucose,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Fucose Breast Carcinoma
AFFECTS,"Nuclear Receptor Subfamily 4, Group A, Member 1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Nuclear Receptor Subfamily 4, Group A, Member 1 Malignant neoplasm of breast"
CAUSES,Difluoromethylornithine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Difluoromethylornithine Malignant neoplasm of breast
AFFECTS,Shock,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Shock Breast Carcinoma
PREDISPOSES,Doxorubicin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Doxorubicin Malignant neoplasm of breast
DISRUPTS,Enovid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Enovid Malignant neoplasm of breast
AUGMENTS,Platinum,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Platinum Breast Carcinoma
PREDISPOSES,ERVW-1|ERVK-20|ERVK-18|ERVK-32,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",ERVW-1|ERVK-20|ERVK-18|ERVK-32 Malignant neoplasm of breast
DISRUPTS,Interferons,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Interferons Malignant neoplasm of breast
AFFECTS,Hypophysectomy,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Hypophysectomy Breast Carcinoma
AUGMENTS,Stimulant,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Stimulant Malignant neoplasm of breast
PREDISPOSES,Clinical finding,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Clinical finding Malignant neoplasm of breast
PREDISPOSES,BAG3,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,"Element, Ion, or Isotope",BAG3 Female Breast Carcinoma
CAUSES,Telomerase,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Telomerase Breast Carcinoma
PREDISPOSES,Readiness,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Readiness Malignant neoplasm of breast
AFFECTS,Manganese Superoxide Dismutase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Manganese Superoxide Dismutase Malignant neoplasm of breast
AFFECTS,Operative Surgical Procedures,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,"Element, Ion, or Isotope",Operative Surgical Procedures Familial cancer of breast
PREDISPOSES,Immune status,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Immunologic Factor,Immune status Breast Carcinoma
PREDISPOSES,Antihistamines,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Antihistamines Malignant neoplasm of breast
DISRUPTS,butyrate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,butyrate Malignant neoplasm of breast
PREDISPOSES,stanniocalcin 2|STC2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,stanniocalcin 2|STC2 Malignant neoplasm of breast
AFFECTS,fluoranthene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,fluoranthene Malignant neoplasm of breast
CAUSES,17q21,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,17q21 Breast Carcinoma
CAUSES,Sterically Stabilized Liposome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Sterically Stabilized Liposome Malignant neoplasm of breast
CAUSES,Nitrosamines,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Neoplastic Process,Nitrosamines Ductal Breast Carcinoma
AFFECTS,Early Diagnosis,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,"Element, Ion, or Isotope",Early Diagnosis Carcinoma of Male Breast
PREDISPOSES,Histidine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Histidine Malignant neoplasm of breast
AUGMENTS,Androgens,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Disease or Syndrome,Androgens Carcinoma of Male Breast
PREDISPOSES,Silicones,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Silicones Malignant neoplasm of breast
AFFECTS,Somatropin|GH1|GGH,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Somatropin|GH1|GGH Malignant neoplasm of breast
AFFECTS,"Ether, Ethyl",Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,"Ether, Ethyl Breast Carcinoma"
AFFECTS,small molecule,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",small molecule Malignant neoplasm of breast
AFFECTS,factor C,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,factor C Malignant neoplasm of breast
PREDISPOSES,"Plants, Edible",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,"Plants, Edible Malignant neoplasm of breast"
DISRUPTS,Raloxifene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Raloxifene Malignant neoplasm of breast
PREDISPOSES,"Risk factor, cardiovascular",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Risk factor, cardiovascular Malignant neoplasm of breast"
PREDISPOSES,Pregnancy History,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Pregnancy History Malignant neoplasm of breast
AFFECTS,telomerase activity,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",telomerase activity Malignant neoplasm of breast
AFFECTS,Mutant,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Mutant Malignant neoplasm of breast
PREDISPOSES,Watermelon,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Watermelon Malignant neoplasm of breast
AFFECTS,Genomic Instability,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Genomic Instability Breast Carcinoma
PREDISPOSES,HSD17B1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,HSD17B1 Malignant neoplasm of breast
DISRUPTS,Fibrin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Fibrin Malignant neoplasm of breast
AFFECTS,SLC39A6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,SLC39A6 Malignant neoplasm of breast
DISRUPTS,AVP,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,AVP Breast cancer invasive NOS
PREDISPOSES,Chocolate milk,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Chocolate milk Malignant neoplasm of breast
AUGMENTS,fulvestrant,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,fulvestrant Malignant neoplasm of breast
PREDISPOSES,Coping Behavior,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Coping Behavior Malignant neoplasm of breast
CAUSES,dominant allele,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",dominant allele Breast Carcinoma
AUGMENTS,SLIT3|SLIT2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,SLIT3|SLIT2 Malignant neoplasm of breast
PREDISPOSES,CTCFL,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,CTCFL Malignant neoplasm of breast
PREDISPOSES,Therapeutic procedure,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Therapeutic procedure Malignant neoplasm of breast
PREDISPOSES,Cheese,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Cheese Malignant neoplasm of breast
AUGMENTS,Manganese Superoxide Dismutase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Manganese Superoxide Dismutase Malignant neoplasm of breast
PREDISPOSES,WNT5B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,WNT5B Malignant neoplasm of breast
AFFECTS,Alanine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Alanine Malignant neoplasm of breast
AUGMENTS,CXC Chemokines,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,CXC Chemokines Malignant neoplasm of breast
DISRUPTS,SLC3A2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",SLC3A2 Malignant neoplasm of breast
AUGMENTS,Gonadotropins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Gonadotropins Malignant neoplasm of breast
AUGMENTS,Endopeptidases,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Neoplastic Process,"Endopeptidases Carcinoma, Ductal, Breast"
PREDISPOSES,cysteinylglycine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,cysteinylglycine Malignant neoplasm of breast
PREDISPOSES,Aspirin,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,Aspirin Breast cancer invasive NOS
PREDISPOSES,myricetin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,myricetin Malignant neoplasm of breast
PREDISPOSES,Adriamycin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Adriamycin Malignant neoplasm of breast
PREDISPOSES,prolyl-proline,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,prolyl-proline Malignant neoplasm of breast
AFFECTS,Heterocyclic Amines,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Heterocyclic Amines Malignant neoplasm of breast
AFFECTS,Eating,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Eating Malignant neoplasm of breast
AFFECTS,Siramesine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Siramesine Malignant neoplasm of breast
CAUSES,CALCIUM PHOSPHATE CRYSTALS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",CALCIUM PHOSPHATE CRYSTALS Malignant neoplasm of breast
CAUSES,Quantitative Trait Loci,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Quantitative Trait Loci Malignant neoplasm of breast
AFFECTS,5-Trimethoxyamphetamine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,5-Trimethoxyamphetamine Malignant neoplasm of breast
PREDISPOSES,5'-NUCLEOTIDASE|TRIM33,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,5'-NUCLEOTIDASE|TRIM33 Breast Carcinoma
AUGMENTS,ADAMTS4|ADAMTS3,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,ADAMTS4|ADAMTS3 Breast Carcinoma
PREDISPOSES,alpha 1-Antitrypsin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",alpha 1-Antitrypsin Malignant neoplasm of breast
AFFECTS,Prolactin Receptor|PRLR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Prolactin Receptor|PRLR Malignant neoplasm of breast
AFFECTS,Benzodiazepine Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Benzodiazepine Receptor Malignant neoplasm of breast
AUGMENTS,Antibodies,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Antibodies Malignant neoplasm of breast
PREDISPOSES,LFNG,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,LFNG Malignant neoplasm of breast
AFFECTS,gemcitabine,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",gemcitabine Breast cancer metastatic
PREDISPOSES,Dancing,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Dancing Malignant neoplasm of breast
PREDISPOSES,valylvaline,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,valylvaline Malignant neoplasm of breast
AFFECTS,Toremifene,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Toremifene Breast cancer metastatic
DISRUPTS,glypican 3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,glypican 3 Malignant neoplasm of breast
DISRUPTS,Gelatinase A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Gelatinase A Malignant neoplasm of breast
AFFECTS,doxifluridine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,doxifluridine Malignant neoplasm of breast
DISRUPTS,Doxorubicin,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Doxorubicin Breast cancer metastatic
PREDISPOSES,Transient Receptor Potential Channels,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Transient Receptor Potential Channels Malignant neoplasm of breast
AUGMENTS,Phosphorylcholine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Phosphorylcholine Malignant neoplasm of breast
PREDISPOSES,"Fruit, Citrus",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,"Fruit, Citrus Malignant neoplasm of breast"
AFFECTS,Stanolone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Stanolone Malignant neoplasm of breast
CAUSES,4-octylphenol,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,4-octylphenol Breast Carcinoma
CAUSES,RA 25,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",RA 25 Malignant neoplasm of breast
PREDISPOSES,Pressure,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Pressure Malignant neoplasm of breast
AUGMENTS,GATA3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",GATA3 Malignant neoplasm of breast
PREDISPOSES,AURKA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",AURKA Malignant neoplasm of breast
AFFECTS,Glucocorticoid Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Glucocorticoid Receptor Malignant neoplasm of breast
PREDISPOSES,AIP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,AIP Malignant neoplasm of breast
PREDISPOSES,PARP2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,PARP2 Malignant neoplasm of breast
AFFECTS,Apigenin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Apigenin Malignant neoplasm of breast
PREDISPOSES,ADIPOR2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ADIPOR2 Malignant neoplasm of breast
AUGMENTS,17q21,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,17q21 Malignant neoplasm of breast
DISRUPTS,BHLHE41,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,BHLHE41 Breast cancer metastatic
AUGMENTS,arrestin3|ARR3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,arrestin3|ARR3 Malignant neoplasm of breast
AUGMENTS,versican|VCAN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",versican|VCAN Malignant neoplasm of breast
PREDISPOSES,"Insulin, Regular, Human",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Insulin, Regular, Human Malignant neoplasm of breast"
AFFECTS,vinorelbine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,vinorelbine Malignant neoplasm of breast
AUGMENTS,HRAS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",HRAS Malignant neoplasm of breast
PREDISPOSES,HOXB9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,HOXB9 Malignant neoplasm of breast
PREDISPOSES,Phosphatidylinositols,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Phosphatidylinositols Malignant neoplasm of breast
PREDISPOSES,thyroid microsomal antibodies|TPO,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",thyroid microsomal antibodies|TPO Malignant neoplasm of breast
DISRUPTS,bakuchiol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,bakuchiol Malignant neoplasm of breast
AUGMENTS,"9,10-Dimethyl-1,2-benzanthracene",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","9,10-Dimethyl-1,2-benzanthracene Malignant neoplasm of breast"
PREDISPOSES,Herceptin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Herceptin Malignant neoplasm of breast
AUGMENTS,FABP7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,FABP7 Malignant neoplasm of breast
PREDISPOSES,KLF10,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,KLF10 Malignant neoplasm of breast
AUGMENTS,HRG,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,HRG Malignant neoplasm of breast
AFFECTS,PANDAR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,PANDAR Malignant neoplasm of breast
AFFECTS,"Lymphoma, Large-Cell, Diffuse",Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope","Lymphoma, Large-Cell, Diffuse Breast Carcinoma"
AFFECTS,"Antiretroviral Therapy, Highly Active",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Antiretroviral Therapy, Highly Active Malignant neoplasm of breast"
AFFECTS,Proteome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Proteome Malignant neoplasm of breast
AFFECTS,germacrone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,germacrone Malignant neoplasm of breast
AFFECTS,ADAR1|ADAR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",ADAR1|ADAR Malignant neoplasm of breast
AFFECTS,chemokine,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",chemokine Breast cancer metastatic
PREDISPOSES,PORPHOBILINOGEN SYNTHASE|ALAD,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",PORPHOBILINOGEN SYNTHASE|ALAD Malignant neoplasm of breast
AFFECTS,Clinical Treatment,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Clinical Treatment Malignant neoplasm of breast
PREDISPOSES,Hyaluronan,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Hyaluronan Malignant neoplasm of breast
AUGMENTS,DDX3X,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,DDX3X Breast cancer metastatic
AFFECTS,[M]Skin appendage adenoma,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",[M]Skin appendage adenoma Breast Carcinoma
AFFECTS,SLC19A3,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",SLC19A3 Breast cancer metastatic
PREDISPOSES,May-Hegglin anomaly,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Lipid,May-Hegglin anomaly Breast cancer recurrent
PREDISPOSES,ANXA1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",ANXA1 Malignant neoplasm of breast
PREDISPOSES,multicatalytic endopeptidase complex,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",multicatalytic endopeptidase complex Malignant neoplasm of breast
CAUSES,beta catenin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",beta catenin Malignant neoplasm of breast
AUGMENTS,angiogenin|ANG,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,angiogenin|ANG Breast cancer metastatic
PREDISPOSES,DOK7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,DOK7 Malignant neoplasm of breast
PREDISPOSES,NKX2-1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,NKX2-1 Malignant neoplasm of breast
PREDISPOSES,pyridoxine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,pyridoxine Malignant neoplasm of breast
PREDISPOSES,GPR55,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",GPR55 Breast cancer metastatic
PREDISPOSES,Cathepsin L|CTSL,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Cathepsin L|CTSL Breast cancer metastatic
CAUSES,Adenosine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Adenosine Malignant neoplasm of breast
AFFECTS,Anthracyclines,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Anthracyclines Breast cancer metastatic
AFFECTS,CCT2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,CCT2 Malignant neoplasm of breast
AFFECTS,DEFA1|CBX5|DEFA1B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,DEFA1|CBX5|DEFA1B Malignant neoplasm of breast
PREDISPOSES,Stopped work,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Stopped work Malignant neoplasm of breast
DISRUPTS,cyclin-dependent kinase 3,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",cyclin-dependent kinase 3 Breast cancer metastatic
PREDISPOSES,preference,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",preference Familial cancer of breast
AFFECTS,DMPK|IGHD1-7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",DMPK|IGHD1-7 Malignant neoplasm of breast
PREDISPOSES,NF-kappa B,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",NF-kappa B Breast cancer metastatic
PREDISPOSES,TRIM28,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,TRIM28 Breast cancer metastatic
AFFECTS,Consanguinous Mating,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Consanguinous Mating Malignant neoplasm of breast
CAUSES,Biotin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Biotin Malignant neoplasm of breast
DISRUPTS,PAQR3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,PAQR3 Malignant neoplasm of breast
AUGMENTS,PTF1A,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Neoplastic Process,"PTF1A Carcinoma, Ductal, Breast"
AFFECTS,temozolomide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,temozolomide Malignant neoplasm of breast
AFFECTS,SUMO1P3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,SUMO1P3 Malignant neoplasm of breast
AFFECTS,Echinococcosis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Echinococcosis Malignant neoplasm of breast
AFFECTS,Immune defect,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Immune defect Malignant neoplasm of breast
AUGMENTS,SLC4A7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,SLC4A7 Malignant neoplasm of breast
AFFECTS,5'-NUCLEOTIDASE|NT5E,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,5'-NUCLEOTIDASE|NT5E Malignant neoplasm of breast
DISRUPTS,PRDX2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,PRDX2 Malignant neoplasm of breast
DISRUPTS,phospholipase C delta 1|DLK1|DLL1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",phospholipase C delta 1|DLK1|DLL1 Malignant neoplasm of breast
AFFECTS,Interleukin-18,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Interleukin-18 Malignant neoplasm of breast
PREDISPOSES,CCAT2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,CCAT2 Malignant neoplasm of breast
PREDISPOSES,Acetate,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Element, Ion, or Isotope",Acetate Breast cancer invasive NOS
PREDISPOSES,TRPS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,TRPS1 Malignant neoplasm of breast
PREDISPOSES,nuclear receptor coactivator 1,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Element, Ion, or Isotope",nuclear receptor coactivator 1 Breast cancer invasive NOS
PREDISPOSES,inorganic phosphate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",inorganic phosphate Malignant neoplasm of breast
DISRUPTS,RBM38,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,RBM38 Breast cancer metastatic
PREDISPOSES,F2-Isoprostanes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,F2-Isoprostanes Malignant neoplasm of breast
PREDISPOSES,stromelysin 3,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",stromelysin 3 Breast cancer metastatic
PREDISPOSES,IkappaB Kinase beta,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",IkappaB Kinase beta Malignant neoplasm of breast
PREDISPOSES,ADAMTS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ADAMTS Malignant neoplasm of breast
AFFECTS,Cantaloupes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Cantaloupes Malignant neoplasm of breast
PREDISPOSES,Quinones,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Quinones Breast cancer metastatic
AUGMENTS,Glucocorticoid Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Glucocorticoid Receptor Malignant neoplasm of breast
AFFECTS,D4-GDI,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,D4-GDI Breast cancer invasive NOS
AUGMENTS,Benzodiazepine Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Benzodiazepine Receptor Malignant neoplasm of breast
CAUSES,alpha Catenin,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Amino Acid, Peptide, or Protein",alpha Catenin Breast cancer invasive NOS
AFFECTS,BANCR,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",BANCR Breast cancer metastatic
AUGMENTS,LINC00310,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,LINC00310 Malignant neoplasm of breast
PREDISPOSES,Gonadotropins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Gonadotropins Malignant neoplasm of breast
AFFECTS,SIRT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",SIRT1 Malignant neoplasm of breast
CAUSES,Quercetin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Quercetin Malignant neoplasm of breast
PREDISPOSES,Smoking,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,Smoking Breast cancer invasive NOS
PREDISPOSES,Rice,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Rice Malignant neoplasm of breast
DISRUPTS,PTGER1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",PTGER1 Breast cancer metastatic
AFFECTS,Pancreatitis,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Neoplastic Process,"Pancreatitis Carcinoma, Ductal, Breast"
DISRUPTS,PHGDH,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",PHGDH Malignant neoplasm of breast
PREDISPOSES,fulvestrant,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,fulvestrant Malignant neoplasm of breast
AUGMENTS,Lysine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Lysine Malignant neoplasm of breast
PREDISPOSES,Is informed,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Is informed Malignant neoplasm of breast
AFFECTS,NFKB1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",NFKB1 Breast cancer metastatic
AFFECTS,Signaling Molecule,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Signaling Molecule Malignant neoplasm of breast
AFFECTS,Fatty fish,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Fatty fish Malignant neoplasm of breast
AFFECTS,Combined Oral Contraceptives,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Combined Oral Contraceptives Malignant neoplasm of breast
AFFECTS,Serpins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Serpins Malignant neoplasm of breast
PREDISPOSES,Hydroxyl Radical,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Hydroxyl Radical Malignant neoplasm of breast
PREDISPOSES,Lindane,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Lindane Breast Carcinoma
PREDISPOSES,Irritable Mood,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,Irritable Mood Breast cancer invasive NOS
PREDISPOSES,Cytochrome P-450 CYP1A1,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Cytochrome P-450 CYP1A1 Breast Carcinoma
AUGMENTS,Gelatinase A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Gelatinase A Malignant neoplasm of breast
CAUSES,Transcript,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Transcript Malignant neoplasm of breast
PREDISPOSES,TWSG1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",TWSG1 Malignant neoplasm of breast
AFFECTS,"Endometriosis, site unspecified",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Endometriosis, site unspecified Malignant neoplasm of breast"
AFFECTS,PTGIS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,PTGIS Malignant neoplasm of breast
PREDISPOSES,nuclear receptor coactivator 1|SRC,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Element, Ion, or Isotope",nuclear receptor coactivator 1|SRC Breast cancer recurrent
AFFECTS,"7,3'-dihydroxy-4'-methoxyisoflavone",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,"7,3'-dihydroxy-4'-methoxyisoflavone Malignant neoplasm of breast"
AFFECTS,TBXAS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,TBXAS1 Malignant neoplasm of breast
AUGMENTS,MNX1,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",MNX1 Breast Carcinoma
PREDISPOSES,MMP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,MMP Malignant neoplasm of breast
AFFECTS,Light,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Light Malignant neoplasm of breast
PREDISPOSES,Coconut milk,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Coconut milk Malignant neoplasm of breast
AFFECTS,Epithelial hyperplasia,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",Epithelial hyperplasia Noninfiltrating Intraductal Carcinoma
PREDISPOSES,FAU,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,FAU Malignant neoplasm of breast
AUGMENTS,Smoke,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Smoke Malignant neoplasm of breast
CAUSES,PPAR gamma|EREG|ESR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",PPAR gamma|EREG|ESR1 Malignant neoplasm of breast
AFFECTS,2-hydroxyestrone,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,2-hydroxyestrone Breast cancer invasive NOS
PREDISPOSES,Non-Aspirin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Non-Aspirin Malignant neoplasm of breast
AFFECTS,Bioluminescence,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Bioluminescence Malignant neoplasm of breast
AFFECTS,RUNX2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",RUNX2 Breast cancer metastatic
AUGMENTS,MED28,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Neoplastic Process,"MED28 Carcinoma, Ductal, Breast"
PREDISPOSES,Family problems,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Family problems Malignant neoplasm of breast
AFFECTS,TOX3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,TOX3 Malignant neoplasm of breast
AUGMENTS,C19orf12,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,C19orf12 Malignant neoplasm of breast
PREDISPOSES,Sexual exposure,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Sexual exposure Malignant neoplasm of breast
AFFECTS,Physical therapy exercises,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Physical therapy exercises Malignant neoplasm of breast
PREDISPOSES,prohibitin|PHB,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,prohibitin|PHB Malignant neoplasm of breast
AFFECTS,DDX3X,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",DDX3X Malignant neoplasm of breast
AFFECTS,Neprilysin|MME,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Neprilysin|MME Malignant neoplasm of breast
CAUSES,daidzein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,daidzein Malignant neoplasm of breast
AUGMENTS,VEGFA,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",VEGFA Breast cancer metastatic
PREDISPOSES,Inorganic arsenic,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Inorganic arsenic Malignant neoplasm of breast
PREDISPOSES,Prolactin,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,Prolactin Breast cancer invasive NOS
AUGMENTS,drospirenone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,drospirenone Malignant neoplasm of breast
AFFECTS,SLC5A7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,SLC5A7 Malignant neoplasm of breast
AUGMENTS,Norethindrone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Norethindrone Malignant neoplasm of breast
PREDISPOSES,chronic stressor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",chronic stressor Malignant neoplasm of breast
AFFECTS,Expressed Sequence Tags,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Expressed Sequence Tags Malignant neoplasm of breast
PREDISPOSES,Metformin,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,Metformin Breast cancer invasive NOS
PREDISPOSES,ADAM12,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ADAM12 Malignant neoplasm of breast
AUGMENTS,Lamins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Lamins Malignant neoplasm of breast
AUGMENTS,"Insulin, Regular, Human",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Insulin, Regular, Human Malignant neoplasm of breast"
PREDISPOSES,Metric,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,"Element, Ion, or Isotope",Metric Familial cancer of breast
AFFECTS,"Chemotherapy, Adjuvant",Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Element, Ion, or Isotope","Chemotherapy, Adjuvant Breast cancer invasive NOS"
AFFECTS,ixabepilone,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",ixabepilone Breast cancer metastatic
AFFECTS,pertuzumab,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",pertuzumab Breast cancer metastatic
PREDISPOSES,BAG1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,BAG1 Malignant neoplasm of breast
AFFECTS,Bulimia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Bulimia Malignant neoplasm of breast
AFFECTS,Tissue Model,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Tissue Model Malignant neoplasm of breast
PREDISPOSES,"2-methyl-5,6-cyclopentapyrimidine",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","2-methyl-5,6-cyclopentapyrimidine Malignant neoplasm of breast"
AFFECTS,crocetin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,crocetin Malignant neoplasm of breast
CAUSES,Study models,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,Study models Breast cancer metastatic
AFFECTS,DIO3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",DIO3 Malignant neoplasm of breast
PREDISPOSES,French fries,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,French fries Malignant neoplasm of breast
AFFECTS,Opioids,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Opioids Breast cancer recurrent
AFFECTS,FOXP3,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",FOXP3 Breast Carcinoma
AFFECTS,Digoxin,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Digoxin Breast cancer recurrent
AFFECTS,AGAP2-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",AGAP2-AS1 Malignant neoplasm of breast
AFFECTS,Aspirin,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Aspirin Breast cancer recurrent
AFFECTS,CNTN1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,CNTN1 Malignant neoplasm of breast
PREDISPOSES,Prolactin|PRL,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Element, Ion, or Isotope",Prolactin|PRL Breast cancer invasive NOS
DISRUPTS,Androgens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Androgens Malignant neoplasm of breast
PREDISPOSES,Epirubicin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Epirubicin Malignant neoplasm of breast
AFFECTS,allograft inflammatory factor-1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",allograft inflammatory factor-1 Malignant neoplasm of breast
CAUSES,Tobacco smoke,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Tobacco smoke Malignant neoplasm of breast
PREDISPOSES,matriptase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,matriptase Malignant neoplasm of breast
AFFECTS,Olive oil - dietary,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Olive oil - dietary Malignant neoplasm of breast
AFFECTS,VDR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",VDR Malignant neoplasm of breast
AUGMENTS,FOXQ1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",FOXQ1 Breast cancer metastatic
CAUSES,Antimony,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Antimony Malignant neoplasm of breast
DISRUPTS,Telomerase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Telomerase Malignant neoplasm of breast
AUGMENTS,Gelatinase B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Gelatinase B Malignant neoplasm of breast
AFFECTS,Sterically Stabilized Liposome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Sterically Stabilized Liposome Malignant neoplasm of breast
PREDISPOSES,PGLS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,PGLS Malignant neoplasm of breast
PREDISPOSES,2'-Deoxythymidine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,2'-Deoxythymidine Malignant neoplasm of breast
AFFECTS,Immunoliposome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Immunoliposome Malignant neoplasm of breast
PREDISPOSES,inhibin B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,inhibin B Malignant neoplasm of breast
CAUSES,Interleukin-4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Interleukin-4 Malignant neoplasm of breast
CAUSES,Cysteine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Cysteine Malignant neoplasm of breast
AFFECTS,Harvest of stem cells,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Harvest of stem cells Breast Carcinoma
PREDISPOSES,Dioxins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Dioxins Malignant neoplasm of breast
PREDISPOSES,TGM2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,TGM2 Malignant neoplasm of breast
AFFECTS,GC,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,GC Malignant neoplasm of breast
PREDISPOSES,Positive Lymph Node,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,"Element, Ion, or Isotope","Positive Lymph Node Carcinoma, Ductal, Breast"
AFFECTS,perchlorate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,perchlorate Malignant neoplasm of breast
AFFECTS,ASAP1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,ASAP1 Breast cancer metastatic
AFFECTS,Calcium Channel,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Calcium Channel Malignant neoplasm of breast
AFFECTS,FTY 720,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,FTY 720 Malignant neoplasm of breast
AUGMENTS,C1QBP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,C1QBP Malignant neoplasm of breast
AFFECTS,PITX2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",PITX2 Malignant neoplasm of breast
AFFECTS,Mammography,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Mammography Contralateral breast cancer
PREDISPOSES,membership,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,membership Malignant neoplasm of breast
DISRUPTS,astaxanthine,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,astaxanthine Breast Carcinoma
AFFECTS,tomography,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Element, Ion, or Isotope",tomography Breast cancer recurrent
AFFECTS,CD151,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,CD151 Malignant neoplasm of breast
AFFECTS,HSPA5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",HSPA5 Malignant neoplasm of breast
AFFECTS,thrombocytosis,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Neoplastic Process,thrombocytosis Inflammatory Breast Carcinoma
PREDISPOSES,CHD8,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,CHD8 Malignant neoplasm of breast
AUGMENTS,Environmental Tobacco Smoke,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Environmental Tobacco Smoke Malignant neoplasm of breast
PREDISPOSES,AOX1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,AOX1 Malignant neoplasm of breast
PREDISPOSES,hepcidin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,hepcidin Malignant neoplasm of breast
AFFECTS,RHBDD1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,RHBDD1 Malignant neoplasm of breast
AFFECTS,Obesity,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,"Element, Ion, or Isotope",Obesity Contralateral breast cancer
AFFECTS,GABARAP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,GABARAP Malignant neoplasm of breast
PREDISPOSES,SEMA4C,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",SEMA4C Malignant neoplasm of breast
AFFECTS,Systemic Therapy,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Element, Ion, or Isotope",Systemic Therapy Breast cancer recurrent
PREDISPOSES,Gynecological history NOS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Gynecological history NOS Malignant neoplasm of breast
PREDISPOSES,Fibrinogen,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Fibrinogen Malignant neoplasm of breast
PREDISPOSES,Cataract,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,Cataract Breast cancer invasive NOS
PREDISPOSES,Antithrombin III,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Antithrombin III Malignant neoplasm of breast
PREDISPOSES,CYTOR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",CYTOR Malignant neoplasm of breast
AFFECTS,METHOTREXATE TREATMENT,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",METHOTREXATE TREATMENT Malignant neoplasm of breast
CAUSES,Glutamine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Glutamine Malignant neoplasm of breast
AUGMENTS,SP7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",SP7 Malignant neoplasm of breast
CAUSES,Environmental Tobacco Smoke,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Environmental Tobacco Smoke Malignant neoplasm of breast
AFFECTS,citron rho-interacting kinase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",citron rho-interacting kinase Malignant neoplasm of breast
AUGMENTS,MUTYH,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,"Element, Ion, or Isotope",MUTYH Female Breast Carcinoma
PREDISPOSES,Opioids,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Opioids Breast cancer recurrent
PREDISPOSES,IMPAD1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,IMPAD1 Malignant neoplasm of breast
PREDISPOSES,desires,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",desires Contralateral breast cancer
PREDISPOSES,TMEM68,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,TMEM68 Malignant neoplasm of breast
AFFECTS,Ovariectomy,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Ovariectomy Contralateral breast cancer
PREDISPOSES,ENPP2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ENPP2 Malignant neoplasm of breast
AFFECTS,syringin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,syringin Malignant neoplasm of breast
DISRUPTS,KPNA2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",KPNA2 Breast cancer metastatic
AFFECTS,Propofol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Propofol Malignant neoplasm of breast
PREDISPOSES,FRZB,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,FRZB Breast cancer invasive NOS
AFFECTS,Therapeutic regimen,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Therapeutic regimen Breast Carcinoma
AUGMENTS,PSMD3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,PSMD3 Malignant neoplasm of breast
AUGMENTS,CYP4Z1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,CYP4Z1 Malignant neoplasm of breast
DISRUPTS,FOXP3,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,"Element, Ion, or Isotope",FOXP3 Inflammatory Breast Carcinoma
AUGMENTS,SNHG6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",SNHG6 Malignant neoplasm of breast
AFFECTS,beta-Chemokines,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",beta-Chemokines Malignant neoplasm of breast
PREDISPOSES,Redness,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Redness Malignant neoplasm of breast
AUGMENTS,CYP4Z2P,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,CYP4Z2P Malignant neoplasm of breast
PREDISPOSES,RANTES|CCL5,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Element, Ion, or Isotope",RANTES|CCL5 Breast cancer recurrent
PREDISPOSES,CST1|CLSTN1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,CST1|CLSTN1 Malignant neoplasm of breast
DISRUPTS,Azurin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Azurin Malignant neoplasm of breast
PREDISPOSES,Macrophage Chemotactic Factors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Macrophage Chemotactic Factors Malignant neoplasm of breast
DISRUPTS,LINC00968,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,LINC00968 Malignant neoplasm of breast
PREDISPOSES,Intraductal Hyperplasia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Intraductal Hyperplasia Malignant neoplasm of breast
PREDISPOSES,Moderate Exercise,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,Moderate Exercise Breast cancer invasive NOS
PREDISPOSES,PHLDB1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,PHLDB1 Malignant neoplasm of breast
PREDISPOSES,Vitronectin|VTN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Vitronectin|VTN Malignant neoplasm of breast
DISRUPTS,LINC00707,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,LINC00707 Malignant neoplasm of breast
CAUSES,Glucocorticoids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Glucocorticoids Malignant neoplasm of breast
AUGMENTS,C1orf106,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,C1orf106 Malignant neoplasm of breast
PREDISPOSES,Sedentary lifestyle,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,Sedentary lifestyle Breast cancer invasive NOS
AUGMENTS,heparanase|HPSE,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",heparanase|HPSE Malignant neoplasm of breast
AFFECTS,metabolomics,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,metabolomics Malignant neoplasm of breast
CAUSES,Porifera,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Porifera Malignant neoplasm of breast
PREDISPOSES,survivin|BIRC5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",survivin|BIRC5 Malignant neoplasm of breast
AFFECTS,Phosphotransferases,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Phosphotransferases Breast cancer metastatic
DISRUPTS,ADCY4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ADCY4 Malignant neoplasm of breast
PREDISPOSES,SRC,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",SRC Malignant neoplasm of breast
AUGMENTS,Integrin alpha4beta1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Integrin alpha4beta1 Malignant neoplasm of breast
AFFECTS,E-Cadherin,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,Neoplastic Process,"E-Cadherin Carcinoma, Ductal, Breast"
AFFECTS,Toll-Like Receptor 5,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Toll-Like Receptor 5 Triple Negative Breast Neoplasms
PREDISPOSES,LINC01614,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,LINC01614 Malignant neoplasm of breast
AFFECTS,RASAL2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",RASAL2 Malignant neoplasm of breast
AUGMENTS,EIF4A1|EIF4A2,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,EIF4A1|EIF4A2 Breast cancer invasive NOS
AFFECTS,Immunity,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Immunity Triple Negative Breast Neoplasms
AFFECTS,other medicated shampoos in ATC,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",other medicated shampoos in ATC Malignant neoplasm of breast
DISRUPTS,Minisatellite Repeats,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Minisatellite Repeats Malignant neoplasm of breast
AFFECTS,derivatives,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,derivatives Malignant neoplasm of breast
AFFECTS,stevioside,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,stevioside Malignant neoplasm of breast
PREDISPOSES,Healthy Lifestyle,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Neoplastic Process,Healthy Lifestyle Invasive carcinoma of breast
AUGMENTS,copper,Lobular carcinoma in situ of breast,0.0,Female Breast Cancer,"Element, Ion, or Isotope",copper Lobular carcinoma in situ of breast
AFFECTS,gamma-Tocopherol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",gamma-Tocopherol Malignant neoplasm of breast
AFFECTS,multiple pathologies,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Hazardous or Poisonous Substance,multiple pathologies Triple Negative Breast Neoplasms
CAUSES,Adiponectin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Adiponectin Malignant neoplasm of breast
AFFECTS,peer support,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",peer support Malignant neoplasm of breast
AUGMENTS,rasagiline,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,rasagiline Malignant neoplasm of breast
AFFECTS,DOK1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,DOK1 Malignant neoplasm of breast
AFFECTS,veliparib,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",veliparib Triple Negative Breast Neoplasms
DISRUPTS,artesunate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,artesunate Malignant neoplasm of breast
CAUSES,Pads,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Pads Malignant neoplasm of breast
AFFECTS,Cannabinoids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Cannabinoids Malignant neoplasm of breast
DISRUPTS,Checkpoint kinase 1,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",Checkpoint kinase 1 HER2-positive carcinoma of breast
AFFECTS,vinorelbine,HER2-negative breast cancer,0.0,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",vinorelbine HER2-negative breast cancer
PREDISPOSES,Marital Status,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Marital Status Malignant neoplasm of breast
PREDISPOSES,assessment.initial,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",assessment.initial Malignant neoplasm of breast
AUGMENTS,ethyl acetate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",ethyl acetate Malignant neoplasm of breast
AFFECTS,N-acetyltransferase 1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",N-acetyltransferase 1 Triple Negative Breast Neoplasms
AUGMENTS,PROM1,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Neoplastic Process,PROM1 Noninfiltrating Intraductal Carcinoma
AFFECTS,Adjuvant Therapy,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",Adjuvant Therapy Noninfiltrating Intraductal Carcinoma
DISRUPTS,CLDN15,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",CLDN15 Triple Negative Breast Neoplasms
AUGMENTS,diethylstilbestrol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,diethylstilbestrol Malignant neoplasm of breast
CAUSES,Multiple malignancy,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Hazardous or Poisonous Substance,Multiple malignancy Triple Negative Breast Neoplasms
AFFECTS,water,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,water Malignant neoplasm of breast
PREDISPOSES,catechin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,catechin Malignant neoplasm of breast
AFFECTS,Energy Metabolism,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Immunologic Factor,Energy Metabolism Triple Negative Breast Neoplasms
DISRUPTS,methacrylamide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,methacrylamide Malignant neoplasm of breast
AFFECTS,Hypersensitivity,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",Hypersensitivity HER2-positive carcinoma of breast
PREDISPOSES,NEDD9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,NEDD9 Malignant neoplasm of breast
PREDISPOSES,SHC3 wt Allele|GDF1|RNH1|PPP1R13L|SHC3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",SHC3 wt Allele|GDF1|RNH1|PPP1R13L|SHC3 Malignant neoplasm of breast
AFFECTS,timosaponin AIII,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,timosaponin AIII Malignant neoplasm of breast
AFFECTS,MVP wt Allele|RPSA|LRP1|PTPRA|MVP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",MVP wt Allele|RPSA|LRP1|PTPRA|MVP Malignant neoplasm of breast
PREDISPOSES,Mastitis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Mastitis Malignant neoplasm of breast
PREDISPOSES,Insulin Resistance,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,"Element, Ion, or Isotope",Insulin Resistance Inflammatory Breast Carcinoma
AFFECTS,phosphorus,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,phosphorus Malignant neoplasm of breast
AFFECTS,Anticoagulants,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Anticoagulants Malignant neoplasm of breast
PREDISPOSES,Human cells,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Human cells Malignant neoplasm of breast
CAUSES,paclitaxel,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,paclitaxel Malignant neoplasm of breast
PREDISPOSES,pseudouridine synthase 1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",pseudouridine synthase 1 Malignant neoplasm of breast
PREDISPOSES,AXL,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,AXL Malignant neoplasm of breast
AFFECTS,PTTG1 wt Allele,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",PTTG1 wt Allele Malignant neoplasm of breast
CAUSES,Heating,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Heating Malignant neoplasm of breast
PREDISPOSES,metformin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,metformin Malignant neoplasm of breast
PREDISPOSES,Glucocorticoids,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Glucocorticoids Malignant neoplasm of breast
PREDISPOSES,ADIPOQ wt Allele,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",ADIPOQ wt Allele Malignant neoplasm of breast
PREDISPOSES,Risk Scores,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Risk Scores Triple Negative Breast Neoplasms
AFFECTS,Neoadjuvant Chemotherapy,Locally advanced breast cancer,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Neoadjuvant Chemotherapy Locally advanced breast cancer
PREDISPOSES,Geographic pattern,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Geographic pattern Malignant neoplasm of breast
AFFECTS,dihydroartemisinin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,dihydroartemisinin Malignant neoplasm of breast
PREDISPOSES,Biological Factors,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,"Element, Ion, or Isotope",Biological Factors Inflammatory Breast Carcinoma
AFFECTS,Bariatric Surgery,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Bariatric Surgery Malignant neoplasm of breast
AFFECTS,hippo signaling,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",hippo signaling Malignant neoplasm of breast
PREDISPOSES,valine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,valine Malignant neoplasm of breast
PREDISPOSES,Social Risk Factor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Social Risk Factor Malignant neoplasm of breast
AFFECTS,Sodium metavanadate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Sodium metavanadate Malignant neoplasm of breast
CAUSES,Anthracyclines,Carcinoma breast stage IV,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Anthracyclines Carcinoma breast stage IV
PREDISPOSES,prenatal exposure,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",prenatal exposure Malignant neoplasm of breast
AFFECTS,Post-mastectomy radiotherapy,Locally advanced breast cancer,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Post-mastectomy radiotherapy Locally advanced breast cancer
PREDISPOSES,Prognosis bad,estrogen receptor-negative breast cancer,0.0,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Prognosis bad estrogen receptor-negative breast cancer
AFFECTS,Imaging Techniques,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Imaging Techniques Breast Carcinoma
CAUSES,Paste,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Paste Malignant neoplasm of breast
AFFECTS,multiple pathologies,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",multiple pathologies Breast Carcinoma
CAUSES,Neurofibromatosis 1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Neurofibromatosis 1 Malignant neoplasm of breast
PREDISPOSES,Syndecan-4,estrogen receptor-negative breast cancer,0.0,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Syndecan-4 estrogen receptor-negative breast cancer
AFFECTS,Vitiligo,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Vitiligo Malignant neoplasm of breast
CAUSES,R & C,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Neoplastic Process,R & C Inflammatory Breast Carcinoma
PREDISPOSES,Negative,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Negative Triple Negative Breast Neoplasms
PREDISPOSES,triclosan,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,triclosan Malignant neoplasm of breast
AFFECTS,lapatinib,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",lapatinib HER2-positive carcinoma of breast
PREDISPOSES,Handling,"Breast Cancer, Familial",0.0,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","Handling Breast Cancer, Familial"
PREDISPOSES,pamidronate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,pamidronate Malignant neoplasm of breast
PREDISPOSES,estrophilin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,estrophilin Malignant neoplasm of breast
PREDISPOSES,Very Important,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Very Important Malignant neoplasm of breast
AFFECTS,fulvestrant,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",fulvestrant HER2-positive carcinoma of breast
AFFECTS,everolimus,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",everolimus HER2-positive carcinoma of breast
PREDISPOSES,FBXL20,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,FBXL20 Malignant neoplasm of breast
AUGMENTS,6-Phosphofructokinase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,6-Phosphofructokinase Malignant neoplasm of breast
DISRUPTS,phytochlorin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,phytochlorin Malignant neoplasm of breast
PREDISPOSES,CK-34 beta E12,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",CK-34 beta E12 Malignant neoplasm of breast
AFFECTS,Interleukin-1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Interleukin-1 Malignant neoplasm of breast
PREDISPOSES,>65 years,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,>65 years Malignant neoplasm of breast
PREDISPOSES,Monosaccharides,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Monosaccharides Malignant neoplasm of breast
PREDISPOSES,Aurora Kinase A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Aurora Kinase A Malignant neoplasm of breast
AFFECTS,Antral Follicle Count,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Antral Follicle Count Malignant neoplasm of breast
DISRUPTS,mifepristone,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Neoplastic Process,mifepristone Secondary malignant neoplasm of breast
PREDISPOSES,Aquaporin 1|AQP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Aquaporin 1|AQP1 Malignant neoplasm of breast
AFFECTS,removal technique,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Neoplastic Process,removal technique Ductal Breast Carcinoma
DISRUPTS,UNC 0638,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,UNC 0638 Malignant neoplasm of breast
DISRUPTS,echinacoside,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,echinacoside Malignant neoplasm of breast
CAUSES,Metabolite,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Metabolite Malignant neoplasm of breast
DISRUPTS,CI 994,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,CI 994 Malignant neoplasm of breast
AFFECTS,rasagiline,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",rasagiline Triple Negative Breast Neoplasms
AFFECTS,Early Diagnosis,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Early Diagnosis Triple Negative Breast Neoplasms
CAUSES,tissue markers,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",tissue markers Malignant neoplasm of breast
DISRUPTS,"Antibodies, Anti-Idiotypic",Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,"Element, Ion, or Isotope","Antibodies, Anti-Idiotypic Secondary malignant neoplasm of breast"
AFFECTS,Hepatitis B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Hepatitis B Malignant neoplasm of breast
AFFECTS,Hypoxia,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Hypoxia Triple Negative Breast Neoplasms
PREDISPOSES,liraglutide,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",liraglutide Triple Negative Breast Neoplasms
CAUSES,norethindrone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,norethindrone Malignant neoplasm of breast
PREDISPOSES,erbB-2 Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",erbB-2 Receptor Malignant neoplasm of breast
PREDISPOSES,ergocalciferol,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Neoplastic Process,ergocalciferol Noninfiltrating Intraductal Carcinoma
DISRUPTS,vexibinol,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",vexibinol Triple Negative Breast Neoplasms
PREDISPOSES,Mammographic Breast Density,contralateral breast cancer,0.0029970029970029,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Mammographic Breast Density contralateral breast cancer
PREDISPOSES,"Diet, Healthy",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,"Diet, Healthy Malignant neoplasm of breast"
COMPLICATES,Acne,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Acne estrogen receptor-positive breast cancer
DISRUPTS,"Peroxisome Proliferator-Activated Receptor Gamma, human",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Virus,"Peroxisome Proliferator-Activated Receptor Gamma, human Malignant neoplasm of breast"
AFFECTS,"Diet, High-Fat",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope","Diet, High-Fat Triple Negative Breast Neoplasms"
PREDISPOSES,Late chronotype,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Late chronotype Malignant neoplasm of breast
DISRUPTS,ginsenoside M1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein",ginsenoside M1 Triple Negative Breast Neoplasms
PREDISPOSES,VARIANT OF UNKNOWN SIGNIFICANCE,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",VARIANT OF UNKNOWN SIGNIFICANCE Malignant neoplasm of breast
PREDISPOSES,Interleukin-1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Interleukin-1 Malignant neoplasm of breast
AFFECTS,Catabolism,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Catabolism Malignant neoplasm of breast
AFFECTS,pimozide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,pimozide Malignant neoplasm of breast
PREDISPOSES,Aurora Kinase A,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",Aurora Kinase A Noninfiltrating Intraductal Carcinoma
DISRUPTS,andrographolide,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,"Amino Acid, Peptide, or Protein",andrographolide estrogen receptor-positive breast cancer
AFFECTS,Apoptosis,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Apoptosis Triple Negative Breast Neoplasms
AFFECTS,Protac,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Protac Malignant neoplasm of breast
PREDISPOSES,Liver Cirrhosis,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,"Element, Ion, or Isotope",Liver Cirrhosis Carcinoma of Male Breast
PREDISPOSES,Breast present,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Breast present Malignant neoplasm of breast
PREDISPOSES,1 time,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein",1 time Triple Negative Breast Neoplasms
PREDISPOSES,survivin,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",survivin Triple Negative Breast Neoplasms
DISRUPTS,calcium,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",calcium estrogen receptor-positive breast cancer
PREDISPOSES,Oxysterols,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Oxysterols Malignant neoplasm of breast
PREDISPOSES,CBL,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,CBL Malignant neoplasm of breast
AFFECTS,erbB-2 Receptor,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",erbB-2 Receptor Triple Negative Breast Neoplasms
AUGMENTS,Cytochrome P450,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Cytochrome P450 Malignant neoplasm of breast
AFFECTS,multiple pathologies,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",multiple pathologies Malignant neoplasm of breast
DISRUPTS,caveolin 1,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Neoplastic Process,caveolin 1 Secondary malignant neoplasm of breast
PREDISPOSES,Hematoxylin,malignant neoplasm of breast staging,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Hematoxylin malignant neoplasm of breast staging
AFFECTS,Elective Surgical Procedures,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",Elective Surgical Procedures Noninfiltrating Intraductal Carcinoma
DISRUPTS,metformin,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",metformin HER2-positive carcinoma of breast
AFFECTS,ROS1 wt Allele|ROS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",ROS1 wt Allele|ROS1 Malignant neoplasm of breast
DISRUPTS,carbidopa,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,"Amino Acid, Peptide, or Protein",carbidopa estrogen receptor-positive breast cancer
DISRUPTS,stigmasterol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,stigmasterol Malignant neoplasm of breast
PREDISPOSES,Small Molecule,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Small Molecule Breast Carcinoma
AFFECTS,Coitus,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Coitus Malignant neoplasm of breast
AFFECTS,CD274,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",CD274 Malignant neoplasm of breast
DISRUPTS,ZNF217,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",ZNF217 Malignant neoplasm of breast
CAUSES,benzopyrene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,benzopyrene Malignant neoplasm of breast
PREDISPOSES,Endometriosis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Endometriosis Malignant neoplasm of breast
AFFECTS,Biological Response Modifier Therapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Biological Response Modifier Therapy Malignant neoplasm of breast
PREDISPOSES,iron increased,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",iron increased Malignant neoplasm of breast
AUGMENTS,ST8SIA1,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",ST8SIA1 Triple Negative Breast Neoplasms
PREDISPOSES,Dietary Selenium,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Dietary Selenium Malignant neoplasm of breast
AFFECTS,olaparib,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,olaparib Malignant neoplasm of breast
AFFECTS,Benign Prostatic Hyperplasia,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Benign Prostatic Hyperplasia Triple Negative Breast Neoplasms
PREDISPOSES,pyridine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,pyridine Malignant neoplasm of breast
CAUSES,lapatinib,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",lapatinib Triple Negative Breast Neoplasms
AFFECTS,Neuregulins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Neuregulins Malignant neoplasm of breast
AFFECTS,Ultrasound-Guided Core Biopsy,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",Ultrasound-Guided Core Biopsy Noninfiltrating Intraductal Carcinoma
AUGMENTS,Lignans,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Lignans Malignant neoplasm of breast
CAUSES,ABCB1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",ABCB1 Malignant neoplasm of breast
AUGMENTS,acrylamide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,acrylamide Malignant neoplasm of breast
AFFECTS,Uveitis,Early-Stage Breast Carcinoma,0.0,Female Breast Cancer,Neoplastic Process,Uveitis Early-Stage Breast Carcinoma
PREDISPOSES,Amides,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Amides Malignant neoplasm of breast
PREDISPOSES,High Level,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Virus,High Level estrogen receptor-positive breast cancer
AFFECTS,Adjuvant Therapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Adjuvant Therapy Malignant neoplasm of breast
DISRUPTS,pimagedine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,pimagedine Malignant neoplasm of breast
PREDISPOSES,myosin VI,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,myosin VI Malignant neoplasm of breast
AFFECTS,doxorubicin liposome,Carcinoma breast stage IV,0.0,Female Breast Cancer,"Element, Ion, or Isotope",doxorubicin liposome Carcinoma breast stage IV
DISRUPTS,Proteome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Proteome Malignant neoplasm of breast
PREDISPOSES,Place of Birth,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Place of Birth Malignant neoplasm of breast
AFFECTS,Fixatives,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",Fixatives HER2-positive carcinoma of breast
CAUSES,ethanol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ethanol Malignant neoplasm of breast
PREDISPOSES,erbB-2 Receptor|ERBB2,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Immunologic Factor,erbB-2 Receptor|ERBB2 Secondary malignant neoplasm of breast
PREDISPOSES,benzopyrene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,benzopyrene Malignant neoplasm of breast
PREDISPOSES,3 times,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,3 times Malignant neoplasm of breast
DISRUPTS,royal jelly,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,royal jelly Malignant neoplasm of breast
CAUSES,BARRIER,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Neoplastic Process,BARRIER Inflammatory Breast Carcinoma
AFFECTS,Aurora Kinase A,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Aurora Kinase A Breast Carcinoma
AFFECTS,Poly(ADP-ribose) Polymerase Inhibitors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Poly(ADP-ribose) Polymerase Inhibitors Malignant neoplasm of breast
PREDISPOSES,personal health,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",personal health Malignant neoplasm of breast
DISRUPTS,metformin,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",metformin Triple Negative Breast Neoplasms
CAUSES,interferon type II|IFNG,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",interferon type II|IFNG Breast Carcinoma
DISRUPTS,bruceine D,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Neoplastic Process,bruceine D Secondary malignant neoplasm of breast
CAUSES,Feces,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Feces Malignant neoplasm of breast
AFFECTS,Ultrasonography,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Ultrasonography Triple Negative Breast Neoplasms
DISRUPTS,sevoflurane,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,sevoflurane Malignant neoplasm of breast
AFFECTS,Postoperative chemotherapy,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",Postoperative chemotherapy HER2-positive carcinoma of breast
AFFECTS,calcium,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein",calcium Triple Negative Breast Neoplasms
PREDISPOSES,Dietary Zinc,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Dietary Zinc Malignant neoplasm of breast
PREDISPOSES,"Platelets, CTCAE",Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,"Platelets, CTCAE Breast Carcinoma"
AFFECTS,"Analgesics, Opioid",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope","Analgesics, Opioid Triple Negative Breast Neoplasms"
AFFECTS,hydrocortisone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,hydrocortisone Malignant neoplasm of breast
AFFECTS,Osteopenia,Malignant neoplasm of female breast,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Osteopenia Malignant neoplasm of female breast
AFFECTS,cantharidin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,cantharidin Malignant neoplasm of breast
CAUSES,pregnane X receptor,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",pregnane X receptor Triple Negative Breast Neoplasms
PREDISPOSES,White meat intake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",White meat intake Malignant neoplasm of breast
DISRUPTS,"7,3'-dihydroxy-4'-methoxyisoflavone",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope","7,3'-dihydroxy-4'-methoxyisoflavone Triple Negative Breast Neoplasms"
PREDISPOSES,RARB,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,RARB Malignant neoplasm of breast
AFFECTS,Aurora Kinase A,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Aurora Kinase A Triple Negative Breast Neoplasms
PREDISPOSES,risk factors,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",risk factors Triple Negative Breast Neoplasms
AFFECTS,echinacoside,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,echinacoside Malignant neoplasm of breast
AUGMENTS,Matrix,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Biologically Active Substance,Matrix Invasive carcinoma of breast
DISRUPTS,CYP3A4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,CYP3A4 Malignant neoplasm of breast
CAUSES,abemaciclib,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,abemaciclib Malignant neoplasm of breast
PREDISPOSES,Cell markers,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Cell markers Malignant neoplasm of breast
AFFECTS,beta-eudesmol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",beta-eudesmol Malignant neoplasm of breast
PREDISPOSES,antineoplaston A10,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,antineoplaston A10 Malignant neoplasm of breast
PREDISPOSES,vasomotor symptom,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,vasomotor symptom Malignant neoplasm of breast
PREDISPOSES,lindane,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,lindane Malignant neoplasm of breast
AUGMENTS,doxorubicin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,doxorubicin Malignant neoplasm of breast
AFFECTS,Decreased Immunologic Activity [PE],Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Decreased Immunologic Activity [PE] Triple Negative Breast Neoplasms
AFFECTS,Intrapartum fetal hypoxia,Carcinoma breast stage IV,0.0,Female Breast Cancer,Gene or Genome,Intrapartum fetal hypoxia Carcinoma breast stage IV
CAUSES,"9,10-Dimethyl-1,2-benzanthracene",Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope","9,10-Dimethyl-1,2-benzanthracene Noninfiltrating Intraductal Carcinoma"
PREDISPOSES,metacresol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,metacresol Malignant neoplasm of breast
PREDISPOSES,elongin B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,elongin B Malignant neoplasm of breast
AFFECTS,astaxanthin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,astaxanthin Malignant neoplasm of breast
DISRUPTS,"Receptor, PAR-1",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope","Receptor, PAR-1 Triple Negative Breast Neoplasms"
PREDISPOSES,Comorbidity,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Comorbidity Malignant neoplasm of breast
AUGMENTS,"glutamate carboxypeptidase II, human|FOLH1",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Virus,"glutamate carboxypeptidase II, human|FOLH1 Malignant neoplasm of breast"
PREDISPOSES,Fat-free mass,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Fat-free mass Malignant neoplasm of breast
AUGMENTS,"N-succinyl-1,2-dioleoylphosphatidylethanolamine",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,"N-succinyl-1,2-dioleoylphosphatidylethanolamine Malignant neoplasm of breast"
PREDISPOSES,alpha-adrenergic receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",alpha-adrenergic receptor Malignant neoplasm of breast
DISRUPTS,Oral form sodium,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Carbohydrate,Oral form sodium Malignant neoplasm of breast
AFFECTS,Phentolamine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Phentolamine Malignant neoplasm of breast
DISRUPTS,TET1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,TET1 Malignant neoplasm of breast
AFFECTS,Cyclin-Dependent Kinases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Cyclin-Dependent Kinases Malignant neoplasm of breast
AUGMENTS,EB 1089,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,EB 1089 Malignant neoplasm of breast
AFFECTS,RARRES1|GPRC5A|MED15,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,"Element, Ion, or Isotope",RARRES1|GPRC5A|MED15 Inflammatory Breast Carcinoma
AFFECTS,heparanase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,heparanase Malignant neoplasm of breast
PREDISPOSES,Quantitative Trait Loci,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Quantitative Trait Loci Malignant neoplasm of breast
AUGMENTS,alkylglycerophosphoethanolamine phosphodiesterase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,alkylglycerophosphoethanolamine phosphodiesterase Malignant neoplasm of breast
AFFECTS,Biological Phenomena,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Biological Phenomena Malignant neoplasm of breast
PREDISPOSES,CDK7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",CDK7 Malignant neoplasm of breast
PREDISPOSES,Fibrosing adenosis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Fibrosing adenosis Malignant neoplasm of breast
DISRUPTS,Anticoagulants,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Anticoagulants Malignant neoplasm of breast
AFFECTS,pigment epithelium-derived factor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",pigment epithelium-derived factor Malignant neoplasm of breast
AFFECTS,NEDD9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,NEDD9 Malignant neoplasm of breast
AUGMENTS,XBP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",XBP1 Malignant neoplasm of breast
AFFECTS,RECK,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",RECK Breast cancer metastatic
CAUSES,GRN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,GRN Malignant neoplasm of breast
PREDISPOSES,HOTAIR,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",HOTAIR Breast cancer metastatic
PREDISPOSES,Mucins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Mucins Malignant neoplasm of breast
AFFECTS,Phosphatidylethanolamine N-Methyltransferase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Phosphatidylethanolamine N-Methyltransferase Malignant neoplasm of breast
PREDISPOSES,discoidin domain receptor 2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",discoidin domain receptor 2 Breast cancer metastatic
AFFECTS,Annexin A2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Annexin A2 Malignant neoplasm of breast
PREDISPOSES,ABL2|RERE,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Disease or Syndrome,ABL2|RERE Carcinoma of Male Breast
AFFECTS,SPAG5,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Disease or Syndrome,SPAG5 Carcinoma of Male Breast
AFFECTS,Benign ovarian cyst,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Benign ovarian cyst Malignant neoplasm of breast
PREDISPOSES,hormonal changes,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Disease or Syndrome,hormonal changes Carcinoma of Male Breast
AUGMENTS,PKM,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",PKM Malignant neoplasm of breast
AFFECTS,Methylnitrosourea,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Methylnitrosourea Breast Carcinoma
AFFECTS,THY1,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Disease or Syndrome,THY1 Carcinoma of Male Breast
AFFECTS,Weaning,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Weaning Breast cancer metastatic
AFFECTS,PARP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",PARP1 Malignant neoplasm of breast
DISRUPTS,IGKV1-16|FAM49B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",IGKV1-16|FAM49B Malignant neoplasm of breast
PREDISPOSES,FOXA1,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",FOXA1 Breast Carcinoma
AFFECTS,Paclitaxel,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Paclitaxel Breast Carcinoma
PREDISPOSES,PITPNM3,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",PITPNM3 Breast cancer metastatic
DISRUPTS,HIC1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",HIC1 Malignant neoplasm of breast
DISRUPTS,CpG Islands,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",CpG Islands Malignant neoplasm of breast
AFFECTS,Organochlorine pesticide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Organochlorine pesticide Malignant neoplasm of breast
AFFECTS,MCM3AP|FIG4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",MCM3AP|FIG4 Malignant neoplasm of breast
PREDISPOSES,TNFRSF12A,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,TNFRSF12A Breast Carcinoma
PREDISPOSES,CTSG,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,CTSG Malignant neoplasm of breast
AUGMENTS,Kinesin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Kinesin Malignant neoplasm of breast
AFFECTS,Phosphatidylinositols,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Phosphatidylinositols Malignant neoplasm of breast
AFFECTS,IL33,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,IL33 Malignant neoplasm of breast
PREDISPOSES,OPRM1,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",OPRM1 Breast cancer recurrent
PREDISPOSES,Medical follow-up,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Medical follow-up Malignant neoplasm of breast
DISRUPTS,ADGRF5,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,ADGRF5 Breast cancer metastatic
AUGMENTS,sulfamate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,sulfamate Malignant neoplasm of breast
PREDISPOSES,Malondialdehyde,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Malondialdehyde Malignant neoplasm of breast
PREDISPOSES,"3,4-Methylenedioxyamphetamine",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,"3,4-Methylenedioxyamphetamine Malignant neoplasm of breast"
PREDISPOSES,pioglitazone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,pioglitazone Malignant neoplasm of breast
AFFECTS,Interleukin-8,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,Interleukin-8 Breast cancer metastatic
AFFECTS,rosiglitazone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,rosiglitazone Malignant neoplasm of breast
CAUSES,Telomerase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Telomerase Malignant neoplasm of breast
CAUSES,Cocci,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Cocci Breast Carcinoma
PREDISPOSES,KRT5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,KRT5 Malignant neoplasm of breast
PREDISPOSES,CCL28,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,CCL28 Malignant neoplasm of breast
AFFECTS,calusterone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,calusterone Malignant neoplasm of breast
AFFECTS,DELIVER,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,DELIVER Malignant neoplasm of breast
PREDISPOSES,Physical findings,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Physical findings Malignant neoplasm of breast
AFFECTS,prohibitin|PHB,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,prohibitin|PHB Malignant neoplasm of breast
PREDISPOSES,Primary biliary cirrhosis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Primary biliary cirrhosis Malignant neoplasm of breast
AUGMENTS,ELP3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",ELP3 Malignant neoplasm of breast
CAUSES,DDT,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",DDT Malignant neoplasm of breast
PREDISPOSES,Lactalbumin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Lactalbumin Malignant neoplasm of breast
PREDISPOSES,paclitaxel liposome,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Disease or Syndrome,paclitaxel liposome Sporadic Breast Carcinoma
AUGMENTS,CTU1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,CTU1 Malignant neoplasm of breast
DISRUPTS,Thrombospondins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Thrombospondins Malignant neoplasm of breast
CAUSES,particle,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,particle Breast Carcinoma
PREDISPOSES,Thrombospondin 1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Thrombospondin 1 Malignant neoplasm of breast
PREDISPOSES,Running,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Running Malignant neoplasm of breast
PREDISPOSES,Asthenia,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,Asthenia Breast cancer invasive NOS
AFFECTS,midkine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,midkine Malignant neoplasm of breast
CAUSES,Prolactinoma,bilateral breast cancer,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Prolactinoma bilateral breast cancer
AFFECTS,Misonidazole,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Misonidazole Malignant neoplasm of breast
AFFECTS,Abdominal obesity,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Abdominal obesity Malignant neoplasm of breast
CAUSES,cholanthrene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,cholanthrene Malignant neoplasm of breast
AFFECTS,Adriamycin,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Adriamycin Breast Carcinoma
PREDISPOSES,Lymph Node Involvement,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Lymph Node Involvement Breast Carcinoma
AFFECTS,Caffeine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Caffeine Malignant neoplasm of breast
AFFECTS,"3,4-Methylenedioxyamphetamine",Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,"3,4-Methylenedioxyamphetamine Breast Carcinoma"
AFFECTS,Dietary Fats,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Dietary Fats Breast cancer metastatic
AUGMENTS,Cholestyramine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Cholestyramine Malignant neoplasm of breast
AFFECTS,Diethylstilbestrol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Diethylstilbestrol Malignant neoplasm of breast
AFFECTS,radical mastectomy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,radical mastectomy Malignant neoplasm of breast
AFFECTS,Rheumatoid Arthritis,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Rheumatoid Arthritis Breast Carcinoma
CAUSES,ptaquiloside,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ptaquiloside Malignant neoplasm of breast
AUGMENTS,Prolactin|PRL,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Prolactin|PRL Malignant neoplasm of breast
CAUSES,Cycasin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Cycasin Malignant neoplasm of breast
CAUSES,Bromocriptine,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Bromocriptine Breast Carcinoma
PREDISPOSES,Prolonged periods,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Prolonged periods Malignant neoplasm of breast
PREDISPOSES,Transferase,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Transferase Breast Carcinoma
DISRUPTS,Prolactin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Prolactin Malignant neoplasm of breast
AFFECTS,Trimetrexate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Trimetrexate Malignant neoplasm of breast
AUGMENTS,Paroxetine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Paroxetine Malignant neoplasm of breast
PREDISPOSES,Bone Density,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Bone Density Breast Carcinoma
AUGMENTS,PTPRF,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,PTPRF Malignant neoplasm of breast
PREDISPOSES,Endopeptidases|ERVK-7|ERVK-8|ERVK-10|ERVK-9|ERVK-21|ERVK-18|ERVK-25|ERVK-24|ERVK-19,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Endopeptidases|ERVK-7|ERVK-8|ERVK-10|ERVK-9|ERVK-21|ERVK-18|ERVK-25|ERVK-24|ERVK-19 Breast Carcinoma
AFFECTS,heparanase|HPSE,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",heparanase|HPSE Malignant neoplasm of breast
DISRUPTS,Fenretinide,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Fenretinide Breast Carcinoma
DISRUPTS,Proline,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Proline Breast Carcinoma
CAUSES,Free Radicals,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Free Radicals Breast Carcinoma
PREDISPOSES,Sedentary lifestyle,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Sedentary lifestyle Breast Carcinoma
AFFECTS,Acetate,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Acetate Breast Carcinoma
PREDISPOSES,Physical activity,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Physical activity Breast Carcinoma
AFFECTS,Nitrites,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Nitrites Malignant neoplasm of breast
AUGMENTS,Endopeptidases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Endopeptidases Malignant neoplasm of breast
PREDISPOSES,Sarcoidosis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Sarcoidosis Malignant neoplasm of breast
AFFECTS,LGD 1069,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,LGD 1069 Breast Carcinoma
AFFECTS,chemokine receptor,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",chemokine receptor Breast cancer metastatic
PREDISPOSES,"polio, NOS",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,"polio, NOS Malignant neoplasm of breast"
PREDISPOSES,Treatment/Psychosocial Effects,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Treatment/Psychosocial Effects Malignant neoplasm of breast
CAUSES,Silicones,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Silicones Malignant neoplasm of breast
CAUSES,chromosome 11q,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",chromosome 11q Malignant neoplasm of breast
CAUSES,6-nitrochrysene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,6-nitrochrysene Malignant neoplasm of breast
AUGMENTS,17q23,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,17q23 Breast Carcinoma
CAUSES,Tenascin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Tenascin Malignant neoplasm of breast
AFFECTS,WWOX,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",WWOX Malignant neoplasm of breast
AUGMENTS,Cytochrome P-450 CYP1A1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Cytochrome P-450 CYP1A1 Malignant neoplasm of breast
CAUSES,beta-hexachlorocyclohexane,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",beta-hexachlorocyclohexane Malignant neoplasm of breast
AFFECTS,inhibitors,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,"Element, Ion, or Isotope",inhibitors Sporadic Breast Carcinoma
PREDISPOSES,SLC12A3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,SLC12A3 Malignant neoplasm of breast
AFFECTS,Adrenalectomy,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Adrenalectomy Breast Carcinoma
AFFECTS,Thyroidectomy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Thyroidectomy Malignant neoplasm of breast
AFFECTS,Polyamines,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Polyamines Breast cancer metastatic
PREDISPOSES,"Fats, Unsaturated",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,"Fats, Unsaturated Malignant neoplasm of breast"
PREDISPOSES,Premature Birth,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,"Element, Ion, or Isotope",Premature Birth Female Breast Carcinoma
AFFECTS,Angiogenic Switch,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Angiogenic Switch Malignant neoplasm of breast
COMPLICATES,"Liver Failure, Acute",Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,"Element, Ion, or Isotope","Liver Failure, Acute Ductal Breast Carcinoma"
CAUSES,Estradiol,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Neoplastic Process,Estradiol Noninfiltrating Intraductal Carcinoma
PREDISPOSES,CD55|TCN2,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,"Element, Ion, or Isotope",CD55|TCN2 Female Breast Carcinoma
AUGMENTS,Durapatite,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Durapatite Malignant neoplasm of breast
AFFECTS,Cysteine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Cysteine Malignant neoplasm of breast
DISRUPTS,SELPLG,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,SELPLG Malignant neoplasm of breast
PREDISPOSES,Gruyere cheese,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Gruyere cheese Malignant neoplasm of breast
CAUSES,Study models,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,"Element, Ion, or Isotope",Study models Inflammatory Breast Carcinoma
AFFECTS,chemokine receptor D6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,chemokine receptor D6 Malignant neoplasm of breast
PREDISPOSES,DPYS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,DPYS Malignant neoplasm of breast
PREDISPOSES,HFE,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,"Element, Ion, or Isotope",HFE Carcinoma of Male Breast
CAUSES,NUCLEAR MITOTIC APPARATUS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",NUCLEAR MITOTIC APPARATUS Malignant neoplasm of breast
PREDISPOSES,CLEC14A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,CLEC14A Malignant neoplasm of breast
AFFECTS,Thrombospondins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Thrombospondins Malignant neoplasm of breast
PREDISPOSES,Angiotensinogen|AGT,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Angiotensinogen|AGT Malignant neoplasm of breast
DISRUPTS,Sermorelin|GH1|GGH,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Sermorelin|GH1|GGH Breast Carcinoma
PREDISPOSES,Night shift worker,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Night shift worker Malignant neoplasm of breast
DISRUPTS,ASAP1|MYCBPAP,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Element, Ion, or Isotope",ASAP1|MYCBPAP Breast cancer invasive NOS
AFFECTS,NELFB,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,NELFB Malignant neoplasm of breast
DISRUPTS,ITGB3BP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ITGB3BP Malignant neoplasm of breast
AFFECTS,isopeptidase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,isopeptidase Malignant neoplasm of breast
AFFECTS,Breast radiotherapies,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Breast radiotherapies Contralateral breast cancer
PREDISPOSES,ADH1C,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ADH1C Malignant neoplasm of breast
AFFECTS,Adenomatous Polyposis Coli,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Neoplastic Process,Adenomatous Polyposis Coli Inflammatory Breast Carcinoma
PREDISPOSES,methyl group,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",methyl group Malignant neoplasm of breast
PREDISPOSES,gamma-Tocopherol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",gamma-Tocopherol Malignant neoplasm of breast
CAUSES,Tocopherols,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Tocopherols Malignant neoplasm of breast
AUGMENTS,Genistein,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Genistein Malignant neoplasm of breast
AFFECTS,exemestane,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,exemestane Malignant neoplasm of breast
PREDISPOSES,PREDICTED,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",PREDICTED Breast cancer recurrent
AFFECTS,RNF115,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",RNF115 Breast cancer metastatic
CAUSES,Aromatic Amines,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Aromatic Amines Breast Carcinoma
PREDISPOSES,NOD2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,NOD2 Malignant neoplasm of breast
PREDISPOSES,Hyperandrogenism,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Hyperandrogenism Malignant neoplasm of breast
PREDISPOSES,Grapes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Grapes Malignant neoplasm of breast
AUGMENTS,PDIA6,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,PDIA6 Breast cancer invasive NOS
AFFECTS,Thalidomide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Thalidomide Malignant neoplasm of breast
AFFECTS,multicatalytic endopeptidase complex,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",multicatalytic endopeptidase complex Malignant neoplasm of breast
AFFECTS,andrographolide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,andrographolide Malignant neoplasm of breast
PREDISPOSES,Atrophy of vagina,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Atrophy of vagina Malignant neoplasm of breast
DISRUPTS,docetaxel,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,docetaxel Malignant neoplasm of breast
PREDISPOSES,RIN1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,RIN1 Malignant neoplasm of breast
AUGMENTS,FOXA1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",FOXA1 Malignant neoplasm of breast
AFFECTS,HBP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,HBP1 Malignant neoplasm of breast
PREDISPOSES,Aborted pregnancy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Aborted pregnancy Malignant neoplasm of breast
AUGMENTS,5'-NUCLEOTIDASE|NT5E,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,5'-NUCLEOTIDASE|NT5E Malignant neoplasm of breast
AFFECTS,Interleukin-8|EREG|ESR1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Interleukin-8|EREG|ESR1 Malignant neoplasm of breast
PREDISPOSES,SNAI1,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Element, Ion, or Isotope",SNAI1 Breast cancer recurrent
AUGMENTS,PPIA,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,PPIA Malignant neoplasm of breast
AFFECTS,Alpha tocopheryl succinate,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Alpha tocopheryl succinate Breast Carcinoma
DISRUPTS,Stearates,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Stearates Breast Carcinoma
PREDISPOSES,estrone sulfate,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,"Element, Ion, or Isotope",estrone sulfate Female Breast Carcinoma
PREDISPOSES,Dihydrofolate Reductase|DHFR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Dihydrofolate Reductase|DHFR Malignant neoplasm of breast
AUGMENTS,Acrylamide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Acrylamide Malignant neoplasm of breast
CAUSES,Silicon,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Silicon Breast cancer recurrent
DISRUPTS,IFI27|PSMD9|SSSCA1|DCTN6|TMED7,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,IFI27|PSMD9|SSSCA1|DCTN6|TMED7 Breast Carcinoma
AFFECTS,Xenograft procedure,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Xenograft procedure Breast cancer metastatic
PREDISPOSES,Prognostic Factor,bilateral breast cancer,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Prognostic Factor bilateral breast cancer
PREDISPOSES,RAB27B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,RAB27B Malignant neoplasm of breast
DISRUPTS,PARP1|COL11A2,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",PARP1|COL11A2 Breast cancer metastatic
AFFECTS,D4-GDI,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,D4-GDI Malignant neoplasm of breast
PREDISPOSES,TIMM17A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",TIMM17A Malignant neoplasm of breast
CAUSES,ADM,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",ADM Malignant neoplasm of breast
AFFECTS,erbB-2 Receptor|ERBB2,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Element, Ion, or Isotope",erbB-2 Receptor|ERBB2 Breast cancer invasive NOS
AFFECTS,docetaxel,Breast cancer stage II,0.0,Female Breast Cancer,"Element, Ion, or Isotope",docetaxel Breast cancer stage II
PREDISPOSES,exemestane,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",exemestane Contralateral breast cancer
PREDISPOSES,SOX4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,SOX4 Malignant neoplasm of breast
PREDISPOSES,Alleles,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,Alleles Breast cancer invasive NOS
AFFECTS,Interstitial Collagenase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Interstitial Collagenase Malignant neoplasm of breast
CAUSES,Quinones,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Quinones Malignant neoplasm of breast
AUGMENTS,ERBB2|NEU1|NEURL1,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,"Element, Ion, or Isotope","ERBB2|NEU1|NEURL1 Carcinoma, Ductal, Breast"
CAUSES,Garlic,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Garlic Malignant neoplasm of breast
AFFECTS,VEGFA,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,"Element, Ion, or Isotope","VEGFA Carcinoma, Ductal, Breast"
AFFECTS,Body mass index procedure,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Element, Ion, or Isotope",Body mass index procedure Breast cancer invasive NOS
PREDISPOSES,AVP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,AVP Malignant neoplasm of breast
AUGMENTS,SPDYA,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,SPDYA Breast Carcinoma
AFFECTS,CD24,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",CD24 Noninfiltrating Intraductal Carcinoma
PREDISPOSES,cytochrome P-450 CYP1B1|CYP1B1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",cytochrome P-450 CYP1B1|CYP1B1 Malignant neoplasm of breast
DISRUPTS,ORALIT,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ORALIT Malignant neoplasm of breast
AFFECTS,Lithium,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Lithium Malignant neoplasm of breast
AFFECTS,nuclear receptor coactivator 1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",nuclear receptor coactivator 1 Malignant neoplasm of breast
PREDISPOSES,phenylalanylphenylalanine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,phenylalanylphenylalanine Malignant neoplasm of breast
CAUSES,Norepinephrine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Norepinephrine Malignant neoplasm of breast
AUGMENTS,S100A6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,S100A6 Malignant neoplasm of breast
DISRUPTS,caveolin 1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,caveolin 1 Malignant neoplasm of breast
AUGMENTS,CDKN1A|TCEAL1|NSG1|H3F3AP6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",CDKN1A|TCEAL1|NSG1|H3F3AP6 Malignant neoplasm of breast
AFFECTS,MAPK15,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,MAPK15 Malignant neoplasm of breast
AFFECTS,Velcade,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Velcade Malignant neoplasm of breast
DISRUPTS,GATA3,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",GATA3 Breast cancer metastatic
AFFECTS,collagenase 3,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",collagenase 3 Breast cancer metastatic
AUGMENTS,HSPA1A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,HSPA1A Malignant neoplasm of breast
AUGMENTS,casein kinase II,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",casein kinase II Malignant neoplasm of breast
AFFECTS,Tristetraprolin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Tristetraprolin Malignant neoplasm of breast
DISRUPTS,SUSD3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,SUSD3 Malignant neoplasm of breast
AFFECTS,iturin A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,iturin A Malignant neoplasm of breast
AUGMENTS,PSPHP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,PSPHP1 Malignant neoplasm of breast
AFFECTS,Genistein,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Genistein Breast cancer metastatic
AFFECTS,Naphthalene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Naphthalene Malignant neoplasm of breast
PREDISPOSES,Purines,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Purines Malignant neoplasm of breast
AFFECTS,toll-like receptor 4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",toll-like receptor 4 Malignant neoplasm of breast
PREDISPOSES,Interleukin 6 Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Interleukin 6 Receptor Malignant neoplasm of breast
AUGMENTS,Growth stimulant,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Biologically Active Substance,Growth stimulant Malignant neoplasm of breast
PREDISPOSES,SLOPE,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,SLOPE Breast Carcinoma
PREDISPOSES,CLOCK,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",CLOCK Malignant neoplasm of breast
AFFECTS,PTGER2|SPAG11B,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",PTGER2|SPAG11B Breast cancer metastatic
PREDISPOSES,AMOTL1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,AMOTL1 Malignant neoplasm of breast
AFFECTS,tubeimoside I,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",tubeimoside I Breast cancer metastatic
PREDISPOSES,1/24,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",1/24 Malignant neoplasm of breast
PREDISPOSES,SH3PXD2A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,SH3PXD2A Malignant neoplasm of breast
PREDISPOSES,LY6K,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,LY6K Malignant neoplasm of breast
AFFECTS,cofilin|CFL1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",cofilin|CFL1 Breast cancer metastatic
PREDISPOSES,MLLT11,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",MLLT11 Breast cancer metastatic
AUGMENTS,FOXP3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",FOXP3 Malignant neoplasm of breast
AUGMENTS,FBXO42,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,FBXO42 Malignant neoplasm of breast
PREDISPOSES,CMTS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,CMTS Malignant neoplasm of breast
AFFECTS,ARGININOSUCCINATE LYASE|ASL,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ARGININOSUCCINATE LYASE|ASL Malignant neoplasm of breast
AFFECTS,Platinum,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Platinum Malignant neoplasm of breast
AFFECTS,Transcript,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,Transcript Breast cancer invasive NOS
PREDISPOSES,SOD1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",SOD1 Malignant neoplasm of breast
AFFECTS,ESR2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",ESR2 Malignant neoplasm of breast
DISRUPTS,costunolide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,costunolide Malignant neoplasm of breast
AUGMENTS,anthracene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,anthracene Malignant neoplasm of breast
AFFECTS,MEG3|FAM129B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",MEG3|FAM129B Malignant neoplasm of breast
CAUSES,chemokine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,chemokine Malignant neoplasm of breast
PREDISPOSES,ZNF143,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ZNF143 Malignant neoplasm of breast
AFFECTS,Fibrosing adenosis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Fibrosing adenosis Malignant neoplasm of breast
AUGMENTS,EIF2S1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,EIF2S1 Malignant neoplasm of breast
PREDISPOSES,Increased effect,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Increased effect Malignant neoplasm of breast
AFFECTS,NF-Kappa B p65,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,NF-Kappa B p65 Malignant neoplasm of breast
AFFECTS,"Hazards, Environmental",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Hazards, Environmental Malignant neoplasm of breast"
AUGMENTS,NF-AT,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,NF-AT Malignant neoplasm of breast
DISRUPTS,ERBB2,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",ERBB2 Breast Carcinoma
AFFECTS,indoleamine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,indoleamine Malignant neoplasm of breast
DISRUPTS,EHMT2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,EHMT2 Malignant neoplasm of breast
PREDISPOSES,ethylene glycol,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,Disease or Syndrome,ethylene glycol Carcinoma of Male Breast
PREDISPOSES,Pasta intake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Pasta intake Malignant neoplasm of breast
AFFECTS,Beads,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Beads Malignant neoplasm of breast
AFFECTS,Thioridazine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Thioridazine Malignant neoplasm of breast
PREDISPOSES,SCARA5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,SCARA5 Malignant neoplasm of breast
CAUSES,CDCA7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,CDCA7 Malignant neoplasm of breast
DISRUPTS,DDAVP,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",DDAVP Breast cancer metastatic
PREDISPOSES,Pyruvate Kinase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Pyruvate Kinase Malignant neoplasm of breast
AFFECTS,Prolactin,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,Prolactin Breast cancer invasive NOS
PREDISPOSES,nicotinamide phosphoribosyltransferase|NAMPT,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",nicotinamide phosphoribosyltransferase|NAMPT Malignant neoplasm of breast
AUGMENTS,Morphine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Morphine Malignant neoplasm of breast
AFFECTS,CYTOR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",CYTOR Malignant neoplasm of breast
AFFECTS,Doxorubicin,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Doxorubicin Breast Carcinoma
AFFECTS,B-pyridine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,B-pyridine Malignant neoplasm of breast
AFFECTS,Alkanes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Alkanes Malignant neoplasm of breast
PREDISPOSES,Prior Therapy,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Element, Ion, or Isotope",Prior Therapy Breast cancer recurrent
AFFECTS,SNHG14,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",SNHG14 Malignant neoplasm of breast
AUGMENTS,ACKR3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ACKR3 Malignant neoplasm of breast
DISRUPTS,LACTB,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,LACTB Malignant neoplasm of breast
AFFECTS,IkappaB Kinase beta,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",IkappaB Kinase beta Malignant neoplasm of breast
AFFECTS,Granulocyte Colony-Stimulating Factor,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Granulocyte Colony-Stimulating Factor Breast cancer metastatic
AFFECTS,"Diet, Fat-Restricted",Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","Diet, Fat-Restricted Breast cancer recurrent"
AFFECTS,NNT-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",NNT-AS1 Malignant neoplasm of breast
PREDISPOSES,KISS1R,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",KISS1R Malignant neoplasm of breast
AFFECTS,IL32,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,IL32 Malignant neoplasm of breast
AUGMENTS,ferrocene,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ferrocene Malignant neoplasm of breast
AUGMENTS,PPP2R2A,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",PPP2R2A Breast cancer metastatic
AFFECTS,schizandrin B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,schizandrin B Malignant neoplasm of breast
DISRUPTS,CHI3L1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",CHI3L1 Breast cancer metastatic
PREDISPOSES,osteoactivin,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",osteoactivin Breast cancer metastatic
CAUSES,Phosphoric Monoester Hydrolases,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Phosphoric Monoester Hydrolases Malignant neoplasm of breast
PREDISPOSES,N-myristoyltransferase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,N-myristoyltransferase Malignant neoplasm of breast
PREDISPOSES,caspase-3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,caspase-3 Malignant neoplasm of breast
AUGMENTS,Platelet Factor 4|PF4,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",Platelet Factor 4|PF4 Noninfiltrating Intraductal Carcinoma
AFFECTS,Chromosomal Rearrangement,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Chromosomal Rearrangement Malignant neoplasm of breast
DISRUPTS,P3H1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,P3H1 Malignant neoplasm of breast
PREDISPOSES,lymphocyte product,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",lymphocyte product Malignant neoplasm of breast
CAUSES,IkappaB Kinase epsilon,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",IkappaB Kinase epsilon Malignant neoplasm of breast
PREDISPOSES,ZNF326,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ZNF326 Malignant neoplasm of breast
AFFECTS,ZIC1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ZIC1 Malignant neoplasm of breast
AUGMENTS,Polymerase|ERVK-9|ERVK-19|ERVK-11,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Polymerase|ERVK-9|ERVK-19|ERVK-11 Malignant neoplasm of breast
AUGMENTS,LBH589,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,LBH589 Malignant neoplasm of breast
PREDISPOSES,ADRA1D,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ADRA1D Malignant neoplasm of breast
DISRUPTS,8-hydroxy-2'-deoxyguanosine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",8-hydroxy-2'-deoxyguanosine Malignant neoplasm of breast
PREDISPOSES,Thromboplastin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Thromboplastin Malignant neoplasm of breast
PREDISPOSES,WWC1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,WWC1 Malignant neoplasm of breast
PREDISPOSES,Mammographic breast density,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Mammographic breast density Noninfiltrating Intraductal Carcinoma
CAUSES,PGC,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,PGC Malignant neoplasm of breast
AFFECTS,Estradiol Receptors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Estradiol Receptors Malignant neoplasm of breast
PREDISPOSES,cryptochrome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,cryptochrome Malignant neoplasm of breast
PREDISPOSES,REPS2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,REPS2 Malignant neoplasm of breast
AFFECTS,Somatostatin analog|SST,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Somatostatin analog|SST Malignant neoplasm of breast
PREDISPOSES,Atherosclerosis,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Atherosclerosis Malignant neoplasm of breast
PREDISPOSES,versican|VCAN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",versican|VCAN Malignant neoplasm of breast
AFFECTS,Urokinase,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Urokinase Breast Carcinoma
PREDISPOSES,Tenascin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Tenascin Malignant neoplasm of breast
PREDISPOSES,Fat tissue increased,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Fat tissue increased Breast Carcinoma
AFFECTS,Androgen Receptor|AR,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Androgen Receptor|AR Breast Carcinoma
AFFECTS,Tegafur,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Tegafur Breast cancer metastatic
PREDISPOSES,Desipramine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Desipramine Malignant neoplasm of breast
DISRUPTS,Serpins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Serpins Malignant neoplasm of breast
PREDISPOSES,Size of lymph node,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Size of lymph node Malignant neoplasm of breast
PREDISPOSES,ADH1B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",ADH1B Malignant neoplasm of breast
PREDISPOSES,decisiveness,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,decisiveness Malignant neoplasm of breast
PREDISPOSES,Vaccines,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Vaccines Malignant neoplasm of breast
PREDISPOSES,caffeinated beverage,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,caffeinated beverage Malignant neoplasm of breast
AFFECTS,Pharmacotherapy,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Pharmacotherapy Contralateral breast cancer
AFFECTS,RAC1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,RAC1 Malignant neoplasm of breast
PREDISPOSES,cultural differences,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",cultural differences Malignant neoplasm of breast
CAUSES,Epiregulin|EREG,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",Epiregulin|EREG Noninfiltrating Intraductal Carcinoma
AFFECTS,Fertility,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,Fertility Breast cancer metastatic
AFFECTS,Buformin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Buformin Malignant neoplasm of breast
PREDISPOSES,RGS17,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,RGS17 Malignant neoplasm of breast
DISRUPTS,Adrenergic beta-Antagonists,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Adrenergic beta-Antagonists Malignant neoplasm of breast
AFFECTS,RGS17,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,RGS17 Malignant neoplasm of breast
AFFECTS,Cytochrome P-450 CYP2D6,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Lipid,Cytochrome P-450 CYP2D6 Breast cancer recurrent
PREDISPOSES,Mayonnaise,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Mayonnaise Malignant neoplasm of breast
CAUSES,ING1|LTB|CENPK,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Element, Ion, or Isotope",ING1|LTB|CENPK Breast cancer invasive NOS
PREDISPOSES,Fibromyalgia,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Fibromyalgia Malignant neoplasm of breast
AFFECTS,Signal Pathways,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",Signal Pathways Noninfiltrating Intraductal Carcinoma
PREDISPOSES,Body mass index,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,"Element, Ion, or Isotope",Body mass index Contralateral breast cancer
AFFECTS,Increased Metabolic Rate,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,"Element, Ion, or Isotope",Increased Metabolic Rate Inflammatory Breast Carcinoma
PREDISPOSES,PROM1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,PROM1 Malignant neoplasm of breast
AUGMENTS,Signaling Molecule,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,"Element, Ion, or Isotope","Signaling Molecule Carcinoma, Ductal, Breast"
AFFECTS,STARD3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,STARD3 Malignant neoplasm of breast
AUGMENTS,Estratest,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,Estratest Breast cancer invasive NOS
PREDISPOSES,GLO1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",GLO1 Malignant neoplasm of breast
AFFECTS,Doxorubicin,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Doxorubicin Breast cancer metastatic
DISRUPTS,Hydroxymethylglutaryl-CoA Reductase Inhibitors,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Element, Ion, or Isotope",Hydroxymethylglutaryl-CoA Reductase Inhibitors Breast cancer recurrent
AFFECTS,BMP4|BMP4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",BMP4|BMP4 Malignant neoplasm of breast
PREDISPOSES,Primigravida,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,Primigravida Breast cancer invasive NOS
PREDISPOSES,PPARGC1B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",PPARGC1B Malignant neoplasm of breast
AFFECTS,DDIT4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,DDIT4 Malignant neoplasm of breast
PREDISPOSES,Axillary Lymph Node Involvement,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Axillary Lymph Node Involvement Malignant neoplasm of breast
AFFECTS,Leukocyte Elastase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Leukocyte Elastase Malignant neoplasm of breast
PREDISPOSES,[D]Mammogram abnormal,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,[D]Mammogram abnormal Malignant neoplasm of breast
AFFECTS,NEUROD1|TUBB4B,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Element, Ion, or Isotope",NEUROD1|TUBB4B Breast cancer invasive NOS
PREDISPOSES,Hay fever,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Hay fever Malignant neoplasm of breast
PREDISPOSES,Recombinant Interferon-gamma|IFNG,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Recombinant Interferon-gamma|IFNG Malignant neoplasm of breast
AUGMENTS,URI1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,URI1 Malignant neoplasm of breast
PREDISPOSES,ABCC5,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",ABCC5 Breast cancer metastatic
PREDISPOSES,IL17F,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Disease or Syndrome,IL17F Sporadic Breast Carcinoma
AUGMENTS,POP4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,POP4 Malignant neoplasm of breast
PREDISPOSES,CSH1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,CSH1 Malignant neoplasm of breast
PREDISPOSES,patient characteristics,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,Lipid,patient characteristics Breast cancer recurrent
PREDISPOSES,Smoking Behavior,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Smoking Behavior Malignant neoplasm of breast
CAUSES,XRCC1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",XRCC1 Malignant neoplasm of breast
PREDISPOSES,Estrone,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,Estrone Breast cancer invasive NOS
AFFECTS,Mangifera indica extract,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Mangifera indica extract Malignant neoplasm of breast
AFFECTS,NAP1L2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,NAP1L2 Malignant neoplasm of breast
AUGMENTS,Folate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Folate Malignant neoplasm of breast
PREDISPOSES,Stathmin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Stathmin Malignant neoplasm of breast
PREDISPOSES,Cigarette Smoking,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Element, Ion, or Isotope",Cigarette Smoking Breast cancer invasive NOS
AFFECTS,astragaloside IV,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,astragaloside IV Malignant neoplasm of breast
AFFECTS,PRRX2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,PRRX2 Malignant neoplasm of breast
AFFECTS,crocin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,crocin Malignant neoplasm of breast
DISRUPTS,ING5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ING5 Malignant neoplasm of breast
CAUSES,Annexin A2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Annexin A2 Malignant neoplasm of breast
AFFECTS,Proton therapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Proton therapy Malignant neoplasm of breast
DISRUPTS,brucine,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",brucine Breast cancer metastatic
PREDISPOSES,histone deacetylase 3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,histone deacetylase 3 Malignant neoplasm of breast
AFFECTS,FTO,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",FTO Malignant neoplasm of breast
AUGMENTS,SDC1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",SDC1 Malignant neoplasm of breast
AFFECTS,KLHL7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,KLHL7 Malignant neoplasm of breast
PREDISPOSES,RETN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",RETN Malignant neoplasm of breast
DISRUPTS,PIP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,PIP Malignant neoplasm of breast
AFFECTS,stem cell therapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",stem cell therapy Malignant neoplasm of breast
AFFECTS,Cytochrome P-450 CYP2D6,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Cytochrome P-450 CYP2D6 Breast cancer metastatic
PREDISPOSES,ACACA|BMS1,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,"Element, Ion, or Isotope",ACACA|BMS1 Female Breast Carcinoma
PREDISPOSES,decorin|DCN,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,decorin|DCN Malignant neoplasm of breast
AFFECTS,inhibitors,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,"Element, Ion, or Isotope",inhibitors Familial cancer of breast
PREDISPOSES,Financial circumstances,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Neoplastic Process,Financial circumstances Noninfiltrating Intraductal Carcinoma
AUGMENTS,beta catenin,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",beta catenin Noninfiltrating Intraductal Carcinoma
PREDISPOSES,2q33-q34,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,2q33-q34 Malignant neoplasm of breast
DISRUPTS,PERP,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,PERP Malignant neoplasm of breast
AUGMENTS,NEK2,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",NEK2 Noninfiltrating Intraductal Carcinoma
PREDISPOSES,Interleukin-10,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Interleukin-10 Malignant neoplasm of breast
PREDISPOSES,Osteonectin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Osteonectin Malignant neoplasm of breast
PREDISPOSES,"Subarachnoid Hemorrhage, Aneurysmal",Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Neoplastic Process,"Subarachnoid Hemorrhage, Aneurysmal Noninfiltrating Intraductal Carcinoma"
PREDISPOSES,thiopurine,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",thiopurine Breast cancer recurrent
PREDISPOSES,Body mass index,"Carcinoma, Ductal, Breast",0.0029970029970029,Female Breast Cancer,"Element, Ion, or Isotope","Body mass index Carcinoma, Ductal, Breast"
PREDISPOSES,Boiled potato,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Boiled potato Malignant neoplasm of breast
AFFECTS,Hypothyroidism,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Hypothyroidism Malignant neoplasm of breast
PREDISPOSES,CHEST SYMPTOM,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,CHEST SYMPTOM Malignant neoplasm of breast
AFFECTS,ERBB2|NEU1|NEURL1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",ERBB2|NEU1|NEURL1 Breast cancer metastatic
DISRUPTS,Ritonavir,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Ritonavir Malignant neoplasm of breast
PREDISPOSES,Soluble ErbB-1|EGFR,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Soluble ErbB-1|EGFR Breast cancer metastatic
PREDISPOSES,RANTES,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,RANTES Breast Carcinoma
AFFECTS,Microsatellite Repeats,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",Microsatellite Repeats Noninfiltrating Intraductal Carcinoma
AFFECTS,Local Therapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Local Therapy Malignant neoplasm of breast
CAUSES,Thymidylate Synthase,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Gene or Genome,Thymidylate Synthase Breast Carcinoma
DISRUPTS,CD68,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,CD68 Malignant neoplasm of breast
PREDISPOSES,DES EXPOSURE,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",DES EXPOSURE Malignant neoplasm of breast
PREDISPOSES,SABER,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",SABER Breast cancer recurrent
PREDISPOSES,BABAM1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,BABAM1 Malignant neoplasm of breast
PREDISPOSES,Xenobiotics,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Xenobiotics Malignant neoplasm of breast
AFFECTS,Hematoxylin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Hematoxylin Malignant neoplasm of breast
AFFECTS,Mitogens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Mitogens Malignant neoplasm of breast
PREDISPOSES,SCREEN TECHNIQUES,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,SCREEN TECHNIQUES Malignant neoplasm of breast
AFFECTS,erbB-2 Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",erbB-2 Receptor Malignant neoplasm of breast
PREDISPOSES,Adenomatous goiter,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Adenomatous goiter Malignant neoplasm of breast
AFFECTS,PFKFB4,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,PFKFB4 Breast cancer metastatic
PREDISPOSES,Disintegrins,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Disintegrins Malignant neoplasm of breast
DISRUPTS,HSPA5,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",HSPA5 Malignant neoplasm of breast
PREDISPOSES,Abdominal circumference,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Abdominal circumference Malignant neoplasm of breast
PREDISPOSES,tibolone,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",tibolone Breast cancer recurrent
PREDISPOSES,LAMTOR3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,LAMTOR3 Malignant neoplasm of breast
PREDISPOSES,DSCAM-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",DSCAM-AS1 Malignant neoplasm of breast
PREDISPOSES,Cooking,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Cooking Malignant neoplasm of breast
AFFECTS,Lymphedema,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Lymphedema Malignant neoplasm of breast
PREDISPOSES,Diuretics,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Diuretics Breast Carcinoma
PREDISPOSES,Trihalomethanes,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,"Element, Ion, or Isotope",Trihalomethanes Female Breast Carcinoma
PREDISPOSES,Histologic type,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",Histologic type Noninfiltrating Intraductal Carcinoma
PREDISPOSES,"Iron, Dietary",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Iron, Dietary Malignant neoplasm of breast"
AFFECTS,JMJD6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,JMJD6 Malignant neoplasm of breast
AFFECTS,Cadaverine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Cadaverine Malignant neoplasm of breast
AFFECTS,FRA16D,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,FRA16D Malignant neoplasm of breast
AUGMENTS,S100A7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",S100A7 Malignant neoplasm of breast
DISRUPTS,Thioglucosides,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Thioglucosides Malignant neoplasm of breast
PREDISPOSES,Dietary fat intake,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,"Element, Ion, or Isotope",Dietary fat intake Breast cancer invasive NOS
AFFECTS,PNU,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,PNU Malignant neoplasm of breast
AFFECTS,MED19,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,MED19 Malignant neoplasm of breast
CAUSES,CYTOR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",CYTOR Malignant neoplasm of breast
AFFECTS,Fruit,Breast cancer recurrent,0.0049950049950049,Recurrent Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Fruit Breast cancer recurrent
PREDISPOSES,UBE2N,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",UBE2N Breast cancer metastatic
PREDISPOSES,GJB2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,GJB2 Malignant neoplasm of breast
AFFECTS,"Chemotherapy, Adjuvant",Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope","Chemotherapy, Adjuvant Noninfiltrating Intraductal Carcinoma"
AUGMENTS,ENPP2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ENPP2 Malignant neoplasm of breast
PREDISPOSES,KRT8,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Neoplastic Process,KRT8 Breast cancer invasive NOS
AFFECTS,PTCSC3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,PTCSC3 Malignant neoplasm of breast
CAUSES,Arsenic,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Arsenic Malignant neoplasm of breast
DISRUPTS,AQP4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,AQP4 Malignant neoplasm of breast
DISRUPTS,salinomycin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,salinomycin Malignant neoplasm of breast
CAUSES,Mandibular right first molar abutment,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Mandibular right first molar abutment Malignant neoplasm of breast
AFFECTS,Cathepsins B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Cathepsins B Malignant neoplasm of breast
AUGMENTS,FAM84B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,FAM84B Malignant neoplasm of breast
DISRUPTS,AQP7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,AQP7 Malignant neoplasm of breast
AFFECTS,Ca(2+)-Transporting ATPase|CA2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Ca(2+)-Transporting ATPase|CA2 Malignant neoplasm of breast
AFFECTS,therapeutic use,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",therapeutic use Malignant neoplasm of breast
AFFECTS,verbenone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,verbenone Malignant neoplasm of breast
PREDISPOSES,moderate drinking,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,moderate drinking Malignant neoplasm of breast
PREDISPOSES,RBM12B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,RBM12B Malignant neoplasm of breast
AUGMENTS,CASC9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,CASC9 Malignant neoplasm of breast
AUGMENTS,EIF4EBP1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",EIF4EBP1 Malignant neoplasm of breast
AFFECTS,FUT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,FUT1 Malignant neoplasm of breast
AFFECTS,1-Phosphatidylinositol 4-Kinase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",1-Phosphatidylinositol 4-Kinase Malignant neoplasm of breast
AUGMENTS,Cullin 1,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,Gene or Genome,Cullin 1 Breast cancer metastatic
AFFECTS,Transferrin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Transferrin Malignant neoplasm of breast
PREDISPOSES,PIEZO2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,PIEZO2 Malignant neoplasm of breast
AFFECTS,Vinegar,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Vinegar Malignant neoplasm of breast
AUGMENTS,Interferon Type I,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,"Element, Ion, or Isotope",Interferon Type I Inflammatory Breast Carcinoma
AUGMENTS,UCHL3,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,UCHL3 Malignant neoplasm of breast
PREDISPOSES,Kinesin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Kinesin Malignant neoplasm of breast
AFFECTS,BCL11A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,BCL11A Malignant neoplasm of breast
DISRUPTS,Dipeptidyl-Peptidase IV|DPP4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Dipeptidyl-Peptidase IV|DPP4 Malignant neoplasm of breast
AFFECTS,lysyllysine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,lysyllysine Malignant neoplasm of breast
PREDISPOSES,FAM13A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,FAM13A Malignant neoplasm of breast
PREDISPOSES,LINC01133,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,LINC01133 Malignant neoplasm of breast
AUGMENTS,APOBEC3B,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Neoplastic Process,APOBEC3B Noninfiltrating Intraductal Carcinoma
DISRUPTS,honokiol,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",honokiol Breast cancer metastatic
PREDISPOSES,Ephrin B Receptors,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Ephrin B Receptors Malignant neoplasm of breast
PREDISPOSES,Obesity,Contralateral breast cancer,0.0019980019980019,Female Breast Cancer,"Element, Ion, or Isotope",Obesity Contralateral breast cancer
PREDISPOSES,ATXN3,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",ATXN3 Breast cancer metastatic
AUGMENTS,PCB 118,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,PCB 118 Malignant neoplasm of breast
PREDISPOSES,CERS6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,CERS6 Malignant neoplasm of breast
AFFECTS,ingredient,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ingredient Malignant neoplasm of breast
DISRUPTS,cardamonin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,cardamonin Malignant neoplasm of breast
AFFECTS,RAB1A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,RAB1A Malignant neoplasm of breast
AFFECTS,Cyclin-Dependent Kinase Inhibitor 2A|CDK4,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Cyclin-Dependent Kinase Inhibitor 2A|CDK4 Malignant neoplasm of breast
AFFECTS,DSCAM-AS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",DSCAM-AS1 Malignant neoplasm of breast
AFFECTS,paracrine,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",paracrine Breast cancer metastatic
AFFECTS,Adrenergic Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Adrenergic Receptor Malignant neoplasm of breast
PREDISPOSES,PCB 101,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,PCB 101 Malignant neoplasm of breast
DISRUPTS,Docosahexaenoate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Docosahexaenoate Malignant neoplasm of breast
PREDISPOSES,Bleomycin|BLM,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Bleomycin|BLM Malignant neoplasm of breast
PREDISPOSES,MDM1,Familial cancer of breast,0.0039960039960039,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",MDM1 Familial cancer of breast
AUGMENTS,Cisplatin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Cisplatin Malignant neoplasm of breast
AFFECTS,Cathepsins|CTSS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Cathepsins|CTSS Malignant neoplasm of breast
AFFECTS,SORBS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,SORBS1 Malignant neoplasm of breast
PREDISPOSES,erbB-2 Receptor|ECD,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",erbB-2 Receptor|ECD Malignant neoplasm of breast
AFFECTS,Hydrogel,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Hydrogel Malignant neoplasm of breast
AFFECTS,p65|RELA|SYT1|GORASP1|WNK1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",p65|RELA|SYT1|GORASP1|WNK1 Malignant neoplasm of breast
PREDISPOSES,Annexin A1|ANXA1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Annexin A1|ANXA1 Malignant neoplasm of breast
PREDISPOSES,SOX5,Breast cancer metastatic,0.0279720279720279,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",SOX5 Breast cancer metastatic
PREDISPOSES,OGDHL,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,OGDHL Malignant neoplasm of breast
AFFECTS,Postmenopause,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Neoplastic Process,Postmenopause Noninfiltrating Intraductal Carcinoma
AFFECTS,SP 1049C,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,SP 1049C Malignant neoplasm of breast
AUGMENTS,Parabens,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Parabens Malignant neoplasm of breast
AFFECTS,talazoparib,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",talazoparib Triple Negative Breast Neoplasms
PREDISPOSES,insulin isophane,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",insulin isophane Malignant neoplasm of breast
PREDISPOSES,Alcohol intake above recommended sensible limits,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Alcohol intake above recommended sensible limits Malignant neoplasm of breast
PREDISPOSES,Infertility risk,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Infertility risk Malignant neoplasm of breast
PREDISPOSES,levothyroxine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,levothyroxine Malignant neoplasm of breast
DISRUPTS,ceramide kinase,Carcinoma breast stage IV,0.0,Female Breast Cancer,Gene or Genome,ceramide kinase Carcinoma breast stage IV
AFFECTS,Primary Neoplasm,Carcinoma breast stage IV,0.0,Female Breast Cancer,Gene or Genome,Primary Neoplasm Carcinoma breast stage IV
DISRUPTS,cisplatin,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",cisplatin Triple Negative Breast Neoplasms
AFFECTS,"Receptor, Notch4",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope","Receptor, Notch4 Triple Negative Breast Neoplasms"
DISRUPTS,chitosan,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,chitosan Malignant neoplasm of breast
AFFECTS,IGFBP7|SFPQ,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,"Amino Acid, Peptide, or Protein",IGFBP7|SFPQ estrogen receptor-positive breast cancer
AFFECTS,physiological aspects,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,physiological aspects Breast Carcinoma
AFFECTS,prothrombin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,prothrombin Malignant neoplasm of breast
AFFECTS,cisplatin,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,"Amino Acid, Peptide, or Protein",cisplatin estrogen receptor-positive breast cancer
AUGMENTS,methylene chloride,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",methylene chloride Malignant neoplasm of breast
PREDISPOSES,tryptophan,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,tryptophan Malignant neoplasm of breast
AFFECTS,OSW 1,Carcinoma breast stage IV,0.0,Female Breast Cancer,"Element, Ion, or Isotope",OSW 1 Carcinoma breast stage IV
AFFECTS,Saponin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Saponin Malignant neoplasm of breast
PREDISPOSES,Late Relapse,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Chemical,Late Relapse estrogen receptor-positive breast cancer
AUGMENTS,EXT1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,EXT1 Malignant neoplasm of breast
PREDISPOSES,Cyclin B1|CCNB1,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",Cyclin B1|CCNB1 HER2-positive carcinoma of breast
PREDISPOSES,Growth pattern,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Biologically Active Substance,Growth pattern Invasive carcinoma of breast
PREDISPOSES,Biological Markers,Recurrent Breast Carcinoma,0.0009990009990009,Recurrent Breast Cancer,"Element, Ion, or Isotope",Biological Markers Recurrent Breast Carcinoma
DISRUPTS,ELK1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ELK1 Malignant neoplasm of breast
AFFECTS,Hypoxia,Carcinoma breast stage IV,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Hypoxia Carcinoma breast stage IV
AFFECTS,Ginkgo biloba extract,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Ginkgo biloba extract Triple Negative Breast Neoplasms
PREDISPOSES,Fenamole,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Fenamole Malignant neoplasm of breast
PREDISPOSES,Rocky,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Rocky Malignant neoplasm of breast
AFFECTS,Lactones,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Lactones Malignant neoplasm of breast
PREDISPOSES,Sapphire,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Sapphire Malignant neoplasm of breast
PREDISPOSES,Antioxidants,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Antioxidants Triple Negative Breast Neoplasms
AFFECTS,MIR451A wt Allele,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",MIR451A wt Allele Malignant neoplasm of breast
PREDISPOSES,PROGRESSIVE ENCEPHALOMYELITIS WITH RIGIDITY,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,PROGRESSIVE ENCEPHALOMYELITIS WITH RIGIDITY Malignant neoplasm of breast
AUGMENTS,bis(4-hydroxyphenyl)sulfone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,bis(4-hydroxyphenyl)sulfone Malignant neoplasm of breast
PREDISPOSES,S100P,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,S100P Malignant neoplasm of breast
AUGMENTS,glycogen synthase kinase 3 beta,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",glycogen synthase kinase 3 beta Invasive carcinoma of breast
AFFECTS,Ingredient,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Ingredient Malignant neoplasm of breast
AUGMENTS,triptolide,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,triptolide Malignant neoplasm of breast
AFFECTS,Isolate - microorganism,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Isolate - microorganism Malignant neoplasm of breast
AUGMENTS,Potassium Channel,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Potassium Channel Malignant neoplasm of breast
AUGMENTS,resistin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,resistin Malignant neoplasm of breast
PREDISPOSES,Treatment Status,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Treatment Status Breast Carcinoma
AUGMENTS,shikonin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,shikonin Malignant neoplasm of breast
AFFECTS,Suppressor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Suppressor Malignant neoplasm of breast
DISRUPTS,berbamine,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",berbamine Triple Negative Breast Neoplasms
PREDISPOSES,"Discoidin Domain-Containing Receptor 2, Human|DDR2",Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope","Discoidin Domain-Containing Receptor 2, Human|DDR2 Breast Carcinoma"
AFFECTS,Cell Cycle Control,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Cell Cycle Control Triple Negative Breast Neoplasms
AFFECTS,Malaria,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Malaria Malignant neoplasm of breast
PREDISPOSES,arginine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,arginine Malignant neoplasm of breast
AUGMENTS,prolactin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,prolactin Malignant neoplasm of breast
PREDISPOSES,Collagen Type IV,Carcinoma breast stage IV,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Collagen Type IV Carcinoma breast stage IV
PREDISPOSES,proline,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,proline Malignant neoplasm of breast
PREDISPOSES,Echogenic,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Echogenic Triple Negative Breast Neoplasms
DISRUPTS,crocin,Carcinoma breast stage IV,0.0,Female Breast Cancer,"Element, Ion, or Isotope",crocin Carcinoma breast stage IV
PREDISPOSES,Open Reading Frames,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Open Reading Frames Malignant neoplasm of breast
PREDISPOSES,methylate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,methylate Malignant neoplasm of breast
AFFECTS,ginsenoside Rh1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ginsenoside Rh1 Malignant neoplasm of breast
AUGMENTS,cryptotanshinone,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,cryptotanshinone Malignant neoplasm of breast
AUGMENTS,cyclin A2|CCNA2,Carcinoma breast stage IV,0.0,Female Breast Cancer,"Element, Ion, or Isotope",cyclin A2|CCNA2 Carcinoma breast stage IV
DISRUPTS,alpha-hydroxyglutarate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",alpha-hydroxyglutarate Malignant neoplasm of breast
CAUSES,MYC,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",MYC Triple Negative Breast Neoplasms
DISRUPTS,metformin,Carcinoma breast stage IV,0.0,Female Breast Cancer,"Element, Ion, or Isotope",metformin Carcinoma breast stage IV
PREDISPOSES,Challenge:Type:Point in time:^Patient:Nominal,HER2-negative breast cancer,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Challenge:Type:Point in time:^Patient:Nominal HER2-negative breast cancer
AUGMENTS,CUL4B,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",CUL4B Malignant neoplasm of breast
AUGMENTS,"BAG Family Molecular Chaperone Regulator 3, human",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide","BAG Family Molecular Chaperone Regulator 3, human Malignant neoplasm of breast"
AFFECTS,Mouse Model,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Mouse Model Breast Carcinoma
AFFECTS,cinnamic aldehyde,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",cinnamic aldehyde Malignant neoplasm of breast
PREDISPOSES,Thyroid microsomal antibodies,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Thyroid microsomal antibodies Malignant neoplasm of breast
PREDISPOSES,Increased risk,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",Increased risk Noninfiltrating Intraductal Carcinoma
PREDISPOSES,Coal,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Coal Malignant neoplasm of breast
AFFECTS,PCYT1A wt Allele,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",PCYT1A wt Allele Malignant neoplasm of breast
CAUSES,Beta-glucuronidase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Beta-glucuronidase Malignant neoplasm of breast
DISRUPTS,ruyiping,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",ruyiping Triple Negative Breast Neoplasms
PREDISPOSES,Multiparity,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Multiparity Malignant neoplasm of breast
PREDISPOSES,Glucocorticoids,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Neoplastic Process,Glucocorticoids Invasive carcinoma of breast
AFFECTS,MIR31 wt Allele,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",MIR31 wt Allele Malignant neoplasm of breast
PREDISPOSES,Breast Density,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Breast Density Triple Negative Breast Neoplasms
AUGMENTS,erbB-2 Receptor|ERBB2,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,"Element, Ion, or Isotope",erbB-2 Receptor|ERBB2 Inflammatory Breast Carcinoma
CAUSES,Progranulins,Carcinoma breast stage IV,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Progranulins Carcinoma breast stage IV
DISRUPTS,MIR34A,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",MIR34A Malignant neoplasm of breast
AFFECTS,Neoadjuvant Therapy,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,"Element, Ion, or Isotope",Neoadjuvant Therapy Noninfiltrating Intraductal Carcinoma
DISRUPTS,GABPA|NFE2L2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",GABPA|NFE2L2 Malignant neoplasm of breast
PREDISPOSES,cyclin-dependent kinase inhibitor 1B|IFI27|PSMD9|SSSCA1|DCTN6|TMED7,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",cyclin-dependent kinase inhibitor 1B|IFI27|PSMD9|SSSCA1|DCTN6|TMED7 Malignant neoplasm of breast
AFFECTS,PITPNM1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,PITPNM1 Malignant neoplasm of breast
AFFECTS,Cell Growth,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Biologically Active Substance,Cell Growth Breast Carcinoma
PREDISPOSES,MAL2,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,MAL2 Malignant neoplasm of breast
PREDISPOSES,T-Cell Receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",T-Cell Receptor Malignant neoplasm of breast
AFFECTS,ketamine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ketamine Malignant neoplasm of breast
AFFECTS,"Analgesics, Opioid",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,"Analgesics, Opioid Malignant neoplasm of breast"
AUGMENTS,"N-methylsulfonyl-12,12-dibromododec-11-enamide",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","N-methylsulfonyl-12,12-dibromododec-11-enamide Malignant neoplasm of breast"
PREDISPOSES,Dietary Polyphenol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Dietary Polyphenol Malignant neoplasm of breast
AFFECTS,Core needle biopsy,malignant neoplasm of breast staging,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Core needle biopsy malignant neoplasm of breast staging
DISRUPTS,CSTB wt Allele|CST6,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",CSTB wt Allele|CST6 Secondary malignant neoplasm of breast
CAUSES,Molecular Target,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Molecular Target Malignant neoplasm of breast
PREDISPOSES,Thioredoxin 1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Thioredoxin 1 Malignant neoplasm of breast
AFFECTS,quiescence,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,"Amino Acid, Peptide, or Protein",quiescence estrogen receptor-positive breast cancer
AFFECTS,chromosome loss,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Immunologic Factor,chromosome loss Triple Negative Breast Neoplasms
AFFECTS,decitabine,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",decitabine Triple Negative Breast Neoplasms
AFFECTS,docetaxel,Triple-Negative Breast Carcinoma,0.0,Female Breast Cancer,Neoplastic Process,docetaxel Triple-Negative Breast Carcinoma
PREDISPOSES,False Positive,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,"Element, Ion, or Isotope",False Positive Inflammatory Breast Carcinoma
AUGMENTS,chemokine receptor,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,chemokine receptor Malignant neoplasm of breast
CAUSES,cytidylyl-3'-5'-guanosine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,cytidylyl-3'-5'-guanosine Malignant neoplasm of breast
AFFECTS,curcumin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,curcumin Malignant neoplasm of breast
PREDISPOSES,Orosomucoid,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Orosomucoid Malignant neoplasm of breast
PREDISPOSES,Married (finding),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Married (finding) Malignant neoplasm of breast
PREDISPOSES,Androgen Receptor,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Pharmacologic Substance,Androgen Receptor estrogen receptor-positive breast cancer
AFFECTS,ESR1,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,"Element, Ion, or Isotope",ESR1 Secondary malignant neoplasm of breast
PREDISPOSES,Premature Menopause,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Premature Menopause Malignant neoplasm of breast
PREDISPOSES,Postmenopausal status NOS,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Postmenopausal status NOS Malignant neoplasm of breast
PREDISPOSES,Fatty pancreas,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Fatty pancreas Malignant neoplasm of breast
DISRUPTS,MIR451A wt Allele,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",MIR451A wt Allele Invasive carcinoma of breast
AFFECTS,Calcium Signaling,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Calcium Signaling Malignant neoplasm of breast
DISRUPTS,Sodium Butyrate,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Sodium Butyrate Malignant neoplasm of breast
PREDISPOSES,ethanol,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Neoplastic Process,ethanol Invasive carcinoma of breast
PREDISPOSES,Procedure findings:Finding:Point in time:^Patient:Narrative,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,"Element, Ion, or Isotope",Procedure findings:Finding:Point in time:^Patient:Narrative estrogen receptor-positive breast cancer
AUGMENTS,dehydrodolichyl diphosphate synthase,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",dehydrodolichyl diphosphate synthase Triple Negative Breast Neoplasms
CAUSES,Oxysterols,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Oxysterols Malignant neoplasm of breast
AFFECTS,sinomenine hydrochloride,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,sinomenine hydrochloride Malignant neoplasm of breast
PREDISPOSES,>40 years,Noninfiltrating Intraductal Carcinoma,0.0109890109890109,Female Breast Cancer,Neoplastic Process,>40 years Noninfiltrating Intraductal Carcinoma
AFFECTS,Cell Cycle Checkpoints,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Cell Cycle Checkpoints Triple Negative Breast Neoplasms
PREDISPOSES,Hypersensitivity,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Hypersensitivity Breast Carcinoma
AFFECTS,Warburg Effect,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Warburg Effect Malignant neoplasm of breast
AUGMENTS,Revival,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Revival Malignant neoplasm of breast
AFFECTS,fluid flow,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,fluid flow Malignant neoplasm of breast
AFFECTS,Segmental Mastectomy,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,"Element, Ion, or Isotope",Segmental Mastectomy Female Breast Carcinoma
AUGMENTS,Methylnitrosourea,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Methylnitrosourea Malignant neoplasm of breast
AUGMENTS,Discoidin Domain Receptor 1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Discoidin Domain Receptor 1 Malignant neoplasm of breast
AFFECTS,inecalcitol,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,inecalcitol Malignant neoplasm of breast
AFFECTS,specific immunity,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",specific immunity Triple Negative Breast Neoplasms
AFFECTS,Diagnosis,Carcinoma of Male Breast,0.0049950049950049,Male Breast Cancer,"Element, Ion, or Isotope",Diagnosis Carcinoma of Male Breast
CAUSES,Molecular Target,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Molecular Target Triple Negative Breast Neoplasms
AFFECTS,"Membrane Potential, Mitochondrial",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","Membrane Potential, Mitochondrial Malignant neoplasm of breast"
PREDISPOSES,asparagine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,asparagine Malignant neoplasm of breast
PREDISPOSES,Leisure physical activity,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Leisure physical activity Triple Negative Breast Neoplasms
DISRUPTS,margetuximab,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,margetuximab Malignant neoplasm of breast
PREDISPOSES,PROM1,Carcinoma breast stage IV,0.0,Female Breast Cancer,"Element, Ion, or Isotope",PROM1 Carcinoma breast stage IV
DISRUPTS,gamma-Glutamylcyclotransferase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",gamma-Glutamylcyclotransferase Malignant neoplasm of breast
PREDISPOSES,Adipokines,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Adipokines Triple Negative Breast Neoplasms
PREDISPOSES,ezogabine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,ezogabine Malignant neoplasm of breast
PREDISPOSES,VDR,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",VDR Malignant neoplasm of breast
AFFECTS,"Radiosurgery, Stereotactic",Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,Immunologic Factor,"Radiosurgery, Stereotactic Triple Negative Breast Neoplasms"
PREDISPOSES,Trichorhinophalangeal dysplasia type I,Carcinoma breast stage IV,0.0,Female Breast Cancer,Gene or Genome,Trichorhinophalangeal dysplasia type I Carcinoma breast stage IV
PREDISPOSES,Tandem Repeat Sequences,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Tandem Repeat Sequences Malignant neoplasm of breast
PREDISPOSES,Wild Type,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Wild Type Malignant neoplasm of breast
PREDISPOSES,Offered,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Offered Malignant neoplasm of breast
AFFECTS,Pesticides,Malignant neoplasm of female breast,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Pesticides Malignant neoplasm of female breast
PREDISPOSES,copper,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",copper Malignant neoplasm of breast
AFFECTS,navitoclax,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,"Amino Acid, Peptide, or Protein",navitoclax estrogen receptor-positive breast cancer
DISRUPTS,dihydrotanshinone I,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Neoplastic Process,dihydrotanshinone I Secondary malignant neoplasm of breast
AFFECTS,inhibitors,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Pharmacologic Substance,inhibitors estrogen receptor-positive breast cancer
AUGMENTS,pertuzumab,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,pertuzumab Malignant neoplasm of breast
PREDISPOSES,chromium,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,chromium Malignant neoplasm of breast
AFFECTS,sulfoenolpyruvate,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",sulfoenolpyruvate Triple Negative Breast Neoplasms
DISRUPTS,icariin,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",icariin Triple Negative Breast Neoplasms
CAUSES,Pyruvate Kinase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Pyruvate Kinase Malignant neoplasm of breast
PREDISPOSES,Dietary Intake,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,Virus,Dietary Intake estrogen receptor-positive breast cancer
PREDISPOSES,Performance,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Neoplastic Process,Performance Secondary malignant neoplasm of breast
CAUSES,Pyrimidine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Pyrimidine Malignant neoplasm of breast
PREDISPOSES,"Soluble Interleukin-6 Receptor Subunit Alpha, Human",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Chemical,"Soluble Interleukin-6 Receptor Subunit Alpha, Human Malignant neoplasm of breast"
AFFECTS,NAD+ kinase,Carcinoma breast stage IV,0.0,Female Breast Cancer,Gene or Genome,NAD+ kinase Carcinoma breast stage IV
AFFECTS,Fibronectins,Inflammatory Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Neoplastic Process,Fibronectins Inflammatory Breast Carcinoma
PREDISPOSES,Skin tanning,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Skin tanning Malignant neoplasm of breast
DISRUPTS,MYC,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,"Element, Ion, or Isotope",MYC Secondary malignant neoplasm of breast
PREDISPOSES,Experimental Result,Carcinoma breast stage IV,0.0,Female Breast Cancer,Gene or Genome,Experimental Result Carcinoma breast stage IV
AFFECTS,Diagnostic assessment,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Diagnostic assessment Malignant neoplasm of breast
AFFECTS,Puberty,estrogen receptor-positive breast cancer,0.0089910089910089,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Puberty estrogen receptor-positive breast cancer
PREDISPOSES,Oral health,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Oral health Malignant neoplasm of breast
AFFECTS,TNF receptor-associated factor 6|TRAF6,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",TNF receptor-associated factor 6|TRAF6 Malignant neoplasm of breast
AFFECTS,AKR1A1 wt Allele,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",AKR1A1 wt Allele Malignant neoplasm of breast
PREDISPOSES,CXCL8,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",CXCL8 Malignant neoplasm of breast
PREDISPOSES,ethanol,Female Breast Carcinoma,0.0049950049950049,Female Breast Cancer,"Element, Ion, or Isotope",ethanol Female Breast Carcinoma
AUGMENTS,Acetyl-CoA Carboxylase,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Acetyl-CoA Carboxylase Malignant neoplasm of breast
AFFECTS,Secretome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Secretome Malignant neoplasm of breast
PREDISPOSES,histone deacetylase 2,Invasive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Neoplastic Process,histone deacetylase 2 Invasive carcinoma of breast
PREDISPOSES,"interleukin-1, beta|IL1A|IL1B",Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope","interleukin-1, beta|IL1A|IL1B Malignant neoplasm of breast"
AFFECTS,abemaciclib,Carcinoma breast stage IV,0.0,Female Breast Cancer,"Element, Ion, or Isotope",abemaciclib Carcinoma breast stage IV
AUGMENTS,MAP kinase kinase kinase 7,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",MAP kinase kinase kinase 7 Triple Negative Breast Neoplasms
AFFECTS,Treatment Protocols,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Amino Acid, Peptide, or Protein",Treatment Protocols Triple Negative Breast Neoplasms
PREDISPOSES,cathepsin Z,Early-Stage Breast Carcinoma,0.0,Female Breast Cancer,Neoplastic Process,cathepsin Z Early-Stage Breast Carcinoma
PREDISPOSES,Basis,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Neoplastic Process,Basis Secondary malignant neoplasm of breast
AFFECTS,Ultrasonography,malignant neoplasm of breast staging,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Ultrasonography malignant neoplasm of breast staging
PREDISPOSES,Nicotinamide N-Methyltransferase,Carcinoma breast stage IV,0.0,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",Nicotinamide N-Methyltransferase Carcinoma breast stage IV
AUGMENTS,Biological Response Modifiers,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Biological Response Modifiers Triple Negative Breast Neoplasms
AFFECTS,garcinone E,Carcinoma breast stage IV,0.0,Female Breast Cancer,"Element, Ion, or Isotope",garcinone E Carcinoma breast stage IV
DISRUPTS,GW 4869,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",GW 4869 Triple Negative Breast Neoplasms
DISRUPTS,imipramine,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",imipramine Triple Negative Breast Neoplasms
PREDISPOSES,Abnormal,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Abnormal Malignant neoplasm of breast
CAUSES,interleukin-8,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,"Element, Ion, or Isotope",interleukin-8 Secondary malignant neoplasm of breast
CAUSES,TAF8 wt Allele,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",TAF8 wt Allele Malignant neoplasm of breast
AUGMENTS,Lactates,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Lactates Malignant neoplasm of breast
AFFECTS,metformin,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",metformin Triple Negative Breast Neoplasms
PREDISPOSES,Performance,Papillary carcinoma of the breast,0.0,Female Breast Cancer,"Element, Ion, or Isotope",Performance Papillary carcinoma of the breast
AFFECTS,Terpenes,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Terpenes Triple Negative Breast Neoplasms
AFFECTS,magnoflorine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,magnoflorine Malignant neoplasm of breast
AFFECTS,directive therapy,Carcinoma breast stage IV,0.0,Female Breast Cancer,Gene or Genome,directive therapy Carcinoma breast stage IV
PREDISPOSES,interleukin-10,HER2-negative breast cancer,0.0,Female Breast Cancer,"Element, Ion, or Isotope",interleukin-10 HER2-negative breast cancer
DISRUPTS,iridium,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,iridium Malignant neoplasm of breast
PREDISPOSES,Fresh fruit,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Fresh fruit Malignant neoplasm of breast
AFFECTS,Post-mastectomy radiotherapy,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,"Element, Ion, or Isotope",Post-mastectomy radiotherapy Breast Carcinoma
AUGMENTS,oxaliplatin,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,oxaliplatin Malignant neoplasm of breast
PREDISPOSES,Dried fruit intake,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Dried fruit intake Malignant neoplasm of breast
AFFECTS,Aptamer,Breast Carcinoma,0.0279720279720279,Female Breast Cancer,Neoplastic Process,Aptamer Breast Carcinoma
AFFECTS,Tobacco,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Tobacco Malignant neoplasm of breast
PREDISPOSES,Detected (finding),Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Detected (finding) Malignant neoplasm of breast
AUGMENTS,Liposomes,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Liposomes Triple Negative Breast Neoplasms
DISRUPTS,beta catenin,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",beta catenin Triple Negative Breast Neoplasms
AFFECTS,tomography,Early-Stage Breast Carcinoma,0.0,Female Breast Cancer,"Element, Ion, or Isotope",tomography Early-Stage Breast Carcinoma
CAUSES,ROS1 wt Allele|ROS1,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",ROS1 wt Allele|ROS1 Malignant neoplasm of breast
AFFECTS,Neoadjuvant Systemic Therapy,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Gene or Genome,Neoadjuvant Systemic Therapy Malignant neoplasm of breast
PREDISPOSES,Nuclear magnetic resonance normal,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Nuclear magnetic resonance normal Malignant neoplasm of breast
AFFECTS,reserpine,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",reserpine Triple Negative Breast Neoplasms
CAUSES,Cytokeratin,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Cytokeratin Triple Negative Breast Neoplasms
AFFECTS,scopolamine,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,scopolamine Malignant neoplasm of breast
CAUSES,CD8A wt Allele|CD8A,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Nucleic Acid, Nucleoside, or Nucleotide",CD8A wt Allele|CD8A Triple Negative Breast Neoplasms
AFFECTS,Saturated fat,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Saturated fat Malignant neoplasm of breast
CAUSES,Histone Deacetylase|HDAC9,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Histone Deacetylase|HDAC9 Malignant neoplasm of breast
AFFECTS,Scutellaria barbata extract,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Scutellaria barbata extract Triple Negative Breast Neoplasms
AFFECTS,Erianin,Triple Negative Breast Neoplasms,0.0189810189810189,Female Breast Cancer,"Element, Ion, or Isotope",Erianin Triple Negative Breast Neoplasms
PREDISPOSES,Total body fat,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Total body fat Malignant neoplasm of breast
CAUSES,Secretome,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Secretome Malignant neoplasm of breast
DISRUPTS,Triterpenes,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,Neoplastic Process,Triterpenes Malignant neoplasm of breast
CAUSES,Mammary Neoplasms,Secondary malignant neoplasm of breast,0.0029970029970029,Female Breast Cancer,Gene or Genome,Mammary Neoplasms Secondary malignant neoplasm of breast
PREDISPOSES,Histopathology finding,Malignant neoplasm of breast,0.3386613386613387,Female Breast Cancer,"Element, Ion, or Isotope",Histopathology finding Malignant neoplasm of breast
